Citrus Sinensis ID: 022241
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | 2.2.26 [Sep-21-2011] | |||||||
| Q5HZ38 | 407 | Serine/threonine-protein | yes | no | 0.933 | 0.687 | 0.645 | 1e-107 | |
| Q93V58 | 396 | Serine/threonine-protein | no | no | 0.936 | 0.709 | 0.618 | 1e-100 | |
| Q54WW7 | 695 | Probable serine/threonine | yes | no | 0.646 | 0.279 | 0.465 | 1e-41 | |
| P50526 | 652 | Serine/threonine-protein | yes | no | 0.653 | 0.300 | 0.436 | 1e-33 | |
| O88831 | 587 | Calcium/calmodulin-depend | yes | no | 0.59 | 0.301 | 0.381 | 1e-29 | |
| Q96RR4 | 588 | Calcium/calmodulin-depend | no | no | 0.59 | 0.301 | 0.381 | 1e-29 | |
| Q8C078 | 588 | Calcium/calmodulin-depend | yes | no | 0.59 | 0.301 | 0.381 | 1e-29 | |
| P38990 | 1142 | SNF1-activating kinase 1 | yes | no | 0.666 | 0.175 | 0.381 | 2e-27 | |
| Q8VBY2 | 505 | Calcium/calmodulin-depend | no | no | 0.656 | 0.390 | 0.371 | 7e-27 | |
| P97756 | 505 | Calcium/calmodulin-depend | no | no | 0.656 | 0.390 | 0.371 | 1e-26 |
| >sp|Q5HZ38|GRIK2_ARATH Serine/threonine-protein kinase GRIK2 OS=Arabidopsis thaliana GN=GRIK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 197/305 (64%), Positives = 234/305 (76%), Gaps = 25/305 (8%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
MFR + + R +GC CFG + + +Q+ +P DDD +S +
Sbjct: 1 MFRDSFLFARTIGCFGCFGSSGSRNQQSPKPY-------------------DDDTHSCDS 41
Query: 61 EATNTADGDGGE------MQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGT 114
+ T+TA G+ E ++ +KRSEEI + R NGLICR PV+E+N+LIR EDENG
Sbjct: 42 DVTSTARGEEEEDEEEVEQKSRSKRSEEILKYRLDNGLICRHIPVRETNELIRGEDENGD 101
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
K INEYV V KIG+GSYGKVVLYRS+LDG++YAIKAFHKSHL +LRVAPSETAM+DV RE
Sbjct: 102 KTINEYVRVCKIGSGSYGKVVLYRSTLDGQYYAIKAFHKSHLLRLRVAPSETAMSDVLRE 161
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
V+IMK+L+HPNIVNLIEVIDDP +DHFYMVLEYV+GKW DG G PGA+GE ARKYLRD
Sbjct: 162 VMIMKILEHPNIVNLIEVIDDPETDHFYMVLEYVDGKWVYDGSGPPGALGEKTARKYLRD 221
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
IV+GLMYLH H+V+HGDIKPDNLLV SGTVKIGDFSVSQVF+DD+D LRRSPGTPVFTA
Sbjct: 222 IVTGLMYLHAHDVIHGDIKPDNLLVTSSGTVKIGDFSVSQVFKDDDDQLRRSPGTPVFTA 281
Query: 295 PECCL 299
PECCL
Sbjct: 282 PECCL 286
|
Activates SnRK1.1/KIN10 and SnRK1.2/KIN11 by phosphorylation of their activation-loop 'Thr-198' and 'Thr-176', respectively. Required for the regulation by SnRK1 kinases of the transcription of a large set of genes, the modification the activity of metabolic enzymes, and the control of various nutrient-responsive cellular developmental processes. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q93V58|GRIK1_ARATH Serine/threonine-protein kinase GRIK1 OS=Arabidopsis thaliana GN=GRIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 190/307 (61%), Positives = 223/307 (72%), Gaps = 26/307 (8%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
MF + ++ + M C CFG + R + + P DDD + +G
Sbjct: 1 MFCDSFAFAQVMSCFGCFGGSERS-RHSPNPY------------------DDDTYSHDSG 41
Query: 61 EATNTADGDGGEMQ-------NHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENG 113
E +N D + + +KRSEEI + + NGL+CRQFPVKE+NKL R EDE+G
Sbjct: 42 ETSNPGGDDEEGEEEEEVEELSRSKRSEEILKCKLQNGLVCRQFPVKETNKLTRGEDEDG 101
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
K INE+V RKIG+GSYGKVVLYRS++D KHYAIKAFHKSHLS+LRVAPSETAM DV R
Sbjct: 102 NKTINEFVRERKIGSGSYGKVVLYRSTVDDKHYAIKAFHKSHLSRLRVAPSETAMGDVLR 161
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
EV+IMK L+HPNIVNLIEVIDDP D FYMVLEYV+GKW D G PGA+GE ARKYLR
Sbjct: 162 EVMIMKTLEHPNIVNLIEVIDDPEFDDFYMVLEYVDGKWAYDDSGPPGALGEITARKYLR 221
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
D+V+GLMYLH HNV+HGDIKPDNLLV +G VKIGDFSVSQVF+DD+D LRRSPGTPVFT
Sbjct: 222 DVVAGLMYLHAHNVIHGDIKPDNLLVTSTGRVKIGDFSVSQVFKDDDDQLRRSPGTPVFT 281
Query: 294 APECCLG 300
APECCLG
Sbjct: 282 APECCLG 288
|
Activates SnRK1.1/KIN10 and SnRK1.2/KIN11 by phosphorylation of their activation-loop 'Thr-198' and 'Thr-176', respectively. Required for the regulation by SnRK1 kinases of the transcription of a large set of genes, the modification the activity of metabolic enzymes, and the control of various nutrient-responsive cellular developmental processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54WW7|Y0010_DICDI Probable serine/threonine-protein kinase DDB_G0279405 OS=Dictyostelium discoideum GN=DDB_G0279405 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 93/200 (46%), Positives = 122/200 (61%), Gaps = 6/200 (3%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
KE+ + + ++G KM+NEYV VRK+G G++GKV L YAIK F+K L K
Sbjct: 181 KETLRAHKKRHKDGHKMVNEYVFVRKLGKGTFGKVKLAYHHDTHHLYAIKIFNKIRLKKQ 240
Query: 160 RVAPSE-TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG 218
+ A DV +E+ IMK + H N+V L EVI+DP ++ Y+V+EY+EG
Sbjct: 241 TMGIGRPNAFDDVLKEIAIMKKMNHINVVKLYEVINDPQEEYIYIVMEYIEG----GSIM 296
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
E +ARKY RDIV GL YLH V+H D+KP+NLLV G VKI DF VS +F+D
Sbjct: 297 SANETSEDLARKYFRDIVFGLEYLHEQKVIHKDLKPENLLVNSEGVVKITDFGVSHIFDD 356
Query: 279 DNDVLRRSPGTPVFTAPECC 298
D DV+R S G+P F APE C
Sbjct: 357 D-DVVRCSRGSPAFLAPELC 375
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P50526|SSP1_SCHPO Serine/threonine-protein kinase ssp1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ssp1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (361), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 92/211 (43%), Positives = 123/211 (58%), Gaps = 15/211 (7%)
Query: 99 VKESNKLIRSEDE-NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL- 156
VKE+ K+ + D +G K IN Y ++++G G +GKV L R ++ + AIK K+
Sbjct: 113 VKETKKIRKRFDRFSGRKYINHYEIIKELGRGMHGKVKLGRDTVTRELLAIKIIPKTERR 172
Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KW- 212
KL A + + VRRE+ I+K HPN+V L EVIDDP+S Y+VLEY+ G W
Sbjct: 173 PKLGRANASSQKEKVRREIAILKKCVHPNVVRLREVIDDPSSTKVYLVLEYMSGGEVPWT 232
Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
D D + S AR+Y RD+V GL YLH ++H DIKP NLL+ S VKI DF V
Sbjct: 233 DCDS----PVLSISEARQYFRDVVLGLEYLHYQGIIHRDIKPANLLLNSSNCVKISDFGV 288
Query: 273 SQV----FEDDNDV-LRRSPGTPVFTAPECC 298
S + +DNDV L ++ GTP F APE C
Sbjct: 289 SYIANAGLNEDNDVELAKTVGTPAFFAPELC 319
|
Involved in actin localization and thus in polarized cell growth. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus GN=Camkk2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 130 bits (327), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/199 (38%), Positives = 105/199 (52%), Gaps = 22/199 (11%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
+N+Y +IG GSYG V L + D +YA+K K L +
Sbjct: 161 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 220
Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
+ P + V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G
Sbjct: 221 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 279
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
+P + E AR Y +D++ G+ YLH ++H DIKP NLLV G +KI DF VS F+
Sbjct: 280 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 337
Query: 278 DDNDVLRRSPGTPVFTAPE 296
+ +L + GTP F APE
Sbjct: 338 GSDALLSNTVGTPAFMAPE 356
|
Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1 and CAMK4. Phosphorylates CAMK1D (By similarity). Seems to be involved in hippocampal activation of CREB1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q96RR4|KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 130 bits (327), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/199 (38%), Positives = 105/199 (52%), Gaps = 22/199 (11%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
+N+Y +IG GSYG V L + D +YA+K K L +
Sbjct: 162 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 221
Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
+ P + V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G
Sbjct: 222 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 280
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
+P + E AR Y +D++ G+ YLH ++H DIKP NLLV G +KI DF VS F+
Sbjct: 281 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 338
Query: 278 DDNDVLRRSPGTPVFTAPE 296
+ +L + GTP F APE
Sbjct: 339 GSDALLSNTVGTPAFMAPE 357
|
Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. Seems to be involved in hippocampal activation of CREB1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q8C078|KKCC2_MOUSE Calcium/calmodulin-dependent protein kinase kinase 2 OS=Mus musculus GN=Camkk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 130 bits (326), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/199 (38%), Positives = 105/199 (52%), Gaps = 22/199 (11%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
+N+Y +IG GSYG V L + D +YA+K K L +
Sbjct: 162 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGARPAPG 221
Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
+ P + V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G
Sbjct: 222 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 280
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
+P + E AR Y +D++ G+ YLH ++H DIKP NLLV G +KI DF VS F+
Sbjct: 281 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 338
Query: 278 DDNDVLRRSPGTPVFTAPE 296
+ +L + GTP F APE
Sbjct: 339 GSDALLSNTVGTPAFMAPE 357
|
Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK4 and CAMK1D (By similarity). Seems to be involved in hippocampal activation of CREB1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|P38990|SAK1_YEAST SNF1-activating kinase 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SAK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 123 bits (308), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 87/228 (38%), Positives = 122/228 (53%), Gaps = 28/228 (12%)
Query: 99 VKESNKLIRSEDE-NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
VKE+N++ + D + K++N Y ++++G G +GKV L R L + AIK + H
Sbjct: 111 VKETNRISLTYDPVSKRKVLNTYEIIKELGHGQHGKVKLARDILSKQLVAIKIVDR-HEK 169
Query: 158 KLR-----VAPSETAMTD-VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV--- 208
K R + S+ + D ++RE+ IMK H ++V LIEV+DD S Y+VLEY
Sbjct: 170 KQRKFFTFIKSSKISENDKIKREIAIMKKCHHKHVVQLIEVLDDLKSRKIYLVLEYCSRG 229
Query: 209 EGKW------DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS 262
E KW ++D G P + R+ LR +V GL YLH ++H DIKP NLL++
Sbjct: 230 EVKWCPPDCMESDAKG-PSLLSFQETREILRGVVLGLEYLHYQGIIHRDIKPANLLISGD 288
Query: 263 GTVKIGDFSVS----------QVFEDDNDVLRRSPGTPVFTAPECCLG 300
GTVKI DF VS D L ++ GTP F APE CLG
Sbjct: 289 GTVKISDFGVSLAASSTNSSDSSESLDELELAKTVGTPAFFAPEMCLG 336
|
Serine/threonine-protein kinase that phosphorylates SNF1, the catalytic subunit of the SNF1 kinase complex. Acts as an activator of the SNF1 kinase complex and controls its nuclear localization upon glucose and nitrogen depletion. Also required for SNF1 kinase activation under other stress conditions like alkaline pH or presence of cadmium. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VBY2|KKCC1_MOUSE Calcium/calmodulin-dependent protein kinase kinase 1 OS=Mus musculus GN=Camkk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 81/218 (37%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHK---- 153
P ES+++ S+ E+ ++ N+Y +IG G+YG V L + + +HYA+K K
Sbjct: 107 PTIESHRVAISDTEDCVQL-NQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLL 165
Query: 154 -------------SHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
S ++ A + V +E+ I+K L H N+V LIEV+DDP D+
Sbjct: 166 KQYGFPRRPPPRGSQATQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 225
Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
Y+V + + +G +P E AR YLRDI+ GL YLH +VH DIKP NLL+
Sbjct: 226 LYLVFDLLRKGPVMEVPCDKP--FPEEQARLYLRDIILGLEYLHCQKIVHRDIKPSNLLL 283
Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
G VKI DF VS FE ++ L + GTP F APE
Sbjct: 284 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEA 321
|
Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|P97756|KKCC1_RAT Calcium/calmodulin-dependent protein kinase kinase 1 OS=Rattus norvegicus GN=Camkk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (301), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 81/218 (37%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK-------- 149
P ES+ + S+ E+ ++ N+Y +IG G+YG V L + + +HYA+K
Sbjct: 107 PTIESHHVAISDTEDCVQL-NQYKLQSEIGKGAYGVVRLAYNEREDRHYAMKVLSKKKLL 165
Query: 150 ---AFHKSHLSKLRVAPSE------TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
F + + AP + V +E+ I+K L H N+V LIEV+DDP D+
Sbjct: 166 KQYGFPRRPPPRGSQAPQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 225
Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
Y+V + + +G +P E AR YLRDI+ GL YLH +VH DIKP NLL+
Sbjct: 226 LYLVFDLLRKGPVMEVPCDKP--FPEEQARLYLRDIILGLEYLHCQKIVHRDIKPSNLLL 283
Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
G VKI DF VS FE ++ L + GTP F APE
Sbjct: 284 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEA 321
|
Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | ||||||
| 255578876 | 423 | calcium/calmodulin-dependent protein kin | 0.993 | 0.704 | 0.766 | 1e-122 | |
| 225435291 | 414 | PREDICTED: probable serine/threonine-pro | 0.993 | 0.719 | 0.731 | 1e-121 | |
| 449455998 | 426 | PREDICTED: probable serine/threonine-pro | 0.99 | 0.697 | 0.703 | 1e-119 | |
| 449502498 | 416 | PREDICTED: probable serine/threonine-pro | 0.953 | 0.687 | 0.719 | 1e-117 | |
| 147860766 | 411 | hypothetical protein VITISV_016074 [Viti | 0.956 | 0.698 | 0.712 | 1e-116 | |
| 224106748 | 435 | predicted protein [Populus trichocarpa] | 0.996 | 0.687 | 0.710 | 1e-114 | |
| 357453881 | 341 | Calcium/calmodulin-dependent protein kin | 0.98 | 0.862 | 0.667 | 1e-108 | |
| 356543468 | 409 | PREDICTED: probable serine/threonine-pro | 0.97 | 0.711 | 0.675 | 1e-108 | |
| 357453879 | 404 | Calcium/calmodulin-dependent protein kin | 0.98 | 0.727 | 0.667 | 1e-108 | |
| 297793609 | 407 | hypothetical protein ARALYDRAFT_919290 [ | 0.933 | 0.687 | 0.652 | 1e-106 |
| >gi|255578876|ref|XP_002530292.1| calcium/calmodulin-dependent protein kinase kinase, putative [Ricinus communis] gi|223530190|gb|EEF32099.1| calcium/calmodulin-dependent protein kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1142), Expect = e-122, Method: Compositional matrix adjust.
Identities = 230/300 (76%), Positives = 252/300 (84%), Gaps = 2/300 (0%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
M+RK+ S R MGCCSCFGF+ KPK+ RP+TG NY +S++ LL D+ +D+DD SYNG
Sbjct: 1 MYRKSYSIARAMGCCSCFGFSW-KPKRQSRPVTGRNYNLSQELLL-DEEIEDEDDGSYNG 58
Query: 61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
+ T+T D GE+ N KRSEEI R RE NG+ICRQFPVKE+ LIRSEDENG KMINEY
Sbjct: 59 DITDTTYEDDGELPNRVKRSEEILRFREQNGMICRQFPVKETQILIRSEDENGNKMINEY 118
Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL KLRVAPSETAM+DV REVLIMKM
Sbjct: 119 VRECKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLLKLRVAPSETAMSDVLREVLIMKM 178
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
L HPNIVNLIEVIDDPN+DHFYMVLEYV+GKW +G G PG I E ARKYLRDIV+GLM
Sbjct: 179 LDHPNIVNLIEVIDDPNTDHFYMVLEYVDGKWVWEGSGPPGGIEEITARKYLRDIVAGLM 238
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
YLH HN+VHGDIKPDNLLV SG VKIGDFSVSQVFEDDND LRRSPGTPVFTAPECCLG
Sbjct: 239 YLHAHNIVHGDIKPDNLLVTRSGRVKIGDFSVSQVFEDDNDELRRSPGTPVFTAPECCLG 298
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435291|ref|XP_002282279.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1134), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/302 (73%), Positives = 248/302 (82%), Gaps = 4/302 (1%)
Query: 1 MFRKTCSWIR--DMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSY 58
MF K S R +MGCC CFGF R KP+ RP +G +S++FLL +DI++ DD SY
Sbjct: 1 MFSKDYSIARVTEMGCCGCFGFVR-KPESLSRPGSGSTNCLSQEFLLEEDIEEVDD-RSY 58
Query: 59 NGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMIN 118
NGE ++TA GD GE+Q+ +RSEEI R NG+ICR+FPVKE++KLIRSEDENG K IN
Sbjct: 59 NGEVSDTAHGDDGELQSRVQRSEEILMLRTQNGMICREFPVKETHKLIRSEDENGNKTIN 118
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
EYV KIG+GSYGKVVLYRS DG HYAIKAFHKSHL KLRVAPSETAMTDV REVLIM
Sbjct: 119 EYVREYKIGSGSYGKVVLYRSLKDGNHYAIKAFHKSHLLKLRVAPSETAMTDVLREVLIM 178
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
KML HPNIVNLIEVIDDP++DHFYMVLE+VEGKW +G G PG IGE+ ARKYLRDIVSG
Sbjct: 179 KMLNHPNIVNLIEVIDDPSTDHFYMVLEFVEGKWVCEGSGPPGGIGENTARKYLRDIVSG 238
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
L+YLH HN+VHGDIKPDNLLV +GTVKI DFSVSQVFEDDND LRRSPGTPVFTAPECC
Sbjct: 239 LIYLHAHNIVHGDIKPDNLLVTRTGTVKIADFSVSQVFEDDNDELRRSPGTPVFTAPECC 298
Query: 299 LG 300
LG
Sbjct: 299 LG 300
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455998|ref|XP_004145737.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1114), Expect = e-119, Method: Compositional matrix adjust.
Identities = 211/300 (70%), Positives = 248/300 (82%), Gaps = 3/300 (1%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
M++K+ S + MGCC CFGFT+ KPK+ LRP +G N R+S DFLLG+D++D++ +S N
Sbjct: 1 MYKKSFSISKMMGCCGCFGFTK-KPKRVLRPASGFN-RLSEDFLLGEDMEDEESCSS-ND 57
Query: 61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
+ T+ + E + K SEEI + R NGLICRQFPVKE+N++IRSEDENG KM+NEY
Sbjct: 58 DMTSPTHEEETESHSRVKNSEEILQHRTQNGLICRQFPVKETNRVIRSEDENGNKMVNEY 117
Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V KIGAGSYGKVVLYRS +DGK+YAIKAFHKSHLSKLRVAPSETAMTDV REVLIMKM
Sbjct: 118 VREYKIGAGSYGKVVLYRSRMDGKYYAIKAFHKSHLSKLRVAPSETAMTDVLREVLIMKM 177
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
L+HPNIVNL+EVIDDP D FYMVLEYVEGKW +G+ P + E++ARKYLRDIVSGL+
Sbjct: 178 LEHPNIVNLVEVIDDPEDDRFYMVLEYVEGKWACEGYDPPRGLDENIARKYLRDIVSGLI 237
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
YLH HN+VHGDIKPDNLL+ GT+KIGDFSVSQVFED+ND LRRSPGTPVFTAPECCLG
Sbjct: 238 YLHDHNIVHGDIKPDNLLITLDGTIKIGDFSVSQVFEDENDELRRSPGTPVFTAPECCLG 297
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449502498|ref|XP_004161657.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 208/289 (71%), Positives = 241/289 (83%), Gaps = 3/289 (1%)
Query: 12 MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGG 71
MGCC CFGFT+ KPK+ LRP +G N R+S DFLLG+D++D++ +S N + T+ +
Sbjct: 2 MGCCGCFGFTK-KPKRVLRPASGFN-RLSEDFLLGEDMEDEESCSS-NDDMTSPTHEEET 58
Query: 72 EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
E + K SEEI + R NGLICRQFPVKE+N++IRSEDENG KM+NEYV KIGAGSY
Sbjct: 59 ESHSRVKNSEEILQHRTQNGLICRQFPVKETNRVIRSEDENGNKMVNEYVREYKIGAGSY 118
Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191
GKVVLYRS +DGK+YAIKAFHKSHLSKLRVAPSETAMTDV REVLIMKML+HPNIVNL+E
Sbjct: 119 GKVVLYRSRMDGKYYAIKAFHKSHLSKLRVAPSETAMTDVLREVLIMKMLEHPNIVNLVE 178
Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
VIDDP D FYMVLEYVEGKW +G+ P + E++ARKYLRDIVSGL+YLH HN+VHGD
Sbjct: 179 VIDDPEDDRFYMVLEYVEGKWACEGYDPPRGLDENIARKYLRDIVSGLIYLHDHNIVHGD 238
Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
IKPDNLL+ GT+KIGDFSVSQVFED+ND LRRSPGTPVFTAPECCLG
Sbjct: 239 IKPDNLLITLDGTIKIGDFSVSQVFEDENDELRRSPGTPVFTAPECCLG 287
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147860766|emb|CAN82578.1| hypothetical protein VITISV_016074 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 213/299 (71%), Positives = 240/299 (80%), Gaps = 12/299 (4%)
Query: 12 MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGG 71
MGCC CFGF R KP+ RP +G +S++FLL +DI++ DD SYNGE ++TA GD G
Sbjct: 1 MGCCGCFGFVR-KPESLSRPGSGSTNCLSQEFLLEEDIEEVDD-RSYNGEVSDTAHGDDG 58
Query: 72 EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
E+Q+ +RSEEI R NG+ICR+FPVKE++KLIRSEDENG K INEYV KIG+GSY
Sbjct: 59 ELQSRVQRSEEILMLRTQNGMICREFPVKETHKLIRSEDENGNKTINEYVREYKIGSGSY 118
Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191
GKVVLYRS DG HYAIKAFHKSHL KLRVAPSETAMTDV REVLIMKML HPNIVNLIE
Sbjct: 119 GKVVLYRSLKDGNHYAIKAFHKSHLLKLRVAPSETAMTDVLREVLIMKMLNHPNIVNLIE 178
Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
VIDDP++DHFYMVLE+VEGKW +G G PG IGE+ ARKYLRDIVSGL+YLH HN+VHGD
Sbjct: 179 VIDDPSTDHFYMVLEFVEGKWVCEGSGPPGGIGENTARKYLRDIVSGLIYLHAHNIVHGD 238
Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVF----------EDDNDVLRRSPGTPVFTAPECCLG 300
IKPDNLLV +GTVKI DFSVSQ +DDND LRRSPGTPVFTAPECCLG
Sbjct: 239 IKPDNLLVTRTGTVKIADFSVSQSLVIQDVTCIDIKDDNDELRRSPGTPVFTAPECCLG 297
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106748|ref|XP_002314272.1| predicted protein [Populus trichocarpa] gi|222850680|gb|EEE88227.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1072), Expect = e-114, Method: Compositional matrix adjust.
Identities = 221/311 (71%), Positives = 247/311 (79%), Gaps = 12/311 (3%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPIT--GLNYR-------ISRDFLLGDDIDD 51
M K+ S+ R MGCCSCFGF R KPK+ PI+ G NY +S++ LL +IDD
Sbjct: 1 MIHKSYSFARAMGCCSCFGFLR-KPKRRPVPISSGGRNYHHHNNNNHLSQELLLDSEIDD 59
Query: 52 DDDDN--SYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSE 109
D ++ S+NG+ T T+ D E+ N AKRSEE R RELNGL+CR+ PVKE++ L+RSE
Sbjct: 60 DGGEDDGSFNGDITGTSYCDYAELPNRAKRSEENLRLRELNGLVCRKSPVKETHLLVRSE 119
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
DE+G KMINEYV KIGAGSYGKVVLY+SS+DG AIKAFHKSHL KLRVAPSETAMT
Sbjct: 120 DEDGNKMINEYVRQYKIGAGSYGKVVLYQSSIDGNLCAIKAFHKSHLLKLRVAPSETAMT 179
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
DV REV IMKML HPNIVNLIEVIDDPN+DHFYMVLEYV+GKW +G G PG IGE AR
Sbjct: 180 DVLREVQIMKMLDHPNIVNLIEVIDDPNTDHFYMVLEYVDGKWVWEGSGPPGGIGEDTAR 239
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
KYLRDIVSGLMYLH HN+VHGDIKPDNLLV SGTVKIGDFSVSQV EDDND LRRSPGT
Sbjct: 240 KYLRDIVSGLMYLHAHNIVHGDIKPDNLLVTRSGTVKIGDFSVSQVVEDDNDELRRSPGT 299
Query: 290 PVFTAPECCLG 300
PVFTAPECCLG
Sbjct: 300 PVFTAPECCLG 310
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357453881|ref|XP_003597221.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula] gi|355486269|gb|AES67472.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 199/298 (66%), Positives = 235/298 (78%), Gaps = 4/298 (1%)
Query: 4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEAT 63
++ S+ + +GC SCFG +++P++ R G+ +S+ L D + + D+ SY+G+ T
Sbjct: 5 RSFSFTKMIGCWSCFGLIKKQPRRG-RTKRGIKNFLSQGLL--TDGETEYDEVSYSGDYT 61
Query: 64 -NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVH 122
NT GD E QN RSEEI R NG+ICR FPVKE+ KL+RSEDENG KM+NEY+
Sbjct: 62 SNTTSGDDSEPQNLRNRSEEILNFRAENGMICRPFPVKETVKLVRSEDENGNKMLNEYIR 121
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
KIG+GSYGKV LY+SS+DG+HYAIK+FHKSHL KLRVAPSETAMTDV REVLIMKML+
Sbjct: 122 EYKIGSGSYGKVALYQSSIDGQHYAIKSFHKSHLRKLRVAPSETAMTDVLREVLIMKMLE 181
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
HPNIVNLIEVIDDP SD FYMVLEYVEGKW +G G+ AIGE ARKY+RDIVSGL YL
Sbjct: 182 HPNIVNLIEVIDDPESDDFYMVLEYVEGKWVCEGSGRQCAIGEETARKYMRDIVSGLTYL 241
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H HN+VHGDIKPDNLL+ +GTVKIGDFSVSQ FE+ ND LRRSPGTPVFTAPECCLG
Sbjct: 242 HAHNIVHGDIKPDNLLITRNGTVKIGDFSVSQAFENGNDELRRSPGTPVFTAPECCLG 299
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543468|ref|XP_003540182.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 202/299 (67%), Positives = 233/299 (77%), Gaps = 8/299 (2%)
Query: 4 KTCSWIRDMGCCSCFGFTRR-KPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEA 62
K+ S+ + MGCC CFGF ++ +P++A R I+ L +S+ LL + + ++ +Y+G+
Sbjct: 5 KSFSFSKMMGCCGCFGFVQKPRPRRAKRSISNL---LSQGLLLDGETEGEE---TYSGDV 58
Query: 63 T-NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYV 121
T N GD E+Q RSE+I R NG++CR FPVKE+ KL RSEDENG KMINEYV
Sbjct: 59 TSNCTSGDDNEVQAVRNRSEDILNFRAENGMVCRPFPVKETCKLDRSEDENGNKMINEYV 118
Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
KIG GSYGKV LYRSS+DGKHYAIK+FHKSHL KLRVAPSETAMTDV REVLIMKM+
Sbjct: 119 REYKIGCGSYGKVALYRSSVDGKHYAIKSFHKSHLQKLRVAPSETAMTDVLREVLIMKMV 178
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
+HPNIVNLIEVIDDP SD FYMVLEYVE KW +G G P A+GE ARKYLRDIVSGL Y
Sbjct: 179 EHPNIVNLIEVIDDPESDDFYMVLEYVESKWVCEGTGHPCALGEETARKYLRDIVSGLTY 238
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
LH HN+VHGDIKPDNLL+ GTVKIGDFSVSQ FED ND LRRSPGTPVFTAPECCLG
Sbjct: 239 LHAHNIVHGDIKPDNLLITRHGTVKIGDFSVSQAFEDGNDELRRSPGTPVFTAPECCLG 297
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357453879|ref|XP_003597220.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula] gi|355486268|gb|AES67471.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 199/298 (66%), Positives = 235/298 (78%), Gaps = 4/298 (1%)
Query: 4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEAT 63
++ S+ + +GC SCFG +++P++ R G+ +S+ L D + + D+ SY+G+ T
Sbjct: 5 RSFSFTKMIGCWSCFGLIKKQPRRG-RTKRGIKNFLSQGLLT--DGETEYDEVSYSGDYT 61
Query: 64 -NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVH 122
NT GD E QN RSEEI R NG+ICR FPVKE+ KL+RSEDENG KM+NEY+
Sbjct: 62 SNTTSGDDSEPQNLRNRSEEILNFRAENGMICRPFPVKETVKLVRSEDENGNKMLNEYIR 121
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
KIG+GSYGKV LY+SS+DG+HYAIK+FHKSHL KLRVAPSETAMTDV REVLIMKML+
Sbjct: 122 EYKIGSGSYGKVALYQSSIDGQHYAIKSFHKSHLRKLRVAPSETAMTDVLREVLIMKMLE 181
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
HPNIVNLIEVIDDP SD FYMVLEYVEGKW +G G+ AIGE ARKY+RDIVSGL YL
Sbjct: 182 HPNIVNLIEVIDDPESDDFYMVLEYVEGKWVCEGSGRQCAIGEETARKYMRDIVSGLTYL 241
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H HN+VHGDIKPDNLL+ +GTVKIGDFSVSQ FE+ ND LRRSPGTPVFTAPECCLG
Sbjct: 242 HAHNIVHGDIKPDNLLITRNGTVKIGDFSVSQAFENGNDELRRSPGTPVFTAPECCLG 299
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793609|ref|XP_002864689.1| hypothetical protein ARALYDRAFT_919290 [Arabidopsis lyrata subsp. lyrata] gi|297310524|gb|EFH40948.1| hypothetical protein ARALYDRAFT_919290 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1005), Expect = e-106, Method: Compositional matrix adjust.
Identities = 199/305 (65%), Positives = 232/305 (76%), Gaps = 25/305 (8%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
MFR + + R MGC CFG + + +Q +P DDD S +
Sbjct: 1 MFRDSILFARTMGCFGCFGTSGGRTRQPPKPY-------------------DDDTYSCDS 41
Query: 61 EATNTADGDGGE------MQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGT 114
+ T+TA G+ E ++ +KRSEEI + R NGLICR PV+E+N+LIR EDENG
Sbjct: 42 DVTSTARGEEEEDEEEVEQKSRSKRSEEILKYRLDNGLICRHIPVRETNELIRGEDENGD 101
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
K INEYV V KIGAGSYGKVVLYRS+LDG++YAIKAFHKSHL +LRVAPSETAM+DV RE
Sbjct: 102 KTINEYVRVCKIGAGSYGKVVLYRSTLDGQYYAIKAFHKSHLLRLRVAPSETAMSDVLRE 161
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
V+IMK+L+HPNIVNLIEVIDDP +DHFYMVLEYV+GKW DG G PGA+GE ARKYLRD
Sbjct: 162 VMIMKILEHPNIVNLIEVIDDPETDHFYMVLEYVDGKWVYDGSGPPGALGEKTARKYLRD 221
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
IV+GLMYLH H+V+HGDIKPDNLLV SGTVKIGDFSVSQVF+DD+D LRRSPGTPVFTA
Sbjct: 222 IVTGLMYLHAHDVIHGDIKPDNLLVTSSGTVKIGDFSVSQVFKDDDDQLRRSPGTPVFTA 281
Query: 295 PECCL 299
PECCL
Sbjct: 282 PECCL 286
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | ||||||
| TAIR|locus:2175113 | 407 | GRIK2 "geminivirus rep interac | 0.953 | 0.702 | 0.645 | 7.4e-98 | |
| TAIR|locus:2096930 | 396 | GRIK1 "geminivirus rep interac | 0.96 | 0.727 | 0.626 | 7.8e-94 | |
| DICTYBASE|DDB_G0279405 | 695 | DDB_G0279405 "Meta subfamily p | 0.64 | 0.276 | 0.475 | 4e-41 | |
| POMBASE|SPCC297.03 | 652 | ssp1 "serine/threonine protein | 0.653 | 0.300 | 0.440 | 2.7e-34 | |
| UNIPROTKB|G4N7H1 | 651 | MGG_06421 "CAMKK/META protein | 0.486 | 0.224 | 0.429 | 5.2e-34 | |
| ZFIN|ZDB-GENE-080722-13 | 484 | zgc:194737 "zgc:194737" [Danio | 0.413 | 0.256 | 0.464 | 1.4e-30 | |
| UNIPROTKB|F1RNP6 | 579 | CAMKK2 "Uncharacterized protei | 0.656 | 0.340 | 0.373 | 8.7e-30 | |
| UNIPROTKB|E2R3S0 | 578 | CAMKK2 "Uncharacterized protei | 0.593 | 0.307 | 0.393 | 1.1e-29 | |
| UNIPROTKB|F1NKZ8 | 506 | CAMKK1 "Uncharacterized protei | 0.653 | 0.387 | 0.400 | 1.4e-29 | |
| ZFIN|ZDB-GENE-050327-62 | 481 | camkk1 "calcium/calmodulin-dep | 0.683 | 0.426 | 0.382 | 1.8e-29 |
| TAIR|locus:2175113 GRIK2 "geminivirus rep interacting kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 193/299 (64%), Positives = 229/299 (76%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNG 60
MFR + + R +GC CFG + + +Q+ +P + D ++ G
Sbjct: 1 MFRDSFLFARTIGCFGCFGSSGSRNQQSPKPYDDDTHSCDSDV-----------TSTARG 49
Query: 61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
E D + E ++ +KRSEEI + R NGLICR PV+E+N+LIR EDENG K INEY
Sbjct: 50 EEEE--DEEEVEQKSRSKRSEEILKYRLDNGLICRHIPVRETNELIRGEDENGDKTINEY 107
Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V V KIG+GSYGKVVLYRS+LDG++YAIKAFHKSHL +LRVAPSETAM+DV REV+IMK+
Sbjct: 108 VRVCKIGSGSYGKVVLYRSTLDGQYYAIKAFHKSHLLRLRVAPSETAMSDVLREVMIMKI 167
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
L+HPNIVNLIEVIDDP +DHFYMVLEYV+GKW DG G PGA+GE ARKYLRDIV+GLM
Sbjct: 168 LEHPNIVNLIEVIDDPETDHFYMVLEYVDGKWVYDGSGPPGALGEKTARKYLRDIVTGLM 227
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
YLH H+V+HGDIKPDNLLV SGTVKIGDFSVSQVF+DD+D LRRSPGTPVFTAPECCL
Sbjct: 228 YLHAHDVIHGDIKPDNLLVTSSGTVKIGDFSVSQVFKDDDDQLRRSPGTPVFTAPECCL 286
|
|
| TAIR|locus:2096930 GRIK1 "geminivirus rep interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
Identities = 188/300 (62%), Positives = 222/300 (74%)
Query: 1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNG 60
MF + ++ + M C CFG + R + + P Y S D ++ G
Sbjct: 1 MFCDSFAFAQVMSCFGCFGGSERS-RHSPNPYDDDTY--SHD---------SGETSNPGG 48
Query: 61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
+ + + E + +KRSEEI + + NGL+CRQFPVKE+NKL R EDE+G K INE+
Sbjct: 49 DDEEGEEEEEVEELSRSKRSEEILKCKLQNGLVCRQFPVKETNKLTRGEDEDGNKTINEF 108
Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V RKIG+GSYGKVVLYRS++D KHYAIKAFHKSHLS+LRVAPSETAM DV REV+IMK
Sbjct: 109 VRERKIGSGSYGKVVLYRSTVDDKHYAIKAFHKSHLSRLRVAPSETAMGDVLREVMIMKT 168
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
L+HPNIVNLIEVIDDP D FYMVLEYV+GKW D G PGA+GE ARKYLRD+V+GLM
Sbjct: 169 LEHPNIVNLIEVIDDPEFDDFYMVLEYVDGKWAYDDSGPPGALGEITARKYLRDVVAGLM 228
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
YLH HNV+HGDIKPDNLLV +G VKIGDFSVSQVF+DD+D LRRSPGTPVFTAPECCLG
Sbjct: 229 YLHAHNVIHGDIKPDNLLVTSTGRVKIGDFSVSQVFKDDDDQLRRSPGTPVFTAPECCLG 288
|
|
| DICTYBASE|DDB_G0279405 DDB_G0279405 "Meta subfamily protein kinase DDB_G0279405" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 4.0e-41, P = 4.0e-41
Identities = 96/202 (47%), Positives = 125/202 (61%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVL-YRSSLDGKH-YAIKAFHKSHLS 157
KE+ + + ++G KM+NEYV VRK+G G++GKV L Y D H YAIK F+K L
Sbjct: 181 KETLRAHKKRHKDGHKMVNEYVFVRKLGKGTFGKVKLAYHH--DTHHLYAIKIFNKIRLK 238
Query: 158 KLRVAPSE-TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG 216
K + A DV +E+ IMK + H N+V L EVI+DP ++ Y+V+EY+EG
Sbjct: 239 KQTMGIGRPNAFDDVLKEIAIMKKMNHINVVKLYEVINDPQEEYIYIVMEYIEG----GS 294
Query: 217 FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
E +ARKY RDIV GL YLH V+H D+KP+NLLV G VKI DF VS +F
Sbjct: 295 IMSANETSEDLARKYFRDIVFGLEYLHEQKVIHKDLKPENLLVNSEGVVKITDFGVSHIF 354
Query: 277 EDDNDVLRRSPGTPVFTAPECC 298
+DD DV+R S G+P F APE C
Sbjct: 355 DDD-DVVRCSRGSPAFLAPELC 375
|
|
| POMBASE|SPCC297.03 ssp1 "serine/threonine protein kinase Ssp1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 2.7e-34, P = 2.7e-34
Identities = 93/211 (44%), Positives = 124/211 (58%)
Query: 99 VKESNKLIRSEDE-NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
VKE+ K+ + D +G K IN Y ++++G G +GKV L R ++ + AIK K+
Sbjct: 113 VKETKKIRKRFDRFSGRKYINHYEIIKELGRGMHGKVKLGRDTVTRELLAIKIIPKTERR 172
Query: 158 -KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KW- 212
KL A + + VRRE+ I+K HPN+V L EVIDDP+S Y+VLEY+ G W
Sbjct: 173 PKLGRANASSQKEKVRREIAILKKCVHPNVVRLREVIDDPSSTKVYLVLEYMSGGEVPWT 232
Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
D D P + S AR+Y RD+V GL YLH ++H DIKP NLL+ S VKI DF V
Sbjct: 233 DCDS---P-VLSISEARQYFRDVVLGLEYLHYQGIIHRDIKPANLLLNSSNCVKISDFGV 288
Query: 273 SQV----FEDDNDV-LRRSPGTPVFTAPECC 298
S + +DNDV L ++ GTP F APE C
Sbjct: 289 SYIANAGLNEDNDVELAKTVGTPAFFAPELC 319
|
|
| UNIPROTKB|G4N7H1 MGG_06421 "CAMKK/META protein kinase" [Magnaporthe oryzae 70-15 (taxid:242507)] | Back alignment and assigned GO terms |
|---|
Score = 312 (114.9 bits), Expect = 5.2e-34, Sum P(2) = 5.2e-34
Identities = 64/149 (42%), Positives = 90/149 (60%)
Query: 154 SHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKW 212
S L++ R A ++ A+ +R E+ IMK L HPN+V LIEV+DDP D +MVLE + G
Sbjct: 169 SRLNEYRTAEAKDALYLIREEIAIMKKLNHPNLVQLIEVLDDPEEDSLWMVLEMCKKGVI 228
Query: 213 DNDGFGQPGA-IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
G Q GE R + RD++ G+ YLH +VH DIKPDNLL+ +K+ DF
Sbjct: 229 MKVGLDQAAEPYGEEQCRHWFRDLILGIEYLHAQGIVHRDIKPDNLLLTEDDILKVVDFG 288
Query: 272 VSQVFEDDNDV-LRRSPGTPVFTAPECCL 299
VS++FE N++ +S G+P F PE C+
Sbjct: 289 VSEMFEKPNEMQTAKSAGSPAFLPPELCV 317
|
|
| ZFIN|ZDB-GENE-080722-13 zgc:194737 "zgc:194737" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 280 (103.6 bits), Expect = 1.4e-30, Sum P(2) = 1.4e-30
Identities = 59/127 (46%), Positives = 77/127 (60%)
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMAR 229
V +E+ I+K L H N+V L+EV+DDP D+ +MV E V +G P + E MA
Sbjct: 164 VYQEIAILKKLDHLNVVKLVEVLDDPAEDNLHMVFELVPKGPVMEVPTDSP--LSEEMAH 221
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
Y RDI+ G+ YLH ++H DIKP NLL+ G VKI DF VS FE ++ +L S GT
Sbjct: 222 LYFRDIILGIEYLHYQKIIHRDIKPSNLLLGDDGHVKIADFGVSNEFEGNDALLSNSAGT 281
Query: 290 PVFTAPE 296
P F APE
Sbjct: 282 PAFMAPE 288
|
|
| UNIPROTKB|F1RNP6 CAMKK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 8.7e-30, P = 8.7e-30
Identities = 81/217 (37%), Positives = 113/217 (52%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
P ES+ + + + +N+Y +IG GSYG V L + D +YA+K K L
Sbjct: 136 PTVESHHVSITGMQQDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLI 195
Query: 158 K------------LRVAPS-----ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
+ R AP + V +E+ I+K L HPN+V L+EV+DDPN DH
Sbjct: 196 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH 255
Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
YMV E V +G +P + E AR Y +D++ G+ YLH ++H DIKP NLLV
Sbjct: 256 LYMVFELVNQGPVMEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 313
Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
G +KI DF VS F+ + +L + GTP F APE
Sbjct: 314 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE 350
|
|
| UNIPROTKB|E2R3S0 CAMKK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 1.1e-29, P = 1.1e-29
Identities = 78/198 (39%), Positives = 107/198 (54%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK------------LRVAPS 164
+N+Y +IG GSYG V L + D +YA+K K L + R+AP
Sbjct: 154 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRLAPG 213
Query: 165 -----ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFG 218
+ V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G
Sbjct: 214 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 273
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
+P + E AR Y +D++ G+ YLH ++H DIKP NLLV G +KI DF VS F+
Sbjct: 274 KP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 331
Query: 279 DNDVLRRSPGTPVFTAPE 296
+ +L + GTP F APE
Sbjct: 332 SDALLSNTVGTPAFMAPE 349
|
|
| UNIPROTKB|F1NKZ8 CAMKK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 330 (121.2 bits), Expect = 1.4e-29, P = 1.4e-29
Identities = 87/217 (40%), Positives = 118/217 (54%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
P ESN++ S+ E+ ++ N+Y +IG GSYG V L + D K+YA+K K L
Sbjct: 108 PTIESNRVSISDAEDCVQL-NQYKLQSEIGKGSYGVVKLAYNKDDDKYYAMKVLSKKKLL 166
Query: 158 KL-----RVAP--SETAMTD----------VRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
K R P S+T+ + V +E+ I+K L H N+V LIEV+DDP D+
Sbjct: 167 KQYGFPRRPPPRGSKTSTGEHSKTMAPLDRVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 226
Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
YMV + + +G +P E AR Y RDIV G+ YLH ++H DIKP NLL+
Sbjct: 227 LYMVFDLLRKGAVMEVPSDKP--FSEDQARLYFRDIVLGIEYLHYQKIIHRDIKPSNLLL 284
Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
G VKI DF VS FE ++ L + GTP F APE
Sbjct: 285 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPE 321
|
|
| ZFIN|ZDB-GENE-050327-62 camkk1 "calcium/calmodulin-dependent protein kinase kinase 1, alpha" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 327 (120.2 bits), Expect = 1.8e-29, P = 1.8e-29
Identities = 86/225 (38%), Positives = 118/225 (52%)
Query: 89 LNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
++ I RQ P ES ++ S+ ++ ++ N+Y +IG GSYG V L + D K+YA+
Sbjct: 74 MSSRIARQ-PTIESKRVSISDSQDCIQL-NQYKLKSEIGKGSYGVVKLAYNEDDDKYYAM 131
Query: 149 KAFHKSHLSKL------------RVAPSETA-----MTDVRREVLIMKMLQHPNIVNLIE 191
K K L K + A E + V +E+ I+K L H NIV L+E
Sbjct: 132 KVVSKKKLMKQYGFPRRPPPRGPKAAQGEQPKVLGPLERVYQEIAILKKLDHLNIVKLVE 191
Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
V+DDP D+ +MV E ++ K E AR Y RDIV G+ YLH +VH D
Sbjct: 192 VLDDPAEDNLHMVFELMQ-KGPVMEVPSDSPFSEDQARHYFRDIVLGIEYLHYQKIVHRD 250
Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
IKP NLL+ G VKI DF VS FE ++ +L + GTP F APE
Sbjct: 251 IKPSNLLLGDDGHVKIADFGVSNQFEGNDALLSSTAGTPAFMAPE 295
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5HZ38 | GRIK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6459 | 0.9333 | 0.6879 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 300 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-30 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-20 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 4e-04 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 7e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 7e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-51
Identities = 73/186 (39%), Positives = 97/186 (52%), Gaps = 21/186 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + K+G GS+GKV L R GK AIK K + K R + RE+ I+K
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE--------RILREIKILK 52
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYLRD 234
L+HPNIV L +V +D D Y+V+EY EG G + E AR YLR
Sbjct: 53 KLKHPNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQ 105
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
I+S L YLH +VH D+KP+N+L+ G VK+ DF ++ D + L GTP + A
Sbjct: 106 ILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLA-RQLDPGEKLTTFVGTPEYMA 164
Query: 295 PECCLG 300
PE LG
Sbjct: 165 PEVLLG 170
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-45
Identities = 67/182 (36%), Positives = 95/182 (52%), Gaps = 22/182 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G V L R GK AIK K S L ++ RE+ I+K L HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--------EELLREIEILKKLNHPN 52
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDIVSGL 239
IV L V +D N H Y+V+EY EG G G + E + L I+ GL
Sbjct: 53 IVKLYGVFEDEN--HLYLVMEYCEG-----GSLKDLLKENEGKLSEDEILRILLQILEGL 105
Query: 240 MYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
YLH + ++H D+KP+N+L+ + +G VK+ DF +S++ D +L+ GTP + APE
Sbjct: 106 EYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165
Query: 299 LG 300
LG
Sbjct: 166 LG 167
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 62/186 (33%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
E+ +G GS+G V L G+ A+K+ S S+ + + RE+ I+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-------LEREIRIL 53
Query: 179 KMLQHPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
LQHPNIV E ++ N + LEYV G + + G + E + RKY R I+
Sbjct: 54 SSLQHPNIVRYYGSERDEEKN--TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
GL YLH + +VH DIK N+LV G VK+ DF + ++ + + S GTP + A
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 295 PECCLG 300
PE G
Sbjct: 172 PEVIRG 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 64/177 (36%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y +RK+G+GS+G V + GK A+K K + + RRE+ I++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-------RREIRILR 53
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L HPNIV LI+ +D DH Y+V+EY EG D + G + E A+K I+ GL
Sbjct: 54 RLSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGL 111
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH + ++H D+KP+N+L+ +G VKI DF +++ + L GTP + APE
Sbjct: 112 EYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 5e-38
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y +++IG GS+GKV L R DGK Y +K + LS + SE D EV I+K
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLK---EIDLSNM----SEKEREDALNEVKILK 54
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIGESMAR 229
L HPNI+ E ++ +V+EY +G K + F E
Sbjct: 55 KLNHPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFP------EEQIL 106
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
+ + L YLH ++H DIKP N+ + +G VK+GDF +S+V D+ + GT
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166
Query: 290 PVFTAPECCLG 300
P + +PE C
Sbjct: 167 PYYLSPELCQN 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 57/174 (32%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L R GK YA+K K + K + E T E I+ + HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK----EVEHT--LTERNILSRINHPF 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
IV L + Y+VLEY G + F + G E AR Y +IV L YL
Sbjct: 55 IVKLHYAFQTE--EKLYLVLEYAPG---GELFSHLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +++ D+KP+N+L+ G +K+ DF +++ + GTP + APE
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + K+G G+YG V R G+ A+K K L TA+ RE+ ++K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK---KIRLDNEEEGIPSTAL----REISLLK 53
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDI 235
L+HPNIV L++VI Y+V EY D D +PG + ++ + + +
Sbjct: 54 ELKHPNIVKLLDVIHTERK--LYLVFEYC----DMDLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
+ GL Y H H ++H D+KP N+L+ G +K+ DF +++ F
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 58/174 (33%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 125 KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
IG G++G V Y+ G AIK + E A+ + +E+ ++K L+
Sbjct: 7 LIGRGAFGVV--YKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLK 57
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
HPNIV I I SD Y++LEY E + G ES+ Y+ ++ GL YL
Sbjct: 58 HPNIVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H V+H DIK N+L G VK+ DF V+ D + GTP + APE
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 54/188 (28%), Positives = 77/188 (40%), Gaps = 31/188 (16%)
Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+K+G G++G+V + +G A+K L+ SE + E IMK
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVK--------TLKEGASEEEREEFLEEASIMK 56
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKY 231
L HPNIV L+ V + Y+V EY+ G G + +
Sbjct: 57 KLSHPNIVRLLGVC--TQGEPLYIVTEYMPG-------GDLLDFLRKHGEKLTLKDLLQM 107
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTP 290
I G+ YL N VH D+ N LV + VKI DF +S ++EDD R P
Sbjct: 108 ALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 291 VF-TAPEC 297
+ APE
Sbjct: 168 IKWMAPES 175
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ KIG G +G+V R GK AIK +++ S+ + E+ I+K +
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIK--------VIKL-ESKEKKEKIINEIQILKKCK 55
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGL 239
HPNIV D ++V+E+ G D Q + ES ++++ GL
Sbjct: 56 HPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGL 111
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH + ++H DIK N+L+ G VK+ DF +S D GTP + APE
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-GTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 9/181 (4%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + KIG G+YG V R L G+ AIK S E RE+ ++K
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-------EGIPKTALREIKLLK 53
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L HPNI+ L++V Y+V E+++ + + ES+ + YL ++ GL
Sbjct: 54 ELNHPNIIKLLDVFRHKG--DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGL 111
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
+ H H ++H D+KP+NLL+ G +K+ DF +++ F T + APE L
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 300 G 300
G
Sbjct: 172 G 172
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 33/197 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVLIM 178
Y + +IG G+YG V R G+ A+K K+RV SE + RE+ ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK--------KVRVPLSEEGIPLSTLREIALL 52
Query: 179 KMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDNDGF----GQPGAIGESMA 228
K L+ HPNIV L++V P +D +V E+V+ D + +PG +
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPG-LPPETI 109
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ +R ++ G+ +LH H +VH D+KP N+LV G VKI DF +++++ +
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE------MAL 163
Query: 289 TPV-----FTAPECCLG 300
T V + APE L
Sbjct: 164 TSVVVTLWYRAPEVLLQ 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 65/183 (35%), Positives = 98/183 (53%), Gaps = 9/183 (4%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+Y ++ +G GSYG V+ + G+ AIK F +S K + AM RE+ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAM----REIRM 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L+H N+VNLIEV Y+V E+V+ +D P + ES RKYL I+
Sbjct: 54 LKQLRHENLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR 111
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
G+ + H HN++H DIKP+N+LV+ SG VK+ DF ++ +V T + APE
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
Query: 298 CLG 300
+G
Sbjct: 172 LVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 5e-29
Identities = 53/171 (30%), Positives = 89/171 (52%), Gaps = 25/171 (14%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TAMTDVRRE 174
Y + +IG G+YG+V R+ G+ A+K K+R+ + TA+ RE
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK--------KIRMENEKEGFPITAI----RE 48
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGA-IGESMARK 230
+ +++ L+HPNIV L E++ YMV EY+ D+D G P ES +
Sbjct: 49 IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM----DHDLTGLLDSPEVKFTESQIKC 104
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
Y++ ++ GL YLH + ++H DIK N+L+ G +K+ DF +++ + N
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 43/208 (20%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+++ + IG GS+ VVL + K YAIK K L K E + V+ E +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK------EKKVKYVKIEKEV 54
Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMAR 229
+ L HP I+ L D + Y VLEY G + G++ E R
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPN-------GELLQYIRKYGSLDEKCTR 105
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--------D 281
Y +I+ L YLH ++H D+KP+N+L+ +KI DF ++V + ++
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 282 VLRRSP------------GTPVFTAPEC 297
S GT + +PE
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPEL 193
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS-HLSKLRVAPSETAMTDVRREVLIMKMLQ 182
R IG G++GKV + + K +A+K +K + K V +V E I++ L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-------NVLNERRILQELN 58
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
HP +VNL D ++ Y+V++ + G ++ Q E + ++ +IV L
Sbjct: 59 HPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYH---LSQKVKFSEEQVKFWICEIVLAL 113
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH ++H DIKPDN+L+ G V I DF+++ D S GTP + APE
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-GTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 61/185 (32%), Positives = 100/185 (54%), Gaps = 17/185 (9%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+YV V+KIG GS+GK +L +S DGK Y IK + S +++P E + R+EV ++
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINIS-----KMSPKER--EESRKEVAVL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPG-AIGESMARKYLR 233
++HPNIV E ++ + + Y+V++Y EG D + Q G E +
Sbjct: 54 SNMKHPNIVQYQESFEE--NGNLYIVMDYCEG---GDLYKKINAQRGVLFPEDQILDWFV 108
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
I L ++H ++H DIK N+ + GT+K+GDF +++V ++ R GTP +
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 294 APECC 298
+PE C
Sbjct: 169 SPEIC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 33/189 (17%)
Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+K+G G++G+V + DGK A+K L+ SE + + RE IM+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--------TLKEDASEQQIEEFLREARIMR 56
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---------QPGAIGESMARK 230
L HPNIV L+ V + + +V+EY+ G G +P + S
Sbjct: 57 KLDHPNIVKLLGVCTEE--EPLMIVMEYMPG-------GDLLDYLRKNRPKELSLSDLLS 107
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT- 289
+ I G+ YL N +H D+ N LV + VKI DF +S+ D+D + G
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKL 166
Query: 290 PVF-TAPEC 297
P+ APE
Sbjct: 167 PIRWMAPES 175
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 65/189 (34%), Positives = 94/189 (49%), Gaps = 22/189 (11%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
Y +RK+G GS+G+V L + D K A+K K SK + RE+ I+
Sbjct: 1 SYRILRKLGEGSFGEVYL---ARDRKLVALKVLAKKLESK------SKEVERFLREIQIL 51
Query: 179 KMLQHP-NIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRD 234
L HP NIV L + D Y+V+EYV+G + G+ G + ES A L
Sbjct: 52 ASLNHPPNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDND------VLRRSP 287
I+S L YLH ++H DIKP+N+L+ G VK+ DF ++++ D + S
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 288 GTPVFTAPE 296
GTP + APE
Sbjct: 170 GTPGYMAPE 178
|
Length = 384 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 60/186 (32%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
I G+YG+V L + G YAIK K+ + + V E I+ Q P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ------VLTERDILSQAQSPY 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
+V L + Y+V+EY+ G D G++ E +AR Y+ +IV L YL
Sbjct: 55 VVKLYYSFQG--KKNLYLVMEYLPG---GDLASLLENVGSLDEDVARIYIAEIVLALEYL 109
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV--------FEDDNDVLRRSPGTPVFTA 294
H + ++H D+KPDN+L+ +G +K+ DF +S+V DD +R GTP + A
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 295 PECCLG 300
PE LG
Sbjct: 170 PEVILG 175
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y +K+G G+Y V R G+ AIK + + + TA+ RE+ +++
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQ 57
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW-----DNDGFGQPGAIGESMARKYLRD 234
L+HPNI+ L++V + + +V E++E D P I + Y+
Sbjct: 58 ELKHPNIIGLLDVF--GHKSNINLVFEFMETDLEKVIKDKSIVLTPADI-----KSYMLM 110
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-VFT 293
+ GL YLH + ++H D+KP+NLL+A G +K+ DF +++ F N + T V T
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-----THQVVT 165
Query: 294 ----APECCLG 300
APE G
Sbjct: 166 RWYRAPELLFG 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
Y + +IG G++G V + G+ A+K K L +L A+ RE+ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQAL----REIKAL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ QHP +V L++V P+ F +V+EY+ + + E+ + Y+R ++ G
Sbjct: 54 QACQHPYVVKLLDVF--PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKG 111
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT----A 294
+ Y+H + ++H D+KP NLL++ G +KI DF ++++F ++ R V T A
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---RLYSHQVATRWYRA 168
Query: 295 PECCLG 300
PE G
Sbjct: 169 PELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+K+G G++G+V + K A+K L+ SE + + RE IM+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--------TLKEDASEQQIEEFLREARIMR 56
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
L HPN+V L+ V + + Y+V+EY+EG D + + S + I
Sbjct: 57 KLDHPNVVKLLGVCTEE--EPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVF-TAP 295
G+ YL N +H D+ N LV + VKI DF +S +++DD R P+ AP
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAP 172
Query: 296 EC 297
E
Sbjct: 173 ES 174
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 54/153 (35%), Positives = 82/153 (53%), Gaps = 9/153 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
N+Y + +G G+YG V+ R+ G+ AIK F +S + +TA+ REV +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE---DVKKTAL----REVKV 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
++ L+H NIVNL E Y+V EYVE PG + R Y+ ++
Sbjct: 54 LRQLRHENIVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ Y H HN++H DIKP+N+LV+ SG +K+ DF
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 55/180 (30%), Positives = 94/180 (52%), Gaps = 15/180 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++ I G++G V L + G ++AIK KS + ++ +T+V+ E IM M+Q
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI------AKNQVTNVKAERAIM-MIQ 53
Query: 183 --HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
P + L + D+ Y+V+EY+ G G + E A++Y+ ++V G+
Sbjct: 54 GESPYVAKLYYSFQ--SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE 111
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
LH ++H DIKP+NLL+ +G +K+ DF +S+ ++ GTP + APE LG
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----ENKKFVGTPDYLAPETILG 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 8e-26
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IM 178
Y ++++G G++G V L R+ G+ AIK K + E M REV +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMN--LREVKSLR 52
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW-----DNDGFGQPGAIGESMARKYLR 233
K+ +HPNIV L EV + +D Y V EY+EG D G ES+ R +
Sbjct: 53 KLNEHPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKG----KPFSESVIRSIIY 106
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
I+ GL ++H H H D+KP+NLLV+ VKI DF
Sbjct: 107 QILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADF 143
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G+GS+G V + DG +A+K + + + A+ + +E+ ++ LQHPN
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT----GQEAVKQLEQEIALLSKLQHPN 63
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + + D+ Y+ LE V G + G+ E + R Y R I+ GL YLH
Sbjct: 64 IVQYLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
N VH DIK N+LV +G VK+ DF +++ + + G+P + APE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIA 174
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++G+V L G+ A+K S ++ + + E+ ++K LQH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHER 65
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + D + + +EY+ G D GA+ E++ RKY R I+ G+ YLH +
Sbjct: 66 IVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVS---QVFEDDNDVLRRSPGTPVFTAPECCLG 300
+VH DIK N+L +G VK+GDF S Q ++ GTP + +PE G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 56/175 (32%), Positives = 81/175 (46%), Gaps = 11/175 (6%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
V+ +G GS G V R GK YA+K H + R + RE+ ++ +
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--------LLRELKTLRSCE 57
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
P +V +VLEY++G D + G I E + R I+ GL YL
Sbjct: 58 SPYVVKCYGAFYKEGE--ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 243 HG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +++H DIKP NLL+ G VKI DF +S+V E+ D GT + +PE
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 9e-25
Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 8/177 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG+GS+G V L ++ G+ A+K +S + + + RE+ ++K LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + ++DH + LEYV G GA E++ R ++R I+ GL YLH
Sbjct: 68 IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF------TAPE 296
++H DIK N+LV G +KI DF +S+ E ++ + + P APE
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 3e-24
Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+K+G G++G+V Y+ L GK A+K L+ SE D +E +M
Sbjct: 1 KKLGEGAFGEV--YKGKLKGKDGKTTEVAVK--------TLKEDASEEERKDFLKEARVM 50
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDNDGFGQPGAIGESMAR 229
K L HPN+V L+ V + + Y+VLEY+EG + +
Sbjct: 51 KKLGHPNVVRLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPG 288
+ I G+ YL VH D+ N LV VKI DF +S V++DD +
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 289 TPVF-TAPEC 297
P+ APE
Sbjct: 169 LPIRWMAPES 178
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 60/180 (33%), Positives = 97/180 (53%), Gaps = 13/180 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVL 176
+++ ++ +G GS+G+V+L R GK+YA+K K+ + KL+ V V E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-------HVLNEKR 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
I++ ++HP +VNL D ++ Y+V+EYV G + G E +AR Y +V
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH ++V+ D+KP+NLL+ G +KI DF ++ + L GTP + APE
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 61/182 (33%), Positives = 92/182 (50%), Gaps = 21/182 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++ KIG G+ G+V GK AIK K L K + E+LIMK
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQN-------KELIINEILIMK 70
Query: 180 MLQHPNIVNLIE-VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVS 237
+HPNIV+ + + D ++V+EY++G D Q + E R+++
Sbjct: 71 DCKHPNIVDYYDSYLVG---DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
GL YLH NV+H DIK DN+L++ G+VK+ DF + Q+ + +R+ GTP + A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGTPYWMA 184
Query: 295 PE 296
PE
Sbjct: 185 PE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y+ +R +G G++G+ LYR + D K + + LS E D E++I+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-------EKERRDALNEIVILS 54
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVS 237
+LQHPNI+ D N+ + +EY G D + E M YL IVS
Sbjct: 55 LLQHPNIIAYYNHFMDDNT--LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
+ Y+H ++H DIK N+ + +G +K+GDF +S++ + + GTP + +PE
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
Query: 298 CLG 300
C G
Sbjct: 173 CQG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 63/192 (32%), Positives = 92/192 (47%), Gaps = 36/192 (18%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKML 181
V KIG G+YG V R+ L G+ A+K K+R+ +E + RE+ ++K L
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREISLLKEL 56
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
HPNIV L++VI N Y+V E++ K D I + + YL ++ GL
Sbjct: 57 NHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGL 113
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT------ 293
+ H H V+H D+KP NLL+ G +K+ DF +++ F G PV T
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-----------GVPVRTYTHEVV 162
Query: 294 -----APECCLG 300
APE LG
Sbjct: 163 TLWYRAPEILLG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 9e-23
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G+V L + + +A+K K H+ + + E I++ HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG------QQEHIFSEKEILEECNHPF 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV L D + YM++EY G G E AR Y+ +V YLH
Sbjct: 55 IVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVFTAPECCLG 300
+++ D+KP+NLL+ +G VK+ DF ++ + ++ GTP + APE L
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILN 166
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-23
Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 48/201 (23%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTDVRR 173
Y V KIG G+YG V R L G+ A+K K+R+ PS TA+ R
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK--------KIRLETEDEGVPS-TAI----R 47
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDH-FYMVLEYVEG--KWDNDGFGQPGAIGESMARK 230
E+ ++K L HPNIV L++V+ +S++ Y+V E+++ K D G + + +
Sbjct: 48 EISLLKELNHPNIVRLLDVV---HSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKS 103
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
YL ++ G+ Y H H V+H D+KP NLL+ G +K+ DF L R+ G P
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG-----------LARAFGVP 152
Query: 291 VFT-----------APECCLG 300
V T APE LG
Sbjct: 153 VRTYTHEVVTLWYRAPEILLG 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 21/189 (11%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TAMTDVRR 173
+Y + KIG G+YG V R+ G+ A+K K+R+ E TA+ R
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK--------KIRLESEEEGVPSTAI----R 48
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV--EGKWDNDGFGQPGAIGESMARKY 231
E+ ++K LQHPNIV L +V+ + Y++ E++ + K D + + + + Y
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSY 106
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
L I+ G+++ H V+H D+KP NLL+ G +K+ DF +++ F V T
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW 166
Query: 292 FTAPECCLG 300
+ APE LG
Sbjct: 167 YRAPEVLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 35/197 (17%)
Query: 125 KIGAGSYGKVVLYRS--SLDGKHYAIKAF--HKSHLSKLRVAPSETAMTDVRREVLIMKM 180
IG G+YG+V + DGK YAIK F K + + S++A RE+ +++
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI----SQSAC----REIALLRE 58
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG------QPGA--IGESMARKYL 232
L+H N+V+L+EV + Y++ +Y E +D + Q I SM + L
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
I++G+ YLH + V+H D+KP N+LV G VKIGD ++++F + + +
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADL 172
Query: 289 TPV-----FTAPECCLG 300
PV + APE LG
Sbjct: 173 DPVVVTIWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-22
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 20/185 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLD------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
++++G G +GKV L R D G+ A+K L + E +D RE+
Sbjct: 9 IKQLGEGHFGKVELCR--YDPLGDNTGEQVAVK--------SLNHSGEEQHRSDFEREIE 58
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDI 235
I++ L H NIV V + P +++EY+ G + I + I
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF- 292
G+ YL +H D+ N+LV VKI DF +++V +D D + PG +P+F
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 293 TAPEC 297
APEC
Sbjct: 179 YAPEC 183
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-22
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
KIG G++GKV + G+ A+K ++R+ ++ + E+ ++++L+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 183 HPNIVNL--IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
HPN+V +EV + Y+ +EY G + + E + R Y ++ GL
Sbjct: 58 HPNLVKYYGVEVHRE----KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS----PGTPVFTAPE 296
YLH H +VH DIKP N+ + +G +K+GDF + +++ + GTP + APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 5/174 (2%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQHP 184
IG G+YG+V L + G+ A+K R + M +R E+ +K L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
NIV + + LEYV G G E + R + ++ GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPE 296
++H D+K DNLLV G KI DF +S+ +D DND G+ + APE
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 11/171 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++G+V L R + +YA+K + +L+ V E ++K + HP
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK------QEQHVHNEKRVLKEVSHPF 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
I+ L D YM++EYV G G S Y +IV L YLH
Sbjct: 63 IIRLFWTEHDQR--FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+V+ D+KP+N+L+ G +K+ DF ++ D L GTP + APE
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 16/183 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
Y VR +G GSYG+V L R DGK Y IK + + S+ +E +E ++
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE-------QEAQLL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAI-GESMARKYLR 233
L+HPNIV E + + Y+V+ + EG D + Q G + E+ ++
Sbjct: 54 SQLKHPNIVAYRESWEGEDG-LLYIVMGFCEG---GDLYHKLKEQKGKLLPENQVVEWFV 109
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
I L YLH +++H D+K N+ + + +K+GD +++V E+ D+ GTP +
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169
Query: 294 APE 296
+PE
Sbjct: 170 SPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + K+G G+Y V R+ G+ A+K H L PS TA+ RE+ +MK
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPS-TAI----REISLMK 53
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYLRDIVS 237
L+H NIV L +VI N +V EY++ K D G GA+ + + + ++
Sbjct: 54 ELKHENIVRLHDVIHTENK--LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
G+ + H + V+H D+KP NLL+ G +K+ DF +++ F
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 58/171 (33%), Positives = 85/171 (49%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+L + DGK YA+K K + K E R VL+ K ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK----KKEQKHIMAERNVLL-KNVKHPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+V L +D Y VL+YV G + + E AR Y +I S L YLH
Sbjct: 58 LVGLHYSFQ--TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
N+++ D+KP+N+L+ G V + DF + + + + GTP + APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-21
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 15/177 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+K+G GSYG V + D + YA+K + L + E A+ ++R I+ + H
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIR----ILASVNH 58
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
PNI++ E D N +V+EY K + + I E + ++ GL
Sbjct: 59 PNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
LH ++H D+K N+L+ + VKIGD +S+V + ++ + GTP + APE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 23/171 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR---REVL 176
Y ++ IG+G+YG V G+ AIK +++ + D + RE+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK----------KISNVFDDLIDAKRILREIK 51
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVE---GKWDNDGFGQPGAIGESMARK 230
+++ L+H NI+ L++++ P+ + F Y+V E +E K P + + +
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKV----IKSPQPLTDDHIQY 107
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
+L I+ GL YLH NV+H D+KP N+LV + +KI DF +++ + D D
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR----- 173
+Y + IG GS+G V R DGK K + MT+ +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------------MTEKEKQQLVS 48
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAI 223
EV I++ L+HPNIV + I D ++ Y+V+EY EG K + I
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YI 102
Query: 224 GESMARKYLRDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
E + L ++ L H G+ V+H D+KP N+ + + VK+GDF ++++
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 279 DNDVLRRSPGTPVFTAPECCLG 300
D+ + GTP + +PE
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNH 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-21
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS----HLSKLRVAPSETAMTDVRREV 175
Y + KIG GSYG V R+ G+ AIK F +S + K+ A+ RE+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-------AL----REI 51
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
++K L+HPN+VNLIEV H +V EY + N+ P + E + +K +
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLH--LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
+ + + H HN +H D+KP+N+L+ G +K+ DF +++ D T + AP
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 296 ECCLG 300
E +G
Sbjct: 170 ELLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 32/184 (17%)
Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+ K+G GSYG V +++ + G+ AIK V P E + ++ +E+ I+K
Sbjct: 8 LEKLGEGSYGSVYKAIHKET--GQVVAIK-----------VVPVEEDLQEIIKEISILKQ 54
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY--------L 232
P IV + ++V+EY +D I + + L
Sbjct: 55 CDSPYIVKYYGSYF--KNTDLWIVMEYCGAGSVSD-------IMKITNKTLTEEEIAAIL 105
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
+ GL YLH + +H DIK N+L+ G K+ DF VS D GTP +
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 293 TAPE 296
APE
Sbjct: 166 MAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 57/186 (30%), Positives = 100/186 (53%), Gaps = 20/186 (10%)
Query: 114 TKMINEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDV 171
K ++E V +IG+G+ G V V++R + G+ YA+K + +H +T +
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH--------EDTVRRQI 119
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARK 230
RE+ I++ + HPN+V ++ D ++ ++LE+++ G + + + +AR+
Sbjct: 120 CREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEFMDGGSLEGTHIADEQFLAD-VARQ 176
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
I+SG+ YLH ++VH DIKP NLL+ + VKI DF VS++ D S GT
Sbjct: 177 ----ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 291 VFTAPE 296
+ +PE
Sbjct: 233 AYMSPE 238
|
Length = 353 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 42/214 (19%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TA 167
G + +Y + K+G G++G+V R G+ A+K K+ + + TA
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--------KILMHNEKDGFPITA 54
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVE----GKWDNDGF 217
+ RE+ I+K L+HPN+V LI++ + YMV Y++ G +N
Sbjct: 55 L----REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV 110
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
+ ES + Y+ ++ G+ YLH ++++H DIK N+L+ G +KI DF +++ ++
Sbjct: 111 ----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 278 DDNDVLRRSPG------TPV-----FTAPECCLG 300
+ G T + + PE LG
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
I E+V V+ I G++GKV L R + K YA+K K+ + ++ + V+ E
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI------NKNMVHQVQAERD 56
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
+ + + P IV+L + N + Y+V+EY+ G G E MA KY+ ++
Sbjct: 57 ALALSKSPFIVHLYYSLQSAN--NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
L YLH H ++H D+KPDN+L++ G +K+ DF +S+V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 18/182 (9%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++KIG GS+GK+ L ++ D +H IK L+K+ V E + ++EV+++ ++
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEID---LTKMPVKEKEAS----KKEVILLAKMK 57
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAI-GESMARKYLRDIVS 237
HPNIV + ++V+EY +G K N Q G + E + I
Sbjct: 58 HPNIVTFFASFQENG--RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISL 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL ++H ++H DIK N+ ++ +G V K+GDF +++ D ++ GTP + +PE
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 297 CC 298
C
Sbjct: 173 IC 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 61/187 (32%), Positives = 93/187 (49%), Gaps = 13/187 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
++EY + +I G+YG V R G+ A+K K+ +T +R E+
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLR-EIN 56
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYL-R 233
I+ LQHPNIV + EV+ N D YMV+EYVE K + QP E K L
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE---VKCLML 113
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
++SG+ +LH + ++H D+K NLL+ G +KI DF +++ + + T +
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173
Query: 294 APECCLG 300
APE LG
Sbjct: 174 APELLLG 180
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 29/148 (19%)
Query: 166 TAMTDVRREVLIMKMLQHPNIVN----LIEVIDDPNSDHFYMVLEYVEG---------KW 212
T++ ++R+EV M HPN+V + D ++V+ Y+ G +
Sbjct: 41 TSVDELRKEVQAMSQCNHPNVVKYYTSFVV------GDELWLVMPYLSGGSLLDIMKSSY 94
Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
G E++ L++++ GL YLH + +H DIK N+L+ G+VKI DF V
Sbjct: 95 PRGGLD------EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGV 148
Query: 273 SQVFEDDNDVLRRSP----GTPVFTAPE 296
S D D R+ GTP + APE
Sbjct: 149 SASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-19
Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 7/178 (3%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++G+V L G+ A K S + ++ + E+ ++K LQH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHER 65
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + D + +EY+ G D GA+ ES+ RKY R I+ G+ YLH +
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED---DNDVLRRSPGTPVFTAPECCLG 300
+VH DIK N+L +G VK+GDF S+ + +R GTP + +PE G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 59/171 (34%), Positives = 87/171 (50%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+L + LDGK YA+K K K+ + E R VL +K ++HP
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQK----KIVLNRKEQKHIMAERNVL-LKNVKHPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+V L ++ Y VL++V G + + E AR Y +I S L YLH
Sbjct: 58 LVGLHYSFQ--TTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
N+V+ D+KP+N+L+ G V + DF + + +D GTP + APE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+L + DG YA+K K + K + E R VL +K L+HP
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK----EQNHIMAERNVL-LKNLKHPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+V L + Y VL+YV G + E AR Y ++ S + YLH
Sbjct: 58 LVGLHYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
N+++ D+KP+N+L+ G V + DF + + + + GTP + APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 24/180 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G+V + R G YA+K KS V ++ ++ E I+ + P
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKS------VLLAQETVSFFEEERDILSISNSPW 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
I L D D+ Y+V+EY G +++ E MA+ YL ++V
Sbjct: 63 IPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYE-------DQFDEDMAQFYLAELVL 113
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
+ +H VH DIKP+N+L+ +G +K+ DF + + V + P GTP + APE
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 31/201 (15%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+++Y + KIG G++G+V R + A+K K + + TA+ RE+
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITAL----REIK 63
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
I+++L+H N+VNLIE+ + + FY+V E+ E D G + +++
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSEI 121
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+K ++ +++GL Y+H + ++H D+K N+L+ G +K+ DF +++ F L ++
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF-----SLSKNSK 176
Query: 289 TPVFT---------APECCLG 300
+T PE LG
Sbjct: 177 PNRYTNRVVTLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 7/178 (3%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++G+V L + G+ A+K S+ + + + E+ ++K L+H
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ----ETSKEVNALECEIQLLKNLRHDR 65
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + DP + +EY+ G D GA+ E++ R+Y R I+ G+ YLH +
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVS---QVFEDDNDVLRRSPGTPVFTAPECCLG 300
+VH DIK N+L +G VK+GDF S Q ++ GTP + +PE G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 16/179 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIK--AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+G G+YG V ++ G+ A+K S+ V +E ++ EV ++K L+H
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSN-----VLAAEKEYEKLQEEVDLLKSLKH 61
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
NIV + D N+ +M E+V G + + G + E + KY + I+ G+ YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE------DDNDVLRRSPGTPVFTAPE 296
+ VVH DIK +N+++ P+G +K+ DF ++ +++L+ GTP + APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---EV 175
Y + IG+G+YG V + GK AIK ++ + T +R E+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK----------KIPHAFDVPTLAKRTLREL 55
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDND-----GFGQPGAIGESMA 228
I++ +H NI+ + +++ P +D Y+V++ +E +D QP + E
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME----SDLHHIIHSDQP--LTEEHI 109
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
R +L ++ GL Y+H NV+H D+KP NLLV ++IGDF
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + KIG G++ +V+ +S GK+YAIK K S +V RE+ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--------REIQALR 52
Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
L HPNI+ LIEV+ D + +V E ++ G+ + E + Y+ ++
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFT---- 293
L ++H + + H DIKP+N+L+ +K+ DF S ++ P +T
Sbjct: 113 LDHMHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIY-----------SKPPYTEYIS 160
Query: 294 -----APECCL 299
APEC L
Sbjct: 161 TRWYRAPECLL 171
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 8/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++GKV+L R G++YA+K K ++ +A E A T VL + +HP
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL--QNTRHPF 56
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D V+EY G + E AR Y +IVS L YLH
Sbjct: 57 LTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+VV+ DIK +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 16/168 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y + KIG G+YGKV R GK A+K K+ L TA+ RE+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTAL----REISL 53
Query: 178 MKMLQH-PNIVNLIEV---IDDPNSDHFYMVLEYVEG---KW-DNDGFGQPGAIGESMAR 229
++ML IV L++V + Y+V EY++ K+ D++G G + +
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVF 276
++ ++ G+ + H H V+H D+KP NLLV G +KI D + + F
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 59/184 (32%), Positives = 85/184 (46%), Gaps = 36/184 (19%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE-----VLIMK 179
KIG GS G V + G+ A+K K L K + RRE V+IM+
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQ-----------RRELLFNEVVIMR 71
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
QHPNIV + +S D ++V+E++EG D + E +
Sbjct: 72 DYQHPNIVEMY------SSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAV 124
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVF 292
+ L +LH V+H DIK D++L+ G VK+ DF +QV + +V RR GTP +
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EVPRRKSLVGTPYW 181
Query: 293 TAPE 296
APE
Sbjct: 182 MAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 53/167 (31%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT-DVRREVLI 177
+Y V +IG G+YGKV R +G + L ++RV E M REV +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVA-------LKRVRVQTGEEGMPLSTIREVAV 54
Query: 178 MKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMAR 229
++ L+ HPN+V L +V +D +V E+V+ D +PG E++ +
Sbjct: 55 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-K 113
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
+ ++ GL +LH H VVH D+KP N+LV SG +K+ DF +++++
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 57/171 (33%), Positives = 84/171 (49%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+L R + K YA+K K + K + E R VL +K ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK----EEKHIMSERNVL-LKNVKHPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+V L +D Y VL+Y+ G + E AR Y +I S L YLH
Sbjct: 58 LVGLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
N+V+ D+KP+N+L+ G + + DF + + + N GTP + APE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 30/204 (14%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G + ++++ + +IG G+YG+V R G+ A+K K L + TA+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAI---- 54
Query: 173 REVLIMKMLQHPNIVNLIEVIDD--------PNSDHFYMVLEYVEGKWDNDGFG--QPGA 222
RE+ I++ L H NIVNL E++ D + FY+V EY+ D+D G + G
Sbjct: 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM----DHDLMGLLESGL 110
Query: 223 I--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
+ E + +++ ++ GL Y H N +H DIK N+L+ G +K+ DF +++++ +
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 281 DVLRRSPGTPVFT----APECCLG 300
R V T PE LG
Sbjct: 171 ---SRPYTNKVITLWYRPPELLLG 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 17/189 (8%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ E+ + +IG G+YG ++YR+ D I A K + R +++ RE+
Sbjct: 6 VTEFEKLNRIGEGTYG--IVYRAR-DTTSGEIVALKKVRMDNERDGIPISSL----REIT 58
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
++ L+HPNIV L EV+ + D ++V+EY E + P ES + + ++
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV----- 291
GL YLH + ++H D+K NLL+ G +KI DF +++ + P TP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----KPMTPKVVTLW 173
Query: 292 FTAPECCLG 300
+ APE LG
Sbjct: 174 YRAPELLLG 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+G+V + + G++YAIK K + K++ + V +E I+ L HP
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK------QVQHVAQEKSILMELSHPF 79
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IVN++ D + Y +LE+V G + G +A+ Y ++V YLH
Sbjct: 80 IVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
++++ D+KP+NLL+ G VK+ DF ++ D L GTP + APE
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 7/178 (3%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++G+V L + G+ A+K S + + + E+ ++K L H
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPES----PETSKEVNALECEIQLLKNLLHER 65
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + DP + +E++ G D GA+ E++ RKY R I+ G+ YLH +
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED---DNDVLRRSPGTPVFTAPECCLG 300
+VH DIK N+L G VK+GDF S+ + ++ GTP + +PE G
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 8/175 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+ R + YA+K K+H+ V+ SE T R VL + P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVL--AQVNCPF 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV L P + Y+VL ++ G + G S AR Y +++ L LH
Sbjct: 55 IVPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
NV++ D+KP+N+L+ G + + DF + ++ D+D GTP + APE LG
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-18
Identities = 61/174 (35%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+G G +GKV+L G+ YAIKA K +++ V E+ M + +R +HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV---ESLMCE-KRIFETANSERHP 62
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
+VNL DH V+EY G D E A Y +V GL YLH
Sbjct: 63 FLVNLFACFQ--TEDHVCFVMEYAAGG-DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPE 296
+ +V+ D+K DNLL+ G VKI DF + + E R S GTP F APE
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-18
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 21/163 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIM 178
Y + KIG G+YG V ++ + A+K ++R+ E + RE+ ++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICLL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDH-FYMVLEYVEGK----WDNDGFGQPGAIGESMARKYLR 233
K L+H NIV L +V+ +SD +V EY + +D+ G I + + ++
Sbjct: 54 KELKHKNIVRLYDVL---HSDKKLTLVFEYCDQDLKKYFDSCN----GDIDPEIVKSFMF 106
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
++ GL + H HNV+H D+KP NLL+ +G +K+ DF +++ F
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 53/167 (31%), Positives = 87/167 (52%), Gaps = 18/167 (10%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVLI 177
+Y V +IG G+YG V R G A+K+ +RV +E + REV +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKS--------VRVQTNEDGLPLSTVREVAL 52
Query: 178 MKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMAR 229
+K L+ HPNIV L++V +D +V E+V+ D PG E++ +
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI-K 111
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
+R + GL +LH + +VH D+KP+N+LV G VK+ DF +++++
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 8/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++GKV+L R GK+YA+K K + +A E A T VL + +HP
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVI----IAKDEVAHTLTESRVL--QNTRHPF 56
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D V+EY G + E AR Y +IVS L YLH
Sbjct: 57 LTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+VV+ D+K +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 7/173 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+ +G GS+GKV+L + YA+K K + + + T + VL + +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKD----VILQDDDVECTMTEKRVLALAG-KH 55
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
P + L D + V+EYV G + G E AR Y +IV GL +LH
Sbjct: 56 PFLTQLHSCFQTK--DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+L+ G +KI DF + + GTP + APE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++ ++ I G+YG V L R + +A+K +K +L LR ++ V R++L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LR---NQIQQVFVERDILT 56
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
++P +V++ + H MV+EYVEG GA+ MAR Y + V
Sbjct: 57 FA--ENPFVVSMFCSFE--TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV---------FEDDNDVLRRS-- 286
L YLH + +VH D+KPDNLL+ G +K+ DF +S++ +E + R
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 287 ----PGTPVFTAPECCL 299
GTP + APE L
Sbjct: 173 DKQVCGTPEYIAPEVIL 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 12/180 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y +R +G GS+G+ +L + + YA+K ++R+ S +A+ D R+E +++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK--------EIRLPKSSSAVEDSRKEAVLL 52
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAI-GESMARKYLRDIV 236
++HPNIV E + H Y+V+EY + G Q G + E ++ +
Sbjct: 53 AKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
G+ ++H V+H DIK N+ + +G VK+GDF +++ GTP + PE
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 31/189 (16%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ + IG GS+G+V + AIK +E + D+++E+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEIEDIQQEIQF 52
Query: 178 MKMLQHPNIVNLIE-VIDDPNSDHFYMVLEYVEGKWDNDGFG------QPGAIGESMARK 230
+ + P I + ++++EY G G +PG + E+
Sbjct: 53 LSQCRSPYITKYYGSFLKGSK---LWIIMEYCGG-------GSCLDLLKPGKLDETYIAF 102
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-- 287
LR+++ GL YLH +H DIK N+L++ G VK+ DF VS Q+ + + +R+
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFV 159
Query: 288 GTPVFTAPE 296
GTP + APE
Sbjct: 160 GTPFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 8/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++GKV+L R GK+YA+K K ++ +A E A T VL K +HP
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK----EVIIAKDEVAHTLTESRVL--KNTRHPF 56
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ +L D V+EYV G + E R Y +IVS L YLH
Sbjct: 57 LTSLKYSFQ--TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+V+ D+K +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-17
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 11/174 (6%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+++IG+G+YG V R+ G+ AIK +++ P E V++E+++MK +
Sbjct: 14 IQRIGSGTYGDVYKARNVNTGELAAIKV--------IKLEPGED-FAVVQQEIIMMKDCK 64
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
H NIV D ++ +E+ G D + G + ES R+ + GL YL
Sbjct: 65 HSNIVAYFGSY--LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +H DIK N+L+ +G VK+ DF VS + GTP + APE
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+IG+G+YG V R G+ AIK +++ P + +++E+ ++K +HP
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKV--------IKLEPGDD-FEIIQQEISMLKECRHP 60
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLH 243
NIV D ++V+EY G D + G + E R+ + GL YLH
Sbjct: 61 NIVAYFGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPE 296
+H DIK N+L+ G VK+ DF VS + +R GTP + APE
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 38/188 (20%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ ++G G++GKV + G A +K+ SE + D E+ I+ +
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFAA---------AKIIQIESEEELEDFMVEIDILSECK 60
Query: 183 HPNIVNLIEV-IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIG-----------ESMARK 230
HPNIV L E + ++++E+ +G GA+ E R
Sbjct: 61 HPNIVGLYEAYFYENK---LWILIEFCDG----------GALDSIMLELERGLTEPQIRY 107
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
R ++ L +LH H V+H D+K N+L+ G VK+ DF VS + +R G
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIG 165
Query: 289 TPVFTAPE 296
TP + APE
Sbjct: 166 TPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-17
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y+++ K+G GSY V S ++G+ A+K + E RE ++K
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVIS--------MKTEEGVPFTAIREASLLK 58
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L+H NIV L ++I + F V EY+ PG + R ++ ++ GL
Sbjct: 59 GLKHANIVLLHDIIHTKETLTF--VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
Y+HG +++H D+KP NLL++ G +K+ DF +++
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y KIG G+ G V G+ AIK + L+ P + + + E+L+M
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN------LQKQPKKELIIN---EILVM 70
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
K L++PNIVN ++ D ++V+EY+ G D + + E+ R+ +
Sbjct: 71 KELKNPNIVNFLDSF--LVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQA 127
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH + V+H DIK DN+L+ G+VK+ DF + GTP + APE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 57/182 (31%), Positives = 82/182 (45%), Gaps = 23/182 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHP 184
IG G+YGKV R G+ AIK E +++ E I++ HP
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILRKYSNHP 63
Query: 185 NIVNL----IEVIDDPNSDHFYMVLEYVEGKWDND---GF-GQPGAIGESMARKYLRDIV 236
NI I+ N D ++V+E G D G + + E LR+ +
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVFTA 294
GL YLH + V+H DIK N+L+ + VK+ DF VS + D+ + RR GTP + A
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMA 181
Query: 295 PE 296
PE
Sbjct: 182 PE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 14/183 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ V + ++G G+ G V R G +A+K + P+ + RE+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT--------ITTDPNPDLQKQILRELEI 52
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLR 233
K + P IV D +S + +EY EG + + + G IGE + K
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
++ GL YLH ++H DIKP N+L+ G VK+ DF VS E N + GT +
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYM 170
Query: 294 APE 296
APE
Sbjct: 171 APE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++ + KIG GS+G V D + YA+K + LSK+ E A+ E ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMK---QIDLSKMNRREREEAI----DEARVL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
L I+ E D +V+EY E K G+P + E ++
Sbjct: 54 AKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQ 109
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
I+ GL +LH ++H DIK NL + VKIGD V+++ D+ + GTP + +
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169
Query: 295 PECC 298
PE C
Sbjct: 170 PELC 173
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 18/181 (9%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y KIG G+ G V G+ AIK + K + + E+L+M
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---------IINEILVM 70
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ +HPNIVN ++ D ++V+EY+ G D + + E R+ +
Sbjct: 71 RENKHPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 127
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVFTAP 295
L +LH + V+H DIK DN+L+ G+VK+ DF +Q+ + + +RS GTP + AP
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAP 184
Query: 296 E 296
E
Sbjct: 185 E 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHP 184
IG G++G+V R + YA+K K K VA E A T R +L+ +L + P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGK---WDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
IV L + Y+V +Y+ G W + G E A+ Y+ ++V L +
Sbjct: 57 FIVGLKFSFQTDSD--LYLVTDYMSGGELFWH---LQKEGRFSEDRAKFYIAELVLALEH 111
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
LH +++V+ D+KP+N+L+ +G + + DF +S+ DN GT + APE L
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 28/181 (15%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G+YG V YR GKH + L + + + ++D++REV ++ L+
Sbjct: 9 IGRGAYGAV--YR----GKH--VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 186 IVNLIE----VIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVS 237
N+ + + P ++++EY EG G + G I E +R+++
Sbjct: 61 PPNITKYYGSYLKGPR---LWIIMEYAEG-----GSVRTLMKAGPIAEKYISVIIREVLV 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAP 295
L Y+H V+H DIK N+LV +G VK+ DF V+ + ++ +RS GTP + AP
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAP 170
Query: 296 E 296
E
Sbjct: 171 E 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-16
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y + K+G GSY V +S ++GK A+K +R+ E RE +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKV--------IRLQEEEGTPFTAIREASL 56
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L+H NIV L ++I + +V EYV PG + + +L ++
Sbjct: 57 LKGLKHANIVLLHDIIH--TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
GL Y+H ++H D+KP NLL++ +G +K+ DF +++
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
N YV ++ +G G++G V R L G++ AIK K P T + R RE+
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK---------PFSTPVLAKRTYREL 60
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
++K L+H NI++L ++ P D Y V E + D + + + +L I
Sbjct: 61 KLLKHLRHENIISLSDIFISPLED-IYFVTELLGT--DLHRLLTSRPLEKQFIQYFLYQI 117
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
+ GL Y+H VVH D+KP N+L+ + +KI DF ++++
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 36/179 (20%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR------R 173
Y+ +R +G GS G V S++D RVA + +TD + R
Sbjct: 7 YMDLRPLGCGSNGLVF---SAVDSD------------CDKRVAVKKIVLTDPQSVKHALR 51
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSD---------HF---YMVLEYVEGKWDNDGFGQPG 221
E+ I++ L H NIV + EV+ SD Y+V EY+E D + G
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET--DLANVLEQG 109
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDD 279
+ E AR ++ ++ GL Y+H NV+H D+KP N+ + V KIGDF ++++ +
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + K+G GSY V RS L G+ A+K ++R+ E A RE ++K
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALK--------EIRLEHEEGAPFTAIREASLLK 58
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L+H NIV L ++I + V EY++ G + R +L ++ GL
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTL--VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
Y H V+H D+KP NLL++ G +K+ DF
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADF 147
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 56/172 (32%), Positives = 83/172 (48%), Gaps = 9/172 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++GKV+L + G++YA+K K ++ VA E A T VL + +HP
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL--QNSRHPF 56
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D V+EY G + E AR Y +IVS L YLH
Sbjct: 57 LTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114
Query: 246 -NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
NVV+ D+K +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+++Y V KIG G+YG V R + + A+K K L + TA+ RE+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAI----REIS 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDI 235
++K +QH NIV L +V+ + Y+V EY++ P A + + YL I
Sbjct: 54 LLKEMQHGNIVRLQDVVH--SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT- 293
+ G+ Y H H V+H D+KP NLL+ +K+ DF +++ F G PV T
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----------GIPVRTF 160
Query: 294 ----------APECCLG 300
APE LG
Sbjct: 161 THEVVTLWYRAPEILLG 177
|
Length = 294 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 19/181 (10%)
Query: 124 RKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+++G G++G VV +Y GK A+K + H++ + + RE +M
Sbjct: 1 KELGHGNFGSVVKGVYLMK-SGKEVEVAVKTLKQEHIAAGK--------KEFLREASVMA 51
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L HP IV LI V +V+E + I S ++ + G+
Sbjct: 52 QLDHPCIVRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
YL + VH D+ N+L+ KI DF +S+ +D R + P+ + APE
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 297 C 297
C
Sbjct: 169 C 169
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 60/182 (32%), Positives = 79/182 (43%), Gaps = 26/182 (14%)
Query: 126 IGAGSYGKVVLYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
IG G +G+V R L GK AIK L+ S+ D E IM
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKT--------LKAGSSDKQRLDFLTEASIMGQFD 63
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDGFGQPGAIGESMARKYLRDIV 236
HPNI+ L V+ S ++ EY+E G D NDG G + LR I
Sbjct: 64 HPNIIRLEGVVT--KSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-----VGMLRGIA 116
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTA 294
SG+ YL N VH D+ N+LV + K+ DF +S+ ED G P+ +TA
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 295 PE 296
PE
Sbjct: 177 PE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + +AIKA K + + + T V R VL + +HP
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKD----VVLEDDDVECTMVERRVLALAW-EHPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ +L +H + V+EY+ G G E+ AR Y +I+ GL +LH
Sbjct: 58 LTHLFCTFQ--TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
+++ D+K DN+L+ G +KI DF + + + GTP + APE G
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 43/176 (24%)
Query: 126 IGAGSYGKVVLYRSSLDGKHY-------AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+G G++GKV Y+ L G + AIK ++ K++ + R+E +M
Sbjct: 13 LGEGAFGKV--YKGELTGPNERLSATSVAIKTLKENAEPKVQ--------QEFRQEAELM 62
Query: 179 KMLQHPNIVNLIEVI--DDPNSDHFYMVLEY------------------VEGKWDNDGFG 218
LQHPNIV L+ V + P M+ EY V + ++
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTC----MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ + I +G+ YL H+ VH D+ N LV TVKI DF +S+
Sbjct: 119 SSLDCSDFLHIAI--QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 123 VRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
++ +G G YGKV R + GK +A+K K+ + + +TA T R I++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR---NQKDTAHTKAERN--ILE 55
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
++HP IV+LI Y++LEY+ G + G E A YL +I L
Sbjct: 56 AVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+LH +++ D+KP+N+L+ G VK+ DF + + + V GT + APE
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 28/191 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+R +G G +GKV L R +G + + KS L+ + D+++E+ I++ L
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS----LKPESGGNHIADLKKEIEILRNLY 64
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR-----------KY 231
H NIV + + + +++E++ G++ E + R KY
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPS----------GSLKEYLPRNKNKINLKQQLKY 114
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGT 289
I G+ YL VH D+ N+LV VKIGDF +++ E D + ++ +
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 290 PVF-TAPECCL 299
PVF APEC +
Sbjct: 175 PVFWYAPECLI 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-15
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + KIG GS+G+V + K AIK + + +E + D+++E+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 57
Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
P + + D ++++EY+ G D +PG + E+ LR+I+ G
Sbjct: 58 QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 113
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH +H DIK N+L++ G VK+ DF V+ D GTP + APE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 43/211 (20%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+++ ++ IG G++G+V L R G+ YA+K KS + + ++ A VR E I
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM----IKRNQIAH--VRAERDI 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRD 234
+ P IV L D +H Y+V+EY+ G D + E AR Y+ +
Sbjct: 55 LADADSPWIVKLYYSFQD--EEHLYLVMEYMPG---GDLMNLLIRKDVFPEETARFYIAE 109
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND------------- 281
+V L +H +H DIKPDN+L+ G +K+ DF + + D
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 282 ---------------VLRRSP-GTPVFTAPE 296
V S GTP + APE
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 12/178 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y KIG G+ G V G+ AI+ + L+ P + + + E+L+M
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ ++PNIVN ++ D ++V+EY+ G D + + E R+ +
Sbjct: 72 RENKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 128
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH + V+H DIK DN+L+ G+VK+ DF + GTP + APE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 7/173 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
R +G GS+GKV+L R G+ YA+K K + L+ E MT+ R ++ H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKR---ILSLARNH 55
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
P + L P D + V+E+V G + E+ AR Y +I S LM+LH
Sbjct: 56 PFLTQLYCCFQTP--DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+L+ G K+ DF + + + GTP + APE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ IG G+YGKV + +G A+K P ++ E I+K L
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILD----------PIHDIDEEIEAEYNILKALS 72
Query: 183 -HPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDND---GFGQPGA-IGESMARKYLRD 234
HPN+V + D N D ++VLE G D GF + G + E + L +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVF 292
+ GL +LH + +H D+K +N+L+ G VK+ DF VS + LRR S GTP +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFW 190
Query: 293 TAPE 296
APE
Sbjct: 191 MAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 62/186 (33%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+ IGAG +G+V R L GK AIK L+ +E D E IM
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKT--------LKAGYTEKQRRDFLSEASIMGQ 61
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLR 233
HPNI++L V+ S +V EY+E G D +DG F +G LR
Sbjct: 62 FDHPNIIHLEGVVT--KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG------MLR 113
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-- 291
I SG+ YL VH D+ N+LV + K+ DF +S+V EDD + + G +
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 292 -FTAPE 296
+TAPE
Sbjct: 174 RWTAPE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYR-SSLDGKHYAIKAFHKSHLSK 158
K+S+ + +N K ++ +R +G GS+G+V+L + D AIK F KS + K
Sbjct: 13 KDSDSTKEPKRKNKMKY-EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 159 LRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG 218
+ + V E I+ + HP VNL D + Y+VLE+V G
Sbjct: 72 ------QKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLR 123
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
+ + Y IV YL N+V+ D+KP+NLL+ G +K+ DF ++V +
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183
Query: 279 DNDVLRRSPGTPVFTAPECCL 299
L GTP + APE L
Sbjct: 184 RTYTL---CGTPEYIAPEILL 201
|
Length = 340 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 61/203 (30%), Positives = 85/203 (41%), Gaps = 47/203 (23%)
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
DENG +++ +G G+YG V YA + +++R+A E
Sbjct: 8 DENGERVV--------LGKGTYGIV-----------YAARDLS----TQVRIAIKEIPER 44
Query: 170 DVR------REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDN 214
D R E+ + L+H NIV + D + F + +E V G KW
Sbjct: 45 DSRYVQPLHEEIALHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWG- 101
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVS 273
P E Y + I+ GL YLH + +VH DIK DN+LV SG VKI DF S
Sbjct: 102 -----PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156
Query: 274 QVFEDDNDVLRRSPGTPVFTAPE 296
+ N GT + APE
Sbjct: 157 KRLAGINPCTETFTGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++ ++ ++GAG+ G V GK A+K +R+ +E + RE+ I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVK--------TIRLEINEAIQKQILRELDI 52
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIV 236
+ P IV + + +EY++G + + G I E + K ++
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 237 SGLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
GL YLH H ++H D+KP N+LV G +K+ DF VS N + + GT + AP
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAP 168
Query: 296 E 296
E
Sbjct: 169 E 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 2e-14
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 12/178 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y KIG G+ G V G+ AIK + L+ P + + + E+L+M
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN------LQQQPKKELIIN---EILVM 70
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ ++PNIVN ++ D ++V+EY+ G D + + E R+ +
Sbjct: 71 RENKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 127
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH + V+H DIK DN+L+ G+VK+ DF + GTP + APE
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y +R +G G++G V L R D K IK ++K + E ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-------DERLAAQNECQVL 53
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYM-VLEYVEGKWDNDGFGQPGA--IGESMARKYLRDI 235
K+L HPNI IE ++ D M V+EY G + + + E + I
Sbjct: 54 KLLSHPNI---IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ L ++H ++H D+K N+L+ V KIGDF +S++ + GTP + +
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-YTVVGTPCYIS 169
Query: 295 PECCLG 300
PE C G
Sbjct: 170 PELCEG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 12/182 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
++ ++ IG G++G+V L R + YA+K K + K S++A R+
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK----RSDSAFFWEERD-- 95
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
IM IV L D + YMV+EY+ G D I E AR Y ++V
Sbjct: 96 IMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGG-DLVNLMSNYDIPEKWARFYTAEVV 152
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTA 294
L +H +H D+KPDN+L+ SG +K+ DF + D N ++R GTP + +
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYIS 211
Query: 295 PE 296
PE
Sbjct: 212 PE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ + +KIG G + V LDG+ A+K + + A D +E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK------ARQDCLKEID 54
Query: 177 IMKMLQHPNIVN-LIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKY 231
++K L HPN++ L I++ + +VLE + + Q I E KY
Sbjct: 55 LLKQLDHPNVIKYLASFIEN---NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
+ S L ++H ++H DIKP N+ + +G VK+GD + + F GTP
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 292 FTAPE 296
+ +PE
Sbjct: 172 YMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +R+IG GS+G V R + + AIK S S D+ +EV ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG------KQSNEKWQDIIKEVRFLQ 70
Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
L+HPN I+ +H ++V+EY G + + E + G
Sbjct: 71 KLRHPNT---IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
L YLH HN++H D+K N+L++ G VK+GDF + + N + GTP + APE
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVI 183
Query: 299 LG 300
L
Sbjct: 184 LA 185
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++ +G G G+V L R GK +A+K K + K + V E I+ L
Sbjct: 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLD 59
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGA-IGESMARKYLRDIVS 237
HP + L + +V++Y G + F QPG + E +AR Y +++
Sbjct: 60 HPFLPTLYASFQ--TETYLCLVMDYCPG---GELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
L YLH +V+ D+KP+N+L+ SG + + DF +S
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++ R G A+K + + E + +R+E+ +M L HP+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPH 64
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
I+ ++ HF + +E++ G + + GA E++ Y ++ GL YLH +
Sbjct: 65 IIRMLGATC--EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 246 NVVHGDIKPDNLLVAPSGT-VKIGDF 270
++H D+K NLL+ +G ++I DF
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G + Y+ + K+G G+Y V RS L A+K ++R+ E A
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAI 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA---- 228
REV ++K L+H NIV L +++ S +V EY+ D D G M+
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKS--LTLVFEYL----DKDLKQYMDDCGNIMSMHNV 106
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ +L I+ GL Y H V+H D+KP NLL+ G +K+ DF +++
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 32/185 (17%)
Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
RK+GAG +G+V + + A+K +S +E IMK
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK---VAVKTLKPGTMSP----------EAFLQEAQIMKK 57
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQ----PGAIGESMARKYL 232
L+H +V L V + + Y+V EY+ + G G+ P + MA +
Sbjct: 58 LRHDKLVQLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD--MAAQ-- 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
I G+ YL N +H D+ N+LV + KI DF ++++ EDD R P+
Sbjct: 112 --IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169
Query: 292 FTAPE 296
+TAPE
Sbjct: 170 WTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
YV + K+G G+Y V RS L A+K ++R+ E A REV ++K
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAIREVSLLK 58
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA----RKYLRDI 235
L+H NIV L ++I +V EY+ D+D G M+ + ++ +
Sbjct: 59 NLKHANIVTLHDIIHTERC--LTLVFEYL----DSDLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ GL Y H ++H D+KP NLL+ G +K+ DF +++
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---EVL 176
YV ++ IG G+YG V ++S + AIK + ++ D +R E+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR----------IDAKRTLREIK 56
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQ----PGAIGESMAR 229
+++ L H N++ + +++ P+ + F Y+V E + D D Q + + +
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM----DTD-LHQIIRSSQTLSDDHCQ 111
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
+L ++ GL Y+H NV+H D+KP NLL+ + +KI DF +++ + D + T
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 290 PVFTAPECCL 299
+ APE L
Sbjct: 172 RWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 32/190 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +R+IG GS+G V R + AIK S S D+ +EV ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQ 70
Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI--- 235
L+HPN IE +H ++V+EY G I E + +K L+++
Sbjct: 71 QLRHPNT---IEYKGCYLREHTAWLVMEYC--------LGSASDILE-VHKKPLQEVEIA 118
Query: 236 ------VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
+ GL YLH H +H DIK N+L+ GTVK+ DF + + N + GT
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV----GT 174
Query: 290 PVFTAPECCL 299
P + APE L
Sbjct: 175 PYWMAPEVIL 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 24/172 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++ V+ IG G++G+V L + GK YA+K KS + K + + V+ E +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK------KDQLAHVKAERDV 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMAR 229
+ P +V+L D + + Y+++E++ G K+D E + R
Sbjct: 55 LAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYD--------TFSEDVTR 104
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
Y+ + V + +H +H DIKPDN+L+ G +K+ DF +S F +D
Sbjct: 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-14
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 12/177 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+KIG G + +V LD K A+K K + ++ A A D +E+ ++K L H
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALK---KVQIFEMMDA---KARQDCVKEIDLLKQLNH 61
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGL 239
PN++ ++ + N +VLE + + Q I E KY + S +
Sbjct: 62 PNVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
++H V+H DIKP N+ + +G VK+GD + + F GTP + +PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 11/177 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + +IG GS+G+V + + AIK + + +E + D+++E+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKI--------IDLEEAEDEIEDIQQEITVLS 57
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
P I ++++EY+ G D +PG + E+ LR+I+ GL
Sbjct: 58 QCDSPYITRYYGSY--LKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGL 114
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH +H DIK N+L++ G VK+ DF V+ D GTP + APE
Sbjct: 115 DYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 27/166 (16%)
Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREVL 176
++++G G+YG V + + + AIK F K L+K + RE+
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----------RELK 53
Query: 177 IMKMLQ-HPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARK 230
+++ + H NI L +++ N + Y+ E +E D GQP + ++ +
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME--ADLHQIIRSGQP--LTDAHFQS 109
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
++ I+ GL Y+H NV+H D+KP NLLV +KI DF +++ F
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 10/179 (5%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y V+ IG G++G+V L R K YA+K K + K S++A R+ IM
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 97
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
P +V L D + YMV+EY+ G D + E AR Y ++V
Sbjct: 98 AFANSPWVVQLFYAFQD--DRYLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPE 296
L +H +H D+KPDN+L+ SG +K+ DF + V + GTP + +PE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G + Y+ + K+G G+Y V RS L A+K ++R+ E A
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALK--------EIRLEHEEGAPCTAI 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN--DGFGQPGAIGESMARK 230
REV ++K L+H NIV L ++I S +V EY++ D G +I +
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGN--SINMHNVKL 108
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+L ++ GL Y H V+H D+KP NLL+ G +K+ DF +++
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 10/179 (5%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y V+ IG G++G+V L R K YA+K K + K S++A R+ IM
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 97
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
P +V L D + YMV+EY+ G D + E A+ Y ++V
Sbjct: 98 AFANSPWVVQLFCAFQD--DKYLYMVMEYMPGG-DLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPE 296
L +H ++H D+KPDN+L+ G +K+ DF ++ V + GTP + +PE
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 30/181 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---------EV 175
KIG GS G V + R G+ A+K M D+R+ EV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK------------------MMDLRKQQRRELLFNEV 69
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
+IM+ QH N+V + + + ++++E+++G D Q E +A +
Sbjct: 70 VIMRDYQHQNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-TVCESV 126
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
+ L YLH V+H DIK D++L+ G VK+ DF D + GTP + AP
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 296 E 296
E
Sbjct: 187 E 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 16/179 (8%)
Query: 124 RKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+KIG G + +V YR++ LDG A+K L + A D +E+ ++K L
Sbjct: 8 KKIGRGQFSEV--YRATCLLDGVPVALKKVQIFDLMDAK------ARADCIKEIDLLKQL 59
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVS 237
HPN++ + N +VLE + + Q I E KY + S
Sbjct: 60 NHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L ++H V+H DIKP N+ + +G VK+GD + + F GTP + +PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YAIK K + ++ E M + R L K P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGK---PPF 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D Y V+EYV G Q G E A Y +I GL +LH
Sbjct: 63 LTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+++ G +KI DF + + R GTP + APE
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 14/182 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL-RVAPSETAMTDVRREVLIMKMLQ 182
R IG G++G V DGK A+K K+ V + + V RE+ ++ +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALK--------KMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 183 HPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
H N+++ ++++ P+ D F Y+V E ++ P + + +L I+ GL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKI-IVSPQPLSSDHVKVFLYQILRGL 116
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSPGTPVFTAPECC 298
YLH ++H DIKP NLLV + +KI DF +++V E D++ + + T + APE
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 299 LG 300
+G
Sbjct: 177 MG 178
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 52/172 (30%), Positives = 73/172 (42%), Gaps = 25/172 (14%)
Query: 123 VRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLS-------KLRVAPSETAMTDVRRE 174
V K+G G +G+V L + L A + + + LR S+ A D +E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQ---PGAIGESMARK 230
V I+ L PNI L+ V M++EY+E G D + F Q G + K
Sbjct: 70 VKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENG--DLNQFLQKHVAETSGLACNSK 125
Query: 231 YLR---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
L I SG+ YL N VH D+ N LV + T+KI DF +S
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFH----KSHLSKLRVAPSETAMT-DVRREVLIMKM 180
+G G+YGKV +L GK AIK + ++K R + RE+ IM
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVS 237
++H NI+ L++V D +V++ + K + + ES + L I++
Sbjct: 77 IKHENIMGLVDVY--VEGDFINLVMDIMASDLKKVVDRKI----RLTESQVKCILLQILN 130
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
GL LH +H D+ P N+ + G KI DF +++ +
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YAIK K + L+ + MT+ R L K HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAK---HPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D + V+EYV G + E +R Y ++ LM+LH H
Sbjct: 58 LTALHCCFQTK--DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
V++ D+K DN+L+ G K+ DF + + + GTP + APE
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +R+IG GS+G V R + AIK S S D+ +EV ++
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG------KQSNEKWQDIIKEVKFLQ 80
Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
++HPN IE +H ++V+EY G + + E + G
Sbjct: 81 RIKHPNS---IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
L YLH HN++H DIK N+L+ G VK+ DF + + N + GTP + APE
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV----GTPYWMAPEVI 193
Query: 299 LG 300
L
Sbjct: 194 LA 195
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL----IMKM 180
++G G YG+V L + G+ A+K KS L KL + R VL I+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL----------NEVRHVLTERDILTT 57
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
+ +V L+ D + Y+ +EYV G G + E AR Y+ ++ +
Sbjct: 58 TKSEWLVKLLYAFQDDE--YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPVFTAPE 296
LH +H D+KP+N L+ SG +K+ DF +S+ + N V+ G+P + APE
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 44/201 (21%)
Query: 125 KIGAGSYGKVVLYR--SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
K+G G+YG V + D K YA+K + +S RE+ +++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----------MSACREIALLRELK 56
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGF-------GQPGAIGESMARKYLRD 234
HPN++ L +V + +++ +Y E W F +P + SM + L
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
I+ G+ YLH + V+H D+KP N+LV G VKI D +++F SP P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--------SPLKP 168
Query: 291 V-----------FTAPECCLG 300
+ + APE LG
Sbjct: 169 LADLDPVVVTFWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 35/171 (20%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVL 176
Y ++ IG G+YG V G AIK +++P E R RE+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK----------KISPFEHQTFCQRTLREIK 55
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEG---------KWDNDGFGQPGAIG 224
I++ +H NI+ ++++I P+ + F Y+V E +E ND
Sbjct: 56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSND--------- 106
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
+ +L I+ GL Y+H NV+H D+KP NLL+ + +KI DF ++++
Sbjct: 107 --HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 36/187 (19%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+RK+GAG +G+V + + A+K + P D E IMK L
Sbjct: 11 LRKLGAGQFGEV--WEGLWNNTTPVAVKT----------LKPGTMDPKDFLAEAQIMKKL 58
Query: 182 QHPNIVNLIEV--IDDPNSDHFYMV---------LEYVEGKWDNDGFGQPGAIGESMARK 230
+HP ++ L V +++P Y+V LEY++G P I MA +
Sbjct: 59 RHPKLIQLYAVCTLEEP----IYIVTELMKYGSLLEYLQGG-AGRALKLPQLID--MAAQ 111
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
+ SG+ YL N +H D+ N+LV + K+ DF +++V ++D R P
Sbjct: 112 ----VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 291 V-FTAPE 296
+ +TAPE
Sbjct: 168 IKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 57/216 (26%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--RE 174
+ Y +R IG G G+V L Y + L K+R SE + R RE
Sbjct: 1 MQRYDIIRLIGKGGMGEVYL--------AYDPVCSRRVALKKIREDLSENPLLKKRFLRE 52
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK---------WDNDGFGQPGAIGE 225
I L HP IV + + D D Y + Y+EG W + + A
Sbjct: 53 AKIAADLIHPGIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT 110
Query: 226 SMARKYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
S+ +L I + + Y+H V+H D+KPDN+L+ G V I D+ + + + +
Sbjct: 111 SVG-AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 283 LR------------------RSPGTPVFTAPECCLG 300
L + GTP + APE LG
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 34/190 (17%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G+V + GK YA K +K L K + E AM + R I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK--GYEGAMVEKR----ILAKVHSRF 54
Query: 186 IVNLIEVIDDPNSD---------------HFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
IV+L +D H Y V E +N GF +P A
Sbjct: 55 IVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIYNVDE------ENPGFPEPRAC------F 101
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
Y I+SGL +LH +++ D+KP+N+L+ G V+I D ++ +D + GTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 291 VFTAPECCLG 300
F APE G
Sbjct: 162 GFMAPELLQG 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 39/196 (19%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRR---EV 175
++K+G G+YG V + A+K AF + TD +R E+
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--------------TDAQRTFREI 57
Query: 176 LIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY-LR 233
+ ++ L HPNIV L+ VI N Y+V EY+E D + I E + ++Y +
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET--DLHAVIRAN-ILEDVHKRYIMY 114
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
++ L Y+H NV+H D+KP N+L+ VK+ DF +++ + + +P PV T
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE----NPENPVLT 170
Query: 294 ---------APECCLG 300
APE LG
Sbjct: 171 DYVATRWYRAPEILLG 186
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G+YG V+ R + AIK F S +E RE+ +++ L+ N
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSE-------ENEEVKETTLRELKMLRTLKQEN 61
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV L E Y+V EYVE P + R Y+ ++ + + H +
Sbjct: 62 IVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPECCLG 300
++VH DIKP+NLL++ + +K+ DF ++ + ++ T + +PE LG
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-13
Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 126 IGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
IG G +G V+L YR G+ A+K K TA E +M L+H
Sbjct: 14 IGKGEFGDVMLGDYR----GQKVAVKCL-KDDS---------TAAQAFLAEASVMTTLRH 59
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMY 241
PN+V L+ V+ + Y+V EY+ D G I + + D+ G+ Y
Sbjct: 60 PNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
L N VH D+ N+LV+ K+ DF +++ D + PV +TAPE
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+V + +IG GS+G V +S + A+K S + D+ +EV ++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG------KQTNEKWQDIIKEVKFLQ 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
L+HPN IE +H ++V+EY G + + E + G
Sbjct: 77 QLKHPNT---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
L YLH HN++H DIK N+L+ G VK+ DF + N + GTP + APE
Sbjct: 134 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVI 189
Query: 299 LG 300
L
Sbjct: 190 LA 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 42/193 (21%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHK--SHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
IG GSYG V + G+ AIK + H+S T + RE+ ++++L+H
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD---------ATRILREIKLLRLLRH 58
Query: 184 PNIVNLIEVIDDPNSDHF---YMVLEYVEG------KWDNDGFGQPGAIGESMARKYLRD 234
P+IV + ++ P+ F Y+V E +E K ++D + + +L
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-------LTPEHHQFFLYQ 111
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT- 293
++ L Y+H NV H D+KP N+L +KI DF +++V +D +P +T
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND------TPTAIFWTD 165
Query: 294 --------APECC 298
APE C
Sbjct: 166 YVATRWYRAPELC 178
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 11/179 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++Y ++++G+G+YG V R+ G+ A+K +++ P + + +++E+ +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKI--------IKLEPGDD-FSLIQQEIFM 59
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K +H NIV + + ++ +EY G D + G + E R+ +
Sbjct: 60 VKECKHCNIVAYFGSY--LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL YLH +H DIK N+L+ +G VK+ DF V+ + GTP + APE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G++G+V + + G+ YA+K +K + K +ETA R+VL+ +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK----RAETACFREERDVLVNGDRRW-- 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
I NL D N + Y+V++Y G K+++ + E MAR YL ++V
Sbjct: 63 ITNLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYLAEMVL 113
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFTAPE 296
+ +H VH DIKPDN+L+ +G +++ DF D V + GTP + +PE
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YAIK K + + + T V + VL ++ + P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALQD-KPPF 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D Y V+EYV G Q G E A Y +I GL +LH
Sbjct: 63 LTQLHSCFQ--TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+++ G +KI DF + + D R GTP + APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 49/169 (28%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV---APSETAMTDVRREVLIMK 179
R++G G++GKV L G+ Y ++ + L ++ S A D RE ++
Sbjct: 10 KRELGEGAFGKVFL------GECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDN------------DGFGQP-GAIGE 225
QH NIV V + D MV EY+E G + P G +
Sbjct: 64 NFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
S + I SG++YL + VH D+ N LV VKIGDF +S+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 43/174 (24%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA----PSETAMTDVRR---EVL 176
R IG G +G V + + + K+ VA + T+ + + E
Sbjct: 12 RCIGEGQFGDV----------YQGV--YMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR------- 229
IM+ HP+IV LI VI + ++V+E G + +
Sbjct: 60 IMRQFDHPHIVKLIGVITENPV---WIVME----------LAPLGELRSYLQVNKYSLDL 106
Query: 230 ----KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
Y + + L YL VH DI N+LV+ VK+GDF +S+ ED+
Sbjct: 107 ASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 10/178 (5%)
Query: 123 VRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+R +G G+YGKV L R GK YA+K K+ + + + +E T+ R+VL
Sbjct: 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTE--RQVL-EA 60
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
+ + P +V L +++L+YV G Q ES R Y+ +IV L
Sbjct: 61 VRRCPFLVTLHYAFQ--TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTAPE 296
+LH +++ DIK +N+L+ G V + DF +S+ F + + S GT + APE
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 52/184 (28%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 125 KIGAGSYGKVVLYR---SSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
K+G GS+G V+ R S+ GK A+K LS M D +E IM
Sbjct: 2 KLGDGSFG--VVRRGEWSTSGGKVIPVAVKCLKSDKLSD--------IMDDFLKEAAIMH 51
Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIV 236
L H N++ L V+ P MV E D G S Y I
Sbjct: 52 SLDHENLIRLYGVVLTHP----LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FT 293
+G+ YL +H D+ N+L+A VKIGDF + + + D V +
Sbjct: 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 294 APEC 297
APE
Sbjct: 168 APES 171
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G+V + GK YA K K L K + M +++L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK----GEQMALNEKKIL--EKVSSRF 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
IV+L + D +V+ + G K+ G+PG E+ A Y I+ GL +L
Sbjct: 55 IVSLAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHL 111
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H +V+ D+KP+N+L+ G V+I D ++ + + R+ GTP + APE G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQG 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 54/188 (28%), Positives = 77/188 (40%), Gaps = 38/188 (20%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDV---RREVL---- 176
KIG G++G V Y+ L G VA T +R+ L
Sbjct: 1 EKIGKGNFGDV--YKGVLKGN--------------TEVAVKTCRSTLPPDLKRKFLQEAE 44
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL---- 232
I+K HPNIV LI V Y+V+E V G + + K L
Sbjct: 45 ILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMS 99
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--- 289
D +G+ YL N +H D+ N LV + +KI DF +S+ E++ + S G
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQI 157
Query: 290 PV-FTAPE 296
P+ +TAPE
Sbjct: 158 PIKWTAPE 165
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 45/181 (24%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y+ +++G GS+G V L + +K + + +L P+ET + E ++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN--PNETVQANQ--EAQLLS 57
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR----KYLRDI 235
L HP IV + D F ++ EY EG+ + + G++++ ++ +
Sbjct: 58 KLDHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
+ G+ Y+H ++H D+K N+ + + +KIGDF VS++ D+ GTP + +P
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 296 E 296
E
Sbjct: 175 E 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIMKML 181
++ IG G++G+V L + G YA+K KS L K +VA VR E I+
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA-------HVRAERDILAEA 58
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLR 233
+P +V L D N + Y+++EY+ G K D E R Y+
Sbjct: 59 DNPWVVKLYYSFQDEN--YLYLIMEYLPGGDMMTLLMKKD--------TFTEEETRFYIA 108
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ + + +H +H DIKPDNLL+ G +K+ DF
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDF 145
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 35/177 (19%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
+ Y ++ +G+G+YG+V + G+ AIK KL P ++A+ R RE+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--------KLS-RPFQSAIHAKRTYREL 65
Query: 176 LIMKMLQHPNIVNLIEVI--DDPNSD--HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++K + H N++ L++V D Y+V + D + + +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM----GAD-------LNNIVKCQK 114
Query: 232 LRD---------IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
L D I+ GL Y+H ++H D+KP N+ V +KI DF +++ +D+
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++ IG G++G+V + + + YA+K +K + K +ETA R VL+ Q
Sbjct: 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK----RAETACFREERNVLVNGDCQ 61
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
I L D N + Y+V++Y G K+++ + E MAR Y+ +
Sbjct: 62 W--ITTLHYAFQDEN--YLYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYIAE 110
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFT 293
+V + +H + VH DIKPDN+L+ +G +++ DF D V + GTP +
Sbjct: 111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 294 APE 296
+PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L G+++A+KA K + + + T V + VL + ++P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD----VVLIDDDVECTMVEKRVLALAW-ENPF 57
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ +L +H + V+E++ G G A Y +IV GL +LH
Sbjct: 58 LTHLYCTFQ--TKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQ--VFEDDNDVLRRSP--GTPVFTAPECCLG 300
+++ D+K DN+++ G +KI DF + + VF D+ R S GTP + APE G
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN----RASTFCGTPDYIAPEILQG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 44/201 (21%)
Query: 125 KIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
K+G G+YG V + D + YA+K + +S RE+ +++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----------MSACREIALLRELK 56
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGF-------GQPGAIGESMARKYLRD 234
HPN+++L +V +++ +Y E W F +P + M + L
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
I+ G+ YLH + V+H D+KP N+LV G VKI D +++F SP P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--------SPLKP 168
Query: 291 V-----------FTAPECCLG 300
+ + APE LG
Sbjct: 169 LADLDPVVVTFWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
+ IG G+YGKV + DG A+K P ++ E I++ L
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILD----------PISDVDEEIEAEYNILQSLP 76
Query: 182 QHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDND---GFGQPGA-IGESMARKYLRD 234
HPN+V + D ++VLE G + G G + E+M L
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVF 292
+ GL +LH + ++H D+K +N+L+ G VK+ DF VS LRR S GTP +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFW 194
Query: 293 TAPE 296
APE
Sbjct: 195 MAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 57/186 (30%), Positives = 81/186 (43%), Gaps = 33/186 (17%)
Query: 126 IGAGSYGKVVLYRSSLD--GKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
IGAG +G+V +R L G+ AIK + K R D E IM
Sbjct: 13 IGAGEFGEV--FRGILKMPGRKEVAVAIKTLKPGYTEKQRQ--------DFLSEASIMGQ 62
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW------DNDG-FGQPGAIGESMARKYLR 233
H NI+ L V+ ++ EY+E D+DG F +G LR
Sbjct: 63 FSHHNIIRLEGVVT--KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLR 114
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-- 291
I +G+ YL N VH D+ N+LV + K+ DF +S+V EDD + + G +
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 292 -FTAPE 296
+TAPE
Sbjct: 175 RWTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
+V ++ IG G++G+V L R YA+K K+ L + + A V+ E I+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-------HVKAERDIL 55
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ +V L D D+ Y V++Y+ G + G E +AR Y+ ++
Sbjct: 56 AEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA 113
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ +H +H DIKPDN+L+ G +K+ DF
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V+K+GAG +G+V + Y +S A+K + P ++ E +MK
Sbjct: 11 VKKLGAGQFGEVWMGYYNNS---TKVAVKT----------LKPGTMSVQAFLEEANLMKT 57
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK---YLRDIVS 237
LQH +V L V+ + Y++ EY+ K F + G+ + K + I
Sbjct: 58 LQHDKLVRLYAVVT--KEEPIYIITEYM-AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
G+ Y+ N +H D++ N+LV+ S KI DF +++V ED+ R P+ +TAPE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 20/176 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
KIG GS G V + GK A+K LR + + EV+IM+ H
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFN---EVVIMRDYHHE 79
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
N+V++ NS D ++V+E++EG D E +A L ++ L
Sbjct: 80 NVVDMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL-SVLRALS 132
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH V+H DIK D++L+ G +K+ DF + + GTP + APE
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 18/160 (11%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
++++G+G +G V L +R +D AIK + +S+ D E +M
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMIREGAMSE----------DDFIEEAKVMMK 55
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L HPN+V L V ++V EY+ G N + G +G D+ +
Sbjct: 56 LSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
YL + +H D+ N LV VK+ DF +++ DD
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
H R +G G +G+V + GK YA K K + K + E + ++ I++ +
Sbjct: 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKQ---ILEKV 57
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSG 238
+V+L + D +VL + G K+ G PG E A Y +I G
Sbjct: 58 NSRFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCG 114
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L LH +V+ D+KP+N+L+ G ++I D ++ V + + +R GT + APE
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ ++G G++GKV Y++ K + A K +K SE + D E+ I+
Sbjct: 10 IGELGDGAFGKV--YKAQ--NKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCD 60
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
HPNIV L++ N+ ++++E+ G D + E R + + L Y
Sbjct: 61 HPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
LH + ++H D+K N+L G +K+ DF VS ++ + RR GTP + APE +
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVM 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 107 RSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS 164
E+ N T ++ Y ++++G+G+YG V G+ AIK R S
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQS 54
Query: 165 ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH----FYMVLEYVEGKWDNDGFGQP 220
E RE+ ++K +QH N++ L++V S FY+V+ Y++ G P
Sbjct: 55 EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHP 113
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ E + + ++ GL Y+H ++H D+KP NL V +KI DF +++
Sbjct: 114 --LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 55/164 (33%), Positives = 75/164 (45%), Gaps = 26/164 (15%)
Query: 126 IGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
IGAG +G+V R L GK AIK L+ +E D E IM
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKT--------LKSGYTEKQRRDFLSEASIMGQFD 63
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLRDI 235
HPNI++L V+ S ++ E++E G D NDG F +G LR I
Sbjct: 64 HPNIIHLEGVVT--KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGI 115
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+G+ YL N VH D+ N+LV + K+ DF +S+ EDD
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YAIK K + + + T V + VL + + P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALSG-KPPF 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
+ L D Y V+EYV G Q G E A Y +I GL +LH
Sbjct: 63 LTQLHSCFQ--TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+++ G +KI DF + + D + GTP + APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 21/140 (15%)
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-----WDNDGFGQPGAIGES 226
RRE + L HPNIV L++ + P + V EYV G+ DG G G
Sbjct: 26 RRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVL 283
M + ++ L H +VH D+KP N++V+ +G K+ DF + + D
Sbjct: 85 MLQ-----VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 284 RRSP-------GTPVFTAPE 296
+ GTP + APE
Sbjct: 140 VATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 7/177 (3%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+ +G GS+GKV L + +AIKA K + + + T V + VL + +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKD----VVLMDDDVECTMVEKRVLSLAW-EH 55
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
P + +L ++ + V+EY+ G A Y +I+ GL +LH
Sbjct: 56 PFLTHLYCTFQ--TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
+V+ D+K DN+L+ G +KI DF + + + GTP + APE LG
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 21/183 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKML 181
V +G G+YG+V R G+ AIK + E +++ E+ ++ K
Sbjct: 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----------EDEEEEIKLEINMLKKYS 70
Query: 182 QHPNIVN----LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDI 235
H NI I+ + D ++V+E+ D A+ E R+I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFT 293
+ GL +LH H V+H DIK N+L+ + VK+ DF VS + D V RR+ GTP +
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWM 188
Query: 294 APE 296
APE
Sbjct: 189 APE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 11/177 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + +IG GS+G+V +D + + A L + +E + D+++E+ ++
Sbjct: 6 FTKLERIGKGSFGEVF---KGIDNRTQQVVAIKIIDLEE-----AEDEIEDIQQEITVLS 57
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
P + ++++EY+ G D + G E L++I+ GL
Sbjct: 58 QCDSPYVTKYYGSY--LKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGL 114
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH +H DIK N+L++ G VK+ DF V+ D GTP + APE
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++++G+G+YG V S+LD + A A K + R SE RE+ ++K
Sbjct: 17 YRDLKQVGSGAYGTVC---SALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69
Query: 180 MLQHPNIVNLIEVID-DPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
++H N++ L++V D + D F Y+V+ ++ D + + E + + +
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT--DLGKLMKHEKLSEDRIQFLVYQM 127
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ GL Y+H ++H D+KP NL V +KI DF +++
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 58/182 (31%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+ KIG GS G V + GK A+K LR + + EV+IM+
Sbjct: 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDY 74
Query: 182 QHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
QH N+V + NS D ++V+E++EG D E +A L ++
Sbjct: 75 QHENVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLK 127
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVFTA 294
L LH V+H DIK D++L+ G VK+ DF +QV +V RR GTP + A
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMA 184
Query: 295 PE 296
PE
Sbjct: 185 PE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 18/180 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
++ +G GS+GKV L R G+ YA+K K+ L K+R + T + R++L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVR----DRVRTKMERDILAE- 54
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIV 236
+ HP IV L Y++L+++ G D F + E + YL ++
Sbjct: 55 -VNHPFIVKLHYAFQTEGK--LYLILDFLRG---GDLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH +++ D+KP+N+L+ G +K+ DF +S+ D GT + APE
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 10/163 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
+V ++ +G G++G+V L R YA+K K L + +VA V+ E I+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVA-------HVKAERDIL 55
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ +V L D D+ Y V++Y+ G + G E +AR Y+ ++
Sbjct: 56 AEADNEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
+ +H +H DIKPDN+L+ G +K+ DF + F +D
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 25/181 (13%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
V+K+GAG +G+V + Y AIK+ + +S P E +MK
Sbjct: 11 VKKLGAGQFGEVWMGYYNGH---TKVAIKSLKQGSMS-----PEA-----FLAEANLMKQ 57
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IV 236
LQHP +V L V+ + Y++ EY+E D P I ++ + L D I
Sbjct: 58 LQHPRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINK--LIDMAAQIA 112
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
G+ ++ N +H D++ N+LV+ + KI DF ++++ ED+ R P+ +TAP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 296 E 296
E
Sbjct: 173 E 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 10/182 (5%)
Query: 123 VRKIGAGSYGKVVLYR--SSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
++ +G G+YGKV L R S D GK YA+K K+ + + T T R+VL
Sbjct: 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ---KAKTTEHTRTERQVL-EH 60
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
+ Q P +V L H ++L+Y+ G Q E + Y +IV L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLH--LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGTPVFTAPECC 298
+LH +++ DIK +N+L+ +G V + DF +S+ F ED+ + GT + AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 299 LG 300
G
Sbjct: 179 RG 180
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
K+G G YG+V A+K + + + + +E +MK ++HP
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHP 62
Query: 185 NIVNLIEVI--DDPNSDHFYMVLEY------VEGKWDNDGFGQPGAIGESMARKYLRDIV 236
N+V L+ V + P FY++ E+ ++ + + + MA + I
Sbjct: 63 NLVQLLGVCTREPP----FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ----IS 114
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
S + YL N +H D+ N LV + VK+ DF +S++ D P+ +TAP
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 296 E 296
E
Sbjct: 175 E 175
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 35/187 (18%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
K+G G +G+V + + +G AIK + P + +E +MK L+H
Sbjct: 13 KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 60
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
+V L V+ + + Y+V EY+ +G + G+ G KYLR
Sbjct: 61 EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAA 109
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
I SG+ Y+ N VH D++ N+LV + K+ DF ++++ ED+ R+ P+ +
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 293 TAPECCL 299
TAPE L
Sbjct: 170 TAPEAAL 176
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-11
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
++G G+YG V G A+K ++R+ E+ + E+ I+ P
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK--------EIRLELDESKFNQIIMELDILHKAVSP 59
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE-GKWDN--DGFGQPGAIGESMARKYLRDIVSGLMY 241
IV+ + YM +EY++ G D G I E + R+ +V GL +
Sbjct: 60 YIVDFYGAFFIEGA--VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 242 L-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
L HN++H D+KP N+LV +G VK+ DF VS
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 56/179 (31%), Positives = 79/179 (44%), Gaps = 35/179 (19%)
Query: 124 RKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
R++G G++GKV L + D A+KA P+ A D +RE ++
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---------PTLAARKDFQREAELL 61
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-------------GQP----G 221
LQH +IV V D D MV EY++ D + F GQP G
Sbjct: 62 TNLQHEHIVKFYGVCGD--GDPLIMVFEYMK-HGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+G S I SG++YL + VH D+ N LV + VKIGDF +S+ V+ D
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 31/170 (18%)
Query: 125 KIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
++G G++GKV L D A+KA ++ SE+A D +RE ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLT 62
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYV--------------EGKWDNDGFGQP-GAIG 224
+LQH +IV V + MV EY+ + K G G +
Sbjct: 63 VLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
I SG++YL + VH D+ N LV VKIGDF +S+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G +G+V R + GK YA+K K ++++ ET + R + ++ P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + P D +L+ + G + Q G E R Y +I+ GL ++H
Sbjct: 59 IVCMTYAFHTP--DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
VV+ D+KP N+L+ G V+I D ++ F S GT + APE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 25/185 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKML 181
V +G G+YG+V R G+ AIK + V E ++++E+ ++ K
Sbjct: 11 VELVGNGTYGQVYKGRHVKTGQLAAIKV--------MDVTGDEE--EEIKQEINMLKKYS 60
Query: 182 QHPNIVNLIEVIDDPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL----R 233
H NI N D ++V+E+ D G ++ +++ R
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICR 118
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV 291
+I+ GL +LH H V+H DIK N+L+ + VK+ DF VS + D V RR+ GTP
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPY 176
Query: 292 FTAPE 296
+ APE
Sbjct: 177 WMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 53/183 (28%), Positives = 92/183 (50%), Gaps = 24/183 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++ IG G++G+V + + K +A+K +K + K +ETA R+VL+
Sbjct: 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK----RAETACFREERDVLVNG--D 59
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
+ I L D N+ Y+V++Y G K+++ + E MAR YL +
Sbjct: 60 NQWITTLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYLAE 110
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFT 293
+V + +H + VH DIKPDN+L+ +G +++ DF S ++ ED + GTP +
Sbjct: 111 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 294 APE 296
+PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 21/169 (12%)
Query: 125 KIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHL----SKLRVAPSETAMTDVRREVL 176
K+G G +G+V L + K +++ + LR ++ A D +E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-----GFGQPGAIGESMARKY 231
IM L+ PNI+ L+ V SD M+ EY+E N + + + Y
Sbjct: 72 IMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 232 ------LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
I SG+ YL N VH D+ N LV + T+KI DF +S+
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 16/182 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+R +G G +GKV LY + G+ A+K L+ + + ++E+ I+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT--------LKRECGQQNTSGWKKEINIL 60
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
K L H NIV + +++EYV D + + + + + I G
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-YLPKHKLNLAQLLLFAQQICEG 119
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
+ YLH + +H D+ N+L+ VKIGDF +++ + ++ R R G +PVF A
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 296 EC 297
EC
Sbjct: 180 EC 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++++G G++G V L R G+ A+K S LR D RE+ I+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---------DFEREIEIL 59
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIVS 237
K LQH NIV V + +V+EY+ D + + Y I
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
G+ YL VH D+ N+LV VKIGDF +++V D + + R PG +P+F A
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 295 PE 296
PE
Sbjct: 180 PE 181
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 15/181 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+E V++IG+G +G +V L+ + AIK + +S+ D E +
Sbjct: 4 SELTLVQEIGSGQFG-LVWLGYWLEKRKVAIKTIREGAMSE----------EDFIEEAQV 52
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
M L HP +V L V + + +V E++E +D Q G + D+
Sbjct: 53 MMKLSHPKLVQLYGVCTERSP--ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC 110
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
G+ YL NV+H D+ N LV + VK+ DF +++ DD PV +++P
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 296 E 296
E
Sbjct: 171 E 171
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+K+GAG +G+V + + K A+K + P ++ E +MK LQH
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK-VAVKT----------MKPGSMSVEAFLAEANVMKTLQH 60
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMY 241
+V L V+ + Y++ E++ D + + + + I G+ +
Sbjct: 61 DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
+ N +H D++ N+LV+ S KI DF +++V ED+ R P+ +TAPE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 50/170 (29%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH------LSKLRVAPSETAMTDVRREVLIM 178
K+G G +G+V L + + A + LR ++TA D +E+ IM
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 179 KMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE--------SMA 228
L++PNI+ L+ V DDP M+ EY+E N Q S++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 229 RKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
L I SG+ YL N VH D+ N LV T+KI DF +S+
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
+V ++ +G G++G+V L YA+K K L++ +VA V+ E I+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-------HVKAERDIL 55
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ +V L D D+ Y V++Y+ G + E +AR Y+ ++
Sbjct: 56 AEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA 113
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
+ +H +H DIKPDN+L+ G +K+ DF + F
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 54/175 (30%), Positives = 81/175 (46%), Gaps = 10/175 (5%)
Query: 126 IGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+G G+YGKV L R GK YA+K K+ L + + E T+ R VL + Q
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTE--RNVLEH-VRQ 63
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
P +V L H ++L+YV G Q E R Y +I+ L +L
Sbjct: 64 SPFLVTLHYAFQTEAKLH--LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGTPVFTAPE 296
H +V+ DIK +N+L+ G V + DF +S+ F ++ + GT + APE
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 7/171 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G +G+V R + GK YA+K K ++++ ET + R + ++ P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
IV + P D +L+ + G + Q G E+ R Y +I+ GL ++H
Sbjct: 59 IVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
VV+ D+KP N+L+ G V+I D ++ F S GT + APE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
+E ++++G+G +G V L +R+ + AIKA ++ +S+ D E
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQI---KVAIKAINEGAMSE----------EDFIEEA 50
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRD 234
+M L HP +V L V Y+V E++E G N + G + + M +D
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
+ G+ YL ++ +H D+ N LV+ +G VK+ DF +++ DD PV ++
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168
Query: 294 APE 296
PE
Sbjct: 169 PPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 126 IGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
IG G +G V+L YR G A+K ++ +A E +M L+H
Sbjct: 14 IGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLA-----------EASVMTQLRH 58
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMY 241
N+V L+ VI + Y+V EY+ D G +G K+ D+ + Y
Sbjct: 59 SNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
L +N VH D+ N+LV+ K+ DF +++ D + PV +TAPE
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 11/173 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G +G+V + GK YA K K L K S M + +E+L + + P
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK----KSGEKMALLEKEIL--EKVNSPF 54
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMYLH 243
IVNL + + H +V+ + G G G M R Y I G+++LH
Sbjct: 55 IVNLAYAFE--SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
++V+ D+KP+N+L+ G ++ D ++ +D + +R+ GT + APE
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 9/178 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
R IG GSY KV+L R + YA+K K + + + V+ E + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKK------ELVNDDEDIDWVQTEKHVFEQASN 54
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
HP +V L + V+EYV G + + E AR Y +I L YL
Sbjct: 55 HPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H +++ D+K DN+L+ G +K+ D+ + + D GTP + APE G
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 26/186 (13%)
Query: 119 EYVHVRKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
E+ RK+G+G +G+V L+++ + AIK L K + D ++EV
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRV---RVAIKILKSDDLLKQQ---------DFQKEVQ 54
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDI 235
+K L+H ++++L V + Y++ E +E K F P G+ + L D+
Sbjct: 55 ALKRLRHKHLISLFAVCS--VGEPVYIITELME-KGSLLAFLRSPE--GQVLPVASLIDM 109
Query: 236 VS----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
G+ YL N +H D+ N+LV K+ DF ++++ ++D L P
Sbjct: 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPY 168
Query: 292 -FTAPE 296
+TAPE
Sbjct: 169 KWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
++ Y +++ IG+G+ G V ++ ++ AIK R ++T RE+
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++MK + H NI+ L+ V S Y+V+E ++ Q E M+
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV----FEDDNDVLRRSP 287
L ++ G+ +LH ++H D+KP N++V T+KI DF +++ F V+ R
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR-- 189
Query: 288 GTPVFTAPECCLG 300
+ APE LG
Sbjct: 190 ---YYRAPEVILG 199
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+IG G++G+V R D A+K+ ++ L+ +E I+K HP
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--------AKFLQEARILKQYSHP 53
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMYL 242
NIV LI V Y+V+E V+G D F + + + + + +G+ YL
Sbjct: 54 NIVRLIGVCTQKQP--IYIVMELVQGG-DFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG---TPV-FTAPE 296
+ +H D+ N LV +KI DF +S+ E+++ V + G PV +TAPE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPE 166
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 15/176 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ +GAG+ G V + G A K H S +R + RE+ IM +
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--------KQILRELQIMHECR 61
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDIVSGLMY 241
P IV+ N ++ M +E+++ D + + G I + K +V GL Y
Sbjct: 62 SPYIVSFYGAF--LNENNICMCMEFMD-CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 242 LHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L+ H ++H DIKP N+LV G +K+ DF VS E N + GT + +PE
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++K+G G +G+V + + +G A+K + P + E IMK L
Sbjct: 11 IKKLGNGQFGEV--WMGTWNGNTKVAVKT----------LKPGTMSPESFLEEAQIMKKL 58
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGE--SMARKYLRDI 235
+H +V L V+ + + Y+V EY+ + DG G+ + MA + +
Sbjct: 59 RHDKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ----V 111
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTA 294
+G+ Y+ N +H D++ N+LV KI DF ++++ ED+ R+ P+ +TA
Sbjct: 112 AAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA 171
Query: 295 PECCL 299
PE L
Sbjct: 172 PEAAL 176
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
R +G G +G+V + GK YA K K + K + E+ + E I++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK---GESMALN---EKQILEKVNS 59
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
+VNL + D +VL + G K+ G PG E A Y +I+ GL
Sbjct: 60 QFVVNLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLE 116
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
LH N V+ D+KP+N+L+ G ++I D ++ V + + +R GT + APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 21/165 (12%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+R +G G++G+V LYR DG ++ K+ L + SE +D E LIM
Sbjct: 11 LRALGHGAFGEVYEGLYRG-RDGDAVELQVAVKT----LPESCSEQDESDFLMEALIMSK 65
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYL 232
H NIV LI V + +++LE + G D F +P ++
Sbjct: 66 FNHQNIVRLIGVSFERLP--RFILLELMAGG-DLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQ 274
RD+ G YL ++ +H DI N L+ P KI DF +++
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 43/135 (31%), Positives = 59/135 (43%), Gaps = 21/135 (15%)
Query: 159 LRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD---- 213
LR ++ A D +EV I+ L+ PNI+ L+ V D D M+ EY+E G +
Sbjct: 54 LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLS 111
Query: 214 -----------NDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
ND AI S I SG+ YL N VH D+ N LV
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171
Query: 260 APSGTVKIGDFSVSQ 274
+ T+KI DF +S+
Sbjct: 172 GENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 27/195 (13%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
++ Y ++ IG+G+ G V ++ G + A+K R ++T RE+
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYREL 71
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGK------WDNDGFGQPGAIGE 225
+++K + H NI++L+ V S Y+V+E ++ + D E
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH--------E 123
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
M+ L ++ G+ +LH ++H D+KP N++V T+KI DF +++ N ++
Sbjct: 124 RMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTP 181
Query: 286 SPGTPVFTAPECCLG 300
T + APE LG
Sbjct: 182 YVVTRYYRAPEVILG 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
R IG GSY KV+L + YA+K K ++ + + V+ E + +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN------DDEDIDWVQTEKHVFETASN 54
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
HP +V L + + V+E+V G + + E AR Y +I L +L
Sbjct: 55 HPFLVGLHSCFQTES--RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +++ D+K DN+L+ G +K+ D+ + + D GTP + APE
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 44/186 (23%), Positives = 86/186 (46%), Gaps = 11/186 (5%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHY-AIKA--FHKSHLSKLRVAPSETAMTDVRREV 175
EY + +G+G++G V R +G++ A+K H K + ++ V
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
+I + L+HPNIV + + +D Y+V++ +EG + F + + + +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 236 VSGLM----YLHGHN-VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
++ YLH +VH D+ P+N+++ V I DF +++ + L GT
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTI 177
Query: 291 VFTAPE 296
+++ PE
Sbjct: 178 LYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ- 182
R IG GSY KV+L R + + YA+K K + + + V+ E + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKK------ELVHDDEDIDWVQTEKHVFEQASS 54
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
+P +V L + ++V+EYV G + + E AR Y +I L +L
Sbjct: 55 NPFLVGLHSCFQ--TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H +++ D+K DN+L+ G +K+ D+ + + D GTP + APE G
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
+E IMK L+H +V L V+ + + Y+V E++ GK F + G G+ + L
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEFM-GKGSLLDFLKEGD-GKYLKLPQL 104
Query: 233 RDIVS----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
D+ + G+ Y+ N +H D++ N+LV + KI DF ++++ ED+ R+
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 289 TPV-FTAPECCL 299
P+ +TAPE L
Sbjct: 165 FPIKWTAPEAAL 176
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-09
Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 124 RKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++IG G +GKV+L S +K +LRV+ S E + L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVK--------ELRVSASVQEQMKFLEEAQPYRSL 52
Query: 182 QHPNIVNLI----EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA------RKY 231
QH N++ + EV + +V+E+ D G+ + E M ++
Sbjct: 53 QHSNLLQCLGQCTEVTP------YLLVMEFCP-LGDLKGYLRSCRKAELMTPDPTTLQRM 105
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+I GL++LH +N +H D+ N L+ TVKIGD+ +S
Sbjct: 106 ACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 126 IGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+G+G++G V ++ + AIK LR S A ++ E +M +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--------LREETSPKANKEILDEAYVMASV 66
Query: 182 QHPNIVNLIEVIDDPNSDHF----YM----VLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
HP++V L+ + +S M +L+YV DN IG +
Sbjct: 67 DHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDN--------IGSQYLLNWCV 116
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV- 291
I G+ YL +VH D+ N+LV VKI DF ++++ + D G P+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 292 FTAPEC 297
+ A E
Sbjct: 177 WMALES 182
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
++ Y +++ IG+G+ G V ++ ++ AIK R ++T RE+
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 67
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++MK + H NI++L+ V S Y+V+E ++ Q E M+
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
L ++ G+ +LH ++H D+KP N++V T+KI DF +++ + ++ T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 183
Query: 292 FTAPECCLG 300
+ APE LG
Sbjct: 184 YRAPEVILG 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 38/188 (20%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ ++G G++GKV ++ G A K SE + D E+ I+
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYMVEIEILATCN 67
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESM-----------ARK 230
HP IV L+ Y +GK W F GA+ M +
Sbjct: 68 HPYIVKLLGAF-------------YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
R ++ L YLH ++H D+K N+L+ G +K+ DF VS ++ + RR G
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIG 172
Query: 289 TPVFTAPE 296
TP + APE
Sbjct: 173 TPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 49/182 (26%), Positives = 73/182 (40%), Gaps = 33/182 (18%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
N +VR IG G++G+V R+ L + + + A + L+ S D +RE
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVA-----VKMLKEEASADMQADFQREA 59
Query: 176 LIMKMLQHPNIVNLIEV--IDDPNSDHF-YMVL----EYVEGKWDNDGFGQPGAI-GESM 227
+M HPNIV L+ V + P F YM E++ Q S
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---HRSPRAQCSLSHSTSS 116
Query: 228 ARKYL---------------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
ARK + + +G+ YL VH D+ N LV + VKI DF +
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 273 SQ 274
S+
Sbjct: 177 SR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
E V+ +G+G++G V +G+ I + L A + E LIM
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV----AIKILNETTGPKANVEFMDEALIM 63
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMV------LEYVEGKWDNDGFGQPGAIGESMARKYL 232
+ HP++V L+ V P + L+YV DN IG + +
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN--------IGSQLLLNWC 115
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
I G+MYL +VH D+ N+LV VKI DF ++++ E D
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 51/205 (24%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
Y +++ IG+G+ G V ++ G++ AIK LS+ P + R RE+
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSR----PFQNVTHAKRAYREL 66
Query: 176 LIMKMLQHPNIVNLIEVID-DPNSDHF---YMVLEYVEG------KWDNDGFGQPGAIGE 225
++MK++ H NI+ L+ V + + F Y+V+E ++ + D D E
Sbjct: 67 VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD--------HE 118
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
M+ L ++ G+ +LH ++H D+KP N++V T+KI DF L R
Sbjct: 119 RMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LAR 166
Query: 286 SPG-----TP-VFT----APECCLG 300
+ G TP V T APE LG
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVILG 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 126 IGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+G G++G+V ++ +L D A+K + +L++ E I+K HP
Sbjct: 3 LGKGNFGEV--FKGTLKDKTPVAVKTCKEDLPQELKIK--------FLSEARILKQYDHP 52
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMYL 242
NIV LI V Y+V+E V G D F + + K+ D +G+ YL
Sbjct: 53 NIVKLIGVCTQRQP--IYIVMELVPGG-DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS--PGTPV-FTAPE 296
N +H D+ N LV + +KI DF +S+ ++D+ + S P+ +TAPE
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPE 164
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-08
Identities = 34/155 (21%), Positives = 62/155 (40%), Gaps = 27/155 (17%)
Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
++ + G V Y + Y L++ PS D REV I+++
Sbjct: 1 SSIKLLKGG-LTNRV-YLLGTKDEDYV-----------LKINPSREKGADREREVAILQL 47
Query: 181 LQHPNIVNLIEVID-DPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSG 238
L + + +V+ + Y+++E++EG+ D + I E +A + L
Sbjct: 48 LAR-KGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLA-ELLAK---- 101
Query: 239 LMYLHGHN---VVHGDIKPDNLLVAPSGTVKIGDF 270
LH + HGD+ P N+LV + I D+
Sbjct: 102 ---LHQLPLLVLCHGDLHPGNILVDDGKILGIIDW 133
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 34/176 (19%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA---PSETAMTDVRREVL---- 176
R++G GS+G V Y G + RVA +E A R E L
Sbjct: 12 RELGQGSFGMV--YEGLAKGV--------VKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLE---------YVEGKWDNDGFGQPGAIGESM 227
+MK ++V L+ V+ +V+E Y+ +
Sbjct: 62 VMKEFNCHHVVRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP--PT 117
Query: 228 ARKYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+K+++ +I G+ YL VH D+ N +VA TVKIGDF +++ ++E D
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 44/185 (23%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
Y ++ +G+G+YG V + G A+K + S + + RE+ ++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLL 70
Query: 179 KMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
K ++H N++ L++V S + Y+V + +N Q + + + +
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQ 128
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
I+ GL Y+H +++H D+KP NL V +KI DF +++ +D+ + T + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 185
Query: 295 PECCL 299
PE L
Sbjct: 186 PEIML 190
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ H R +G G +G+V + GK YA K K + K + E + +R I++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKR---ILE 55
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIV 236
+ +V+L + D +VL + G K+ G PG E A Y ++
Sbjct: 56 KVNSRFVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELC 112
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFTAP 295
GL L +V+ D+KP+N+L+ G ++I D ++ Q+ E + +R GT + AP
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRVGTVGYMAP 170
Query: 296 E 296
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++G+G++G V +Y+ AIK L+ ++ ++ RE IM L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKV--------LKNENEKSVRDEMMREAEIMHQLD 53
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMY 241
+P IV +I V + ++ +V+E G N G+ I S + + + G+ Y
Sbjct: 54 NPYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPEC 297
L G N VH D+ N+L+ KI DF +S+ DD+ RS G P+ + APEC
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVL 176
+++ ++ IG G++G+V L + G YA+K K+ L K +VA +R E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA-------HIRAERD 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
I+ +V + D + Y+++E++ G + + E + Y+ + V
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRN--LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+ +H +H DIKPDNLL+ G VK+ DF +
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 6e-08
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
+ ++G +NEY ++KIG G +G+V L + + + KA L E
Sbjct: 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KERE 55
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAI 223
+ + EV +M+ L+H NIV I+ + + Y+++E+ + + + G I
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 224 GESMARKYLRDIVSGLMYLH-------GHNVVHGDIKPDNLLVAPS-------------- 262
E R ++ L Y H G V+H D+KP N+ ++
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 263 ---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
KIGDF +S+ ++ + GTP + +PE L
Sbjct: 176 NGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLL 214
|
Length = 1021 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--KLRVAPSETAMTDVRRE 174
+N+ ++ +IG+G+ G+V R G A+K ++ R+ + D+
Sbjct: 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI------LMDLD-- 65
Query: 175 VLIMKMLQHPNIVN----LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
+++K P IV I +SD F + +E + D G I E + K
Sbjct: 66 -VVLKSHDCPYIVKCYGYFIT-----DSDVF-ICMELMSTCLDKLLKRIQGPIPEDILGK 118
Query: 231 YLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
IV L YL H V+H D+KP N+L+ SG VK+ DF +S D+ RS G
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAKTRSAGC 177
Query: 290 PVFTAPE 296
+ APE
Sbjct: 178 AAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 32/176 (18%)
Query: 124 RKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
R++G G++GKV L D A+K + S+ A D RE ++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELL 61
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------------GQPGAIG 224
LQH +IV V + D MV EY++ D + F +P +
Sbjct: 62 TNLQHEHIVKFYGVCVE--GDPLIMVFEYMK-HGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+S + I +G++YL + VH D+ N LV + VKIGDF +S+ V+ D
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 9e-08
Identities = 30/134 (22%), Positives = 62/134 (46%), Gaps = 23/134 (17%)
Query: 129 GSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIV 187
G +GKV + + K + K + + + E ++ ++++ +PN +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------------EPMVHQLMKDNPNFI 72
Query: 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHG 244
L + ++++Y++ D D F + G + E+ +K +R +V L LH
Sbjct: 73 KLYYSVTTLK--GHVLIMDYIK---DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 245 HNVVHGDIKPDNLL 258
HN++H DIK +N+L
Sbjct: 128 HNIIHNDIKLENVL 141
|
Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 26/66 (39%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+V GL YL ++H D+KP N+LV G VK+ DF VS N + + GT + A
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMA 161
Query: 295 PECCLG 300
PE G
Sbjct: 162 PERISG 167
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 91 GLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKA 150
G +CR FP ++ + +Y R +G+G+ G V+ + DG+ +A+K
Sbjct: 10 GRVCRTFP-----DTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKV 64
Query: 151 FHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE--VIDDPNSDH----FYMV 204
+S E + EV + +IV E DP + +V
Sbjct: 65 VDMEGMS-------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL---------HGHNVVHGDIKPD 255
L+Y N G + + + R+ +GL+++ H +++H DIK
Sbjct: 118 LDYA-----NAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 256 NLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPE 296
N+L+ +G VK+GDF S+++ +DV R GTP + APE
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 31/165 (18%), Positives = 61/165 (36%), Gaps = 27/165 (16%)
Query: 123 VRKIGAGSYGK--VVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+ IG V L + A+K + L E + +++E++ +
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN------LDSCSKED-LKLLQQEIITSRQ 55
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------PGAIGESMARKY 231
LQHPNI+ + + Y+V + +G P + E
Sbjct: 56 LQHPNILPYVTSFIVDSE--LYVVSPLM-------AYGSCEDLLKTHFPEGLPELAIAFI 106
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
L+D+++ L Y+H +H +K ++L++ G V + S
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKML 181
++G+G++G V +Y+ K A+K L+ ++ A+ D + RE +M+ L
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKI--------LKNDNNDPALKDELLREANVMQQL 53
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
+P IV +I + + ++ + +V+E E N + + E + + + G+ Y
Sbjct: 54 DNPYIVRMIGICE---AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPEC 297
L N VH D+ N+L+ KI DF +S+ D+N ++ G PV + APEC
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 38/166 (22%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVLI 177
Y ++ +G+G+YG V Y + K + KL P ++ + R RE+ +
Sbjct: 17 YQNLTPVGSGAYGSVC--------SAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRL 67
Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
+K ++H N++ L++V S + Y+V + +N Q + + + +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIY 125
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
++ GL Y+H ++H D+KP N+ V ++I DF +++ +D+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 13/176 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
R +G G +G+V + GK YA K K + K + E+ + E I++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMALN---EKQILEKVNS 59
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
+V+L + D +VL + G K+ G+ G E A Y +I GL
Sbjct: 60 RFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLE 116
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
LH +V+ D+KP+N+L+ G ++I D ++ V + ++ GT + APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLI 177
++ ++ IG G++G+V L + G YA+K K+ L K +V +R E I
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-------HIRAERDI 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ +V + D + Y+++E++ G + + E + Y+ + V
Sbjct: 55 LVEADSLWVVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+ +H +H DIKPDNLL+ G VK+ DF +
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 19/163 (11%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-SETAMTDVRREVLIMKMLQ 182
+ +G G +G V+ L+ +K K+ +++A + + M D E + MK
Sbjct: 5 KTLGEGEFGSVM--EGQLNQDDSILKVAVKT----MKIAICTRSEMEDFLSEAVCMKEFD 58
Query: 183 HPNIVNLIEVIDDPNSDHFY----MVLEYVEGKWDNDGF-------GQPGAIGESMARKY 231
HPN++ LI V Y ++L +++ D F P + M K+
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMK-HGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ DI SG+ YL + +H D+ N ++ + V + DF +S+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHP 184
IG G++G+V+ DG + + L+ SE D E+ ++ K+ HP
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMN------AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE-GKW-----------DNDGFGQPGAIGESM-ARKY 231
NI+NL+ + N + Y+ +EY G + F + ++ +++
Sbjct: 64 NIINLLGACE--NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 232 LR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
L+ D+ +G+ YL +H D+ N+LV + KI DF +S+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+IG G +GKV+L G+ + + + + +LR + + +EV + L H
Sbjct: 1 DEIGNGWFGKVLL------GEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH 54
Query: 184 PNIVNL----IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA---RKYLR--- 233
PN++ IE I + +VLE+ D + + + R
Sbjct: 55 PNVLQCLGQCIESIP------YLLVLEFCP-LGDLKNYLRSNRGMVAQMAQKDVLQRMAC 107
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV--SQVFED 278
++ SGL++LH + +H D+ N + +VKIGD+ + Q ED
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 28/179 (15%)
Query: 122 HVRKIG---AGSYGKVVL----------YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
H R I AG++GK+ + K + ++K RV A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK-RVKAGSRAA 207
Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGES 226
+ E+L + L H NI+ + E++ + YM+ + K+D D F A
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSE--ANTYMITQ----KYDFDLYSFMYDEAFDWK 261
Query: 227 ------MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
R ++ ++ + Y+H ++H DIK +N+ + G + +GDF + FE +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
|
Length = 501 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNL---IEVIDDPNSDHFYMVLEYVEG---- 210
K+R P+ T M R + Q +++L + +D P + FY L + EG
Sbjct: 19 KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-FREGDVWI 77
Query: 211 ----------KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLV 259
K+ + + I E + K IV L YLH +V+H D+KP N+L+
Sbjct: 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137
Query: 260 APSGTVKIGDFSVS 273
+G VK+ DF +S
Sbjct: 138 NRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
+ +GAG++GKVV + L +K K + E M+ E+ IM L
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS----ELKIMSHLG 96
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL--RDIVS-- 237
H NIVNL+ ++ EY +G +L D++S
Sbjct: 97 NHENIVNLLGACT--IGGPILVITEYCC-------YGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 238 -----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV 291
G+ +L N +H D+ N+L+ VKI DF +++ + D N V++ + PV
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 292 -FTAPE 296
+ APE
Sbjct: 208 KWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 29/189 (15%)
Query: 126 IGAGSYGKVVL--YRSSLDGKHYA---IKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+G G +G+V L + + +KA K+ E ++ RRE+ + +
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--------KDENLQSEFRRELDMFRK 64
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-----------GKWDNDGFGQPGAIGESMAR 229
L H N+V L+ + + ++ YM+LEY + D P + + +A
Sbjct: 65 LSHKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
I G+ +L VH D+ N LV+ VK+ S+S+ + R+
Sbjct: 123 CT--QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 290 PV-FTAPEC 297
P+ + APE
Sbjct: 181 PLRWLAPEA 189
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 118 NEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
+++ + ++GAG+ G V V ++ S G A K H L + P+ + RE+
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPS--GLIMARKLIH------LEIKPA--IRNQIIREL 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
++ P IV + + +E+++G + + G I E + K +
Sbjct: 55 QVLHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 236 VSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ GL YL H ++H D+KP N+LV G +K+ DF VS D + GT + +
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 170
Query: 295 PE 296
PE
Sbjct: 171 PE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 33/198 (16%)
Query: 126 IGAGSYGKVV-LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+G G +GKVV L G+ + + L+ S + + D+ E ++K + HP
Sbjct: 8 LGEGEFGKVVKATAFRLKGR----AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE----------------------GKWDNDGFGQPG- 221
+++ L +++EY + G ++ P
Sbjct: 64 HVIKLYGACS--QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 222 -AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
A+ + I G+ YL +VH D+ N+LVA +KI DF +S+ V+E+D
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 280 NDVLRRSPGTPV-FTAPE 296
+ V R PV + A E
Sbjct: 182 SYVKRSKGRIPVKWMAIE 199
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 2/64 (3%)
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVF 292
IV L +H ++H D+K N+ + P+G +K+GDF S+ + D DV GTP +
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 293 TAPE 296
APE
Sbjct: 238 LAPE 241
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 21/179 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++++G G +G VV Y G++ AIK + +S+ + E +M L
Sbjct: 9 LKELGTGQFG-VVKY-GKWRGQYDVAIKMIKEGSMSE----------DEFIEEAKVMMKL 56
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMAR--KYLRDIVSG 238
H +V L V Y+V EY+ G N + + ++ + +D+ G
Sbjct: 57 SHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEG 112
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
+ YL +H D+ N LV G VK+ DF +S+ DD PV ++ PE
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 38/166 (22%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHP 184
IG G++G+V+ R DG + + +++ S+ D E+ ++ K+ HP
Sbjct: 3 IGEGNFGQVLKARIKKDGLRM------DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 56
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE-GKW-----------DNDGFGQPGAIGESMA-RKY 231
NI+NL+ + + + Y+ +EY G + F + +++ ++
Sbjct: 57 NIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 232 LR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
L D+ G+ YL +H D+ N+LV + KI DF +S+
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 21/42 (50%), Positives = 28/42 (66%)
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
+R +++GL LH +VH DIKP+NLLV G VKI DF +
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
E+ ++ +G+G++G V +G+ I K +LR A S A ++ E +M
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK----ELREATSPKANKEILDEAYVM 63
Query: 179 KMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
+ +P++ L+ + F +L+YV DN IG +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWC 115
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
I G+ YL +VH D+ N+LV VKI DF ++++ D
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 13/180 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+++ + ++GAG+ G V + G A K H L + P+ + RE+ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPA--IRNQIIRELQV 56
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ P IV + + +E+++G + + I E + K ++
Sbjct: 57 LHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLR 114
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL YL H ++H D+KP N+LV G +K+ DF VS D + GT + +PE
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+ I+ GL YLH ++H D+K +N+ + V IGD +Q
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 35/161 (21%), Positives = 69/161 (42%), Gaps = 28/161 (17%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
++IG G +GKV+L + Y + + +L+ S + ++ ++LQH
Sbjct: 1 QEIGNGWFGKVLL------SEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 184 PNIVNLI----EVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA-RKY 231
PNI+ + E I + +V EY E + + + ++
Sbjct: 55 PNILQCLGQCVEAIP------YLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRM 104
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+I +G+ ++H HN +H D+ N + TVK+GD+ +
Sbjct: 105 ACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 34/131 (25%), Positives = 53/131 (40%), Gaps = 17/131 (12%)
Query: 177 IMKMLQHPNIVNLIEV-IDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRD 234
+M L H ++V L V + D N MV EYV+ G D + + +
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDENI----MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVA-------PSGTVKIGDFSVSQVFEDDNDVLRRSP 287
+ S L YL +VHG++ N+LVA +K+ D + + + R P
Sbjct: 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 288 GTPVFTAPECC 298
+ APEC
Sbjct: 170 ----WIAPECI 176
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 22/54 (40%), Positives = 32/54 (59%), Gaps = 1/54 (1%)
Query: 221 GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
G I E++ K ++ GL YL H ++H D+KP N+LV G +K+ DF VS
Sbjct: 94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KY 231
E +M L H N+V L+ VI + Y+V+E + + G S+ + ++
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
D+ G+ YL +VH D+ N+LV+ G K+ DF +++V D + PV
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK----LPV 161
Query: 292 -FTAPE 296
+TAPE
Sbjct: 162 KWTAPE 167
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 36/131 (27%), Positives = 57/131 (43%), Gaps = 14/131 (10%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEV-IDDPNSDHFYMVLEYVEGKWDNDGFGQPGA 222
SE +T + +E ++ L H NI+ ++ V I+D VL + F Q
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE---PPFVLYPYMNWGNLKLFLQQCR 104
Query: 223 IGESMARKYLR---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
+GE+ + L I G+ YLH V+H DI N ++ VKI D ++S
Sbjct: 105 LGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164
Query: 274 Q-VFEDDNDVL 283
+ +F D L
Sbjct: 165 RDLFPMDYHCL 175
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 16/115 (13%)
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIG 224
+E +M HPNIV L+ V ++ Y+++E +EG + FG P
Sbjct: 48 KEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TVKIGDFSVSQ 274
+ + L D+ G +YL + +H D+ N LV+ G VKIGDF +++
Sbjct: 106 KELLDICL-DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 38/165 (23%)
Query: 126 IGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQ 182
IG G++G V +L++ S G A+K ++R E + ++ ++M+
Sbjct: 12 IGRGAFGTVNKMLHKPS--GTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 183 HPNIVNL-------------IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
P IV +E++D + D FY YV I E +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMD-ISLDKFYK---YVYEV-------LKSVIPEEILG 110
Query: 230 KYLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
K V L YL ++H D+KP N+L+ +G +K+ DF +S
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 102 SNKLIRSEDENGTKMINEYVHVRK---------IGAGSYGKVVLYRSSLDGKHYAIKAFH 152
S+ EDE+ KMI+ ++ IG GS+G V+Y + I
Sbjct: 41 SHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFG--VVYEA------ICIDTSE 92
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL-----IEVIDDPNSDHFY-MVLE 206
K + K+ P RE+LIMK L H NI+ L E + F +V+E
Sbjct: 93 KVAIKKVLQDPQYK-----NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 207 YVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-S 262
++ K+ A+ + + Y + L Y+H + H D+KP NLL+ P +
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207
Query: 263 GTVKIGDF 270
T+K+ DF
Sbjct: 208 HTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 43/175 (24%)
Query: 126 IGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
IG G++G+V+ R DG K YA K H+ +L V
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-------------- 60
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKW-----------DNDGFGQPGAI 223
+ K+ HPNI+NL+ + + + Y+ +EY G + F +
Sbjct: 61 -LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+++ + L D+ G+ YL +H D+ N+LV + KI DF +S+
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 10/121 (8%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEV---IDDPNSDHFYMVLEYVEGKWDNDGF--- 217
+ + + + E MK HPN++ LI V MV+ D F
Sbjct: 41 TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY 100
Query: 218 ----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
G P + K++ DI G+ YL N +H D+ N ++ TV + DF +S
Sbjct: 101 SRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
Query: 274 Q 274
+
Sbjct: 161 K 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 133 KVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192
KV+L + + + +K KS S +T + V PN+V L +
Sbjct: 8 KVLLVMDTRTQQTFILKGLRKSSEY------SRERLTIIPHCV--------PNMVCLHKY 53
Query: 193 IDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHG 250
I + D ++VL++ EG W + + I E +++ ++V L LH +V
Sbjct: 54 I--VSEDSVFLVLQHAEGGKLWSH--ISKFLNIPEECVKRWAAEMVVALDALHREGIVCR 109
Query: 251 DIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPE 296
D+ P+N+L+ G +++ FS ED D + + ++ APE
Sbjct: 110 DLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-----MYCAPE 152
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
D +G + + ++G S+ KV R L + +A +LS+L A
Sbjct: 36 DPDGNPVA---LKFHRLGRTSFRKVKRKRDYLGDRKHA----SWLYLSRL------AAQ- 81
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGA 222
+E +K L + + + ID + H +V+EY++G ++
Sbjct: 82 ---KEFAALKAL-YEEGFPVPKPID--WNRHA-VVMEYIDGVELYRVRVLED-------- 126
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDN 280
+ L +I+ ++ + H ++HGD+ N+LV + I D+ VS +
Sbjct: 127 -----PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHPNAE 181
Query: 281 DVLRR 285
++L R
Sbjct: 182 ELLDR 186
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 34/180 (18%)
Query: 123 VRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
+ ++G +GKV Y+ L G + AIK LR + + E
Sbjct: 10 MEELGEDRFGKV--YKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--------EEFKHEA 59
Query: 176 LIMKMLQHPNIVNLIEVIDD-----------PNSD-HFYMVLEYVE---GKWDNDGFGQP 220
++ LQHPNIV L+ V+ +SD H ++V+ G D+D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK- 118
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDD 279
+ + + I +G+ +L H+VVH D+ N+LV VKI D + +V+ D
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 40/178 (22%)
Query: 123 VRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+ +G G++G+VV + LD + K L+ +E ++D+ E+ +MKM+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK----MLKDDATEKDLSDLVSEMEMMKMI 72
Query: 182 -QHPNIVNLIEVI--DDPNSDHFYMVLEY---------------VEGKWDNDGFGQPGAI 223
+H NI+NL+ V + P Y+V+EY D P
Sbjct: 73 GKHKNIINLLGVCTQEGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDD---PRPP 125
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
E++ +D+VS G+ +L +H D+ N+LV +KI DF +++
Sbjct: 126 EETLT---QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 20/100 (20%)
Query: 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY--LHGHNVVHGDI 252
DP++ +V+EY+EGK D E + LR+I G + LH +VHGD+
Sbjct: 68 DPDN--KTIVMEYIEGKPLKDVI-------EEGNDELLREI--GRLVGKLHKAGIVHGDL 116
Query: 253 KPDNLLVAPSGTVKIGDFSVSQVFEDDND------VLRRS 286
N++V I DF + + ++ D VL+RS
Sbjct: 117 TTSNIIVRDDKLYLI-DFGLGKYSDEIEDKAVDLHVLKRS 155
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPV 291
R++ S LH H V GD+ ++ LV+ V + D Q+ + N L P G
Sbjct: 124 RNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI--NANGTLHLCPVGVSE 181
Query: 292 FTAPE 296
FT PE
Sbjct: 182 FTPPE 186
|
Length = 637 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 32/165 (19%)
Query: 109 EDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
D G K+ V ++G S+ KV R L K H S L R+A
Sbjct: 111 IDPKGRKVA---VKFHRLGRTSFRKVKRNRDYLADKE------HGSWLYVSRLA------ 155
Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGE 225
RE ++ L +P V + + I + H +V+EY+EG +
Sbjct: 156 --AEREFEALQRL-YPEGVKVPKPIA--WNRH-AVVMEYIEGV--------ELYRLRLDV 201
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ L I+ + + +VHGD+ N+LV G + + D+
Sbjct: 202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+I G+ YL+ + VH D+ N +VA TVKIGDF +++ ++E D
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 10/112 (8%)
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDNDGFGQPGAIGES--- 226
RE MK HPN++ LI V + MV+ D F IGE
Sbjct: 50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT 109
Query: 227 ----MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
+++ DI SG+ YL N +H D+ N ++ + TV + DF +S+
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+I G+ YL+ VH D+ N +VA TVKIGDF +++ ++E D
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 50/183 (27%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
+ +G G +G+VV+ + K +A + + L+ +E ++D+ E+ +MKM+ +
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR--------- 233
H NI+NL+ Y+++EY + R+YLR
Sbjct: 80 HKNIINLLGACTQDGP--LYVIVEYA---------------SKGNLREYLRARRPPGMEY 122
Query: 234 ---------------DIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
D+VS G+ YL +H D+ N+LV + +KI DF
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 272 VSQ 274
+++
Sbjct: 183 LAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 54/185 (29%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
+ +G G +G+VV+ + K + K + L+ +E ++D+ E+ +MKM+ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRV-TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR------- 233
H NI+NL+ D P Y+++EY + R+YLR
Sbjct: 83 HKNIINLLGACTQDGP----LYVIVEYA---------------SKGNLREYLRARRPPGM 123
Query: 234 -----------------DIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269
D+VS G+ YL +H D+ N+LV +KI D
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 183
Query: 270 FSVSQ 274
F +++
Sbjct: 184 FGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 16/89 (17%)
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA----RKYLR 233
M LQHPNIV LI + Y++ EY+EGK + +++ RK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGA--YLIHEYIEGK-------NLSEVLRNLSWERRRKIAI 787
Query: 234 DIVSGLMYLHGH---NVVHGDIKPDNLLV 259
I L +LH VV G++ P+ +++
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 42/202 (20%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-----PSETAMTDVRREVLIM 178
+ +G G +G+VV + Y I + V ++ + D+ E+ +M
Sbjct: 18 KPLGEGCFGQVV------RAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 179 KML-QHPNIVNLIEVI--DDPNSDHFYMVLEYV-EGKWD-----------NDGFGQPGAI 223
K++ +H NI+NL+ V + P Y+++EY +G + F
Sbjct: 72 KLIGKHKNIINLLGVCTQEGP----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
E ++ +D+VS G+ YL +H D+ N+LV +KI DF +++
Sbjct: 128 EEQLS---FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 277 EDDNDVLRRSPG-TPV-FTAPE 296
D + + S G PV + APE
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 123 VRKIGAGSYGKVV---LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ ++G ++GK+ LY +D H + A + L+ + + ++E +M
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMD--HAQLVA-----IKTLKDINNPQQWGEFQQEASLMA 62
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------------GQPGAIGE 225
L HPNIV L+ V+ M+ EY+ + D F + G +
Sbjct: 63 ELHHPNIVCLLGVVTQEQP--VCMLFEYL-NQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 226 SMAR-KYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
S+ +L I +G+ YL H VH D+ N+L+ VKI D +S+
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 15/104 (14%)
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYM------VLEYVEGKWDNDGFGQPGAIGES 226
RE+ I+K + H I+NLI ++ M + YV+ G +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS---------GPLPLE 185
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
A R ++ L YLHG ++H D+K +N+ + +GDF
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 14/38 (36%), Positives = 24/38 (63%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
R ++ + YLH + ++H DIK +N+ + G V +GDF
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 16/45 (35%), Positives = 30/45 (66%)
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
++D+++ L Y+H H + HGDIKP+N++V + I D+ ++ F
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 37/167 (22%)
Query: 124 RKIGAGSYGKVVLYRSSL---DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVR---REV 175
R IG G +G V Y +L DG+ H A+K+ L+++ T + +V +E
Sbjct: 1 RVIGKGHFGCV--YHGTLIDSDGQKIHCAVKS-----LNRI------TDLEEVEQFLKEG 47
Query: 176 LIMKMLQHPNIVNLIEV-IDDPNSDHF---YM----VLEYVEGKWDNDGFGQPGAIGESM 227
+IMK HPN+++L+ + + S YM + ++ + N G +
Sbjct: 48 IIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV 107
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
A+ G+ YL VH D+ N ++ S TVK+ DF +++
Sbjct: 108 AK--------GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 30/98 (30%)
Query: 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY--------LHGHNVVHGDIKP 254
+V+EY+EG+ + + L + L+ LH +VHGD+
Sbjct: 76 IVMEYIEGE---------------LLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTT 120
Query: 255 DNLLVAPSGTVKIGDFSVSQVFEDDND------VLRRS 286
N++++ I DF + + ++ D VL R+
Sbjct: 121 SNIILSGGRIYFI-DFGLGEFSDEVEDKAVDLHVLERA 157
|
Length = 204 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 29/128 (22%), Positives = 51/128 (39%), Gaps = 8/128 (6%)
Query: 166 TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIG 224
+TD +L M L H IV L+ + + +V + G + ++
Sbjct: 54 QEITD---HMLAMGSLDHAYIVRLLGICPGAS---LQLVTQLSPLGSLLDHVRQHRDSLD 107
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
+ I G+ YL H +VH ++ N+L+ V+I DF V+ ++ DD
Sbjct: 108 PQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 284 RRSPGTPV 291
TP+
Sbjct: 168 YSEHKTPI 175
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 47/178 (26%), Positives = 67/178 (37%), Gaps = 15/178 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
R +G G +G++ L K A H LR S+ E L + H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHT-----LRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMY 241
NIV L VI N+ +V EY+ D F G + L + SG+ Y
Sbjct: 66 SNIVRLEGVITRGNT--MMIVTEYM-SNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG--TPV-FTAPE 296
L VH + +LV KI F Q ED ++ + + +PV + APE
Sbjct: 123 LSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ--EDKSEAIYTTMSGKSPVLWAAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.89 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.51 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.21 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.97 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.63 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.59 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.15 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.05 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.02 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 94.81 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.6 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 94.43 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.16 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.03 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-53 Score=365.03 Aligned_cols=288 Identities=24% Similarity=0.330 Sum_probs=212.4
Q ss_pred CCcccchhhhccccccccccc-ccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCCCCccccchhhc
Q 022241 1 MFRKTCSWIRDMGCCSCFGFT-RRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKR 79 (300)
Q Consensus 1 ~~~~~~~~~r~~~c~~~~~~~-~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~~~~~~~~~~~~~~ 79 (300)
+++++|+|||+..|+...+.. -.....++..+++.++.+++.-....+...+.+|.|+||+..|.+....+......+.
T Consensus 61 ~~nd~f~fGR~~~~d~~ln~~~~s~~~~~i~~~~~~~~~~f~~dr~~~sn~~y~~DhS~nGT~VN~e~i~k~~~r~lkN~ 140 (475)
T KOG0615|consen 61 LANDEFTFGRGDSCDAPLNLNNVSNKHFKILLYNKISKIHFRIDRDKNSNRVYLHDHSRNGTFVNDEMIGKGLSRILKNG 140 (475)
T ss_pred eccceEEecCCCcccccccCccccccchheeeeeeeeeeeecccCCCccceEEEEecccCcccccHhHhhccccccccCC
Confidence 468999999998888666555 2233334445545554444322224444567789999999998765544443333332
Q ss_pred hHHHHHHhhhcccccccCCccchhhhhhccccccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccc
Q 022241 80 SEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159 (300)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~ 159 (300)
.+..++....+.+...+...+.+. --.....+.|.+.+.||+|+||.|.+|..+.+|+.||||++++......
T Consensus 141 dei~is~p~~~~~v~~~~s~d~~~-------~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~ 213 (475)
T KOG0615|consen 141 DEISISIPALKIFVFEDLSRDSSK-------VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGC 213 (475)
T ss_pred CEEEeccchhheeeeecccchhcc-------CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccc
Confidence 222112111221111111111111 0112244668899999999999999999999999999999998765432
Q ss_pred ccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHH
Q 022241 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239 (300)
Q Consensus 160 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l 239 (300)
.. .......+.+|+++|++|+|||||+++++|..+ +..||||||++||.|.+.+..++.+.+...+.++.|++.||
T Consensus 214 s~--~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~av 289 (475)
T KOG0615|consen 214 SR--AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAV 289 (475)
T ss_pred cc--cccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHH
Confidence 11 122333478999999999999999999999864 47899999999999999999999999999999999999999
Q ss_pred HHHHhCCcEeCCCCCCCEEEccC---CcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 240 MYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 240 ~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.|||++||+||||||+|||+..+ ..+||+|||+|+... ....+.+.||||.|.|||+|.+
T Consensus 290 kYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 290 KYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred HHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheec
Confidence 99999999999999999999876 689999999999876 4567889999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=314.13 Aligned_cols=178 Identities=33% Similarity=0.553 Sum_probs=164.6
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++++.||+|+||+||+++.+.+++.||+|++++....+ .........|..+|..++||+||+++..|+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~------~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE------KKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh------hhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 34578999999999999999999999999999999999876542 356778999999999999999999999999
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ .+.+|+|+||+.||.|..++.+.+.+++..++.++..|+.||.|||+.|||||||||+|||||.+|+++|+||||++
T Consensus 96 t--~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 96 T--EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred c--CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 7 46899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+.|||+.|||||++++
T Consensus 174 ~~~~~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 174 EDLKDGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred hcccCCCccccccCCccccChHHHhc
Confidence 87666677788999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=313.95 Aligned_cols=174 Identities=33% Similarity=0.618 Sum_probs=158.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
....+|.+.+.||.|+||.||+++++.++..||||.+.+..+ .....+.+..|+.+|+.++|||||.+++++.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 345689999999999999999999999999999999987643 3456778999999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC------CcEEEe
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS------GTVKIG 268 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~------~~~kl~ 268 (300)
+ .+.+|||||||.||.|..++...+.+++.+++.++.|++.||++||+++||||||||.||||+.. -.+||+
T Consensus 80 ~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 80 D--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred c--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 6 45899999999999999999999999999999999999999999999999999999999999875 368999
Q ss_pred cccCceeecCCccccccCCCccccccCccc
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
|||+|+.+. +.....+.||+|.|||||++
T Consensus 158 DFGfAR~L~-~~~~a~tlcGSplYMAPEV~ 186 (429)
T KOG0595|consen 158 DFGFARFLQ-PGSMAETLCGSPLYMAPEVI 186 (429)
T ss_pred ccchhhhCC-chhHHHHhhCCccccCHHHH
Confidence 999999875 44577889999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=313.31 Aligned_cols=211 Identities=47% Similarity=0.741 Sum_probs=179.5
Q ss_pred cccccccCCccchhhhhhccccccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChH---
Q 022241 90 NGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET--- 166 (300)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--- 166 (300)
+........+++.++..........+.+++|++.+.||+|.||.|.+|++..+++.||||++.+.............
T Consensus 69 ~~~~~~~~~vket~k~~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~ 148 (576)
T KOG0585|consen 69 NNSPRSWRRVKETNKIVRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMK 148 (576)
T ss_pred ccccccccccceeeeeeeecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccc
Confidence 34445566777888887788888899999999999999999999999999999999999999987665433322222
Q ss_pred --HHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022241 167 --AMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244 (300)
Q Consensus 167 --~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 244 (300)
..+.+.+||.+|++|+|||||+|+++..++..+.+|||+|||..|.....-.....+++.+++.|+.+++.||+|||.
T Consensus 149 ~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~ 228 (576)
T KOG0585|consen 149 LMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY 228 (576)
T ss_pred cCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh
Confidence 345899999999999999999999999999999999999999988766543333339999999999999999999999
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCceeec-----CCccccccCCCccccccCcccCC
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-----DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~-----~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|||||||||+|+||+.+|+|||+|||.+..+. +........+|||.|+|||++.|
T Consensus 229 QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 229 QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999999999999999999999999999998772 33334455789999999999865
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.58 Aligned_cols=174 Identities=32% Similarity=0.485 Sum_probs=162.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
..|...+.||+|||+.||.+++..+|+.||+|++.+..+. .....+.+.+||+|.++|+|||||+++++|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~------k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-- 89 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK------KPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-- 89 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc------CcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--
Confidence 4699999999999999999999999999999999887554 35567889999999999999999999999997
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++|||+|+|..+++..++..+++++|.+++.++.||+.||.|||+++|+|||||..|+||+++.+|||+|||||..+.
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.+.....+.||||.|+|||+|.
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred CcccccceecCCCcccChhHhc
Confidence 7767778899999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=288.67 Aligned_cols=175 Identities=31% Similarity=0.546 Sum_probs=161.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|+.++.||.|+||.|.+++.+.+|..||+|++.+....+ -.+.+...+|..+|+.+.||+++++.+.|.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk------lKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK------LKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH------HHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 45578999999999999999999999999999999998876543 346788999999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ..++||||||++||.+..+++..+++++..++.++.||+.||+|||+++|++|||||+|||||.+|++||+|||.|+
T Consensus 115 d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 115 D--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred c--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 7 46899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ..+.||||.|+|||++++
T Consensus 193 ~v~~r---T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 193 RVSGR---TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred EecCc---EEEecCCccccChHHhhc
Confidence 87553 567899999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.03 Aligned_cols=174 Identities=30% Similarity=0.489 Sum_probs=158.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
...+.+.+..||+|..|+||+++++.+++.+|+|.+... ..+...+++.+|+.+++..+||+||.+||+|..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 345678889999999999999999999999999998432 256677899999999999999999999999997
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+.. .+.|+||||++|+|...+...+++++.....++.+|++||.|||+ ++||||||||+|||++..|.|||+|||.|+
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 543 699999999999999999988999999999999999999999995 999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.+. ...+++||..|||||.+.|
T Consensus 228 ~lvnS--~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 228 ILVNS--IANTFVGTSAYMSPERISG 251 (364)
T ss_pred Hhhhh--hcccccccccccChhhhcC
Confidence 87665 6678999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=301.38 Aligned_cols=180 Identities=28% Similarity=0.472 Sum_probs=156.2
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....+.|+.+++||+|.||.||+|++..+|+.||+|.+..... .+....-..+||.||++|+||||++|.+..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-------~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-------KEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-------CCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 3345779999999999999999999999999999999976543 223344567999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+..+..+|||+|||+..+........-.|++.+++.|+.|++.||+|+|.+||+|||||.+|||||.+|.+||+|||||
T Consensus 186 t~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 87656799999999998655544444557999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCc-cccccCCCccccccCcccCC
Q 022241 274 QVFEDDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
+++.... ...+..+-|.+|.|||+|+|
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcC
Confidence 9875443 34777889999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=284.94 Aligned_cols=174 Identities=31% Similarity=0.527 Sum_probs=159.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|+.+.++|+|+||.||+++++.+|+.||||.+..+ ++++...+--++|+.+|++|.|||+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-- 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-- 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--
Confidence 5789999999999999999999999999999998654 2234555667899999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++||+|||+...|.++-.....++...++.+++|++.|+.|+|++++|||||||+||||+.+|.+||+|||+|+.+.
T Consensus 73 krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 73 KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 56899999999998888888888889999999999999999999999999999999999999999999999999999987
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+....+..+.|.+|.|||.|.|
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcc
Confidence 77777788899999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.97 Aligned_cols=153 Identities=29% Similarity=0.504 Sum_probs=143.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.-.++|.++..||+|+||.||+|+.+.+|..||+|++++..+. ...++..+..|..+|...++|+||+|+..|+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~------~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML------KKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH------hhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 3468899999999999999999999999999999999998765 3457789999999999999999999999999
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ .+++||||||++||....++...+.|++..++.++.+++.|++-||+.|+|||||||+|+|||..|++||+||||+.
T Consensus 212 D--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 212 D--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred C--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 7 46899999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred e
Q 022241 275 V 275 (300)
Q Consensus 275 ~ 275 (300)
-
T Consensus 290 g 290 (550)
T KOG0605|consen 290 G 290 (550)
T ss_pred h
Confidence 4
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=280.01 Aligned_cols=183 Identities=27% Similarity=0.393 Sum_probs=160.7
Q ss_pred cccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 111 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
..+...+++|+.+++|++|+||.||.++++.+++.||+|.++-.... ..---.-++||.+|.+++|||||.+-
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-------~GFPItsLREIniLl~~~H~NIV~vk 141 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-------EGFPITSLREINILLKARHPNIVEVK 141 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-------CCCcchhHHHHHHHHhcCCCCeeeeE
Confidence 45577788999999999999999999999999999999998754311 11112356999999999999999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.+....+-+.+|||||||+.....-.-...++++...++.++.|++.||+|||.++|+||||||+|+|+...|.+||+||
T Consensus 142 EVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 142 EVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred EEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 99988777889999999987644333344568999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+.++++...++..+-|.+|.|||+|+|
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG 251 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLG 251 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcC
Confidence 999999988888888999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=283.23 Aligned_cols=179 Identities=29% Similarity=0.484 Sum_probs=157.6
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee-E
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE-V 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~ 192 (300)
.....+|+++++||+|+||.||++.+..+|..||.|.++-..+ +....+.+..|+.+|++|+|||||++++ .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHS 87 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence 3344679999999999999999999999999999999874332 5667788999999999999999999999 4
Q ss_pred EEcCCCCEEEEEEEeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeCCCCCCCEEEccCCc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHG--HN--VVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~--~~--iiHrDlkp~NIll~~~~~ 264 (300)
|.+ +..-++||||||..|.|...+ .....+++.++|+++.|++.||..+|. .. |+||||||.||+|+.+|.
T Consensus 88 f~~-~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 88 FIE-DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred hhc-cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 443 344589999999999988766 345679999999999999999999998 44 999999999999999999
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+||||++.+........+.+|||.||+||.+.+
T Consensus 167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc
Confidence 999999999999888888889999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=268.08 Aligned_cols=173 Identities=28% Similarity=0.514 Sum_probs=150.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|..+++||+|.||.||+|++..+|+.||||.++..... ........+|+.+|+.++||||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-------dGi~~talREIK~Lqel~h~nIi~LiD~F~~-- 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-------DGINRTALREIKLLQELKHPNIIELIDVFPH-- 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-------cCccHHHHHHHHHHHHccCcchhhhhhhccC--
Confidence 4688889999999999999999999999999999765321 1122356799999999999999999999975
Q ss_pred CCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+.||+|||+.. |...+ ...-.++...++.++.++++||+|||+++|+||||||.|+|++++|.+||+|||+|+.+
T Consensus 73 ~~~l~lVfEfm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 73 KSNLSLVFEFMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred CCceEEEEEecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 56799999999864 44444 34457999999999999999999999999999999999999999999999999999998
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..+....+..+-|.+|.|||.|.|
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFG 175 (318)
T ss_pred CCCCcccccceeeeeccChHHhcc
Confidence 877766666689999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=287.92 Aligned_cols=180 Identities=35% Similarity=0.642 Sum_probs=158.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 193 (300)
.....|.+.+.||+|+||+|+++.+..+++.||||++.+..... .. ....+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~---~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS---KS-QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc---cc-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 44568999999999999999999999999999999877652211 01 123456678999999999 99999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DFGl 272 (300)
..+. .+|+||||+.||.|.+.+...+++.+..++.++.|++.|++|||++||+||||||+|||++.+ +++||+|||+
T Consensus 90 ~t~~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 90 ATPT--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred ecCC--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 8754 599999999999999999999999999999999999999999999999999999999999999 9999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...........+.+||+.|+|||+|.|
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCC
Confidence 9987544567788999999999999976
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.56 Aligned_cols=175 Identities=35% Similarity=0.640 Sum_probs=162.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
-.+|++.+.||+|.||+|.+|.....|+.||||.++++.+. +++.+-.+.+|+.||..|+||||+.++.+|.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk------deqDlvhIRREIeIMSsLNHPhII~IyEVFE-- 123 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK------DEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-- 123 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc------cHHHHHHHHHHHHHHhhcCCCceeehhhhhc--
Confidence 35799999999999999999999899999999999887553 5667778999999999999999999999997
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+.+.+.|||||..+|.|++++...+.|++..++++++||+.|+.|+|.++++|||||.+|||+|.|+++||+||||+..+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+. ....++||+|.|.+||++.|
T Consensus 204 ~~~-kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 204 ADK-KFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred ccc-cHHHHhcCCcccCCccccCC
Confidence 655 46688999999999999876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=290.22 Aligned_cols=178 Identities=30% Similarity=0.479 Sum_probs=159.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 192 (300)
....++|.++++||+|+||+|+++..+.+++.||||.++|..+- ....++..+.|..|+.... ||.++.++..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il------~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL------QRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee------ccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 44568899999999999999999999999999999999987553 3456777888888888775 9999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
|+. .+++|+||||+.||. .-++.....+++..++.|++.|+.||.|||++||||||||.+|||||..|++||+|||+
T Consensus 438 fQT--~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 438 FQT--KEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred ccc--CCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 997 469999999999999 55556667899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++..........++||||.|||||+|.|
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e 542 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTE 542 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhcc
Confidence 9986655567789999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.65 Aligned_cols=178 Identities=34% Similarity=0.532 Sum_probs=159.0
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
..-..+|...+.||.|+|++|++|+.+.+++.||||++.+..+.+ +..+..+..|..+|.+| .||.||+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik------e~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK------EKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh------hcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 445678999999999999999999999999999999998876543 34556788899999999 89999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
|+|. ..+|+|+||+++|.|..++...+.|++..++.++.||+.||+|||++|||||||||+|||||.++++||+|||.
T Consensus 143 FQD~--~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 143 FQDE--ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eecc--cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence 9974 57999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-------------ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-------------VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-------------~~~~~~gt~~y~aPE~l~ 299 (300)
|+.+..... ...+++||..|.+||+|.
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 998753211 114578999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=283.08 Aligned_cols=173 Identities=31% Similarity=0.510 Sum_probs=148.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
.+++|.++++||.|+||.||+|+.+.+|+.||||.+++..... ..-.=++|+..|++|+ |||||++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~--------ee~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW--------EECMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH--------HHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 4578999999999999999999999999999999997754321 1122358999999999 999999999998
Q ss_pred cCCCCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+.. ..+|+|||||+.. |+.++ .++..|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||||
T Consensus 80 d~~-~~L~fVfE~Md~N-LYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 80 DND-RILYFVFEFMDCN-LYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred ccC-ceEeeeHHhhhhh-HHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccc
Confidence 744 3899999999864 44444 44667999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..... ...+..+.|.+|.|||+|+
T Consensus 158 Rev~Sk-pPYTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 158 REVRSK-PPYTEYVSTRWYRAPEVLL 182 (538)
T ss_pred cccccC-CCcchhhhcccccchHHhh
Confidence 986543 3556778999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.53 Aligned_cols=173 Identities=28% Similarity=0.447 Sum_probs=147.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCce-EEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+....+.||+|+||+||.+. +.|+. ||||++...... ......|.+|+.+|.+++|||||+++|++.++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~-------~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFD-------DESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred HHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345566779999999997554 45766 999999765332 22277899999999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeCCCCCCCEEEccCC-cEEEecccC
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHN-VVHGDIKPDNLLVAPSG-TVKIGDFSV 272 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~-iiHrDlkp~NIll~~~~-~~kl~DFGl 272 (300)
.. .+.||||||++|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 112 ~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 112 PG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 32 68999999999999998877 678999999999999999999999999 99999999999999998 999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++........++...||+.|||||++.+
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcC
Confidence 9986554344455789999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=283.43 Aligned_cols=173 Identities=35% Similarity=0.579 Sum_probs=161.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||+++.+.+.+.||||.+.+.. ..+.....+.+|+.|++.++|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-- 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-------RNEKELKNLRQEVRILRSLKHPNIVEMLESFET-- 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--
Confidence 57999999999999999999999999999999998753 256678889999999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++|+|+||+.| .|..++...+.++++.+..++.|++.||.|||+++|+|||+||.|||++.+|.+|++|||+|+.+.
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 5689999999998 889999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
....+.++..|||.|||||++.|
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e 174 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEE 174 (808)
T ss_pred cCceeeeeccCcccccCHHHHcC
Confidence 88888888999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=266.47 Aligned_cols=173 Identities=33% Similarity=0.584 Sum_probs=149.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|...+.||+|+||.||++.+..+|+.+|||.+.... +. ..+.+.+|+.+|..++|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--------~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--------SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--------ch-hHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 45888899999999999999999999999999986431 11 2677899999999999999999999744322
Q ss_pred CCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~ 275 (300)
...+++.|||+++|++.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+++.
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 236899999999999999998766 7999999999999999999999999999999999999999 79999999999987
Q ss_pred ecC---CccccccCCCccccccCcccC
Q 022241 276 FED---DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~---~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... .........||+.|||||++.
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred cccccccccccccccCCccccCchhhc
Confidence 653 112233568999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=274.76 Aligned_cols=173 Identities=27% Similarity=0.370 Sum_probs=144.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
.+++|...+.||+|+||.||++... +|+.||||.+..... .. ..+|.+|+.+|.+++|||+|+++|||.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~--------~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSG--------QG-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCC--------cc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 4467888899999999999977665 448999997754321 11 3459999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcEeCCCCCCCEEEccCCcEEEecc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~---~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
... ..+||+|||++|+|.+++.... +++|..+.+|+.++|.||+|||+. .||||||||+|||||.++.+||+||
T Consensus 143 ~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 143 GGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred CCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 432 6999999999999998886655 899999999999999999999974 4999999999999999999999999
Q ss_pred cCceeecC-CccccccCCCccccccCcccC
Q 022241 271 SVSQVFED-DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~-~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|+..+. .....+...||.+|+|||++.
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhc
Confidence 99977654 332222118999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=262.23 Aligned_cols=176 Identities=32% Similarity=0.579 Sum_probs=147.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc-eeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~ 195 (300)
+..|..+++||+|+||+||+|+.+.+|+.||+|.++..... +..-....+|+.+|+.|+|+| ||.+++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-------EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-------EGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-------cCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 44688889999999999999999999999999999765321 112234579999999999999 9999999986
Q ss_pred CC----CCEEEEEEEeeCCCccccccCC-C---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEE
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQ-P---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~-~---~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl 267 (300)
.+ ...+++|+||+.... ..++.. . ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||
T Consensus 83 ~~~~~~~~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred cccccccceEEEEEEeecccH-HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEee
Confidence 33 137899999998643 333322 1 35777899999999999999999999999999999999999999999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|||+|+.+.-+....+...+|.+|.|||+|+|
T Consensus 162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG 194 (323)
T ss_pred eccchHHHhcCCcccccccEEEeeccCHHHhcC
Confidence 999999977655555677889999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.83 Aligned_cols=175 Identities=35% Similarity=0.601 Sum_probs=159.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+.-|.+.+.||.|+-|.|.+|++..+|+.+|||++.+.. .-+......+.+|+.||+.+.|||++++|++|..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~- 83 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN- 83 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccc------ccccccccchhhhhHHHHHhcCCCeeeeeeeecc-
Confidence 345899999999999999999999999999999998762 1134455678899999999999999999999985
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++|+|+||+++|.|++++...+++++..+.++++||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|..
T Consensus 84 -~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL- 161 (786)
T KOG0588|consen 84 -KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL- 161 (786)
T ss_pred -CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec-
Confidence 579999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+.......+.||+|-|+|||++.|
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred ccCCccccccCCCcccCCchhhcC
Confidence 344567788999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=251.82 Aligned_cols=177 Identities=31% Similarity=0.480 Sum_probs=157.9
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|-||.||+++.+.++..||+|++.+..+.+ .....++.+|++|-..|+||||+++|++|
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~------~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK------TQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH------hcchhhhhheeEeecccCCccHHhhhhhe
Confidence 445678999999999999999999999999999999998875432 23345788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.+ ...+||++||.+.|.+...+. ....+++..+..++.|+|.||.|+|.++||||||||+|+|++..+.+||+|||
T Consensus 92 hd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 92 HD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred ec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 87 458999999999999998887 56679999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++..-+ .....+.|||..|.|||+..|
T Consensus 170 wsV~~p--~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 170 WSVHAP--SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred ceeecC--CCCceeeecccccCCHhhcCC
Confidence 998754 445678999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=268.67 Aligned_cols=175 Identities=25% Similarity=0.445 Sum_probs=150.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++++..+++.||||++.+.... .......+..|+.++..++||||+++++.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-- 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML------EKEQVGHIRAERDILVEADSLWVVKMFYSFQD-- 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 3689999999999999999999999999999999764321 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+|+||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 45899999999999999988888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCc-----------------------------------cccccCCCccccccCcccCC
Q 022241 278 DDN-----------------------------------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~-----------------------------------~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......+||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 210 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence 210 01124579999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=261.17 Aligned_cols=169 Identities=30% Similarity=0.466 Sum_probs=147.1
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++++..+|+.||||++.+.... .......+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCF 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEE
Confidence 4699999999999999999999999998764321 23445678899999999999999999999986 458999
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccc
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||||+++++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 99999999998888888889999999999999999999999999999999999999999999999999998643333344
Q ss_pred ccCCCccccccCcccCC
Q 022241 284 RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~G 300 (300)
...+||+.|+|||++.|
T Consensus 153 ~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 153 KTFCGTPEYLAPEVLED 169 (323)
T ss_pred cceecCccccChhhhcC
Confidence 45679999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=261.44 Aligned_cols=175 Identities=29% Similarity=0.503 Sum_probs=153.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||+++++.+++.||||++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL------KMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3457899999999999999999999999999999999765321 2234567889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ .+.+++||||+++++|.+.+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 89 D--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred c--CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 6 45899999999999999888888889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ....||+.|+|||++.|
T Consensus 167 ~~~~~~---~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 167 KVPDRT---FTLCGTPEYLAPEVIQS 189 (329)
T ss_pred EcCCCc---ceecCChhhcCHHHHcC
Confidence 764322 34579999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=265.25 Aligned_cols=151 Identities=27% Similarity=0.493 Sum_probs=136.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++++..+++.||||++.+.... .......+.+|+.+|..++||||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-- 72 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML------EKEQVAHVRAERDILAEADNPWVVKLYYSFQD-- 72 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--
Confidence 3699999999999999999999999999999999764321 22345668899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++++|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 4589999999999999998887788999999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=266.00 Aligned_cols=150 Identities=27% Similarity=0.483 Sum_probs=135.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+++.||+|+||.||++.+..+++.||||++.+.... .......+.+|+.++..++|||||++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-- 72 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF------KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-- 72 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--
Confidence 3689999999999999999999999999999998754321 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||||+++++|..++.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 73 AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 458999999999999998888778899999999999999999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=265.88 Aligned_cols=149 Identities=27% Similarity=0.483 Sum_probs=134.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|..++.||+|+||.||++++..+++.||||++.+.... .......+.+|+.+++.++|||||++++++.+ .
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~ 73 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL------LRNQVAHVKAERDILAEADNEWVVRLYYSFQD--K 73 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh------hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--C
Confidence 589999999999999999999999999999998764321 23455678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+|+||||+++++|...+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 58999999999999988887777899999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=256.95 Aligned_cols=170 Identities=32% Similarity=0.465 Sum_probs=141.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..-.|...+++|.|+||.||.+....+++.||||.+..+.. --.+|..+|+.++|||||++..+|..
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------------~knrEl~im~~l~HpNIV~L~~~f~~ 88 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------------YKNRELQIMRKLDHPNIVRLLYFFSS 88 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------------cCcHHHHHHHhcCCcCeeeEEEEEEe
Confidence 34468899999999999999999999999999998865421 12379999999999999999998876
Q ss_pred CCCC---EEEEEEEeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEE
Q 022241 196 PNSD---HFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKI 267 (300)
Q Consensus 196 ~~~~---~~~lv~E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl 267 (300)
.... ...+|||||+... ...+ ..+..++...++-+++||++||+|||+.||+||||||.|+|+|.+ |.+||
T Consensus 89 ~~~~d~~~lnlVleymP~tL-~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 89 STESDEVYLNLVLEYMPETL-YRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred cCCCchhHHHHHHHhchHHH-HHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEe
Confidence 4333 3457999999743 3333 346789999999999999999999999999999999999999976 89999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||||.|+.+..... ..+-..|..|.|||.++|
T Consensus 168 cDFGSAK~L~~~ep-niSYicSRyYRaPELifg 199 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEP-NISYICSRYYRAPELIFG 199 (364)
T ss_pred ccCCcceeeccCCC-ceeEEEeccccCHHHHcC
Confidence 99999998755432 244557889999999987
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=265.18 Aligned_cols=148 Identities=28% Similarity=0.506 Sum_probs=134.0
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++++.||+|+||.||++++..+++.||||++.+.... .......+.+|+.+|..++||||+++++.+.+ .
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL------MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 699999999999999999999999999999998654321 12334668899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+.+++||||+++++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|.
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 5899999999999999988888889999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.23 Aligned_cols=149 Identities=26% Similarity=0.451 Sum_probs=135.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|..++.||+|+||.||++++..+++.||||++.+.... .......+.+|+.++..++||||+++++++.+ .
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~ 73 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL------NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--C
Confidence 588999999999999999999999999999999764321 23455678999999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 58999999999999998888778899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=253.14 Aligned_cols=178 Identities=29% Similarity=0.458 Sum_probs=162.7
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
...+++|..+++||+|.||+|.+++.+.+|+.||||++++.... ....+..-+.|-.+|+..+||.+..+...|
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii------akdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII------AKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee------ehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 34578899999999999999999999999999999999887542 455667788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+. .+.+++||||..||.|.-++.....+++..++.+-..|+.||.|||+++||+||||.+|+|+|.+|++||+||||+
T Consensus 238 Qt--~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 238 QT--QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred cc--CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence 85 5789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.-......++++||||.|+|||+|-
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred hhcccccceeccccCChhhcCchhhc
Confidence 97666667788999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=254.37 Aligned_cols=173 Identities=29% Similarity=0.457 Sum_probs=151.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.|++.+.||.|..+.||+|+....++.||||+++... ....+..+.+|+..|+.++||||++++..|..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--------c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--------CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--------hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 3467999999999999999999999999999999997653 23447899999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+..+|+||.||.+|++.+.+.. ...+.|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+
T Consensus 96 --~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 96 --DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred --cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 4689999999999999987754 345999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCcccc----ccCCCccccccCccc
Q 022241 274 QVFEDDNDVL----RRSPGTPVFTAPECC 298 (300)
Q Consensus 274 ~~~~~~~~~~----~~~~gt~~y~aPE~l 298 (300)
..+.+..... .+++|||.|||||+|
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHh
Confidence 7654432211 456899999999995
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.51 Aligned_cols=169 Identities=30% Similarity=0.471 Sum_probs=146.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++++..+++.||||++.+.... .......+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEE
Confidence 4689999999999999999999999999764321 23455678899999999999999999999985 458999
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccc
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||||++++++...+.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus 73 v~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 73 VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 99999999998888777789999999999999999999999999999999999999999999999999998643333334
Q ss_pred ccCCCccccccCcccCC
Q 022241 284 RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~G 300 (300)
...+||+.|+|||++.|
T Consensus 153 ~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 153 KTFCGTPEYLAPEVLED 169 (328)
T ss_pred ccccCCcCccChhhhcC
Confidence 45679999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=259.01 Aligned_cols=172 Identities=28% Similarity=0.469 Sum_probs=151.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-- 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF------KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-- 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--
Confidence 3699999999999999999999999999999999765321 22345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+|+||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 45899999999999999998887889999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
. ......||+.|+|||++.|
T Consensus 153 ~---~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 153 T---YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred c---ccCCcccCccccChhHhcC
Confidence 3 2345679999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=259.76 Aligned_cols=174 Identities=37% Similarity=0.592 Sum_probs=155.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
....|.+.+.||+|.||.||.++.+.+|+.||+|.+.+.... .......+.+|+.+|+.+. |||||.++++|.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~------~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR------GKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc------ccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 345799999999999999999999999999999999887543 2225568899999999999 999999999999
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC----CcEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~----~~~kl~DF 270 (300)
++ ..+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+... +.+|++||
T Consensus 107 ~~--~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 107 DP--DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred cC--CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 74 4899999999999999888666 49999999999999999999999999999999999999654 47999999
Q ss_pred cCceeecCCccccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|..... .......+|||.|+|||++.
T Consensus 184 Gla~~~~~-~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 184 GLAKFIKP-GERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred CCceEccC-CceEeeecCCccccCchhhc
Confidence 99998766 55677889999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=256.13 Aligned_cols=172 Identities=28% Similarity=0.502 Sum_probs=150.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.||||++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 72 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI------RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-- 72 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--
Confidence 3689999999999999999999999999999998654221 12345678899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 45899999999999999888888889999999999999999999999999999999999999999999999999998754
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.. .....||+.|+|||++.|
T Consensus 153 ~~---~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 153 DR---TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred CC---cccccCChhhcCHHHHcC
Confidence 32 234579999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.30 Aligned_cols=169 Identities=30% Similarity=0.473 Sum_probs=146.4
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++++..+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCF 72 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEE
Confidence 4699999999999999999999999998764321 23445677889999999999999999999986 458999
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccc
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||||+++++|...+.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..........
T Consensus 73 v~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 99999999998888777789999999999999999999999999999999999999999999999999988643333334
Q ss_pred ccCCCccccccCcccCC
Q 022241 284 RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~G 300 (300)
....||+.|+|||++.|
T Consensus 153 ~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 153 KTFCGTPEYLAPEVLED 169 (323)
T ss_pred ccccCCcCcCCcccccC
Confidence 45679999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=260.41 Aligned_cols=151 Identities=25% Similarity=0.465 Sum_probs=135.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|+.++.||+|+||.||++.+..+++.||||++.+.... .......+..|+.++..++||||+++++.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 72 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML------EKEQVAHIRAERDILVEADGAWVVKMFYSFQD-- 72 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 3689999999999999999999999999999999754321 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++++|...+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 4589999999999999998888888999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.48 Aligned_cols=175 Identities=30% Similarity=0.462 Sum_probs=151.5
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCC-ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
...++|.+.+.||+|+||.||+|....++ ..||+|.+.+.... .......+.+|+.++..++||||+++++++
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII------KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 34568999999999999999999876654 68999998764321 233456788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ...+++||||+++++|..++.....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 101 KD--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 86 4589999999999999998888888999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... .....||+.|+|||++.|
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 179 KVVDTR---TYTLCGTPEYIAPEILLN 202 (340)
T ss_pred eecCCC---cceecCChhhcCHHHHhC
Confidence 875432 235679999999998754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.71 Aligned_cols=174 Identities=39% Similarity=0.602 Sum_probs=160.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
...|.+...||+|.|+.|.++++..++..||||++.+... .......+.+|+.+|+.|+|||||+++.+...
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t- 126 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIET- 126 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-------ChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-
Confidence 4569999999999999999999999999999999988754 34455568999999999999999999999985
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||+.+|.+.+++...+.+.+..++.++.|++.|++|||++.|+|||||++||||+.+-++||+|||++.++
T Consensus 127 -~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 127 -EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred -cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 4689999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
. ......+.||++.|+|||++.|
T Consensus 206 ~-~~~~lqt~cgsppyAaPEl~~g 228 (596)
T KOG0586|consen 206 D-YGLMLQTFCGSPPYAAPELFNG 228 (596)
T ss_pred c-ccccccccCCCCCccChHhhcC
Confidence 6 4567788999999999999887
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=261.29 Aligned_cols=175 Identities=28% Similarity=0.441 Sum_probs=149.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++++..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 346799999999999999999999999999999998754221 22234567889999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||||+++++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|..
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 4689999999999999887754 3689999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc-ccccCCCccccccCcccC
Q 022241 276 FEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+..... ...+.+||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHh
Confidence 643322 223567999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=263.06 Aligned_cols=170 Identities=31% Similarity=0.520 Sum_probs=152.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
...|....+||+|+.|.||.|+...+++.||||.+..... ...+-+.+|+.+|+..+|+|||.+++.|..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---------~~keLilnEi~Vm~~~~H~NiVnfl~Sylv- 341 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---------PKKELLLNEILVMRDLHHPNIVNFLDSYLV- 341 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---------CchhhhHHHHHHHHhccchHHHHHHHHhcc-
Confidence 4568888999999999999999999999999999976532 234568899999999999999999998875
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+|||||+||+|.+.+... .++|.++..|.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+
T Consensus 342 -~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 342 -GDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred -cceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 46899999999999988877554 5999999999999999999999999999999999999999999999999999988
Q ss_pred cCCccccccCCCccccccCccc
Q 022241 277 EDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l 298 (300)
........+.+|||.|||||+.
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVv 441 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVV 441 (550)
T ss_pred ccccCccccccCCCCccchhhh
Confidence 7766677788999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=255.40 Aligned_cols=167 Identities=31% Similarity=0.502 Sum_probs=145.9
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|+||.||++++..+++.||+|++.+.... .......+.+|+.++..++||||+++++++.+ ...+++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV------SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEE
Confidence 79999999999999999999999998754321 23455678899999999999999999999985 45899999
Q ss_pred EeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccccc
Q 022241 206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285 (300)
Q Consensus 206 E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 285 (300)
||+++++|...+...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...........
T Consensus 73 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 73 AFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 99999999988887888999999999999999999999999999999999999999999999999999865443334445
Q ss_pred CCCccccccCcccCC
Q 022241 286 SPGTPVFTAPECCLG 300 (300)
Q Consensus 286 ~~gt~~y~aPE~l~G 300 (300)
.+||+.|+|||++.|
T Consensus 153 ~~gt~~y~aPE~~~~ 167 (312)
T cd05585 153 FCGTPEYLAPELLLG 167 (312)
T ss_pred ccCCcccCCHHHHcC
Confidence 679999999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=253.27 Aligned_cols=173 Identities=28% Similarity=0.480 Sum_probs=145.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--------EGTPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--------cccchhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence 579999999999999999999999999999999864321 1122356789999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||++++.+.......+.+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 45899999999865544444445678999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........||+.|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLG 177 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcC
Confidence 44334445678999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=255.05 Aligned_cols=169 Identities=30% Similarity=0.467 Sum_probs=146.1
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++++..+++.||+|++.+.... .......+..|+.++..++||||+++++++.. ...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCF 72 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEE
Confidence 4699999999999999999999999999764321 23345677889999999999999999999986 458999
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
||||+++++|...+.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 73 v~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 99999999998888777789999999999999999999997 79999999999999999999999999999865433334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED 170 (325)
T ss_pred cccccCCcccCCHHHHcc
Confidence 445679999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=263.09 Aligned_cols=176 Identities=26% Similarity=0.490 Sum_probs=157.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|..++++|+|+||.+++++++.++..|++|.+..... .+.......+|+.++++++|||||.+.+.|.+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-------t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-------TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-------CchhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 4679999999999999999999999999999999976543 233444778999999999999999999999863
Q ss_pred CCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+..++|||+||+||++.+.+... .-+++..+..++.||+.||.|||++.|+|||||+.|||+..++.|||+|||+|+
T Consensus 76 -~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 76 -GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred -CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhh
Confidence 34599999999999999887554 369999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+........+..|||.||.||++.|
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSD 180 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCC
Confidence 98777667888999999999999865
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=258.55 Aligned_cols=175 Identities=31% Similarity=0.525 Sum_probs=152.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++.+.... .......+..|+.++..++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 72 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI------KRNQIAHVRAERDILADADSPWIVKLYYSFQD-- 72 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhcCCCCccchhhheec--
Confidence 3699999999999999999999999999999999765321 12345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 45899999999999999888777889999999999999999999999999999999999999999999999999998754
Q ss_pred CCc-----------------------------cccccCCCccccccCcccCC
Q 022241 278 DDN-----------------------------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~-----------------------------~~~~~~~gt~~y~aPE~l~G 300 (300)
... .......||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 432 12234569999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=249.48 Aligned_cols=172 Identities=28% Similarity=0.468 Sum_probs=144.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||.|+||.||++++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--------EGAPCTAIREVSLLKNLKHANIVTLHDIIHT-- 74 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--------CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 579999999999999999999999999999999864321 1123456789999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||+++ .+...+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 3579999999986 55555433 345889999999999999999999999999999999999999999999999999875
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred cCCCccccCceecccccChHHhcC
Confidence 443333445678999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.98 Aligned_cols=174 Identities=28% Similarity=0.419 Sum_probs=148.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC-ceeeeeeEEEcCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP-NIVNLIEVIDDPN 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~ 197 (300)
+|++++.||+|+||.||++++..+++.||||++.+.... .......+..|+.++..+.|+ +|+++++++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-- 72 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-- 72 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--
Confidence 488999999999999999999999999999999765321 233456788899999999765 57888888875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+|+||||+++++|...+.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 73 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 45899999999999998888777889999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........+||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 153 FGGKTTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred CCCCceeeecCCccccChhhhcC
Confidence 33333445679999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.50 Aligned_cols=173 Identities=28% Similarity=0.436 Sum_probs=158.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
..|..++.||+|+||.||++.+..+++.||+|++.... .+...+.+.+|+.+|.+++++||.++|+.+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--------~~deIediqqei~~Ls~~~~~~it~yygsyl~-- 82 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-- 82 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--------cchhhHHHHHHHHHHHhcCcchHHhhhhheee--
Confidence 35888899999999999999999999999999986542 55677889999999999999999999999885
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
+..+|++||||.||+..+.+.....+.+..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+.
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 46899999999999999999988888999999999999999999999999999999999999999999999999999988
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.......+++|||.|||||++.+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ 185 (467)
T ss_pred chhhccccccccccccchhhhcc
Confidence 77777688999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=257.56 Aligned_cols=175 Identities=28% Similarity=0.413 Sum_probs=149.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++++..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI------KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 356899999999999999999999999999999998754321 12234457789999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++||||+++++|..++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 115 --DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 4589999999999999887754 4689999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc-ccccCCCccccccCcccC
Q 022241 276 FEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
...... .....+||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhc
Confidence 643322 223467999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.90 Aligned_cols=175 Identities=27% Similarity=0.489 Sum_probs=151.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc-
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD- 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 195 (300)
...|..++.||+|+||.|..+.++.+|+.||||.+.... .+....++..+|+.+|+.++|+||+.+++++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-------hchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 345777899999999999999999999999999886322 255677889999999999999999999999875
Q ss_pred --CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 --PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 --~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
..-..+|+|+|+|+ ..|...+..+..+++..+..+++|++.||+|+|+.+|+||||||+|+|++.+..+||+|||||
T Consensus 94 ~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 23467899999994 567777778878999999999999999999999999999999999999999999999999999
Q ss_pred eeecC--CccccccCCCccccccCcccC
Q 022241 274 QVFED--DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~--~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.... ....++.-+.|.+|.|||+++
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll 200 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLL 200 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHh
Confidence 98753 234456678999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.78 Aligned_cols=175 Identities=29% Similarity=0.444 Sum_probs=149.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++++..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 346899999999999999999999999999999998754221 22334567889999999999999999999985
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++||||+++++|..++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 --DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 4689999999999999887754 3589999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc-ccccCCCccccccCcccC
Q 022241 276 FEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
...... .....+||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHh
Confidence 643322 223567999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.66 Aligned_cols=174 Identities=25% Similarity=0.417 Sum_probs=149.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++.+.... .......+..|+.++..++|+||+++++++.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-- 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML------KRAETACFREERNVLVNGDCQWITTLHYAFQD-- 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH------hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 4699999999999999999999999999999998754221 22344568889999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+..|+||||+++++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 4689999999999999988865 467999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCccccccCcccC
Q 022241 277 EDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
..... ......||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHh
Confidence 44332 223356999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=253.15 Aligned_cols=174 Identities=27% Similarity=0.438 Sum_probs=149.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++++..+++.||||++.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML------KRAETACFREERDVLVNGDRRWITNLHYAFQD-- 72 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--
Confidence 3699999999999999999999999999999998754221 22345568899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||+++++|..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 4689999999999999888755 457999999999999999999999999999999999999999999999999999875
Q ss_pred cCCccc-cccCCCccccccCcccC
Q 022241 277 EDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
...... .....||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCCCCccccceeccccccCHHHHh
Confidence 443322 22346999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=252.34 Aligned_cols=171 Identities=29% Similarity=0.484 Sum_probs=145.3
Q ss_pred eeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
++.||+|+||.||+++.. .+++.||||++.+..... .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~ 73 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GG 73 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CC
Confidence 368999999999999864 478899999987643211 22334567899999999999999999999986 45
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
.+|+||||+++++|...+...+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 74 KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred eEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 89999999999999988888888999999999999999999999999999999999999999999999999999865443
Q ss_pred ccccccCCCccccccCcccCC
Q 022241 280 NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 280 ~~~~~~~~gt~~y~aPE~l~G 300 (300)
........||+.|+|||++.+
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMR 174 (323)
T ss_pred CCcccccCCCccccChhhccC
Confidence 334445679999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.43 Aligned_cols=176 Identities=31% Similarity=0.431 Sum_probs=157.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.|.+++++.+++.||||+++++.+.+ ...-.-|..|..+|.-.+.+-||.++.+|++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK------r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK------RAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh------chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3568999999999999999999999999999999999876643 2233468899999999999999999999997
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+ .++|+|||||+||.+..++....++++.+++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.
T Consensus 147 ~--~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 147 E--RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred c--cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence 4 58999999999999999998888999999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc-ccccCCCccccccCcccC
Q 022241 276 FEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+..+.. .....+|||.|++||+|.
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHH
Confidence 764443 444568999999999985
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=241.96 Aligned_cols=180 Identities=26% Similarity=0.424 Sum_probs=157.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
..+.|...+.||+|..+.|..+.++.+|..+|+|++....-... .+......+.-..|+.||+++. ||+|+++.++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~-~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTES-GETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccC-CccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34568888999999999999999999999999999876543221 2223445567788999999985 999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ...+++|+|.|+.|.|.+++.+.-.+++...+.|+.|++.|++|||.++||||||||+|||++++-++||+|||+|.
T Consensus 94 s--~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 94 S--DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred C--cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 6 45899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.++.. ...+..||||+|+|||.+.
T Consensus 172 ~l~~G-ekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 172 QLEPG-EKLRELCGTPGYLAPETIK 195 (411)
T ss_pred ccCCc-hhHHHhcCCCcccChhhee
Confidence 88654 4567899999999999863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=244.89 Aligned_cols=172 Identities=24% Similarity=0.372 Sum_probs=146.0
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|+..+.||+|+||.||++.+..+++.||||.+.+.... .......+.+|+.++..++|+||+++++++.+ .+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~ 73 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh------hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence 78889999999999999999999999999998764321 12233467789999999999999999999975 45
Q ss_pred EEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++||||++++++...+.. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 89999999999998765532 3468999999999999999999999999999999999999999999999999998754
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......||+.|+|||++.|
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 154 EGE-TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred CCC-eecCCCCCCCccCHhhhcC
Confidence 322 2344579999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.26 Aligned_cols=174 Identities=28% Similarity=0.418 Sum_probs=148.3
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPN 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 197 (300)
+|.+.+.||+|+||.||++++..+++.||||++.+.... .......+..|..++..+ +||+|+++++++.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-- 72 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-- 72 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--
Confidence 488999999999999999999999999999998764321 223445567788888776 58999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+|+||||+++++|...+.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 45899999999999998888777889999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........+||+.|+|||++.+
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 153 WDGVTTKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CCCCccccCCCChhhcCHHHhcC
Confidence 33334445679999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.28 Aligned_cols=169 Identities=28% Similarity=0.429 Sum_probs=145.7
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||||++++.... .......+..|..++..+ +||||+++++++.+ ...+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~ 72 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN------DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLF 72 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEE
Confidence 4699999999999999999999999999765321 233456788999999888 69999999999986 35899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|..++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 99999999999888777788999999999999999999999999999999999999999999999999999753333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG 170 (329)
T ss_pred cccccCCccccCHHHHcC
Confidence 445679999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.41 Aligned_cols=169 Identities=30% Similarity=0.448 Sum_probs=145.1
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||+|++.+.... .......+..|+.++..+ +||||+++++++.+ ...++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 72 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF 72 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEE
Confidence 4699999999999999999999999999765321 233455678888888776 79999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 99999999999888777778999999999999999999999999999999999999999999999999999864333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG 170 (329)
T ss_pred cccccCCccccCHHHHcC
Confidence 445679999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=247.69 Aligned_cols=154 Identities=26% Similarity=0.409 Sum_probs=138.1
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..-.++|++++.||+|.-|+||+++.+.++..+|||++.+..+. ......+...|..||+.++||.++.||..|
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~------~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA------SRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh------hhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 44457899999999999999999999999999999999887654 345667788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+. .+..++|||||+||.|..+... .+.+++..++.++.+++.||+|||-.|||+|||||+||||.++|+|-|+||.
T Consensus 147 et--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 147 ET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 86 4689999999999999876644 3479999999999999999999999999999999999999999999999999
Q ss_pred Ccee
Q 022241 272 VSQV 275 (300)
Q Consensus 272 la~~ 275 (300)
|+..
T Consensus 225 LS~~ 228 (459)
T KOG0610|consen 225 LSLR 228 (459)
T ss_pred cccc
Confidence 8643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.15 Aligned_cols=169 Identities=32% Similarity=0.506 Sum_probs=142.3
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHH-HHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+|+.||||++.+.... .......+..|.. +++.++||||+++++++.+ ...++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~ 72 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL------KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLY 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEE
Confidence 4699999999999999999999999998764321 1223344555554 5678999999999999985 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 99999999999888877788999999999999999999999999999999999999999999999999999864333334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred cccccCChhhcChhhhcC
Confidence 445679999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=251.54 Aligned_cols=175 Identities=29% Similarity=0.441 Sum_probs=148.0
Q ss_pred ceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
+|++.+.||+|+||.||+++.. .+++.||+|++.+..... .......+..|+.++..+ +||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence 4889999999999999998864 478999999987643211 233456788999999999 5999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ...+++||||++++++...+.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 76 T--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred c--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 5 45799999999999999888777889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc-cccccCCCccccccCcccCC
Q 022241 275 VFEDDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.... .......||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcC
Confidence 653322 22334679999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=250.33 Aligned_cols=169 Identities=28% Similarity=0.480 Sum_probs=142.5
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||||++++.... .......+..|..++.. .+||||+++++++.. ...++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~ 72 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEE
Confidence 4699999999999999999999999999764321 12234455566666664 489999999999985 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 99999999999888877778999999999999999999999999999999999999999999999999999865443334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG 170 (316)
T ss_pred cccccCCccccCHHHHcC
Confidence 455679999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=251.20 Aligned_cols=174 Identities=28% Similarity=0.454 Sum_probs=150.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++++.... .......+..|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-- 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL------AQETVSFFEEERDILSISNSPWIPQLQYAFQD-- 72 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--
Confidence 3689999999999999999999999999999999764321 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 45899999999999999888665 67999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCccccccCcccC
Q 022241 277 EDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
..... ......||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CCCCceeeecccCCccccCHHHhc
Confidence 44332 223457999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=251.46 Aligned_cols=169 Identities=29% Similarity=0.451 Sum_probs=144.5
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||+++++.+++.||||++.+.... .......+..|..++..+ +||||+++++++.+ ...+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~ 72 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLF 72 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEE
Confidence 4699999999999999999999999998764321 223455677888888776 69999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 73 iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred EEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99999999999888877788999999999999999999999999999999999999999999999999999864333334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE 170 (320)
T ss_pred ccccccCccccCHHHHcC
Confidence 455679999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=251.04 Aligned_cols=169 Identities=31% Similarity=0.503 Sum_probs=141.4
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHH-HHHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||+|++.+.... .......+..|. .+++.++||||+++++++.+ .+.+|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~ 72 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLY 72 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEE
Confidence 4699999999999999999999999998764321 112223444444 45688999999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||++++++...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 99999999999988887788999999999999999999999999999999999999999999999999999865443334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred cccccCCccccCHHHHcC
Confidence 455679999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=249.97 Aligned_cols=172 Identities=33% Similarity=0.446 Sum_probs=144.2
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHH---HHCCCCceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM---KMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~ 196 (300)
|.+++.||+|+||.||++.+..+++.||||.+++.... .......+.+|+.++ ..++||||+++++++.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQT- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-
Confidence 67889999999999999999999999999999764321 223445666776665 46679999999999985
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||++++++...+.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 74 -~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 74 -EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred -CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 4689999999999988776643 57999999999999999999999999999999999999999999999999998764
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+||+.|+|||++.|
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred CCCCCcccccccCccccCHhHhcC
Confidence 333333455679999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=250.62 Aligned_cols=169 Identities=28% Similarity=0.417 Sum_probs=144.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||||++.+.... .......+..|..++..+ +||||+++++++.+ ...+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~ 72 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLF 72 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEE
Confidence 4699999999999999999999999998764321 233455677888888865 79999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99999999999888877788999999999999999999999999999999999999999999999999999865444444
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE 170 (321)
T ss_pred ccccccCccccCHHHHcC
Confidence 455679999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.45 Aligned_cols=174 Identities=28% Similarity=0.429 Sum_probs=147.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPN 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 197 (300)
+|...+.||+|+||.||+++++.+++.||||++.+.... .......+..|..++..+. |++|+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-- 72 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-- 72 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--
Confidence 377889999999999999999999999999998764321 2234556778888888876 5677889888876
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+|+||||+++++|..++.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 73 VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 35899999999999998888777889999999999999999999999999999999999999999999999999998644
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 153 VDGVTTRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CCCccccCccCCccccCHHHHcC
Confidence 33333445679999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=250.40 Aligned_cols=169 Identities=33% Similarity=0.505 Sum_probs=142.2
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHH-HHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+|+.||||++.+.... .......+..|.. +++.++||||+++++++.. .+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~ 72 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLY 72 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEE
Confidence 4699999999999999999999999998764221 1223345555554 5678999999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||++++++...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 99999999999888877788999999999999999999999999999999999999999999999999999864333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK 170 (325)
T ss_pred cccccCChhhCCHHHHcC
Confidence 445679999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=249.76 Aligned_cols=169 Identities=30% Similarity=0.494 Sum_probs=141.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHH-HHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||+|++.+.... .......+..|.. +++.++||||+++++++.+ .+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~ 72 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLY 72 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEE
Confidence 4699999999999999999999999998764321 1223344555554 6788999999999999976 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||++++++...+.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 99999999999887777778999999999999999999999999999999999999999999999999999864333334
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK 170 (321)
T ss_pred cccccCCcccCCHHHhcC
Confidence 455679999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=249.94 Aligned_cols=169 Identities=28% Similarity=0.444 Sum_probs=145.8
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||+++...+++.||||++.+.... .......+..|+.++..+ +||||+++++++.+ ...++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 72 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH------DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLF 72 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEE
Confidence 4799999999999999999999999999765321 234456788999999887 69999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 99999999999888777778999999999999999999999999999999999999999999999999999864333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG 170 (327)
T ss_pred eecccCCcccCCHHHHCC
Confidence 455679999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=248.93 Aligned_cols=174 Identities=25% Similarity=0.413 Sum_probs=148.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||+++.+.+++.||+|++.+.... .......+..|+.++..++|+||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 72 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML------KRAETACFREERDVLVNGDNQWITTLHYAFQD-- 72 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH------HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--
Confidence 3689999999999999999999999999999998754221 12334567889999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 3589999999999999988865 467999999999999999999999999999999999999999999999999999765
Q ss_pred cCCcc-ccccCCCccccccCcccC
Q 022241 277 EDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
..... .....+||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 153 MEDGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred ccCCcceecccccCccccCHHHHh
Confidence 43322 223457999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=250.86 Aligned_cols=174 Identities=20% Similarity=0.306 Sum_probs=141.1
Q ss_pred cceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
++|++.+.||+|+||.||++.+. .+++.||||++.... .......+.+|+.+|..+ +||||+++++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--------TASEHKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--------chHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence 57999999999999999999752 356789999885421 233456789999999999 8999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC----------------------------------------------------
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------------------------------------------- 219 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~---------------------------------------------------- 219 (300)
++... ...+++||||+++|+|.+++..
T Consensus 79 ~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 79 ACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred EecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 98754 3578999999999998766532
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCC
Q 022241 220 ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSP 287 (300)
Q Consensus 220 ----------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~ 287 (300)
..++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 13478888999999999999999999999999999999999999999999999986533221 112334
Q ss_pred CccccccCcccCC
Q 022241 288 GTPVFTAPECCLG 300 (300)
Q Consensus 288 gt~~y~aPE~l~G 300 (300)
+++.|+|||++.+
T Consensus 238 ~~~~y~aPE~~~~ 250 (338)
T cd05102 238 LPLKWMAPESIFD 250 (338)
T ss_pred CCccccCcHHhhc
Confidence 6788999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=243.78 Aligned_cols=174 Identities=28% Similarity=0.473 Sum_probs=148.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||+++++.+++.||||.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-------NEEVKETTLRELKMLRTLKQENIVELKEAFRR-- 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-------cccchhhHHHHHHHHHhCCCccccchhhhEec--
Confidence 369999999999999999999999999999999865421 22344577889999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+++||||++++.+.........+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 46899999999988776655555679999999999999999999999999999999999999999999999999998764
Q ss_pred CCc-cccccCCCccccccCcccCC
Q 022241 278 DDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
... .......||+.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLG 175 (287)
T ss_pred ccccccccccccccccCCcHHHcC
Confidence 322 12234569999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=248.15 Aligned_cols=168 Identities=27% Similarity=0.425 Sum_probs=144.3
Q ss_pred eeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|+||.||+++.. .+|+.||+|++.+.... ......+..|+.+|+.++||||+++++++.+ ...
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGK 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCE
Confidence 67999999999998764 47899999999764321 2233457789999999999999999999986 458
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
+|+||||+++++|...+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999999999998888777789999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccCCCccccccCcccCC
Q 022241 281 DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 281 ~~~~~~~gt~~y~aPE~l~G 300 (300)
.......||+.|+|||++.+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNR 172 (318)
T ss_pred CceecccCChhhcCHHHHcC
Confidence 34455679999999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=247.88 Aligned_cols=169 Identities=26% Similarity=0.432 Sum_probs=142.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||+++++.+|+.||||++++.... .......+..|..++.. ++||||+++++++.+ .+.+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~ 72 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEE
Confidence 4699999999999999999999999999764321 12234456677777765 489999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+.+++|...+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred EEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 99999999999888877778999999999999999999999999999999999999999999999999998754333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG 170 (316)
T ss_pred eeccCCCcCccCHHHHcC
Confidence 455679999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=261.53 Aligned_cols=170 Identities=29% Similarity=0.470 Sum_probs=148.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC--
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN-- 197 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 197 (300)
|...+.||+|+||.||.++++.+|+.||||.+++.. .....+.+.+|+++|++++|||||+++++=.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 566789999999999999999999999999997643 3456678999999999999999999998755433
Q ss_pred --CCEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC--C--cEEEe
Q 022241 198 --SDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--G--TVKIG 268 (300)
Q Consensus 198 --~~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~--~--~~kl~ 268 (300)
.....+|||||.+|+|...+..+. .|++.....++.+++.||.|||++||+||||||.||++... | ..||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 456689999999999998886653 69999999999999999999999999999999999998533 3 57999
Q ss_pred cccCceeecCCccccccCCCccccccCccc
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
|||.|+-+++.. ...+..||+.|+|||++
T Consensus 167 DfG~Arel~d~s-~~~S~vGT~~YLhPel~ 195 (732)
T KOG4250|consen 167 DFGAARELDDNS-LFTSLVGTEEYLHPELY 195 (732)
T ss_pred cccccccCCCCC-eeeeecCchhhcChHHH
Confidence 999999987655 77889999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.77 Aligned_cols=169 Identities=30% Similarity=0.452 Sum_probs=147.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
-|..++.||.|+||.||.|++..+.+.||||.+.-..- .+...++.++.|+..|..+.|||+|.+-|+|...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK------Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-- 98 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-- 98 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc------ccHHHHHHHHHHHHHHHhccCCCcccccceeecc--
Confidence 47788999999999999999999999999998864422 2456678899999999999999999999999853
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...|||||||-|...+.+-...+++.+..+..|..+++.||+|||+.+.||||||..|||+.+.|.|||+|||.|....
T Consensus 99 ~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 99 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 4689999999875444334556789999999999999999999999999999999999999999999999999998753
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..+++|||.|||||+++
T Consensus 178 ---PAnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVIL 195 (948)
T ss_pred ---chhcccCCccccchhHhe
Confidence 345789999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.77 Aligned_cols=170 Identities=27% Similarity=0.399 Sum_probs=141.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
...+.+++.||+|-||.|+++.... ...||+|.++...+ ..+.|.+|+++|++|+|+|||+++++|..
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~- 272 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----------SPEAFLREAQIMKKLRHEKLVKLYGVCTK- 272 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----------ChhHHHHHHHHHHhCcccCeEEEEEEEec-
Confidence 3456778899999999998776552 23799999875432 23578899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+.+|||||||+.|+|.+++.. ...+.......++.|||.|++||+++++|||||.++||||+++..+||+|||||+
T Consensus 273 -~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 273 -QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred -CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 3479999999999999999986 5578999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCC-CccccccCcccC
Q 022241 275 VFEDDNDVLRRSP-GTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~-gt~~y~aPE~l~ 299 (300)
...++....+... --..|.|||++.
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALN 377 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHh
Confidence 6555443332221 223499999873
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=248.06 Aligned_cols=173 Identities=28% Similarity=0.449 Sum_probs=144.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 48899999999999999999999999999998864311 12234568899999999999999999998864321
Q ss_pred ---CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 ---DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ---~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+|+||||+++ .+...+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 74 REFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred CCCceEEEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 358999999964 6666676677899999999999999999999999999999999999999999999999999986
Q ss_pred ecCCc---cccccCCCccccccCcccC
Q 022241 276 FEDDN---DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~---~~~~~~~gt~~y~aPE~l~ 299 (300)
..... .......||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 179 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCG 179 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHh
Confidence 43221 1223457999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=248.51 Aligned_cols=166 Identities=28% Similarity=0.431 Sum_probs=140.6
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeeeEEEcCCCCEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 202 (300)
||+|+||.||++++..+++.||||++.+.... ..........|..++..+ .||||+++++++.+ ...+|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~ 72 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLY 72 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEE
Confidence 79999999999999999999999998754321 122334556677777655 69999999999986 35899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred EEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 99999999999888877888999999999999999999999999999999999999999999999999999764433334
Q ss_pred cccCCCccccccCcccC
Q 022241 283 LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~ 299 (300)
....+||+.|+|||++.
T Consensus 153 ~~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 153 TNTFCGTTEYLAPEVLL 169 (330)
T ss_pred ccCccCCccccCHHHHc
Confidence 45567999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=252.82 Aligned_cols=165 Identities=21% Similarity=0.269 Sum_probs=141.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+++.||+|+||.||++.+..+++.||||.... ..+.+|+.+|+.++|||||+++++|..
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------------~~~~~E~~il~~l~HpnIv~~~~~~~~-- 154 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------------GGTATEAHILRAINHPSIIQLKGTFTY-- 154 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------------hhhHHHHHHHHhCCCCCCCCEeEEEEE--
Confidence 579999999999999999999999999999996421 246789999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++|||++. +.+..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 457899999986 4566666666789999999999999999999999999999999999999999999999999997543
Q ss_pred CC-ccccccCCCccccccCcccCC
Q 022241 278 DD-NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~-~~~~~~~~gt~~y~aPE~l~G 300 (300)
.. ........||+.|+|||++.|
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLAR 257 (391)
T ss_pred cccccccccccCccCCCChhhhcC
Confidence 22 223334679999999998754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=246.47 Aligned_cols=169 Identities=27% Similarity=0.422 Sum_probs=142.7
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||||++.+.... ..........|..++.. ++||||+++++++.+ .+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 72 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLF 72 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEE
Confidence 4699999999999999999999999999765321 12234456677777775 589999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 99999999999988877778999999999999999999999999999999999999999999999999999864333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....||+.|+|||++.|
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG 170 (316)
T ss_pred eeeecCCccccCHHHHcC
Confidence 345679999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.10 Aligned_cols=176 Identities=30% Similarity=0.486 Sum_probs=154.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..+.+.|.+.+.||+|.|+.|+.+.+..+|+.+|+|+++...+. ....+.+.+|+.|.+.|+|||||++.+.+
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-------~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-------cccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 34557799999999999999999999999999999999876553 23567899999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDF 270 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DF 270 (300)
.. ....|||+|+|.|+.+..-+..+--+++..+.++++||+.||.|+|.++|||||+||+|+|+-... -+||+||
T Consensus 80 ~~--~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 80 QE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred cc--cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeeccc
Confidence 75 458999999999999887666666789999999999999999999999999999999999996433 6999999
Q ss_pred cCceeecCCccccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|..+. +...+...+|||.|||||++.
T Consensus 158 GvAi~l~-~g~~~~G~~GtP~fmaPEvvr 185 (355)
T KOG0033|consen 158 GLAIEVN-DGEAWHGFAGTPGYLSPEVLK 185 (355)
T ss_pred ceEEEeC-CccccccccCCCcccCHHHhh
Confidence 9999887 556677889999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.42 Aligned_cols=176 Identities=35% Similarity=0.560 Sum_probs=156.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++..-|.+.+.||+|.|+.|.+|++..+|+.||||++.+..+. ......+..|+..|+.++|||||++|++..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-------~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-------TLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-------hhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 3445688999999999999999999999999999999987653 344567899999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE-ccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll-~~~~~~kl~DFGl 272 (300)
. ...+|||+|+-++|.+++++.. ...+.+..+++|+.||+.|+.|+|+..+|||||||+|+.+ ..-|.|||+|||+
T Consensus 88 T--QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 88 T--QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred c--cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccc
Confidence 5 5689999999999999988754 5679999999999999999999999999999999999866 5678999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..+.. .....+.||+..|.|||+|+|
T Consensus 166 SNkf~P-G~kL~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 166 SNKFQP-GKKLTTSCGSLAYSAPEILLG 192 (864)
T ss_pred cccCCC-cchhhcccchhhccCchhhhc
Confidence 987744 456788999999999999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=247.19 Aligned_cols=168 Identities=29% Similarity=0.422 Sum_probs=151.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
-|.++.+||+|+||.||+|.++.+|..+|||.+. -+..++.+..|+.||.++..|++|++||.+.. .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP-----------V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~ 100 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP-----------VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK--H 100 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC-----------ccchHHHHHHHHHHHHHcCCchhhhhhhhhcc--C
Confidence 3788899999999999999999999999999874 34567889999999999999999999997664 3
Q ss_pred CEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..+|||||||.-|+..+.++. +++|+++.+..++...+.||+|||...-||||||..|||++.+|..||+|||.|..+.
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 579999999999999887754 5689999999999999999999999999999999999999999999999999999887
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.-....+..|||.|||||++.
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~ 202 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIE 202 (502)
T ss_pred hhHHhhCccccCcccccHHHHH
Confidence 7766667788999999999863
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=240.21 Aligned_cols=167 Identities=27% Similarity=0.415 Sum_probs=141.8
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|+||.||++.+..+++.||||.+.+.... .......+..|+.+++.++||||+++.+++.. ...+++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 72 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK------KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVM 72 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh------hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEE
Confidence 79999999999999999999999998754321 22334567889999999999999999999875 35799999
Q ss_pred EeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 206 EYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 206 E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
||+++++|...+ .....+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..+.....
T Consensus 73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 999999887554 2345799999999999999999999999999999999999999999999999999987654443
Q ss_pred ccccCCCccccccCcccCC
Q 022241 282 VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 282 ~~~~~~gt~~y~aPE~l~G 300 (300)
......||+.|+|||++.|
T Consensus 153 ~~~~~~g~~~y~aPE~~~~ 171 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG 171 (280)
T ss_pred cccccCCCcCccCHHHhcC
Confidence 3445679999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=247.61 Aligned_cols=169 Identities=32% Similarity=0.537 Sum_probs=145.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
...+|..++.||+|+||.||++++..+++.||||++.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 3467888999999999999999999999999999985431 23445678999999999999999999999975
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++||||+.++++... ....+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 144 --~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 144 --NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred --CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence 4589999999999887643 3456788889999999999999999999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCccc
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+...........||+.|+|||++
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERI 240 (353)
T ss_pred cccccccccccccCccccCcccc
Confidence 65443334456799999999986
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.40 Aligned_cols=169 Identities=28% Similarity=0.432 Sum_probs=144.8
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||++++..+++.||||++.+.... .......+..|..++..+ +||||+++++++.+ .+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~ 72 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL------QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLF 72 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEE
Confidence 4699999999999999999999999999765321 233455677888888877 69999999999986 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|...+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99999999999888877778999999999999999999999999999999999999999999999999999764333333
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
....+||+.|+|||++.|
T Consensus 153 ~~~~~g~~~y~aPE~~~~ 170 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY 170 (318)
T ss_pred ccceecCccccCHHHhcC
Confidence 345679999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=248.23 Aligned_cols=166 Identities=30% Similarity=0.546 Sum_probs=146.1
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|-||.||-++++.+|+.||||++.+..+. ......+.+|++||..++||.||.+...|+.+ +.+++
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFV 640 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-------TKQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFV 640 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCC-------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEE
Confidence 7899999999999999999999999999876543 23336789999999999999999999999864 58999
Q ss_pred EEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecccCceeecCC
Q 022241 204 VLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDD 279 (300)
Q Consensus 204 v~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~ 279 (300)
|||-+.|..|.-.+. ..++|++...+.++.||+.||.|||.++|+|+||||+|||+.... .+||+|||+|++++..
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999999887776664 456899999999999999999999999999999999999997654 7999999999998765
Q ss_pred ccccccCCCccccccCcccC
Q 022241 280 NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 280 ~~~~~~~~gt~~y~aPE~l~ 299 (300)
. ..++.+|||.|+|||+|+
T Consensus 721 s-FRrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 721 S-FRRSVVGTPAYLAPEVLR 739 (888)
T ss_pred h-hhhhhcCCccccCHHHHh
Confidence 3 456788999999999985
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=242.48 Aligned_cols=174 Identities=28% Similarity=0.469 Sum_probs=144.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|.+.+.||+|+||.||++++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--------EGAPCTAIREVSLLKDLKHANIVTLHDIVHT- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--------CCcchhHHHHHHHHHhCCCCCcceEEEEEee-
Confidence 3579999999999999999999999999999999865321 1122356789999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+..++||||+++..+.........+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 76 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 76 -DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred -CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 3579999999987443333333456899999999999999999999999999999999999999999999999999875
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........+|+.|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLG 178 (309)
T ss_pred CCCccccccccccccccCCHHHhC
Confidence 443333344568999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=243.42 Aligned_cols=171 Identities=25% Similarity=0.398 Sum_probs=150.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++++..++..||+|.+.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 74 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-- 74 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--
Confidence 57999999999999999999999999999999886431 23445679999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 458999999999999999888777899999999999999999999986 6999999999999999999999999999865
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......||+.|+|||++.|
T Consensus 155 ~~~--~~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 155 IDS--MANSFVGTRSYMSPERLQG 176 (331)
T ss_pred ccc--ccccCCCCcCcCCHhHhcC
Confidence 432 2344579999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=245.42 Aligned_cols=174 Identities=24% Similarity=0.429 Sum_probs=143.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-------chhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 45789999999999999999999999999999999864321 23345677899999999999999999999864
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ...+|+||||++++.... + ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~-~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDANLCQV-I--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CCCccccceeEEEEeCCCcCHHHH-H--hccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 32 135799999998764332 2 2358899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... .......||+.|+|||++.|
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCchhccC
Confidence 99864332 22344578999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=252.88 Aligned_cols=172 Identities=23% Similarity=0.332 Sum_probs=146.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccC-CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..|.+.+.||+|+||.||+|....+ ++.||+|.+... .......+.+|+.+|+.++|||||++++++..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---------DERQAAYARSELHCLAACDHFGIVKHFDDFKS- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-
Confidence 4599999999999999999998877 788999976322 33445567889999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+.+||||||+++++|.+.+. ...++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 137 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 137 -DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred -CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence 468999999999999876543 345789999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc--ccccCCCccccccCcccCC
Q 022241 273 SQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
++.+..... .....+||+.|+|||++.+
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCC
Confidence 987654322 2345679999999998753
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-33 Score=242.76 Aligned_cols=177 Identities=28% Similarity=0.424 Sum_probs=154.5
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...+.|..-+.||+|+||.|+-++.+.+|+.||+|.+.+..+.+ .......++|..||.+++.+.||.+-.+|.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk------r~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK------RKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH------hhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 33467889999999999999999999999999999998765432 223345678999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
. .+.+.+||..|+||.|.-++.+.+ .++++.+..++.+|+.||++||..+||+|||||+|||||+.|+|+|+|+||
T Consensus 256 T--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 256 T--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred C--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 6 468999999999999998887766 799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|..+.... ..+..+||.+|||||++.+
T Consensus 334 Avei~~g~-~~~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 334 AVEIPEGK-PIRGRVGTVGYMAPEVLQN 360 (591)
T ss_pred EEecCCCC-ccccccCcccccCHHHHcC
Confidence 99876644 3344489999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=236.06 Aligned_cols=173 Identities=25% Similarity=0.386 Sum_probs=145.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|++.+.||+|+||.||++.+..+++.||||++...... .......+.+|+.+++.++||||+++++.+.+ .
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQILEKVNSRFVVSLAYAYET--K 72 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh------hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--C
Confidence 388899999999999999999999999999998654321 12233457789999999999999999999875 3
Q ss_pred CEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+.+++||||+++++|...+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 589999999999998766543 346999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ......||+.|+|||++.+
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 153 PEGE-TIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred CCCC-ccccccCCCCccCcHHhcC
Confidence 4332 2234579999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=242.32 Aligned_cols=171 Identities=25% Similarity=0.413 Sum_probs=149.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 74 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-- 74 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--
Confidence 57999999999999999999999999999999876431 23445678999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 458999999999999999888777899999999999999999999975 7999999999999999999999999999765
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......||+.|+|||++.|
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 155 IDS--MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred hhh--ccccCCCCccccCHHHhcC
Confidence 332 2234579999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=253.68 Aligned_cols=178 Identities=25% Similarity=0.374 Sum_probs=149.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.++..++|+||++++..+..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 44689999999999999999999999999999999865422 34456678899999999999999999887753
Q ss_pred CCC------CEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 196 PNS------DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 196 ~~~------~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
... ..+++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 211 147899999999998876643 3579999999999999999999999999999999999999999999
Q ss_pred EEecccCceeecCC--ccccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDD--NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||+++.+... .......+||+.|+|||++.|
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 99999999875432 223345679999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=238.66 Aligned_cols=172 Identities=30% Similarity=0.382 Sum_probs=140.3
Q ss_pred cceeEeeeecCCCceEEEEEEEcc----------------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL----------------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 181 (300)
++|++.+.||+|+||.||++.... ++..||+|.+.... .......+.+|+.+|..+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l 76 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--------NKNARNDFLKEVKILSRL 76 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--------CHHHHHHHHHHHHHHhhc
Confidence 579999999999999999997532 34479999875431 334556789999999999
Q ss_pred CCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC-------------------CCCCHHHHHHHHHHHHHHHHHH
Q 022241 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------------GAIGESMARKYLRDIVSGLMYL 242 (300)
Q Consensus 182 ~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------------------~~l~~~~~~~i~~qi~~~l~yL 242 (300)
+||||+++++++.+. ...++||||++++++.+++... ..+++..+..++.||+.||.||
T Consensus 77 ~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 77 KDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred CCCCeeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999863 5789999999999887655321 2467888999999999999999
Q ss_pred HhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 243 H~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+.+|+||||||+|||++.++.+||+|||++..+..... ......+++.|+|||++.
T Consensus 155 H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 999999999999999999999999999999986533221 122345678899999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=250.37 Aligned_cols=170 Identities=26% Similarity=0.348 Sum_probs=137.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..+|.+.+.||+|+||.||++.+..+++.||||.+.... ....+|+.+|+.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 357999999999999999999999999999999875321 1234799999999999999999887431
Q ss_pred ------CCCEEEEEEEeeCCCccc---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEE
Q 022241 197 ------NSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVK 266 (300)
Q Consensus 197 ------~~~~~~lv~E~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~k 266 (300)
....+++||||++++... ........+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+|
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred ccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence 123567999999875422 1223456799999999999999999999999999999999999999665 799
Q ss_pred EecccCceeecCCccccccCCCccccccCcccCC
Q 022241 267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|||+|+.+.... ......||+.|+|||++.|
T Consensus 212 L~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLG 244 (440)
T ss_pred eeccccchhccCCC-CcccCCCCcCccCHHHhcC
Confidence 99999998764332 2334578999999998764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=260.45 Aligned_cols=175 Identities=27% Similarity=0.406 Sum_probs=145.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.++||+|+||.||++.+..+++.||||++.... .........+.+|+.+++.++||||+++++++.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-- 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-- 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--
Confidence 57999999999999999999999999999999986532 1133455679999999999999999999999976
Q ss_pred CCEEEEEEEeeCCCccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
.+..++||||+++++|.+.+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence 4589999999999988776532 12456677889999999999999999999999999999999999999
Q ss_pred EecccCceeecCCc------------------cccccCCCccccccCcccCC
Q 022241 267 IGDFSVSQVFEDDN------------------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~~~~~~~------------------~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|||++....... .......||+.|+|||++.|
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 99999998752110 01122469999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=217.78 Aligned_cols=173 Identities=27% Similarity=0.479 Sum_probs=148.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.-.++||+|.||+||+++++.+++.||+|.++...- .+.......+|+.+|+.+.|.|||+++++... .
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-------degvpssalreicllkelkhknivrl~dvlhs--d 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-------CCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--C
Confidence 56677899999999999999999999999999875421 22333456799999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+-+|+|||......-+-.-++.++.+.++.++.|+++||.|+|++++.||||||.|.||+.+|.+||+|||+|+.+.-
T Consensus 74 kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 74 KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 57999999998654443445577899999999999999999999999999999999999999999999999999998876
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+-...+..+-|.+|.+|.++.|
T Consensus 154 pvrcysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred ceEeeeceeeeeeccCcceeee
Confidence 6555556678999999999987
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=236.10 Aligned_cols=175 Identities=31% Similarity=0.502 Sum_probs=141.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCC----ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..|+....||+|.||.||+|..+.+. ..||||.++...- .......-.+|+.+++.++||||+.+..+|
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-------GTGISMSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-------CCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence 46899999999999999999655532 3789998865411 011112345899999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC----CcE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTV 265 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~----~~~ 265 (300)
... ...+++++||.+...+.-. ......++..+++.|++||+.|+.|||+++|+||||||+|||+..+ |.|
T Consensus 97 l~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 97 LSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred hcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 863 5789999999997654421 1223479999999999999999999999999999999999999887 899
Q ss_pred EEecccCceeecCCcccc---ccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDNDVL---RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~---~~~~gt~~y~aPE~l~G 300 (300)
||+|||+|+.+.++-... ...+-|.+|.|||+|+|
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 999999999887655433 23568999999999998
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.99 Aligned_cols=165 Identities=21% Similarity=0.288 Sum_probs=138.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+++.||+|+||.||+++...+++.||+|+.... ....|+.+++.++||||+++++++..
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------------~~~~E~~~l~~l~h~~iv~~~~~~~~-- 128 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------------TTLIEAMLLQNVNHPSVIRMKDTLVS-- 128 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------------ccHHHHHHHHhCCCCCCcChhheEEe--
Confidence 3699999999999999999999999999999975322 22468999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||+.+..+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 129 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 129 GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 35789999999764433333445679999999999999999999999999999999999999999999999999997533
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.. .......||+.|+|||++.|
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred cC-cccccccccccccCCeecCC
Confidence 22 22234579999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=244.65 Aligned_cols=174 Identities=28% Similarity=0.478 Sum_probs=144.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC-
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN- 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 197 (300)
+|++.+.||+|+||.||++.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 4778899999999999999999999999999875421 12234567889999999999999999999987632
Q ss_pred --CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 --SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 --~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||||+.+ .+...+.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 74 DPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred cccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 1268999999985 4555566667899999999999999999999999999999999999999999999999999987
Q ss_pred ecCCc-cccccCCCccccccCcccCC
Q 022241 276 FEDDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
..... .......+|+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcC
Confidence 54322 22334568999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=261.19 Aligned_cols=180 Identities=28% Similarity=0.487 Sum_probs=151.1
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
+....++|.+++.||+|+||.||++++..++..||+|.+..... .......+..|+.+|..|+|||||+++++
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-------CHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 35566789999999999999999999999999999999865422 33455678999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeCCCCCCCEEEcc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH-------NVVHGDIKPDNLLVAP 261 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~-------~iiHrDlkp~NIll~~ 261 (300)
|.+.....+||||||+++++|..++.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 876556789999999999998877643 35799999999999999999999984 4999999999999964
Q ss_pred -----------------CCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 262 -----------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.+||+|||++..+... .......||+.|+|||++.|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhc
Confidence 235999999999876433 23345679999999998753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=245.27 Aligned_cols=174 Identities=24% Similarity=0.389 Sum_probs=146.4
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
..+..++..+...||+|.||+||++ .+.|. ||||.++-... ....++.|++|+..+++-+|.||+-+.|+
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg--~whGd-VAVK~Lnv~~p-------t~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRG--RWHGD-VAVKLLNVDDP-------TPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cccCHHHhhccceeccccccceeec--ccccc-eEEEEEecCCC-------CHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 3455677889999999999999655 44564 99999976533 55688999999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
|..+ .+.||+-+|+|.+|+.++.-. ..|.......|+.||++|+.|||.++|||||||..|||+.+++.|||+|||
T Consensus 457 ~~~p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 457 CMNP---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred hcCC---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccc
Confidence 9864 359999999999999888554 468889999999999999999999999999999999999999999999999
Q ss_pred Cceeec--CCccccccCCCccccccCcccC
Q 022241 272 VSQVFE--DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~--~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+.... ..........|...|||||++.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIR 563 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIR 563 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHh
Confidence 986532 2223344556889999999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=232.85 Aligned_cols=171 Identities=33% Similarity=0.581 Sum_probs=150.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.||+|.+.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV------KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-- 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--
Confidence 3699999999999999999999999999999998754321 22345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++++.+.+.....+++..+..++.|++.||+|||+.+|+|+||+|+|||++.++.+||+|||++....
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 45899999999999999888888889999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.. .....|++.|+|||.+.
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~ 171 (290)
T cd05580 153 GR---TYTLCGTPEYLAPEIIL 171 (290)
T ss_pred CC---CCCCCCCccccChhhhc
Confidence 43 33457999999999875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=233.95 Aligned_cols=172 Identities=30% Similarity=0.483 Sum_probs=136.7
Q ss_pred ceeEeeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeeeEEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVID 194 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~ 194 (300)
+|++.+.||+|+||.||++++.. +++.||||.+..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-------CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 68999999999999999999854 568899998865421 111223455677776665 6999999999885
Q ss_pred c---CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 195 D---PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 195 ~---~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
. .....+++||||+++ .+..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 75 VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred cccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 2 123568999999985 45544432 34589999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++...... .......||+.|+|||++.
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHh
Confidence 9999876443 2334567999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=242.47 Aligned_cols=174 Identities=25% Similarity=0.435 Sum_probs=143.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-------cChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence 4578999999999999999999999999999999886432 123445678899999999999999999998864
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ...+++||||++++... .+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~l~~-~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccccccceeEEEhhhhcccHHH-HHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 22 23579999999875433 332 358899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+++..... .......||+.|+|||++.|
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcC
Confidence 99865432 23345679999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=231.75 Aligned_cols=171 Identities=34% Similarity=0.592 Sum_probs=149.1
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|++.+.||+|+||.||++++..+++.||+|++...... ........+|+.+++.++||||+++++++.+ ..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-------EEEREENIREIKILRRLRHPNIVQILDVFQD--DN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-------HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SS
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-------ccccchhhhhhhccccccccccccccccccc--cc
Confidence 78899999999999999999999999999999765321 2222334569999999999999999999986 46
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
..++||||++++++.+++.....+++..+..++.|++.||++||+.+|+|+||||+||+++.++.++|+|||++......
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999999988888876778999999999999999999999999999999999999999999999999999875444
Q ss_pred ccccccCCCccccccCcccC
Q 022241 280 NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 280 ~~~~~~~~gt~~y~aPE~l~ 299 (300)
........+|+.|+|||++.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHT
T ss_pred cccccccccccccccccccc
Confidence 44555678999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=246.10 Aligned_cols=168 Identities=25% Similarity=0.428 Sum_probs=144.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-C-----Cceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H-----PNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~ 190 (300)
.-+|.+++.||+|+||.|.+|.+..+++.||||+++.. .....+-..|+.+|..|+ | -|+|+++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----------KRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 34799999999999999999999999999999998753 445667788999999997 4 4899999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC--cEE
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVK 266 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~--~~k 266 (300)
++|.. ..+++||+|.+.. +|++++..+ ..++...++.|+.||+.||.+||+.+|||+||||+||||...+ .||
T Consensus 255 d~F~f--r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 255 DYFYF--RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred ecccc--ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCcee
Confidence 99986 4689999999864 577777554 3689999999999999999999999999999999999998655 799
Q ss_pred EecccCceeecCCccccccCCCccccccCcccCC
Q 022241 267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|||+|.+..... .+..-+..|.|||+++|
T Consensus 332 VIDFGSSc~~~q~v---ytYiQSRfYRAPEVILG 362 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV---YTYIQSRFYRAPEVILG 362 (586)
T ss_pred EEecccccccCCcc---eeeeeccccccchhhcc
Confidence 99999999754332 25567889999999998
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=230.14 Aligned_cols=171 Identities=27% Similarity=0.461 Sum_probs=148.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+.++..++||||+++++++..
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-- 77 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-- 77 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Confidence 46999999999999999999999999999999986431 1233467889999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||+++++|.+.+.....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 45899999999999998888777789999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..........|++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccccCccccCccccCHhHcc
Confidence 4333334456899999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=265.23 Aligned_cols=177 Identities=29% Similarity=0.545 Sum_probs=144.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
...+|+.++.||+||||.||+++++.+|+.||||.+.... +......+.+|+.+|.+|+|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--------s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--------SDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 3567889999999999999999999999999999886532 45566789999999999999999998832210
Q ss_pred C-------------------------------------------------------------------------------
Q 022241 196 P------------------------------------------------------------------------------- 196 (300)
Q Consensus 196 ~------------------------------------------------------------------------------- 196 (300)
.
T Consensus 549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~ 628 (1351)
T KOG1035|consen 549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR 628 (1351)
T ss_pred cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence 0
Q ss_pred -----------------------------C-C--------CEEEEEEEeeCCCccccccCCCCCC-CHHHHHHHHHHHHH
Q 022241 197 -----------------------------N-S--------DHFYMVLEYVEGKWDNDGFGQPGAI-GESMARKYLRDIVS 237 (300)
Q Consensus 197 -----------------------------~-~--------~~~~lv~E~~~~~~l~~~~~~~~~l-~~~~~~~i~~qi~~ 237 (300)
. . -.+||.||||+..++.+.+..+... .....|+++++|+.
T Consensus 629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence 0 0 2468899999988888777666544 46778999999999
Q ss_pred HHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec------------------CCccccccCCCccccccCcccC
Q 022241 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE------------------DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 238 ~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~------------------~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|+|+.|||||||||.|||+++++.|||+|||+|+... ......+...||..|+|||++.
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999999999999999999998721 0111334567999999999985
Q ss_pred C
Q 022241 300 G 300 (300)
Q Consensus 300 G 300 (300)
+
T Consensus 789 ~ 789 (1351)
T KOG1035|consen 789 D 789 (1351)
T ss_pred c
Confidence 4
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=233.95 Aligned_cols=173 Identities=29% Similarity=0.467 Sum_probs=144.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~- 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLLKDLKHANIVTLHDIIHT- 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--------cCchhHHHHHHHHHHhcCCCCcceEEEEEec-
Confidence 4679999999999999999999999999999999864321 1223456789999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++||||+++ ++...+. ....+++..++.++.|++.||+|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 76 -~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 76 -EKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred -CCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 3579999999986 4444443 345689999999999999999999999999999999999999999999999999986
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
............+++.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLG 178 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhC
Confidence 5443333344567899999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=230.31 Aligned_cols=172 Identities=26% Similarity=0.382 Sum_probs=145.2
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|+..+.||+|+||.||++.+..+++.||+|.+...... .......+.+|+.+|+.++|+||+.+++++.. .+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK------KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KD 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh------hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CC
Confidence 77889999999999999999999999999998654221 12233457789999999999999999999875 45
Q ss_pred EEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++||||++++++...+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 89999999999988766643 3469999999999999999999999999999999999999999999999999997654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......|++.|+|||++.|
T Consensus 154 ~~~-~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 154 EGE-SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred CCC-cccCCCCCcCccChHHhcC
Confidence 322 2234579999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=226.25 Aligned_cols=177 Identities=27% Similarity=0.421 Sum_probs=155.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~ 194 (300)
-.++|.+++.||+|+|++|.+++.+.+.+.||+|++++..+.. .....-+..|..+..+ -+||.+|.+..+|+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd------dedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC------cccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 4578999999999999999999999999999999998764432 2223334456666654 47999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+ ..+++|.||++||.|.-++.....++++.++.+...|+.||.|||++|||+||||.+|+|+|..|++||+|+|+++
T Consensus 322 te--srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 322 TE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cc--ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 64 4799999999999999989888899999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.--.+....+++||||.|+|||+|.|
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRG 425 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcc
Confidence 86666777889999999999999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=230.84 Aligned_cols=170 Identities=30% Similarity=0.485 Sum_probs=149.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||+|.++... ......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-- 77 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-- 77 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence 47889999999999999999999999999999986431 2234567889999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+++||||+++++|.+++...+.+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 46899999999999999988777889999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCccccccCccc
Q 022241 278 DDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l 298 (300)
..........||+.|+|||++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred CcccccccccCcccccChhhh
Confidence 433333445799999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=242.71 Aligned_cols=174 Identities=22% Similarity=0.290 Sum_probs=140.5
Q ss_pred ecceeEeeeecCCCceEEEEEEE-----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 190 (300)
.++|++.+.||+|+||.||++.. ..++..||||+++... .......+.+|+.+|..+ +|||||+++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--------CcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 34799999999999999999864 2356789999886431 223456788999999999 899999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCC--------------------------------------------------
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------------------------------------------- 220 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------------------------------------------------- 220 (300)
+++.+ ....++||||+++|+|.+++...
T Consensus 106 ~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 106 GACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred eeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 99976 45789999999999887655321
Q ss_pred -------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 221 -------------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 221 -------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 2478889999999999999999999999999999999999999999999999987
Q ss_pred ecCCccc--cccCCCccccccCcccCC
Q 022241 276 FEDDNDV--LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~--~~~~~gt~~y~aPE~l~G 300 (300)
....... .....+++.|+|||++.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcC
Confidence 6433221 112335677999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=242.71 Aligned_cols=173 Identities=22% Similarity=0.286 Sum_probs=140.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 190 (300)
.++|.+.+.||+|+||.||++..... +..||||.+.... .......+.+|+.+++.+ +|||||+++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--------HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--------CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 35799999999999999999986543 3579999986432 233456788999999999 899999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCC---------------------------------------------------
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------------------------------------------- 219 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~--------------------------------------------------- 219 (300)
+++.+ ...+++||||+++++|.+++..
T Consensus 109 ~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 109 GACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred eEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 99986 3579999999999888765422
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 220 -------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 220 -------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
..++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 1247888999999999999999999999999999999999999999999999998654322
Q ss_pred c--ccccCCCccccccCcccC
Q 022241 281 D--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 281 ~--~~~~~~gt~~y~aPE~l~ 299 (300)
. ......+++.|+|||++.
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred ceeeccCCCCccceeCHHHhc
Confidence 1 111233567899999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=240.60 Aligned_cols=174 Identities=25% Similarity=0.431 Sum_probs=143.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~ 94 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-------CchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence 45789999999999999999999999999999999864321 23345677899999999999999999998764
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ...+|+||||++++.. ..+. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~l~-~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 95 QKSLEEFQDVYIVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccccccCeEEEEEeCCCCCHH-HHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 21 2368999999987543 3332 358889999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... .......||+.|+|||++.|
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhC
Confidence 99865432 22344579999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=242.51 Aligned_cols=173 Identities=25% Similarity=0.359 Sum_probs=143.2
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc---e-EEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---H-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++..+.++||+|+||.||+++.+..+. . ||||..+... .........+.+|+++|++++|||||++||+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc------cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556899999999999998876432 3 8999876421 12567788999999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++||||+|.||+|.+++...+ .++......++.+++.||+|||++++|||||-.+|+|++.++.+||+||||
T Consensus 231 ~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 231 VL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred cC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 76 458999999999999999998877 599999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccc-cCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLR-RSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~-~~~gt~~y~aPE~l~ 299 (300)
++.... ..... ...--..|+|||++.
T Consensus 309 s~~~~~-~~~~~~~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 309 SRAGSQ-YVMKKFLKKLPIRWLAPETLN 335 (474)
T ss_pred ccCCcc-eeeccccccCcceecChhhhc
Confidence 986431 11111 112335699999874
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=245.45 Aligned_cols=166 Identities=23% Similarity=0.279 Sum_probs=139.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
...|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|+.+|+.++|||||++++++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~- 231 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVV- 231 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence 3579999999999999999999999999999995321 234689999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++|||++.+ .+..++. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 232 -~~~~~lv~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 232 -GGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred -CCEEEEEEEccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 4578999999975 4444443 345799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc--ccccCCCccccccCcccCC
Q 022241 276 FEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......||+.|+|||++.|
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcC
Confidence 643221 1224579999999999764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=226.89 Aligned_cols=179 Identities=29% Similarity=0.495 Sum_probs=150.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||+|+||.||.+.+..+++.||||.+...... .........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES----PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC----cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 4799999999999999999999999999999988543211 112345678899999999999999999999987654
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++++|||+++++|.+++.....+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 56789999999999998888776778999999999999999999999999999999999999999999999999987643
Q ss_pred CCc---cccccCCCccccccCcccCC
Q 022241 278 DDN---DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~---~~~~~~~gt~~y~aPE~l~G 300 (300)
... .......||..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred cccccccccccCCCCccccChhhhcC
Confidence 211 12233568999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=233.50 Aligned_cols=166 Identities=30% Similarity=0.507 Sum_probs=133.7
Q ss_pred eeeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 123 VRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
.++||+|+||.||+++.+. +++.||+|.+.... ....+.+|+.+|+.++||||+++++++.......
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----------ISMSACREIALLRELKHPNVISLQKVFLSHADRK 74 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence 3689999999999998663 67899999885431 1234678999999999999999999997666678
Q ss_pred EEEEEEeeCCCcccccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE----ccCCcEEE
Q 022241 201 FYMVLEYVEGKWDNDGF---------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKI 267 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----~~~~~~kl 267 (300)
++++|||+++.. ...+ .....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||
T Consensus 75 ~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 75 VWLLFDYAEHDL-WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEEEeccCCCH-HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999999998643 2222 122358999999999999999999999999999999999999 45678999
Q ss_pred ecccCceeecCCcc---ccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
+|||+|..+..... ......||+.|+|||++.|
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcC
Confidence 99999987643321 2234578999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=239.19 Aligned_cols=173 Identities=22% Similarity=0.401 Sum_probs=143.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-------SLIHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 45689999999999999999999999999999998864321 12334567789999999999999999998753
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ....+++||++. +++...+. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~~-~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 86 ATSIENFNEVYLVTNLMG-ADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccccccCcEEEEeecCC-CCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 21 235789999884 45555443 4579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... .....||+.|+|||++.|
T Consensus 164 ~~~~~~~~---~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 164 LARQADDE---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cceecCCC---cCCccccccccCchHhcC
Confidence 99875432 244579999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=229.22 Aligned_cols=172 Identities=24% Similarity=0.383 Sum_probs=145.2
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|+..+.||+|+||.||++.+..+++.||||.+.+.... .......+.+|+.+++.++|+||+.+++.+.+ .+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence 77889999999999999999999999999998654221 22334557789999999999999999999875 45
Q ss_pred EEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 89999999999998876643 2358999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......||+.|+|||++.+
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 154 EGQ-TIKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred CCc-cccCCCCCccccChHHHcC
Confidence 322 2234579999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=226.67 Aligned_cols=175 Identities=26% Similarity=0.445 Sum_probs=148.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||+++...+++.||||.+..... ........+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM------MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-- 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc------CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--
Confidence 479999999999999999999999999999998764321 133455678899999999999999999999886
Q ss_pred CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+..++||||++++++...+. ....+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 357899999999988876553 3345899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..............|++.|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 154 RFFSSKTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred eeccchhHHHhcCCCCccccChhhhcc
Confidence 876544433345578999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=223.46 Aligned_cols=173 Identities=31% Similarity=0.584 Sum_probs=150.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+.++.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-------SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--D 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--C
Confidence 48999999999999999999999999999999865422 23455678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++++|||++++++.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++...
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 5899999999999998877654 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........|++.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQG 175 (256)
T ss_pred ccccccccccCCCccccCHhhcCC
Confidence 554434445679999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.32 Aligned_cols=166 Identities=24% Similarity=0.408 Sum_probs=138.6
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|+||.||+++.+.+|+.||+|.+...... .......+..|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~ 72 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK------KKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVM 72 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEE
Confidence 79999999999999999999999998654321 11223345679999999999999999999975 45899999
Q ss_pred EeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccc
Q 022241 206 EYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 206 E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||++++++...+.. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++....... ..
T Consensus 73 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 151 (277)
T cd05607 73 SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TI 151 (277)
T ss_pred ecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-ee
Confidence 99999988766533 3358899999999999999999999999999999999999999999999999998764432 22
Q ss_pred ccCCCccccccCcccCC
Q 022241 284 RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~G 300 (300)
....||+.|+|||++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~ 168 (277)
T cd05607 152 TQRAGTNGYMAPEILKE 168 (277)
T ss_pred eccCCCCCccCHHHHcc
Confidence 34579999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=231.08 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=149.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 70 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-- 70 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--
Confidence 36999999999999999999999999999999875421 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 71 ~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 71 DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 46899999999999999888777889999999999999999999997 68999999999999999999999999998765
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......|++.|+|||++.|
T Consensus 151 ~~~--~~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 151 IDS--MANSFVGTRSYMSPERLQG 172 (308)
T ss_pred ccc--ccccCCCCcCccChhHhcC
Confidence 332 2344678999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=223.14 Aligned_cols=174 Identities=29% Similarity=0.535 Sum_probs=149.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|||++++++.+... .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-D 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-C
Confidence 48899999999999999999999999999999865322 233456788999999999999999999987642 3
Q ss_pred CEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++++|||++++++.+.+.. ...+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 478999999999988877754 346899999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........|++.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred cccCCccccccCCcCccChhHhcC
Confidence 554444556679999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=227.81 Aligned_cols=172 Identities=21% Similarity=0.257 Sum_probs=142.3
Q ss_pred cceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|.+.+.||+|+||.||++... ..+..||+|.++... .......+.+|+.++..++||||+++++++.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--------SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 46999999999999999998765 356789999886431 2344567899999999999999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ....++||||++++++.+++.. ...+++..++.++.|++.||+|||+++++||||||+|||++.++.+|++|||++
T Consensus 77 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 77 R--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred c--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 5 4579999999999999887765 357899999999999999999999999999999999999999999999999987
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
........ ......+++.|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHh
Confidence 65422211 111234567899999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=247.38 Aligned_cols=171 Identities=25% Similarity=0.417 Sum_probs=151.9
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
.....||+|+|-+||++.+..+|-.||--.++...+.+ ++...++|..|+.+|+.|+|||||++|++|.+.....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc-----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 45578999999999999999999999987776554433 6677899999999999999999999999999887778
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeCCCCCCCEEEcc-CCcEEEecccCceeec
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFE 277 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~ 277 (300)
+.+|+|++..|+|..+....+.++...++.|++||+.||.|||++ .|||||||.+||||+. .|.|||+|+|||..+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999999999999999999999999999999999986 5999999999999985 4799999999999875
Q ss_pred CCccccccCCCccccccCccc
Q 022241 278 DDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l 298 (300)
... .....|||.|||||+.
T Consensus 198 ~s~--aksvIGTPEFMAPEmY 216 (632)
T KOG0584|consen 198 KSH--AKSVIGTPEFMAPEMY 216 (632)
T ss_pred ccc--cceeccCccccChHHH
Confidence 543 3457899999999974
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=225.05 Aligned_cols=177 Identities=30% Similarity=0.516 Sum_probs=149.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|.+.+.||+|++|.||.+.+..+++.||+|.+...... .........+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS----PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-- 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--
Confidence 4689999999999999999999999999999988654221 1122345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++++.+.+...+.+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 35899999999999998888777789999999999999999999999999999999999999999999999999998653
Q ss_pred CCcccc---ccCCCccccccCcccCC
Q 022241 278 DDNDVL---RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~---~~~~gt~~y~aPE~l~G 300 (300)
...... ....|++.|+|||++.|
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred ccccccccccCCCcCccccCcceecc
Confidence 322111 23468899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=252.91 Aligned_cols=174 Identities=31% Similarity=0.512 Sum_probs=152.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|.++++||+|+||.||++.+..+++.||||++..... ........+..|+.++..++||||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM------INKNMVHQVQAERDALALSKSPFIVHLYYSLQS- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-
Confidence 4679999999999999999999999999999999875422 133455678899999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+||||||+.++.|..++...+.+++..++.++.||+.||.|||.++|+||||||+||||+.++.+||+|||+++..
T Consensus 76 -~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 76 -ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred -CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 4589999999999999888877778999999999999999999999999999999999999999999999999999986
Q ss_pred cCCccccccCCCccccccCccc
Q 022241 277 EDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l 298 (300)
...........+|+.|+|||..
T Consensus 155 ~~~~~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 155 LNRELNMMDILTTPSMAKPKND 176 (669)
T ss_pred cCCcccccccccCccccCcccc
Confidence 5554445567799999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=228.61 Aligned_cols=173 Identities=28% Similarity=0.488 Sum_probs=143.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++....+++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-- 74 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--------EGVPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--------CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--
Confidence 579999999999999999999999999999999864321 1122356789999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||+.++.+.........+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.+||+|||++....
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 45899999999765544444445668899999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+++.|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCCCCCCCccccccccCCceeec
Confidence 43333344568999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=222.88 Aligned_cols=171 Identities=27% Similarity=0.525 Sum_probs=147.8
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++.+..+++.||+|.++... .....+.+..|+.+++.++||||+++++.+.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 70 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--D 70 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--C
Confidence 4889999999999999999999999999999885431 23345678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++++|||++++++...+.. ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 689999999999988776643 346899999999999999999999999999999999999999999999999999877
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........|++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~ 173 (255)
T cd08219 151 TSPGAYACTYVGTPYYVPPEIWE 173 (255)
T ss_pred cccccccccccCCccccCHHHHc
Confidence 55444444567999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=227.70 Aligned_cols=174 Identities=28% Similarity=0.434 Sum_probs=144.0
Q ss_pred cceeEeeeecCCCceEEEEEEE----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|++.+.||+|+||.||++.. ..+++.||||.+... .......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---------TAEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 4689999999999999999873 457889999987543 334556789999999999999999999988
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.......+++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 66555678999999999999988754 34689999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccc---cccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDV---LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~---~~~~~gt~~y~aPE~l~G 300 (300)
+......... .....++..|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 9876443221 111223456999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=227.37 Aligned_cols=174 Identities=32% Similarity=0.529 Sum_probs=148.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|+..+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-------DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-- 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-------CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--
Confidence 368999999999999999999999999999998864321 11223457889999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++.+.........+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++....
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence 45899999999998888777666789999999999999999999999999999999999999999999999999998765
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........++..|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred CCcccccCcccccccCCHHHHhC
Confidence 54333334568899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=233.01 Aligned_cols=171 Identities=22% Similarity=0.346 Sum_probs=141.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCce----EEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.+|++.+.||+|+||.||++.+..+++. ||||.+.... .......+.+|+.+++.++||||+++++++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4699999999999999999987766654 8999875321 234556788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++++||+++|++.+.+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 79 LT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred cC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence 75 357899999999999887765 34689999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcccc--ccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVL--RRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~--~~~~gt~~y~aPE~l~ 299 (300)
++.+....... ....+++.|+|||++.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhc
Confidence 98764332211 2233467899999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=225.38 Aligned_cols=166 Identities=24% Similarity=0.346 Sum_probs=143.0
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--------TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--E 71 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence 5788899999999999999999999999999886431 23345678899999999999999999999986 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++... ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.++.++|+|||++.....
T Consensus 72 ~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 72 NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 578999999999887543 3578999999999999999999999999999999999999999999999999986543
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
. ......||+.|+|||++.+
T Consensus 148 ~--~~~~~~~~~~y~aPE~~~~ 167 (279)
T cd06619 148 S--IAKTYVGTNAYMAPERISG 167 (279)
T ss_pred c--cccCCCCChhhcCceeecC
Confidence 2 2334579999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=231.21 Aligned_cols=173 Identities=27% Similarity=0.487 Sum_probs=143.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLYDVLHS--D 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-------cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--C
Confidence 48889999999999999999999999999999865321 11223456789999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+++|+||++++.+.........+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++..+..
T Consensus 72 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 72 KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 57999999998654333333456799999999999999999999999999999999999999999999999999986644
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........+++.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCCCcCCCccccCCcChHHHhC
Confidence 3333344568899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=226.84 Aligned_cols=172 Identities=30% Similarity=0.531 Sum_probs=142.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--E 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--C
Confidence 48899999999999999999999999999998864321 22234567889999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+++||||+++ .+...+. ....+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 72 SRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CeEEEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 589999999985 4444432 235689999999999999999999999999999999999999999999999999986
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
............+++.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 151 FGIPVRVYTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred cCCCcccccCCcccccccChHHhcC
Confidence 5443333344567899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=222.07 Aligned_cols=172 Identities=27% Similarity=0.451 Sum_probs=149.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++....+++.|++|.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-------NRREREEAIDEARVLAKLDSSYIIRYYESFLD--K 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-------CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--C
Confidence 47888999999999999999999999999998865422 23456678899999999999999999999985 4
Q ss_pred CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...++||||++++++.+++... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 5899999999999988877553 57899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........|++.|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCE 174 (256)
T ss_pred cCccchhhccccCccccCHHHhc
Confidence 55444444567899999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=228.36 Aligned_cols=173 Identities=30% Similarity=0.498 Sum_probs=137.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~ 195 (300)
+|++.+.||+|+||.||+++++.+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-------DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-------CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 488999999999999999999999999999998653211 11122344566666554 79999999998864
Q ss_pred C---CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 196 P---NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 196 ~---~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
. ....+++||||+++ .+...+.. ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred ccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence 2 23568999999986 44444433 235899999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++...... .......||+.|+|||++.|
T Consensus 153 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 153 GLARIYSCQ-MALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred CccccccCc-ccCCCccccccccCchHhhC
Confidence 999876432 22344568999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=223.86 Aligned_cols=179 Identities=31% Similarity=0.516 Sum_probs=150.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|...+.||+|+||.||++.+..++..||+|.+...... .........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC----chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 3688999999999999999999999999999988654211 112345567899999999999999999999987655
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++++|||+++++|.+.+.....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 56889999999999998888777789999999999999999999999999999999999999999999999999987643
Q ss_pred CC---ccccccCCCccccccCcccCC
Q 022241 278 DD---NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~---~~~~~~~~gt~~y~aPE~l~G 300 (300)
.. ........++..|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC
Confidence 21 111223568999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=250.14 Aligned_cols=171 Identities=23% Similarity=0.389 Sum_probs=150.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|.++..||.|+||.||+|..+.++-..|-|.+... ++..++.++-|+.||..++||+||++++.|...
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---------seEELEDylVEIeILa~CdHP~ivkLl~ayy~e- 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE- 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-
Confidence 4588889999999999999999988888888877533 667888999999999999999999999977653
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+.+||+.|||+||.....+.. ...|++..+..+.+|++.||.|||+++|||||||..|||+.-+|.++|+|||.+...
T Consensus 102 -nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 102 -NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred -CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 479999999999987766544 457999999999999999999999999999999999999999999999999998775
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
........++.|||.|||||+..
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVM 203 (1187)
T ss_pred hhHHhhhccccCCcccccchhee
Confidence 55555566788999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=240.29 Aligned_cols=181 Identities=28% Similarity=0.411 Sum_probs=153.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~ 191 (300)
....+|..++.+|.|+||.|++|.++.+...|+||.+.+...-..... ....+-.+-.|++||..|+ |+||+++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWv-rDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWV-RDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhh-cccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 345669999999999999999999999999999999987643211000 0111223567999999997 999999999
Q ss_pred EEEcCCCCEEEEEEEeeC-CCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
+|++ ++++||+||.-. +-.|++++.....++|..++.|+.||+.|+++||+.||||||||-+|+.++.+|.+||+||
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9986 579999999774 5567888888899999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|.|... .+.+...+.||..|.|||+|.|
T Consensus 715 gsaa~~--ksgpfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 715 GSAAYT--KSGPFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred cchhhh--cCCCcceeeeeccccchhhhCC
Confidence 998764 3356677899999999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=222.97 Aligned_cols=179 Identities=29% Similarity=0.514 Sum_probs=150.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||+|+||.||++.+..+++.||+|.+...... .........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS----QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc----chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 4699999999999999999999999999999987532111 112345668899999999999999999999987755
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++++|||++++++.+.+...+.+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 56789999999999998888777779999999999999999999999999999999999999999999999999998653
Q ss_pred CC---ccccccCCCccccccCcccCC
Q 022241 278 DD---NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~---~~~~~~~~gt~~y~aPE~l~G 300 (300)
.. ........|++.|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC
Confidence 21 111223568999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=237.79 Aligned_cols=174 Identities=24% Similarity=0.293 Sum_probs=140.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 190 (300)
.++|++.++||+|+||.||++.+... +..||||++.... .....+.+.+|+.+|+.+. |||||+++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--------RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 45799999999999999999886432 3469999885431 2344567899999999996 99999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCC---------------------------------------------------
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------------------------------------------- 219 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~--------------------------------------------------- 219 (300)
+++.+ ...+||||||+++|+|.+++..
T Consensus 108 ~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 108 GACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 99975 4579999999999988654421
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCC
Q 022241 220 ---------------------------------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP 254 (300)
Q Consensus 220 ---------------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp 254 (300)
...+++..+..++.||+.||+|||+.+|+||||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 12477888899999999999999999999999999
Q ss_pred CCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 255 DNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 255 ~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
+|||++.++.+||+|||++........ ......+++.|+|||++.|
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 999999999999999999987543222 1122346788999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=226.63 Aligned_cols=171 Identities=25% Similarity=0.411 Sum_probs=147.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|+++++||+|+||.||++++..+++.||+|.+... .......+.+|+.+++.++||||+++++.+..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-- 80 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--
Confidence 5699999999999999999999999999999998543 34456778899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||++++++...+.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 3589999999999988766543 456899999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........+++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred cccccccceecCCccccCceeec
Confidence 44333334556899999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=247.83 Aligned_cols=172 Identities=26% Similarity=0.370 Sum_probs=142.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc-
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD- 195 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~- 195 (300)
.++++.+.|.+|||+.||+|.+...|..||+|++.. .++...+.+.+||.+|+.|. |+|||.+++....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---------~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---------NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---------CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 357889999999999999999998889999998743 36788899999999999998 9999999993221
Q ss_pred ---CC-CCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcEEE
Q 022241 196 ---PN-SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 196 ---~~-~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~kl 267 (300)
.+ ...++|+||||.+|.|.+++.. ...|++.++.+|+.|+++|+++||... |||||||-+||||+.+|+.||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 12 3578899999999888888863 346999999999999999999999876 999999999999999999999
Q ss_pred ecccCceeecCCcccc---------ccCCCccccccCccc
Q 022241 268 GDFSVSQVFEDDNDVL---------RRSPGTPVFTAPECC 298 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~---------~~~~gt~~y~aPE~l 298 (300)
||||.|.......... -....|+.|+|||++
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 9999986422111000 011379999999985
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=224.27 Aligned_cols=176 Identities=29% Similarity=0.450 Sum_probs=146.9
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++..+ +||||++++++
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----------DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----------chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 345678999999999999999999999999999999875321 1234677899999998 69999999998
Q ss_pred EEc---CCCCEEEEEEEeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 193 IDD---PNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 193 ~~~---~~~~~~~lv~E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
+.. ..+..+++||||+++++|.+.+ .....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 743 2346799999999999987654 234568999999999999999999999999999999999999999999
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|||++..............|++.|+|||++.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhc
Confidence 9999999987654333334557999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=225.24 Aligned_cols=169 Identities=26% Similarity=0.436 Sum_probs=145.9
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|++.+.||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~ 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---------SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--EN 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CC
Confidence 67889999999999999999999999999987543 23456678899999999999999999999876 45
Q ss_pred EEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++||||++++++...+.. ..++++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence 89999999999988776543 45799999999999999999999999999999999999999999999999999976544
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.........+|+.|+|||++.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred cccccccccccccccCHhhcc
Confidence 333334457999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=240.96 Aligned_cols=150 Identities=27% Similarity=0.497 Sum_probs=137.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.-|..++.||-|+||+|.+++...+...||+|.+++.... ....+..+..|..||..-+.+-||+||..|++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl------~rnQvaHVKAERDILAEADn~WVVrLyySFQD-- 700 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL------MRNQVAHVKAERDILAEADNEWVVRLYYSFQD-- 700 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH------hhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--
Confidence 3488889999999999999999989999999999876443 34566788999999999999999999999997
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+.+|+||+|++||.+..++...+.|.|..++.++..+..|+++.|..|.|||||||+|||||.+|++||+||||+.-
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence 568999999999999999999999999999999999999999999999999999999999999999999999999753
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=221.44 Aligned_cols=171 Identities=30% Similarity=0.494 Sum_probs=149.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 71 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---------GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-- 71 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---------hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--
Confidence 57999999999999999999999899999999986431 2245688899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...++++|||++++++.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++...
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence 45899999999999998877665 68999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........+++.|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~ 174 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAA 174 (262)
T ss_pred hhhhhccccccCCccccCchhhc
Confidence 54333334457899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=221.42 Aligned_cols=175 Identities=26% Similarity=0.446 Sum_probs=149.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++....+|+.||+|.++..... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-- 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM------DAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-- 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc------chhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--
Confidence 5799999999999999999999999999999988643221 23345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
....++||||+++++|..++. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 358899999999998876653 2346899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..+...........+++.|+|||.+.|
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 154 RFFSSKTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred eeccCCCcccceecCCccccCHHHhcc
Confidence 876544433444568999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=225.99 Aligned_cols=174 Identities=26% Similarity=0.469 Sum_probs=144.8
Q ss_pred ceeEeeeecCCCceEEEEEEE----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.|++++.||+|+||.||+++. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 378899999999999999874 4578899999875331 2334567899999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+......++||||+++++|..++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence 75456789999999999998877543 46899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc---ccccCCCccccccCcccCC
Q 022241 274 QVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
..+..... ......++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhcc
Confidence 87543322 1223457778999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=226.69 Aligned_cols=173 Identities=29% Similarity=0.477 Sum_probs=142.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++..+.+++.||||.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--------GAPFTAIREASLLKDLKHANIVTLHDIIHT- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--------CCchhHHHHHHHHhhCCCcceeeEEEEEec-
Confidence 36799999999999999999999989999999998653211 112345689999999999999999999985
Q ss_pred CCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++ ++...+. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 75 -~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 75 -KKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred -CCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 4689999999986 5555443 345789999999999999999999999999999999999999999999999999876
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
............+++.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 153 KSVPSKTYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred cCCCCccccccccccccCCcHHhhc
Confidence 4332222233457889999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=227.30 Aligned_cols=166 Identities=31% Similarity=0.498 Sum_probs=132.7
Q ss_pred eeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
.+||+|+||.||+++... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.......+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 689999999999998654 56889999875431 12356789999999999999999999876556789
Q ss_pred EEEEEeeCCCccccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE----ccCCcEEEec
Q 022241 202 YMVLEYVEGKWDNDG--------FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGD 269 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~--------~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----~~~~~~kl~D 269 (300)
++||||++++.+... ......+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 76 WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 999999987532211 1122358999999999999999999999999999999999999 5567999999
Q ss_pred ccCceeecCCcc---ccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
||+++....... ......||+.|+|||++.|
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcC
Confidence 999987643321 2234568999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=227.74 Aligned_cols=174 Identities=36% Similarity=0.586 Sum_probs=149.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-- 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-------cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--
Confidence 368999999999999999999998899999998764321 12234567889999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||++++.+.........+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 45899999999998888776666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+++.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred CCccccCcccceeeccCcHHhcc
Confidence 54444445568999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=233.35 Aligned_cols=178 Identities=28% Similarity=0.422 Sum_probs=153.6
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
.....+|..+..||+|+||.|.++..+.+.+.||||++++....+ ...++--+.|-.+|... +-|.++++...
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ------dDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ------DDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee------cCcccceehhhhheecCCCCchHHHHHHH
Confidence 344567999999999999999999999999999999999876543 22233344566677655 57889999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
|+.. +.+|+||||+.||.|.-++.+.+.+.+..+..++..|+-||-|||++|||+||||.+||||+..|++||+|||+
T Consensus 419 FQTm--DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 419 FQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred hhhh--hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccc
Confidence 9864 57999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++.-.-......++||||.|+|||++.
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEE
Confidence 987544555667899999999999863
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=241.79 Aligned_cols=169 Identities=20% Similarity=0.289 Sum_probs=136.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC------Cceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH------PNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~ 190 (300)
.++|.++++||+|+||.||++.+..+++.||||+++.. .........|+.+++.++| +++++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 46899999999999999999999999999999998542 1122345567777776654 4588999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCC------
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSG------ 263 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~------ 263 (300)
++|... ..++++|||++. +.+.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~-~~~~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEEEcC-CceEEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence 998764 458899999884 4566666666789999999999999999999997 6999999999999998765
Q ss_pred ----------cEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 264 ----------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 264 ----------~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+||+|||++.... ......+||+.|+|||++.|
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhc
Confidence 49999999886432 22345679999999999865
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=227.85 Aligned_cols=177 Identities=29% Similarity=0.491 Sum_probs=145.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-------RDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-------CCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 45689999999999999999999999999999998864321 11122345679999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+.+++||||+.+. +...+. ....+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 78 KHLDSIFLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred CCCCeEEEEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 5556789999999863 444333 24679999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............+++.|+|||++.|
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcC
Confidence 76544333334456888999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=226.80 Aligned_cols=171 Identities=28% Similarity=0.436 Sum_probs=148.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-- 73 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--
Confidence 4699999999999999999999889999999988532 34455678899999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++..++.. ...+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 4589999999999999887755 357999999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........||+.|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred cccccccceeecchhhcCHHHHh
Confidence 44333334456899999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=224.91 Aligned_cols=172 Identities=28% Similarity=0.422 Sum_probs=146.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 196 (300)
+.|.+.+.||+|+||.||++....+++.||+|.+.... .....+..|+.++..+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 46888899999999999999999999999999985431 2234678899999988 699999999998753
Q ss_pred C----CCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 197 N----SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 197 ~----~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
. ...+|+||||++++++..++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence 2 2468999999999998887764 346899999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|++..............|++.|+|||++.
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhc
Confidence 99987644333344567999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=224.83 Aligned_cols=174 Identities=28% Similarity=0.449 Sum_probs=148.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++....+++.||||.+...... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM------DAKARADCIKEIDLLKQLNHPNVIKYYASFIE-- 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh------hHHHHHHHHHHHHHHHHccCCchhhhhheeEe--
Confidence 4688899999999999999999999999999987653211 23445678899999999999999999999885
Q ss_pred CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+..+++|||++++++.+++. ....+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 358999999999998877654 2456899999999999999999999999999999999999999999999999998
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..............|++.|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 154 RFFSSKTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred hccccCCcccccccCCcCccCHHHhc
Confidence 87654433334557999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=226.17 Aligned_cols=171 Identities=29% Similarity=0.467 Sum_probs=147.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 87 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---------QPKKELIINEILVMRENKNPNIVNYLDSYLV-- 87 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---------cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 67999999999999999999999999999999886432 2234567899999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||++++++..++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 4589999999999998887644 468899999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+++.|+|||.+.+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTR 189 (297)
T ss_pred CCccCcCcccCCccccCHHHHcC
Confidence 44333344578999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=236.90 Aligned_cols=168 Identities=23% Similarity=0.310 Sum_probs=139.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
...+|.+++.||+|+||.||++.... ++..||+|.+... ....+|+.+|+.++|||||++++++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 34579999999999999999987543 5678999987432 1345799999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.. ...+++|||++.+ .+..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 156 ~~--~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 156 RW--KSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred ee--CCEEEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccc
Confidence 75 4589999999975 45555566678999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc--ccccCCCccccccCcccCC
Q 022241 274 QVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
..+..... ......||+.|+|||++.|
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcC
Confidence 76543322 2224569999999999764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=232.83 Aligned_cols=174 Identities=20% Similarity=0.320 Sum_probs=140.6
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
++|++.+.||+|+||.||++.... +++.||+|++.... .......+..|+.++..+ +||||+++++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--------TASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--------CHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 579999999999999999987433 45789999885421 233456788899999999 8999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC----------------------------------------------------
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------------------------------------------- 219 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~---------------------------------------------------- 219 (300)
++... ...++++|||++++++.+.+..
T Consensus 79 ~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 79 ACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 88753 4578999999999888765532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCC
Q 022241 220 ---------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPG 288 (300)
Q Consensus 220 ---------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~g 288 (300)
...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+..... ......+
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 12688999999999999999999999999999999999999999999999999987533221 1123346
Q ss_pred ccccccCcccCC
Q 022241 289 TPVFTAPECCLG 300 (300)
Q Consensus 289 t~~y~aPE~l~G 300 (300)
++.|+|||++.+
T Consensus 238 ~~~y~aPE~~~~ 249 (337)
T cd05054 238 PLKWMAPESIFD 249 (337)
T ss_pred CccccCcHHhcC
Confidence 778999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=220.69 Aligned_cols=174 Identities=30% Similarity=0.519 Sum_probs=150.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+++.||.|+||.||++.+..+++.||+|.+..... .......+..|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 48889999999999999999999999999998865322 34456678899999999999999999998876556
Q ss_pred CEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH-----~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
..++++|||++++++...+.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 678999999999988776643 467999999999999999999999 89999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++..............+++.|+|||.+.
T Consensus 154 ~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 183 (265)
T cd08217 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183 (265)
T ss_pred ccccccccCCcccccccccCCCccChhhhc
Confidence 999988765443344567999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=224.99 Aligned_cols=165 Identities=15% Similarity=0.147 Sum_probs=141.2
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc--CCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD--PNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~~ 201 (300)
..||+|++|.||++.. +|+.||||.+.+... ........+.+|+.+|.+++|||||++++++.+ .....+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK------GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence 5799999999988765 799999999865421 123345778899999999999999999999876 444578
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
++||||+++|+|.+.+.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999999999888889999999999999999999998 489999999999999999999999999998654322
Q ss_pred cccccCCCccccccCcccC
Q 022241 281 DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 281 ~~~~~~~gt~~y~aPE~l~ 299 (300)
....||+.|+|||++.
T Consensus 178 ---~~~~~~~~y~aPE~~~ 193 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLN 193 (283)
T ss_pred ---ccccCcccccCHHHhh
Confidence 3456899999999874
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=225.50 Aligned_cols=172 Identities=28% Similarity=0.464 Sum_probs=147.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..+|.+.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.+.||||+++++.+..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~- 88 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPNIVNYLDSYLV- 88 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---------cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-
Confidence 357999999999999999999999899999999886532 2234668899999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++..++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 89 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred -CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 4589999999999999887643 46899999999999999999999999999999999999999999999999998865
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........|++.|+|||.+.+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTR 190 (296)
T ss_pred cccccccCcccCCccccCHHHHcC
Confidence 443333344579999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=223.38 Aligned_cols=172 Identities=24% Similarity=0.436 Sum_probs=141.2
Q ss_pred ce-eEeeeecCCCceEEEEEEE----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 119 EY-VHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 119 ~y-~~~~~iG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
+| ..++.||+|+||.||++.. ..++..||+|.+.... .......+.+|+.+|+.++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--------GQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45 8899999999999988653 3467899999886431 223446788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.......+++||||++++++.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccc
Confidence 76555678999999999998887754 35999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccc---cccCCCccccccCcccC
Q 022241 274 QVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
......... .....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 876432211 12234566799999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=231.98 Aligned_cols=174 Identities=18% Similarity=0.313 Sum_probs=139.7
Q ss_pred cceeEeeeecCCCceEEEEEEE-----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
++|++.+.||+|+||.||++.+ ..+++.||||.++... .......+.+|+.+|..+ +||||+++++
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--------ChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 5799999999999999999974 3467899999986431 233456788999999999 6899999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC---------------------------------------------------
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP--------------------------------------------------- 220 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--------------------------------------------------- 220 (300)
++... ...++++|||+++++|.+++...
T Consensus 79 ~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 79 ACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred eeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 88753 35789999999999887655321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--c
Q 022241 221 ----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--V 282 (300)
Q Consensus 221 ----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~ 282 (300)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 2367788889999999999999999999999999999999999999999999986533222 1
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....+++.|+|||++.+
T Consensus 238 ~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 238 KGDARLPLKWMAPETIFD 255 (343)
T ss_pred cCCCCCCcceECcHHhcC
Confidence 112345678999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=224.27 Aligned_cols=173 Identities=34% Similarity=0.565 Sum_probs=149.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++.+..+++.||||.++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 72 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-------DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--K 72 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-------cccchhHHHHHHHHHHhcCCCCeeehhheEEE--C
Confidence 69999999999999999999999999999998865321 23345678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
+..++||||++++.+.........+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 58999999999887776666667799999999999999999999999999999999999999999999999999987654
Q ss_pred Ccc-ccccCCCccccccCcccCC
Q 022241 279 DND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
... ......+++.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~ 175 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVG 175 (288)
T ss_pred CccccccCcccccCCcCCchhcC
Confidence 432 3344568899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=224.87 Aligned_cols=174 Identities=26% Similarity=0.471 Sum_probs=147.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++.+..+++.||||.+....... ........+..|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE----AKDGINFTALREIKLLQELKHPNIIGLLDVFGH--K 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc----ccchhhHHHHHHHHHHhhcCCCCChhhhheeec--C
Confidence 4788899999999999999999899999999987653221 012234457789999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++||||+ ++++..++.... .+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 6899999999 788888776665 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..........+++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLF 175 (298)
T ss_pred CCCccccccccceeeeCHHHHh
Confidence 5444444456788999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=221.73 Aligned_cols=180 Identities=32% Similarity=0.512 Sum_probs=148.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+...||+|+||.||++.+..+++.||+|.+...................+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 37778899999999999999998999999998865432110001112344678899999999999999999999886 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++..++...+.+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 57899999999999988887778899999999999999999999999999999999999999999999999999987642
Q ss_pred Ccc------ccccCCCccccccCcccCC
Q 022241 279 DND------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~------~~~~~~gt~~y~aPE~l~G 300 (300)
... ......|++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc
Confidence 211 1123458899999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=224.72 Aligned_cols=173 Identities=29% Similarity=0.362 Sum_probs=144.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCC----------------ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDG----------------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 180 (300)
.++|++.+.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.++..
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--------SDNAREDFLKEVKILSR 75 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--------CHHHHHHHHHHHHHHHh
Confidence 357999999999999999998876533 458999876432 23456788999999999
Q ss_pred CCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 022241 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-----------AIGESMARKYLRDIVSGLMYLHGHNVVH 249 (300)
Q Consensus 181 l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~~l~yLH~~~iiH 249 (300)
++||||+++++++.. ...++++|||++++++..++.... .+++..++.++.|++.||+|||+.+|+|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 999999999999975 358999999999998887765544 6899999999999999999999999999
Q ss_pred CCCCCCCEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 250 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
|||||+||+++.++.++|+|||++....... .......+++.|+|||++.
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred cccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 9999999999999999999999998653322 1223445778899999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=224.28 Aligned_cols=174 Identities=32% Similarity=0.512 Sum_probs=147.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+++.||+|+||.||++.+..+++.||+|.+.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 72 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI------LRNQIQQVFVERDILTFAENPFVVSMFCSFET-- 72 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--
Confidence 3689999999999999999999999999999988654221 22345678899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++++..++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 45899999999999999888777889999999999999999999999999999999999999999999999999987421
Q ss_pred CCc---------------cccccCCCccccccCcccC
Q 022241 278 DDN---------------DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~---------------~~~~~~~gt~~y~aPE~l~ 299 (300)
... .......|++.|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhcc
Confidence 100 0111245788999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=223.36 Aligned_cols=173 Identities=22% Similarity=0.307 Sum_probs=141.1
Q ss_pred cceeEeeeecCCCceEEEEEEEc----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.+|++.+.||+|+||.||++... .++..||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--------NPQQWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--------CHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 56899999999999999998853 356789999885321 234456788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
.. ....++||||++++++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 77 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n 154 (283)
T cd05090 77 TQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154 (283)
T ss_pred ec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence 75 4578999999999988776532 2347888899999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccCC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
||++.++.+||+|||++....... .......++..|+|||++.|
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence 999999999999999998653322 11223446778999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=223.71 Aligned_cols=172 Identities=27% Similarity=0.355 Sum_probs=142.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCC-----ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDG-----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|++++.||+|+||.||++.....+ ..||+|.+.... .......+.+|+.++..++||||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--------EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 46899999999999999999876544 679999875331 33445678999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+.. ....+++|||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 875 35789999999999887766432 458889999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
||++.++.+||+|||++....... .......+++.|+|||.+.
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence 999999999999999998653322 1223345788999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=225.56 Aligned_cols=175 Identities=31% Similarity=0.436 Sum_probs=146.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.||+|.++..... ......+.+|+.++..++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-------EGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 5799999999999999999999989999999998654221 222335678999999999999999999988654
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||+++ ++...+.. ...+++..++.++.|++.||+|||+.+++|+||||+|||++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 78 LDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred CCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 4789999999985 55555433 346999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........+++.|+|||.+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLG 180 (293)
T ss_pred cCCccccccccccccccCchhhcC
Confidence 554333344568899999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=223.34 Aligned_cols=170 Identities=30% Similarity=0.496 Sum_probs=147.2
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|++.+.||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 87 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---------QPKKELIINEILVMKELKNPNIVNFLDSFLV-- 87 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---------CchHHHHHHHHHHHHhcCCCceeeeeeeEec--
Confidence 56999999999999999999999999999999886431 2234568899999999999999999999975
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++|+||++++++...+.. ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 4589999999999998887654 468999999999999999999999999999999999999999999999999988654
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..........|++.|+|||.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVT 188 (296)
T ss_pred cccccCCCcCCCccccCcchhc
Confidence 4333334457899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=232.78 Aligned_cols=183 Identities=30% Similarity=0.462 Sum_probs=156.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..+-++|.++.+||+|||+.||+|.+....+.||||+-.... .++.+..+...+...+|..|.+.|+||.||++|++|
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK--~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK--NWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc--chhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 344578999999999999999999999999999999865432 234444566677888999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeCCCCCCCEEEcc---CCcEEEe
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVAP---SGTVKIG 268 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--~iiHrDlkp~NIll~~---~~~~kl~ 268 (300)
.-. .+.++-|+|||+|..|.-++.....+++..++.|+.||+.||.||.+. .|||-||||.||||.. -|.+||+
T Consensus 537 slD-tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLD-TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eec-cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 753 467899999999999999999999999999999999999999999975 5999999999999964 3589999
Q ss_pred cccCceeecCCcc-------ccccCCCccccccCcccC
Q 022241 269 DFSVSQVFEDDND-------VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 269 DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~ 299 (300)
||||++++.++.. ......||.+|++||++.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 9999999876442 334567999999999973
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=218.40 Aligned_cols=167 Identities=26% Similarity=0.347 Sum_probs=137.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 70 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 70 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEE
Confidence 46999999999999999999999999875321 23445678999999999999999999999976 357899
Q ss_pred EEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 204 VLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
||||++++++.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 71 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 71 VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred EEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 99999999998887554 46899999999999999999999999999999999999999999999999998764332111
Q ss_pred cc--cCCCccccccCcccCC
Q 022241 283 LR--RSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~--~~~gt~~y~aPE~l~G 300 (300)
.. ...++..|+|||.+.+
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~ 170 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNY 170 (252)
T ss_pred ccCCCCCCceeecCchhhcC
Confidence 11 1123456999998753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=223.21 Aligned_cols=164 Identities=32% Similarity=0.486 Sum_probs=142.5
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+++.|--+....+|..||||++.+. ......++.+|++++..++ |+||+.++++|++ ...+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FY 152 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---------PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFY 152 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEE
Confidence 6899999999999999999999999999775 2345678999999999986 9999999999987 45899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecccCceeecCC
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDD 279 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~ 279 (300)
||||-|.||.+..++....-+++.++.++..+|+.||.|||.+||.||||||+|||-.... -|||+||.|..-..-.
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999987655 4899999987543211
Q ss_pred -------ccccccCCCccccccCccc
Q 022241 280 -------NDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 280 -------~~~~~~~~gt~~y~aPE~l 298 (300)
.....+.+|+..|||||+.
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHH
Confidence 1123456799999999974
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=221.26 Aligned_cols=171 Identities=23% Similarity=0.314 Sum_probs=142.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|++.+.||+|+||.||++.+..+++ .||+|.+.... .......+.+|+.++..+.||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--------SPKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--------CHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 579999999999999999998877766 48999875431 334456788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...+++|||+++|++.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 79 LT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred cC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence 74 357899999999999888765 45699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccc--cccCCCccccccCcccC
Q 022241 273 SQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
++.+...... .....+++.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhc
Confidence 9876432221 11223567899999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=222.95 Aligned_cols=172 Identities=28% Similarity=0.386 Sum_probs=141.9
Q ss_pred cceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|.+.+.||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---------CHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 57999999999999999999753 24567899987542 33455678999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll 259 (300)
+.. ...+++||||++++++.+++... ..+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili 153 (288)
T cd05093 76 CVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 153 (288)
T ss_pred Eec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 985 45799999999999887766432 248999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 260 APSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 260 ~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
+.++.+||+|||++........ ......+++.|+|||++.|
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 9999999999999986533221 1223446788999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=221.64 Aligned_cols=173 Identities=21% Similarity=0.259 Sum_probs=139.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|++.+.||+|+||.||++.+.. ++..||||.+.... .......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4579999999999999999987642 45679999874321 2234456889999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
++.+ ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.
T Consensus 77 ~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 77 VVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence 9875 45789999999999888766431 23677888999999999999999999999999999999999
Q ss_pred CCcEEEecccCceeecCCccc--cccCCCccccccCcccC
Q 022241 262 SGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ~~~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
++.++|+|||++......... .....+++.|+|||++.
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 999999999998765332221 11234678899999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=241.02 Aligned_cols=178 Identities=26% Similarity=0.402 Sum_probs=159.9
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
......++..+..||-|+||.|=+++.......+|+|++++.+.. ...+.+.+..|..||..++.|.||++|..
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV------dtkQqeHv~sEr~Im~~~~s~fIvrLYrT 488 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV------DTKQQEHVFSERNIMMECRSDFIVRLYRT 488 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc------chhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence 344556778888999999999999887766667999999887653 45677889999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
|.+ .+++|++||-|-||.+...++.++.+.+.+++.++..++.|++|||++|||+|||||+|.+++.+|.+||.|||+
T Consensus 489 frd--~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 489 FRD--SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hcc--chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 986 578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+.+... ....++||||.|.|||+++
T Consensus 567 AKki~~g-~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 567 AKKIGSG-RKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred HHHhccC-CceeeecCCcccccchhhh
Confidence 9988654 4567899999999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=217.15 Aligned_cols=173 Identities=33% Similarity=0.628 Sum_probs=148.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-------SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--N 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--C
Confidence 48899999999999999999999999999999865322 23345678899999999999999999999975 4
Q ss_pred CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...++||||++++++.+.+... ..+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++...
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 5899999999999888776543 35889999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........|++.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICEN 175 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCC
Confidence 544333344568999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=218.54 Aligned_cols=172 Identities=29% Similarity=0.392 Sum_probs=143.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|.+.+.||+|+||.||++....+ ...||||.+.... .......+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 5699999999999999999988654 4579999875431 3344567889999999999999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ....++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 76 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 76 K--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred c--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 5 4578999999999999887755 347899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcccc--ccCCCccccccCcccC
Q 022241 274 QVFEDDNDVL--RRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~--~~~~gt~~y~aPE~l~ 299 (300)
.......... ....+++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhc
Confidence 8764222211 1234567899999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=220.04 Aligned_cols=171 Identities=26% Similarity=0.420 Sum_probs=149.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||.|+||.||++++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--G 71 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--C
Confidence 6888999999999999999999999999999986431 23345678899999999999999999999886 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+++|+||++++++.+.+... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 6899999999999998887655 899999999999999999999999999999999999999999999999999988765
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........|++.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQ 172 (274)
T ss_pred cccccccccCCccccChhhhcc
Confidence 4334445678999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=258.93 Aligned_cols=177 Identities=29% Similarity=0.488 Sum_probs=154.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...-+|+....||.|.||.||-+.+..+|+..|||.++.+.. .......+.+|..+|..++|||+|+++|+=.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-------~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-------DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-------ccccCcchHHHHHHHHhccCccccccCceee
Confidence 344568888999999999999999999999999998865432 1445567889999999999999999999876
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ .+.++|.||||.+|+|.+.+...+..++.....+..|++.|++|||+.|||||||||+||||+.+|.+|++|||.|.
T Consensus 1305 H--Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1305 H--REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred c--HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeeccccee
Confidence 5 46799999999999999999888889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc----cccccCCCccccccCcccCC
Q 022241 275 VFEDDN----DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~----~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.... ......+|||.|||||++.|
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcc
Confidence 875442 12234579999999999876
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=217.82 Aligned_cols=169 Identities=26% Similarity=0.426 Sum_probs=140.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++..+ ++..+|+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 70 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-- 70 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----------ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--
Confidence 46889999999999999999775 45679999875431 123568889999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++.+.+.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 4579999999999998887754 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCcccc-ccCCCccccccCcccC
Q 022241 277 EDDNDVL-RRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~-~~~~gt~~y~aPE~l~ 299 (300)
....... ....++..|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcc
Confidence 3322211 1223566799999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=220.43 Aligned_cols=172 Identities=30% Similarity=0.515 Sum_probs=150.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||.|+||.||++.+..+++.||+|.+.+.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------EKGSVRNVLNERRILQELNHPFLVNLWYSFQD--E 72 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc------chhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--C
Confidence 488999999999999999999989999999999764321 23456789999999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+++|+||+.+++|...+.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 58999999999999998887777899999999999999999999999999999999999999999999999999887544
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.. ......|+..|+|||++.
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 153 DT-LTTSTSGTPGYMAPEVLC 172 (258)
T ss_pred Cc-cccccCCChhhcCHHHHc
Confidence 32 234456899999999864
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=225.34 Aligned_cols=176 Identities=33% Similarity=0.503 Sum_probs=142.9
Q ss_pred ceeEeeeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+|.+.+.||+|+||.||++.... +++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ------YTGISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc------ccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 48889999999999999999988 8999999998763211 122335677899999999999999999999876
Q ss_pred CCCEEEEEEEeeCCCcccccc---C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc----CCcEEEe
Q 022241 197 NSDHFYMVLEYVEGKWDNDGF---G-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP----SGTVKIG 268 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~---~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~----~~~~kl~ 268 (300)
....+++||||++++++.... . ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 557899999999875433211 1 2237899999999999999999999999999999999999999 8999999
Q ss_pred cccCceeecCCcc---ccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
|||++........ ......+|+.|+|||++.|
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhC
Confidence 9999987643322 1223468899999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=218.74 Aligned_cols=171 Identities=24% Similarity=0.342 Sum_probs=143.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||+|+||.||++....+++.||+|.+... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-- 73 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----------chHHHHHHHHHHHHHhCCCCChhheEEEEcC--
Confidence 4689999999999999999999989999999987532 2234578899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...++++|||++++++.+++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 4578999999999998887744 34689999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcccc-ccCCCccccccCcccCC
Q 022241 276 FEDDNDVL-RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~-~~~~gt~~y~aPE~l~G 300 (300)
........ ....+++.|+|||.+.|
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 179 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAY 179 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhcc
Confidence 64432211 12234678999998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=218.86 Aligned_cols=174 Identities=30% Similarity=0.444 Sum_probs=148.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+++.+ .||||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII----------EDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC----------chhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 346899999999999999999999989999999987643 22345788999999998 6999999999987
Q ss_pred cCC----CCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 195 DPN----SDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 195 ~~~----~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
... ...+++||||++++++.+.+.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence 533 4568999999999988776643 45799999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCccccccCCCccccccCcccC
Q 022241 267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 267 l~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++..............|++.|+|||++.
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA 186 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhc
Confidence 999999987654444444567999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=240.92 Aligned_cols=185 Identities=19% Similarity=0.358 Sum_probs=135.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccC-CceEEEEEeeccccc--------ccccCCChHHHHHHHHHHHHHHHCCCC
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLS--------KLRVAPSETAMTDVRREVLIMKMLQHP 184 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~~~~~~~~~~E~~~l~~l~h~ 184 (300)
....++|++++.||+|+||.||++..+.. +..+++|.+...... .............+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 44567899999999999999999876543 222333311110000 000111233456788999999999999
Q ss_pred ceeeeeeEEEcCCCCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc
Q 022241 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260 (300)
Q Consensus 185 niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~ 260 (300)
|||++++++.+. +..|+|+|++.+..+..... .........++.++.||+.||+|||+++|+||||||+|||++
T Consensus 224 nIv~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 224 NILKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcCcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999863 57899999987543322211 122344667788999999999999999999999999999999
Q ss_pred cCCcEEEecccCceeecCCcc-ccccCCCccccccCcccCC
Q 022241 261 PSGTVKIGDFSVSQVFEDDND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 261 ~~~~~kl~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
.++.+||+|||++..+..... ......||+.|+|||++.|
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 999999999999987654322 2234579999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=220.47 Aligned_cols=171 Identities=22% Similarity=0.336 Sum_probs=140.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCce----EEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|++++.||+|+||.||++....+++. +|+|.+... ........+..|+.+++.+.||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--------SGRQTFQEITDHMLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--------cchHHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 4689999999999999999998777764 566655321 1233456788889999999999999999988
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++++||++++++.+++.. ...+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+
T Consensus 79 ~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 79 PG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 53 457899999999999988854 45789999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc--ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
++....... ......+++.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 184 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESIL 184 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhc
Confidence 987543221 222345778899999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=223.44 Aligned_cols=175 Identities=26% Similarity=0.432 Sum_probs=147.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|...+.||+|+||.||++....+++.||+|.+.+.... .......+..|+.++..++||||+++++.+.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 72 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI------KRNKVKRVLTEQEILATLDHPFLPTLYASFQT-- 72 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc------hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--
Confidence 3699999999999999999999999999999998754321 12355678899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+.+++|.+.+... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 73 ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 46899999999999998877543 5689999999999999999999999999999999999999999999999999876
Q ss_pred ecCCcc-----------------------------ccccCCCccccccCcccCC
Q 022241 276 FEDDND-----------------------------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......||..|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 206 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence 432111 1112358899999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=219.90 Aligned_cols=176 Identities=25% Similarity=0.483 Sum_probs=147.3
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||+|+||.||++.+..+++.||+|.+....... .........+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc---hhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--C
Confidence 4778899999999999999999999999999986432111 1122346789999999999999999999999976 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~~ 277 (300)
+..++||||+++++|.+.+...+++++..+..++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 57999999999999998887777899999999999999999999999999999999999998776 69999999998764
Q ss_pred CCcc----ccccCCCccccccCcccC
Q 022241 278 DDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......||+.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred cccccCCccccccccccceeCHhHhc
Confidence 3311 112345889999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=222.46 Aligned_cols=169 Identities=27% Similarity=0.426 Sum_probs=145.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++++.||+|+||.||++++..++..||+|.+... ........+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--E 71 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--C
Confidence 688999999999999999999999999999987532 133445678899999999999999999999876 4
Q ss_pred CEEEEEEEeeCCCccccccCCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
..+++||||++++.+..++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 5899999999999887766542 379999999999999999999996 699999999999999999999999999997
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.+... ......+++.|+|||++.
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 152 NLVAS--LAKTNIGCQSYMAPERIK 174 (286)
T ss_pred cccCC--ccccCCCccCccCcchhc
Confidence 65332 223456889999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=220.74 Aligned_cols=173 Identities=31% Similarity=0.526 Sum_probs=140.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-- 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-------cccchHHHHHHHHHHHhccCCCEeeEEEEEec--
Confidence 579999999999999999999999999999998754321 12234567889999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~ 274 (300)
....++||||+++ .+...+.... .+++..++.++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 73 EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred CCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence 4589999999975 4444443322 3688889999999999999999999999999999999985 5579999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............+++.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 152 AFGIPVRTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred ccCCCccccccCceeecccCHHHHhC
Confidence 65443333344568899999998743
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=218.38 Aligned_cols=173 Identities=32% Similarity=0.406 Sum_probs=142.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.+|.+.+.||+|+||.||++....++. .+|+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 468999999999999999998765443 79999875431 2334567899999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. .+.+++||||+++++|.+++... +.+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 5 45799999999999988877553 46899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccc---cCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLR---RSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~---~~~gt~~y~aPE~l~G 300 (300)
..+........ ...+++.|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhcc
Confidence 87644322111 1224567999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=220.35 Aligned_cols=170 Identities=22% Similarity=0.316 Sum_probs=145.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.++||.|+||.||++.... ++.+|+|.+... .......+..|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 73 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---------DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-- 73 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---------chhhHHHHHHHHHHHhcCCCcchhheeeeEec--
Confidence 469999999999999999999887 889999998653 22345578899999999999999999999876
Q ss_pred CCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 4578999999999999888764 34689999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
............+++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~ 177 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAAS 177 (261)
T ss_pred cCCccccccCCCCceEecCHHHHc
Confidence 654433333445677899999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=231.45 Aligned_cols=175 Identities=23% Similarity=0.314 Sum_probs=140.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVN 188 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 188 (300)
...++|.+.+.||+|+||.||++++. ..+..||||+++... .......+.+|+.+|..+. |||||+
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--------RSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--------ChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 33467889999999999999999854 345689999986432 2233457889999999997 999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCCC------------------------------------------------
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP------------------------------------------------ 220 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~------------------------------------------------ 220 (300)
+++++... ..+++||||+++|+|.+++...
T Consensus 106 ~~~~~~~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 106 LLGACTKG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEccC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 99999863 5799999999999887655321
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeC
Q 022241 221 --------------------------------------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHG 250 (300)
Q Consensus 221 --------------------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHr 250 (300)
..+++..+..++.||+.||+|||+.+|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 236777888999999999999999999999
Q ss_pred CCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 251 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||||+|||++.++.+||+|||+++....... ......+++.|+|||++.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 9999999999999999999999986533221 112345778899999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=227.11 Aligned_cols=174 Identities=25% Similarity=0.445 Sum_probs=142.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|...+.||+|+||.||++++..+++.||||.+.+... .......+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP 86 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-------ChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence 34679999999999999999999999999999998854311 23344567789999999999999999998864
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ....|+||||+.+ .+...+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 87 QKSLEEFQDVYLVMELMDA-NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CCCccccCcEEEEEeccCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 22 2357999999976 44444432 28899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++....... ......+|+.|+|||++.|
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhC
Confidence 998754332 2334568999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=220.13 Aligned_cols=171 Identities=28% Similarity=0.507 Sum_probs=142.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||.|++|.||++++..+|+.||||.+..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 70 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--------EGTPSTAIREISLMKELKHENIVRLHDVIHT--E 70 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--------ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--C
Confidence 48899999999999999999999999999999865421 1223456789999999999999999999986 3
Q ss_pred CEEEEEEEeeCCCccccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+..++||||+++ .+.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 578999999986 44444432 24689999999999999999999999999999999999999999999999999976
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
............+|+.|+|||++.|
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred hcCCccccccccccccccChHHhcC
Confidence 5443333334567899999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=215.63 Aligned_cols=173 Identities=28% Similarity=0.555 Sum_probs=150.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||.+....+++.||+|.+..... .......+..|+.+++.++|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--R 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-------chHHHHHHHHHHHHHHhCCCCChhheeeeEec--C
Confidence 48889999999999999999988999999999865422 23467789999999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+++|+||++++++.+.+.....+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 68999999999999999888777799999999999999999999999999999999999999999999999999987654
Q ss_pred Cccccc----cCCCccccccCcccCC
Q 022241 279 DNDVLR----RSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~----~~~gt~~y~aPE~l~G 300 (300)
...... ...+++.|+|||++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccC
Confidence 332211 3568899999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=218.52 Aligned_cols=174 Identities=28% Similarity=0.434 Sum_probs=145.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|.+.+.||+|+||.||++....+++.||+|.+... ......+.+|+.++..+ +|||++++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 357899999999999999999999999999999987542 12234677899999988 7999999999987
Q ss_pred cCC---CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEE
Q 022241 195 DPN---SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 195 ~~~---~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl 267 (300)
... ...+++||||++++++.+++. ....+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 532 246899999999998877653 3457899999999999999999999999999999999999999999999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++..............|++.|+|||++.
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhc
Confidence 99999987544333333456899999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=221.78 Aligned_cols=179 Identities=27% Similarity=0.457 Sum_probs=142.5
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-------cCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 345689999999999999999999999999999998854321 1122234568999999999999999999886
Q ss_pred cCC------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 195 DPN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 195 ~~~------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
... ....++||||+.+............+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence 532 23579999999864333332333478999999999999999999999999999999999999999999999
Q ss_pred cccCceeecCCcc----ccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDND----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~G 300 (300)
|||++..+..... ......+++.|+|||++.|
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcC
Confidence 9999986543221 1123457889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.01 Aligned_cols=169 Identities=18% Similarity=0.276 Sum_probs=138.9
Q ss_pred EeeeecCC--CceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 122 HVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 122 ~~~~iG~G--~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
++++||+| +|++||++..+.+|+.||||.+..... .......+.+|+.+++.++||||+++++++.. .+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CC
Confidence 45789999 789999999999999999999865321 22344567889999999999999999999986 35
Q ss_pred EEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++||||++++++.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+....
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence 89999999999998887744 3458999999999999999999999999999999999999999999999998754432
Q ss_pred CCcc-------ccccCCCccccccCcccC
Q 022241 278 DDND-------VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~-------~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......++..|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181 (327)
T ss_pred cccccccccccccccccceecccChHHhh
Confidence 1111 112235778899999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=220.55 Aligned_cols=173 Identities=30% Similarity=0.377 Sum_probs=142.5
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|.+.+.||+|+||.||++.... +++.||||.+.... .......+.+|+.+|+.++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--------SNDARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--------CHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence 468889999999999999998753 46789999885431 22345688999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEE
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP--------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL 258 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIl 258 (300)
+.. ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nil 154 (280)
T cd05049 77 CTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL 154 (280)
T ss_pred Eec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEE
Confidence 986 35799999999999988776432 34788999999999999999999999999999999999
Q ss_pred EccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 259 VAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 259 l~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
++.++.+||+|||++........ ......+++.|+|||++.|
T Consensus 155 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05049 155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY 198 (280)
T ss_pred EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence 99999999999999986532221 1223346788999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=236.06 Aligned_cols=172 Identities=30% Similarity=0.452 Sum_probs=152.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 195 (300)
.+.|++.+.||.|.+|.||+++++.+++..|+|+.... ...-+.+..|.+||+.+ +|||++.++++|.-
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----------~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----------EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----------ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 35699999999999999999999999999999997543 33445777899999877 59999999998753
Q ss_pred ---CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 196 ---PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 196 ---~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
..++++|||||||.+|+.-++... ..++.|..+..|++.++.||.+||.+.++|||||-.|||++.++.|||.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 356899999999999998776643 457999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCccc
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
|++..+........++.|||.|||||++
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEVi 195 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVI 195 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceee
Confidence 9999988877777888999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=219.84 Aligned_cols=174 Identities=27% Similarity=0.445 Sum_probs=145.9
Q ss_pred ceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
+|++.+.||+|+||.||+++.. .+|+.||+|.+....... .......+.+|+.++..+ +||||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-----cchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 4888999999999999999875 378999999987542211 223445678899999999 5999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ...+++||||++++++.+++.....+++..+..++.|++.||.|||+.+++||||+|+|||++.++.+||+|||++.
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 76 T--DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred c--CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 5 35789999999999999888777789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc-cccccCCCccccccCcccC
Q 022241 275 VFEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
...... .......|++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred ecccccccccccccCCcccCChhhcc
Confidence 754322 1223456899999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=221.92 Aligned_cols=175 Identities=21% Similarity=0.348 Sum_probs=141.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCcee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV 187 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 187 (300)
..++|.+.+.||+|+||.||++++.. ++..||+|.+.... .......+..|+.+++.+ +||||+
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--------ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34689999999999999999998643 23579999886431 233456788899999999 799999
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCC
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrD 251 (300)
++++++.. ....|+||||+++++|.+++... ..+++..+..++.|++.||+|||+++++|||
T Consensus 88 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 88 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred eEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999975 35799999999999888776432 2488899999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEecccCceeecCCcccc--ccCCCccccccCcccCC
Q 022241 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL--RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 252 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~l~G 300 (300)
|||+|||++.++.+||+|||++.......... ....+++.|+|||++.|
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence 99999999999999999999997654322111 12234578999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-31 Score=235.90 Aligned_cols=173 Identities=25% Similarity=0.409 Sum_probs=148.7
Q ss_pred hhccccccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc
Q 022241 106 IRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185 (300)
Q Consensus 106 ~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 185 (300)
.....+.....++....++-||.|+-|.||+.+ ..++.||||.++.. -..+|..|++|+|||
T Consensus 112 k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------------kETdIKHLRkLkH~N 173 (904)
T KOG4721|consen 112 KQQQEELWEIPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------------KETDIKHLRKLKHPN 173 (904)
T ss_pred hhhhhhhccCCHHHhhhhhhhccCcccceeeee--ccCceehhHHHhhh----------------hhhhHHHHHhccCcc
Confidence 334444455666777778899999999998765 45889999987532 136788999999999
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
|+.+.|+|.. ...++||||||..|.|...+.....++......+..+||.|+.|||.+.|||||||.-||||..+..|
T Consensus 174 II~FkGVCtq--sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~V 251 (904)
T KOG4721|consen 174 IITFKGVCTQ--SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVV 251 (904)
T ss_pred eeeEeeeecC--CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceE
Confidence 9999999985 45788999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|||-++.+.+... .-.++||..|||||++.
T Consensus 252 KIsDFGTS~e~~~~ST-kMSFaGTVaWMAPEvIr 284 (904)
T KOG4721|consen 252 KISDFGTSKELSDKST-KMSFAGTVAWMAPEVIR 284 (904)
T ss_pred EeccccchHhhhhhhh-hhhhhhhHhhhCHHHhh
Confidence 9999999998766533 34689999999999974
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=218.02 Aligned_cols=170 Identities=24% Similarity=0.384 Sum_probs=136.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHH-HHHCCCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~ 196 (300)
++|++.+.||+|+||.||++.+..+|+.||||.+..... ......+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--------SQEQKRLLMDLDISMRSVDCPYTVTFYGALFR- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--------cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-
Confidence 368999999999999999999999999999999865421 1122344455554 677899999999999975
Q ss_pred CCCEEEEEEEeeCCCccccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 197 NSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
...++++|||+++. +... ......+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 72 -~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 72 -EGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred -CCcEEEEhhhhccc-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 35799999999853 3322 23345799999999999999999999997 99999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++....... ......|++.|+|||++.
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 150 ISGYLVDSV-AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred ccccccccc-ccccccCCccccChhhcC
Confidence 998754322 223356899999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=222.58 Aligned_cols=172 Identities=25% Similarity=0.338 Sum_probs=138.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCce--EEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
+++|.+.+.||+|+||.||++.++.++.. +|+|.+... ........+.+|+.++..+ +||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--------ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 46799999999999999999998877764 466665421 1334556788999999999 899999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL 257 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NI 257 (300)
.+ ....|+||||++++++.+++... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 78 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Ni 155 (303)
T cd05088 78 EH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 155 (303)
T ss_pred CC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence 75 45799999999999887766432 3578999999999999999999999999999999999
Q ss_pred EEccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 258 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|++.++.+||+|||++....... ......+++.|+|||++.
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN 196 (303)
T ss_pred EecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHh
Confidence 99999999999999986432111 111123466799999764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=218.51 Aligned_cols=170 Identities=29% Similarity=0.505 Sum_probs=146.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 195 (300)
.|+..+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++.+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 4778899999999999999999999999999875431 2334567888999999986 9999999999875
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++..
T Consensus 74 --~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 74 --GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred --CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 4589999999999998887755 4789999999999999999999999999999999999999999999999999988
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+...........|++.|+|||.+.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred cCCCccccccccCCcceeCHHHhc
Confidence 755444444557999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=216.24 Aligned_cols=170 Identities=26% Similarity=0.391 Sum_probs=142.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.++||+|+||.||++... ++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG----------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK- 72 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC----------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 357999999999999999999865 5677999987532 2234678899999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....+++|||++++++.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.
T Consensus 73 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 73 -EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred -CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 4578999999999998877743 3468899999999999999999999999999999999999999999999999998
Q ss_pred eecCCccc-cccCCCccccccCcccC
Q 022241 275 VFEDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
........ .....++..|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhc
Confidence 76443221 12234667899999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=216.41 Aligned_cols=165 Identities=24% Similarity=0.378 Sum_probs=137.6
Q ss_pred eecCCCceEEEEEEE--ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 125 KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
.||+|+||.||++.. ..++..||+|++.... ......+.+.+|+.+++.+.||||+++++++.. +..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 71 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWM 71 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcE
Confidence 589999999999854 4567899999875431 133456788999999999999999999999853 4678
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||++++++.+++.....+++..+..++.|++.||+|||+++|+||||||.|||++.++.+||+|||++..+......
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999999999888877778999999999999999999999999999999999999999999999999999876443221
Q ss_pred ---cccCCCccccccCcccC
Q 022241 283 ---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 283 ---~~~~~gt~~y~aPE~l~ 299 (300)
.....+++.|+|||++.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMN 171 (257)
T ss_pred eeecCCCCCCccccCHhHhc
Confidence 12223467899999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=221.59 Aligned_cols=171 Identities=27% Similarity=0.420 Sum_probs=148.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE- 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-
Confidence 46889999999999999999999999999999875431 233456788999999999999999999999864
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..+++||||++++++...+...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 76 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 76 -NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred -CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 5899999999999998888777789999999999999999999997 68999999999999999999999999998764
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... .....||+.|+|||++.+
T Consensus 155 ~~~~--~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 155 INSI--ADTFVGTSTYMSPERIQG 176 (284)
T ss_pred hhhc--cCccccCcccCCHHHHcc
Confidence 3322 234579999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=221.75 Aligned_cols=172 Identities=28% Similarity=0.343 Sum_probs=139.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccC--------------CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD--------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 183 (300)
++|++.+.||+|+||.||++..... ...||||.+.... .......+.+|+.+++.++|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--------TKTARNDFLKEIKIMSRLKN 76 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCC
Confidence 4799999999999999999887543 2358999876431 23455678999999999999
Q ss_pred CceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCC
Q 022241 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251 (300)
Q Consensus 184 ~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrD 251 (300)
|||+++++++.. ....++||||++++++.+++... ..+++..+..++.|++.||.|||+++++|||
T Consensus 77 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 154 (295)
T cd05097 77 PNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD 154 (295)
T ss_pred CCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 999999999975 45789999999999887765322 2468889999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 252 lkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|||+|||++.++.+||+|||++........ ......+++.|+|||++.
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 999999999999999999999976533221 112234577899999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=236.75 Aligned_cols=163 Identities=31% Similarity=0.483 Sum_probs=145.4
Q ss_pred eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEE
Q 022241 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV 204 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 204 (300)
.||+|.||+||-+++..+...+|||.+... .....+-+..|+.+.+.|+|.|||+++|.+.. ++++-|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---------cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 699999999999999999999999988543 44556678999999999999999999999864 4588999
Q ss_pred EEeeCCCccccccCCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCceeecCCc
Q 022241 205 LEYVEGKWDNDGFGQP-GAI--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 205 ~E~~~~~~l~~~~~~~-~~l--~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~ 280 (300)
||-++||+|..+++.. +++ .+.++-.+..||+.||+|||++.|||||||-+|+||+. .|.+||+|||-++.+..-+
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 9999999999888654 566 88999999999999999999999999999999999974 6799999999999887666
Q ss_pred cccccCCCccccccCccc
Q 022241 281 DVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 281 ~~~~~~~gt~~y~aPE~l 298 (300)
....++.||..|||||++
T Consensus 731 P~TETFTGTLQYMAPEvI 748 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVI 748 (1226)
T ss_pred ccccccccchhhhChHhh
Confidence 667788999999999986
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=221.29 Aligned_cols=176 Identities=20% Similarity=0.352 Sum_probs=142.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-------cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCce
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-------LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNI 186 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 186 (300)
...++|.+.+.||+|+||.||+++.. .++..||+|.+.... .......+.+|+.+++.+ +||||
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--------chHHHHHHHHHHHHHHhhccCCCc
Confidence 33467999999999999999999753 234579999875321 234456788999999999 89999
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeC
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHG 250 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHr 250 (300)
+++++++.. ...+++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999986 35789999999999887766432 357888899999999999999999999999
Q ss_pred CCCCCCEEEccCCcEEEecccCceeecCCccc--cccCCCccccccCcccCC
Q 022241 251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 251 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~G 300 (300)
||||+|||++.++.+||+|||+++........ .....+++.|+|||++.|
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc
Confidence 99999999999999999999999876432221 222346778999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=217.91 Aligned_cols=171 Identities=26% Similarity=0.509 Sum_probs=145.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-------EGGIPNQALREIKALQACQHPYVVKLLDVFPH--G 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-------cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence 48899999999999999999998999999999865421 12344678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..+++||||+ ++++.+.+.. ...+++..++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 6899999999 8888776643 4679999999999999999999999999999999999999999999999999998764
Q ss_pred CCcc-ccccCCCccccccCcccC
Q 022241 278 DDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......|++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CCCCCccccccCcccccCceeee
Confidence 4321 233456899999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=218.75 Aligned_cols=174 Identities=22% Similarity=0.354 Sum_probs=141.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
..++|.+.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--------CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 346799999999999999999987643 3689999876431 233456788999999999 79999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFG----------------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK 253 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk 253 (300)
++++.. ...++++|||++++++..++. ....+++..+..++.|++.||.|||+.+|+|||||
T Consensus 82 ~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 82 LGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred EEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 999875 457999999999998877663 23468899999999999999999999999999999
Q ss_pred CCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 254 PDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 254 p~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++.++.+||+|||++..+..... ......+++.|+|||++.
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 207 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence 9999999999999999999987543221 112233567899999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=216.46 Aligned_cols=176 Identities=29% Similarity=0.479 Sum_probs=146.3
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||+|+||.||++... +++.+|||.+...... ..........+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSN---VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccc---hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--C
Confidence 4778899999999999999764 7889999988643211 11123445678999999999999999999999986 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++++|||++++++..++.....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 68999999999999998887777899999999999999999999999999999999999999999999999999876422
Q ss_pred C------ccccccCCCccccccCcccCC
Q 022241 279 D------NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~------~~~~~~~~gt~~y~aPE~l~G 300 (300)
. ........|++.|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC
Confidence 1 112234568999999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=214.54 Aligned_cols=174 Identities=31% Similarity=0.508 Sum_probs=148.8
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||+|+||.||++....+++.||+|.+...... .........+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG----QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--E 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc----ccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--C
Confidence 367778999999999999999889999999988653211 1123455678999999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++++|||++++++.+++.....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 58999999999999988887777899999999999999999999999999999999999999999999999999987544
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.. ......|++.|+|||.+.
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred cc-cccccCCCcceeCHHHhc
Confidence 33 234567899999999764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=214.41 Aligned_cols=170 Identities=26% Similarity=0.354 Sum_probs=140.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++... +++.||||.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 72 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-- 72 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----------ccHHHHHHHHHHHHHCCCCCccceeEEEec--
Confidence 56999999999999999998865 45789999876432 123568899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++||||++++++.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 357899999999999988876543 689999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccccc-cCCCccccccCcccCC
Q 022241 276 FEDDNDVLR-RSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~-~~~gt~~y~aPE~l~G 300 (300)
......... ....+..|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALY 178 (261)
T ss_pred ccCCcccccCCCcCceeccCcccccc
Confidence 653221111 1123457999998653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=216.97 Aligned_cols=173 Identities=23% Similarity=0.265 Sum_probs=142.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|.+.+.||+|+||.||++..... +..||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--------SMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--------CHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 35799999999999999999887643 4789999875331 2234457889999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
++.. ....++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 77 ~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~ 154 (277)
T cd05032 77 VVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence 9876 3579999999999988876643 224788899999999999999999999999999999999999
Q ss_pred CCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 262 SGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
++.+||+|||+++.+..... ......+|+.|+|||.+.
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 99999999999976543321 222345788999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.92 Aligned_cols=175 Identities=26% Similarity=0.468 Sum_probs=146.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence 3579999999999999999999999999999998864321 122345677899999999999999999988643
Q ss_pred C---CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 197 N---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 197 ~---~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ...+++||||+.+ .+...+...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 77 HREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cccccCcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 2 1358999999974 56666666778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..............+|..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred cccCCCcccccccccccCccChHHHh
Confidence 87644433344556899999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=217.23 Aligned_cols=171 Identities=26% Similarity=0.456 Sum_probs=147.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|+..+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.+.||||+++++++.+ .
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--G 74 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 4778899999999999999999899999999886431 23456788999999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 589999999999999887754 5789999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........++..|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~ 175 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQ 175 (277)
T ss_pred CccccccccCcccccCHhHhcc
Confidence 4333344568899999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=216.43 Aligned_cols=173 Identities=22% Similarity=0.297 Sum_probs=138.0
Q ss_pred eEeeeecCCCceEEEEEEEccCCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC-
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN- 197 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 197 (300)
.+.+.||+|+||.||++....++. .||||.++... ........+.+|+.+++.++||||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 456889999999999998877665 68999875431 13455678899999999999999999999874321
Q ss_pred ---CCEEEEEEEeeCCCccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 198 ---SDHFYMVLEYVEGKWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 198 ---~~~~~lv~E~~~~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
....+++|||++++++...+. ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence 235689999999988766542 23458999999999999999999999999999999999999999999999
Q ss_pred cccCceeecCCccc--cccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~G 300 (300)
|||++..+...... .....+++.|+|||++.+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence 99999876433211 122346678999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=220.12 Aligned_cols=172 Identities=32% Similarity=0.555 Sum_probs=142.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+.++.||.|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--E 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-------ccccchHHHHHHHHHHhcCCCCCcchhhhccc--C
Confidence 48899999999999999999999999999998864321 12233568899999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+..++||||+.+ .+..++.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++...
T Consensus 72 ~~~~~v~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 72 NKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred CcEEEEeecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 589999999974 45544422 456899999999999999999999999999999999999999999999999998865
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........+++.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 151 GVPVRTYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred ccCccccccccccccccCCeEEec
Confidence 443333344567899999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=217.37 Aligned_cols=168 Identities=29% Similarity=0.415 Sum_probs=135.3
Q ss_pred eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEE
Q 022241 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV 204 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 204 (300)
.||+|+||.||++++..+++.||+|.+.+..... ...............++....||+|+++++++.+ .+.+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc---chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEE
Confidence 4899999999999999999999999987643211 0011111112223344555689999999999986 3589999
Q ss_pred EEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccc
Q 022241 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284 (300)
Q Consensus 205 ~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 284 (300)
|||+++++|...+...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..+.... ..
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~ 153 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH 153 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--Cc
Confidence 9999999998888777789999999999999999999999999999999999999999999999999987653322 23
Q ss_pred cCCCccccccCcccC
Q 022241 285 RSPGTPVFTAPECCL 299 (300)
Q Consensus 285 ~~~gt~~y~aPE~l~ 299 (300)
...|++.|+|||++.
T Consensus 154 ~~~~~~~y~aPE~~~ 168 (278)
T cd05606 154 ASVGTHGYMAPEVLQ 168 (278)
T ss_pred CcCCCcCCcCcHHhc
Confidence 457999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=215.22 Aligned_cols=169 Identities=30% Similarity=0.416 Sum_probs=141.8
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
+.....||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 78 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG 78 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence 44446899999999999999989999999987543 23455678999999999999999999999876 45
Q ss_pred EEEEEEEeeCCCccccccCCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCcee
Q 022241 200 HFYMVLEYVEGKWDNDGFGQP-GAI--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV 275 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~-~~l--~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~ 275 (300)
..++|+||+++++|...+... ..+ ++..+..++.||+.||+|||+++|+||||||+||+++. ++.++|+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 899999999999998877543 445 88889999999999999999999999999999999976 67999999999987
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
............|++.|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVID 182 (268)
T ss_pred cccCCCccccCCCCccccChhhhc
Confidence 644333333456899999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=218.81 Aligned_cols=173 Identities=22% Similarity=0.253 Sum_probs=138.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|.+.+.||+|+||.||++..+. .+..||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--------SLRERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4679999999999999999987652 34589999875331 2233446788999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
++.+. ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 77 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~ 154 (288)
T cd05061 77 VVSKG--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154 (288)
T ss_pred EEcCC--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence 98753 4789999999999998877432 23567788899999999999999999999999999999999
Q ss_pred CCcEEEecccCceeecCCccc--cccCCCccccccCcccC
Q 022241 262 SGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ~~~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
++.++|+|||++......... .....++..|+|||.+.
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence 999999999998865332211 12234567899999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=219.56 Aligned_cols=171 Identities=29% Similarity=0.439 Sum_probs=143.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
...|...+.||+|+||.||++....+++.||+|.+..... ........+.+|+.+++.++||||+++.+++.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~- 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR- 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc------CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-
Confidence 3569999999999999999999998999999998854321 123445678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++.+.........+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++...
T Consensus 87 -~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 87 -EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred -CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 4578999999986544333334557999999999999999999999999999999999999999999999999999765
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... ....+++.|+|||++.
T Consensus 166 ~~~----~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 166 SPA----NSFVGTPYWMAPEVIL 184 (307)
T ss_pred CCC----CCccCCccccCceeee
Confidence 322 2456889999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=218.03 Aligned_cols=171 Identities=30% Similarity=0.454 Sum_probs=142.6
Q ss_pred ceeecceeEe-eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 114 TKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 114 ~~~~~~y~~~-~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
...+++|.+. ++||-|-.|.|..+.++.+|+.+|+|++... ..-.+|+.+.-.. .|||||.+++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~Iid 122 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIID 122 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeeh
Confidence 3455678665 6799999999999999999999999988532 2445777765443 6999999999
Q ss_pred EEEc--CCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC---Cc
Q 022241 192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GT 264 (300)
Q Consensus 192 ~~~~--~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~---~~ 264 (300)
+|.. .....+.+|||.|+||.|+..+...+ .+++..+..|+.||..|+.|||+.+|.||||||+|+|...+ ..
T Consensus 123 VyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 123 VYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcc
Confidence 8864 23457889999999999999887765 59999999999999999999999999999999999999754 47
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+||+|||+|+..... ....+.|-||.|.|||+|.
T Consensus 203 lKLtDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 203 LKLTDFGFAKETQEP-GDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred eEecccccccccCCC-ccccCCcccccccCHHHhC
Confidence 999999999975443 4556788999999999873
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=214.95 Aligned_cols=164 Identities=26% Similarity=0.405 Sum_probs=134.1
Q ss_pred eecCCCceEEEEEEEc--cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 125 KIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
.||+|+||.||++... ..+..||+|++.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~ 70 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALM 70 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeE
Confidence 3899999999988765 345679999875431 23445678999999999999999999999853 4689
Q ss_pred EEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 203 MVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++..+.....
T Consensus 71 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 99999999999887754 45799999999999999999999999999999999999999999999999999986543322
Q ss_pred ccc---cCCCccccccCcccC
Q 022241 282 VLR---RSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ~~~---~~~gt~~y~aPE~l~ 299 (300)
... ...+++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECIN 171 (257)
T ss_pred ceeccCCCCCCcccCCHHHHc
Confidence 111 122457899999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=217.62 Aligned_cols=165 Identities=28% Similarity=0.422 Sum_probs=134.6
Q ss_pred eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHH---HHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL---IMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
.||+|+||.||++.+..+++.||+|.+.+.... .........+|.. ++....||||+.+++++.. .+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~ 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKL 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccc------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeE
Confidence 489999999999999999999999998754321 1111122334443 3444579999999999975 3579
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
++||||+++++|..++...+.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.......
T Consensus 73 ~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999999999998888777789999999999999999999999999999999999999999999999999997653322
Q ss_pred ccccCCCccccccCcccC
Q 022241 282 VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ~~~~~~gt~~y~aPE~l~ 299 (300)
.....||+.|+|||.+.
T Consensus 152 -~~~~~~~~~y~aPE~~~ 168 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQ 168 (279)
T ss_pred -ccCcCCCcCccCHHHhc
Confidence 23456999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=223.43 Aligned_cols=169 Identities=27% Similarity=0.412 Sum_probs=143.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|.....||+|+||.||++.+..++..||||.+... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~ 91 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--G 91 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--C
Confidence 455567899999999999999989999999987542 23345678899999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
+..++||||++++++.+++. .+.+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 68999999999998887664 34689999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.........|++.|+|||++.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~ 191 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVIS 191 (292)
T ss_pred ccccCceeecCccccCHHHHc
Confidence 333334456899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=220.81 Aligned_cols=171 Identities=27% Similarity=0.466 Sum_probs=146.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|...+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--G 74 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--C
Confidence 4777889999999999999999899999999875431 23345678999999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++...+.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 579999999999998877654 5789999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........|+..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred cchhhhcccCcccccCHHHhCc
Confidence 4333334568999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=223.84 Aligned_cols=170 Identities=28% Similarity=0.429 Sum_probs=143.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|.....||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++..++||||+++++++.. .
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~ 90 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--G 90 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---------cchHHHHHHHHHHHHhCCCCchhhhhhheee--C
Confidence 3555568999999999999999899999999985431 1234568899999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++...+.. ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 689999999999988776543 5689999999999999999999999999999999999999999999999999876544
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........|++.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~ 191 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISR 191 (297)
T ss_pred ccccccceecCccccCHHHHcc
Confidence 3333345679999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=211.49 Aligned_cols=172 Identities=34% Similarity=0.522 Sum_probs=151.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.++..++|||++++++++.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-------KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--S 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-------CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--C
Confidence 48889999999999999999998999999999875432 23456789999999999999999999999876 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...+++|||++++++.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 58999999999999988887778899999999999999999999999999999999999999999999999999988755
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.........+++.|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~ 172 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIE 172 (254)
T ss_pred CcccccccccchhhcCHhhhc
Confidence 443334567899999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=216.83 Aligned_cols=172 Identities=30% Similarity=0.463 Sum_probs=146.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|...+.||.|++|.||++.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 36889999999999999999999999999999886431 2244567899999999999999999999987655
Q ss_pred CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
...+++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+++|+||+|.||+++.++.++|+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence 567999999999998876542 3456899999999999999999999999999999999999999999999999998
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
....... .....++..|+|||.+.
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~pE~~~ 176 (287)
T cd06621 153 GELVNSL--AGTFTGTSFYMAPERIQ 176 (287)
T ss_pred ccccccc--cccccCCccccCHHHhc
Confidence 7643322 22456888999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=221.85 Aligned_cols=168 Identities=20% Similarity=0.237 Sum_probs=130.4
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceee-eee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN-LIE 191 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~ 191 (300)
....+.|.+.+.||+|+||.||++.+.. +++.||||.+..... ..........+.+|+.+|+.++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~----~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP----WWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc----ccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 4456789999999999999999998876 678889998642210 0012234567999999999999999985 443
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC-CCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI-KPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl-kp~NIll~~~~~~kl~DF 270 (300)
+ ...|+||||++|++|... . ... ...++.|++.||.|||++||+|||| ||+|||++.++.+||+||
T Consensus 90 ~------~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 T------GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred c------CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 2 247999999999887632 1 111 1467899999999999999999999 999999999999999999
Q ss_pred cCceeecCCccc--------cccCCCccccccCccc
Q 022241 271 SVSQVFEDDNDV--------LRRSPGTPVFTAPECC 298 (300)
Q Consensus 271 Gla~~~~~~~~~--------~~~~~gt~~y~aPE~l 298 (300)
|+|+.+...... .++..+++.|+|||.+
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 999976543311 1355789999999986
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=215.76 Aligned_cols=170 Identities=24% Similarity=0.376 Sum_probs=139.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 70 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----------SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-- 70 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence 35889999999999999999876 466899998754321 22467789999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 3578999999999998887754 347899999999999999999999999999999999999999999999999999865
Q ss_pred cCCcccc-ccCCCccccccCcccCC
Q 022241 277 EDDNDVL-RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~-~~~~gt~~y~aPE~l~G 300 (300)
.+..... ....++..|+|||.+.+
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~ 175 (256)
T cd05059 151 LDDQYTSSQGTKFPVKWAPPEVFDY 175 (256)
T ss_pred ccccccccCCCCCCccccCHHHhcc
Confidence 4322111 11224457999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=215.80 Aligned_cols=179 Identities=30% Similarity=0.450 Sum_probs=147.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc-CCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+|.+.+.||+|+||.||++....+++.||+|.+.......... .......+.+..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4888899999999999999999899999999886432111000 0012234578899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||++++++.+.+...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 45799999999999999888777889999999999999999999999999999999999999999999999999998654
Q ss_pred CCcc--ccccCCCccccccCcccC
Q 022241 278 DDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......|++.|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~ 183 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIH 183 (272)
T ss_pred ccccccccccccCCccccCHHHhc
Confidence 3211 123456899999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=220.38 Aligned_cols=178 Identities=27% Similarity=0.471 Sum_probs=144.5
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++.+.||+|+||.||++....+++.||||.++.... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~ 76 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-------KEGFPITAIREIKILRQLNHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-------ccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence 345689999999999999999999999999999999865321 1122346678999999999999999999987
Q ss_pred cCC--------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 195 DPN--------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 195 ~~~--------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
+.. ...+++|+||++++.+.........+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+|
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 532 237899999998754443333445799999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCcc-ccccCCCccccccCcccC
Q 022241 267 IGDFSVSQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 267 l~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++........ ......+++.|+|||++.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhc
Confidence 999999987644332 222335678899999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=215.85 Aligned_cols=170 Identities=28% Similarity=0.478 Sum_probs=145.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
-|...+.||+|+||.||++.+..+++.||||.+.... .......+.+|+.++..++||||+++++++.+ .
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 74 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--D 74 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--C
Confidence 3778899999999999999998899999999875331 23345678899999999999999999999985 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||++++++...+.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 589999999999988877654 4689999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.........++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~ 174 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIK 174 (277)
T ss_pred chhhhccccCCccccChhhhc
Confidence 333333456899999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=226.50 Aligned_cols=169 Identities=25% Similarity=0.336 Sum_probs=141.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH--CCCCceeeeeeEEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 194 (300)
.....++++||+|.||.||++ +.+++.||||++. ....+.|.+|.+|.+. +.|+||++++++=.
T Consensus 209 l~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp------------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFP------------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehh--hccCceeEEEecC------------HHHHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 345678899999999999765 4567999999984 3456678888888765 57999999998754
Q ss_pred cCC--CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcEeCCCCCCCEEEccCC
Q 022241 195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG---------HNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 195 ~~~--~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~---------~~iiHrDlkp~NIll~~~~ 263 (300)
... ...++||+||.+.|+|.+++..+ .++|....+++..|++||+|||+ ..|+|||||..||||..++
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 321 34789999999999999998775 68999999999999999999995 2599999999999999999
Q ss_pred cEEEecccCceeecCC--ccccccCCCccccccCcccCC
Q 022241 264 TVKIGDFSVSQVFEDD--NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.|+|||||-.+... .......+||..|||||+|-|
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 9999999999887532 223334689999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=221.05 Aligned_cols=178 Identities=27% Similarity=0.454 Sum_probs=142.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.++||+|+||.||++.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-------DGFPITALREIKILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-------CCcchhHHHHHHHHHhcCCCCccchhhheec
Confidence 357899999999999999999999999999999998654211 1122356689999999999999999998764
Q ss_pred CC------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 196 PN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 196 ~~------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
.. ...+++||||+.+..+.........+++..++.++.|++.||.|||+.+|+|+||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 32 235799999998754444444455799999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCcc-----------ccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDND-----------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~-----------~~~~~~gt~~y~aPE~l~G 300 (300)
||++........ ..+...+++.|+|||++.|
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 999976533221 1122357888999998653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=214.05 Aligned_cols=170 Identities=28% Similarity=0.410 Sum_probs=148.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|...+.||+|+||.||++....+++.||+|.+... .....+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-- 69 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----------EDLQEIIKEISILKQCDSPYIVKYYGSYFK-- 69 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----------HHHHHHHHHHHHHHhCCCCcEeeeeeeeec--
Confidence 5799999999999999999999988999999987542 125688999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++++||++++++.+.+.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 3689999999999999887754 457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........|++.|+|||++.|
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 150 TDTMAKRNTVIGTPFWMAPEVIQE 173 (256)
T ss_pred ccCccccccccCCccccCHHHHhc
Confidence 554433344568999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=213.62 Aligned_cols=166 Identities=30% Similarity=0.424 Sum_probs=143.0
Q ss_pred eeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|+||.||++..... +..||+|.+.... .......+.+|+.++..++|+||+++++++.+ ...
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--------SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEP 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--------chhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCc
Confidence 4699999999999999866 8899999986542 12246788999999999999999999999986 568
Q ss_pred EEEEEEeeCCCccccccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 201 FYMVLEYVEGKWDNDGFGQP---------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+++||||++++++.+.+... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg 150 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFG 150 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccc
Confidence 99999999999999888764 789999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCc--cccccCCCccccccCcccC
Q 022241 272 VSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
++....... .......+++.|+|||.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhc
Confidence 998765432 2233456889999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=213.51 Aligned_cols=172 Identities=33% Similarity=0.497 Sum_probs=151.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|++|.||++.+..+++.||||.+.... .......+.+|+.++..++||||+++++++..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 70 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-- 70 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--
Confidence 36889999999999999999999999999999886532 11455778999999999999999999999976
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++++|.+.+.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 71 EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 36899999999999999988777889999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........++..|+|||.+.
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~ 173 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQ 173 (264)
T ss_pred ccCCCcccceeecccccCHhhhC
Confidence 55444333556899999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=219.11 Aligned_cols=174 Identities=28% Similarity=0.428 Sum_probs=140.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 196 (300)
++|.+.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-------ccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 368999999999999999999999999999998765321 1223346778999999995 69999999988753
Q ss_pred C---CCEEEEEEEeeCCCccccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEE
Q 022241 197 N---SDHFYMVLEYVEGKWDNDGFGQ-----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKI 267 (300)
Q Consensus 197 ~---~~~~~lv~E~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl 267 (300)
. ....|+||||+++ .+...+.. ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEE
Confidence 2 1247999999997 44444321 246899999999999999999999999999999999999998 889999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++..+...........+++.|+|||++.
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhh
Confidence 99999987644333333446789999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=214.45 Aligned_cols=165 Identities=30% Similarity=0.492 Sum_probs=143.6
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||.|+||.||++++..+++.||+|.+.+.... .....+.+.+|+.+++.++||||+++++++.+ ...++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 72 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLM 72 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEE
Confidence 79999999999999989999999998754321 22345679999999999999999999999875 35799999
Q ss_pred EeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccccc
Q 022241 206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285 (300)
Q Consensus 206 E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 285 (300)
||+++++|.+.+.....+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~ 151 (262)
T cd05572 73 EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT 151 (262)
T ss_pred ecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccc
Confidence 999999999988877789999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred CCCccccccCcccC
Q 022241 286 SPGTPVFTAPECCL 299 (300)
Q Consensus 286 ~~gt~~y~aPE~l~ 299 (300)
..|++.|+|||.+.
T Consensus 152 ~~~~~~~~~PE~~~ 165 (262)
T cd05572 152 FCGTPEYVAPEIIL 165 (262)
T ss_pred ccCCcCccChhHhc
Confidence 56899999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=215.45 Aligned_cols=168 Identities=25% Similarity=0.356 Sum_probs=139.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.++||+|+||.||++.+..+ ..||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-- 72 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 72 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----------cCHHHHHHHHHHHHhCCCCCcceEEEEECC--
Confidence 5799999999999999999987655 469999886432 123468899999999999999999998753
Q ss_pred CCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...++||||++++++.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 457999999999998887754 23588999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcccc-ccCCCccccccCcccC
Q 022241 276 FEDDNDVL-RRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~-~~~~gt~~y~aPE~l~ 299 (300)
+....... ....++..|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred ccccccccccCCcccceecCHhHhc
Confidence 64432211 2334667899999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=225.54 Aligned_cols=175 Identities=29% Similarity=0.488 Sum_probs=144.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|++.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.++..+ +||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-------NATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-------cchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence 44679999999999999999999998999999998854311 223345677899999999 9999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
......+++||||+++ .+...+... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 78 AENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred cCCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 6555678999999985 566555444 78899999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc-----ccccCCCccccccCcccC
Q 022241 275 VFEDDND-----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~-----~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......||+.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred ccccccccccCcchhcccccccccCceeee
Confidence 6543221 223346899999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=214.36 Aligned_cols=173 Identities=22% Similarity=0.270 Sum_probs=138.8
Q ss_pred eeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
|.+.+.||+|+||.||.+....+ +..||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 56788999999999999987653 47899998864321 344567889999999999999999999987653
Q ss_pred CC----CEEEEEEEeeCCCccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 197 NS----DHFYMVLEYVEGKWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 197 ~~----~~~~lv~E~~~~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
.. ...+++|||++++++...+. ....+++..+..++.|++.||.|||+++|+||||||+||++++++.+|
T Consensus 74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence 21 24789999999998876552 224689999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCccc--cccCCCccccccCcccC
Q 022241 267 IGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 267 l~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
|+|||+++........ .....+++.|+|||.+.
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcc
Confidence 9999999876433211 11233567899999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=219.79 Aligned_cols=174 Identities=22% Similarity=0.285 Sum_probs=142.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
..++|.+.+.||+|+||.||++... .++..||||.+.... .......+.+|+.+++.+ +||||+++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--------HSSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--------ChHHHHHHHHHHHHHHhccCCCCcceE
Confidence 3457999999999999999998752 345689999875431 233456789999999999 79999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEE
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl 267 (300)
++++.. .+..++||||+++++|..++.... .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|
T Consensus 105 ~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 105 LGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred EEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 999876 357999999999999888775432 3899999999999999999999999999999999999999999999
Q ss_pred ecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++........ ......+++.|+|||.+.
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 216 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhc
Confidence 99999986543321 112234678899999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=211.72 Aligned_cols=172 Identities=27% Similarity=0.500 Sum_probs=146.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||+|+||.||++.+..+++.+|||.+..... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-------TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--D 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-------ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--C
Confidence 48899999999999999999999999999999865422 23446778999999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~ 275 (300)
...++||||++++++.+++... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .+||+|||++..
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 5899999999999988877553 3589999999999999999999999999999999999998654 689999999987
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......|++.|+|||.+.+
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 152 LSSKS-KAYTVVGTPCYISPELCEG 175 (256)
T ss_pred cCCCc-cccccccCCcccCchhccC
Confidence 65432 2234568999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=217.89 Aligned_cols=172 Identities=31% Similarity=0.406 Sum_probs=140.9
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.+|.+.+.||+|+||.||++.... ++..+|+|.+... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---------TLAARKDFQREAELLTNLQHEHIVKFYGV 75 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---------cHHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 468899999999999999987542 4556899987532 23344578899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+.. ....++||||++++++.+++... ..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 153 (291)
T cd05094 76 CGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN 153 (291)
T ss_pred Ecc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcce
Confidence 975 45799999999999888776432 348999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
||++.++.++|+|||++........ ......+++.|+|||++.|
T Consensus 154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence 9999999999999999976533221 1223456788999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=215.55 Aligned_cols=171 Identities=23% Similarity=0.355 Sum_probs=142.2
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.+|++.+.||+|+||.||++....+|+ .||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--------SPKANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 568999999999999999999876665 58999775431 234556788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++||||++++++.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 79 LS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred ec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 75 578999999999999887765 34699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccc--cCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLR--RSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~--~~~gt~~y~aPE~l~ 299 (300)
+........... ...+++.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESIL 184 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhh
Confidence 987643322111 122456799999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=223.17 Aligned_cols=173 Identities=29% Similarity=0.478 Sum_probs=141.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+|+.||||.+.... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--------HQTFCQRTLREIKILRRFKHENIIGILDIIRPP 75 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--------cchhHHHHHHHHHHHHhCCCCCcCchhheeecc
Confidence 357999999999999999999999999999999875321 223455678899999999999999999987642
Q ss_pred C---CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 197 N---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 197 ~---~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ...+++|+||+++ .+...+ ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 76 SFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred cccccceEEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 2 2468999999986 444444 3357999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc---ccccCCCccccccCcccC
Q 022241 274 QVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
........ ......||+.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhh
Confidence 87543221 122346899999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=217.10 Aligned_cols=166 Identities=27% Similarity=0.435 Sum_probs=140.1
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|+||.||++.+..+|+.||+|.+.+.... .......+..|+.+|+.++||||+++++++.. .+.+++||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 72 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK------KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVM 72 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh------hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEE
Confidence 69999999999999999999999998754221 12234456789999999999999999999975 45899999
Q ss_pred EeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccc
Q 022241 206 EYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 206 E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||+++++|.+.+.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++...... ...
T Consensus 73 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~ 151 (277)
T cd05577 73 TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKI 151 (277)
T ss_pred ecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccc
Confidence 9999999987776544 7999999999999999999999999999999999999999999999999998765432 222
Q ss_pred ccCCCccccccCcccCC
Q 022241 284 RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~G 300 (300)
....++..|+|||++.|
T Consensus 152 ~~~~~~~~y~~PE~~~~ 168 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG 168 (277)
T ss_pred ccccCCCCcCCHHHhcC
Confidence 34568889999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=216.90 Aligned_cols=173 Identities=28% Similarity=0.422 Sum_probs=145.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 195 (300)
.+.|++.+.||+|+||.||++.+..+++.||+|.+... ......+..|+.++..+ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35799999999999999999999999999999987542 23345678899999888 69999999999853
Q ss_pred C----CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 196 P----NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 196 ~----~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
. ....++++|||++++++.+++.. ...+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 2 24578999999999988877754 34588999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++..............|++.|+|||.+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcC
Confidence 999886543333334567999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=214.61 Aligned_cols=172 Identities=31% Similarity=0.398 Sum_probs=141.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
..|.+.+.||+|+||.||++....+++ .||||.+... ........+..|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 468899999999999999999887664 5999987542 13445678999999999999999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ....++||||++++++..++.. .+.+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 76 K--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred C--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccc
Confidence 5 4578999999999998877754 456899999999999999999999999999999999999999999999999998
Q ss_pred eeecCCccc--cc-cCC--CccccccCcccC
Q 022241 274 QVFEDDNDV--LR-RSP--GTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~--~~-~~~--gt~~y~aPE~l~ 299 (300)
......... .. ... .+..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhc
Confidence 765432211 11 111 245799999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=220.38 Aligned_cols=173 Identities=21% Similarity=0.356 Sum_probs=139.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVN 188 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 188 (300)
.++|.+.+.||+|+||.||++++.. ....||+|.+.... .......+..|+.+++.+ +||||++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--------TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3579999999999999999998642 34579999875431 234456788999999999 6999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI 252 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl 252 (300)
+++++.+ ...++++|||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||
T Consensus 83 ~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 160 (314)
T cd05099 83 LLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160 (314)
T ss_pred EEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 9999875 3578999999999988776643 235889999999999999999999999999999
Q ss_pred CCCCEEEccCCcEEEecccCceeecCCccc--cccCCCccccccCcccC
Q 022241 253 KPDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 253 kp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
||+|||++.++.+||+|||+++........ .....+++.|+|||++.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence 999999999999999999999865432211 12223456799999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=214.19 Aligned_cols=169 Identities=24% Similarity=0.360 Sum_probs=139.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++... .+..+|||.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 70 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-- 70 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc----------ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46999999999999999998765 34469999875432 123568899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+.++++.+++.. ...+++..++.++.||+.||+|||+.+++|+||||+|||++.++.+||+|||+++..
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 3468999999999988887755 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCccc-cccCCCccccccCcccC
Q 022241 277 EDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
...... .....++..|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 151 LDDEYTSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred CCCceeecCCCccChhhCCHHHHh
Confidence 433221 11223567799999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=220.25 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=139.8
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.+|.+.+.||+|+||.||++.... .+..||||.+.... .......+..|+.++..++||||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 358888999999999999998754 35789999986431 22345678899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+.+. ...++++||++++.+..++.. ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 77 ~~~~--~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcCC--CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 9763 468999999998877766531 2358888999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||++.++.+||+|||+++....... ......+++.|+|||.+.
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05091 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM 199 (283)
T ss_pred eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence 9999999999999999886533221 122345678999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=214.37 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=140.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.|++.++||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----------MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----------CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 357999999999999999999865 67889999886432 223578899999999999999999998753
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
..++++|||+.++++.+.+.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 468999999999998877643 3468999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc-ccccCCCccccccCcccC
Q 022241 275 VFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......+++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhc
Confidence 7653222 112334667899999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=216.75 Aligned_cols=172 Identities=30% Similarity=0.396 Sum_probs=140.7
Q ss_pred cceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.+|...++||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---------CHHHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 46888999999999999998643 35668999987532 34456689999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCE
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP---------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL 257 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NI 257 (300)
+.+ ....+++|||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ni 153 (280)
T cd05092 76 CTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNC 153 (280)
T ss_pred Eec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhE
Confidence 876 35789999999999888766433 3488999999999999999999999999999999999
Q ss_pred EEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 258 LVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 258 ll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
|++.++.+||+|||++........ ......+++.|+|||++.|
T Consensus 154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 999999999999999976533221 1122345788999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=214.76 Aligned_cols=160 Identities=21% Similarity=0.263 Sum_probs=134.5
Q ss_pred eeecCCCceEEEEEEEccCC----------ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
+.||+|+||.||++....++ ..+++|.+... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD----------HRDSLAFFETASLMSQLSHKHLVKLYGVC 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc----------hhhHHHHHHHHHHHHcCCCcchhheeeEE
Confidence 46999999999999988766 34777766432 11256788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-------cE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------TV 265 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-------~~ 265 (300)
.. ...++||||+++++|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 71 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~ 147 (259)
T cd05037 71 VR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147 (259)
T ss_pred ec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeE
Confidence 75 35789999999999998886655 799999999999999999999999999999999999999887 79
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||++..... .....+++.|+|||++.+
T Consensus 148 kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 148 KLSDPGIPITVLS----REERVERIPWIAPECIRN 178 (259)
T ss_pred EeCCCCccccccc----ccccccCCCccChhhhcC
Confidence 9999999986543 223457788999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=213.24 Aligned_cols=166 Identities=27% Similarity=0.433 Sum_probs=138.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..+|.+.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+|++++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 35799999999999999998765 4888999987432 2245688999999999999999999986543
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....+++|||++++++.+++.... .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 72 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred -CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 357899999999999888775433 48899999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...... ....++..|+|||++.
T Consensus 151 ~~~~~~---~~~~~~~~y~aPE~~~ 172 (256)
T cd05082 151 EASSTQ---DTGKLPVKWTAPEALR 172 (256)
T ss_pred eccccC---CCCccceeecCHHHHc
Confidence 653322 2344567899999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=217.44 Aligned_cols=171 Identities=29% Similarity=0.475 Sum_probs=146.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++....++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~- 87 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---------QQPKKELIINEILVMRENKHPNIVNYLDSYLV- 87 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---------cchHHHHHHHHHHHHhhcCCCCeeehhheeee-
Confidence 36799999999999999999998889999999987532 12234678899999999999999999999976
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....|+|+||++++++.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++...
T Consensus 88 -~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 88 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred -CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 3579999999999998887754 35889999999999999999999999999999999999999999999999998766
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........|++.|+|||++.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~ 188 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVT 188 (293)
T ss_pred cccccccccccCChhhcCchhhc
Confidence 54433334456899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=223.68 Aligned_cols=174 Identities=28% Similarity=0.487 Sum_probs=145.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC-
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP- 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 196 (300)
++|.+.+.||+|+||.||++....+++.||+|.+..... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-------cccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 579999999999999999999999999999998864321 123455677899999999999999999987642
Q ss_pred -CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 -NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 -~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....+++||||+.+ .+...+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 78 ADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCCceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 23578999999975 6777776677799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc----ccccCCCccccccCcccC
Q 022241 276 FEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
...... ......|+..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLL 184 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhc
Confidence 543221 122446899999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=215.04 Aligned_cols=166 Identities=22% Similarity=0.269 Sum_probs=133.1
Q ss_pred eeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
+.||+|+||.||++.... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPY 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCc
Confidence 368999999999987543 45679999875431 22334578889999999999999999999875 3468
Q ss_pred EEEEEeeCCCccccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 202 YMVLEYVEGKWDNDGFGQ-----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
++||||++++++.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++...
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence 999999999998877643 224667788899999999999999999999999999999999999999999999754
Q ss_pred cCCccc--cccCCCccccccCcccC
Q 022241 277 EDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
...... .....+++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhc
Confidence 332211 12345788899999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=217.64 Aligned_cols=171 Identities=22% Similarity=0.331 Sum_probs=138.2
Q ss_pred ceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
+|++.+.||+|+||.||++.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--------SSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 47888999999999999998753 23578998875431 233456788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ------------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVH 249 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 249 (300)
.. ....+++|||+.++++.+++.. ...+++..+..++.|++.||+|||+.+|+|
T Consensus 73 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH 150 (290)
T cd05045 73 SQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVH 150 (290)
T ss_pred ec--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence 75 3578999999999888765432 235789999999999999999999999999
Q ss_pred CCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 250 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|||||+|||++.++.+||+|||++........ ......++..|+|||++.
T Consensus 151 ~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred hhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 99999999999999999999999986533222 112334677899999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=212.25 Aligned_cols=165 Identities=25% Similarity=0.393 Sum_probs=137.8
Q ss_pred eeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|+||.||++.....+ ..||+|.+..... ......+.+|+.+++.+.|||||++++++.. ..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 69 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EP 69 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cc
Confidence 46999999999999876544 7899998865422 1345678899999999999999999998763 46
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
+++||||++++++.+++.....+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||++.......
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 89999999999999888777789999999999999999999999999999999999999999999999999998764433
Q ss_pred ccccc---CCCccccccCcccC
Q 022241 281 DVLRR---SPGTPVFTAPECCL 299 (300)
Q Consensus 281 ~~~~~---~~gt~~y~aPE~l~ 299 (300)
..... ..++..|+|||++.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECIN 171 (257)
T ss_pred cccccccCccccccccCHHHhc
Confidence 22211 22356799999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=212.80 Aligned_cols=172 Identities=30% Similarity=0.504 Sum_probs=147.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||.|+||.||++....++..+|+|.+..... ......+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 70 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-- 70 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--------chHHHHHHHHHHHHHhcCCCCEEEEEEEEee--
Confidence 368999999999999999999888999999998864321 2255678999999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....++||||++++++.+.+... ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++.
T Consensus 71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 45899999999999988877543 468999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccc----cccCCCccccccCcccC
Q 022241 275 VFEDDNDV----LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~----~~~~~gt~~y~aPE~l~ 299 (300)
.+...... .....|++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHc
Confidence 76543322 13346899999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=219.33 Aligned_cols=172 Identities=26% Similarity=0.388 Sum_probs=140.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|+..+.||+|+||.||++.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--------GPKANVEFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 468899999999999999999887776 46888765321 233345688999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++++||+++|.+.+.+... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 79 LS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred cC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence 74 2467999999999888877554 3689999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccc--cccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDV--LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~--~~~~~gt~~y~aPE~l~G 300 (300)
+......... .....++..|+|||++.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhcc
Confidence 9876433221 122345778999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=211.62 Aligned_cols=165 Identities=28% Similarity=0.419 Sum_probs=141.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++... |+.||||.+... ......+.+|+.+++.++|+||+++++++.+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 71 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD----------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-- 71 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccc----------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence 46889999999999999988764 889999988543 1145678999999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||++++++.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 457899999999999988876554 699999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..... ....++..|+|||++.
T Consensus 152 ~~~~~---~~~~~~~~~~ape~~~ 172 (256)
T cd05039 152 ASQGQ---DSGKLPVKWTAPEALR 172 (256)
T ss_pred ccccc---ccCCCcccccCchhhc
Confidence 63222 1234566799999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=214.93 Aligned_cols=172 Identities=23% Similarity=0.345 Sum_probs=142.3
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|+.++.||.|+||.||+++.+. +.+.||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--------DENLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--------chHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 468999999999999999999764 34678999774321 22355678999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~ 263 (300)
+.+ ....++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR 154 (275)
T ss_pred ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC
Confidence 875 357899999999999988776544 689999999999999999999999999999999999999999
Q ss_pred cEEEecccCceeecCCc-cccccCCCccccccCcccC
Q 022241 264 TVKIGDFSVSQVFEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
.++|+|||++....... .......+++.|+|||.+.
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhc
Confidence 99999999987543221 1222345677899999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=215.16 Aligned_cols=165 Identities=21% Similarity=0.295 Sum_probs=130.7
Q ss_pred eeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~ 70 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPY 70 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCce
Confidence 368999999999986432 34568888764321 23345678899999999999999999999875 4579
Q ss_pred EEEEEeeCCCccccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 202 YMVLEYVEGKWDNDGFGQP-----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccc
Confidence 9999999999998876443 23567888999999999999999999999999999999999999999999998753
Q ss_pred cCCcc--ccccCCCccccccCccc
Q 022241 277 EDDND--VLRRSPGTPVFTAPECC 298 (300)
Q Consensus 277 ~~~~~--~~~~~~gt~~y~aPE~l 298 (300)
..... ......+++.|+|||++
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELV 174 (269)
T ss_pred ccchheeccCCCCCcccccCHHHH
Confidence 22211 11223466789999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=215.65 Aligned_cols=160 Identities=21% Similarity=0.263 Sum_probs=129.7
Q ss_pred eecCCCceEEEEEEEccC------------------------CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH
Q 022241 125 KIGAGSYGKVVLYRSSLD------------------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 180 (300)
+||+|+||.||++....+ ...||+|.+... .......+.+|+.+++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~ 72 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ 72 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence 699999999998875321 235888887543 12334568889999999
Q ss_pred CCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE
Q 022241 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259 (300)
Q Consensus 181 l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll 259 (300)
++||||+++++++.+ ....++||||++++++...+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 73 l~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill 150 (274)
T cd05076 73 VSHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL 150 (274)
T ss_pred CCCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence 999999999999986 3578999999999998877754 4578999999999999999999999999999999999999
Q ss_pred ccCC-------cEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 260 APSG-------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 260 ~~~~-------~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..+ .+|++|||++...... ....+++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVP 193 (274)
T ss_pred eccCcccCccceeeecCCccccccccc----cccccCCcccCchhhc
Confidence 7644 4899999998654222 2235788899999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=217.42 Aligned_cols=172 Identities=28% Similarity=0.361 Sum_probs=138.3
Q ss_pred cceeEeeeecCCCceEEEEEEEcc----------------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL----------------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 181 (300)
++|++.+.||+|+||.||++.... ++..||+|.+.... .......+.+|+.+++.+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHhC
Confidence 469999999999999999886432 34568999875431 234556889999999999
Q ss_pred CCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeC
Q 022241 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-----------GAIGESMARKYLRDIVSGLMYLHGHNVVHG 250 (300)
Q Consensus 182 ~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHr 250 (300)
+||||+++++++.. ....++||||++++++..++... ..+++..+..++.|++.||+|||+.+++||
T Consensus 77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 77 KDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred CCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999999976 35789999999998887765432 246788899999999999999999999999
Q ss_pred CCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 251 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||||+|||++.++.++|+|||++..+..... ...+..+++.|+|||++.
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 9999999999999999999999986533221 112233467899999754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=212.23 Aligned_cols=173 Identities=25% Similarity=0.383 Sum_probs=144.6
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
..+++.+.+..||.|++|.|++++.+.+|...|||++.+.. +....++++..+.++... ++|+||+.+|+|
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--------Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--------NKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 34567778889999999999999999999999999987653 455667778888776655 499999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
... ..+++.||.|..-....+..-.++++|..+-++...++.||.||.+ ++|+|||+||+|||+|+.|++||+|||+
T Consensus 161 i~n--~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 161 ITN--TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eeC--chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 863 4689999998754333333456689999999999999999999996 6899999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCccc
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+..+.+.... +...|.+.|||||.|
T Consensus 239 sGrlvdSkAh-trsAGC~~YMaPERi 263 (391)
T KOG0983|consen 239 SGRLVDSKAH-TRSAGCAAYMAPERI 263 (391)
T ss_pred cceeeccccc-ccccCCccccCcccc
Confidence 9988665433 456799999999976
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=214.38 Aligned_cols=169 Identities=29% Similarity=0.477 Sum_probs=137.7
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNS 198 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 198 (300)
|++.+.||+|+||.||++.+..+++.||+|.+.+... .... ....+|+.++..+. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-------~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-------SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-------Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence 6788999999999999999999999999998865321 1111 23457888888885 9999999999987544
Q ss_pred CEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
+.+++||||++++ +.+.+. ....+++..+..++.|++.||+|||+.+++||||+|+||+++. +.+||+|||++....
T Consensus 73 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 73 GRLALVFELMDMN-LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred CcEEEEEecCCcc-HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 6899999999864 444443 3457899999999999999999999999999999999999998 999999999998764
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... ......+++.|+|||++.
T Consensus 151 ~~~-~~~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 151 SKP-PYTEYISTRWYRAPECLL 171 (282)
T ss_pred cCC-CcCCCCCCcccCChhHhh
Confidence 332 223456889999999753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=220.26 Aligned_cols=173 Identities=20% Similarity=0.341 Sum_probs=139.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccC-------CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD-------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
.+|.+.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--------TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--------CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4699999999999999999986432 2368999875421 234566889999999999 79999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK 253 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk 253 (300)
++++.. ...++++|||+++++|.+++... ..+++..+..++.|++.||+|||+++|+|||||
T Consensus 84 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 84 LGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 999975 35789999999999888766432 247888899999999999999999999999999
Q ss_pred CCCEEEccCCcEEEecccCceeecCCccc--cccCCCccccccCcccCC
Q 022241 254 PDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 254 p~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~G 300 (300)
|+|||++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 99999999999999999999865432211 122234567999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=216.55 Aligned_cols=171 Identities=25% Similarity=0.331 Sum_probs=137.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
++|++.+.||+|+||.||++..+.++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--------ASENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--------CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 579999999999999999998877665 4688876532 1233456788999999999 7999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEE
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL 258 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIl 258 (300)
. ....++||||++++++.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 151 (297)
T cd05089 74 N--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151 (297)
T ss_pred c--CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEE
Confidence 5 35789999999999887766432 35889999999999999999999999999999999999
Q ss_pred EccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 259 VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 259 l~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++.++.+||+|||++....... .......+..|+|||++.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 191 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLN 191 (297)
T ss_pred ECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhc
Confidence 9999999999999986432111 111122345799999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=216.22 Aligned_cols=170 Identities=28% Similarity=0.452 Sum_probs=147.3
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--------NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--N 71 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--------ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--C
Confidence 5788899999999999999999999999999886532 22455678899999999999999999999876 3
Q ss_pred CEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..+++++||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 6899999999999998887665 789999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ....+++.|+|||++.|
T Consensus 152 ~~~~~--~~~~~~~~y~~PE~~~~ 173 (265)
T cd06605 152 VNSLA--KTFVGTSSYMAPERIQG 173 (265)
T ss_pred HHHHh--hcccCChhccCHHHHcC
Confidence 33221 22678999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=214.69 Aligned_cols=173 Identities=25% Similarity=0.290 Sum_probs=140.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|.+.+.||+|+||.||++.... .+..||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--------SEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3579999999999999999999887 67889999875321 2334567889999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG- 263 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~- 263 (300)
++.+. ...++||||+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus 77 ~~~~~--~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 77 VSFER--LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred EEccC--CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC
Confidence 88763 4678999999999988766433 2589999999999999999999999999999999999998765
Q ss_pred --cEEEecccCceeecCCccc--cccCCCccccccCcccC
Q 022241 264 --TVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 264 --~~kl~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~ 299 (300)
.+||+|||+++........ ......++.|+|||++.
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence 6999999999865322211 11223456799999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=212.90 Aligned_cols=169 Identities=24% Similarity=0.393 Sum_probs=139.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++... .+..||+|.+..... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----------SPESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----------CHHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 357999999999999999999766 566799998865321 22468899999999999999999998853
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++|||++++++.+++.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+|||++.
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 357899999999998887754 3458999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcccc-ccCCCccccccCcccC
Q 022241 275 VFEDDNDVL-RRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~-~~~~gt~~y~aPE~l~ 299 (300)
.+....... ....++..|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred eccCcccccccCCCCCccccChHHHh
Confidence 764432211 1233566799999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=214.64 Aligned_cols=169 Identities=28% Similarity=0.463 Sum_probs=137.5
Q ss_pred eEeeeecCCCceEEEEEEEc----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 121 VHVRKIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.+.||.|.||.||.+... ..+..|+||.++.. ........+.+|+..+.+++||||+++++++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~- 72 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE- 72 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--------cccccceeeeecccccccccccccccccccccc-
Confidence 45689999999999999888 35678999998432 134457889999999999999999999999984
Q ss_pred CCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||+++++|++|+|+|||++.++.+||+|||++.
T Consensus 73 -~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 73 -NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp -SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34699999999999999888665 679999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc--cccccCCCccccccCcccC
Q 022241 275 VFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
...... .......+...|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~ 178 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLK 178 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHH
T ss_pred ccccccccccccccccccccccccccc
Confidence 762211 1223345778899999863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=212.80 Aligned_cols=173 Identities=30% Similarity=0.533 Sum_probs=143.7
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|.+.+.||+|+||.||++....+++.||+|.+.... ........+.+|+.+++.++|||++++++++.+....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence 678899999999999999999899999999987642 1223345678899999999999999999999864336
Q ss_pred EEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++||||+++ ++...+... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 89999999986 555555443 5799999999999999999999999999999999999999999999999999987654
Q ss_pred Ccc-ccccCCCccccccCcccCC
Q 022241 279 DND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
... ......+++.|+|||.+.|
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred CCcccccccccccccCCceeeEc
Confidence 331 1233457889999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=220.18 Aligned_cols=172 Identities=26% Similarity=0.464 Sum_probs=142.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||++.+..++..||||.+.... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 4567999999999999999999999999999999885421 123344568899999999999999999999875
Q ss_pred CCC----CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~~----~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
... ..+++||||+ ++++...+. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 321 2468999999 455655544 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++...... .....+++.|+|||++.
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~ 188 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPEVIL 188 (343)
T ss_pred cccccccC---ccccccCCcccCHHHHh
Confidence 99865332 23346889999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=215.34 Aligned_cols=174 Identities=30% Similarity=0.512 Sum_probs=149.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 196 (300)
++|.+.+.||+|+||.||++....+++.||+|++.+.... .......+..|+.++..+. ||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-
Confidence 3699999999999999999999999999999998764321 2334467889999999999 9999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++.+.+.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 74 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 74 -EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred -CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 4589999999999999988888778999999999999999999999999999999999999999999999999998865
Q ss_pred cCCc--------------------cccccCCCccccccCcccC
Q 022241 277 EDDN--------------------DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~--------------------~~~~~~~gt~~y~aPE~l~ 299 (300)
.... .......+++.|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 195 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence 4322 1112345789999999764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=215.07 Aligned_cols=171 Identities=32% Similarity=0.570 Sum_probs=142.0
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|++.+.||.|++|.||++.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+ ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-------DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--EN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-------cccchhHHHHHHHHHHhcCCCCccCHhheecc--CC
Confidence 5678899999999999999999999999999865321 12233467789999999999999999999975 46
Q ss_pred EEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..+++|||++ +.+...+.... .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 8999999996 46666665444 68999999999999999999999999999999999999999999999999997654
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+++.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLG 173 (283)
T ss_pred CCccccCccccccCCCCCceeec
Confidence 33323333457899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=210.86 Aligned_cols=171 Identities=26% Similarity=0.350 Sum_probs=142.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++... ++..||||.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE- 72 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----------cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-
Confidence 357999999999999999999876 55789999886432 223568899999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....++||||++++++.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.
T Consensus 73 -~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 73 -EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred -CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 35789999999999988877554 368999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc-ccccCCCccccccCcccCC
Q 022241 275 VFEDDND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
....... ......++..|+|||.+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~ 178 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANY 178 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhcc
Confidence 7643221 1112234568999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=211.17 Aligned_cols=172 Identities=28% Similarity=0.388 Sum_probs=141.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|+..+.||+|+||.||+++...++. .+|||.+.... .......+..|+.+++.++||||+++.+++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--------TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 468889999999999999999876554 79999875431 2334567889999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ .+..++||||+++++|..++.. .+.+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 77 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 77 K--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred c--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence 5 3578999999999999887754 357899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccc---cCCCccccccCcccC
Q 022241 274 QVFEDDNDVLR---RSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~---~~~gt~~y~aPE~l~ 299 (300)
........... ....++.|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhh
Confidence 87643221111 112345799999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=213.21 Aligned_cols=174 Identities=28% Similarity=0.473 Sum_probs=143.9
Q ss_pred cceeEeeeecCCCceEEEEEEEcc----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..|.+.+.||+|+||.||+++... ++..||||.+..... ......+.+|+.+++.+.||||+++++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 357888999999999999998653 478999999864321 13456899999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
........++||||++++++.+++.... .+++..+..++.|++.||+|||+++++|+||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 8755668999999999999988876544 699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccc---cccCCCccccccCcccC
Q 022241 273 SQVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
+......... .....++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHc
Confidence 9876532211 11223556799999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=210.81 Aligned_cols=165 Identities=32% Similarity=0.554 Sum_probs=137.2
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHH-HHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
+.||+|+||.||+|.+..+++.||||.+.+.... .......+..|..+ ....+|||++++++++.. .+.+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 73 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI------AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLY 73 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh------HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEE
Confidence 5799999999999999999999999998654221 11222334455444 445689999999999975 46899
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
+||||+++++|..++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 74 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999999998887777899999999999999999999999999999999999999999999999999886433
Q ss_pred cccCCCccccccCcccCC
Q 022241 283 LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~~~~~gt~~y~aPE~l~G 300 (300)
.....|++.|+|||.+.|
T Consensus 150 ~~~~~~~~~y~~pe~~~~ 167 (260)
T cd05611 150 NKKFVGTPDYLAPETILG 167 (260)
T ss_pred cccCCCCcCccChhhhcC
Confidence 233468899999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-31 Score=217.90 Aligned_cols=179 Identities=28% Similarity=0.498 Sum_probs=142.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.....|.-+.+||+|.||.||+|+.+.+|+.||+|++--... .+..-..-.+|+.+|..|.|+|++.+++.|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-------KeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-------ccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 344568888999999999999999999999999987633211 1222234568999999999999999998775
Q ss_pred cC------CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 195 DP------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 195 ~~------~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
.. ....+|+||.+|+......+-.....++..++++++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+
T Consensus 87 tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred hccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 31 224589999999875433322334679999999999999999999999999999999999999999999999
Q ss_pred cccCceeecCCcc----ccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDND----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~G 300 (300)
|||+++.+..... ..+..+-|.+|.+||.|+|
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 9999977643322 1233456999999999998
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=213.42 Aligned_cols=170 Identities=28% Similarity=0.425 Sum_probs=144.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|...+.||+|++|.||++.+..+++.||+|.+... .....+.+.+|+.+++.+.||||+++++++.. .
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~ 88 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--G 88 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---------chhHHHHHHHHHHHHHHcCCCChheEEEEEEc--C
Confidence 455668999999999999999889999999987532 22334568899999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
+..++++||++++++.+.+.. ..+++..+..++.|++.||+|||+++|+||||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 578999999999999887766 5789999999999999999999999999999999999999999999999998876544
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........|++.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~ 189 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISR 189 (285)
T ss_pred CCcccccccCCccccCHHHhcC
Confidence 3333334568999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=208.28 Aligned_cols=172 Identities=34% Similarity=0.632 Sum_probs=149.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+.+++.++|||++++.+.+.. .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-------SEKEREDALNEVKILKKLNHPNIIKYYESFEE--K 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-------ChHHHHHHHHHHHHHHhcCCCChhheEEEEec--C
Confidence 48899999999999999999998999999999865321 23455678899999999999999999999886 3
Q ss_pred CEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...++|+||++++++...+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~ 151 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK 151 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCcccee
Confidence 689999999999988877754 3679999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.............|++.|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~ 176 (258)
T cd08215 152 VLSSTVDLAKTVVGTPYYLSPELCQ 176 (258)
T ss_pred ecccCcceecceeeeecccChhHhc
Confidence 7655443444567899999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=212.80 Aligned_cols=174 Identities=18% Similarity=0.193 Sum_probs=143.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.++|.+.+.||+|+||.||.+.+.. .+..||+|.+... ........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 76 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--------ASEIQVTLLLQESCLLYGLSHQNILPILHV 76 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3579999999999999999998876 3578999987532 134456778999999999999999999998
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP--------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~--------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
+... ....++++||++++++..++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.
T Consensus 77 ~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 77 CIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred EecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence 7753 45789999999988888766432 46899999999999999999999999999999999999999999
Q ss_pred EEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 265 VKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+||+|||+++.+..... ......++..|+|||++.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 192 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence 99999999986533221 112234677899999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=209.55 Aligned_cols=169 Identities=28% Similarity=0.395 Sum_probs=142.3
Q ss_pred eEeeeecCCCceEEEEEEEccCC----ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
++.+.||.|+||.||++.....+ ..||+|.+.... .......+..|+.++..++||||+++++++.+.
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 46689999999999999998766 899999985431 222567889999999999999999999999863
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++|||++++++.+.+..... +++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus 74 --~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 74 --EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred --CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCce
Confidence 589999999999999888765444 9999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccc-cCCCccccccCcccC
Q 022241 275 VFEDDNDVLR-RSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~-~~~gt~~y~aPE~l~ 299 (300)
.......... ...+++.|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~ 177 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLK 177 (258)
T ss_pred ecccccccccccCCCcccccChHHhc
Confidence 7654322111 233778999999763
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=210.62 Aligned_cols=172 Identities=27% Similarity=0.571 Sum_probs=145.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++....+|..||+|.+..... .......+.+|+.+++.++||||+++++.+.+ .
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-------PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--N 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-------cchhhHHHHHHHHHHHhCCCCChhhhhheecc--C
Confidence 48899999999999999999999999999999865422 12234567899999999999999999999875 4
Q ss_pred CEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~ 275 (300)
...++|+||++++++.+.+.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||.+..
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence 58999999999999887765432 579999999999999999999999999999999999999886 569999999987
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
............|++.|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 152 LNDSMELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred ccCCcccccccCCCccccCHHHHc
Confidence 655443334456899999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=211.29 Aligned_cols=161 Identities=20% Similarity=0.251 Sum_probs=130.6
Q ss_pred eeecCCCceEEEEEEEccC------------CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 124 RKIGAGSYGKVVLYRSSLD------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
+.||+|+||.||++..... ...||+|.+... .......+..|+.++..++||||+++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~l~~l~hp~iv~~~~ 71 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---------HRDISLAFFETASMMRQVSHKHIVLLYG 71 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---------hhhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4689999999999874322 235888876432 2234457888999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc------
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT------ 264 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~------ 264 (300)
++.+. ...++||||++++.+..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 72 ~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 72 VCVRD--VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEecC--CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCc
Confidence 98863 467899999999988777654 456899999999999999999999999999999999999987664
Q ss_pred -EEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 265 -VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 -~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++++|||++...... ....+++.|+|||++.
T Consensus 150 ~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 150 FIKLSDPGIPITVLSR----QECVERIPWIAPECVE 181 (262)
T ss_pred eeEeCCCCCCccccCc----ccccccccccChhhhc
Confidence 899999998764322 2345888999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=219.15 Aligned_cols=180 Identities=26% Similarity=0.390 Sum_probs=142.8
Q ss_pred cceeE-eeeecCCCceEEEEEEEccCCceEEEEEeecccccccc-----cCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 118 NEYVH-VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-----VAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 118 ~~y~~-~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
++|.. .+.||+|+||.||++.+..+++.||||.+......... ..........+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 47799999999999999999999999998654322100 0000011225778999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
++.. ....++||||+.+ .+...+.....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9875 4589999999985 667767666789999999999999999999999999999999999999999999999999
Q ss_pred CceeecCC--------------ccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDD--------------NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~--------------~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... ........+++.|+|||++.|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 99875411 111223357889999998754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=214.91 Aligned_cols=172 Identities=25% Similarity=0.345 Sum_probs=140.4
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|++.+.||+|+||.||++.... ++..||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--------CHHHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 579999999999999999998753 57889999875431 23445678899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHG 250 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHr 250 (300)
+.+ ....++||||++++++.+++... ..+++..++.++.|++.||.|||+++++||
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~ 154 (288)
T cd05050 77 CAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154 (288)
T ss_pred EcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 875 45789999999998887666421 247888899999999999999999999999
Q ss_pred CCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 251 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||||+|||++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 9999999999999999999999886533221 112233567799999764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=219.44 Aligned_cols=174 Identities=29% Similarity=0.497 Sum_probs=146.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC-
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN- 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 197 (300)
+|.+.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 48899999999999999999998899999998865321 1334567889999999999999999999987632
Q ss_pred --CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 --SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 --~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||||+++ .+...+.....+++..++.++.|++.||+|||+.||+||||||.|||++.++.++|+|||++..
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 74 EDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred ccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 2368999999985 5666666666899999999999999999999999999999999999999999999999999998
Q ss_pred ecCCc---cccccCCCccccccCcccCC
Q 022241 276 FEDDN---DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~---~~~~~~~gt~~y~aPE~l~G 300 (300)
..... .......+|+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLS 180 (330)
T ss_pred ecccccccccccccccccCcCCceeeec
Confidence 65543 12344568999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=214.32 Aligned_cols=161 Identities=20% Similarity=0.220 Sum_probs=133.1
Q ss_pred eeecCCCceEEEEEEEccCCc-------eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 124 RKIGAGSYGKVVLYRSSLDGK-------HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+.||+|+||.||++.....+. .||+|.+... .....+.+..|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 71 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG 71 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence 469999999999998765443 4888876432 223456788999999999999999999999863
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc--------EEE
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--------VKI 267 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~--------~kl 267 (300)
...++||||+++++|..++...+ .+++..+..++.||+.||+|||+++|+||||||+|||++.++. +++
T Consensus 72 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 72 --DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred --CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 46899999999999988876544 5899999999999999999999999999999999999987764 699
Q ss_pred ecccCceeecCCccccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++..... .....+++.|+|||++.
T Consensus 150 ~d~g~~~~~~~----~~~~~~~~~y~aPE~~~ 177 (258)
T cd05078 150 SDPGISITVLP----KEILLERIPWVPPECIE 177 (258)
T ss_pred cccccccccCC----chhccccCCccCchhcc
Confidence 99999875432 22356889999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=209.24 Aligned_cols=168 Identities=24% Similarity=0.344 Sum_probs=137.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++....+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 72 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-- 72 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 4699999999999999999987644 469999875421 123567889999999999999999998853
Q ss_pred CCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+++|||++++++.+++... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 4578999999999888777543 3588999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccc-cccCCCccccccCcccC
Q 022241 276 FEDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
....... .....++..|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhc
Confidence 6433221 12234667899999764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=214.97 Aligned_cols=169 Identities=29% Similarity=0.446 Sum_probs=141.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|...+.||+|+||.||++++..++..||+|.+..... ........+.+|+.+++.++|||++++++++.+ .
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK------QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 47788999999999999999998999999998864321 123445678899999999999999999999986 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||+++..+.........+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+||+|||++.....
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 57899999998644333334456799999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.....|++.|+|||++.
T Consensus 178 ----~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred ----cccccCCccccChhhhh
Confidence 23456899999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=205.82 Aligned_cols=174 Identities=35% Similarity=0.525 Sum_probs=151.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|...+.||+|++|.||++....+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-------SEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 47888999999999999999998999999999865421 23556789999999999999999999999986433
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..+++++||++++++.+.+.....+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 68999999999999998887777899999999999999999999999999999999999999999999999999988655
Q ss_pred Ccc--ccccCCCccccccCcccC
Q 022241 279 DND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
... ......++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred ccccccccCCCCCccccCHhhhc
Confidence 432 134467899999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=209.98 Aligned_cols=171 Identities=26% Similarity=0.348 Sum_probs=140.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|.+.+.||+|+||.||++..... ...||||...... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--------SPSVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--------CHHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4688999999999999999987543 3468999875331 2345568899999999999999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ...++||||++++++.+++.... .+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||++
T Consensus 78 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 78 E---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred C---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 4 35789999999999988876533 5899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccc-cccCCCccccccCcccC
Q 022241 274 QVFEDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
......... .....+++.|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred eecccccceecCCCCccccccChhhhc
Confidence 876443221 11223456799999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=216.88 Aligned_cols=173 Identities=26% Similarity=0.413 Sum_probs=140.6
Q ss_pred ceeEeeeecCCCceEEEEEEEccC--CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLD--GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 195 (300)
+|.+.+.||+|+||.||++.+..+ +..||||.+..... .......+.+|+.+++.+ .||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-------KKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-------cchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 488899999999999999999887 88999998754211 222345678899999998 59999999987542
Q ss_pred C--CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 P--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~--~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ....+|+++||+++ .|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 74 FPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred ccccCCcEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 1 23467899999874 56666666778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc----ccccCCCccccccCcccC
Q 022241 274 QVFEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
..+..... ......||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHh
Confidence 87543221 122346899999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=218.14 Aligned_cols=172 Identities=25% Similarity=0.440 Sum_probs=140.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+++.||||.+.+... .......+.+|+.++..++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45789999999999999999999998999999998864311 22234567889999999999999999998864
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ....+++++++ ++++...+.. ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 21 23478888887 4556554433 468999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++...... .....+|+.|+|||.+.
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 166 LARHTDDE---MTGYVATRWYRAPEIML 190 (345)
T ss_pred cccccccc---ccccccCCCccCHHHHh
Confidence 99864322 23456899999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=236.05 Aligned_cols=173 Identities=31% Similarity=0.452 Sum_probs=143.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
..+.+..+.||+|+||+||+++... +...||||.++.. .+.+...+|.+|+.+|..++|||||+++|
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--------a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--------AENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--------ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 4566778999999999999988653 3468999998754 24557889999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCE
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL 257 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NI 257 (300)
+|.. ++.+++|+|||..|+|.+++.. +.+|+..+...|+.|||.|+.||-++..|||||-.+|.
T Consensus 557 VC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 9985 5789999999999998887732 23488899999999999999999999999999999999
Q ss_pred EEccCCcEEEecccCceee-cCCccccc-cCCCccccccCcccC
Q 022241 258 LVAPSGTVKIGDFSVSQVF-EDDNDVLR-RSPGTPVFTAPECCL 299 (300)
Q Consensus 258 ll~~~~~~kl~DFGla~~~-~~~~~~~~-~~~gt~~y~aPE~l~ 299 (300)
||.++-.|||+||||++.. ..+..... ...--..|||||.++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL 678 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence 9999999999999999853 22222211 222346799999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=216.52 Aligned_cols=168 Identities=29% Similarity=0.413 Sum_probs=138.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH--HCCCCceeeeeeEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK--MLQHPNIVNLIEVI 193 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~ 193 (300)
...+.++.+.||+|.||.| +++.+.|+.||||+|... ....|.+|.+|.+ .|+|+||+.+++.=
T Consensus 209 iarqI~L~e~IGkGRyGEV--wrG~wrGe~VAVKiF~sr------------dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEV--WRGRWRGEDVAVKIFSSR------------DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhheeEEEEEecCccccce--eeccccCCceEEEEeccc------------chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 3456889999999999999 566777999999999533 2346777777775 57999999999763
Q ss_pred Ec--CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeCCCCCCCEEEccCC
Q 022241 194 DD--PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG--------HNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 194 ~~--~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~--------~~iiHrDlkp~NIll~~~~ 263 (300)
.. ..-.++|||++|-+.|+|++++.. ..++.....+++..+|.||++||- ..|.|||||..|||+..++
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 22 123479999999999999999987 589999999999999999999993 2499999999999999999
Q ss_pred cEEEecccCceeecCCcc----ccccCCCccccccCccc
Q 022241 264 TVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECC 298 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l 298 (300)
.+-|+|+|||........ .....+||..|||||+|
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvL 392 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVL 392 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHh
Confidence 999999999988755432 22345799999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=210.41 Aligned_cols=165 Identities=22% Similarity=0.316 Sum_probs=130.7
Q ss_pred eecCCCceEEEEEEEccCC--ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEE
Q 022241 125 KIGAGSYGKVVLYRSSLDG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 202 (300)
.||+|+||.||++.....+ ..+++|.+... ........+.+|+.+++.++||||+++++.+.+ ....+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~ 71 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN--------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYL 71 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC--------CChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccE
Confidence 5999999999998754322 34566655432 123445689999999999999999999999985 35789
Q ss_pred EEEEeeCCCccccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 203 MVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
+||||+++++|..++... ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.....
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 999999999988776542 3467778889999999999999999999999999999999999999999999864322
Q ss_pred Cc--cccccCCCccccccCcccC
Q 022241 279 DN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
.. .......+++.|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVG 174 (268)
T ss_pred chhhhcccCCcCcccccCchhcc
Confidence 11 1123456889999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=207.31 Aligned_cols=169 Identities=24% Similarity=0.359 Sum_probs=140.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.++||+|+||.||++... .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 467999999999999999999755 5567999987532 2234678899999999999999999999875
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++|||++++++.+++.. ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 73 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 468999999999998887754 3457888999999999999999999999999999999999999999999999998
Q ss_pred eecCCcccc-ccCCCccccccCcccC
Q 022241 275 VFEDDNDVL-RRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~-~~~~gt~~y~aPE~l~ 299 (300)
......... ....++..|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhc
Confidence 764432211 1233567799999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=206.17 Aligned_cols=165 Identities=27% Similarity=0.354 Sum_probs=135.0
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|+||.||++... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 69 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYI 69 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEE
Confidence 36899999999999865 68889999875431 23334578899999999999999999999975 357899
Q ss_pred EEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 204 VLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
||||++++++.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.........
T Consensus 70 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 70 VMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred EEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 9999999998877654 346899999999999999999999999999999999999999999999999999764332111
Q ss_pred c-ccCCCccccccCcccC
Q 022241 283 L-RRSPGTPVFTAPECCL 299 (300)
Q Consensus 283 ~-~~~~gt~~y~aPE~l~ 299 (300)
. ....+++.|+|||++.
T Consensus 150 ~~~~~~~~~~y~aPE~~~ 167 (250)
T cd05085 150 SSGLKQIPIKWTAPEALN 167 (250)
T ss_pred cCCCCCCcccccCHHHhc
Confidence 1 1223467799999865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=209.52 Aligned_cols=165 Identities=25% Similarity=0.348 Sum_probs=131.9
Q ss_pred eeecCCCceEEEEEEEccCCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|+||.||+++...++. .+|+|.+.... .......+.+|+.++..+ +||||+++++++.. ...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~ 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCC
Confidence 368999999999999887775 46888765321 234456788999999999 79999999999976 357
Q ss_pred EEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 201 FYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~ 150 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 150 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe
Confidence 89999999999887766432 24789999999999999999999999999999999999999999
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+||+|||++....... .......++.|+|||++.
T Consensus 151 ~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 151 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN 184 (270)
T ss_pred EEECCCCCccccchhh-hccCCCCccccCChHHHc
Confidence 9999999986422111 111123456799999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=222.06 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=140.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
-..|+++++||+||.+.||++... +.+.||+|.+... ..+...+..+.+|+.+|.+|+ |.+||++++|-..
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 456999999999999999999876 4456777766432 336778889999999999996 9999999999775
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+.+||||||-+. .|...+.+.. .++...++.|+.||+.|++++|+.||||.||||+|+|+. .|.+||+|||+|.
T Consensus 432 --d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 432 --DGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred --CceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence 5699999998654 4455555544 344458899999999999999999999999999999998 8999999999999
Q ss_pred eecCCc--cccccCCCccccccCcccC
Q 022241 275 VFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
.+..+. ....+.+||+.|||||.|.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~ 534 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALT 534 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHh
Confidence 875443 2344678999999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=211.73 Aligned_cols=175 Identities=29% Similarity=0.444 Sum_probs=144.9
Q ss_pred ceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
+|.+.+.||+|+||.||+++.. .+++.||||.+.+.... ........+.+|+.++..+ +||||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-----hhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 4788999999999999998864 36789999998754221 1223445688999999999 5999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ....++||||++++++...+.....+++..++.++.|++.||.|||+.+++||||+|.||+++.++.++|+|||++.
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 76 T--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred c--CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 5 45789999999999998888777789999999999999999999999999999999999999999999999999987
Q ss_pred eecCCcc-ccccCCCccccccCcccCC
Q 022241 275 VFEDDND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
....... ......|++.|+|||.+.|
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred ccccccccccccccCCccccCHHHhcC
Confidence 6543321 1223468999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=211.27 Aligned_cols=173 Identities=32% Similarity=0.486 Sum_probs=150.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.|...+.||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK----------QNKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc----------hhHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 4456889999999999999999999889999999986431 145678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ...++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 87 G--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred C--CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 3 68999999999999998887766 89999999999999999999999999999999999999999999999999987
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............+++.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~ 190 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKR 190 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcC
Confidence 65444333344568899999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=208.04 Aligned_cols=165 Identities=29% Similarity=0.410 Sum_probs=137.9
Q ss_pred eeecCCCceEEEEEEEcc-CCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|++|.||++.+.. .++ .||||.+..... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 69 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HP 69 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---Ce
Confidence 468999999999998765 333 689998865422 1456789999999999999999999999875 57
Q ss_pred EEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 201 FYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
.++||||++++++...+... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|||++..+..
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence 89999999999988877554 3689999999999999999999999999999999999999999999999999987644
Q ss_pred Ccc---ccccCCCccccccCcccC
Q 022241 279 DND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
... ......++..|+|||++.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~ 173 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLR 173 (257)
T ss_pred cccceecccCCCCCceecCHHHhc
Confidence 221 112345788999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=208.75 Aligned_cols=163 Identities=22% Similarity=0.394 Sum_probs=134.7
Q ss_pred cceeEeeee--cCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEE
Q 022241 118 NEYVHVRKI--GAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~i--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~ 194 (300)
++|.+.+.+ |+|+||.||++..+.++..+|+|.+...... . .|+..... .+||||+++++.+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------~--~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------------A--IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------------h--hhHHHHHHhhcCCCEEEEEEEEe
Confidence 356666655 9999999999999999999999998654221 0 12222222 27999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla 273 (300)
.. +.+++||||+++++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++
T Consensus 80 ~~--~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 80 TL--KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred cC--CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 63 48999999999999998887777899999999999999999999999999999999999999998 9999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ....|++.|+|||++.+
T Consensus 158 ~~~~~~----~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 158 KIIGTP----SCYDGTLDYFSPEKIKG 180 (267)
T ss_pred eecCCC----ccCCCCCcccChhhhcC
Confidence 875432 23468999999998753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=210.03 Aligned_cols=166 Identities=34% Similarity=0.567 Sum_probs=141.4
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||.|+||.||++.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++.+.. ....+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 72 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI------RKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVM 72 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh------hhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEE
Confidence 68999999999999989999999998654221 23456678899999999999999999998875 46899999
Q ss_pred EeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc----
Q 022241 206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---- 281 (300)
Q Consensus 206 E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 281 (300)
||++++++.+.+...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 73 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 73 EYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999999988887767899999999999999999999999999999999999999999999999999876433211
Q ss_pred ----ccccCCCccccccCcccC
Q 022241 282 ----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ----~~~~~~gt~~y~aPE~l~ 299 (300)
......+++.|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred cccccccCcccCccccCHHHhc
Confidence 223346888999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=205.89 Aligned_cols=169 Identities=26% Similarity=0.403 Sum_probs=140.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|++.+.||+|+||.||++... ++..+|+|.+..... ....+..|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 70 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----------SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-- 70 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----------CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--
Confidence 46899999999999999999775 477899998754321 23467889999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||+++++|.+++.. .+.+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 3578999999999998887754 356899999999999999999999999999999999999999999999999999865
Q ss_pred cCCccc-cccCCCccccccCcccC
Q 022241 277 EDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
...... .....++..|+|||.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFS 174 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhc
Confidence 432211 11223567899999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=211.67 Aligned_cols=168 Identities=29% Similarity=0.441 Sum_probs=140.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|...+.||+|+||.||++++..+++.||+|.+..... ........+.+|+.+++.++|||++++++++.+ ..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK------QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EH 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc------CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CC
Confidence 6667889999999999999999999999999864321 133445678899999999999999999999986 45
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
..|+||||+.+..+........++++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 7999999997654333334456799999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccCCCccccccCcccC
Q 022241 280 NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 280 ~~~~~~~~gt~~y~aPE~l~ 299 (300)
.....|++.|+|||++.
T Consensus 174 ---~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred ---CCCccccccccChhhcc
Confidence 23456899999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=203.61 Aligned_cols=170 Identities=31% Similarity=0.497 Sum_probs=147.9
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|...+.||+|++|.||++....+++.|++|.+.... ......+.+|+.+++.++|||++++++++.. .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 69 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---------KEKKEKIINEIQILKKCKHPNIVKYYGSYLK--K 69 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--C
Confidence 4788899999999999999999899999999986532 1355688899999999999999999999876 3
Q ss_pred CEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...++++||++++++.+.+... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 70 ~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 5799999999999988877665 679999999999999999999999999999999999999999999999999998765
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... .....++..|+|||.+.+
T Consensus 150 ~~~~-~~~~~~~~~~~~PE~~~~ 171 (253)
T cd05122 150 DTKA-RNTMVGTPYWMAPEVING 171 (253)
T ss_pred cccc-ccceecCCcccCHHHHcC
Confidence 4332 345678999999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=207.91 Aligned_cols=171 Identities=29% Similarity=0.507 Sum_probs=146.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+..|+.+++.++||||+++.+++.+ .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-------SQKEREDAVNEIRILASVNHPNIISYKEAFLD--G 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--C
Confidence 48899999999999999999999999999999865432 23345677889999999999999999999875 3
Q ss_pred CEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...++||||++++++...+.. ...+++..++.++.|++.||+|||+.|++|+||+|.||+++.++.+||+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~ 151 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK 151 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchh
Confidence 689999999999988776644 3568999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......+++.|+|||.+.+
T Consensus 152 ~~~~~--~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 152 VLKKN--MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred hhccC--CcccccCCccccCHHHHCC
Confidence 76544 2334568899999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=207.65 Aligned_cols=167 Identities=22% Similarity=0.245 Sum_probs=133.6
Q ss_pred eeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
+.||+|+||.||++.... ....||+|.+... ........+..|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 71 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGS 71 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCC
Confidence 468999999999998653 3457999987432 1234566788999999999999999999987643 346
Q ss_pred EEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 201 FYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
.++||||+.++++..++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 78999999999998887553 35677888899999999999999999999999999999999999999999999765332
Q ss_pred cc----ccccCCCccccccCcccC
Q 022241 280 ND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 280 ~~----~~~~~~gt~~y~aPE~l~ 299 (300)
.. ......+++.|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred cceeecccccCcCCccccChhHhc
Confidence 11 112334677899999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=207.10 Aligned_cols=163 Identities=25% Similarity=0.374 Sum_probs=136.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 70 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----------VTAQAFLEETAVMTKLHHKNLVRLLGVILH-- 70 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC--
Confidence 569999999999999998764 57889999987532 123578899999999999999999999864
Q ss_pred CCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+..++||||++++++...+... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++..
T Consensus 71 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred -CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 3479999999999988877543 3588999999999999999999999999999999999999999999999999976
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......+..|+|||.+.
T Consensus 150 ~~~~---~~~~~~~~~y~~pe~~~ 170 (254)
T cd05083 150 GSMG---VDNSKLPVKWTAPEALK 170 (254)
T ss_pred cccc---CCCCCCCceecCHHHhc
Confidence 4322 12233456799999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=212.41 Aligned_cols=168 Identities=28% Similarity=0.390 Sum_probs=142.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|....+||+|+||.||++....+++.||||.+... .......+.+|+.+++.++||||+++++++.. .+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 90 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GD 90 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---------chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CC
Confidence 33446899999999999999999999999987432 23345678899999999999999999999985 46
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
..++||||++++++.+.+. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 91 ELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 8999999999998887654 346899999999999999999999999999999999999999999999999998766443
Q ss_pred ccccccCCCccccccCcccC
Q 022241 280 NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 280 ~~~~~~~~gt~~y~aPE~l~ 299 (300)
........|++.|+|||.+.
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~ 189 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELIS 189 (292)
T ss_pred cccccccccCccccCHHHhc
Confidence 33334456899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=213.19 Aligned_cols=171 Identities=29% Similarity=0.499 Sum_probs=141.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||.|+||.||++.+..+++.||||.+.+... .......+..|+.++..++||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-------TPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 35689999999999999999999999999999998864321 22334567789999999999999999999875
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
. ...++++|||+++ ++...+. ...+++..+..++.|++.||.|||+.+|+||||+|+|||++.++.++|+|||++..
T Consensus 81 ~-~~~~~lv~e~~~~-~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 81 P-LEDIYFVTELLGT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred C-CCcEEEEeehhcc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 3 3578999999964 5555443 34688999999999999999999999999999999999999999999999999986
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... ......+++.|+|||.+.
T Consensus 158 ~~~---~~~~~~~~~~y~aPE~~~ 178 (328)
T cd07856 158 QDP---QMTGYVSTRYYRAPEIML 178 (328)
T ss_pred cCC---CcCCCcccccccCceeee
Confidence 432 123346788999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=231.93 Aligned_cols=170 Identities=28% Similarity=0.487 Sum_probs=153.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.++..+|+|++|.||+++++.+++..|+|+++... .....-+..|+-+++..+|||||.+++.+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---------~dd~~~iqqei~~~~dc~h~nivay~gsylr- 83 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---------GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR- 83 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---------CccccccccceeeeecCCCcChHHHHhhhhh-
Confidence 357999999999999999999999999999999987542 2234456789999999999999999998864
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|++||||.+|+|.+...--+++++..+....+..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+
T Consensus 84 -~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 84 -RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred -hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence 4679999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccCCCccccccCcc
Q 022241 277 EDDNDVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~ 297 (300)
...-.....+.|||.|||||+
T Consensus 163 tati~KrksfiGtpywmapEv 183 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEV 183 (829)
T ss_pred hhhhhhhhcccCCccccchhH
Confidence 666666778899999999997
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=201.14 Aligned_cols=173 Identities=23% Similarity=0.297 Sum_probs=144.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc-
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD- 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 195 (300)
-++|++.++||.|||+.||++++..++..||+|.+... +....+..++|+...++++|||+++++++...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 36799999999999999999999999999999998764 34567788999999999999999999886543
Q ss_pred --CCCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcEEE
Q 022241 196 --PNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 196 --~~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~kl 267 (300)
......||+++|...|++.+.+.. ..-+++..+.+|+.+|++||++||+.. +.||||||.|||+.+.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 133568999999999988776633 336999999999999999999999988 999999999999999999999
Q ss_pred ecccCceeecC---Ccc------ccccCCCccccccCccc
Q 022241 268 GDFSVSQVFED---DND------VLRRSPGTPVFTAPECC 298 (300)
Q Consensus 268 ~DFGla~~~~~---~~~------~~~~~~gt~~y~aPE~l 298 (300)
.|||.+....- ... .+.....|..|.|||.+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf 210 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELF 210 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence 99999875421 111 11223478999999986
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=204.76 Aligned_cols=166 Identities=27% Similarity=0.312 Sum_probs=136.9
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
++||+|+||.||++.+.. ++.||+|.+.... .......+.+|+.+++.++||||+++++++.+ ....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 69 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL--------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYI 69 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEE
Confidence 479999999999999887 9999999876432 12345678999999999999999999999875 357899
Q ss_pred EEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc
Q 022241 204 VLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 282 (300)
||||++++++..++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++.........
T Consensus 70 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 70 VMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 9999999988877744 446899999999999999999999999999999999999999999999999999865422111
Q ss_pred c--ccCCCccccccCcccCC
Q 022241 283 L--RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 283 ~--~~~~gt~~y~aPE~l~G 300 (300)
. ....++..|+|||.+.|
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~ 169 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNY 169 (251)
T ss_pred eccccCcceeccCChHhhcc
Confidence 1 11234567999998753
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=206.40 Aligned_cols=179 Identities=26% Similarity=0.455 Sum_probs=145.1
Q ss_pred ceeEeeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccc-cCCChHHHHHHHHHHHHHHH-CCCCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 195 (300)
.|++.+.||+|+||.||++.... .++.+|+|.+......... ..........+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999887 6789999988654322110 01233455667888888865 799999999999975
Q ss_pred CCCCEEEEEEEeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.+..+++|||++++++.+.+ .....+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 46899999999998887665 234579999999999999999999996 78999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++....... ......|++.|+|||++.+
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcC
Confidence 9998765433 3345678999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=204.36 Aligned_cols=167 Identities=33% Similarity=0.564 Sum_probs=144.8
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|+||.||.+....+++.||+|.+.+.... .......+..|+.+++.++||||+++++.+.. ....++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVL 72 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc------chHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEE
Confidence 69999999999999888999999998765321 23356678899999999999999999999875 46899999
Q ss_pred EeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcccccc
Q 022241 206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285 (300)
Q Consensus 206 E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 285 (300)
||++++++.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus 73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 73 EYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 99999999988877778999999999999999999999999999999999999999999999999999876544333445
Q ss_pred CCCccccccCcccCC
Q 022241 286 SPGTPVFTAPECCLG 300 (300)
Q Consensus 286 ~~gt~~y~aPE~l~G 300 (300)
..++..|+|||.+.+
T Consensus 153 ~~~~~~~~~Pe~~~~ 167 (250)
T cd05123 153 FCGTPEYLAPEVLLG 167 (250)
T ss_pred CcCCccccChHHhCC
Confidence 678999999998653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=209.55 Aligned_cols=171 Identities=32% Similarity=0.557 Sum_probs=142.8
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|...+.||+|++|.||++.+..+++.+|+|.+..... .......+..|+.+++.++||||+++++++.+ ..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-------SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-------cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CC
Confidence 5677899999999999999998999999998865422 22345678889999999999999999999875 36
Q ss_pred EEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
.+++||||+++ .+...+.. ...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||.+.....
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 89999999986 44444433 46899999999999999999999999999999999999999999999999999987655
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........++..|+|||.+.+
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLG 172 (283)
T ss_pred CcccccCccCcccccCcHHHhc
Confidence 4323334568889999998753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-30 Score=212.49 Aligned_cols=174 Identities=26% Similarity=0.459 Sum_probs=145.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+.+-.+.||-|+||.||.+.+..+|+.||+|.+..-.. +-...+.+.+|+.+|...+|.|++..++..+-++-
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-------~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-------NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-------HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 44556899999999999999999999999998754321 23456788999999999999999999887764432
Q ss_pred C---EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 D---HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~---~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+ .+|+++|+|.. .|...+.+.+.++...++-+++||++||+|||+.+|+||||||.|.|++.|..+||+|||||+.
T Consensus 127 dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence 2 35788898864 5667778888999999999999999999999999999999999999999999999999999997
Q ss_pred ecCC-ccccccCCCccccccCcccCC
Q 022241 276 FEDD-NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~-~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+.+ ...++..+-|..|.|||+|+|
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhc
Confidence 6533 234455567899999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=210.48 Aligned_cols=179 Identities=20% Similarity=0.262 Sum_probs=127.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHH------HHHHHHHHHHHHHCCCCcee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETA------MTDVRREVLIMKMLQHPNIV 187 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv 187 (300)
.++|.+.++||+|+||.||++....+ +..+|+|........ .. .+.. ......+...+..+.|+||+
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~---~~-~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IV-METLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc---hh-hHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 35799999999999999999998876 667787764322110 00 0000 11223344456677899999
Q ss_pred eeeeEEEcCCC--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 188 NLIEVIDDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 188 ~~~~~~~~~~~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
++++.+..... ...+++||++... +...+......++..+..++.|++.||+|||+.+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVEN-TKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccC-HHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99987654322 1346777776542 33333334456788899999999999999999999999999999999999999
Q ss_pred EEecccCceeecCCc-------cccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDN-------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~G 300 (300)
+|+|||+|+.+.... .......||+.|+|||++.|
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 999999998764321 11123469999999998754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=213.58 Aligned_cols=170 Identities=26% Similarity=0.470 Sum_probs=139.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|...+.||+|+||.||++.+..+|+.||||.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-------SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-------cccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence 3579999999999999999999998999999998864321 122345678999999999999999999998643
Q ss_pred C----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 197 N----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 197 ~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
. ...+++|+||+.. .+.... ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 2 1357999999975 333332 23689999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+...... .....+|+.|+|||++.
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~ 187 (342)
T cd07879 164 ARHADAE---MTGYVVTRWYRAPEVIL 187 (342)
T ss_pred CcCCCCC---CCCceeeecccChhhhc
Confidence 8764321 23346889999999875
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=211.05 Aligned_cols=170 Identities=29% Similarity=0.468 Sum_probs=141.2
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|...+.||+|+||.||++++..+++.||+|.+..... ........+.+|+.+++.++|||++++++++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 86 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-- 86 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc------cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--
Confidence 457788999999999999999999999999998864211 123445678899999999999999999999886
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++||||+.+..+.........+++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 35789999999864333333345568999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccCCCccccccCcccC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.. ....|++.|+|||++.
T Consensus 167 ~~----~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 167 PA----NXFVGTPYWMAPEVIL 184 (308)
T ss_pred Cc----ccccCCccccCHHHHh
Confidence 32 2356889999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=209.30 Aligned_cols=171 Identities=22% Similarity=0.323 Sum_probs=138.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 196 (300)
++|...+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.++.++. ||||+++++++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--------DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--------ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 35677789999999999999999999999999886432 1234567889999999986 99999999998763
Q ss_pred CCCEEEEEEEeeCCCc--ccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 197 NSDHFYMVLEYVEGKW--DNDGF--GQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~--l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
...+++|||+.... +...+ .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 76 --~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 76 --GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred --CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 47889999987532 11111 234679999999999999999999997 599999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++....... ......||+.|+|||++.
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 180 (288)
T cd06616 154 ISGQLVDSI-AKTRDAGCRPYMAPERID 180 (288)
T ss_pred hhHHhccCC-ccccccCccCccCHHHhc
Confidence 997654332 223446899999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=206.15 Aligned_cols=173 Identities=22% Similarity=0.281 Sum_probs=136.4
Q ss_pred eeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
|.+.+.||+|+||.||++..+. +++.||||.+..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 5677899999999999998654 578899998864321 334566788999999999999999999988643
Q ss_pred CC----CEEEEEEEeeCCCccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 197 NS----DHFYMVLEYVEGKWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 197 ~~----~~~~lv~E~~~~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
.. ...++++||+.++++..++. ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEE
Confidence 21 13478899999888765442 123588999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 267 IGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 267 l~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++........ ......+++.|++||.+.
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA 188 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHh
Confidence 999999986543221 112334567899999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=225.62 Aligned_cols=171 Identities=33% Similarity=0.434 Sum_probs=147.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
....+.+.||.|.||.|+..+.+..| ..||||.++.. -.+.+...|+.|+.||.+.+||||++|.|+..
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--------ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--------YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--------ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 34567789999999999999888766 47999998643 25667789999999999999999999999987
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ...+.||+|||++|+|+.+++.+ +.|++.+...+++.|+.|++||-++++|||||...|||++.+-.+|++||||+
T Consensus 701 k--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 701 K--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred c--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 4 56899999999999999998664 57999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCc-cccccCCCc--cccccCccc
Q 022241 274 QVFEDDN-DVLRRSPGT--PVFTAPECC 298 (300)
Q Consensus 274 ~~~~~~~-~~~~~~~gt--~~y~aPE~l 298 (300)
+.++++. ...++..|. ..|.|||.+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAI 806 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAI 806 (996)
T ss_pred eecccCCCccccccCCccceeecChhHh
Confidence 9987655 333444454 459999976
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=213.28 Aligned_cols=168 Identities=20% Similarity=0.323 Sum_probs=135.5
Q ss_pred eeecCC--CceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G--~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
..||+| +||.||++++..+|+.||||++..... .....+.+.+|+.+++.++||||++++++|.. ....
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCce
Confidence 456776 999999999999999999999864321 23445788999999999999999999999986 4578
Q ss_pred EEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCC
Q 022241 202 YMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 279 (300)
++||||+.++++...+... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+.+......
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 9999999998888776543 35899999999999999999999999999999999999999999999999865432211
Q ss_pred ccc-------cccCCCccccccCcccCC
Q 022241 280 NDV-------LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 280 ~~~-------~~~~~gt~~y~aPE~l~G 300 (300)
... .....++..|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred CccccccccccccccCccCccChhhhcC
Confidence 111 011235667999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=213.98 Aligned_cols=171 Identities=30% Similarity=0.501 Sum_probs=138.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||.|+||.||++.++.+++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---------CchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 57999999999999999999999999999999885432 234467889999999999999999998765422
Q ss_pred C------------CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCc
Q 022241 198 S------------DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGT 264 (300)
Q Consensus 198 ~------------~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~ 264 (300)
. ...++||||+++ ++...+. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence 1 357899999985 5555443 346899999999999999999999999999999999999974 557
Q ss_pred EEEecccCceeecCCcc---ccccCCCccccccCcccC
Q 022241 265 VKIGDFSVSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
+||+|||++........ ......+++.|+|||++.
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHh
Confidence 89999999986532211 112345788999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=208.58 Aligned_cols=173 Identities=26% Similarity=0.402 Sum_probs=138.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
..++|.+.+.||+|+||.||++.+..+++.||||.+.+.. .......+..|+.++..+. ||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--------NKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--------ChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 3467999999999999999999999889999999986532 1223345666776666664 999999999998
Q ss_pred cCCCCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ....+++|||+++. +.... .....+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.+||+|||+
T Consensus 85 ~--~~~~~~v~e~~~~~-l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 85 T--DSDVFICMELMSTC-LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred c--CCeEEEEeeccCcC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 6 45799999998753 33333 224579999999999999999999997 6999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..+..... .....+++.|+|||++.+
T Consensus 162 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 188 (296)
T cd06618 162 SGRLVDSKA-KTRSAGCAAYMAPERIDP 188 (296)
T ss_pred chhccCCCc-ccCCCCCccccCHhhcCC
Confidence 986543322 233458889999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=206.07 Aligned_cols=168 Identities=33% Similarity=0.499 Sum_probs=139.3
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNS 198 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 198 (300)
|.+.+.||+|+||.||++....+++.||||.+..... ........+|+..+..++ ||||+++++++.+ .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~ 70 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--------SWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--N 70 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--------chhHHHHHHHHHHHHhccCCCCchhHHHHhhc--C
Confidence 6778999999999999999988899999998764321 112223457889999999 9999999999876 4
Q ss_pred CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...++||||+ ++++.+.+... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 71 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 71 DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 6899999999 56666666544 37899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.... ......++..|+|||++.
T Consensus 150 ~~~~-~~~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 150 RSRP-PYTDYVSTRWYRAPEILL 171 (283)
T ss_pred cCCC-CcCCCCCcccccCceeee
Confidence 4332 223456889999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=214.04 Aligned_cols=173 Identities=24% Similarity=0.436 Sum_probs=142.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-------SAIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 345789999999999999999999999999999998754311 2234456778999999999999999998776
Q ss_pred cCC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
... ...+++|+||++ +++.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 85 PASSLEDFQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccccccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence 422 124899999985 456655544 57999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|++...... .....+|+.|+|||.+.
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~ 188 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIML 188 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHh
Confidence 999865332 33456889999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=207.37 Aligned_cols=170 Identities=29% Similarity=0.533 Sum_probs=143.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|+..+.||+|+||.||+++...+++.||+|.+..... .......+..|+.+++.++||||+++++++.+. .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-------EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--R 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--C
Confidence 5677899999999999999999999999999875421 223345677899999999999999999998763 6
Q ss_pred EEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++||||+++ ++.+.+... ..+++..+..++.|++.||+|||+++|+||||+|+||+++.++.++|+|||++.....
T Consensus 72 ~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 72 KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred ceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 89999999985 676666554 5799999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCccccccCcccC
Q 022241 279 DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.........+++.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~ 171 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILL 171 (282)
T ss_pred CccccCccccCcCcCChHHhc
Confidence 433334455788899999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=193.29 Aligned_cols=171 Identities=25% Similarity=0.412 Sum_probs=139.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~ 196 (300)
+...-+..||+|++|.|-++++..+|+..|+|.+.-.. ..+...++++|+.+.. ...+|.+|.+||.+.+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--------n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--------NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--------ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 44556678999999999999999999999999886432 3455667788887654 45799999999987753
Q ss_pred CCCEEEEEEEeeCCCccc---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 197 NSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
..+||.||.|..+... ..+...+.++|..+-+|+..++.||.|||++ .|||||+||+||||+..|+||++|||+
T Consensus 118 --gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 118 --GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred --ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 4799999999854321 3345677899999999999999999999975 799999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..+.++-.. +-..|...|||||.+-
T Consensus 196 sG~L~dSiAk-t~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 196 SGYLVDSIAK-TMDAGCKPYMAPERIN 221 (282)
T ss_pred ceeehhhhHH-HHhcCCCccCChhhcC
Confidence 9988664322 2256889999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=231.39 Aligned_cols=173 Identities=27% Similarity=0.391 Sum_probs=143.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC-Cc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD-GK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
....++.+.||+|+||.||.+..... |. .||||.+.+. .+......|.+|..+|+.++|||||+++|
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--------~~~~~~~~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--------SSEQEVSDFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--------CCHHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence 45677889999999999999887653 32 4899987653 25678889999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
++.+ ....+|++|||.+|.|..+++.. ..++......++.|||+|+.||++++.|||||..+|+||+....
T Consensus 763 v~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 763 VCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred eecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc
Confidence 9987 45789999999999999988664 35888899999999999999999999999999999999999999
Q ss_pred EEEecccCceeecCCccccccCCCc--cccccCcccC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGT--PVFTAPECCL 299 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt--~~y~aPE~l~ 299 (300)
|||+|||+|+.+-..........+. ..|||||.|+
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHh
Confidence 9999999999432222222222233 3599999875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=204.32 Aligned_cols=174 Identities=24% Similarity=0.481 Sum_probs=141.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|.+.+.||+|+||.||++.+...+..+++|.++....... .......+..|+.+++.++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL----NPNETVQANQEAQLLSKLDHPAIVKFHASFLER-- 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc----CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--
Confidence 48889999999999999999988777788887654322111 122334566789999999999999999998753
Q ss_pred CEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...++||||++++++...+. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++ ++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~ 153 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSR 153 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCcee
Confidence 46899999999998876553 345799999999999999999999999999999999999998 4679999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.............|++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHc
Confidence 7654444444567899999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=205.19 Aligned_cols=166 Identities=25% Similarity=0.343 Sum_probs=133.8
Q ss_pred eeecCCCceEEEEEEEccCC------ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 124 RKIGAGSYGKVVLYRSSLDG------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.||+|+||.||++...... ..||||.+.+.. .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 70 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-- 70 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--
Confidence 36899999999999876433 679999875431 12345678899999999999999999999875
Q ss_pred CCEEEEEEEeeCCCccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-----cE
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TV 265 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-----~~ 265 (300)
....++||||++++++..++.. ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .+
T Consensus 71 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcce
Confidence 3578999999999998877642 23478899999999999999999999999999999999999887 89
Q ss_pred EEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 266 KIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 266 kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+|+|||++........ ......++..|+|||++.
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 9999999976533211 112234678899999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=208.39 Aligned_cols=161 Identities=19% Similarity=0.284 Sum_probs=132.8
Q ss_pred CceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeC
Q 022241 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE 209 (300)
Q Consensus 130 ~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~ 209 (300)
++|.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.+ ....+++|||++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~ 82 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMA 82 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-------chhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccC
Confidence 445566688888999999999865421 33456789999999999999999999999985 457999999999
Q ss_pred CCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc------
Q 022241 210 GKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND------ 281 (300)
Q Consensus 210 ~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------ 281 (300)
++++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.+..+.....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9998887754 34689999999999999999999999999999999999999999999999999876533221
Q ss_pred -ccccCCCccccccCcccC
Q 022241 282 -VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 -~~~~~~gt~~y~aPE~l~ 299 (300)
......++..|+|||++.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred cccccccccccccCHHHhc
Confidence 122345778899999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-29 Score=207.31 Aligned_cols=170 Identities=25% Similarity=0.345 Sum_probs=138.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHH-HHHCCCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~ 196 (300)
++.+.+..||.|+||+|++..++.+|+..|||.++... .+....+++.|... +++-+.||||++||++..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--------~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~- 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--------IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS- 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--------chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-
Confidence 45666788999999999999999999999999987542 35566778888765 556679999999998765
Q ss_pred CCCEEEEEEEeeCCCccccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 197 NSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.+..||.||+|+-+....+ ......++|....+|+..++.||.||-+ ..|||||+||+||||+..|.+||+|||
T Consensus 135 -EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 135 -EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred -CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 3469999999985432211 1345679999999999999999999995 579999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCccc
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
++..+.++-. .+.-.|...|||||.+
T Consensus 214 IcGqLv~SiA-kT~daGCrpYmAPERi 239 (361)
T KOG1006|consen 214 ICGQLVDSIA-KTVDAGCRPYMAPERI 239 (361)
T ss_pred chHhHHHHHH-hhhccCCccccChhcc
Confidence 9987755432 2345699999999976
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=217.66 Aligned_cols=171 Identities=29% Similarity=0.366 Sum_probs=139.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+...+.++||+|-||.|.++.-. .+..||||+++.. ........|.+|+++|.+|+|||||.++|+|..
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~--------a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-- 606 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD--------ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-- 606 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc--------cchhHHHHHHHHHHHHhccCCCCeeEEEeeeec--
Confidence 45677899999999999988755 3689999998653 244556889999999999999999999999985
Q ss_pred CCEEEEEEEeeCCCccccccCCCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
++.+.+|+|||++|.|..++..... +.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 4689999999999999988866532 23444567999999999999999999999999999999999999999999985
Q ss_pred e-cCCccc-cccCCCccccccCcccC
Q 022241 276 F-EDDNDV-LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~-~~~~~~-~~~~~gt~~y~aPE~l~ 299 (300)
+ ..+... .-+.+-.+.|||||.++
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHH
Confidence 4 222211 11233446799999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=202.46 Aligned_cols=172 Identities=30% Similarity=0.502 Sum_probs=137.0
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~ 196 (300)
|.+.+.||+|+||.||+++++.+++.||+|.+..... .......+.+|+.+++.+ .||||+++++++.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 6788999999999999999998899999999864321 112233456777777655 599999999998763
Q ss_pred CC---CEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 197 NS---DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 197 ~~---~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ..++++|||+++ .+.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||
T Consensus 74 ~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 74 RTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred cCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccC
Confidence 21 238999999986 455544332 358999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++..+.... ......+++.|+|||++.|
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 153 LARIYSFEM-ALTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred cceeccCCc-ccccccccccccChHHhcc
Confidence 998764432 2234458899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=198.99 Aligned_cols=152 Identities=26% Similarity=0.346 Sum_probs=128.9
Q ss_pred CCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEee
Q 022241 129 GSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV 208 (300)
Q Consensus 129 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~ 208 (300)
|.||.||++++..+++.||+|.+.+.. ...+|...+....||||+++++++.+ ....++||||+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 67 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHA 67 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecC
Confidence 899999999999999999999986531 12244555556679999999999985 46899999999
Q ss_pred CCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCC
Q 022241 209 EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288 (300)
Q Consensus 209 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~g 288 (300)
++++|.+.+.....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...... .....+
T Consensus 68 ~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~ 144 (237)
T cd05576 68 EGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAV 144 (237)
T ss_pred CCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCc
Confidence 99999888777677999999999999999999999999999999999999999999999999988765432 233456
Q ss_pred ccccccCcccC
Q 022241 289 TPVFTAPECCL 299 (300)
Q Consensus 289 t~~y~aPE~l~ 299 (300)
+..|+|||.+.
T Consensus 145 ~~~y~aPE~~~ 155 (237)
T cd05576 145 ENMYCAPEVGG 155 (237)
T ss_pred CccccCCcccC
Confidence 78899999864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=214.35 Aligned_cols=166 Identities=27% Similarity=0.378 Sum_probs=139.5
Q ss_pred eEeeeecCCCceEEEEEEEccC--Cc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLD--GK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.+.||.|-||.||.+..... |+ .||||.-+.+. .....+.|+.|..+|+.++|||||+++|+|.+
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--------t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--------TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--------ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3457899999999998876542 33 58899876542 33457889999999999999999999999985
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...|||||+++-|.|..++..++ .++..+...++.||+.||+|||+...|||||...|||+.....|||+||||++.
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 46999999999999999886654 799999999999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCc--cccccCccc
Q 022241 276 FEDDNDVLRRSPGT--PVFTAPECC 298 (300)
Q Consensus 276 ~~~~~~~~~~~~gt--~~y~aPE~l 298 (300)
++++.....+ .|. .-|||||.+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESI 564 (974)
T ss_pred ccccchhhcc-ccccceeecCcccc
Confidence 8776543222 343 459999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=219.19 Aligned_cols=171 Identities=20% Similarity=0.275 Sum_probs=122.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccC----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLD----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
...++|.+.+.||+|+||.||++....+ +..||||.+.... ..+.+..+ .+....+.+++.+.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----------~~e~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----------AVEIWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----------hhHHHHHH--HHHhhchhhHHHHH
Confidence 3457899999999999999999999988 8999999875321 11111111 11222233333322
Q ss_pred eEEE----cCCCCEEEEEEEeeCCCccccccCCCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 022241 191 EVID----DPNSDHFYMVLEYVEGKWDNDGFGQPG--------------------AIGESMARKYLRDIVSGLMYLHGHN 246 (300)
Q Consensus 191 ~~~~----~~~~~~~~lv~E~~~~~~l~~~~~~~~--------------------~l~~~~~~~i~~qi~~~l~yLH~~~ 246 (300)
..+. ......+++||||+++++|.+++.... ...+..+..++.||+.||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 2211 123467999999999998876664321 1123456789999999999999999
Q ss_pred cEeCCCCCCCEEEcc-CCcEEEecccCceeecCC-ccccccCCCccccccCccc
Q 022241 247 VVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDD-NDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 247 iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~-~~~~~~~~gt~~y~aPE~l 298 (300)
|+||||||+|||++. ++.+||+|||+|+.+... ........+|+.|+|||.+
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 999999999999985 579999999999865322 2334456799999999965
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=189.44 Aligned_cols=150 Identities=21% Similarity=0.206 Sum_probs=112.8
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccc----------c-----CCChH--HHHHHHHHHHHHHHCCCCc
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------V-----APSET--AMTDVRREVLIMKMLQHPN 185 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~----------~-----~~~~~--~~~~~~~E~~~l~~l~h~n 185 (300)
...||+|+||.||++... +|+.||||+++........ + ..... .......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999987 8999999999765321100 0 00000 1123456999999998887
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeCCCCCCCEEEccCCc
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~iiHrDlkp~NIll~~~~~ 264 (300)
+.....+... ..+|||||++++.+.........+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6443333221 2389999999876655444456799999999999999999999 799999999999999998 588
Q ss_pred EEEecccCceeecC
Q 022241 265 VKIGDFSVSQVFED 278 (300)
Q Consensus 265 ~kl~DFGla~~~~~ 278 (300)
++|+|||+|.....
T Consensus 156 v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 LYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEccccccCCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=210.59 Aligned_cols=184 Identities=18% Similarity=0.255 Sum_probs=130.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEc----------------cCCceEEEEEeecccccccc-cC----CChHHHHHHHHH
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS----------------LDGKHYAIKAFHKSHLSKLR-VA----PSETAMTDVRRE 174 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~-~~----~~~~~~~~~~~E 174 (300)
..++|.+.++||+|+||.||++... ..++.||||.+......... +. ......+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999988642 24568999998643110000 00 000111234457
Q ss_pred HHHHHHCCCCce-----eeeeeEEEcC------CCCEEEEEEEeeCCCccccccCCC-----------------------
Q 022241 175 VLIMKMLQHPNI-----VNLIEVIDDP------NSDHFYMVLEYVEGKWDNDGFGQP----------------------- 220 (300)
Q Consensus 175 ~~~l~~l~h~ni-----v~~~~~~~~~------~~~~~~lv~E~~~~~~l~~~~~~~----------------------- 220 (300)
+.++..++|.++ ++++++|... .....+|||||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 6677776531 124689999999998887655321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccc-cccCCCccccccCccc
Q 022241 221 -GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPECC 298 (300)
Q Consensus 221 -~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l 298 (300)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 13456788899999999999999999999999999999999999999999999765332211 1122358999999986
Q ss_pred C
Q 022241 299 L 299 (300)
Q Consensus 299 ~ 299 (300)
.
T Consensus 383 ~ 383 (507)
T PLN03224 383 V 383 (507)
T ss_pred c
Confidence 4
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-27 Score=192.79 Aligned_cols=167 Identities=23% Similarity=0.457 Sum_probs=141.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
..++|++.+++|+|-++.||.+....+.++++||+++. .....+.+|+.||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------------VkkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------------VKKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------------HHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 34789999999999999999999999999999999854 34567899999999998 999999999999
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla 273 (300)
++.+....||+||+.+.....+. ..++...++.++.+++.||.|+|++||+|||+||.|++||... .++|+|+|||
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred CccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 99888899999999876544433 4578888999999999999999999999999999999999655 7999999999
Q ss_pred eeecCCccccccCCCccccccCccc
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
.++.... ...-.+.+..|--||+|
T Consensus 181 EFYHp~~-eYnVRVASRyfKGPELL 204 (338)
T KOG0668|consen 181 EFYHPGK-EYNVRVASRYFKGPELL 204 (338)
T ss_pred hhcCCCc-eeeeeeehhhcCCchhe
Confidence 9874322 22223466678888876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=209.46 Aligned_cols=169 Identities=24% Similarity=0.348 Sum_probs=144.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+.....+||.|-||.||...++.-.-.||||.++.+. ..+++|+.|+.+|+.+.|||+|+|+|+|..+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----------MeveEFLkEAAvMKeikHpNLVqLLGVCT~E- 335 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE- 335 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----------hhHHHHHHHHHHHHhhcCccHHHHhhhhccC-
Confidence 34566789999999999999999888899999987643 3578999999999999999999999999863
Q ss_pred CCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+|||+|||..|.|.++++.- ..++.-....++-||..|++||..++.|||||...|.|+.++..||++||||+++
T Consensus 336 -pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 336 -PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred -CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 4799999999999999998653 3467777788899999999999999999999999999999999999999999999
Q ss_pred ecCCccccccC-CCccccccCccc
Q 022241 276 FEDDNDVLRRS-PGTPVFTAPECC 298 (300)
Q Consensus 276 ~~~~~~~~~~~-~gt~~y~aPE~l 298 (300)
+..+......- .--+-|.|||-|
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsL 438 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESL 438 (1157)
T ss_pred hcCCceecccCccCcccccCcccc
Confidence 87655433221 123459999976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=182.25 Aligned_cols=151 Identities=20% Similarity=0.218 Sum_probs=115.2
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccc----------cC-----CC--hHHHHHHHHHHHHHHHCCCCc
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------VA-----PS--ETAMTDVRREVLIMKMLQHPN 185 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~----------~~-----~~--~~~~~~~~~E~~~l~~l~h~n 185 (300)
.+.||+|+||.||++.+. +|+.||||+++........ .. .. ......+..|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999875321000 00 00 011223468899999999998
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCc
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~ 264 (300)
+.....+... ..+|||||++++.+.........++...+..++.|++.+|.++|. .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7554444332 247999999987544332334568888999999999999999999 9999999999999999 899
Q ss_pred EEEecccCceeecCC
Q 022241 265 VKIGDFSVSQVFEDD 279 (300)
Q Consensus 265 ~kl~DFGla~~~~~~ 279 (300)
++|+|||+|.....+
T Consensus 156 ~~liDFG~a~~~~~~ 170 (190)
T cd05145 156 PYIIDVSQAVELDHP 170 (190)
T ss_pred EEEEEcccceecCCC
Confidence 999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=195.51 Aligned_cols=172 Identities=23% Similarity=0.370 Sum_probs=140.4
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC--C----ce
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--P----NI 186 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----ni 186 (300)
+....++|.++.++|+|.||.|..+.+..++..||||+++.- ....+.-+-|+.+|.++.+ | -+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----------~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----------DKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----------HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 345578899999999999999999999999999999998632 3455566778999998842 2 36
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--- 261 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~--- 261 (300)
|.+.++|.- .++.+||+|.++ .++.+++..+. +++...++.+++|++.+++|||+.+++|-||||+|||+.+
T Consensus 154 v~m~~wFdy--rghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 154 VQMRDWFDY--RGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred Eeeehhhhc--cCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence 778788864 468999999985 35667776543 7999999999999999999999999999999999999853
Q ss_pred -----------------CCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 262 -----------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..|+|+|||.|.+-... .++.+.|.-|.|||+++|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILG 283 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheec
Confidence 235999999999874322 256778999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=223.86 Aligned_cols=160 Identities=24% Similarity=0.352 Sum_probs=131.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
..|...+.||+|+||.||+++...++..||||.+..... ....|+.++++++|||||++++++.+.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~l~~l~HpnIv~~~~~~~~~- 755 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------------IPSSEIADMGKLQHPNIVKLIGLCRSE- 755 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------------ccHHHHHHHhhCCCCCcceEEEEEEcC-
Confidence 346667889999999999999988999999998753211 112458889999999999999999863
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH---GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH---~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...++||||++++++.+++. .++|..+..++.||+.||+||| +.+|+||||||+||+++.++.+++. ||.+.
T Consensus 756 -~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 -KGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred -CCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 46899999999999998874 4889999999999999999999 6799999999999999998888875 66654
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ....||+.|+|||++.+
T Consensus 831 ~~~~~----~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 831 LLCTD----TKCFISSAYVAPETRET 852 (968)
T ss_pred ccccC----CCccccccccCcccccC
Confidence 43221 23468999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=203.29 Aligned_cols=165 Identities=28% Similarity=0.420 Sum_probs=139.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~ 194 (300)
..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+... ...+|+.++. .-+||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------------~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------------DNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------------ccccccchhhhhcCCCcceeecceec
Confidence 45778888999999999999999999999999999866411 2235664444 457999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE-ccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll-~~~~~~kl~DFGla 273 (300)
+ +.+.|+|||++.++.+.+.+.....+. ..+..|+.+|+.|+.|||++|||||||||+|||+ +..++++|+|||.+
T Consensus 387 ~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 387 D--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred C--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechh
Confidence 6 568999999999999998887776666 7888899999999999999999999999999999 68999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..... ..+.+-|..|.|||++.
T Consensus 464 ~~~~~~---~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 464 SELERS---CDTPALTLQYVAPEVLA 486 (612)
T ss_pred hhCchh---hcccchhhcccChhhhc
Confidence 876543 34557889999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=178.70 Aligned_cols=169 Identities=38% Similarity=0.655 Sum_probs=144.8
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|.+.+.||+|++|.||++....+++.+|+|.+...... .....+.+|+..+..++|+|++++++++.. ..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~ 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFED--PE 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CC
Confidence 56778999999999999999988999999998654211 256788899999999999999999999875 35
Q ss_pred EEEEEEEeeCCCccccccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++++||++++++...+..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.....
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 78999999999888888766555 89999999999999999999999999999999999999999999999999988654
Q ss_pred Cc-cccccCCCccccccCccc
Q 022241 279 DN-DVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 279 ~~-~~~~~~~gt~~y~aPE~l 298 (300)
.. .......++..|++||.+
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccccccceeccCCcCCHhHh
Confidence 32 122345688899999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=205.64 Aligned_cols=171 Identities=28% Similarity=0.367 Sum_probs=142.0
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-CCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
+...+.++||+|.||.|+.+.++. .|+ .||||+++.... ...+..|++|+.+|.+|+|||+++|||+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--------~~~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--------NAIMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--------chhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 456777899999999998777665 333 589999875532 226789999999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ..+.||||+++.|+|.+.+.. ...|.......|+.||+.|+.||..++.|||||-..|+||-..-.|||+||||
T Consensus 182 ~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 182 D---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred c---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 5 468899999999999988866 44688889999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcccc--cc-CCCccccccCcccC
Q 022241 273 SQVFEDDNDVL--RR-SPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~--~~-~~gt~~y~aPE~l~ 299 (300)
.+.+....+.. .. ..--..|.|||+|.
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhc
Confidence 99886554432 11 12334599999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=203.48 Aligned_cols=165 Identities=28% Similarity=0.461 Sum_probs=127.3
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 198 (300)
|.-.+.+|.|+-|+|. +++...|+.||||.+-.. ...-..+|+..|..- +|||||++++.=.+ .
T Consensus 511 ~~~~eilG~Gs~Gt~V-f~G~ye~R~VAVKrll~e------------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~ 575 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVV-FRGVYEGREVAVKRLLEE------------FFDFAQREIQLLQESDEHPNVIRYYCSEQD--R 575 (903)
T ss_pred eccHHHcccCCCCcEE-EEEeeCCceehHHHHhhH------------hHHHHHHHHHHHHhccCCCceEEEEeeccC--C
Confidence 3445678999999864 567778999999987432 334567899999887 49999999988664 5
Q ss_pred CEEEEEEEeeCCCccccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CC--cEEEec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPG----AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SG--TVKIGD 269 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~--~~kl~D 269 (300)
.++||.+|.|.. +|.+++.... .......+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|
T Consensus 576 qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 576 QFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred ceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecc
Confidence 689999999975 4555554421 1111345788999999999999999999999999999986 33 799999
Q ss_pred ccCceeecCCccc---cccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDV---LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~---~~~~~gt~~y~aPE~l~G 300 (300)
||+++.+...... .....||-+|+|||+|.+
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhc
Confidence 9999998654432 234679999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=170.27 Aligned_cols=164 Identities=38% Similarity=0.704 Sum_probs=139.8
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 205 (300)
||+|++|.||++....+++.+++|.+..... ......+.+|+..++.+.|++|+++++++... ...+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~ 70 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--------SSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVM 70 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc--------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEE
Confidence 6899999999999988899999999865421 11356789999999999999999999999863 5899999
Q ss_pred EeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCceeecCCcccc
Q 022241 206 EYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDDNDVL 283 (300)
Q Consensus 206 E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~ 283 (300)
||++++++..++... ..+++..+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+..........
T Consensus 71 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 71 EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence 999988888877654 57899999999999999999999999999999999999998 8999999999998765443223
Q ss_pred ccCCCccccccCcccC
Q 022241 284 RRSPGTPVFTAPECCL 299 (300)
Q Consensus 284 ~~~~gt~~y~aPE~l~ 299 (300)
....+...|++||.+.
T Consensus 151 ~~~~~~~~~~~pe~~~ 166 (215)
T cd00180 151 KTIVGTPAYMAPEVLL 166 (215)
T ss_pred hcccCCCCccChhHhc
Confidence 4456888999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-25 Score=185.14 Aligned_cols=175 Identities=26% Similarity=0.427 Sum_probs=141.2
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.....+|.-+..+|.|.- .|..|.+...++.||+|.+... .. ......+-.+|..++..+.|+||++++.+|
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p------f~-n~~~akra~rel~l~~~v~~~nii~l~n~f 84 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP------FQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVF 84 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc------cc-cCccchhhhhhhhhhhhhcccceeeeeecc
Confidence 445578999999999998 6767888999999999987543 11 233445667899999999999999999998
Q ss_pred EcCC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 194 DDPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 194 ~~~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
.-.. -..+|+|||||.... ...+. -.++-.++..+++|++.|++|||+.||+||||||+||++..++.+||.|
T Consensus 85 tP~~~l~~~~e~y~v~e~m~~nl-~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 85 TPQKTLEEFQEVYLVMELMDANL-CQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred CccccHHHHHhHHHHHHhhhhHH-HHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeecc
Confidence 6311 135799999998543 22222 3567788899999999999999999999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|..-..+ -.++..+.|..|.|||+++|
T Consensus 162 fg~ar~e~~~-~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 162 FGLARTEDTD-FMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred chhhcccCcc-cccCchhheeeccCchheec
Confidence 9999864332 45666789999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=176.97 Aligned_cols=159 Identities=40% Similarity=0.674 Sum_probs=137.1
Q ss_pred CceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeC
Q 022241 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE 209 (300)
Q Consensus 130 ~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~ 209 (300)
+||.||++....+++.+|+|.+...... .....+.+|+..++.++|+||+++++++.. ....++++||++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~ 70 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK--------KKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCD 70 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc--------cHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCC
Confidence 5899999999988999999998654221 115788999999999999999999999875 358999999999
Q ss_pred CCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCc
Q 022241 210 GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289 (300)
Q Consensus 210 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt 289 (300)
++++...+.....+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++....... ......++
T Consensus 71 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 149 (244)
T smart00220 71 GGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGT 149 (244)
T ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCC
Confidence 98888887666668999999999999999999999999999999999999999999999999998865432 33456689
Q ss_pred cccccCcccC
Q 022241 290 PVFTAPECCL 299 (300)
Q Consensus 290 ~~y~aPE~l~ 299 (300)
+.|+|||.+.
T Consensus 150 ~~~~~pE~~~ 159 (244)
T smart00220 150 PEYMAPEVLL 159 (244)
T ss_pred cCCCCHHHHc
Confidence 9999999764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=177.93 Aligned_cols=168 Identities=25% Similarity=0.447 Sum_probs=136.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE-
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV- 192 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~- 192 (300)
.+.+.|.+.+.||+|-||.+.+++++.+.+.+++|.+... ......|.+|...---| .|.||+.-|++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----------QTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----------hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 3456799999999999999999999999999999988653 34567899998764444 59999988875
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-C-CcEEEecc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-S-GTVKIGDF 270 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~-~~~kl~DF 270 (300)
|+. .+.+.+++||++-|+|...+.. ..+.+...+.++.|+++|+.|+|+.++||||||.+||||-. + .+|||+||
T Consensus 91 Fqt--~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 91 FQT--SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hhc--CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence 543 4578899999999998876655 46889999999999999999999999999999999999943 3 38999999
Q ss_pred cCceeecCCccccccCCCccccccCccc
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
|+....+.. .....-+..|.|||.+
T Consensus 168 G~t~k~g~t---V~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 168 GLTRKVGTT---VKYLEYVNNYHAPELC 192 (378)
T ss_pred ccccccCce---ehhhhhhcccCCcHHH
Confidence 998864332 2334466779999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=171.67 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=107.3
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-----CCCceeeeeeEEEcC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-----QHPNIVNLIEVIDDP 196 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 196 (300)
-.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ .||||+++++++.+.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 357899999999984 6666665 689875431 12345789999999999 679999999999875
Q ss_pred CC-CEEE-EEEEe--eCCCccccccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeCCCCCCCEEEccC----CcEEE
Q 022241 197 NS-DHFY-MVLEY--VEGKWDNDGFGQPGAIGESMARKYLRDIVSGL-MYLHGHNVVHGDIKPDNLLVAPS----GTVKI 267 (300)
Q Consensus 197 ~~-~~~~-lv~E~--~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~~iiHrDlkp~NIll~~~----~~~kl 267 (300)
.+ ..++ +|||| +.+++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 32 2334 78999 4478999888653 46666 35688888888 99999999999999999999743 38999
Q ss_pred ec-ccCcee
Q 022241 268 GD-FSVSQV 275 (300)
Q Consensus 268 ~D-FGla~~ 275 (300)
+| ||....
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 555444
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=198.78 Aligned_cols=172 Identities=25% Similarity=0.364 Sum_probs=140.3
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
++..+.+.||.|.||.|+++.... ....||||.++... .......+..|+.+|+.+ .||||+.+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--------~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--------SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--------CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 344566799999999999887442 14579999886542 336778899999999988 59999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIK 253 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk 253 (300)
+|++.. ...+++|+||+..|.|..+++... .++......+++||+.|++||++..+|||||-
T Consensus 368 lG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 368 LGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred eeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 999986 568999999999999988876554 48888999999999999999999999999999
Q ss_pred CCCEEEccCCcEEEecccCceeecCCccc-cccCCCccc--cccCcccC
Q 022241 254 PDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPV--FTAPECCL 299 (300)
Q Consensus 254 p~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~gt~~--y~aPE~l~ 299 (300)
.+|||+..+..+||+|||+|+........ .....||.. |||||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~ 494 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF 494 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence 99999999999999999999965443322 233344444 99999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-24 Score=200.86 Aligned_cols=168 Identities=25% Similarity=0.333 Sum_probs=139.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
....++||+|+||+||+..+...|+ +||||++.... .......++.|+..|.+++|||++++++++..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--------~~~~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--------SPKASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--------CchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 3455789999999999988776665 67888875442 34456789999999999999999999999985
Q ss_pred CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
..+.||++||+.|.|.++++. +..+..+....|..||++||.|||+++++||||-.+|||+..-.++||.|||+|+
T Consensus 770 ---s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 770 ---STLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred ---chHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence 348899999999999998865 4579999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCC--ccccccCccc
Q 022241 275 VFEDDNDVLRRSPG--TPVFTAPECC 298 (300)
Q Consensus 275 ~~~~~~~~~~~~~g--t~~y~aPE~l 298 (300)
.+..+........| -+-|||=|.+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHh
Confidence 87665544443333 3447776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=170.05 Aligned_cols=172 Identities=23% Similarity=0.293 Sum_probs=134.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC-CceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~ 193 (300)
....+|.++++||+|+||.+|++....+|+.||||.-... .....+.-|..+...|++ +.|..+..++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----------a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----------AKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----------CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 3457899999999999999999999999999999975332 233467789999999975 5666666666
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC---CcEEEecc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDF 270 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DF 270 (300)
.+ ..+-.+||+++.......+-.....++..++.-++-|++.-++|+|.++.|||||||+|+|..-+ ..+.|+||
T Consensus 81 ~e--~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 TE--KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cc--cccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 54 45678999998764433333345679999999999999999999999999999999999999744 47999999
Q ss_pred cCceeecCCcc-------ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND-------VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~-------~~~~~~gt~~y~aPE~l~ 299 (300)
|||+.+-+... ..+...||..|.+--.+.
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~ 194 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL 194 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhh
Confidence 99998754321 223456999998754443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=176.48 Aligned_cols=170 Identities=22% Similarity=0.339 Sum_probs=139.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
--+|.+.++||+|+||.+++.++..+++.||||.-. -.....++..|....+.|. .++|..++.+..
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-----------rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGq- 94 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-----------RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ- 94 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecc-----------ccCCcchHHHHHHHHHHHcCCCCCCceeeecc-
Confidence 347999999999999999999999999999999643 2334557888999988885 789988887765
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-----cEEEec
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TVKIGD 269 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-----~~kl~D 269 (300)
.+.+-.||||++... |.+++. ....|+..++..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|
T Consensus 95 -eG~~NiLVidLLGPS-LEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 95 -EGKYNILVIDLLGPS-LEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred -ccchhhhhhhhhCcC-HHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 356778999998654 455443 345799999999999999999999999999999999999998644 689999
Q ss_pred ccCceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
||+|+.+-++.. ...+..||..||+--..+|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG 210 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG 210 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeecccc
Confidence 999998866442 2235679999999777766
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=183.93 Aligned_cols=142 Identities=29% Similarity=0.422 Sum_probs=122.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 192 (300)
.+.|...++||.|+|+.||++.... .++.||+|.+... ....++.+|+++|..+. +.||+++.++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----------s~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----------SSPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----------cCchHHHHHHHHHHHhccchhhhcchhh
Confidence 3568999999999999999999887 7889999998643 23356889999999885 9999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFG 271 (300)
+.. .+++.+||||++.....+++. .++...++.+++.++.||+++|.+|||||||||+|+|.+. .+.-.|.|||
T Consensus 104 ~rn--nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 104 FRN--NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred hcc--CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEech
Confidence 974 679999999999866555543 4668889999999999999999999999999999999985 4578999999
Q ss_pred Cce
Q 022241 272 VSQ 274 (300)
Q Consensus 272 la~ 274 (300)
||.
T Consensus 179 LA~ 181 (418)
T KOG1167|consen 179 LAQ 181 (418)
T ss_pred hHH
Confidence 987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=171.41 Aligned_cols=153 Identities=21% Similarity=0.161 Sum_probs=116.1
Q ss_pred eeEeeeecCCCceEEEEEE-EccCCceEEEEEeeccccccccc------------C-CC--hHHHHHHHHHHHHHHHCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYR-SSLDGKHYAIKAFHKSHLSKLRV------------A-PS--ETAMTDVRREVLIMKMLQH 183 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~-~~~~~~~vavK~~~~~~~~~~~~------------~-~~--~~~~~~~~~E~~~l~~l~h 183 (300)
|.+.+.||+|+||.||+|. +..+|+.||||+++......... . .. ......+..|+.++..+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788999999999999998 66789999999997643210000 0 00 0112346789999999976
Q ss_pred Cc--eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeCCCCCCCEEEc
Q 022241 184 PN--IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN-VVHGDIKPDNLLVA 260 (300)
Q Consensus 184 ~n--iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-iiHrDlkp~NIll~ 260 (300)
.+ +.+++++ . ..++||||+++.++.........+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 110 ~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----c--CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 33 3344432 1 24799999999887665544456677778899999999999999999 99999999999999
Q ss_pred cCCcEEEecccCceeecCC
Q 022241 261 PSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 261 ~~~~~kl~DFGla~~~~~~ 279 (300)
++.++|+|||+|.....+
T Consensus 184 -~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 184 -DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred -CCCEEEEEChhhhccCCc
Confidence 889999999999865443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-23 Score=185.17 Aligned_cols=172 Identities=25% Similarity=0.361 Sum_probs=138.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC------Ccee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH------PNIV 187 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv 187 (300)
..+-.+|.+....|+|-|++|..|++...|..||||++..+ +.....=+.|+.||++|+. -|++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----------E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----------EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----------hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 44557788899999999999999999999999999999764 3344566789999999963 4788
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCcccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG- 263 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~- 263 (300)
+|+..|.. ..+++||+|-+.. .|.+.+ ..+-.|....++.|+.|+..||..|-.+||+|.||||.|||++++-
T Consensus 498 rl~r~F~h--knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 498 RLFRHFKH--KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHHhhh--cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence 99988875 4689999997753 233333 3344678888999999999999999999999999999999999765
Q ss_pred cEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+||||||.|....... .+...-+..|.|||+++|
T Consensus 575 iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG 609 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILG 609 (752)
T ss_pred eeeeccCcccccccccc--ccHHHHHHhccCcceeec
Confidence 68999999998765432 233345667999999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=167.83 Aligned_cols=145 Identities=21% Similarity=0.282 Sum_probs=115.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHH------HHHHHHHHHHCCCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD------VRREVLIMKMLQHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~~ 189 (300)
+.++|..++.||.|+||.||++.. ++..+|||.+...... .+..... +.+|+..+.++.||+|..+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~------~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKR------TERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCc------hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 346899999999999999998654 4668999999754321 2222233 6799999999999999999
Q ss_pred eeEEEcCC------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC
Q 022241 190 IEVIDDPN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 190 ~~~~~~~~------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~ 263 (300)
.+++..+. ....+|+|||++|.++.+.. .+++ ..+.+++.+|..+|+.|++|||+||+||+++++|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence 98866432 23578999999998876652 2333 3466999999999999999999999999999888
Q ss_pred cEEEecccCceeec
Q 022241 264 TVKIGDFSVSQVFE 277 (300)
Q Consensus 264 ~~kl~DFGla~~~~ 277 (300)
++|+|||.+....
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 9999999887653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=176.36 Aligned_cols=171 Identities=25% Similarity=0.347 Sum_probs=131.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCC-ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC----CceeeeeeEE
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH----PNIVNLIEVI 193 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~ 193 (300)
+|.+.++||+|+||.||++.+..++ ..+|+|........ ....+..|+.++..+.. +++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---------~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---------KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---------CCccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 7999999999999999999988764 67899987543211 11156678888888873 5888888888
Q ss_pred EcCCCCEEEEEEEeeCCCcccccc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-----CcEE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGF-GQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-----GTVK 266 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~-~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-----~~~k 266 (300)
. ......|+||+.+.. +|.++. .. .+.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.
T Consensus 90 ~-~~~~~~~iVM~l~G~-sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 90 R-STEDFNFIVMSLLGP-SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred c-CCCceeEEEEeccCc-cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEE
Confidence 4 134578999998865 444433 22 4689999999999999999999999999999999999999865 3699
Q ss_pred EecccCce--eecCCcc----c----cccCCCccccccCcccCC
Q 022241 267 IGDFSVSQ--VFEDDND----V----LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~--~~~~~~~----~----~~~~~gt~~y~aPE~l~G 300 (300)
|.|||+|+ .+..... . .....||..|+++.+..|
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 99999998 4322221 1 122449999999987665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=161.00 Aligned_cols=137 Identities=20% Similarity=0.254 Sum_probs=104.6
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCCC
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 199 (300)
.+...|++|+||+|+++.. .+.+++.+.+.....- ........+.+|+++|++|. |+++++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~-----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------ 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW-----LRGVAWWLARREALALRQLDGLPRTPRLLHWD------ 71 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhh-----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------
Confidence 3457899999999996654 6778887765432110 01112225789999999995 58899998862
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC-CCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI-KPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl-kp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..+++|||+.|.+|...... . ...++.|++.+|+++|+.||+|||| ||+|||++.++.++|+|||+|....
T Consensus 72 ~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred CEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 36899999998887543211 1 2357889999999999999999999 7999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=165.83 Aligned_cols=170 Identities=39% Similarity=0.633 Sum_probs=142.9
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC-ceeeeeeEEEcCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP-NIVNLIEVIDDPNS 198 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~ 198 (300)
|.+.+.||.|+||.||++... ..+|+|.+...... .......+.+|+.++..+.|+ +|+++.+.+.. .
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~ 70 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES------KSKEVERFLREIQILASLNHPPNIVKLYDFFQD--E 70 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc------chhHHHHHHHHHHHHHHccCCcceeeEEEEEec--C
Confidence 778899999999999999877 78899998765322 113567899999999999988 79999999964 3
Q ss_pred CEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCce
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQ 274 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~ 274 (300)
...+++++|+.++.+...+.... .++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.
T Consensus 71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 45899999999998886665554 799999999999999999999999999999999999999988 79999999998
Q ss_pred eecCCcc------ccccCCCccccccCcccCC
Q 022241 275 VFEDDND------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~------~~~~~~gt~~y~aPE~l~G 300 (300)
.+..... ......||+.|+|||.+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcC
Confidence 6544332 2356789999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=169.21 Aligned_cols=135 Identities=23% Similarity=0.391 Sum_probs=114.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-----C---Cceeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----H---PNIVNL 189 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~ 189 (300)
.+|.+.++||-|.|++||++.+....+.||+|+.+. .....+.-+.||.+|++++ | .+||+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999999999999999998764 2345566788999999884 2 479999
Q ss_pred eeEEEc--CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccC
Q 022241 190 IEVIDD--PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPS 262 (300)
Q Consensus 190 ~~~~~~--~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~ 262 (300)
++.|.. +++.+++||+|++...+|.-.... ...++...++.|++||+.||.|||. .||||-||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 999874 678899999999976555544333 4569999999999999999999995 799999999999999754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=156.07 Aligned_cols=146 Identities=21% Similarity=0.226 Sum_probs=109.1
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCC-------------ChHHHHHHHHHHHHHHHCCCCc-
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-------------SETAMTDVRREVLIMKMLQHPN- 185 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~n- 185 (300)
|.+.+.||+|+||.||++... +|+.||||++............ ..........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999875 7999999997654211000000 0011224678899999998874
Q ss_pred -eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 186 -IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 186 -iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
++..++. ...++||||++++++...... .....++.+++.++.++|+.+|+||||||+||+++.++.
T Consensus 96 ~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4444432 235899999999887654321 345678899999999999999999999999999999999
Q ss_pred EEEecccCceeecC
Q 022241 265 VKIGDFSVSQVFED 278 (300)
Q Consensus 265 ~kl~DFGla~~~~~ 278 (300)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=158.23 Aligned_cols=143 Identities=22% Similarity=0.299 Sum_probs=111.5
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
+.||+|++|.||+++. .|..++||......... ...........+.+|+.++..+.|++|+....++.+. ...++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRH-PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcC-hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEE
Confidence 5799999999998876 67889999765321110 0000112234688899999999999987766665542 35789
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+|||++|+++.+.+.... + ....++.+++.+|.++|+.+++|+|++|.|||++ ++.++|+|||++...
T Consensus 77 v~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999998887764432 2 7788999999999999999999999999999999 889999999998863
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=152.95 Aligned_cols=139 Identities=22% Similarity=0.257 Sum_probs=104.4
Q ss_pred eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEE
Q 022241 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV 204 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 204 (300)
.||+|+||.||++. .++..|++|......... ...........+.+|+.++..+.|+++....-++.. ....++|
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRH-PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcC-chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEE
Confidence 48999999999987 467889999865332110 000012234668899999999998875544333333 2346899
Q ss_pred EEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 205 ~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
|||++|+++.+.+..... .++.|++.+|.+||+.+++|+|++|.||+++ ++.++++|||++...
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999888766533211 7899999999999999999999999999999 899999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=173.15 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=109.3
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|...+.||+|+||.||++... +..+++|......... ...........+.+|+.++..++|++++....++.+. .
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~ 409 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRH-PELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--E 409 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccc-hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--C
Confidence 455789999999999987654 4445555432211100 0001122346788999999999999998877666543 3
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
..++||||++++++.+.+. ....++.|++.+|.|||+.+++||||||+|||+ .++.++|+|||+++...
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 5689999999988876553 356789999999999999999999999999999 58899999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=145.85 Aligned_cols=147 Identities=20% Similarity=0.221 Sum_probs=99.6
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCC----------C-----hHHHHHHHHHHHHHHHCCCCc--
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP----------S-----ETAMTDVRREVLIMKMLQHPN-- 185 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~----------~-----~~~~~~~~~E~~~l~~l~h~n-- 185 (300)
.+.||+|+||.||++.+. +++.||||++............ . .........|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999877 8999999998754221100000 0 000011235566666665443
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCc
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~ 264 (300)
+.+.+++ ...++||||++++.+........... ..+..++.+++.++.++|. .+|+||||||+||+++ ++.
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 3344433 13589999999854332111111111 5678899999999999999 9999999999999999 999
Q ss_pred EEEecccCceeecC
Q 022241 265 VKIGDFSVSQVFED 278 (300)
Q Consensus 265 ~kl~DFGla~~~~~ 278 (300)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=146.14 Aligned_cols=147 Identities=19% Similarity=0.273 Sum_probs=105.4
Q ss_pred eeec-CCCceEEEEEEEccCCceEEEEEeecccc-ccc---ccCCChHHHHHHHHHHHHHHHCCCCce--eeeeeEEEcC
Q 022241 124 RKIG-AGSYGKVVLYRSSLDGKHYAIKAFHKSHL-SKL---RVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDP 196 (300)
Q Consensus 124 ~~iG-~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 196 (300)
..|| .||.|+||.+... +..++||.+..... .++ ...........+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7788888776553 77899998864321 000 001112344678899999999998885 6677664432
Q ss_pred CCC--EEEEEEEeeCC-CccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 197 NSD--HFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 197 ~~~--~~~lv~E~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
... ..++||||+++ .++.+.+.. .++++.. +.|++.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 221 23599999997 566665543 3455543 578999999999999999999999999999999999999998
Q ss_pred eeec
Q 022241 274 QVFE 277 (300)
Q Consensus 274 ~~~~ 277 (300)
....
T Consensus 190 ~~~~ 193 (239)
T PRK01723 190 ELRT 193 (239)
T ss_pred ccCC
Confidence 8754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-19 Score=169.60 Aligned_cols=177 Identities=26% Similarity=0.418 Sum_probs=137.8
Q ss_pred cce-eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 118 NEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y-~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..| ...+.+|.|++|.|+.+......+.++.|.+... .. ...........+..|+.+-..+.|||++..+..+.+.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 345 4567899999998888887777776777765421 10 1111223333478888899999999998887776642
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+-+||||++ .|...+...+.++...+-.++.|++.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+
T Consensus 394 --~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 394 --DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred --ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 234445999999 88888888788999999999999999999999999999999999999999999999999998765
Q ss_pred cC--Cc--cccccCCCccccccCcccCC
Q 022241 277 ED--DN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~--~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
.- .. ......+|+-.|+|||++-|
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccc
Confidence 32 22 44556789999999999754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-18 Score=132.28 Aligned_cols=133 Identities=21% Similarity=0.341 Sum_probs=109.6
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC--CceeeeeeEEEcCCCC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDPNSD 199 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 199 (300)
+++.||+|.++.||++... +..+++|...... . ...+..|+.++..++| +++++++.+... .+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~----------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~ 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSRE----------K-GADREREVAILQLLARKGLPVPKVLASGES--DG 66 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCC----------c-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CC
Confidence 3578999999999988875 3779999875431 1 3568899999999976 588898888764 35
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..+++|||+++..+... +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||++...
T Consensus 67 ~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 67 WSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 78999999998766544 5667778899999999999984 6999999999999998899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-19 Score=176.87 Aligned_cols=120 Identities=17% Similarity=0.148 Sum_probs=86.8
Q ss_pred HCCC-CceeeeeeEEEcC-----CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC
Q 022241 180 MLQH-PNIVNLIEVIDDP-----NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI 252 (300)
Q Consensus 180 ~l~h-~niv~~~~~~~~~-----~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl 252 (300)
.++| +||++++++|... ....++++|||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5777888877321 12457788898854 67777754 456999999999999999999999999999999
Q ss_pred CCCCEEEcc-------------------CCcEEEecccCceeecCCc----------------cccccCCCccccccCcc
Q 022241 253 KPDNLLVAP-------------------SGTVKIGDFSVSQVFEDDN----------------DVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 253 kp~NIll~~-------------------~~~~kl~DFGla~~~~~~~----------------~~~~~~~gt~~y~aPE~ 297 (300)
||+||||+. ++.+|++|||+++...... ......+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 4456677777765421100 00112458999999999
Q ss_pred cCC
Q 022241 298 CLG 300 (300)
Q Consensus 298 l~G 300 (300)
+.|
T Consensus 187 ~~~ 189 (793)
T PLN00181 187 DNG 189 (793)
T ss_pred hcc
Confidence 865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-19 Score=166.79 Aligned_cols=163 Identities=27% Similarity=0.428 Sum_probs=137.0
Q ss_pred eecCCCceEEEEEEE---ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCCCE
Q 022241 125 KIGAGSYGKVVLYRS---SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 200 (300)
.+|+|+||.|++++. ...|..||+|.+++..... .... ....|..++...+ ||.+|++...++.+ ..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~-----~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~--~k 71 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV-----RDRT--HTKQERIILAFVHNTPFLVKLHYAFQTD--GK 71 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccc-----cccc--ccccHHHHHhhccCCCceeeeeeeeccc--cc
Confidence 379999999998753 3467889999987764321 1111 4556778888887 99999999999864 57
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
.++++++..++.+...+.....+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++......
T Consensus 72 l~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 72 LYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred hhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999764433
Q ss_pred cccccCCCccccccCcccCC
Q 022241 281 DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 281 ~~~~~~~gt~~y~aPE~l~G 300 (300)
.. |||..|||||++.|
T Consensus 152 ~~----cgt~eymApEI~~g 167 (612)
T KOG0603|consen 152 IA----CGTYEYRAPEIING 167 (612)
T ss_pred hc----ccchhhhhhHhhhc
Confidence 22 89999999999753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-17 Score=161.79 Aligned_cols=168 Identities=24% Similarity=0.286 Sum_probs=122.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 194 (300)
..|.+.+.||+|+||+||+|.... |+.||+|+-+.... . +|.-=.+++.+|+ -+.|..+..++.
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---------W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---------W---EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---------e---eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 568899999999999999998876 99999997654321 0 0111112233333 233444444443
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-------CCcEEE
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-------SGTVKI 267 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-------~~~~kl 267 (300)
. .+..+||+||.+-|+|.+++...+.++|..+..+..||+.-++.||..+|||+||||+|+||.. +.-++|
T Consensus 765 ~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 765 F--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred c--CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 3 2346899999999999999999999999999999999999999999999999999999999952 236999
Q ss_pred ecccCceeec--CCccccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFE--DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~--~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|||.|--+. .+....+...+|-.+-.+|++-|
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g 877 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG 877 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcC
Confidence 9999986432 12223444556666666666544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-16 Score=138.40 Aligned_cols=174 Identities=14% Similarity=0.147 Sum_probs=136.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
..++++..++-+|.||.||.+.++. +.+.|-+|.++.. .++.+...+..|..++..+.|||+..+.+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--------AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--------ASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--------ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3457777889999999999886554 2345777776543 25677889999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~ 263 (300)
+..+. ....++++.+++-|.|..++. ..+.++......++.|++.|++|||..+|||.||...|.+|++.-
T Consensus 355 V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 355 VSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 88763 467888999999888877664 234577788889999999999999999999999999999999999
Q ss_pred cEEEecccCceee-cCCcccccc-CCCccccccCcccC
Q 022241 264 TVKIGDFSVSQVF-EDDNDVLRR-SPGTPVFTAPECCL 299 (300)
Q Consensus 264 ~~kl~DFGla~~~-~~~~~~~~~-~~gt~~y~aPE~l~ 299 (300)
.|||+|=.|++-+ +.+.+.... ...-..||+||.|.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 9999999999864 322221111 11234599999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=135.00 Aligned_cols=151 Identities=20% Similarity=0.250 Sum_probs=100.1
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccc----------------cC-----CChHHH----------HHH
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------------VA-----PSETAM----------TDV 171 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~----------------~~-----~~~~~~----------~~~ 171 (300)
.+.||+|++|.||+|+.+ +|+.||||+.+........ .. ...... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999865 7999999998654211100 00 000000 124
Q ss_pred HHHHHHHHHC----CCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 022241 172 RREVLIMKML----QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVS-GLMYLHGH 245 (300)
Q Consensus 172 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~-~l~yLH~~ 245 (300)
.+|+..+..+ .|.+-+.+-.++.+- ....+|||||++|..+.+..... ... ....++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 5566555554 233334444444322 23568999999999887754321 112 23345555555 47889999
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
|++|+|++|.||+++.++.++|+|||++..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.9e-14 Score=116.37 Aligned_cols=149 Identities=17% Similarity=0.159 Sum_probs=105.3
Q ss_pred eeecCCCceEEEEEEEcc------CCceEEEEEeeccccc--c----c----ccC--C-ChHHHHHHH----HHHHHHHH
Q 022241 124 RKIGAGSYGKVVLYRSSL------DGKHYAIKAFHKSHLS--K----L----RVA--P-SETAMTDVR----REVLIMKM 180 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~------~~~~vavK~~~~~~~~--~----~----~~~--~-~~~~~~~~~----~E~~~l~~ 180 (300)
..||.|-=+.||.+.... .+..+|||+.+..... . + +.. . .......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 3578999998865321 0 0 110 0 112233333 89999998
Q ss_pred CCC--CceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeCCCCCCCE
Q 022241 181 LQH--PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL-HGHNVVHGDIKPDNL 257 (300)
Q Consensus 181 l~h--~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~iiHrDlkp~NI 257 (300)
+.. .++...+++. .-+|||||+++..+.........+++.....++.+++.+|..| |..||+|+||+|.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 863 4566666652 3478999998754332222223456666778889999999998 899999999999999
Q ss_pred EEccCCcEEEecccCceeecCC
Q 022241 258 LVAPSGTVKIGDFSVSQVFEDD 279 (300)
Q Consensus 258 ll~~~~~~kl~DFGla~~~~~~ 279 (300)
|+. ++.+.|+|||.|.....+
T Consensus 157 L~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred EEE-CCcEEEEECCCceeCCCC
Confidence 997 678999999998865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=116.80 Aligned_cols=128 Identities=18% Similarity=0.230 Sum_probs=94.9
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCcee-eeeeEEEcCCCCEE
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPNSDHF 201 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~ 201 (300)
++.|+.|.++.||++... +..|++|...... .....+..|+.++..+.+.+++ +++.+.. ...
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~ 66 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----------ELLINRENEAENSKLAAEAGIGPKLYYFDP----ETG 66 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCc----------ccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCC
Confidence 467899999999987754 7889999864321 0112456888888888765554 4454432 134
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNV-----VHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i-----iHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
++||||++|..+... ......++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 67 ~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 67 VLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 799999999776543 01123457789999999999885 9999999999999 77899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-15 Score=145.63 Aligned_cols=136 Identities=31% Similarity=0.486 Sum_probs=98.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
...+|..++.|..|++|.||+++++.+.+.+|+| ++++.+ +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------------ilRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------------ILRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------------hhhc--cccccCCccee--------
Confidence 3467999999999999999999999999999995 444321 1111 22222333333
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
|.-...+...++++... +.+++|||..||+|||+||+|.||..=|++|++|||+++.
T Consensus 136 ---------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ---------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhh
Confidence 22233344445555444 7799999999999999999999999999999999999876
Q ss_pred ecCC---------------ccccccCCCccccccCcccC
Q 022241 276 FEDD---------------NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~---------------~~~~~~~~gt~~y~aPE~l~ 299 (300)
.-.. .-..+..+|||.|+|||+++
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 3210 01224568999999999974
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-14 Score=135.78 Aligned_cols=154 Identities=18% Similarity=0.266 Sum_probs=100.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccc----------------cC-----CCh----HHHH-
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------------VA-----PSE----TAMT- 169 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~----------------~~-----~~~----~~~~- 169 (300)
....|.. +.||+|++|.||.|+.+.+|+.||||+.++.....+. .. ... ....
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 8999999999999999878999999999865311100 00 000 1111
Q ss_pred -----HHHHHHHHHHHC----CCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccc--cCCCC----CCCHHHHHHHHHH
Q 022241 170 -----DVRREVLIMKML----QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--FGQPG----AIGESMARKYLRD 234 (300)
Q Consensus 170 -----~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~--~~~~~----~l~~~~~~~i~~q 234 (300)
++.+|+..+.++ .+.+.+.+-.++.+- ....+|||||++|+.+.+. +...+ .+.+..+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 244444444444 244444444444432 2457899999999887653 22222 2333334444444
Q ss_pred HHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEecccCceeecC
Q 022241 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSVSQVFED 278 (300)
Q Consensus 235 i~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DFGla~~~~~ 278 (300)
+ ...|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 468999999999999999888 999999999987744
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-14 Score=122.65 Aligned_cols=169 Identities=22% Similarity=0.323 Sum_probs=103.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC----------Cceee
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH----------PNIVN 188 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~ 188 (300)
.+...+.||.|+|+.||.+.+..+++.+|||++.... .......+.+.+|.-....+.+ -.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~------~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA------DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS------TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc------ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 4677889999999999999999999999999986543 2244566777777755544332 11111
Q ss_pred eeeE---------EEcCCCC------EEEEEEEeeCCCcccccc---CCC----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022241 189 LIEV---------IDDPNSD------HFYMVLEYVEGKWDNDGF---GQP----GAIGESMARKYLRDIVSGLMYLHGHN 246 (300)
Q Consensus 189 ~~~~---------~~~~~~~------~~~lv~E~~~~~~l~~~~---~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~ 246 (300)
-++. +....+. +.+++|+-+.+ +|...+ ... ..+.......+..|+++.+++||..|
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 1111 1111111 23556666643 333322 111 11222334556689999999999999
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCccccccCcc
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~ 297 (300)
++|+||+|+|+|++.+|.++|+||+......... .....+..|.+||.
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~ 213 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPEL 213 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhh
Confidence 9999999999999999999999999877643322 11335577888885
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-15 Score=144.99 Aligned_cols=169 Identities=21% Similarity=0.270 Sum_probs=125.0
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
+|...+.||++.|=+|.++++. ...|+||++-+.... .+-....+.+.|+. ...++|||.+++..+... .
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~-----~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~ 93 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPT-----ISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--D 93 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCC-----CCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--h
Confidence 6888899999999999655544 445999999765321 12223334445555 667899999999877553 3
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee--
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-- 276 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~-- 276 (300)
...|||-+|... +|++.+..+.-+...+.++|+.|++.||.-+|..||+|+|||.+||||..-+.+.|+||..-+..
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence 456777777754 67888888777888899999999999999999999999999999999999999999999876542
Q ss_pred cCCcc-----ccccCCCccccccCccc
Q 022241 277 EDDND-----VLRRSPGTPVFTAPECC 298 (300)
Q Consensus 277 ~~~~~-----~~~~~~gt~~y~aPE~l 298 (300)
+.++- ...+..-...|+|||.+
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERF 199 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERF 199 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhh
Confidence 22211 11122234569999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-15 Score=142.27 Aligned_cols=174 Identities=32% Similarity=0.499 Sum_probs=139.4
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
..|.+.+.||+|+|+.|-++.... ....+|+|.+.... .+.........|..+-+.+. |+|++.+++...+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-------CccchhhhcCccccccccccccccccccCCccCC
Confidence 358888899999999997766643 34567777665432 13445556667888877777 9999999999876
Q ss_pred CCCCEEEEEEEeeCCCcccccc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeCCCCCCCEEEccCC-cEEEeccc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF-GQPG-AIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSG-TVKIGDFS 271 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~-~~~~-~l~~~~~~~i~~qi~~~l~yLH-~~~iiHrDlkp~NIll~~~~-~~kl~DFG 271 (300)
+ ...+++++|..++.+.... .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||
T Consensus 93 ~--~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 93 P--RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred C--cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCch
Confidence 4 4788999999999988887 5444 6788888999999999999999 99999999999999999999 99999999
Q ss_pred CceeecC-C--ccccccCCC-ccccccCcccCC
Q 022241 272 VSQVFED-D--NDVLRRSPG-TPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~-~--~~~~~~~~g-t~~y~aPE~l~G 300 (300)
+|..+.. . .......+| ++.|+|||.+.|
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccc
Confidence 9987655 2 223334578 999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-13 Score=110.49 Aligned_cols=77 Identities=22% Similarity=0.192 Sum_probs=64.2
Q ss_pred CccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCc
Q 022241 211 KWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289 (300)
Q Consensus 211 ~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt 289 (300)
|+|.+.+.. ...+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++....... ..||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence 345555554 446999999999999999999999998 999999999999999 99998764422 2589
Q ss_pred cccccCcccCC
Q 022241 290 PVFTAPECCLG 300 (300)
Q Consensus 290 ~~y~aPE~l~G 300 (300)
+.|+|||++.|
T Consensus 68 ~~y~aPE~~~~ 78 (176)
T smart00750 68 PYFMAPEVIQG 78 (176)
T ss_pred ccccChHHhcC
Confidence 99999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-11 Score=102.93 Aligned_cols=142 Identities=22% Similarity=0.387 Sum_probs=106.0
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC--ceeeeeeEEEcCC-CCE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP--NIVNLIEVIDDPN-SDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~-~~~ 200 (300)
+.|+.|..+.||++... +|+.|++|....... ......+..|+.+++.+.+. .+.+++.+..... .+.
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~--------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~ 74 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL--------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGT 74 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCccc--------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCC
Confidence 67899999999998764 367899998654321 01234678999999998763 4566777654321 125
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG------------------------------------ 244 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------------------------------------ 244 (300)
.++||||++|..+...+.. ..+++.....++.+++.+|..||+
T Consensus 75 ~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 75 PFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred ceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 6899999999887765532 457777778888888888888883
Q ss_pred --------------------CCcEeCCCCCCCEEEcc--CCcEEEecccCcee
Q 022241 245 --------------------HNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQV 275 (300)
Q Consensus 245 --------------------~~iiHrDlkp~NIll~~--~~~~kl~DFGla~~ 275 (300)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 12599999999999998 56789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.2e-12 Score=100.96 Aligned_cols=140 Identities=22% Similarity=0.287 Sum_probs=94.3
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 203 (300)
..+++|+-+.+|.+.. -|..+.+|.=.+. .-..+.-+..-...+-.+|+.++..+.--.|..-+=+..++ ....|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K-~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPK-RYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCc-ccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEE
Confidence 3578899999976633 4555666643222 11111111223345677899999888654443333333333 34679
Q ss_pred EEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 204 v~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+|||++|..+.+.+... ...++..+=.-+.-||..||+|+||.++||++. ++.+.++||||+.+-
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-~~~i~~IDfGLg~~s 141 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-CCcEEEEECCccccc
Confidence 99999998877666554 134566666678889999999999999999998 445999999999863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6e-12 Score=110.73 Aligned_cols=115 Identities=23% Similarity=0.340 Sum_probs=79.9
Q ss_pred CCCceeeeeeEEEcC-------------------------CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHH
Q 022241 182 QHPNIVNLIEVIDDP-------------------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236 (300)
Q Consensus 182 ~h~niv~~~~~~~~~-------------------------~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~ 236 (300)
.|||||++.++|.+. ....+|+||.-.+. +|..++-. ...+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence 599999998877541 13457778775543 23333322 2456667788999999
Q ss_pred HHHHHHHhCCcEeCCCCCCCEEEc--cCC--cEEEecccCceeecCCc------cccccCCCccccccCccc
Q 022241 237 SGLMYLHGHNVVHGDIKPDNLLVA--PSG--TVKIGDFSVSQVFEDDN------DVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 237 ~~l~yLH~~~iiHrDlkp~NIll~--~~~--~~kl~DFGla~~~~~~~------~~~~~~~gt~~y~aPE~l 298 (300)
.|+.|||.+||.|||+|.+||||. +++ .+.|+|||.+-.-.... ...-...|.-.-||||+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999999999999984 444 57889999874311100 011123577788999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-12 Score=119.56 Aligned_cols=174 Identities=24% Similarity=0.325 Sum_probs=132.0
Q ss_pred cceeEeeeecC--CCceEEEEEEE--ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 118 NEYVHVRKIGA--GSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~--G~fg~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
..+.....+|. |.+|.||..+. ..++..+|+|.-+...- .......-.+|+.....+ .|+|.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-------~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-------PPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-------CccccccccchhhcccccCccccccccCcc
Confidence 34667788999 99999999988 88899999997432211 111112234566666655 49999998888
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcEeCCCCCCCEEEccC-CcEEE
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS----GLMYLHGHNVVHGDIKPDNLLVAPS-GTVKI 267 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl 267 (300)
|.+ ++..|+-+|++...+..........++...++.++.+... ||.++|..+++|-|+||.||++..+ ...++
T Consensus 187 ~e~--~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 187 WEG--SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred ccc--CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence 875 5689999999985444333333445888899999999999 9999999999999999999999999 78999
Q ss_pred ecccCceeecCCcc-----ccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDND-----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~-----~~~~~~gt~~y~aPE~l~G 300 (300)
+|||+...+.+..- ...+..|...|++||.+.|
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 99999988765432 2233367888999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.1e-11 Score=96.71 Aligned_cols=136 Identities=21% Similarity=0.244 Sum_probs=83.9
Q ss_pred EEEEEEEccCCceEEEEEeeccccc--c--------cc-------cCCChHHHHHHHHHHHHHHHCCCC--ceeeeeeEE
Q 022241 133 KVVLYRSSLDGKHYAIKAFHKSHLS--K--------LR-------VAPSETAMTDVRREVLIMKMLQHP--NIVNLIEVI 193 (300)
Q Consensus 133 ~V~~~~~~~~~~~vavK~~~~~~~~--~--------~~-------~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~ 193 (300)
.||.+... +|..+|||+.+..... . .+ ............+|+..|..+... ++.+.+++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37877764 6789999998764211 0 00 011122334578899999999866 456666553
Q ss_pred EcCCCCEEEEEEEeeC--CCccccccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 194 DDPNSDHFYMVLEYVE--GKWDNDGFGQPGAIGESMARKYLRDIVSGLMY-LHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~--~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
. -.|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred C------CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 269999998 5444332211 11134456777888885555 679999999999999999966 9999999
Q ss_pred cCceeecC
Q 022241 271 SVSQVFED 278 (300)
Q Consensus 271 Gla~~~~~ 278 (300)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 99886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-12 Score=108.93 Aligned_cols=166 Identities=15% Similarity=0.315 Sum_probs=123.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
....++.+|.....|.. +++++.|..+++|++..... .......|..|.-.|+...||||+.+++.|..+.
T Consensus 190 ~~lnl~tkl~e~hsgel--wrgrwqgndivakil~vr~~-------t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGEL--WRGRWQGNDIVAKILNVREV-------TARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhhhccCCCccc--ccccccCcchhhhhhhhhhc-------chhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 44556678899999999 45566677788898865433 2233457888999999999999999999998764
Q ss_pred CCEEEEEEEeeCCCccccccCCCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
++.++..||+-|+|+..+..... .+..++.+++.+|++|++|||+.. |.---|....++||++-..+|+ .+-+
T Consensus 261 --nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~ 337 (448)
T KOG0195|consen 261 --NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADT 337 (448)
T ss_pred --CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccc
Confidence 68899999999999988866553 677789999999999999999864 4444688899999998877764 1112
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++--+. ....-.|.||+||.|+
T Consensus 338 kfsfqe----~gr~y~pawmspealq 359 (448)
T KOG0195|consen 338 KFSFQE----VGRAYSPAWMSPEALQ 359 (448)
T ss_pred eeeeec----cccccCcccCCHHHHh
Confidence 221111 1123568899999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-11 Score=94.92 Aligned_cols=149 Identities=19% Similarity=0.234 Sum_probs=99.3
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
.+..|-+|+-+.|+. ....|+...||.=..... ..+.-+..-...+..+|+.+|.++.--.|.--.=+|.+... -
T Consensus 11 ~l~likQGAEArv~~--~~~~Ge~~iIK~Rf~K~Y-RHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPR--GSFSGEAAIIKERFSKRY-RHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--G 85 (229)
T ss_pred cceeeeccceeeEee--eccCCceeEEeecccccc-cchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--C
Confidence 567899999998854 556788888875322111 11111233445678899999998875555433334444343 3
Q ss_pred EEEEEeeCCC-ccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecccCcee
Q 022241 202 YMVLEYVEGK-WDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQV 275 (300)
Q Consensus 202 ~lv~E~~~~~-~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~ 275 (300)
.|+|||++|. .+.+++.. .......-...++.+|=..+.-||.++|+|+||..+||+|.+++ .+.++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5789999873 33333322 11222222357788888899999999999999999999998766 458999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=113.87 Aligned_cols=121 Identities=26% Similarity=0.400 Sum_probs=99.4
Q ss_pred HHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-EeCCCCCC
Q 022241 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNV-VHGDIKPD 255 (300)
Q Consensus 178 l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~i-iHrDlkp~ 255 (300)
|+.+.|.|+.+++|.+.+. ...++|.+||..|++.+.+.. ...+++-....++.+|+.||.|||...| .|+-+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4568999999999999874 678999999999999998876 5578888899999999999999998776 99999999
Q ss_pred CEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccCC
Q 022241 256 NLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 256 NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
|.+++....+||+|||+....+... .......-..-|.|||.+.+
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 9999999999999999988764311 11111123456999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-12 Score=118.73 Aligned_cols=98 Identities=22% Similarity=0.416 Sum_probs=83.7
Q ss_pred EEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
++||.|++|....|.+.+..+. ..++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5889999999999999886443 46778889999999999999 99999999999999999999999999998876
Q ss_pred cCCc------cccccCCCccccccCcccCC
Q 022241 277 EDDN------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~------~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ...+...||+.||+||.|.|
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 5433 23345679999999999876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=97.70 Aligned_cols=137 Identities=12% Similarity=0.166 Sum_probs=91.1
Q ss_pred EccCCceEEEEEeecccccc-cc-cCCChHHHHHHHHHHHHHHHCCCCce--eeeeeEEEcCC---CCEEEEEEEeeCCC
Q 022241 139 SSLDGKHYAIKAFHKSHLSK-LR-VAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDPN---SDHFYMVLEYVEGK 211 (300)
Q Consensus 139 ~~~~~~~vavK~~~~~~~~~-~~-~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~---~~~~~lv~E~~~~~ 211 (300)
....|+.|.||......... .+ ............+|+..+..|...+| +..++++.... ....+||||++++.
T Consensus 41 ~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~ 120 (268)
T PRK15123 41 FELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPT 120 (268)
T ss_pred EEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCC
Confidence 34567889999764332110 00 00000111246688888877753333 33444443211 23578999999975
Q ss_pred -ccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-------CCcEEEecccCcee
Q 022241 212 -WDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-------SGTVKIGDFSVSQV 275 (300)
Q Consensus 212 -~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-------~~~~kl~DFGla~~ 275 (300)
++.+++.. ..+.+......++.+++..+.-||..||+|+|+++.|||++. +..+.|+||+.+..
T Consensus 121 ~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 121 ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 56555432 245566778899999999999999999999999999999985 45899999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-11 Score=110.97 Aligned_cols=152 Identities=22% Similarity=0.241 Sum_probs=119.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
-...+|..+..||.|.|+.|+.+... .++..|++|.+.+.... ......-..|+.+...+ .|.+++.++..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-------~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-------FASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-------hHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 34567899999999999999887755 57889999987654321 11122233555555555 58899998877
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DFG 271 (300)
|.. ..+.|+-.|||.++++.....-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||
T Consensus 335 W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 335 WSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence 764 34678999999988877666556678888999999999999999999999999999999999876 788999999
Q ss_pred Ccee
Q 022241 272 VSQV 275 (300)
Q Consensus 272 la~~ 275 (300)
....
T Consensus 413 ~~t~ 416 (524)
T KOG0601|consen 413 CWTR 416 (524)
T ss_pred cccc
Confidence 8864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.1e-10 Score=103.37 Aligned_cols=125 Identities=24% Similarity=0.411 Sum_probs=97.1
Q ss_pred EEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCcccccc
Q 022241 138 RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF 217 (300)
Q Consensus 138 ~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~ 217 (300)
..+.++.+|.|..++.. .........+-+..|+.++||||+++++.+.. .+.+|||+|-+.. +...+
T Consensus 32 t~k~~~~~vsVF~~~~~---------~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~l 98 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRS---------NGEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRP--LETVL 98 (690)
T ss_pred ceeccCCceEEEEEeCC---------CchhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecccc--HHHHH
Confidence 34557788888877543 12334456777889999999999999999986 3589999998754 22222
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 218 GQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 218 ~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
. .++...+..-+.||+.||.||| +.+++|++|...-|+++..|..||++|.++.....
T Consensus 99 k---~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 99 K---ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred H---HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 1 2336677788899999999998 67899999999999999999999999998865443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.6e-09 Score=88.46 Aligned_cols=109 Identities=21% Similarity=0.282 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHHCCCCc--eeeeeeEEEcCC--CCEEEEEEEeeCCC-ccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022241 169 TDVRREVLIMKMLQHPN--IVNLIEVIDDPN--SDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243 (300)
Q Consensus 169 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~--~~~~~lv~E~~~~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH 243 (300)
....+|...+..|..-. ..+.+++..... ....++|+|++++. ++.+.+.....++......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45667877777765333 344555554311 23468999999874 56666655444777788899999999999999
Q ss_pred hCCcEeCCCCCCCEEEccCC---cEEEecccCceeec
Q 022241 244 GHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFE 277 (300)
Q Consensus 244 ~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~~ 277 (300)
+.||+|+|++|.|||++.++ .+.|+||+.+....
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999887 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.9e-09 Score=88.43 Aligned_cols=145 Identities=21% Similarity=0.248 Sum_probs=102.2
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeeccccc--ccc---------cCCC--hHHHHHHHHHHHHHHHCCCC--c
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--KLR---------VAPS--ETAMTDVRREVLIMKMLQHP--N 185 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~---------~~~~--~~~~~~~~~E~~~l~~l~h~--n 185 (300)
.+...||-|-=+.||.+... .|.++|||.=+....+ +.. ...+ ......-.+|..+|..|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45578999999999988766 7889999965432111 000 0001 12234567889999998755 6
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
+.+.+++ +.-.+||||++|-.|...- +.......++..|+.-+.-+-..||||+|+.+-|||++++|.+
T Consensus 173 VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6666665 2457999999986665432 2344455666667766666668999999999999999999999
Q ss_pred EEecccCceeec
Q 022241 266 KIGDFSVSQVFE 277 (300)
Q Consensus 266 kl~DFGla~~~~ 277 (300)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999998776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=93.54 Aligned_cols=139 Identities=19% Similarity=0.239 Sum_probs=107.3
Q ss_pred ceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc--CCCCEEEEEEEee
Q 022241 131 YGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD--PNSDHFYMVLEYV 208 (300)
Q Consensus 131 fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~~~lv~E~~ 208 (300)
-.+.|++....+|..|++|.++..... .......-+++++++.|+|+|++.++|.. -....+.+|++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~---------~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ---------STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc---------CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 356889999999999999998433211 11122345778999999999999988762 2234688999999
Q ss_pred CCC-cccccc---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 209 EGK-WDNDGF---------------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 209 ~~~-~l~~~~---------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
++. +|.++. ..+...++..+|.++.|+..||.++|+.|..-+-|.|.+||++.+-+++|+..|.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence 863 344332 2233567899999999999999999999999999999999999888999999888
Q ss_pred ceeecC
Q 022241 273 SQVFED 278 (300)
Q Consensus 273 a~~~~~ 278 (300)
...+..
T Consensus 440 ~Dvl~~ 445 (655)
T KOG3741|consen 440 MDVLQE 445 (655)
T ss_pred eeeecC
Confidence 876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.5e-08 Score=81.73 Aligned_cols=147 Identities=21% Similarity=0.217 Sum_probs=99.2
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeeccccccc----------ccCC---Ch-HHHH-HHHHHHHHHHHCC--CCce
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL----------RVAP---SE-TAMT-DVRREVLIMKMLQ--HPNI 186 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~---~~-~~~~-~~~~E~~~l~~l~--h~ni 186 (300)
..|..|--+.||+|.. .++..+|||+++.....-. ++.. .. .... =..+|+.-|.++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4678888889998875 4688999999987643210 0011 11 1111 1345777777764 4444
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCc-cccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCc
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKW-DNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~ 264 (300)
.+-+.+.. -.|||||++... -.-.+.. -++....+..+..+++..+.-|-. .++||+||..-|||+. ++.
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 55555542 368999997542 1122222 233444678888899999888876 8999999999999999 999
Q ss_pred EEEecccCceeecCC
Q 022241 265 VKIGDFSVSQVFEDD 279 (300)
Q Consensus 265 ~kl~DFGla~~~~~~ 279 (300)
+.++|||.|.....+
T Consensus 205 p~iID~~QaV~~~hp 219 (268)
T COG1718 205 PYIIDVSQAVTIDHP 219 (268)
T ss_pred EEEEECccccccCCC
Confidence 999999998765443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.5e-08 Score=82.84 Aligned_cols=148 Identities=21% Similarity=0.264 Sum_probs=89.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc---CCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV---APSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..+|...+.+-......| +.-..+|+.+.+|..+.......+. --.......+......+....-..+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~V--alIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYV--ALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEE--EEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356888888888887878 5666688999999875432110000 00001111122222222222222222322222
Q ss_pred EcC---CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 194 DDP---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 194 ~~~---~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.-. -....+|+|||++|..+.+.. .+++ .++..++.++.-||+.|+.|+|+.|.|+++. ++.++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNGIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCcEEEEEC
Confidence 110 123456899999998776543 2333 3455677889999999999999999999999 555999999
Q ss_pred cCcee
Q 022241 271 SVSQV 275 (300)
Q Consensus 271 Gla~~ 275 (300)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.7e-08 Score=80.37 Aligned_cols=145 Identities=17% Similarity=0.202 Sum_probs=99.1
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeee--EEEcCCCCEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIE--VIDDPNSDHF 201 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~--~~~~~~~~~~ 201 (300)
-|+||-+.|+.. ...|..|-+|.-.......+.. +.....|.+|+..|..|...+ +.+... .-..+.....
T Consensus 26 ~~rgG~SgV~r~--~~~g~~~ylKrq~nhl~~s~r~---P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCV--ERNGKKLYVKRMTHHLFHSVRY---PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRA 100 (216)
T ss_pred cCCCCcceEEEE--EeCCcEEEEEeccCcccccccC---CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEE
Confidence 467888888654 3345578888764222111211 224567889999988886433 333331 1122233456
Q ss_pred EEEEEeeCCC-ccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc--EEEecccCcee
Q 022241 202 YMVLEYVEGK-WDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQV 275 (300)
Q Consensus 202 ~lv~E~~~~~-~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~--~kl~DFGla~~ 275 (300)
+||+|-+++- +|.+.+.. ..+.+......++.+++..+.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8999987753 44444433 235677778899999999999999999999999999999987776 99999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-09 Score=103.93 Aligned_cols=177 Identities=22% Similarity=0.258 Sum_probs=129.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.+.+.+.+-+|+|+.++.+.-..+|...++|...+.... .....+....+-+++-...+|-++.....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i------~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-- 873 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI------RTNDYESIRSKSNILITPRSPAVVRSFPSF-- 873 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhh------ccccccccCCccCccccCCCCceecccCCC--
Confidence 456778888999999999998888778866677655433211 111122333444444445567777655543
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
+.....+|+++|+.++.+...+...+..+...++.+...+..+++|||...+.|||++|.|+|+..++..+++|||....
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 23567899999999999988888888888888888999999999999999999999999999999999999999984322
Q ss_pred ec------CC----------------------c---cccccCCCccccccCcccCC
Q 022241 276 FE------DD----------------------N---DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~------~~----------------------~---~~~~~~~gt~~y~aPE~l~G 300 (300)
.. +. . .......||+.|.|||.++|
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 10 00 0 01123459999999999987
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-08 Score=87.20 Aligned_cols=124 Identities=22% Similarity=0.351 Sum_probs=89.9
Q ss_pred HHHHHHHCCCCceeeeeeEEEcC---CCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022241 174 EVLIMKMLQHPNIVNLIEVIDDP---NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH- 245 (300)
Q Consensus 174 E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~- 245 (300)
-..-|-++.|.|||+++.||.+. +.....++.|||..|++..++.. ...+.....++++-||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34455667899999999999762 23457889999999998877743 44688888889999999999999976
Q ss_pred -CcEeCCCCCCCEEEccCCcEEEecccCceeecC----CccccccCCCccccccCcc
Q 022241 246 -NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED----DNDVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 246 -~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~----~~~~~~~~~gt~~y~aPE~ 297 (300)
.|+|+.+..+-|++..+|.+|+.----...... .........+-++|.|||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES 253 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence 599999999999999999999742111111000 0011112346788888885
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-07 Score=85.96 Aligned_cols=150 Identities=19% Similarity=0.200 Sum_probs=93.3
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeeccccccc-----------------ccC----CChHHHH----------HHH
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL-----------------RVA----PSETAMT----------DVR 172 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~----~~~~~~~----------~~~ 172 (300)
+.|+.++-|.||.|+.. +|+.||||+.+......+ ... ....... ++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999887 599999999887532110 000 0001111 244
Q ss_pred HHHHHHHHCC----CCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 022241 173 REVLIMKMLQ----HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVS-GLMYLHGHN 246 (300)
Q Consensus 173 ~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~-~l~yLH~~~ 246 (300)
+|...+..+. ...-+.+-.++.+- .....|+|||++|-.+.+.... ....+... ++..++. -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 4555554442 22223333344322 2356799999999877766321 13344222 2222222 133344589
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
.+|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887644
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.6e-06 Score=73.44 Aligned_cols=134 Identities=14% Similarity=0.198 Sum_probs=80.8
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce--eeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~ 201 (300)
.+||+|..+.||+. .+..+++|..... .....+.+|.+++..+..-.+ .+.+++..+ .+..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----------~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~ 69 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----------FDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRL 69 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-----------CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCee
Confidence 67899999999863 2556788876432 122356789999988864433 566666654 3457
Q ss_pred EEEEEeeCCCc-ccccc---------------------CCC--CCCCHHH-HHHHHHH----------HHH-HHHHHHh-
Q 022241 202 YMVLEYVEGKW-DNDGF---------------------GQP--GAIGESM-ARKYLRD----------IVS-GLMYLHG- 244 (300)
Q Consensus 202 ~lv~E~~~~~~-l~~~~---------------------~~~--~~l~~~~-~~~i~~q----------i~~-~l~yLH~- 244 (300)
.+|||+++|.. ....+ ... ...+... ...+..+ +.. ...+|..
T Consensus 70 glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~ 149 (226)
T TIGR02172 70 GLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV 149 (226)
T ss_pred eeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC
Confidence 88999999853 11111 000 0111110 0011000 111 1223321
Q ss_pred ---CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 ---HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ---~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..++|+|+.|.||++++++ +.|+||+.+..
T Consensus 150 ~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 150 PDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 2378999999999999888 99999998865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.5e-06 Score=68.13 Aligned_cols=136 Identities=22% Similarity=0.239 Sum_probs=93.7
Q ss_pred cceeEeeeecCCCc-eEEEEEEEccCCceEEEEEeecccccccc-----cC-------CChHHHHHHHHHHHHHHHCC--
Q 022241 118 NEYVHVRKIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLR-----VA-------PSETAMTDVRREVLIMKMLQ-- 182 (300)
Q Consensus 118 ~~y~~~~~iG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~-------~~~~~~~~~~~E~~~l~~l~-- 182 (300)
.+++.++.||.|.- |.||+++. .|+.||+|.+......... .. .......-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 99977654 6889999995443222110 01 01133456888998887775
Q ss_pred -CCce--eeeeeEEEcC----------------CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022241 183 -HPNI--VNLIEVIDDP----------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243 (300)
Q Consensus 183 -h~ni--v~~~~~~~~~----------------~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH 243 (300)
+.++ |+.+||+.-. ......||.||++... .+.. .-+.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8999887321 1123468888876532 2222 33556777899999
Q ss_pred hCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 244 ~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
..||+-+|+++.|..= -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~-----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG-----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC-----CEEEecccC
Confidence 9999999999999862 489999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.2e-06 Score=70.59 Aligned_cols=141 Identities=21% Similarity=0.357 Sum_probs=81.6
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeeeEEEc-CCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDD-PNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-~~~~ 199 (300)
++.|+.|..+.||.+.... ..+++|..... .....+..|..++..+.... +.+++.+... ....
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 4789999999998887654 58999986422 34567778888888875333 4566653322 1234
Q ss_pred EEEEEEEeeCCCcccccc---------------------C--CCCCCCHHHH------HHH---------------HHHH
Q 022241 200 HFYMVLEYVEGKWDNDGF---------------------G--QPGAIGESMA------RKY---------------LRDI 235 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~---------------------~--~~~~l~~~~~------~~i---------------~~qi 235 (300)
..+++|+++++..+.... . ...++..... ... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 578999999987655500 0 1111111110 000 0112
Q ss_pred HH-HHHHHHh-------CCcEeCCCCCCCEEEc-cCCcEEEecccCceee
Q 022241 236 VS-GLMYLHG-------HNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQVF 276 (300)
Q Consensus 236 ~~-~l~yLH~-------~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~~ 276 (300)
.. .+..+++ ..++|+|+.|.|||++ .++.+-|+||+.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 22 3333332 3499999999999999 6677789999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=1e-05 Score=81.18 Aligned_cols=84 Identities=20% Similarity=0.373 Sum_probs=56.4
Q ss_pred EeeeecCCCceEEEEEEEccCC--ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCce--eeeeeEEEcC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNI--VNLIEVIDDP 196 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~ 196 (300)
.++.|+.|.+..+|+......+ ..+++|+..... .......+.+|+.+|+.+. |+++ .+++.++.++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~--------~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~ 113 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK--------LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA 113 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc--------cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC
Confidence 3578899999999988655332 367777643221 1112346789999999985 6665 7777777653
Q ss_pred C-CCEEEEEEEeeCCCcc
Q 022241 197 N-SDHFYMVLEYVEGKWD 213 (300)
Q Consensus 197 ~-~~~~~lv~E~~~~~~l 213 (300)
. .+..|+||||++|..+
T Consensus 114 ~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 114 SVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred CcCCCceEEEEecCCccc
Confidence 1 2357899999998653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-06 Score=81.54 Aligned_cols=150 Identities=23% Similarity=0.235 Sum_probs=88.4
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeeccccccc---------------ccCCC-------hHHHH------HHHHHH
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL---------------RVAPS-------ETAMT------DVRREV 175 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~-------~~~~~------~~~~E~ 175 (300)
+.||..+.|.|+.|+.+. |+.||||+-+....... ...+. ....+ +|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999885 99999998765421100 00000 00001 233343
Q ss_pred HH----HHHCCCCc---eeeeeeEEEcCCCCEEEEEEEeeCCCcccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022241 176 LI----MKMLQHPN---IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGHN 246 (300)
Q Consensus 176 ~~----l~~l~h~n---iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 246 (300)
+- .+.+.|-+ -|.+-.++.+ -.....|+||||+|..+.+.. ... .++...+...+.++. +.-|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~-~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD-LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh-cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHhcC
Confidence 32 22334444 1222233332 124678999999998766543 222 344443333222221 22233578
Q ss_pred cEeCCCCCCCEEEcc----CCcEEEecccCceeecC
Q 022241 247 VVHGDIKPDNLLVAP----SGTVKIGDFSVSQVFED 278 (300)
Q Consensus 247 iiHrDlkp~NIll~~----~~~~kl~DFGla~~~~~ 278 (300)
.+|.|-.|.||++.. ++.+.+-|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999994 56899999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-06 Score=68.77 Aligned_cols=132 Identities=17% Similarity=0.231 Sum_probs=89.9
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCcee-eeeeEEEcCCCC
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPNSD 199 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~ 199 (300)
...+.|++|.+|.||++... |..+|+|.-+. ......+..|+++|..+.-.++. +++.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-----------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----- 86 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-----------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----- 86 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecC-----------CcchhhHHHHHHHHHHhhhcCCCceEEEech-----
Confidence 45578999999999887654 67899997543 34456788999999999877665 3444432
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC-CCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK-PDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk-p~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
-++.|||+.|-.|....... . ++-+..++..---|-..||-|..|. |..++|..++.+.|+||..|.....
T Consensus 87 -~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 87 -DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred -hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 34569999986655443221 1 2334445555334556899999997 5444444466999999999985433
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.7e-06 Score=69.90 Aligned_cols=99 Identities=22% Similarity=0.157 Sum_probs=80.4
Q ss_pred HHHHHHHHHCCC-CceeeeeeEEEcCCCCEEEEEEEeeCCCccccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 022241 172 RREVLIMKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG---FGQPGAIGESMARKYLRDIVSGLMYLHG--- 244 (300)
Q Consensus 172 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~yLH~--- 244 (300)
..|.-+|+.+++ +++++++|+|. .++|.||.+.+++... +..-...+|..+.+|+.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999986 69999999984 2568899987655421 2222357899999999999999999997
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..+...|++|+|+-++++|.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 34788999999999999999999999977553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.7e-06 Score=69.71 Aligned_cols=30 Identities=37% Similarity=0.498 Sum_probs=25.8
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.++|+|+.|.|||++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998665567999998865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.9e-06 Score=69.35 Aligned_cols=136 Identities=15% Similarity=0.110 Sum_probs=79.6
Q ss_pred eecCCCc-eEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCCCEEE
Q 022241 125 KIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 125 ~iG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 202 (300)
.|-.|.. ..||++.. .+..+.||+..... ...+.+|+.+++.+. +.-+.+++++.... +..+
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~ 68 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAW 68 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccE
Confidence 4555555 67887754 34678888764221 234667888888774 34455777776542 4578
Q ss_pred EEEEeeCCCccccccC-------------------C----CCCCCHH---HHHHHHH-------------------HHHH
Q 022241 203 MVLEYVEGKWDNDGFG-------------------Q----PGAIGES---MARKYLR-------------------DIVS 237 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~-------------------~----~~~l~~~---~~~~i~~-------------------qi~~ 237 (300)
+|||+++|..+..... . ..++... ....... .+..
T Consensus 69 lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (244)
T cd05150 69 LLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEE 148 (244)
T ss_pred EEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHH
Confidence 9999999876543210 0 0011100 0000000 0111
Q ss_pred HHHHHH-------hCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 238 GLMYLH-------GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 238 ~l~yLH-------~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+..|- ...++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 149 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 149 LYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred HHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 122221 123899999999999998777889999988653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.2e-07 Score=83.72 Aligned_cols=158 Identities=21% Similarity=0.182 Sum_probs=109.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc-eeeeeeEEEcCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEVIDDPN 197 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~ 197 (300)
.+....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++ .
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~ 305 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------------LSRRLAIELLDKVNNPNPVVRYLEDYD--G 305 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------------hhhHHHHHHHHHccCCCCcccccccCC--c
Confidence 3555667899999999887765444333 4544221 34556889999999999 555555444 3
Q ss_pred CCEEEEEEEeeCCC--ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 198 SDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 198 ~~~~~lv~E~~~~~--~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+..+++++++.++ .........-.+.+-....+.+.-+.+|+|||+..-+||| ||+.. ++..|..||+....
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQ 380 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcc
Confidence 46789999999876 2222222222333334445556677899999998788999 88776 58899999999887
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.... ..++..+|+.++|||+..
T Consensus 381 L~~~~-~~~t~~~~~~~~~pev~~ 403 (829)
T KOG0576|consen 381 LTRTM-KPRTAIGTPEPLAPEVIQ 403 (829)
T ss_pred cCccc-ccccCCCCCCCCCchhhc
Confidence 65543 345678999999999754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00033 Score=61.90 Aligned_cols=81 Identities=15% Similarity=0.123 Sum_probs=55.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC---CceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH---PNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~ 196 (300)
....+.||.|..+.||.+... ++ .+.+|..+.. .....+..|...|+.|.- ..+.++++++.+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~-----------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~ 82 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARSF-----------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE 82 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEeccc-----------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence 344578999999999876432 23 5677764221 122477899999998853 4677888877542
Q ss_pred -CCCEEEEEEEeeCCCcc
Q 022241 197 -NSDHFYMVLEYVEGKWD 213 (300)
Q Consensus 197 -~~~~~~lv~E~~~~~~l 213 (300)
..+..+||||++++..+
T Consensus 83 ~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 83 QSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcCCCeEEEEeccCCEec
Confidence 23458999999998644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00018 Score=61.15 Aligned_cols=75 Identities=17% Similarity=0.307 Sum_probs=46.0
Q ss_pred eeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce-eeeeeEEEcCCCCE
Q 022241 123 VRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVIDDPNSDH 200 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~ 200 (300)
++.|..|-...+|++.... .+..|++|+...... ......+|+.++..+...++ +++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----------LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----------ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C---
Confidence 4567788888999876443 356788997643211 11123468888887754333 44544432 1
Q ss_pred EEEEEEeeCCCcc
Q 022241 201 FYMVLEYVEGKWD 213 (300)
Q Consensus 201 ~~lv~E~~~~~~l 213 (300)
.++|||++|..+
T Consensus 68 -~~l~e~i~G~~l 79 (235)
T cd05157 68 -GLIYEFIPGRTL 79 (235)
T ss_pred -cEEEEeeCCCcC
Confidence 379999998654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00018 Score=64.12 Aligned_cols=149 Identities=22% Similarity=0.237 Sum_probs=99.7
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccc----------ccc------CCChHHHHH-HHHHHHHHHHCCCCce
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK----------LRV------APSETAMTD-VRREVLIMKMLQHPNI 186 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~------~~~~~~~~~-~~~E~~~l~~l~h~ni 186 (300)
..|..|--+.||.|... +|..+|||+++.+.+.- .++ .+....+.- ...|+.-|++++...|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 46778888899987655 78889999998764320 011 011111111 2357777888776664
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeCCCCCCCEEEccCCcE
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~iiHrDlkp~NIll~~~~~~ 265 (300)
.----... ..-.|||+++.......-......++...+..+-.|++.-+.-|. .+++||.||.--|+|+. +|.+
T Consensus 229 P~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 229 PCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 32222221 134689999975433332333446778888888888888877765 57899999999999998 8899
Q ss_pred EEecccCceeecC
Q 022241 266 KIGDFSVSQVFED 278 (300)
Q Consensus 266 kl~DFGla~~~~~ 278 (300)
.|+|.+.+.....
T Consensus 304 yiIDVSQSVE~DH 316 (520)
T KOG2270|consen 304 YIIDVSQSVEHDH 316 (520)
T ss_pred EEEEccccccCCC
Confidence 9999998765433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00014 Score=62.67 Aligned_cols=132 Identities=17% Similarity=0.220 Sum_probs=74.1
Q ss_pred ecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce-eeeeeEEEcCCCCEEEEE
Q 022241 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVIDDPNSDHFYMV 204 (300)
Q Consensus 126 iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~lv 204 (300)
+..|-...+|++. .++..+++|...... ....-...+|..+++.+....+ .+++.... -++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---------~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v 66 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC---------KALGVDRQREYQILQALSALGLAPKPILVNE------HWLL 66 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccc---------ccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEE
Confidence 4567777888765 457788898653221 0000134678888888864433 33444321 2589
Q ss_pred EEeeCCCcccccc-----------------CC----CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------C
Q 022241 205 LEYVEGKWDNDGF-----------------GQ----PGAIGES-MARKYLRDI---------VSGLMYLHG--------H 245 (300)
Q Consensus 205 ~E~~~~~~l~~~~-----------------~~----~~~l~~~-~~~~i~~qi---------~~~l~yLH~--------~ 245 (300)
|||++|..+.... .. ..+++.. .+..+..++ ...+..+-. .
T Consensus 67 ~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (256)
T TIGR02721 67 VEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPL 146 (256)
T ss_pred EEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCC
Confidence 9999986544210 00 0111111 111221111 111222211 2
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.++|+|+.|.||+++.++ +.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00031 Score=58.15 Aligned_cols=142 Identities=18% Similarity=0.233 Sum_probs=87.5
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccc-------cCCChHHHHHHHHHHHHHHHCC------CCceeee
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-------VAPSETAMTDVRREVLIMKMLQ------HPNIVNL 189 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~------h~niv~~ 189 (300)
...||+|+.-.|| .+..+. ...||+.......... -...........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEE--ECCCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3579999999995 455443 4678988766410000 0001123445666766665555 8899999
Q ss_pred eeEEEcCCCCEEEEEEEeeCC--Cc----cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEG--KW----DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~--~~----l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~ 263 (300)
+|+.++.. -..+|+|.+.. |. |.+++ ..+.+++ . +...+-.-..||-+..|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNL--GLGLVVELIRDADGNISPTLEDYL-KEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCC--ceEEEEEEEECCCCCcCccHHHHH-HcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 99998743 47889998753 22 22233 2233444 2 222233445688899999999999999997543
Q ss_pred ----cEEEec-ccCce
Q 022241 264 ----TVKIGD-FSVSQ 274 (300)
Q Consensus 264 ----~~kl~D-FGla~ 274 (300)
.+.|+| ||-..
T Consensus 156 ~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCceEEEEEeCCCCcc
Confidence 467776 35433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00063 Score=62.30 Aligned_cols=82 Identities=16% Similarity=0.128 Sum_probs=53.0
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 199 (300)
.+.||.|.+..||.+.....++.|+||+...... .....-....++...|...|..+. ..++++++.+-. +
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r--~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~ 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVR--VVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----E 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccc--cccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----C
Confidence 4679999999999998763335899998542110 000000224456777888887753 345677777632 3
Q ss_pred EEEEEEEeeCC
Q 022241 200 HFYMVLEYVEG 210 (300)
Q Consensus 200 ~~~lv~E~~~~ 210 (300)
..++||||+++
T Consensus 105 ~~~lVME~L~~ 115 (401)
T PRK09550 105 LAVTVMEDLSD 115 (401)
T ss_pred CCEEEEecCCC
Confidence 57899999976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00046 Score=61.00 Aligned_cols=30 Identities=20% Similarity=0.357 Sum_probs=27.0
Q ss_pred CcEeCCCCCCCEEEccC----CcEEEecccCcee
Q 022241 246 NVVHGDIKPDNLLVAPS----GTVKIGDFSVSQV 275 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~----~~~kl~DFGla~~ 275 (300)
.++|+|+.|.|||++.+ +.+.++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 48999999999999975 8899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0007 Score=59.59 Aligned_cols=140 Identities=15% Similarity=0.168 Sum_probs=80.8
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeeeEEEc----
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDD---- 195 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~---- 195 (300)
-.+.|..|....+|++.. ++..+++|+.... ....+..|+.++..+.+.+ +.+++.....
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~ 83 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLS 83 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC------------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence 356788888888987653 3457889976421 1234566777777775332 3444332100
Q ss_pred CCCCEEEEEEEeeCCCcccccc------------------CC---C----CCCCHHHH--H--------HHHHHHHHHHH
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF------------------GQ---P----GAIGESMA--R--------KYLRDIVSGLM 240 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~------------------~~---~----~~l~~~~~--~--------~i~~qi~~~l~ 240 (300)
...+..++|++|++|..+...- .. . ....+... . .....+..++.
T Consensus 84 ~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 163 (296)
T cd05153 84 ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELA 163 (296)
T ss_pred eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence 0123568999999986543200 00 0 00011110 0 01111233444
Q ss_pred HHHh-------CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 241 YLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 241 yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
++.. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 164 RQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4443 4699999999999999877778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00042 Score=62.74 Aligned_cols=160 Identities=19% Similarity=0.213 Sum_probs=100.2
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeee----eEEEcC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLI----EVIDDP 196 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~----~~~~~~ 196 (300)
..+.||+|+-+.+|-.- . -+..|| |++.... .....+. +..|. --.||-+-.-+ .....+
T Consensus 15 ~gr~LgqGgea~ly~l~-e-~~d~VA-KIYh~Pp---------pa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 15 PGRPLGQGGEADLYTLG-E-VRDQVA-KIYHAPP---------PAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCccccCCccceeeecc-h-hhchhh-eeecCCC---------chHHHHH---HHHhccCCCCcchhhhhcccHHHhhCC
Confidence 45789999999997432 2 222243 7765432 1111221 22222 23455432211 111112
Q ss_pred C-CCEEEEEEEeeCCCccc-ccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 197 N-SDHFYMVLEYVEGKWDN-DGF------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 197 ~-~~~~~lv~E~~~~~~l~-~~~------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
+ +...-+.|..+.+..-. .++ .+.....|......++.++.+.+-||+.|.+-+|+.++|+|+++++.|.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 2 23366778877664211 111 122347789999999999999999999999999999999999999999999
Q ss_pred cccCceeecCCccccccCCCccccccCcc
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~ 297 (300)
|=..-..- .........+|.+.|.+||.
T Consensus 160 dsDsfqi~-~ng~~~~cpVg~~eftPPEl 187 (637)
T COG4248 160 DSDSFQIN-ANGTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred cccceeec-cCCceEecccCccccCCHHH
Confidence 86644432 23334445679999999996
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00073 Score=59.96 Aligned_cols=142 Identities=15% Similarity=0.226 Sum_probs=80.0
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeeeEEE----
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVID---- 194 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~---- 194 (300)
..++.++.|.-..+|++.. ++..+++|+..... ....+..|..++..|.... +.+++....
T Consensus 25 ~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-----------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~ 91 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-----------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQL 91 (307)
T ss_pred eeccccCCccccceEEEEe--CCCcEEEEEecCCC-----------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCee
Confidence 3456778887788987753 34467889764310 1223455667666664322 334433211
Q ss_pred cCCCCEEEEEEEeeCCCcccccc------------------C---CCC----CC-CHHH--HH----------HHHHHHH
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGF------------------G---QPG----AI-GESM--AR----------KYLRDIV 236 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~------------------~---~~~----~l-~~~~--~~----------~i~~qi~ 236 (300)
....+..+++++|++|....... . ... .+ .|.. .. .....+.
T Consensus 92 ~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~ 171 (307)
T TIGR00938 92 STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELD 171 (307)
T ss_pred hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHH
Confidence 01134678999999985432110 0 000 00 0100 00 0011223
Q ss_pred HHHHHHHh-------CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 237 SGLMYLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 237 ~~l~yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..++++.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 34555542 5799999999999999888778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0016 Score=58.06 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=26.4
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999665568999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00018 Score=63.12 Aligned_cols=143 Identities=19% Similarity=0.241 Sum_probs=90.5
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccc--cc---------ccCCC--hHHHHHHHHHHHHHHHCCC-C-
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--KL---------RVAPS--ETAMTDVRREVLIMKMLQH-P- 184 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~---------~~~~~--~~~~~~~~~E~~~l~~l~h-~- 184 (300)
+.+.++||-|--+.||.+-+. .|++.++|.-+....+ .+ +...+ .-..-...+|+..|+.|.- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999977655 7888888864332110 00 00000 0011234578888888853 2
Q ss_pred ceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 185 niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
-+.+.+++ ...++|||++.+-.+.....- .. +..+...+..-+--|..+|+||+|+.--||++++++.
T Consensus 173 pVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPIDH------NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCcccc------cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 23344443 245789999987665543211 11 1233334444456678899999999999999999999
Q ss_pred EEEecccCcee
Q 022241 265 VKIGDFSVSQV 275 (300)
Q Consensus 265 ~kl~DFGla~~ 275 (300)
++++||-....
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999975443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00014 Score=69.26 Aligned_cols=68 Identities=31% Similarity=0.524 Sum_probs=51.4
Q ss_pred HHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc---------ccccCCCccccccCcccCC
Q 022241 233 RDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 233 ~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---------~~~~~~gt~~y~aPE~l~G 300 (300)
.+++.||.|+|. .++||+.|.|++|.++.++.+||+.|+.+........ ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999996 5799999999999999999999999998765433211 1111234567999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0053 Score=53.65 Aligned_cols=30 Identities=27% Similarity=0.563 Sum_probs=25.6
Q ss_pred cEeCCCCCCCEEEccCCc-EEEecccCceee
Q 022241 247 VVHGDIKPDNLLVAPSGT-VKIGDFSVSQVF 276 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~-~kl~DFGla~~~ 276 (300)
++|+|+.|.|||++.++. .-|+||+.+...
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 799999999999997555 569999988764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0018 Score=58.24 Aligned_cols=80 Identities=13% Similarity=0.076 Sum_probs=49.1
Q ss_pred eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CC-ceeeeeeEEEcCCCCEE
Q 022241 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HP-NIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 125 ~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~ 201 (300)
.||.|....||.+.....++.|+||+.....-. ....-+....+..-|...|+... -| .+++++.+ . ....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv--~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D---~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRV--VGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-D---TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhh--cCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-c---cccc
Confidence 479999999999987533368999986543210 00112334455567777776653 34 34445544 2 2356
Q ss_pred EEEEEeeCC
Q 022241 202 YMVLEYVEG 210 (300)
Q Consensus 202 ~lv~E~~~~ 210 (300)
.+|||+++.
T Consensus 76 ~~vMEdL~~ 84 (370)
T TIGR01767 76 VTVMEDLSH 84 (370)
T ss_pred eehHhhCcc
Confidence 799999865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.02 Score=51.77 Aligned_cols=139 Identities=14% Similarity=0.214 Sum_probs=78.2
Q ss_pred EeeeecCCCceEEEEEEEcc----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCcee-eeeeEEEcC
Q 022241 122 HVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDP 196 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~ 196 (300)
.+..|-.|-.-.+|++.... .++.|++|+..... .... .-.+|..+++.+...++. ++++.+.
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---------~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-- 107 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---------ELFF-DRDDEIRTFECMSRHGQGPRLLGRFP-- 107 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---------Ceee-chHHHHHHHHHHHHcCCCCceEEEEC--
Confidence 34556557777888876432 24678999765431 1111 225678888777644443 4556553
Q ss_pred CCCEEEEEEEeeCCCccccc-c-----------------CCC--C---CCCHHHHHHHHHHH-----------------H
Q 022241 197 NSDHFYMVLEYVEGKWDNDG-F-----------------GQP--G---AIGESMARKYLRDI-----------------V 236 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~-~-----------------~~~--~---~l~~~~~~~i~~qi-----------------~ 236 (300)
++ .|++|+++..+... + ... . ...+..+..++.++ .
T Consensus 108 ~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 NG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred Cc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 22 57999987554311 0 000 0 11122222322111 1
Q ss_pred HHHHHH----H----hCCcEeCCCCCCCEEEcc-CCcEEEecccCceee
Q 022241 237 SGLMYL----H----GHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVF 276 (300)
Q Consensus 237 ~~l~yL----H----~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~ 276 (300)
..+..| . ...++|+|+++.|||++. ++.+.|+||..|...
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 112222 1 225899999999999986 468999999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0052 Score=53.93 Aligned_cols=76 Identities=18% Similarity=0.241 Sum_probs=45.5
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEEcC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDP 196 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 196 (300)
.+..+.|+.|....+|.+. .+++.+.||+-... ....+..|..-|+.|. --.+.+++++....
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~ 84 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD 84 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh------------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3455788989999997765 67888999976422 2246778888888883 34566788877653
Q ss_pred CCCEEEEEEEeeCCC
Q 022241 197 NSDHFYMVLEYVEGK 211 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~ 211 (300)
+..+|||||++.+
T Consensus 85 --~~~fLlle~l~~~ 97 (288)
T PF03881_consen 85 --DDAFLLLEFLEMG 97 (288)
T ss_dssp --SCCEEEEE-----
T ss_pred --CCceEEEEeecCC
Confidence 3458999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.016 Score=52.93 Aligned_cols=81 Identities=15% Similarity=0.159 Sum_probs=52.4
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CCc-eeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPN-IVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~n-iv~~~~~~~~~~~~ 199 (300)
.+.||.|.-.-||.+.+...++.|+||+.....-. .+.-+-..++..-|..+|+... -|. +++++.+ . ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv---~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D---~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARI---SDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-D---SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhcc---CCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-C---cH
Confidence 57889999999999987444567999986543210 1112445566677778777653 343 4455554 2 23
Q ss_pred EEEEEEEeeCC
Q 022241 200 HFYMVLEYVEG 210 (300)
Q Consensus 200 ~~~lv~E~~~~ 210 (300)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 56789999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.025 Score=50.82 Aligned_cols=29 Identities=24% Similarity=0.432 Sum_probs=25.7
Q ss_pred cEeCCCCCCCEEEcc-CCcEEEecccCcee
Q 022241 247 VVHGDIKPDNLLVAP-SGTVKIGDFSVSQV 275 (300)
Q Consensus 247 iiHrDlkp~NIll~~-~~~~kl~DFGla~~ 275 (300)
..|.|+.|.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 46899999998865
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.05 Score=50.02 Aligned_cols=81 Identities=12% Similarity=0.102 Sum_probs=51.1
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEEcCCC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPNS 198 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 198 (300)
..+.||.|..-.||++... +..|+||+-...... ..+.-.....+-..|...|+.+. ...+.+++.++.+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~--vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRC--IGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccC--CCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---
Confidence 4678999999999988763 456899976532110 00100113344445566666553 3577888888753
Q ss_pred CEEEEEEEeeCC
Q 022241 199 DHFYMVLEYVEG 210 (300)
Q Consensus 199 ~~~~lv~E~~~~ 210 (300)
..+++|||+++
T Consensus 109 -~~vlvME~L~~ 119 (418)
T PLN02756 109 -MALIGMRYLEP 119 (418)
T ss_pred -CCEEEEeecCC
Confidence 46789999976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.00023 Score=73.45 Aligned_cols=173 Identities=13% Similarity=-0.005 Sum_probs=111.4
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.+++.=-+|-|..+.--..+.+.++ +-+|+.+...+..+ .+...+....|+..++...|+++...+.=.....+
T Consensus 1230 ~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~L----sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1230 HSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENL----SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred hhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHH----hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 3444444555554443222222222 44565554433332 23344556677777777899999888776655556
Q ss_pred CEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC-----CcEeCCCCCCCEEEccCCcEEEec
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH-----NVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~-----~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
..-|.+++|+.+|.+...+.. ...+....+.....+.+.+..-+|.. -.+|+++|+.|.+|..+..+|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 677899999998887766533 22344444444444447777777753 279999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcc
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPEC 297 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~ 297 (300)
+|+.++............+++.|++|++
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHH
Confidence 9999954444444455667888888765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.23 Score=44.15 Aligned_cols=31 Identities=29% Similarity=0.604 Sum_probs=28.1
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.++|+|+.+.||+++..+-+=|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3899999999999999988999999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.015 Score=59.08 Aligned_cols=132 Identities=17% Similarity=0.147 Sum_probs=91.3
Q ss_pred HHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE--EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022241 166 TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243 (300)
Q Consensus 166 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~--~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH 243 (300)
.......-|...+..+.|+|++.++.|....-... ..+..|++..-.+...+...+..+..+.+.+..+++.||+|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34445566777888899999999998876432211 2233477877778888888889999999999999999999999
Q ss_pred hCCcEeCCCCCC---CEEEccCCcEEEe--cccCceeecCCccccccCCCccccccCccc
Q 022241 244 GHNVVHGDIKPD---NLLVAPSGTVKIG--DFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 244 ~~~iiHrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+....|.-|..+ +--.+..+.+.++ ||+.++.+.+.... ....-+..|.|||.+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~ 362 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDL 362 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCcccccccccc
Confidence 986555554444 4444555667766 99988876554332 222334456666643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.16 Score=46.63 Aligned_cols=30 Identities=20% Similarity=0.181 Sum_probs=25.1
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....|.|+-+.|||.+ ++.+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 3479999999999976 55699999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.45 Score=49.32 Aligned_cols=31 Identities=26% Similarity=0.396 Sum_probs=26.3
Q ss_pred CCcEeCCCCCCCEEEccCC--cEE-EecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSG--TVK-IGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~--~~k-l~DFGla~~ 275 (300)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4699999999999999775 555 999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.034 Score=49.16 Aligned_cols=30 Identities=23% Similarity=0.366 Sum_probs=25.9
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.12 Score=46.61 Aligned_cols=71 Identities=20% Similarity=0.199 Sum_probs=52.5
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+.|++|++-.+ .+. ....-.++++..|+++.+.-+.-+.. ...-||++.-.||||+ +|+|.|+||-+++.
T Consensus 299 ~y~yl~~kdhgt-~is----~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGT-PIS----IIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCc-eee----eeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 455666666432 222 12334577788888887777766664 4689999999999999 99999999999985
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.35 Score=45.20 Aligned_cols=29 Identities=21% Similarity=0.406 Sum_probs=24.6
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...|.|+-+.|||.+.+ .++|+||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence 47999999999998744 499999998864
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.026 Score=50.27 Aligned_cols=52 Identities=29% Similarity=0.365 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHHHHHHh----CCcEeCCCCCCCEEEccCC------------------cEEEecccCceee
Q 022241 225 ESMARKYLRDIVSGLMYLHG----HNVVHGDIKPDNLLVAPSG------------------TVKIGDFSVSQVF 276 (300)
Q Consensus 225 ~~~~~~i~~qi~~~l~yLH~----~~iiHrDlkp~NIll~~~~------------------~~kl~DFGla~~~ 276 (300)
.+.++.++.|||.-.--+-+ ...+|-||||+||||-+.. .++|.||.+|+..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 44567788888543321323 3589999999999995422 4788899988764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.0074 Score=55.95 Aligned_cols=71 Identities=24% Similarity=0.385 Sum_probs=60.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
.++|.....+|.|+||+|+.+..+.++..+|||.+... ..+....+..+|+..+..+.|++++++...|..
T Consensus 48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk--------n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK--------NREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hccccccccccccCccccCCccccccchhhHHHHhccc--------chhhhhhhhhccccchhhhcccchhhheeceec
Confidence 45688889999999999999999988889999987532 345566778899999999999999999988765
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.027 Score=46.00 Aligned_cols=28 Identities=25% Similarity=0.436 Sum_probs=25.1
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+|+|+.|.||++.+++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 88999998864
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.32 Score=40.98 Aligned_cols=85 Identities=21% Similarity=0.314 Sum_probs=58.1
Q ss_pred HHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC
Q 022241 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG--HN 246 (300)
Q Consensus 169 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~--~~ 246 (300)
.-+.++..++.++. .|+++. .+ ++-.+-+++|+|..- ...+ ..++.-=+.+|.-.|+ .+
T Consensus 103 ~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy~~---------~i~~----~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCYKI---------KINF----SNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeeccCc---------ccch----hHHHHHhHHHHHHhhccCCC
Confidence 34567788888765 466666 23 445678999998531 1111 1111112466777884 46
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccC
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+|+|..|+||+-|..|.+||.|=+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999999874
|
The function of this family is unknown. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.021 Score=56.34 Aligned_cols=63 Identities=22% Similarity=0.184 Sum_probs=41.7
Q ss_pred HHHHHHhC-CcEeCCCCCC-CEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccCC
Q 022241 238 GLMYLHGH-NVVHGDIKPD-NLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 238 ~l~yLH~~-~iiHrDlkp~-NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
+..|.|.. .-.+++..|. |++++..+.+++.|||.++...... .......||+.|+|||+++|
T Consensus 488 ~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~ 554 (669)
T cd05610 488 GSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLG 554 (669)
T ss_pred ccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCC
Confidence 33444443 2244566665 6777777788999999987653221 22234579999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.035 Score=46.25 Aligned_cols=30 Identities=33% Similarity=0.609 Sum_probs=21.8
Q ss_pred CcEeCCCCCCCEEE-ccCCcEEEecccCcee
Q 022241 246 NVVHGDIKPDNLLV-APSGTVKIGDFSVSQV 275 (300)
Q Consensus 246 ~iiHrDlkp~NIll-~~~~~~kl~DFGla~~ 275 (300)
...|.|+.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 7889999999999876
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.51 Score=39.99 Aligned_cols=75 Identities=19% Similarity=0.286 Sum_probs=46.3
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC---ceeeeeeEEEcCCCCE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP---NIVNLIEVIDDPNSDH 200 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~ 200 (300)
+.+.-|.--..|.+.+ ....|-||+= .......+..|+.=|..+.-. .+.+++.+.. ...+
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n------------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~--~~~~ 85 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCN------------QREQLSMFTAEADGLELLARSNTITVPKVIAVGA--SRDH 85 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEec------------chhhHHHHHHHHHHHHHHHhcCCccccceEEecC--CCCe
Confidence 4455444444443332 3456888853 234456788888877776544 4556666554 4578
Q ss_pred EEEEEEeeCCCccc
Q 022241 201 FYMVLEYVEGKWDN 214 (300)
Q Consensus 201 ~~lv~E~~~~~~l~ 214 (300)
.|+||||++.+.+.
T Consensus 86 sylVle~L~~~~~d 99 (286)
T COG3001 86 SYLVLEYLPTGPLD 99 (286)
T ss_pred eEEEEeeccCCCCC
Confidence 99999999875544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 300 | ||||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-30 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-18 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-04 |
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-71
Identities = 76/216 (35%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP---- 163
S +N+Y +IG GSYG V L + D +YA+K K L + P
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 164 -------------SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG 210
+ V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 211 KWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
G + E AR Y +D++ G+ YLH ++H DIKP NLLV G
Sbjct: 123 -------GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
+KI DF VS F+ + +L + GTP F APE
Sbjct: 176 IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-52
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
+ + + K IN+Y +R + G + K++L K YA+K + KS L K R
Sbjct: 14 SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKR 71
Query: 161 VAP--------SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-- 210
++ D + E+ I+ +++ + +I + D Y++ EY+E
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDS 129
Query: 211 ------KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSG 263
+ I + + ++ +++ Y+H N+ H D+KP N+L+ +G
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189
Query: 264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
VK+ DF S+ D ++ S GT F PE
Sbjct: 190 RVKLSDFGESEYMVDKK--IKGSRGTYEFMPPEFFSN 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 8e-51
Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
K+I +Y+ +G GSYGKV S A+K K L ++ +V++E
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-----PNGEANVKKE 56
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--------GAIGES 226
+ +++ L+H N++ L++V+ + YMV+EY G
Sbjct: 57 IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-------GMQEMLDSVPEKRFPVC 109
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLR 284
A Y ++ GL YLH +VH DIKP NLL+ GT+KI V++ +D R
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 285 RSPGTPVFTAPE 296
S G+P F PE
Sbjct: 170 TSQGSPAFQPPE 181
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 42/191 (21%), Positives = 78/191 (40%), Gaps = 26/191 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ ++ +G G+ V R G +AIK F+ + + RE +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEV 60
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMAR 229
+K L H NIV L + ++ + H +++E+ G + ES
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-----GSLYTVLEEPSNAYGLPESEFL 115
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFEDDNDVLRR 285
LRD+V G+ +L + +VH +IKP N++ K+ DF ++ +D++
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS 174
Query: 286 SPGTPVFTAPE 296
GT + P+
Sbjct: 175 LYGTEEYLHPD 185
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-48
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 8/183 (4%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ YV R +G G + K + + +A K KS L K +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ------REKMSM 64
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
E+ I + L H ++V +D + ++VLE + + + A+ E AR YLR
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
IV G YLH + V+H D+K NL + VKIGDF ++ E D + + GTP +
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 294 APE 296
APE
Sbjct: 183 APE 185
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-48
Identities = 42/191 (21%), Positives = 78/191 (40%), Gaps = 26/191 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ ++ +G G+ V R G +AIK F+ + + RE +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEV 60
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMAR 229
+K L H NIV L + ++ + H +++E+ G + ES
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-----GSLYTVLEEPSNAYGLPESEFL 115
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFEDDNDVLRR 285
LRD+V G+ +L + +VH +IKP N++ K+ DF ++ +D++
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS 174
Query: 286 SPGTPVFTAPE 296
GT + P+
Sbjct: 175 LYGTEEYLHPD 185
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 8/183 (4%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ YV R +G G + K + + +A K KS L K +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ------REKMSM 90
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
E+ I + L H ++V +D + ++VLE + + + A+ E AR YLR
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
IV G YLH + V+H D+K NL + VKIGDF ++ E D + + GTP +
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208
Query: 294 APE 296
APE
Sbjct: 209 APE 211
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-46
Identities = 64/186 (34%), Positives = 98/186 (52%), Gaps = 9/186 (4%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
+G I YV +G G++GKV + L G A+K ++ + L V
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK------ 57
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
++RE+ +K+ +HP+I+ L +VI P F+MV+EYV G D + G + E AR+
Sbjct: 58 IKREIQNLKLFRHPHIIKLYQVISTPT--DFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
+ I+S + Y H H VVH D+KP+N+L+ KI DF +S + D LR S G+P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSP 174
Query: 291 VFTAPE 296
+ APE
Sbjct: 175 NYAAPE 180
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-46
Identities = 68/189 (35%), Positives = 92/189 (48%), Gaps = 16/189 (8%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
I Y ++ IG G++ KV L R L G+ AIK K+ L+ T++ + RE
Sbjct: 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFRE 64
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKY 231
V IMK+L HPNIV L EVI+ Y+++EY G + F G + E AR
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEK--TLYLIMEYASG---GEVFDYLVAHGRMKEKEARSK 119
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
R IVS + Y H +VH D+K +NLL+ +KI DF S F L G P
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFCGAPP 178
Query: 292 FTAPECCLG 300
+ APE G
Sbjct: 179 YAAPELFQG 187
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-46
Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 9/183 (4%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
+ I ++ +G GS+ V S G AIK K + K + + V+ E
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM------VQRVQNE 61
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLR 233
V I L+HP+I+ L +D N + Y+VLE N + E+ AR ++
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
I++G++YLH H ++H D+ NLL+ + +KI DF ++ + ++ GTP +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 294 APE 296
+PE
Sbjct: 180 SPE 182
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-46
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 29/297 (9%)
Query: 10 RDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGD 69
RD C CF K R + ++RI R+ + +D+S NG N
Sbjct: 34 RDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVN----- 88
Query: 70 GGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAG 129
E+ KR + E+ + R + + + + +EY+ + +G+G
Sbjct: 89 -TELVGKGKRRP-LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146
Query: 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189
+ G+V L K AI+ K + A +V E+ I+K L HP I+ +
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAI-GSAREADPALNVETEIEILKKLNHPCIIKI 205
Query: 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSGLMYL 242
D + +Y+VLE +EG G + E+ + Y ++ + YL
Sbjct: 206 KNFFDAED---YYIVLELMEG-------GELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 243 HGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H + ++H D+KP+N+L++ +KI DF S++ + ++R GTP + APE
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPE 311
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-45
Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
EY+ + +G+G+ G+V L K AIK K + ++ A +V E+ I+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 69
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
K L HP I+ + D + +Y+VLE +EG G + E+ + Y
Sbjct: 70 KKLNHPCIIKIKNFFDAED---YYIVLELMEG-------GELFDKVVGNKRLKEATCKLY 119
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
++ + YLH + ++H D+KP+N+L++ +KI DF S++ + ++R G
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCG 178
Query: 289 TPVFTAPE 296
TP + APE
Sbjct: 179 TPTYLAPE 186
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 16/193 (8%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+Y + IG GSYG+ R DGK K ++ E + EV
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVN 57
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYL 232
+++ L+HPNIV + I D + Y+V+EY EG G + + E + +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 233 RDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
+ L H GH V+H D+KP N+ + VK+GDF ++++ D +
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 288 GTPVFTAPECCLG 300
GTP + +PE
Sbjct: 178 GTPYYMSPEQMNR 190
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-45
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ ++ V+ +G G+YG+V L + + + A+K ++++
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--------PENIKK 54
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
E+ I KML H N+V + N Y+ LEY G D + E A+++
Sbjct: 55 EICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPV 291
+++G++YLHG + H DIKP+NLL+ +KI DF ++ VF +N +L + GT
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 292 FTAPE 296
+ APE
Sbjct: 173 YVAPE 177
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-45
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 102 SNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
S+ + + + + +YV ++KIG GS+GK +L +S+ DG+ Y IK + S +S
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---- 63
Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGF 217
+ RREV ++ ++HPNIV E ++ + Y+V++Y EG K N
Sbjct: 64 ---SKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQK 118
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
G E + I L ++H ++H DIK N+ + GTV++GDF +++V
Sbjct: 119 GVL--FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 278 DDNDVLRRSPGTPVFTAPECCLG 300
++ R GTP + +PE C
Sbjct: 177 STVELARACIGTPYYLSPEICEN 199
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 12/205 (5%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
PV + + G + + +KIG G + +V LDG A+K K +
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK---KVQIF 68
Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWD 213
L A D +E+ ++K L HPN++ + + +VLE + +
Sbjct: 69 DL---MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMI 123
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
Q I E KY + S L ++H V+H DIKP N+ + +G VK+GD +
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 274 QVFEDDNDVLRRSPGTPVFTAPECC 298
+ F GTP + +PE
Sbjct: 184 RFFSSKTTAAHSLVGTPYYMSPERI 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 5/183 (2%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
+ +Y + +G+G++G V K +K K + + V E
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLE 79
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE-YVEGKWDNDGFGQPGAIGESMARKYLR 233
+ I+ ++H NI+ ++++ ++ F +V+E + G + + E +A R
Sbjct: 80 IAILSRVEHANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
+VS + YL +++H DIK +N+++A T+K+ DF + E + GT +
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYC 196
Query: 294 APE 296
APE
Sbjct: 197 APE 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ ++ V+ +G G+YG+V L + + + A+K ++++
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--------PENIKK 54
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
E+ I KML H N+V + N Y+ LEY G D + E A+++
Sbjct: 55 EICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPV 291
+++G++YLHG + H DIKP+NLL+ +KI DF ++ VF +N +L + GT
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 292 FTAPE 296
+ APE
Sbjct: 173 YVAPE 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-44
Identities = 60/189 (31%), Positives = 94/189 (49%), Gaps = 16/189 (8%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
+ I Y+ +G GS+GKV L + A+K + L K +
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR------ 55
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESM 227
V RE+ +K+L+HP+I+ L +VI P MV+EY G + F + + E
Sbjct: 56 VEREISYLKLLRHPHIIKLYDVITTPT--DIVMVIEYAGG----ELFDYIVEKKRMTEDE 109
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
R++ + I+ + Y H H +VH D+KP+NLL+ + VKI DF +S + D N L+ S
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC 168
Query: 288 GTPVFTAPE 296
G+P + APE
Sbjct: 169 GSPNYAAPE 177
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-44
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
P + + + + + ++Y +G+G +G V D AIK K +S
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 158 KLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-N 214
P+ T V EV+++K + ++ L++ + P D F ++LE E D
Sbjct: 83 DWGELPNGTR---VPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLF 137
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVS 273
D + GA+ E +AR + ++ + + H V+H DIK +N+L+ G +K+ DF
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 274 QVFEDDNDVLRRSPGTPVFTAPE 296
+ +D GT V++ PE
Sbjct: 198 ALLKDTV--YTDFDGTRVYSPPE 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-44
Identities = 63/192 (32%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 105 LIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS 164
+ + +G I Y+ +G G++GKV + + L G A+K ++ + L V
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 165 ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIG 224
+RRE+ +K+ +HP+I+ L +VI P+ +MV+EYV G D + G +
Sbjct: 63 ------IRREIQNLKLFRHPHIIKLYQVISTPS--DIFMVMEYVSGGELFDYICKNGRLD 114
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
E +R+ + I+SG+ Y H H VVH D+KP+N+L+ KI DF +S + D LR
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLR 173
Query: 285 RSPGTPVFTAPE 296
S G+P + APE
Sbjct: 174 TSCGSPNYAAPE 185
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 157 bits (397), Expect = 1e-43
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 29/198 (14%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
T+ + ++G G +G V+ + G+ AIK + K R
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--------ERWCL 61
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPN----SDHFYMVLEYVEGKWDNDG--------FGQPG 221
E+ IMK L HPN+V+ EV D +D + +EY EG G F
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEG-----GDLRKYLNQFENCC 116
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFED 278
+ E R L DI S L YLH + ++H D+KP+N+++ P KI D ++ D
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-D 175
Query: 279 DNDVLRRSPGTPVFTAPE 296
++ GT + APE
Sbjct: 176 QGELCTEFVGTLQYLAPE 193
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-43
Identities = 55/188 (29%), Positives = 80/188 (42%), Gaps = 14/188 (7%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
+ + ++ R +G G +G V L R A+K K+ L K V
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV------EHQ 55
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
+RREV I L+HPNI+ L D Y++LEY + E
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
Y+ ++ + L Y H V+H DIKP+NLL+ +G +KI DF S RR+ G
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCG 169
Query: 289 TPVFTAPE 296
T + PE
Sbjct: 170 TLDYLPPE 177
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-43
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 24/188 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++G+G + V R G YA K K + R + + ++ REV I++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILR 70
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
+ H N++ L +V ++ ++LE V G G Q ++ E A ++
Sbjct: 71 QVLHHNVITLHDVYENRT--DVVLILELVSG-------GELFDFLAQKESLSEEEATSFI 121
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ I+ G+ YLH + H D+KP+N+++ P +K+ DF ++ +D + G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFG 180
Query: 289 TPVFTAPE 296
TP F APE
Sbjct: 181 TPEFVAPE 188
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 10/189 (5%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
+E I+++ R +G G +G V L R + A+K KS L K V
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV------ 57
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM 227
+RRE+ I L+HPNI+ + D Y++LE+ + G E
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQR 115
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
+ ++ ++ L Y H V+H DIKP+NLL+ G +KI DF S + R
Sbjct: 116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMC 173
Query: 288 GTPVFTAPE 296
GT + PE
Sbjct: 174 GTLDYLPPE 182
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-43
Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 28/194 (14%)
Query: 114 TKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
+ ++ Y ++G G++ V G +A K + LS +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-------KLE 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGE 225
RE I + LQHPNIV L + I + Y+V + V G G E
Sbjct: 54 REARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTG-------GELFEDIVAREFYSE 104
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDV 282
+ A ++ I+ + Y H + +VH ++KP+NLL+A VK+ DF ++ D++
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEA 163
Query: 283 LRRSPGTPVFTAPE 296
GTP + +PE
Sbjct: 164 WHGFAGTPGYLSPE 177
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-43
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 97 FPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL 156
+ N +S G Y +++IG+G KV + + YAIK +
Sbjct: 11 VDLGTENLYFQSMSVKG----RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDPNSDHFYMVLEYVEGKWD- 213
+ R E+ + LQ + I+ L + + YMV+E D
Sbjct: 66 DN-------QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNI--DL 114
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
N + +I + Y ++++ + +H H +VH D+KP N L+ G +K+ DF ++
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 274 QVFEDD-NDVLRRSP-GTPVFTAPE 296
+ D V++ S GT + PE
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-43
Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 24/188 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++G+G + V R GK YA K K +L + + ++ REV I++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKR---RLSSSRRGVSREEIEREVNILR 63
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
++HPNI+ L ++ ++ ++LE V G G + ++ E A ++L
Sbjct: 64 EIRHPNIITLHDIFENKT--DVVLILELVSG-------GELFDFLAEKESLTEDEATQFL 114
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ I+ G+ YLH + H D+KP+N+++ P+ +K+ DF ++ + + + G
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFG 173
Query: 289 TPVFTAPE 296
TP F APE
Sbjct: 174 TPEFVAPE 181
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-43
Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++G+G + V R G YA K K + + + + D+ REV I+K
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKR---RTKSSRRGVSREDIEREVSILK 69
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
+QHPN++ L EV ++ ++LE V G G + ++ E A ++L
Sbjct: 70 EIQHPNVITLHEVYENKT--DVILILELVAG-------GELFDFLAEKESLTEEEATEFL 120
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ I++G+ YLH + H D+KP+N+++ P +KI DF ++ D + + G
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFGNEFKNIFG 179
Query: 289 TPVFTAPE 296
TP F APE
Sbjct: 180 TPEFVAPE 187
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-43
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 15/184 (8%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
+ Y V+ IG+G++G L R L + A+K + V +RE
Sbjct: 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----------QRE 66
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
++ + L+HPNIV EVI P H +++EY G + G E AR + +
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
++SG+ Y H + H D+K +N L+ +P+ +KI DF S+ + + + GTP +
Sbjct: 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAY 183
Query: 293 TAPE 296
APE
Sbjct: 184 IAPE 187
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-43
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 25/190 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y IG G + V + G+ +A+K + + +E D++RE I
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE----DLKREASICH 81
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIGESMAR 229
ML+HP+IV L+E YMV E+++G + E++A
Sbjct: 82 MLKHPHIVELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYS------EAVAS 133
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
Y+R I+ L Y H +N++H D+KP +L+A S VK+G F V+ + V
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 287 PGTPVFTAPE 296
GTP F APE
Sbjct: 194 VGTPHFMAPE 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 26/188 (13%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
EY ++G G++ V L G+ YA + LS + RE I
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-------KLEREARIC 64
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
++L+HPNIV L + I + H Y++ + V G G E+ A
Sbjct: 65 RLLKHPNIVRLHDSISEE--GHHYLIFDLVTG-------GELFEDIVAREYYSEADASHC 115
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
++ I+ +++ H VVH ++KP+NLL+A VK+ DF ++ E + G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 289 TPVFTAPE 296
TP + +PE
Sbjct: 176 TPGYLSPE 183
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 44/213 (20%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+++ + +G G++G+VV R++LD ++YAIK + E ++ + EV++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------EEKLSTILSEVML 55
Query: 178 MKMLQHPNIVNLIEVIDDPN-----------SDHFYMVLEYVEG-----KWDNDGFGQPG 221
+ L H +V + ++ +EY E ++ Q
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ- 114
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
+ R I+ L Y+H ++H D+KP N+ + S VKIGDF +++ D
Sbjct: 115 ---RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 282 VLRRSP--------------GTPVFTAPECCLG 300
+L+ GT ++ A E G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 24/190 (12%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y ++G+G + V R G YA K K + R + ++ REV I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVCREEIEREVSI 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARK 230
++ + HPNI+ L +V ++ ++LE V G G Q ++ E A
Sbjct: 69 LRQVLHPNIITLHDVYENRT--DVVLILELVSG-------GELFDFLAQKESLSEEEATS 119
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRS 286
+++ I+ G+ YLH + H D+KP+N+++ P +K+ DF ++ +D +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNI 178
Query: 287 PGTPVFTAPE 296
GTP F APE
Sbjct: 179 FGTPEFVAPE 188
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 18/231 (7%)
Query: 71 GEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGS 130
G + + E + E + + +K S +E + Y +++IG+G
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGG 68
Query: 131 YGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVN 188
KV + + YAIK + + R E+ + LQ + I+
Sbjct: 69 SSKVFQVLNE-KKQIYAIKYVNLEEADN-------QTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 189 LIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNV 247
L + + YMV+E D N + +I + Y ++++ + +H H +
Sbjct: 121 LYDYEITDQ--YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-NDVLRRSP-GTPVFTAPE 296
VH D+KP N L+ G +K+ DF ++ + D V++ S G + PE
Sbjct: 177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 27/188 (14%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
Y ++G G++ V G +A K + LS + RE I
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-------KLEREARIC 82
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
+ LQHPNIV L + I + + Y+V + V G G E+ A
Sbjct: 83 RKLQHPNIVRLHDSIQEES--FHYLVFDLVTG-------GELFEDIVAREFYSEADASHC 133
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
++ I+ + Y H + +VH ++KP+NLL+A VK+ DF ++ D++ G
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAG 192
Query: 289 TPVFTAPE 296
TP + +PE
Sbjct: 193 TPGYLSPE 200
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-42
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 19/196 (9%)
Query: 110 DENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
+ T E Y +G G V K YA+K + +
Sbjct: 8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 169 TDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QP 220
+EV I++ + HPNI+ L + + F++V + ++ G +
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKK-------GELFDYLTEK 118
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
+ E RK +R ++ + LH N+VH D+KP+N+L+ +K+ DF S +
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG- 177
Query: 281 DVLRRSPGTPVFTAPE 296
+ LR GTP + APE
Sbjct: 178 EKLREVCGTPSYLAPE 193
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-42
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 19/208 (9%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
P ++ EY +G G +G V D AIK ++ +
Sbjct: 11 PAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVL 70
Query: 158 KLRVAPSETAMTDVRREVLIMKML----QHPNIVNLIEVIDDPNSDHFYMVLEY-VEGKW 212
EV ++ + HP ++ L++ + + F +VLE + +
Sbjct: 71 GWSPLSDSVT---CPLEVALLWKVGAGGGHPGVIRLLDWFETQ--EGFMLVLERPLPAQ- 124
Query: 213 DNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIG 268
D F + G +GE +R + +V+ + + H VVH DIK +N+L+ G K+
Sbjct: 125 --DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
DF + D+ GT V++ PE
Sbjct: 183 DFGSGALLHDEP--YTDFDGTRVYSPPE 208
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 15/180 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y IG GS+G+V + A K K + + ++E+ IMK
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---------RFKQEIEIMK 61
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L HPNI+ L E +D Y+V+E G + ES A + ++D++S +
Sbjct: 62 SLDHPNIIRLYETFEDNT--DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 240 MYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
Y H NV H D+KP+N L P +K+ DF ++ ++R GTP + +P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-ARFKPGKMMRTKVGTPYYVSPQ 178
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-42
Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 18/184 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y +++IG+G KV + + YAIK + + R E+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-------QTLDSYRNEIAY 60
Query: 178 MKMLQHPN--IVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRD 234
+ LQ + I+ L + + YMV+E D N + +I + Y ++
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKN 116
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-NDVLRRSP-GTPVF 292
++ + +H H +VH D+KP N L+ G +K+ DF ++ + D V++ S GT +
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 293 TAPE 296
PE
Sbjct: 176 MPPE 179
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
++ RK+G+G++G V L G IK +K M + E+ ++K
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--------PMEQIEAEIEVLK 75
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG---------FGQPGAIGESMARK 230
L HPNI+ + EV +D + + Y+V+E EG G + A+ E +
Sbjct: 76 SLDHPNIIKIFEVFEDYH--NMYIVMETCEG-----GELLERIVSAQARGKALSEGYVAE 128
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSP 287
++ +++ L Y H +VVH D+KP+N+L P +KI DF ++ ++ +
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA-ELFKSDEHSTNAA 187
Query: 288 GTPVFTAPE 296
GT ++ APE
Sbjct: 188 GTALYMAPE 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 103 NKLIRSEDENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
+ E+ E Y V +G GS+G+V+ + + + YA+K +K+
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG 221
+ + REV ++K L HPNI+ L E+++D + FY+V E G D +
Sbjct: 66 S-------TILREVELLKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRK 116
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFED 278
E A + ++ + SG+ Y+H HN+VH D+KP+N+L+ +KI DF +S F+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 279 DNDVLRRSPGTPVFTAPE 296
+ ++ GT + APE
Sbjct: 177 N-TKMKDRIGTAYYIAPE 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-41
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y IG G V G +A+K + +L E RRE I++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE-RLSPEQLEEVREATRRETHILR 154
Query: 180 ML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
+ HP+I+ LI+ + + ++V + + G + A+ E R
Sbjct: 155 QVAGHPHIITLIDSYESSS--FMFLVFDLMRK-------GELFDYLTEKVALSEKETRSI 205
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
+R ++ + +LH +N+VH D+KP+N+L+ + +++ DF S E + LR GTP
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPG 264
Query: 292 FTAPE 296
+ APE
Sbjct: 265 YLAPE 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-41
Identities = 51/195 (26%), Positives = 77/195 (39%), Gaps = 11/195 (5%)
Query: 107 RSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
+ + + ++G GSYG+V RS DG+ YA+K P +
Sbjct: 46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-----RSMSPFRGPKDR 100
Query: 167 AMTDVRREVLIM-KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
A EV K+ QHP V L + ++ Y+ E ++ E
Sbjct: 101 ARK--LAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPE 156
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
+ YLRD + L +LH +VH D+KP N+ + P G K+GDF +
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV 215
Query: 286 SPGTPVFTAPECCLG 300
G P + APE G
Sbjct: 216 QEGDPRYMAPELLQG 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-41
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 32/188 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + +G GS+ + +A+K K + + ++E+ +K
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA------------NTQKEITALK 60
Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
+ + HPNIV L EV D H ++V+E + G G + E+ A
Sbjct: 61 LCEGHPNIVKLHEVFHDQL--HTFLVMELLNG-------GELFERIKKKKHFSETEASYI 111
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+R +VS + ++H VVH D+KP+NLL + +KI DF +++ DN L+
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 289 TPVFTAPE 296
T + APE
Sbjct: 172 TLHYAAPE 179
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-41
Identities = 56/243 (23%), Positives = 90/243 (37%), Gaps = 52/243 (21%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
+ + + + ++ +Y IG GSYG V + + AIK +K+ + ++
Sbjct: 8 SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67
Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------- 210
+ + ++ EV +MK L HPNI L EV +D + +V+E G
Sbjct: 68 ----NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNV 121
Query: 211 -------------------------------KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
E + +R I S L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 240 MYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVF----EDDNDVLRRSPGTPVFT 293
YLH + H DIKP+N L + S +K+ DF +S+ F + + GTP F
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241
Query: 294 APE 296
APE
Sbjct: 242 APE 244
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 49/188 (26%), Positives = 96/188 (51%), Gaps = 30/188 (15%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++ + +G+G++ +V L + L GK +A+K KS + + + E+ ++
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---------DSSLENEIAVL 60
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
K ++H NIV L ++ + H+Y+V++ V G G + G E A
Sbjct: 61 KKIKHENIVTLEDIYEST--THYYLVMQLVSG-------GELFDRILERGVYTEKDASLV 111
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
++ ++S + YLH + +VH D+KP+NLL + + I DF +S++ ++ ++ + G
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACG 169
Query: 289 TPVFTAPE 296
TP + APE
Sbjct: 170 TPGYVAPE 177
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 34/208 (16%)
Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
+ +++ N + + Y IG GSY +A+K KS
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---- 60
Query: 161 VAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG- 218
D E+ I+ QHPNI+ L +V DD + Y+V E ++G G
Sbjct: 61 ---------DPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTELMKG-------GE 102
Query: 219 ------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIG 268
+ E A L I + YLH VVH D+KP N+L +++I
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
DF ++ +N +L T F APE
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAPE 190
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 12/182 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y R +G GS+G+V+L + + G+ A+K K + +T + REV +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK------QKTDKESLLREVQL 79
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L HPNI+ L E +D +FY+V E G D E A + +R ++S
Sbjct: 80 LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
G+ Y+H + +VH D+KP+NLL+ ++I DF +S FE + ++ GT + A
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIA 196
Query: 295 PE 296
PE
Sbjct: 197 PE 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+++G G + V S G+ YA K K + A ++ E+ ++++ +
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA-------EILHEIAVLELAKS 87
Query: 184 -PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---------QPGAIGESMARKYLR 233
P ++NL EV ++ + ++LEY G G + E+ + ++
Sbjct: 88 CPRVINLHEVYENTS--EIILILEYAAG-------GEIFSLCLPELAEMVSENDVIRLIK 138
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
I+ G+ YLH +N+VH D+KP N+L++ P G +KI DF +S+ LR GTP
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTP 197
Query: 291 VFTAPE 296
+ APE
Sbjct: 198 EYLAPE 203
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-40
Identities = 60/182 (32%), Positives = 99/182 (54%), Gaps = 13/182 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y V+K+G+G+YG+V+L R + AIK K+ +S ++ + + EV +
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------SSNSKLLEEVAV 89
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K+L HPNI+ L + +D ++Y+V+E +G D E A ++ ++S
Sbjct: 90 LKLLDHPNIMKLYDFFEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
G+ YLH HN+VH D+KP+NLL+ +KI DF +S VFE + ++ GT + A
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIA 206
Query: 295 PE 296
PE
Sbjct: 207 PE 208
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 35/212 (16%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
+ + ++ ++ +G G +G V ++ +D +YAIK ++R+ E A V RE
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK--------RIRLPNRELAREKVMRE 53
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSD----------HFYMVLEYVEG----KWDNDGFGQP 220
V + L+HP IV + N+ + Y+ ++ W N
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
S+ I + +LH ++H D+KP N+ VK+GDF + + D
Sbjct: 114 -ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 281 DVLRRSP------------GTPVFTAPECCLG 300
+ GT ++ +PE G
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 65/186 (34%), Positives = 96/186 (51%), Gaps = 10/186 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT----DVRR 173
Y VRK+G+G+YG+V+L + AIK KS K R + + ++
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
E+ ++K L HPNI+ L +V +D +FY+V E+ EG + E A ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
I+SG+ YLH HN+VH DIKP+N+L+ +KI DF +S F D LR GT
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTA 212
Query: 291 VFTAPE 296
+ APE
Sbjct: 213 YYIAPE 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 34/205 (16%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ ++ + IG+G +G+V + +DGK Y IK + + R
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNE----------KAER 53
Query: 174 EVLIMKMLQHPNIVNLIEVIDD--------------PNSDHFYMVLEYVEG----KWDND 215
EV + L H NIV+ D + ++ +E+ + +W
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 216 GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
G+ + + +A + I G+ Y+H +++ D+KP N+ + + VKIGDF +
Sbjct: 114 RRGEK--LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 276 FEDDNDVLRRSPGTPVFTAPECCLG 300
++D RS GT + +PE
Sbjct: 172 LKNDGK-RTRSKGTLRYMSPEQISS 195
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 44/186 (23%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y + ++G+G++G V G+ + K + + V+ E+ I
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---------KYTVKNEISI 101
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYL 232
M L HP ++NL + +D ++LE++ G + + + + E+ Y+
Sbjct: 102 MNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYM 155
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
R GL ++H H++VH DIKP+N++ + +VKI DF ++ + +++++ + T
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATA 214
Query: 291 VFTAPE 296
F APE
Sbjct: 215 EFAAPE 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 24/186 (12%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+Y+ +G G +G V + K Y K + V++E+ I
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----------VLVKKEISI 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYL 232
+ + +H NI++L E + M+ E++ G + + F + E Y+
Sbjct: 55 LNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAF----ELNEREIVSYV 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
+ L +LH HN+ H DI+P+N++ S T+KI +F + D R P
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA-RQLKPGDNFRLLFTAP 167
Query: 291 VFTAPE 296
+ APE
Sbjct: 168 EYYAPE 173
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 13/182 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y V +G GS+G+V+ + + + YA+K +K+ + + REV +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-------TILREVEL 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L HPNI+ L E+++D + FY+V E G D + E A + ++ + S
Sbjct: 75 LKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
G+ Y+H HN+VH D+KP+N+L+ +KI DF +S F+ + ++ GT + A
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIA 191
Query: 295 PE 296
PE
Sbjct: 192 PE 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 73 MQNHAKRSEEI------FRERELNGLICRQFPVKESNKLIRSEDENGTKMINE-YVHVRK 125
M +H S + + ++ + P S D + +++ + +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE 60
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G+ V + K YA+K K+ K VR E+ ++ L HPN
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----------IVRTEIGVLLRLSHPN 109
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
I+ L E+ + P +VLE V G G + G E A ++ I+
Sbjct: 110 IIKLKEIFETP--TEISLVLELVTG-------GELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 239 LMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
+ YLH + +VH D+KP+NLL A P +KI DF +S++ E +++ GTP + AP
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAP 219
Query: 296 E 296
E
Sbjct: 220 E 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-39
Identities = 48/247 (19%), Positives = 104/247 (42%), Gaps = 25/247 (10%)
Query: 59 NGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMIN 118
+ + + + E+ ++A +E + + + + P + R + +
Sbjct: 28 GDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS 87
Query: 119 EYV--HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
Y +G G +G+V + G A K + +V+ E+
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---------KEEVKNEIS 138
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKY 231
+M L H N++ L + + N +V+EYV+G + ++ + + E +
Sbjct: 139 VMNQLDHANLIQLYDAFESKN--DIVLVMEYVDGGELFDRIIDESY----NLTELDTILF 192
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
++ I G+ ++H ++H D+KP+N+L + +KI DF +++ + + L+ + GT
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGT 251
Query: 290 PVFTAPE 296
P F APE
Sbjct: 252 PEFLAPE 258
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 46/210 (21%), Positives = 76/210 (36%), Gaps = 29/210 (13%)
Query: 98 PVKESNKLIRSEDENGTKMIN--EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH 155
P E + ++E ++ + +G G+ G +V YR D + A+K
Sbjct: 5 PSLEQDD---GDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPEC 60
Query: 156 LSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN 214
S REV +++ +HPN++ D Y+ +E
Sbjct: 61 FSFAD------------REVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIELCAATLQE 106
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGD 269
+ A L+ SGL +LH N+VH D+KP N+L++ I D
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 270 FSVSQVFEDDNDVLRRSP---GTPVFTAPE 296
F + + R GT + APE
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-37
Identities = 39/194 (20%), Positives = 73/194 (37%), Gaps = 24/194 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y+ ++K+G G + V L DG YA+K ++ + + +RE + +
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALK--------RILC-HEQQDREEAQREADMHR 81
Query: 180 MLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGK--WD--NDGFGQPGAIGESMARKYLR 233
+ HPNI+ L+ + +++L + + W+ + + E L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP------ 287
I GL +H H D+KP N+L+ G + D + R++
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 288 ---GTPVFTAPECC 298
T + APE
Sbjct: 202 AQRCTISYRAPELF 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 45/214 (21%), Positives = 75/214 (35%), Gaps = 40/214 (18%)
Query: 108 SEDENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
+ N + + V + +G GS G VV ++ S G+ A+K
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDF----------- 51
Query: 167 AMTDVRREVLIM-KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG------KWDNDGFGQ 219
E+ ++ + HPN++ Y+ LE + N
Sbjct: 52 -CDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALELCNLNLQDLVESKNVSDEN 108
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------TVK 266
E LR I SG+ +LH ++H D+KP N+LV+ S +
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 267 IGDFSVSQVFEDDNDVLRRSP----GTPVFTAPE 296
I DF + + + R + GT + APE
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 25/185 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y ++G G++G V G ++A K H S VR+E+ M
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---------KETVRKEIQTMS 209
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLR 233
+L+HP +VNL + +D N M+ E++ G G + + E A +Y+R
Sbjct: 210 VLRHPTLVNLHDAFEDDN--EMVMIYEFMSG-----GELFEKVADEHNKMSEDEAVEYMR 262
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
+ GL ++H +N VH D+KP+N++ S +K+ DF ++ D ++ + GT
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAE 321
Query: 292 FTAPE 296
F APE
Sbjct: 322 FAAPE 326
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 35/191 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
V + +G G GKV+ + + +A+K RREV +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARREVELHW 109
Query: 180 MLQ-HPNIVNLIEVIDDPNS--DHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
P+IV +++V ++ + +V+E ++G + F E A
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------EREA 163
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRR 285
+ ++ I + YLH N+ H D+KP+NLL P+ +K+ DF ++ N L
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT 222
Query: 286 SPGTPVFTAPE 296
TP + APE
Sbjct: 223 PCYTPYYVAPE 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 36/189 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP 184
+G G++ +V + + + YA+K K + V REV ++ Q H
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHR 71
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVS 237
N++ LIE ++ D FY+V E + G G + E A ++D+ S
Sbjct: 72 NVLELIEFFEEE--DRFYLVFEKMRG-------GSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSP------- 287
L +LH + H D+KP+N+L VKI DF + + + D S
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 288 GTPVFTAPE 296
G+ + APE
Sbjct: 183 GSAEYMAPE 191
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 102 SNKLIRSEDENGTKMINEYVHVRK-----IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL 156
S + D + +Y + +G G+YG V R + AIK +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KW 212
+ + E+ + K L+H NIV + + + +E V G
Sbjct: 61 RYSQ---------PLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQVPGGSLSAL 109
Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFS 271
+G P E Y + I+ GL YLH + +VH DIK DN+L+ SG +KI DF
Sbjct: 110 LRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPE 296
S+ N GT + APE
Sbjct: 169 TSKRLAGINPCTETFTGTLQYMAPE 193
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 47/207 (22%), Positives = 73/207 (35%), Gaps = 37/207 (17%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
++ E+ + KIG+G +G V LDG YAIK +S + R
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLA----GSVDEQNALR 59
Query: 174 EV-LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMA 228
EV + QH ++V + DH + EY G ++ + E+
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------------TVKIGD 269
+ L + GL Y+H ++VH DIKP N+ ++ + KIGD
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 270 FSVSQVFEDDNDVLRRSPGTPVFTAPE 296
G F A E
Sbjct: 178 LGHVTRISSPQVEE----GDSRFLANE 200
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 26/183 (14%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
KIGAGS+G V +R+ G A+K + + + REV IMK L+H
Sbjct: 43 EKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFH-------AERVNEFLREVAIMKRLRH 93
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMARKYLRDI 235
PNIV + + P + +V EY+ G G + E D+
Sbjct: 94 PNIVLFMGAVTQP--PNLSIVTEYLSR-----GSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 236 VSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
G+ YLH N +VH ++K NLLV TVK+ DF +S++ + + GTP +
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 294 APE 296
APE
Sbjct: 207 APE 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H 183
+G G GKV+ G+ A+K + S R+EV
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------------KARQEVDHHWQASGG 81
Query: 184 PNIVNLIEVIDDPN--SDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLR 233
P+IV +++V ++ + +++E +EG + + F E A + +R
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT------EREAAEIMR 135
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
DI + + +LH HN+ H D+KP+NLL +K+ DF ++ + L+ TP
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTP 193
Query: 291 VFTAPE 296
+ APE
Sbjct: 194 YYVAPE 199
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-35
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 16/178 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
+IG GS+ V + A L+K + + E ++K LQHP
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-------SERQRFKEEAEMLKGLQHP 85
Query: 185 NIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
NIV +V E + + + + R + R I+ GL +L
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 243 HGHN--VVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
H ++H D+K DN+ + P+G+VKIGD ++ + ++ GTP F APE
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPE 200
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-35
Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
M+ +Y + KIG GSYG V R+ G+ AIK F +S V A+ RE+
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP--VIKK-IAL----REI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
++K L+HPN+VNL+EV ++V EY + + E + +
Sbjct: 54 RMLKQLKHPNLVNLLEVF--RRKRRLHLVFEYCD--HTVLHELDRYQRGVPEHLVKSITW 109
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP--- 290
+ + + H HN +H D+KP+N+L+ +K+ DF +++ P
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYYDD 161
Query: 291 -VFT----APECCLG 300
V T +PE +G
Sbjct: 162 EVATRWYRSPELLVG 176
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 102 SNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
S+ + + + + +Y ++ +G GSYG V+ R+ G+ AIK F +S K +
Sbjct: 9 SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--M 66
Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQ 219
AM RE+ ++K L+H N+VNL+EV +Y+V E+V+
Sbjct: 67 VKK-IAM----REIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVD--HTILDDLELF 117
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
P + + +KYL I++G+ + H HN++H DIKP+N+LV+ SG VK+ DF ++
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--- 174
Query: 280 NDVLRRSPGTP----VFT----APECCLG 300
+PG V T APE +G
Sbjct: 175 -----AAPGEVYDDEVATRWYRAPELLVG 198
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 48/202 (23%), Positives = 81/202 (40%), Gaps = 22/202 (10%)
Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
+ ++ D + ++ H ++G GS+G+V + G A+K K+R
Sbjct: 41 LLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVR 92
Query: 161 VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
+ E++ L P IV L + + + +E +EG Q
Sbjct: 93 LEVFR------VEELVACAGLSSPRIVPLYGAVREG--PWVNIFMELLEGGSLGQLIKQM 144
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDD 279
G + E A YL + GL YLH ++HGD+K DN+L++ G+ + DF + + D
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 280 NDVLRRSP-----GTPVFTAPE 296
GT APE
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPE 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 35/197 (17%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTD 170
+ +Y + KIG G+YG V ++ + A+K ++R+ PS +A+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPS-SAL-- 49
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMA 228
RE+ ++K L+H NIV L +V+ +V E+ + D + G + +
Sbjct: 50 --REICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFCD--QDLKKYFDSCNGDLDPEIV 103
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ +L ++ GL + H NV+H D+KP NLL+ +G +K+ +F +++ F
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----- 158
Query: 289 TP-VFT----APECCLG 300
+ V T P+ G
Sbjct: 159 SAEVVTLWYRPPDVLFG 175
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-----APSETAMTDV 171
+++ + K+G G+Y V + G + A+K ++++ PS TA+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK--------EVKLDSEEGTPS-TAI--- 51
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-------NDGFGQPGAIG 224
RE+ +MK L+H NIV L +VI N +V E+++ D P +
Sbjct: 52 -REISLMKELKHENIVRLYDVIHTENK--LTLVFEFMD--NDLKKYMDSRTVGNTPRGLE 106
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
++ + + ++ GL + H + ++H D+KP NLL+ G +K+GDF
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF 152
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 95 RQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFH 152
F VK S++ R ED + K+G G+YG V + D K YA+K
Sbjct: 5 YDFKVKLSSERERVEDL--FEYEGC-----KVGRGTYGHVYKAKRKDGKDDKDYALKQIE 57
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE--- 209
+ +S +A RE+ +++ L+HPN+++L +V +++ +Y E
Sbjct: 58 GTGIS-------MSAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 106
Query: 210 -----GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-- 262
+ +P + M + L I+ G+ YLH + V+H D+KP N+LV
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 166
Query: 263 --GTVKIGDFSVSQVFEDDNDVLRRSPGTP-VFT----APECCLG 300
G VKI D +++F L + P V T APE LG
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPL--ADLDPVVVTFWYRAPELLLG 209
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 29/182 (15%), Positives = 63/182 (34%), Gaps = 28/182 (15%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
K+ G++ ++ G +K S D E +++ H
Sbjct: 16 TKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWS-------TRKSRDFNEECPRLRIFSH 66
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-------FGQPGAIGESMARKYLRDIV 236
PN++ ++ P + H ++ ++ G G + +S A K+ D+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPY-----GSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 237 SGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
G+ +LH + + ++++ T +I V F+ + P + A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVA 176
Query: 295 PE 296
PE
Sbjct: 177 PE 178
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 30/207 (14%), Positives = 52/207 (25%), Gaps = 39/207 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
V + G V L R + +A+K F S + + +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE------NSRSELERLHEATFAAA 117
Query: 180 MLQHPN------------------------IVNLIEVIDDPNSDHFYMVLEYVEG----- 210
L + L DD ++ +++
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177
Query: 211 -KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269
+ + G G ++ L +VHG PDNL + P G + +GD
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237
Query: 270 FSVSQVFEDDNDVLRRSPGTPVFTAPE 296
S S + E
Sbjct: 238 VSALWK---VGTRGPASSVPVTYAPRE 261
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 32/195 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE----TAMTDVR 172
+ Y+ + K+G G+Y V +S L A+K ++R+ E TA+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALK--------EIRLEHEEGAPCTAI---- 48
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARK 230
REV ++K L+H NIV L ++I S +V EY++ D + I +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLD--KDLKQYLDDCGNIINMHNVKL 104
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
+L ++ GL Y H V+H D+KP NLL+ G +K+ DF +++
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-----DN 159
Query: 291 -VFT----APECCLG 300
V T P+ LG
Sbjct: 160 EVVTLWYRPPDILLG 174
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSK 158
+ E+ ++ +Y + K+G G+YG V Y++ G+ A+K +
Sbjct: 3 HHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVV--YKAKDSQGRIVALK--------R 52
Query: 159 LRV------APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
+R+ PS TA+ RE+ ++K L HPNIV+LI+VI +V E++E
Sbjct: 53 IRLDAEDEGIPS-TAI----REISLLKELHHPNIVSLIDVIHSERC--LTLVFEFME--K 103
Query: 213 DNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
D + +S + YL ++ G+ + H H ++H D+KP NLL+ G +K+ DF
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 271 SVSQVFEDDNDVLRRSPGTP-VFT----APECCLG 300
+++ F T V T AP+ +G
Sbjct: 164 GLARAFGIPVRSY-----THEVVTLWYRAPDVLMG 193
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 34/197 (17%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTD 170
+ + V KIG G+YG V R+ L G+ A+K K+R+ PS TA+
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPS-TAI-- 50
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMA 228
RE+ ++K L HPNIV L++VI N Y+V E++ K D G I +
Sbjct: 51 --REISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTG-IPLPLI 105
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
+ YL ++ GL + H H V+H D+KP NLL+ G +K+ DF +++ F
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----- 160
Query: 289 TP-VFT----APECCLG 300
T V T APE LG
Sbjct: 161 THEVVTLWYRAPEILLG 177
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
Y + +G G + V R + AIK H S+ + TA+ RE+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR-TAL----REI 63
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
+++ L HPNI+ L++ + + +V +++E D + + S + Y+
Sbjct: 64 KLLQELSHPNIIGLLDAF--GHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYML 119
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ GL YLH H ++H D+KP+NLL+ +G +K+ DF
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 156
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-33
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
P S + + + K ++ + +G GS+ VVL R + YAIK K H+
Sbjct: 10 PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 69
Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG- 216
K + R+V+ L HP V L D + Y L Y + G
Sbjct: 70 KEN----KVPYVTRERDVM--SRLDHPFFVKLYFTFQDD--EKLYFGLSYAKN-----GE 116
Query: 217 -FGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
G+ E+ R Y +IVS L YLHG ++H D+KP+N+L+ ++I DF
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 273 SQVFEDDNDVLRRSP--GTPVFTAPE 296
++V ++ R + GT + +PE
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPE 202
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 40/183 (21%), Positives = 75/183 (40%), Gaps = 30/183 (16%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
++IG+GS+G V Y+ G A+K + + P+ + + EV +++ +H
Sbjct: 30 QRIGSGSFGTV--YKGKWHG-DVAVKMLNVTA-------PTPQQLQAFKNEVGVLRKTRH 79
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDI 235
NI+ + P +V ++ EG R
Sbjct: 80 VNILLFMGYSTAP---QLAIVTQWCEG-------SSLYHHLHASETKFEMKKLIDIARQT 129
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFT 293
G+ YLH +++H D+K +N+ + TVKIGDF ++ + + G+ ++
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 294 APE 296
APE
Sbjct: 190 APE 192
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 3e-32
Identities = 27/238 (11%), Positives = 68/238 (28%), Gaps = 44/238 (18%)
Query: 90 NGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK 149
+ L+ + SE + V +G + G+ + +
Sbjct: 48 DSLVSTSLWNTGQPFRVESELGERPR---TLVRGTVLGQEDPYAYLEATDQETGESFEVH 104
Query: 150 AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-------------------------HP 184
+ + P A+ ++ EVL +++L+
Sbjct: 105 VPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDIVSG 238
++ + D + + ++ G ++ + ++
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L LH + +VH ++P ++++ G V + F + S + F PE
Sbjct: 219 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSSVSRGFEPPE 272
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 24/220 (10%), Positives = 66/220 (30%), Gaps = 35/220 (15%)
Query: 101 ESNKLIRSEDENGTKMINE-YVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKS 154
KL + + ++ ++ +G G++ +V + + + + +K +
Sbjct: 47 WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106
Query: 155 HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---- 210
+ + + + + +K + + +V E
Sbjct: 107 NPWEFYI---------GTQLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLL 155
Query: 211 -KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--------- 260
+ + + + + ++ + +H ++HGDIKPDN ++
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 261 --PSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPE 296
S + + D S+ + T F E
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 44/204 (21%)
Query: 118 NEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
++ +H +G G +G+ V +R + G+ +K + E +EV
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRET--GEVMVMKELIR---------FDEETQRTFLKEV 58
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESM 227
+M+ L+HPN++ I V+ + EY++G G S
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKD--KRLNFITEYIKG-------GTLRGIIKSMDSQYPWSQ 109
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
+ +DI SG+ YLH N++H D+ N LV + V + DF ++++ D+
Sbjct: 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 288 --------------GTPVFTAPEC 297
G P + APE
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEM 193
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 31/188 (16%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
IG G +GKV YR+ G A+KA + +VR+E + ML+H
Sbjct: 13 EIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKH 65
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGL 239
PNI+ L V + +V+E+ G G I + + I G+
Sbjct: 66 PNIIALRGVCLKE--PNLCLVMEFARG-----GPLNRVLSGKRIPPDILVNWAVQIARGM 118
Query: 240 MYLHGHN---VVHGDIKPDNLLV--------APSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
YLH ++H D+K N+L+ + +KI DF +++ + + G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAG 176
Query: 289 TPVFTAPE 296
+ APE
Sbjct: 177 AYAWMAPE 184
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (297), Expect = 2e-31
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 38/198 (19%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRV------APSETAMT 169
+ +Y + KIG G+YG V Y++ + G+ +A+K K+R+ PS T +
Sbjct: 1 MEKYHGLEKIGEGTYGVV--YKAQNNYGETFALK--------KIRLEKEDEGIPS-TTI- 48
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESM 227
RE+ I+K L+H NIV L +VI +V E+++ D G +
Sbjct: 49 ---REISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLD--QDLKKLLDVCEGGLESVT 101
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
A+ +L +++G+ Y H V+H D+KP NLL+ G +KI DF +++ F
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---- 157
Query: 288 GTP-VFT----APECCLG 300
T + T AP+ +G
Sbjct: 158 -THEIVTLWYRAPDVLMG 174
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 34/165 (20%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
V + +G G GKV+ + + +A+K RREV +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARREVELHW 65
Query: 179 KMLQHPNIVNLIEVIDDPNS--DHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
+ Q P+IV +++V ++ + +V+E ++G + F E A
Sbjct: 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------EREA 119
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDF 270
+ ++ I + YLH N+ H D+KP+NLL P+ +K+ DF
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G+ + Y V +IG G+YG V R G A+K + ++ VR
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVR 60
Query: 173 REVLIMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEG--KWDNDGFGQPGAIG 224
EV +++ L+ HPN+V L++V +D +V E+V+ + D PG +
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LP 118
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
+ +R + GL +LH + +VH D+KP+N+LV GTVK+ DF
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 42/186 (22%), Positives = 70/186 (37%), Gaps = 33/186 (17%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
IG G +G+V Y G+ AI+ +E + +REV+ + +H
Sbjct: 39 ELIGKGRFGQV--YHGRWHGE-VAIRLIDIER-------DNEDQLKAFKREVMAYRQTRH 88
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDI 235
N+V + P H ++ +G + + R+ ++I
Sbjct: 89 ENVVLFMGACMSP--PHLAIITSLCKG-------RTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-----DDNDVLRRSPGTP 290
V G+ YLH ++H D+K N+ +G V I DF + + D LR G
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 291 VFTAPE 296
APE
Sbjct: 199 CHLAPE 204
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 39/205 (19%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTD 170
+++Y + KIG G++G+V R G+ A+K K+ + P TA+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLMENEKEGFPI-TAL-- 64
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVE----GKWDNDGFGQP 220
RE+ I+++L+H N+VNLIE+ S + Y+V ++ E G N
Sbjct: 65 --REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VL 118
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
S ++ ++ +++GL Y+H + ++H D+K N+L+ G +K+ DF +++ F
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 281 DVLRRSPGTP-VFT----APECCLG 300
+ T V T PE LG
Sbjct: 179 NSQPN-RYTNRVVTLWYRPPELLLG 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 27/190 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
E +G G++G V ++ K AIK SE+ E+
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIE-----------SESERKAFIVELRQ 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK--WDN-DGFGQPGAIGESMARKYLRD 234
+ + HPNIV L +P +V+EY EG ++ G + A +
Sbjct: 55 LSRVNHPNIVKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 235 IVSGLMYLHGHN---VVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTP 290
G+ YLH ++H D+KP NLL+ GTV KI DF + D + + G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNKGSA 167
Query: 291 VFTAPECCLG 300
+ APE G
Sbjct: 168 AWMAPEVFEG 177
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 29/170 (17%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSET 166
I+ Y + K+G G+YG+V ++ + AIK ++R+ P T
Sbjct: 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--------RIRLEHEEEGVPG-T 79
Query: 167 AMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGE 225
A+ REV ++K LQH NI+ L VI + +++ EY E D + + +
Sbjct: 80 AI----REVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAE--NDLKKYMDKNPDVSM 131
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-----APSGTVKIGDF 270
+ + +L +++G+ + H +H D+KP NLL+ + + +KIGDF
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 48/188 (25%), Positives = 77/188 (40%), Gaps = 31/188 (16%)
Query: 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++IG G +G V ++ L D AIK+ + + +REV IM L
Sbjct: 25 KQIGKGGFGLV--HKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREVFIMSNL 80
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDI 235
HPNIV L ++ +P MV+E+V G + I S+ + + DI
Sbjct: 81 NHPNIVKLYGLMHNP----PRMVMEFVPC-----GDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 236 VSGLMYLHGHN--VVHGDIKPDNLLVAPSG-----TVKIGDFSVSQVFEDDNDVLRRSPG 288
G+ Y+ N +VH D++ N+ + K+ DF +SQ + G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLG 188
Query: 289 TPVFTAPE 296
+ APE
Sbjct: 189 NFQWMAPE 196
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 27/194 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++Y IG+G+ V + + AIK ++ + +T+M ++ +E+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK--------RINLEKCQTSMDELLKEIQA 66
Query: 178 MKMLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESM 227
M HPNIV+ V+ D ++V++ + G G + G + ES
Sbjct: 67 MSQCHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
LR+++ GL YLH + +H D+K N+L+ G+V+I DF VS D+ R
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 288 -----GTPVFTAPE 296
GTP + APE
Sbjct: 183 RKTFVGTPCWMAPE 196
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 4e-30
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 33/179 (18%)
Query: 109 EDENGTKMINEYVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRV---- 161
E + + +Y V +IG G+YGKV ++ G+ A+K ++RV
Sbjct: 2 EKDGLCRADQQYECVAEIGEGAYGKV--FKARDLKNGGRFVALK--------RVRVQTGE 51
Query: 162 --APSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEG--K 211
P + + REV +++ L+ HPN+V L +V +D +V E+V+
Sbjct: 52 EGMPL-STI----REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 106
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
D +PG + + + ++ GL +LH H VVH D+KP N+LV SG +K+ DF
Sbjct: 107 TYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
V+ IG G++G+V L R K YA+K K + K S++A R+++
Sbjct: 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR----SDSAFFWEERDIM--AFAN 127
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLM 240
P +V L D + YMV+EY+ G D + E AR Y ++V L
Sbjct: 128 SPWVVQLFYAFQDD--RYLYMVMEYMPG---GDLVNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
+H +H D+KPDN+L+ SG +K+ DF + V + GTP + +PE
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 23/207 (11%), Positives = 56/207 (27%), Gaps = 26/207 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH----------------LSKLRVAP 163
V +G + G+ + + + + L LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVID---DPNSDHFYMVLEYVEG------KWDN 214
++ R + +++ P +I V D + + ++ +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
++ + ++ L LH + +VH ++P ++++ G V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 275 VFEDDNDVLRRSP-GTPVFTAPECCLG 300
P TA
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPF 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 16/176 (9%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G++G+V + + K +A+K +K + + +ETA R+VL
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEM----LKRAETACFREERDVL--VNGDSKW 135
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMY 241
I L D ++ Y+V++Y G D + E MAR YL ++V +
Sbjct: 136 ITTLHYAFQDD--NNLYLVMDYYVG---GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
+H + VH DIKPDN+L+ +G +++ DF +D V GTP + +PE
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG G++ +V + + G+ YA+K +K + + E + R+VL+
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM----LKRGEVSCFREERDVLVN--GDRRW 122
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMY 241
I L D ++ Y+V+EY G D I MAR YL +IV +
Sbjct: 123 ITQLHFAFQDE--NYLYLVMEYYVG---GDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
+H VH DIKPDN+L+ G +++ DF D V GTP + +PE
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+R +G G +GKV L R +G + A+K L+ + D+++E+ I+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--------SLKPESGGNHIADLKKEIEIL 77
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ L H NIV + + + +++E++ G I KY I
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
G+ YL VH D+ N+LV VKIGDF +++ E D + PVF A
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 295 PEC 297
PEC
Sbjct: 198 PEC 200
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
R IG GS+GKV + + + K YA+K +K + + +V +E+ IM+ L+H
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN------EVRNVFKELQIMQGLEH 74
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLM 240
P +VNL D + +MV++ + G D Q E + ++ ++V L
Sbjct: 75 PFLVNLWYSFQDE--EDMFMVVDLLLG---GDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YL ++H D+KPDN+L+ G V I DF+++ + + + + GT + APE
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPE 184
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 39/202 (19%), Positives = 69/202 (34%), Gaps = 32/202 (15%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
R + G + V + G+ YA+K + K R + +EV MK
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---------AIIQEVCFMK 80
Query: 180 MLQ-HPNIVNLIEVI-----DDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARK 230
L HPNIV + +++L + + G + K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 231 YLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
+ ++H ++H D+K +NLL++ GT+K+ DF + D +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 288 -----------GTPVFTAPECC 298
TP++ PE
Sbjct: 201 RALVEEEITRNTTPMYRTPEII 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
KE T ++++ ++ +G GS+G+V+L + G HYA+K K + KL
Sbjct: 23 KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG- 218
+ + E I++ + P +V L D + YMV+EYV G G
Sbjct: 83 K------QIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAG-------GE 127
Query: 219 ------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+ G E AR Y IV YLH ++++ D+KP+NLL+ G +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 273 SQVFEDDNDVLRRSPGTPVFTAPE 296
++ + L GTP APE
Sbjct: 188 AKRVKGRTWTLC---GTPEALAPE 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 23/192 (11%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
G + +Y I G G + Y +++G+ +K L + A
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWI--YLALDRNVNGRPVVLKG--------LVHSGDAEA 122
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIG 224
E + + HP+IV + ++ + Y+V+EYV G+ GQ +
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA 182
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
E++A YL +I+ L YLH +V+ D+KP+N+++ +K+ D +
Sbjct: 183 EAIA--YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY- 238
Query: 285 RSPGTPVFTAPE 296
GTP F APE
Sbjct: 239 ---GTPGFQAPE 247
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 12/177 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +R+IG GS+G V R + + AIK S D+ +EV ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM------SYSGKQSNEKWQDIIKEVRFLQ 109
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L+HPN + ++V+EY G + + E + GL
Sbjct: 110 KLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
YLH HN++H D+K N+L++ G VK+GDF + + N + GTP + APE
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPE 220
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 46/192 (23%), Positives = 74/192 (38%), Gaps = 35/192 (18%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
V++IG G YG+V + G+ A+K F +E A E+ +++
Sbjct: 42 VKQIGKGRYGEV--WMGKWRGEKVAVKVFF----------TTEEASWFRETEIYQTVLMR 89
Query: 183 HPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIV 236
H NI+ I Y++ +Y E G + + + K V
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHEN-----GSLYDYLKSTTLDAKSMLKLAYSSV 144
Query: 237 SGLMYLHGHN--------VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
SGL +LH + H D+K N+LV +GT I D ++ F D + + P
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 288 ---GTPVFTAPE 296
GT + PE
Sbjct: 205 TRVGTKRYMPPE 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 27/219 (12%)
Query: 87 RELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHY 146
+G + F + + K I R +G G +GKV LY
Sbjct: 9 HHHHGALEVLFQGPGDPTVF---HKRYLKKI------RDLGEGHFGKVSLYCYDPTNDGT 59
Query: 147 ----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY 202
A+K L+ + ++E+ I++ L H +I+ +D +
Sbjct: 60 GEMVAVK--------ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111
Query: 203 MVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261
+V+EYV G + +IG + + + I G+ YLH + +H D+ N+L+
Sbjct: 112 LVMEYVPLG--SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169
Query: 262 SGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPEC 297
VKIGDF +++ + ++ R PVF APEC
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++++G G++G V + Y D A+K S +E + D RE+ I+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
K LQH NIV V + +++EY+ G + I +Y I
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
G+ YL +H D+ N+LV VKIGDF +++V D + + P+F A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 295 PEC 297
PE
Sbjct: 186 PES 188
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 48/178 (26%), Positives = 73/178 (41%), Gaps = 21/178 (11%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GSY KV+L R + YA+K K + + + V + HP
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELV----NDDEDIDWVQTEKHVF-EQASNHPF 71
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
+V L + V+EYV G G + + E AR Y +I
Sbjct: 72 LVGLHSCF--QTESRLFFVIEYVNG-------GDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH +++ D+K DN+L+ G +K+ D+ + + D GTP + APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 24/227 (10%)
Query: 76 HAKRSEEIFRERELNGLICR--QFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGK 133
A + F+E + R Q+ E+ + + ++ R +G G +G+
Sbjct: 151 LAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPM----------GEDWFLDFRVLGRGGFGE 200
Query: 134 VVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193
V + GK YA K +K L V +++L + IV+L
Sbjct: 201 VFACQMKATGKLYACKKLNKKRL----KKRKGYQGAMVEKKIL--AKVHSRFIVSLAYAF 254
Query: 194 DDPNSDHFYMVLEYVEG---KWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVH 249
+ +V+ + G ++ + E A Y IVSGL +LH N+++
Sbjct: 255 ETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
D+KP+N+L+ G V+I D ++ + + GTP F APE
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++++G G++G V + Y D A+K KL+ + +E + D RE+ I+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--------KLQHS-TEEHLRDFEREIEIL 96
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
K LQH NIV V + +++EY+ G + I +Y I
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
G+ YL +H D+ N+LV VKIGDF +++V D + + P+F A
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 295 PEC 297
PE
Sbjct: 217 PES 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 95 RQFPVKESNKLIR---SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
+ P+ + NK+I+ S+ + G + Y + + IG GS+G V + + AIK
Sbjct: 14 KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-- 70
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI----DDPNSDHFYMVLEY 207
K+ RE+ IM++++HPN+V+L D + +VLEY
Sbjct: 71 ------KVLQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 208 VEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SG 263
V + + + + Y+ ++ L Y+H + H DIKP NLL+ P SG
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179
Query: 264 TVKIGDFSVSQVFEDDNDVLRRSPGTP----VFT----APECCLG 300
+K+ DF +++ G P + + APE G
Sbjct: 180 VLKLIDFGSAKIL---------IAGEPNVSYICSRYYRAPELIFG 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-27
Identities = 57/174 (32%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G G++GKV+L R G++YA+K K + +A E A T VL + +HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL--QNTRHPF 66
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYL 242
+ L D V+EY G + F + E AR Y +IVS L YL
Sbjct: 67 LTALKYAFQTH--DRLCFVMEYANG---GELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +VV+ DIK +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 21/178 (11%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GSY KV+L R + YA++ K + + + V + HP
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELV----NDDEDIDWVQTEKHVF-EQASNHPF 114
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
+V L + V+EYV G G + + E AR Y +I
Sbjct: 115 LVGLHSCFQTE--SRLFFVIEYVNG-------GDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH +++ D+K DN+L+ G +K+ D+ + + D GTP + APE
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 39/190 (20%), Positives = 67/190 (35%), Gaps = 31/190 (16%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ G +G V +++ L ++ A+K F + EV + ++
Sbjct: 29 LEVKARGRFGCV--WKAQLLNEYVAVKIFP----------IQDKQSWQNEYEVYSLPGMK 76
Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSG 238
H NI+ I E +++ + E D F + + + + G
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD---FLKANVVSWNELCHIAETMARG 133
Query: 239 LMYLHGH----------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
L YLH + H DIK N+L+ + T I DF ++ FE
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 288 -GTPVFTAPE 296
GT + APE
Sbjct: 194 VGTRRYMAPE 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 38/197 (19%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + IG GS+G V + G+ AIK K+ RE+ IM+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKN-----RELQIMR 102
Query: 180 MLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYL 232
L H NIV L + + + +VL+YV + + + Y+
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
+ L Y+H + H DIKP NLL+ P + +K+ DF ++ G P
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---------VRGEPN 213
Query: 291 ---VFT----APECCLG 300
+ + APE G
Sbjct: 214 VSYICSRYYRAPELIFG 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV L + +AIKA K + + + T V + VL +HP
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV----LMDDDVECTMVEKRVL-SLAWEHPF 79
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
+ ++ ++ + V+EY+ G G S A Y +I+ G
Sbjct: 80 LTHMFCTFQTK--ENLFFVMEYLNG-------GDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH +V+ D+K DN+L+ G +KI DF + + + GTP + APE
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L R G YA+K K + + + T + +L HP
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVI----LQDDDVECTMTEKRIL-SLARNHPF 85
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
+ L D + V+E+V G D + E+ AR Y +I+S LM+L
Sbjct: 86 LTQLFCCF--QTPDRLFFVMEFVNG---GDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
H +++ D+K DN+L+ G K+ DF + + + GTP + APE
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+G+V L RS +G++YA+K K + +L+ + T+ R +L ++ HP
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK----QVEHTNDERLML--SIVTHPF 67
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
I+ + D +M+++Y+EG G + +A+ Y ++
Sbjct: 68 IIRMWGTFQDA--QQIFMIMDYIEG-------GELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH ++++ D+KP+N+L+ +G +KI DF ++ D L GTP + APE
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---GTPDYIAPE 173
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 25/250 (10%)
Query: 51 DDDDDNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSED 110
+ ++ A T DG + Q A+ + +G + + + + +
Sbjct: 91 ETPEEREEWTTAIQT-VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
K++ G G++GKV+L + G++YA+K K + VA E A T
Sbjct: 150 FEYLKLL---------GKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTL 196
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESM 227
VL + +HP + L D V+EY G + F + E
Sbjct: 197 TENRVL--QNSRHPFLTALKYSFQTH--DRLCFVMEYANG---GELFFHLSRERVFSEDR 249
Query: 228 ARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
AR Y +IVS L YLH NVV+ D+K +NL++ G +KI DF + + D ++
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 287 PGTPVFTAPE 296
GTP + APE
Sbjct: 310 CGTPEYLAPE 319
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 13/174 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YA+K K + + + T V + VL + P
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVL-ALPGKPPF 82
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ---PGAIGESMARKYLRDIVSGLMYL 242
+ L D Y V+EYV G D G E A Y +I GL +L
Sbjct: 83 LTQLHSCF--QTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+++ G +KI DF + + D + GTP + APE
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 31/190 (16%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+ +G G YG+V +R S G++ A+K F E+ ML+
Sbjct: 13 LECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFR----------ETELYNTVMLR 60
Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSG 238
H NI+ I ++ +S +++ Y E +D + Q + + + I SG
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD---YLQLTTLDTVSCLRIVLSIASG 117
Query: 239 LMYLHG--------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--- 287
L +LH + H D+K N+LV +G I D ++ + + L
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 288 -GTPVFTAPE 296
GT + APE
Sbjct: 178 VGTKRYMAPE 187
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 21/185 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+ ++G G++G V L R G + A+K S + R D +RE+ I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQIL 78
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGF--GQPGAIGESMARKYLRDI 235
K L IV V P +V+EY+ G + F + S Y I
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 136
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF- 292
G+ YL VH D+ N+LV VKI DF ++++ D D P+F
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 293 TAPEC 297
APE
Sbjct: 197 YAPES 201
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 45/196 (22%), Positives = 71/196 (36%), Gaps = 41/196 (20%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
IG G YG V Y+ SLD + A+K F ++ +E + + + +++H
Sbjct: 20 LIGRGRYGAV--YKGSLDERPVAVKVFSFANRQNFI---NE-------KNIYRVPLMEHD 67
Query: 185 NIVNLI---EVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVS 237
NI I E + + +V+EY G + + + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPN-----GSLXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 238 GLMYLHG---------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
GL YLH + H D+ N+LV GT I DF +S + V
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 288 -------GTPVFTAPE 296
GT + APE
Sbjct: 183 NAAISEVGTIRYMAPE 198
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 31/207 (14%)
Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
+ + + IN+ ++ ++G+G+ G+V R G A+K ++R
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK--------QMR 59
Query: 161 VAPSETAMTDVRREVLI-MKMLQHPNIVN-----LIEVIDDPNSDHFYMVLEYVEGKWDN 214
+ ++ + ++ + +K P IV + ++ +E + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-------TDVFIAMELMGTCAEK 112
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
G I E + K IV L YL H V+H D+KP N+L+ G +K+ DF +S
Sbjct: 113 LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 274 QVFED----DNDVLRRSPGTPVFTAPE 296
D D G + APE
Sbjct: 173 GRLVDDKAKDRSA-----GCAAYMAPE 194
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 45/192 (23%), Positives = 71/192 (36%), Gaps = 35/192 (18%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
IG G +G+V +R G+ A+K F E+ ML+
Sbjct: 47 QESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFR----------EAEIYQTVMLR 94
Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIV 236
H NI+ I + D+ ++V +Y E G + + K
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEH-----GSLFDYLNRYTVTVEGMIKLALSTA 149
Query: 237 SGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
SGL +LH + H D+K N+LV +GT I D ++ + D + +P
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 288 ---GTPVFTAPE 296
GT + APE
Sbjct: 210 HRVGTKRYMAPE 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
PV+ +++ + ++ + + KIG GS+G+V + K AIK
Sbjct: 5 PVQSGLPGMQNLKADPEEL---FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-------- 53
Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF 217
+ + +E + D+++E+ ++ P + ++++EY+ G
Sbjct: 54 IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGG------- 104
Query: 218 G------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
G +PG + E+ LR+I+ GL YLH +H DIK N+L++ G VK+ DF
Sbjct: 105 GSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164
Query: 272 VS-QVFEDDNDVLRRSP--GTPVFTAPE 296
V+ Q+ + ++R+ GTP + APE
Sbjct: 165 VAGQLT---DTQIKRNTFVGTPFWMAPE 189
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y KIG G+ G V G+ AI+ L+ P + + E+L+M+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKE---LIINEILVMR 72
Query: 180 MLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
++PNIVN ++ ++ D ++V+EY+ G D + E R+ +
Sbjct: 73 ENKNPNIVNYLDSYLVGD----ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
L +LH + V+H DIK DN+L+ G+VK+ DF Q+ + +RS GTP + A
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMA 184
Query: 295 PE 296
PE
Sbjct: 185 PE 186
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
KIG GS G V L R G+ A+K LR + EV+IM+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM------DLRKQQRRE---LLFNEVVIMR 97
Query: 180 MLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
QH N+V + + ++ + ++++E+++G D + E ++
Sbjct: 98 DYQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQ 152
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
L YLH V+H DIK D++L+ G VK+ DF Q+ DV +R GTP + A
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMA 209
Query: 295 PE 296
PE
Sbjct: 210 PE 211
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 56/178 (31%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
IG GS+GKV+L R + YA+K K + + E R VL+ K ++HP
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAI----LKKKEEKHIMSERNVLL-KNVKHPF 100
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
+V L D Y VL+Y+ G G + E AR Y +I S
Sbjct: 101 LVGLHFSFQTA--DKLYFVLDYING-------GELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH N+V+ D+KP+N+L+ G + + DF + + + N GTP + APE
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 47/209 (22%), Positives = 82/209 (39%), Gaps = 35/209 (16%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
K + + + G +++ + ++GAG+ G V G A K +
Sbjct: 15 KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK--------LI 66
Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY----------MVLEYVE 209
+ + RE+ ++ P IV FY + +E+++
Sbjct: 67 HLEIKPAIRNQIIRELQVLHECNSPYIV------------GFYGAFYSDGEISICMEHMD 114
Query: 210 GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIG 268
G + + G I E + K ++ GL YL H ++H D+KP N+LV G +K+
Sbjct: 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 269 DFSVSQVFEDDNDVLRRS-PGTPVFTAPE 296
DF VS D + S GT + +PE
Sbjct: 175 DFGVSGQLIDS---MANSFVGTRSYMSPE 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 23/188 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
N + R +G G +G+V + GK YA K K + AM +++L
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKQIL 238
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
+ + +V+L + D +VL + G GF E+ A
Sbjct: 239 --EKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYHMGQAGFP------EARA 288
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
Y +I GL LH +V+ D+KP+N+L+ G ++I D ++ + ++ G
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRVG 347
Query: 289 TPVFTAPE 296
T + APE
Sbjct: 348 TVGYMAPE 355
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 39/251 (15%), Positives = 76/251 (30%), Gaps = 68/251 (27%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH--------------LSKLR 160
+ + ++ ++ +G G +G V ++ +D +YAIK + L+KL
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 161 -----------------------------------VAPSETAMTDVRREVLIMKMLQHPN 185
S + M ++ M N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
V ++ + Y+ ++ W N + I + +
Sbjct: 123 TVGQLQP--SSPKVYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEF 179
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP------------GT 289
LH ++H D+KP N+ VK+GDF + + D + GT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 290 PVFTAPECCLG 300
++ +PE G
Sbjct: 240 KLYMSPEQIHG 250
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 22/229 (9%)
Query: 72 EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
+ ++F++ + R K N +N++ R IG G +
Sbjct: 150 IEEICQNLRGDVFQKFIESDKFTRFCQWKNVEL-------NIHLTMNDFSVHRIIGRGGF 202
Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLI 190
G+V R + GK YA+K K + + + R +L ++ P IV +
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLALNERIMLSLVSTGDCPFIVCMS 258
Query: 191 EVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYLHGHNV 247
P D +L+ + G D Q G E+ R Y +I+ GL ++H V
Sbjct: 259 YAFHTP--DKLSFILDLMNG---GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
V+ D+KP N+L+ G V+I D ++ + S GT + APE
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPE 360
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 13/174 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
+G GS+GKV+L + YA+K K + + + T V + VL + + P
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVLALPG-KPPF 403
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYL 242
+ L D Y V+EYV G D G E A Y +I GL +L
Sbjct: 404 LTQLHSCF--QTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+++ D+K DN+++ G +KI DF + + D + GTP + APE
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 37/214 (17%)
Query: 99 VKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK 158
++ S KL S +++ + + +IG G+YG V G+ A+K +
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK--------R 54
Query: 159 LRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDPNSDHFY----------MVLEY 207
+R E + ++ + M+ P IV FY + +E
Sbjct: 55 IRSTVDEKEQKQLLMDLDVVMRSSDCPYIV------------QFYGALFREGDCWICMEL 102
Query: 208 VEGKWDND----GFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPS 262
+ +D I E + K V L +L ++H DIKP N+L+ S
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162
Query: 263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
G +K+ DF +S D R G + APE
Sbjct: 163 GNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPE 195
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
Y IG GSYG V L+ + AIK F K R+ RE+
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RIL----------REI 103
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWD-NDGFGQPGAIGESMARKY 231
I+ L H ++V +++++ + + F Y+VLE + D F P + E +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLFRTPVYLTELHIKTL 161
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
L +++ G+ Y+H ++H D+KP N LV +VK+ DF +++ + + + P +P
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 292 FTAPE 296
Sbjct: 222 EDDMN 226
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 126 IGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
+G G YGKV R GK +A+K K+ + + +TA T R +L + ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNIL--EEVK 79
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDI 235
HP IV+LI Y++LEY+ G G + G E A YL +I
Sbjct: 80 HPFIVDLIYAFQTG--GKLYLILEYLSG-------GELFMQLEREGIFMEDTACFYLAEI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
L +LH +++ D+KP+N+++ G VK+ DF + + D V GT + AP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 296 E 296
E
Sbjct: 191 E 191
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ + K+G GSYG V G+ AIK P E+ + ++ +E+ IM+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----------QVPVESDLQEIIKEISIMQ 79
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESMARKYLRDIVSG 238
P++V + ++V+EY +D + + E L+ + G
Sbjct: 80 QCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPE 296
L YLH +H DIK N+L+ G K+ DF V+ + + + +R+ GTP + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPE 195
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 21/200 (10%)
Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
+E + R D N + V ++G G++GKV ++ G A K
Sbjct: 6 REYEHVRRDLDPNEV-----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----- 55
Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFG 218
SE + D E+ I+ HP IV L+ + ++++E+ G +
Sbjct: 56 ----SEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLE 109
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
+ E + R ++ L +LH ++H D+K N+L+ G +++ DF VS ++
Sbjct: 110 LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KN 167
Query: 279 DNDVLRRSP--GTPVFTAPE 296
+ +R GTP + APE
Sbjct: 168 LKTLQKRDSFIGTPYWMAPE 187
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 18/182 (9%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++ +G+G++G V L+ + AIK LR A S A ++ E +M
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--------LREATSPKANKEILDEAYVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ +P++ L+ + + ++ + + G + IG + I
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPVF-TAP 295
G+ YL +VH D+ N+LV VKI DF ++++ + G P+ A
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 296 EC 297
E
Sbjct: 189 ES 190
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 55/183 (30%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ IG+G G+V R AIKA L+ +E D E IM
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--------LKAGYTERQRRDFLSEASIMG 105
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
HPNI+ L V+ +V EY+E D F G LR + +
Sbjct: 106 QFDHPNIIRLEGVVTR--GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTA 294
G+ YL VH D+ N+LV + K+ DF +S+V EDD D + G P+ +TA
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 295 PEC 297
PE
Sbjct: 223 PEA 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 35/195 (17%), Positives = 69/195 (35%), Gaps = 30/195 (15%)
Query: 118 NEYVHVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
Y + IG G V L R G++ ++ L +E +T ++ E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI------NLEACSNEM-VTFLQGEL 77
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-------FGQPGAIGESMA 228
+ K+ HPNIV + ++V ++ G + E
Sbjct: 78 HVSKLFNHPNIVPYRATF--IADNELWVVTSFMAY-----GSAKDLICTHFMDGMNELAI 130
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD------ND 281
L+ ++ L Y+H VH +K ++L++ G V + + + +D
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 282 VLRRSPGTPVFTAPE 296
+ S + +PE
Sbjct: 191 FPKYSVKVLPWLSPE 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 54/183 (29%), Positives = 77/183 (42%), Gaps = 19/183 (10%)
Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +GAG +G+V L S AIK L+V +E D E IM
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT--------LKVGYTEKQRRDFLGEASIMG 101
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
HPNI+ L V+ S +V EY+E D F LR I S
Sbjct: 102 QFDHPNIIRLEGVVTK--SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTA 294
G+ YL VH D+ N+L+ + K+ DF + +V EDD + + G P+ +T+
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 295 PEC 297
PE
Sbjct: 219 PEA 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 56/184 (30%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+ IGAG +G+V + ++S K AIK L+ +E D E IM
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--------LKAGYTEKQRVDFLGEAGIM 100
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
H NI+ L VI ++ EY+E D F + G LR I
Sbjct: 101 GQFSHHNIIRLEGVISK--YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FT 293
+G+ YL N VH D+ N+LV + K+ DF +S+V EDD + + G P+ +T
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 294 APEC 297
APE
Sbjct: 218 APEA 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 28/182 (15%)
Query: 126 IGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHL-SKLRVAPSETAMTDVRREVLIMKML 181
+G GS+GKV L + + YA+K K+ L + RV T M E I+ +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV---RTKM-----ERDILVEV 83
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRD 234
HP IV L Y++L+++ G G + E + YL +
Sbjct: 84 NHPFIVKLHYAFQTE--GKLYLILDFLRG-------GDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ L +LH +++ D+KP+N+L+ G +K+ DF +S+ D GT + A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 295 PE 296
PE
Sbjct: 195 PE 196
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-24
Identities = 39/183 (21%), Positives = 74/183 (40%), Gaps = 20/183 (10%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++ +G+G +G V ++ + IK + + V +L +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--------IEDKSGRQSFQAVTDHMLAI 69
Query: 179 KMLQHPNIVNLIEVI-DDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
L H +IV L+ + +V +Y+ G + GA+G + + I
Sbjct: 70 GSLDHAHIVRLLGLCPGSS----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTA 294
G+ YL H +VH ++ N+L+ V++ DF V+ + D+ L S TP+ + A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 295 PEC 297
E
Sbjct: 186 LES 188
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 49/181 (27%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 124 RKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++G G++G V +YR AIK L+ + ++ RE IM L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQL 67
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
+P IV LI V ++ +V+E G F G+ I S + L + G+
Sbjct: 68 DNPYIVRLIGVCQ---AEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPE 296
YL N VH D+ N+L+ KI DF +S+ D+ P+ APE
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 297 C 297
C
Sbjct: 184 C 184
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVLIM 178
Y VRK+G G Y +V + + + +K L+ V + +RE+ I+
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVK--------ILKPVKKKKI-----KREIKIL 84
Query: 179 KMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ L+ PNI+ L +++ DP S +V E+V D Q + + R Y+ +I+
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILK 141
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDF 270
L Y H ++H D+KP N+++ +++ D+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 175
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 49/193 (25%), Positives = 77/193 (39%), Gaps = 21/193 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLD--GKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
Y R I +GSYG V + +D G AIK + V + R RE+
Sbjct: 24 YTVQRFISSGSYGAVC---AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
++ HPNI+ L ++ Y+V E + Q I + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-V 291
I+ GL LH VVH D+ P N+L+A + + I DF++++ D + T V
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK------THYV 194
Query: 292 FT----APECCLG 300
APE +
Sbjct: 195 THRWYRAPELVMQ 207
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 24/188 (12%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++ + ++G G+YG V R G+ A+K ++R + + ++ I
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK--------RIRATVNSQEQKRLLMDLDI 58
Query: 178 -MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLR 233
M+ + P V + ++ +E ++ D + I E + K
Sbjct: 59 SMRTVDCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 234 DIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED----DNDVLRRSPG 288
IV L +LH +V+H D+KP N+L+ G VK+ DF +S D D D G
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----G 171
Query: 289 TPVFTAPE 296
+ APE
Sbjct: 172 CKPYMAPE 179
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 50/184 (27%), Positives = 69/184 (37%), Gaps = 20/184 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ K+G GS+G V R D A+K LS AM D REV
Sbjct: 23 LEKLGDGSFGVV--RRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNA 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
M L H N++ L V+ + MV E G + G +Y +
Sbjct: 75 MHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-T 293
G+ YL +H D+ NLL+A VKIGDF + + ++D P
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 294 APEC 297
APE
Sbjct: 192 APES 195
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G + Y V K+G G V L ++ AIKA E +
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPP-----REKEETLKRFE 59
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
REV L H NIV++I+V ++ D +Y+V+EY+EG ++ G + A +
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-----NDVLRRSP 287
I+ G+ + H +VH DIKP N+L+ + T+KI DF +++ + N VL
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---- 173
Query: 288 GTPVFTAPE 296
GT + +PE
Sbjct: 174 GTVQYFSPE 182
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-23
Identities = 39/182 (21%), Positives = 74/182 (40%), Gaps = 18/182 (9%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
++ +G+G++G V L+ + AIK LR A S A ++ E +M
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--------LREATSPKANKEILDEAYVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ +P++ L+ + + ++ + + G + IG + I
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTAP 295
G+ YL +VH D+ N+LV VKI DF ++++ + G P+ + A
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 296 EC 297
E
Sbjct: 189 ES 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 26/183 (14%)
Query: 126 IGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHL-SKLRVAPSETAMTDVRREVLIMKML 181
+G G+YGKV L R GK YA+K K+ + K + T T R+VL +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVL-EHIR 116
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRD 234
Q P +V L +++L+Y+ G G Q E + Y+ +
Sbjct: 117 QSPFLVTLHYAFQTE--TKLHLILDYING-------GELFTHLSQRERFTEHEVQIYVGE 167
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFT 293
IV L +LH +++ DIK +N+L+ +G V + DF +S + D+ + GT +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 294 APE 296
AP+
Sbjct: 228 APD 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 11/194 (5%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
S + + + Y +G G +V L R D + A+K + L++ +
Sbjct: 2 SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLAR-----DPSF 55
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
RRE L HP IV + + + P Y+V+EYV+G D G +
Sbjct: 56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
A + + D L + H + ++H D+KP N++++ + VK+ DF +++ D + + +
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 286 SP---GTPVFTAPE 296
+ GT + +PE
Sbjct: 176 TAAVIGTAQYLSPE 189
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 124 RKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+++G+G++G V Y+ K A+K A ++ E +M+ L
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-------ANDPALKDELLAEANVMQQL 75
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
+P IV +I + + ++ + +V+E E N Q + + + + + G+ Y
Sbjct: 76 DNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPEC 297
L N VH D+ N+L+ KI DF +S+ D + + PV + APEC
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ V +G G+YG+V R G+ AIK + + ++++E+ ++K
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK----------VMDVTGDEEEEIKQEINMLK 75
Query: 180 ML-QHPNIVNL----IEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGESMARKYL 232
H NI I+ D ++V+E+ D + + E
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GT 289
R+I+ GL +LH H V+H DIK N+L+ + VK+ DF VS Q+ D V RR+ GT
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGT 192
Query: 290 PVFTAPE 296
P + APE
Sbjct: 193 PYWMAPE 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 19/180 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
+IG G++G+V + L + A+K R +E I+K
Sbjct: 119 GEQIGRGNFGEV--FSGRLRADNTLVAVK--------SCRETLPPDLKAKFLQEARILKQ 168
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSG 238
HPNIV LI V Y+V+E V+G D F + + + + D +G
Sbjct: 169 YSHPNIVRLIGVCTQ--KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PV-FTAPE 296
+ YL +H D+ N LV +KI DF +S+ D PV +TAPE
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 22/183 (12%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
R IG G +G V +Y S + AIK + S++ +E L M+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT--------CKNCTSDSVREKFLQEALTMR 71
Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
HP+IV LI VI ++P ++++E + F + ++ + Y +
Sbjct: 72 QFDHPHIVKLIGVITENP----VWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PVF-TA 294
+ L YL VH DI N+LV+ + VK+GDF +S+ ED + S G P+ A
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMA 185
Query: 295 PEC 297
PE
Sbjct: 186 PES 188
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
R IG G +G V +Y S + AIK + S++ +E L M+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--------CKNCTSDSVREKFLQEALTMR 446
Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
HP+IV LI VI ++P ++++E + F + ++ + Y +
Sbjct: 447 QFDHPHIVKLIGVITENP----VWIIMELCTLG-ELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TAP 295
+ L YL VH DI N+LV+ + VK+GDF +S+ ED P+ AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 296 EC 297
E
Sbjct: 562 ES 563
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 29/197 (14%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK---AFHKSHLSKLRVAPSETAMTDVRREVL 176
+ +G G+YG V G+ AIK F K + R RE+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTL----------REIK 61
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
I+K +H NI+ + + + ++F Y++ E ++ D + + + ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--DLHRVISTQMLSDDHIQYFIY 119
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF- 292
+ + LHG NV+H D+KP NLL+ + +K+ DF ++++ ++ G
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 293 -----T----APECCLG 300
T APE L
Sbjct: 180 VEFVATRWYRAPEVMLT 196
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 21/185 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
Y+ IG GSYG V L K+ AIK F K R+ RE+
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RIL----------REI 76
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWD-NDGFGQPGAIGESMARKY 231
I+ L+ I+ L ++I + F Y+VLE + D F P + E +
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--SDLKKLFKTPIFLTEEHIKTI 134
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
L +++ G ++H ++H D+KP N L+ +VK+ DF +++ + D +
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 292 FTAPE 296
Sbjct: 195 EEPGP 199
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
K+G G +G+V + + +G AIK P + +E +MK L
Sbjct: 189 EVKLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKL 236
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
+H +V L V+ + + Y+V EY+ G MA I
Sbjct: 237 RHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA----QI 289
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TA 294
SG+ Y+ N VH D++ N+LV + K+ DF ++++ ED+ R+ P+ TA
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 295 PEC 297
PE
Sbjct: 350 PEA 352
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 31/186 (16%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
K+G G YG+V Y A+K + + + +E +MK
Sbjct: 225 KHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAVMKE 272
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYL 232
++HPN+V L+ V FY++ E++ + + + MA
Sbjct: 273 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMAT--- 325
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
I S + YL N +H ++ N LV + VK+ DF +S++ D P+
Sbjct: 326 -QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 292 FTAPEC 297
+TAPE
Sbjct: 385 WTAPES 390
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-22
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
R +G G +G+V V + + A+K + + E +IMK
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKT--------CKKDCTLDNKEKFMSEAVIMK 68
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
L HP+IV LI +I+ + ++++E + + ++ Y I
Sbjct: 69 NLDHPHIVKLIGIIE---EEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PV-FTAP 295
+ YL N VH DI N+LVA VK+GDF +S+ ED+ D + S P+ + +P
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSP 183
Query: 296 EC 297
E
Sbjct: 184 ES 185
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-22
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 23/181 (12%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
V++IG+G +G V + K AIK + +S+ D E +M L
Sbjct: 13 VQEIGSGQFGLV--HLGYWLNKDKVAIKTIREGAMSE----------EDFIEEAEVMMKL 60
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
HP +V L V + +V E++E + Q G D+ G+
Sbjct: 61 SHPKLVQLYGVCLE--QAPICLVTEFME-HGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
YL V+H D+ N LV + +K+ DF +++ D D S GT PV + +PE
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPE 175
Query: 297 C 297
Sbjct: 176 V 176
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 9e-22
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
K+G G +G+V + + +G AIK P + +E +MK L
Sbjct: 272 EVKLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKL 319
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
+H +V L V+ + + Y+V EY+ G MA I
Sbjct: 320 RHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA----QI 372
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TA 294
SG+ Y+ N VH D++ N+LV + K+ DF ++++ ED+ R+ P+ TA
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 295 PEC 297
PE
Sbjct: 433 PEA 435
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 27/177 (15%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
+ DE K ++ + R G G++G V L + G AIK K+ P
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--------KVIQDPR--- 61
Query: 168 MTDVRREVLIMKML---QHPNIVNLIEVIDDPNSDHF-----YMVLEYVEG---KWDNDG 216
RE+ IM+ L HPNIV L +V+EYV + +
Sbjct: 62 --FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 217 FGQPGAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVAPS-GTVKIGDF 270
+ + A + + +L ++ + LH NV H DIKP N+LV + GT+K+ DF
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-21
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 29/183 (15%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
V ++GAG +G+V + +G A+K+ + +S E +MK L
Sbjct: 18 VERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSMSP----------DAFLAEANLMKQL 65
Query: 182 QHPNIVNLIEVI-DDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRD 234
QH +V L V+ +P Y++ EY+E G MA
Sbjct: 66 QHQRLVRLYAVVTQEP----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA----Q 117
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
I G+ ++ N +H D++ N+LV+ + + KI DF ++++ ED+ R P+ +T
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 294 APE 296
APE
Sbjct: 178 APE 180
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 23/180 (12%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++++G+G +G V G++ A+K + +S+ + +E M L
Sbjct: 13 LKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSE----------DEFFQEAQTMMKL 60
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
HP +V V Y+V EY+ + + S + D+ G+
Sbjct: 61 SHPKLVKFYGVCSK--EYPIYIVTEYIS-NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
+L H +H D+ N LV VK+ DF +++ DD V S GT PV ++APE
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV--SSVGTKFPVKWSAPE 175
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-21
Identities = 46/201 (22%), Positives = 73/201 (36%), Gaps = 39/201 (19%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ ++G +GKV G+ AIK L+ + R E ++
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--------LKDKAEGPLREEFRHEAML 65
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEG----------------KWDNDGFGQ 219
LQHPN+V L+ V+ D P M+ Y +D
Sbjct: 66 RARLQHPNVVCLLGVVTKDQP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
A+ + I +G+ YL H+VVH D+ N+LV VKI D + +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-A 180
Query: 280 NDVLRRSPGT--PV-FTAPEC 297
D + + P+ + APE
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEA 201
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 55/201 (27%), Positives = 80/201 (39%), Gaps = 40/201 (19%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
R++G G++GKV L + K A+KA L+ + A D +RE +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--------LKDP-TLAARKDFQREAEL 70
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAI 223
+ LQH +IV V DP MV EY++ GQP
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+ + I SG++YL + VH D+ N LV + VKIGDF +S+
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-S 185
Query: 280 NDVLRRSPGT--PV-FTAPEC 297
D R T P+ + PE
Sbjct: 186 TDYYRVGGHTMLPIRWMPPES 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 19/180 (10%)
Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++G G++G V +YR AIK L+ + ++ RE IM L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQLD 394
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLM 240
+P IV LI V ++ +V+E G + F G+ I S + L + G+
Sbjct: 395 NPYIVRLIGVCQ---AEALMLVMEMAGGGPLHK-FLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPEC 297
YL N VH ++ N+L+ KI DF +S+ D+ P+ APEC
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+K+GAG +G+V + ++ + A+K P ++ E +MK L
Sbjct: 193 EKKLGAGQFGEV--WMATYNKHTKVAVKTMK----------PGSMSVEAFLAEANVMKTL 240
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
QH +V L V+ + Y++ E++ ++G QP + I
Sbjct: 241 QHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA----QI 293
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTA 294
G+ ++ N +H D++ N+LV+ S KI DF +++V ED+ R P+ +TA
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 295 PE 296
PE
Sbjct: 354 PE 355
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-21
Identities = 41/185 (22%), Positives = 69/185 (37%), Gaps = 33/185 (17%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++++G G +G V G++ AIK + + E +M L
Sbjct: 29 LKELGTGQFGVV--KYGKWRGQYDVAIKMIK----------EGSMSEDEFIEEAKVMMNL 76
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMARKYLRD 234
H +V L V +++ EY+ + F + M + D
Sbjct: 77 SHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE--MCK----D 128
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV- 291
+ + YL +H D+ N LV G VK+ DF +S+ D D S G+ PV
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVR 186
Query: 292 FTAPE 296
++ PE
Sbjct: 187 WSPPE 191
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-21
Identities = 55/198 (27%), Positives = 81/198 (40%), Gaps = 35/198 (17%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++G G++GKV L + L + A+KA L+ A SE+A D +RE +
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--------LKEA-SESARQDFQREAEL 96
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------------KWDNDGFGQPGA 222
+ MLQH +IV V + MV EY+ PG
Sbjct: 97 LTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
+G + +G++YL G + VH D+ N LV VKIGDF +S+ D
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDY 213
Query: 283 LRRSPGT--PV-FTAPEC 297
R T P+ + PE
Sbjct: 214 YRVGGRTMLPIRWMPPES 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 25/182 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
K+G G YG+V Y A+K + + + +E +MK
Sbjct: 18 KHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAVMKE 65
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVS 237
++HPN+V L+ V FY++ E++ + + + + I S
Sbjct: 66 IKHPNLVQLLGVCTR--EPPFYIITEFMT-YGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
+ YL N +H D+ N LV + VK+ DF +S++ D G P+ TA
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 180
Query: 295 PE 296
PE
Sbjct: 181 PE 182
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 34/196 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK---AFHKSHLSKLRVAPSETAMTDVRREVL 176
Y ++ IG G+YG V +L+ AIK F + R RE+
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTL----------REIK 77
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
I+ +H NI+ + ++I P + Y+V + +E Q + +L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLY 135
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
I+ GL Y+H NV+H D+KP NLL+ + +KI DF +++V + D+D T T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD------HTGFLT 189
Query: 294 ---------APECCLG 300
APE L
Sbjct: 190 EYVATRWYRAPEIMLN 205
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 38/179 (21%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
R++G GS+G V + + + + AIK + A S + E +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--------VNEAASMRERIEFLNEASV 81
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAI 223
MK ++V L+ V P +++E + N+ P ++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 224 GE--SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD 279
+ MA +I G+ YL+ + VH D+ N +VA TVKIGDF ++ ++E D
Sbjct: 138 SKMIQMA----GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVR--R 173
Y V+K+G G+YG V G+ A+K AF S ++ R R
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-------------RTFR 57
Query: 174 EVLIMK-MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
E++I+ + H NIVNL+ V+ N Y+V +Y+E + + +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVV 115
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
++ + YLH ++H D+KP N+L+ VK+ DF
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-20
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 43/205 (20%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK--AFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y+ ++ +G G G V + K AIK K RE+ I
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-HAL----------REIKI 61
Query: 178 MKMLQHPNIVNLIEVIDDPNS------------DHFYMVLEYVEGKWDNDGFGQPGAIGE 225
++ L H NIV + E++ S + Y+V EY+E D + G + E
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET--DLANVLEQGPLLE 119
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLR 284
AR ++ ++ GL Y+H NV+H D+KP NL + +KIGDF ++++ +
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS--- 176
Query: 285 RSPGTPVFT---------APECCLG 300
+ +P L
Sbjct: 177 ---HKGHLSEGLVTKWYRSPRLLLS 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 42/191 (21%), Positives = 68/191 (35%), Gaps = 53/191 (27%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + +G GS+G V GK +A+K K+ P RE+ IMK
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK--------KVLQDPRYK-----NRELDIMK 55
Query: 180 MLQHPNIVNLIEVIDDPNSDHF------------------------------------YM 203
+L H NI+ L++ + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 204 VLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260
++EYV K +I ++ Y+ + + ++H + H DIKP NLLV
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 261 P-SGTVKIGDF 270
T+K+ DF
Sbjct: 176 SKDNTLKLCDF 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 40/182 (21%), Positives = 73/182 (40%), Gaps = 19/182 (10%)
Query: 124 RKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
IG G +G V L + H A+K+ L ++ E +IMK
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--------LNRITDIGEVSQFLTEGIIMKD 146
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSG 238
HPN+++L+ + + +VL Y++ D F + + + G
Sbjct: 147 FSHPNVLSLLGICLR-SEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIGFGLQVAKG 204
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGT--PV-FTA 294
+ +L VH D+ N ++ TVK+ DF ++ +++ + D + G PV + A
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 295 PE 296
E
Sbjct: 265 LE 266
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 33/194 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
Y +++ IG+G+ G V ++ ++ AIK F +K R RE+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAY----------REL 112
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++MK + H NI++L+ V + Y+V+E ++ +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL-CQVIQME--LDHERMSYL 169
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
L ++ G+ +LH ++H D+KP N++V T+KI DF +++ + TP
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPY 223
Query: 291 VFT----APECCLG 300
V T APE LG
Sbjct: 224 VVTRYYRAPEVILG 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 30/130 (23%), Positives = 53/130 (40%), Gaps = 11/130 (8%)
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
+RE LQ P++V + + + Y+ + + G + G + A
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI 139
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-----NDVLRRS 286
+R I S L H H D+KP+N+LV+ + DF ++ D+ + +
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--- 196
Query: 287 PGTPVFTAPE 296
GT + APE
Sbjct: 197 -GTLYYMAPE 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 32/193 (16%), Positives = 67/193 (34%), Gaps = 35/193 (18%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREV 175
+G G++ K+ + R D +K K+H +
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE---------SFFEAA 63
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
+M L H ++V V D +V E+V+ D + I + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCVC--GDENILVQEFVKFG-SLDTYLKKNKNCINILWKLEVAK 120
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--------PSGTVKIGDFSVSQVFEDDNDVLRR 285
+ + + +L + ++HG++ N+L+ +K+ D +S D+L+
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQ- 178
Query: 286 SPGTPV-FTAPEC 297
+ + PEC
Sbjct: 179 ---ERIPWVPPEC 188
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 47/194 (24%), Positives = 72/194 (37%), Gaps = 33/194 (17%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+R +G G++G+V + A+K L SE D E LI
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--------LPEVCSEQDELDFLMEALI 86
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA 228
+ H NIV I V P ++++E + G + QP ++
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLP----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRR 285
RDI G YL ++ +H DI N L+ G KIGDF +++ R+
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRK 201
Query: 286 SPGT--PV-FTAPE 296
PV + PE
Sbjct: 202 GGCAMLPVKWMPPE 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
YV +G+G+YG V G+ AIK F +K R RE+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAY----------REL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWD-NDGFGQPGAIGESMARK 230
L++K +QH N++ L++V +S FY+V+ +++ D G E +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT--DLQKIMGLK--FSEEKIQY 130
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+ ++ GL Y+H VVH D+KP NL V +KI DF +++ + +
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
Y ++ +G+G+YG V G AIK F +K R RE+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAY----------REL 75
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++K ++H N++ L++V + FY+V+ ++ D + +GE +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGEDRIQFL 133
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+ ++ GL Y+H ++H D+KP NL V +KI DF +++ + +
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 25/192 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRR 173
Y +++ IG+G+ G V ++ ++ AIK F +K R R
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAY----------R 73
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWD-NDGFGQPGAIGESMA 228
E+++MK + H NI+ L+ V S Y+V+E ++ + +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA--NLCQVIQME--LDHERM 129
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
L ++ G+ +LH ++H D+KP N++V T+KI DF +++ + ++
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV 188
Query: 289 TPVFTAPECCLG 300
T + APE LG
Sbjct: 189 TRYYRAPEVILG 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-19
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 27/180 (15%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
++ IG G +G V G A+K ++ E +M L+
Sbjct: 26 LQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ-----------AFLAEASVMTQLR 72
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGL 239
H N+V L+ VI + Y+V EY+ K + +G K+ D+ +
Sbjct: 73 HSNLVQLLGVIVE-EKGGLYIVTEYMA-KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
YL G+N VH D+ N+LV+ K+ DF +++ + PV +TAPE
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPE 184
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 40/183 (21%), Positives = 71/183 (38%), Gaps = 19/183 (10%)
Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
IG G +G V L + H A+K+ L ++ E +IMK
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--------LNRITDIGEVSQFLTEGIIMK 81
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
HPN+++L+ + +VL Y++ D F + + +
Sbjct: 82 DFSHPNVLSLLGICLRSEG-SPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGT--PV-FT 293
G+ YL VH D+ N ++ TVK+ DF ++ +++ + + G PV +
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 294 APE 296
A E
Sbjct: 200 ALE 202
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 48/194 (24%), Positives = 72/194 (37%), Gaps = 33/194 (17%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+R +G G++G+V + A+K L SE D E LI
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--------LPEVCSEQDELDFLMEALI 127
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA 228
+ H NIV I V P +++LE + G + QP ++
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLP----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRR 285
RDI G YL ++ +H DI N L+ G KIGDF +++ R+
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RAGYYRK 242
Query: 286 SPGT--PV-FTAPE 296
PV + PE
Sbjct: 243 GGCAMLPVKWMPPE 256
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-19
Identities = 44/196 (22%), Positives = 77/196 (39%), Gaps = 47/196 (23%)
Query: 124 RKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
R IG G +G V Y + AIK+ L + RE L+M+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--------LSRITEMQQVEAFLREGLLMRG 78
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR------- 233
L HPN++ LI ++ P +++L Y+ G + +++R
Sbjct: 79 LNHPNVLALIGIMLPPEG-LPHVLLPYMCH----------GDL-----LQFIRSPQRNPT 122
Query: 234 ---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVL 283
+ G+ YL VH D+ N ++ S TVK+ DF ++ + + + +
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 284 RRSPGT--PV-FTAPE 296
++ PV +TA E
Sbjct: 183 QQHRHARLPVKWTALE 198
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-19
Identities = 39/190 (20%), Positives = 71/190 (37%), Gaps = 24/190 (12%)
Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
R +G G +G V L + A+K + + + + RE MK
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD-------IIASSDIEEFLREAACMK 80
Query: 180 MLQHPNIVNLIEVI--DDPNSDH--FYMVLEYVEGK------WDNDGFGQPGAIGESMAR 229
HP++ L+ V ++L +++ + P +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
+++ DI G+ YL N +H D+ N ++A TV + DF +S+ D R+ +
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGCAS 199
Query: 290 --PV-FTAPE 296
PV + A E
Sbjct: 200 KLPVKWLALE 209
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
Y ++ +G+G+YG V + G A+K F +K R RE+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTY----------REL 79
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
++K ++H N++ L++V S + Y+V + +N Q + + +
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFL 137
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+ I+ GL Y+H +++H D+KP NL V +KI DF +++ D+
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 40/198 (20%), Positives = 72/198 (36%), Gaps = 40/198 (20%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
IG G++G+V ++ + AIK +++ S+ D E+ ++
Sbjct: 30 QDVIGEGNFGQV--LKARIKKDGLRMDAAIK--------RMKEYASKDDHRDFAGELEVL 79
Query: 179 KML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWDNDGFGQPG 221
L HPNI+NL+ + + Y+ +EY
Sbjct: 80 CKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
+ + D+ G+ YL +H D+ N+LV + KI DF +S+ +
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 193
Query: 282 VLRRSPGT--PV-FTAPE 296
V + PV + A E
Sbjct: 194 VYVKKTMGRLPVRWMAIE 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 43/179 (24%), Positives = 64/179 (35%), Gaps = 43/179 (24%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
VR IG G++G+V L + + A+K L+ S D +RE +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--------LKEEASADMQADFQREAAL 103
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG---------------KWDNDGFGQP 220
M +PNIV L+ V + P ++ EY+ +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 221 GAIGESMARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
A S L R + +G+ YL VH D+ N LV + VKI DF
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 50/219 (22%), Positives = 81/219 (36%), Gaps = 37/219 (16%)
Query: 91 GLICR--QFPVKESNKLIRSEDENGTKMIN--EYVHVRKIGAGSYGKVVLYRSSLDGKHY 146
GL R + V E + E +N E ++ IG G +G V G
Sbjct: 162 GLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKV 219
Query: 147 AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE 206
A+K ++ ++ E +M L+H N+V L+ VI + Y+V E
Sbjct: 220 AVKC--------IK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE 267
Query: 207 YVEGK------WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260
Y+ G + D+ + YL G+N VH D+ N+LV+
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSL----DVCEAMEYLEGNNFVHRDLAARNVLVS 323
Query: 261 PSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
K+ DF +++ + PV +TAPE
Sbjct: 324 EDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPE 356
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 25/190 (13%)
Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +G G +G V L + A+K + S + + + E MK
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------QREIEEFLSEAACMK 91
Query: 180 MLQHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGF-------GQPGAIGESMAR 229
HPN++ L+ V ++L +++ D + P I
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIPLQTLL 150
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
K++ DI G+ YL N +H D+ N ++ TV + DF +S+ D R+
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGRIA 209
Query: 290 --PV-FTAPE 296
PV + A E
Sbjct: 210 KMPVKWIAIE 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-18
Identities = 18/156 (11%), Positives = 50/156 (32%), Gaps = 16/156 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
Y + G + ++ ++LD + A+ + + + L
Sbjct: 33 YRLLIFHGGVPPLQF--WQALDTALD-RQVALTFVDPQG------VLPDDVLQETLSRTL 83
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
+ + P + +++V+ +V E++ G + + A + ++ +
Sbjct: 84 RLSRIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLA 139
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+ H V P + V+ G V + +
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT 175
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 45/207 (21%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +G G +GKVV Y A+K L+ S + + D+ E +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK--------MLKENASPSELRDLLSEFNV 79
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG---------------KWDNDGFGQP 220
+K + HP+++ L D P +++EY + + G +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 221 GAIGESMARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
+ + + L I G+ YL +VH D+ N+LVA +KI DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 272 VSQ-VFEDDNDVLRRSPGTPV-FTAPE 296
+S+ V+E+D+ V R PV + A E
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 43/203 (21%), Positives = 75/203 (36%), Gaps = 40/203 (19%)
Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +GAG++GKVV + A+K L+ + T + E+ +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--------MLKPSAHLTEREALMSELKV 79
Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGA 222
+ L H NIVNL+ I P ++ EY +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 223 IGESMARKYL------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QV 275
+ +A + G+ +L N +H D+ N+L+ KI DF ++ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 276 FEDDNDVLRRSPGTPV-FTAPEC 297
D N V++ + PV + APE
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPES 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 34/199 (17%), Positives = 81/199 (40%), Gaps = 33/199 (16%)
Query: 123 VRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +G G++G+V+ + + A+K L+ + + + E+ I
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--------MLKEGATHSEHRALMSELKI 83
Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVE------------GKWDNDGFGQPGAIG 224
+ + H N+VNL+ P +++E+ + ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
+ + ++L + G+ +L +H D+ N+L++ VKI DF +++ +++D
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 280 NDVLRRSPGTPV-FTAPEC 297
+ V + P+ + APE
Sbjct: 203 DYVRKGDARLPLKWMAPET 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 44/198 (22%), Positives = 74/198 (37%), Gaps = 36/198 (18%)
Query: 123 VRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +GAG++GKVV A+K L+ + E+ I
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--------MLKSTAHADEKEALMSELKI 102
Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIG 224
M L QH NIVNL+ P ++ EY +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD 279
+ + + L + G+ +L N +H D+ N+L+ KIGDF ++ + D
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 280 NDVLRRSPGTPV-FTAPE 296
N +++ + PV + APE
Sbjct: 219 NYIVKGNARLPVKWMAPE 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 40/202 (19%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-------PSETAMTDVRREV 175
+ +G G++G+VV A+ + VA +E ++D+ E+
Sbjct: 40 GKPLGEGAFGQVV--------MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 176 LIMKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQP 220
+MKM+ +H NI+NL+ D P Y+++EY +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 221 GAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QV 275
E M K L + G+ YL +H D+ N+LV + +KI DF ++ +
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 276 FEDDNDVLRRSPGTPV-FTAPE 296
D + PV + APE
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPE 229
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 40/174 (22%), Positives = 67/174 (38%), Gaps = 38/174 (21%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-------PSETAMTDVRREV 175
+ +G G +G+VV A+ + VA +E ++D+ E+
Sbjct: 86 GKPLGEGCFGQVV--------MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 176 LIMKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQP 220
+MKM+ +H NI+NL+ D P Y+++EY +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 221 GAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
E M K L + G+ YL +H D+ N+LV + +KI DF
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 45/208 (21%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +G+G++GKV+ A+K L+ + + E+ +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--------MLKEKADSSEREALMSELKM 101
Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------------------KWDND 215
M L H NIVNL+ + P Y++ EY +++N
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 216 GFGQPGAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
+ + + L + G+ +L + VH D+ N+LV VKI DF
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 272 VS-QVFEDDNDVLRRSPGTPV-FTAPEC 297
++ + D N V+R + PV + APE
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPES 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 32/198 (16%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK-----LRVAPSETAMTDVRREVLI 177
+ +G G++G+VVL + + + ++K L+ +E ++D+ E+ +
Sbjct: 74 GKPLGEGAFGQVVL------AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAIG 224
MKM+ +H NI+NL+ Y+++EY +
Sbjct: 128 MKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD 279
E ++ K L + G+ YL +H D+ N+LV +KI DF ++ + D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 280 NDVLRRSPGTPV-FTAPE 296
+ PV + APE
Sbjct: 246 YYKKTTNGRLPVKWMAPE 263
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 7e-14
Identities = 32/197 (16%), Positives = 58/197 (29%), Gaps = 42/197 (21%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ KIG G +G+V +++ D AIK L + ++ E++I
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAI-EGPDLVNGSHQKTFEEILPEIII 76
Query: 178 MKMLQ---------HPNIVNLIEVI----------------------------DDPNSDH 200
K L + L V D D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLV 259
++VLE+ G D + + A+ L + + L H D+ N+L+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 260 APSGTVKIGDFSVSQVF 276
+ K+ +
Sbjct: 196 KKTSLKKLHYTLNGKSS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 37/189 (19%), Positives = 78/189 (41%), Gaps = 46/189 (24%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIM 178
Y+ VRK+G G + V L + ++ H A+K + + T+ E+ ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----------IVRGDKVYTEAAEDEIKLL 69
Query: 179 KMLQ--------HPNIVNLIEVIDD-----PNSDHFYMVLE------Y-VEGKWDNDGFG 218
+ + ++++++D PN H MV E + K+++ G
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPS------GTVKIGDFS 271
++ + ++ GL Y+H ++H DIKP+N+L+ +KI D
Sbjct: 130 LI------YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 272 VSQVFEDDN 280
+ + D++
Sbjct: 184 NA-CWYDEH 191
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 24/160 (15%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
G Y +RK+G G + V L K A+K + K +ETA+
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETAL---- 81
Query: 173 REVLIMKMLQ-----HPNIVNLIEVIDD-----PNSDHFYMVLEYVEGK--WDNDGFGQP 220
E+ ++K ++ PN +++++DD N H MV E V G
Sbjct: 82 DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNY 140
Query: 221 GAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLV 259
+ +K ++ ++ GL YLH ++H DIKP+N+L+
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 36/188 (19%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
K+G G +G V Y+ ++ A+K L+ + +E +E+ +M QH
Sbjct: 38 KMGEGGFGVV--YKGYVNNTTVAVKK-----LAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 185 NIVNLIEV-IDDPNSDHFYMVLEYVE-GKWDNDGFGQPG------------AIGESMARK 230
N+V L+ D D +V Y+ G + G A G A
Sbjct: 91 NLVELLGFSSDG---DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG--AAN- 144
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPG 288
G+ +LH ++ +H DIK N+L+ + T KI DF +++ E + R G
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197
Query: 289 TPVFTAPE 296
T + APE
Sbjct: 198 TTAYMAPE 205
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 36/172 (20%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
N++ RKIG+GS+G++ L + + AIK + +T + E I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLLYESKI 55
Query: 178 MKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEY----VEGKWDNDGFGQPGAIGESMARKYL 232
++LQ I N+ D+ +V++ +E ++ +
Sbjct: 56 YRILQGGTGIPNVRWFG--VEGDYNVLVMDLLGPSLEDLFNF----CSRKLSLKTVLMLA 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDND 281
+++ + ++H + +H DIKPDN L+ V I DF +++ + D +
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 45/172 (26%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSETAMTDVRR 173
Y ++ IG GS+G+VV +H A+K FH+ A
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR------------QAAE---- 142
Query: 174 EVLIMKMLQH------PNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQP 220
E+ I++ L+ N+++++E N H M E + K GF
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSL- 199
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIGDF 270
+ RK+ I+ L LH + ++H D+KP+N+L+ G +K+ DF
Sbjct: 200 -----PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 49/195 (25%)
Query: 125 KIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+G G +GKV Y+ L DG A+K +L+ ++ + EV ++ M H
Sbjct: 37 ILGRGGFGKV--YKGRLADGTLVAVK--------RLKEERTQGGELQFQTEVEMISMAVH 86
Query: 184 PNIVNL----IEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPG-------------AIGE 225
N++ L + +V Y+ G + +P A+G
Sbjct: 87 RNLLRLRGFCMT------PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG- 139
Query: 226 SMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND- 281
AR GL YLH H ++H D+K N+L+ +GDF ++++ + +
Sbjct: 140 -SAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 282 VLRRSPGTPVFTAPE 296
V GT APE
Sbjct: 191 VTTAVRGTIGHIAPE 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 42/172 (24%), Positives = 67/172 (38%), Gaps = 25/172 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
N Y RKIG+GS+G + L G+ AIK + +T + E I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----------LECVKTKHPQLHIESKI 57
Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEY----VEGKWDNDGFGQPGAIGESMARKYL 232
KM+Q I + D+ MV+E +E ++
Sbjct: 58 YKMMQGGVGIPTIRWCG--AEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLA 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDND 281
++S + Y+H N +H D+KPDN L+ V I DF +++ + D
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 36/179 (20%), Positives = 65/179 (36%), Gaps = 37/179 (20%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y R+IG GS+G + + L+ + AIK P + +R E
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----------FEPRRSDAPQLRDEYRT 58
Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESM 227
K+L I N+ H +V++ + G D G + M
Sbjct: 59 YKLLAGCTGIPNVYYFG--QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGDFSVSQVFEDDND 281
++ + +H ++V+ DIKPDN L+ + + + DF + + + D
Sbjct: 116 --------LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 40/190 (21%)
Query: 124 RKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
IG G +GKV Y+ L DG A+K S + + E+ + +
Sbjct: 45 FLIGHGVFGKV--YKGVLRDGAKVALKRRTPE---------SSQGIEEFETEIETLSFCR 93
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPG-------------AIGESMA 228
HP++V+LI D+ + ++ +Y+E G +G IG A
Sbjct: 94 HPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG--AA 149
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRS 286
R GL YLH ++H D+K N+L+ + KI DF +S+ + + +
Sbjct: 150 R--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201
Query: 287 PGTPVFTAPE 296
GT + PE
Sbjct: 202 KGTLGYIDPE 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 37/179 (20%), Positives = 70/179 (39%), Gaps = 37/179 (20%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +KIG G++G++ L ++ ++ AIK + P ++ + E
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----------LEPMKSRAPQLHLEYRF 57
Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESM 227
K L I + P + MVLE + G D F I +
Sbjct: 58 YKQLGSGDGIPQVYYFG--PCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL 114
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGDFSVSQVFEDDND 281
+S + Y+H N+++ D+KP+N L+ G + I DF++++ + D
Sbjct: 115 --------ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 43/191 (22%), Positives = 74/191 (38%), Gaps = 48/191 (25%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSET 166
G K ++ Y IG GS+G+VV ++ + AIK AF
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN------------Q 96
Query: 167 AMTDVRREVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLEYVEG-------KWD 213
A EV +++++ IV+L N H +V E + +
Sbjct: 97 AQI----EVRLLELMNKHDTEMKYYIVHLKRHFMFRN--HLCLVFEMLSYNLYDLLRNTN 150
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDN-LLVAPSGT-VKIGD 269
G ++ RK+ + + + L++L +++H D+KP+N LL P + +KI D
Sbjct: 151 FRGVSL------NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 270 FSVSQVFEDDN 280
F S
Sbjct: 205 FG-SSCQLGQR 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 35/182 (19%), Positives = 69/182 (37%), Gaps = 30/182 (16%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
N++V +KIG+G +G + L + + A ++V E + E+
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV--------VKVEYQENGP--LFSELKF 86
Query: 178 MKMLQHPNIVNLIE-----------------VIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
+ + + + + + + +MV+E + G GQ
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFED 278
G +S + ++ L Y+H + VHGDIK NLL+ V + D+ +S +
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 279 DN 280
+
Sbjct: 206 NG 207
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 40/191 (20%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSET 166
G + N ++ +RK+G G++G+V+L + + K+YA+K + +S
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS------------ 77
Query: 167 AMTDVRREVLIMKMLQH-----PNIVNLIEVIDDPNSDHFYMVLE------YVEGKWDND 215
A E I+K +Q+ NIV + H ++ E Y N+
Sbjct: 78 AKI----EADILKKIQNDDINNNNIVKYHGKFMYYD--HMCLIFEPLGPSLYEIIT-RNN 130
Query: 216 GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
G + Y +I+ L YL ++ H D+KP+N+L+ K
Sbjct: 131 YNGFHI----EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186
Query: 276 FEDDNDVLRRS 286
+ R
Sbjct: 187 DGKKIQIYRTK 197
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 35/174 (20%), Positives = 64/174 (36%), Gaps = 42/174 (24%)
Query: 120 YVHVRKIGAGSYGKVVL-YRSSLDGKHYAIK------AFHKSHLSKLRVAPSETAMTDVR 172
Y V +G G++GKVV G+H A+K + ++ A +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA------------ARS--- 60
Query: 173 REVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLE------YVEGKWDNDGFGQP 220
E+ +++ L V ++E + H +V E Y K +N
Sbjct: 61 -EIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--HICIVFELLGLSTYDFIK-ENGFLPFR 116
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
RK I + +LH + + H D+KP+N+L S + + + +
Sbjct: 117 L----DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 22/184 (11%), Positives = 57/184 (30%), Gaps = 31/184 (16%)
Query: 118 NEYVHVRKIGAGSYGKV--------VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
++ + G + + S + +++K K +L +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA 99
Query: 170 DVRREVLIMKMLQHPNIVNLIEVID--DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM 227
+V K L ++ + + + ++VL + G+ +
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-------DVS 151
Query: 228 ARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFSVSQVF 276
+ L ++ L +LH + VHG++ +N+ V P V + + + +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 277 EDDN 280
Sbjct: 212 CPSG 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 30/175 (17%), Positives = 59/175 (33%), Gaps = 44/175 (25%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHY-AIK------AFHKSHLSKLRVAPSETAMTDVR 172
Y V +G G++GKVV GK A+K + ++ A
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA------------ARL--- 65
Query: 173 REVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLE------Y-VEGKWDNDGFGQ 219
E+ ++K ++ V + + + H + E + + + +
Sbjct: 66 -EINVLKKIKEKDKENKFLCVLMSDWFNFHG--HMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
R + L +LH + + H D+KP+N+L S + + S
Sbjct: 123 ------PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 27/191 (14%), Positives = 55/191 (28%), Gaps = 45/191 (23%)
Query: 118 NEYVHVRKIGAGSYGKV-----VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
+ IG G +G + S +K + L
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFT----------- 82
Query: 173 REVLIMKMLQHPNIVNLIE-----------------VIDDPNSDHFYMVLEY----VEGK 211
E+ + P + + D + +M+++ ++
Sbjct: 83 -ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI 141
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGD 269
++ + I+ L Y+H H VHGDIK NLL+ V + D
Sbjct: 142 YEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 270 FSVSQVFEDDN 280
+ ++ + +
Sbjct: 198 YGLAYRYCPEG 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 18/69 (26%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPG 288
Y + G+ +L +H D+ N+L++ VKI DF ++ +++D + V +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 289 TPV-FTAPE 296
P+ + APE
Sbjct: 257 LPLKWMAPE 265
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 15/89 (16%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 124 RKIGAGSYGKVVL-YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
+ +G G++G+V+ +D K L+ + + + E+ I+ +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIG 83
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG 210
H N+VNL+ +++E+ +
Sbjct: 84 HHLNVVNLLGACTK-PGGPLMVIVEFCKF 111
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 5e-05
Identities = 34/295 (11%), Positives = 84/295 (28%), Gaps = 91/295 (30%)
Query: 8 WIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTAD 67
W+ ++ C P+ L + L Y+I ++ D +
Sbjct: 186 WL-NLKNC-------NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---------- 227
Query: 68 GDGGEMQNHAKRSEEIFRERELNG--LICRQFPVKESNKLIRSEDENGTKMINEYVHVRK 125
+Q +R + + + L+ V+ + K + + K++ + R
Sbjct: 228 ---HSIQAELRR---LLKSKPYENCLLVLLN--VQNA-KAWNAFN-LSCKIL---LTTRF 274
Query: 126 IGAGSYGKVVLYRSSLDGKHYAI----KAFHKSHLSKLRVAPSETAMTDVRREV------ 175
V + S+ H ++ + L + + D+ REV
Sbjct: 275 KQ------VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 176 ---LIMKMLQ----------HPNIVNLIEVID------DPN--SDHFYM----------- 203
+I + ++ H N L +I+ +P F
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388
Query: 204 --VLEYVEGKWDNDGFGQPGAIGESMARKYL--RDIVSGLMYLHGHNVVHGDIKP 254
+L + W + + + + L + + + ++ ++K
Sbjct: 389 TILLSLI---WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKV 437
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 8e-04
Identities = 31/186 (16%), Positives = 58/186 (31%), Gaps = 31/186 (16%)
Query: 115 KMINEYVHVRKIGAGSYGK--VVLYRSSLDGKHYAIKAFHKSHLSKLRVAP--------- 163
+++ GK V S +K H S +V
Sbjct: 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
S A+ R E ++ LQ + + + +++E ++ K +
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYR-------V 190
Query: 224 GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--- 280
+ L I+ + + +VHGD+ N+LV+ G I Q E
Sbjct: 191 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID---FPQSVEVGEEGW 247
Query: 281 -DVLRR 285
++L R
Sbjct: 248 REILER 253
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.98 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.83 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.83 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.5 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.02 | |
| 1gxc_A | 149 | CHK2, CDS1, serine/threonine-protein kinase CHK2; | 95.95 | |
| 4h87_A | 130 | Kanadaptin; FHA domain of PF00498, mRNA processing | 93.87 | |
| 1qu5_A | 182 | Protein kinase SPK1; FHA, RAD53, transferase; NMR | 93.84 | |
| 3hx1_A | 131 | SLR1951 protein; P74513_SYNY3, adenylate cyclase-l | 93.83 | |
| 1dmz_A | 158 | Protein (protein kinase SPK1); beta-sandwich, anti | 92.85 | |
| 1r21_A | 128 | Antigen KI-67; beta sandwich, cell cycle; NMR {Hom | 91.26 | |
| 1g6g_A | 127 | Protein kinase RAD53; beta-sandwich, phosphopeptid | 91.17 | |
| 3po8_A | 100 | RV0020C protein, putative uncharacterized protein | 91.07 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 90.78 | |
| 1g3g_A | 164 | Protien kinase SPK1; FHA domain, RAD53, phosphopep | 90.56 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.37 | |
| 1lgp_A | 116 | Cell cycle checkpoint protein CHFR; FHA, tungstate | 90.27 | |
| 2jqj_A | 151 | DNA damage response protein kinase DUN1; protein/p | 90.08 | |
| 2jpe_A | 140 | Nuclear inhibitor of protein phosphatase 1; FHA do | 89.45 | |
| 2kfu_A | 162 | RV1827 PThr 22; FHA domain, phosphorylation, intra | 89.3 | |
| 2pie_A | 138 | E3 ubiquitin-protein ligase RNF8; FHA domain, comp | 89.19 | |
| 2kb3_A | 143 | Oxoglutarate dehydrogenase inhibitor; forkhead-ass | 88.94 | |
| 1uht_A | 118 | Expressed protein; FHA domain, beta-sandwich, anti | 88.73 | |
| 3elv_A | 205 | PRE-mRNA leakage protein 1; intrinsically unstruct | 88.25 | |
| 2xt9_B | 115 | Putative signal transduction protein GARA; lyase-s | 88.01 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.88 | |
| 3els_A | 158 | PRE-mRNA leakage protein 1; intrinsically unstruct | 87.86 | |
| 3va4_A | 132 | Mediator of DNA damage checkpoint protein 1; cell | 87.79 | |
| 2csw_A | 145 | Ubiquitin ligase protein RNF8; 11-stranded beta sa | 87.59 | |
| 3gqs_A | 106 | Adenylate cyclase-like protein; FHA domain, struct | 86.25 | |
| 1mzk_A | 139 | Kinase associated protein phosphatase; beta sandwi | 85.31 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 85.3 | |
| 2ff4_A | 388 | Probable regulatory protein EMBR; winged-helix, te | 83.99 | |
| 3uv0_A | 102 | Mutator 2, isoform B; FHA, protein binding, dimeri | 81.74 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=341.20 Aligned_cols=176 Identities=31% Similarity=0.502 Sum_probs=157.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||+|+++.+|+.||||++.+..... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 103 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD- 103 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-
Confidence 467999999999999999999999999999999998764321 2345678999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+
T Consensus 104 -~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 104 -DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp -SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 4689999999999999999988889999999999999999999999999999999999999999999999999999987
Q ss_pred cCC--ccccccCCCccccccCcccCC
Q 022241 277 EDD--NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~--~~~~~~~~gt~~y~aPE~l~G 300 (300)
... .....+.+||+.|||||++.|
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred CCCCCcccccCcccCcccCCHHHHcC
Confidence 533 234567799999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=342.38 Aligned_cols=175 Identities=32% Similarity=0.620 Sum_probs=150.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+++++.+|+.||||++.+... .....+.+.+|+.+|+.|+|||||+++++|.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~- 94 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-------SSKEREESRREVAVLANMKHPNIVQYRESFEE- 94 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-------CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence 4789999999999999999999999999999999976532 34556789999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+.+|||||||+||+|.+++. ....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+
T Consensus 95 -~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 95 -NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence 468999999999999998884 34468999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+........+.+||+.|||||++.|
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTT
T ss_pred eecCCcccccccCCCccccCHHHHCC
Confidence 87554444556789999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=337.08 Aligned_cols=171 Identities=27% Similarity=0.376 Sum_probs=154.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-- 142 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---------RRELLFNEVVIMRDYQHENVVEMYNSYLV-- 142 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---------SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 5699999999999999999999999999999999764321 22457899999999999999999999987
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+|||||||++|+|.+++.. +.+++..++.++.||+.||+|||+++||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 4589999999999999987754 579999999999999999999999999999999999999999999999999999887
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.......+.+||+.|||||++.|
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISR 244 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTT
T ss_pred CCCCcccccccCcCcCCHHHHCC
Confidence 66666678899999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=323.52 Aligned_cols=174 Identities=36% Similarity=0.637 Sum_probs=138.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~- 84 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA------KSDMQGRIEREISYLRLLRHPHIIKLYDVIKS- 84 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-
Confidence 47899999999999999999999999999999999765332 23345678999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+||||+ +|.|.+.+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 -~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 85 -KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp -SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred -CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 46899999999 5678888877889999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ....+.+||+.|||||++.|
T Consensus 163 ~~~-~~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 163 TDG-NFLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp -------------CTTSCHHHHSS
T ss_pred CCC-CccCCeeECcccCChhhhcC
Confidence 443 34456789999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=338.52 Aligned_cols=172 Identities=27% Similarity=0.369 Sum_probs=154.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.|+++++||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---------~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~- 219 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHENVVEMYNSYLV- 219 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---------SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHhCCCCCCCceEEEEEE-
Confidence 3579999999999999999999999999999999975421 123467899999999999999999999987
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 220 -~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 220 -GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp -TTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 4589999999999999987754 56999999999999999999999999999999999999999999999999999988
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
........+.+||+.|||||++.|
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISR 321 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTT
T ss_pred CCCCccccccccCcCcCCHHHHCC
Confidence 766666677899999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=319.77 Aligned_cols=172 Identities=25% Similarity=0.381 Sum_probs=151.0
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC--C
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP--N 197 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 197 (300)
|++.++||+|+||.||+++++.+++.||||.+..... .....+.+.+|+.+|+.++|||||+++++|.+. .
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 3677889999999999999999999999999976532 345567899999999999999999999998752 2
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEcc-CCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAP-SGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~-~~~~kl~DFGla~ 274 (300)
...+|||||||++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+||||+. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3468999999999999999988889999999999999999999999998 999999999999984 7899999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ....+.+|||.|||||++.|
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT
T ss_pred eCCC--CccCCcccCccccCHHHcCC
Confidence 6433 34556789999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=330.60 Aligned_cols=175 Identities=25% Similarity=0.390 Sum_probs=147.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|++++.||+|+||.||+|++. .+++.||||++++...... ....+.+|+.+|+.++|||||+++++|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-------DRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-------ECC------CCCCCCCCTTEECEEEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-------HHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 467999999999999999999874 3678999999987643321 122577899999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ .+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|
T Consensus 96 ~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EE--TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EE--CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 87 4589999999999999999988889999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..........+.+||+.|||||++.|
T Consensus 174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 174 KESIDHEKKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp EC-----CCCCSCCCCGGGCCHHHHHT
T ss_pred eeccCCCccccccccCcccCCHHHhcc
Confidence 976555556667899999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=326.35 Aligned_cols=168 Identities=28% Similarity=0.450 Sum_probs=146.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.|.+.++||+|+||.||+++++.+|+.||||+++.... ..+|+.+|+.++|||||+++++|.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~~~~- 121 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGAVRE- 121 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEEEEE-
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 3568999999999999999999999999999999975422 1369999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~ 275 (300)
.+.+|||||||+||+|.+++...+.+++..+..++.||+.||+|||+++||||||||+||||+.+| .+||+|||+|+.
T Consensus 122 -~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 122 -GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred -CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 458999999999999999998888999999999999999999999999999999999999999888 699999999998
Q ss_pred ecCCcc-----ccccCCCccccccCcccCC
Q 022241 276 FEDDND-----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~-----~~~~~~gt~~y~aPE~l~G 300 (300)
+..... .....+||+.|||||++.|
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTT
T ss_pred ccCCCcccceecCCccccCccccCHHHHCC
Confidence 654321 1234579999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=319.79 Aligned_cols=175 Identities=25% Similarity=0.434 Sum_probs=141.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 57999999999999999999999999999999986432 3445678999999999999999999999987533
Q ss_pred C----------CEEEEEEEeeCCCccccccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 198 S----------DHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 198 ~----------~~~~lv~E~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
. ..+|||||||++|+|.+++..... .++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc
Confidence 2 247999999999999988876554 456778999999999999999999999999999999999999
Q ss_pred EEEecccCceeecCCcc------------ccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDND------------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~------------~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||+|+.+..... ..++.+||+.|||||++.|
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 99999999987654321 1234579999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=331.16 Aligned_cols=286 Identities=25% Similarity=0.380 Sum_probs=203.5
Q ss_pred CcccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCCCCccccchhhchH
Q 022241 2 FRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKRSE 81 (300)
Q Consensus 2 ~~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~~~~~~~~~~~~~~~~ 81 (300)
.+++|++||+..|++++..+.-+....++.+|..|++|+++.........+..|.|.||+..|......+..........
T Consensus 26 ~~~~~~iGR~~~~~~~~~~~~~~~~~~~~~vS~~H~~i~~~~~~~~~~~~~i~D~S~nGt~vn~~~~~~~~~~~l~~~d~ 105 (419)
T 3i6u_A 26 VNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSE 105 (419)
T ss_dssp CSSEEEEESSTTSSEETTCTTGGGCSGGGGSCTTCEEEECCEETTTEECCEEEECCSSCEEETTEECCTTCEEECCTTEE
T ss_pred cCCCEEecCCCccCEEECCcccccccccccccccceEEEEEcCCCCceEEEEEECCcCCceECcccccCCCcccCCCCCE
Confidence 46889999999999999999777777778999999999886544433345667789999998876443332211111100
Q ss_pred HHHHHhhhcccccccCCccchhhhhhccccccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc
Q 022241 82 EIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161 (300)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~ 161 (300)
..+.......+....... ...........++|.+.+.||+|+||.||++.+..+++.||||++.+...... .
T Consensus 106 i~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~ 177 (419)
T 3i6u_A 106 IALSLSRNKVFVFFDLTV-------DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG-S 177 (419)
T ss_dssp EEESSTTCEEEEEEESCS-------SCGGGSCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--
T ss_pred eeeeccccceEEEecccc-------ccccccchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc-c
Confidence 000000000000000000 00111123445789999999999999999999999999999999986543210 1
Q ss_pred CCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 022241 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241 (300)
Q Consensus 162 ~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~y 241 (300)
.........+.+|+.+|+.++|||||++++++.. ...++||||+++++|.+.+.....+++..++.++.|++.||+|
T Consensus 178 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~ 254 (419)
T 3i6u_A 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254 (419)
T ss_dssp -------CCHHHHHHHHHHCCCTTBCCCCEEEES---SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 1122233458899999999999999999999864 4689999999999999999888899999999999999999999
Q ss_pred HHhCCcEeCCCCCCCEEEccCC---cEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 242 LHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 242 LH~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+++|+||||||+|||++.++ .+||+|||+|+..... ......+||+.|+|||++.
T Consensus 255 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp HHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC
T ss_pred HHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeee
Confidence 9999999999999999997554 5999999999876443 3345678999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=313.82 Aligned_cols=171 Identities=25% Similarity=0.396 Sum_probs=142.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+++.+.++||+|+||.||+++.. ..||||+++... ......+.|.+|+.+|++++|||||++++++.+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 3467899999999999999998754 359999986432 245667889999999999999999999999864
Q ss_pred CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+.++||||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+
T Consensus 104 ---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 104 ---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp ---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred ---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence 358999999999999988754 5679999999999999999999999999999999999999999999999999998
Q ss_pred eecCC--ccccccCCCccccccCcccC
Q 022241 275 VFEDD--NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~--~~~~~~~~gt~~y~aPE~l~ 299 (300)
..... .....+.+||+.|||||++.
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp C------------CCCCTTSCCHHHHH
T ss_pred ecccCCcceeecccccCCCccCHHHhh
Confidence 76432 23345678999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=321.13 Aligned_cols=176 Identities=29% Similarity=0.457 Sum_probs=152.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-------chHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 3579999999999999999999999999999999865421 344567788999999999999999999998642
Q ss_pred ----CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 197 ----NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 197 ----~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
....+|||||||+ |.|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 2357999999997 56888888888999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCC----ccccccCCCccccccCcccCC
Q 022241 273 SQVFEDD----NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~----~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+.+... .....+.+||+.|+|||+++|
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTT
T ss_pred eeecccCccccccccccceeChHhcCHHHhcC
Confidence 9876432 234456789999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.08 Aligned_cols=173 Identities=31% Similarity=0.441 Sum_probs=141.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|.+.++||+|+||.||+++.. .+++.||||+++.. +....+.|.+|+.+|++++|||||++++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---------~~~~~~~f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---------SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 357899999999999999999865 36889999998643 4556678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+|.+ ...++||||||++|+|.+++.. ..++++..+..|+.||+.||+|||+++||||||||+|
T Consensus 111 ~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 111 VCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 9986 3579999999999999887643 2469999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccCC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+.++.+||+|||+|+...... ......+||+.|||||++.|
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 999999999999999998764332 23345679999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=314.16 Aligned_cols=172 Identities=29% Similarity=0.402 Sum_probs=145.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|.+.+.||+|+||.||+++.. .+++.||||+++.. +....+.|.+|+.+|++++|||||++++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---------~~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---------ChHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 357999999999999999999865 35788999998643 3456678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEE
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL 258 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIl 258 (300)
+|.+ .+.++||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 83 ~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 83 VCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 160 (299)
T ss_dssp EECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence 9986 3579999999999999988743 347999999999999999999999999999999999999
Q ss_pred EccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 259 VAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 259 l~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+.++.+||+|||+|+....... ......||+.|||||++.
T Consensus 161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 203 (299)
T 4asz_A 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 203 (299)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence 99999999999999987543322 222346999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=309.40 Aligned_cols=173 Identities=24% Similarity=0.331 Sum_probs=145.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
..+++++++||+|+||.||+++.. .+++.||||.++... .....+.|.+|+.+|++++|||||+++|
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--------~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--------EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--------CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--------ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 356889999999999999999853 367899999986431 2334568999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCC
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPD 255 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~ 255 (300)
++.+ ...++||||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++||||||||+
T Consensus 97 ~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 97 VVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9986 3578999999999999887743 246899999999999999999999999999999999
Q ss_pred CEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 256 NLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 256 NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
||||+.++.+||+|||+|+...... ......+||+.|||||++.
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~ 220 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM 220 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh
Confidence 9999999999999999998764322 2344568999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=331.80 Aligned_cols=179 Identities=28% Similarity=0.403 Sum_probs=155.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
...+++|.+++.||+|+||.||+|+++.+|+.||||++.+..+.. ............++.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~---~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch---hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 455789999999999999999999999999999999998765432 11223333344556777788999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ .+.+|||||||+||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 262 ~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 262 HT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence 97 4589999999999999999988889999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.+... ...+.+|||.|||||++.
T Consensus 340 ~~~~~~--~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 340 CDFSKK--KPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp EECSSC--CCCSCCSCGGGCCHHHHS
T ss_pred eecCCC--CCCCccCCcCccCHHHHh
Confidence 986543 345679999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=301.81 Aligned_cols=170 Identities=26% Similarity=0.327 Sum_probs=138.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.++||+|+||.||+++. +|+.||||++.... ........|+..+..++|||||++++++.++.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 4689999999999999999875 68999999986431 11123345666677899999999999997643
Q ss_pred C--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeCCCCCCCEEEccCCcEEE
Q 022241 198 S--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 198 ~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~iiHrDlkp~NIll~~~~~~kl 267 (300)
. ..+|||||||++|+|.+++.. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++.+||
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki 149 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence 2 368999999999999998864 4699999999999999999999987 8999999999999999999999
Q ss_pred ecccCceeecCCccc----cccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDNDV----LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~G 300 (300)
+|||+|+........ ....+||+.|||||++.|
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence 999999987543322 224579999999999854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=307.06 Aligned_cols=175 Identities=18% Similarity=0.272 Sum_probs=147.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC-Cceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~ 189 (300)
..++|++.+.||+|+||.||++..... ++.||||.+.... .......+.+|+.+|.++.| ||||++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--------~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--------ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 346899999999999999999987653 3679999886432 34456789999999999965 999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK 253 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk 253 (300)
+++|.++ +..++||||||++|+|.+++.. ...+++..+..++.|||.||+|||+++|||||||
T Consensus 134 ~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 134 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 9999753 3578999999999999887742 3458999999999999999999999999999999
Q ss_pred CCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 254 PDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 254 p~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++.++.+||+|||+|+.+..... ...+.+||+.|||||++.
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~ 260 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 260 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh
Confidence 9999999999999999999987643322 233457999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=302.03 Aligned_cols=169 Identities=23% Similarity=0.371 Sum_probs=142.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
..++|++.++||+|+||.||+|+++. +++.||||.+.+.. ....+.+|+.+|+.+ .|||||++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----------~~~~~~~E~~~l~~~~~h~nIv~l~~ 87 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----------HPIRIAAELQCLTVAGGQDNVMGVKY 87 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----------CHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----------CHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 34679999999999999999998763 57899999885431 234678999999998 6999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DF 270 (300)
+|.+ .+++|||||||++++|.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 88 ~~~~--~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 88 CFRK--NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEE--TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEE--CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9986 46899999999999998877 359999999999999999999999999999999999999876 79999999
Q ss_pred cCceeecCCc----------------------------cccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDN----------------------------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~----------------------------~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|+...+.. ...++.+||+.|+|||++.|
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 9998654321 12334579999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.38 Aligned_cols=173 Identities=27% Similarity=0.528 Sum_probs=153.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 225 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---------chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 457899999999999999999999999999999998653 23445678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC--CcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~--~~~kl~DFGl 272 (300)
...+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+
T Consensus 226 --~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 226 --DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp --SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred --CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 4689999999999999887754 4689999999999999999999999999999999999999854 7999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+.+... ......+||+.|||||++.|
T Consensus 304 a~~~~~~-~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 304 TAHLDPK-QSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp CEECCTT-SEEEEECSSGGGCCHHHHTT
T ss_pred eeEccCC-CceeeeEECccccCHHHhCC
Confidence 9987544 34456789999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.25 Aligned_cols=176 Identities=30% Similarity=0.475 Sum_probs=155.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+++.||+|+||.||+++++.+|+.||||++.+.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 76 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT- 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-
Confidence 46899999999999999999999999999999999765321 12235678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 77 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 77 -HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 4589999999999999888877788999999999999999999999999999999999999999999999999999875
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
........+.+||+.|+|||++.|
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSS
T ss_pred ccCCCcccccccChhhCChhhhcC
Confidence 444445566789999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=279.21 Aligned_cols=177 Identities=38% Similarity=0.602 Sum_probs=157.4
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++++.||+|+||.||++++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 83 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-------NPTSLQKLFREVRIMKILNHPNIVKLFEVI 83 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456789999999999999999999999999999999976532 345567889999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ...+|+||||++++++.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 84 ET--EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EC--SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EE--CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 86 4589999999999999988877788999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......+||+.|+|||++.|
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 162 NEFTVG-GKLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp GGGSSS-CGGGTTSSSGGGCCHHHHHT
T ss_pred eecCCC-CccccccCCcceeCcccccC
Confidence 865443 34456789999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.94 Aligned_cols=177 Identities=28% Similarity=0.437 Sum_probs=154.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|.+++.||+|+||.||+++++.+++.||||++++.... .......+..|..+|..+ +|||||+++++|.
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc------CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 346899999999999999999999999999999999875432 223345677899999876 8999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+|+||||+++++|..++.....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 124 ~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 T--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred E--CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 6 45899999999999999888777889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+.+||+.|+|||++.|
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred ecccCCCccccccCCcccCCchhhcC
Confidence 75444455667889999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=284.66 Aligned_cols=176 Identities=28% Similarity=0.455 Sum_probs=148.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|++++.||+|+||.||+++++.+++.||||++.+.... .......+.+|+.+|..+ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH------HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc------chhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 457899999999999999999999999999999999865322 123456788999999988 6999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+|+||||+++++|..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 95 ~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 95 T--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 6 45899999999999999888777889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..........+.+||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp CSCC---------CCGGGCCHHHHH
T ss_pred ecccCCccccccCCCcCeEChhhcC
Confidence 6544444556678999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=268.52 Aligned_cols=186 Identities=39% Similarity=0.636 Sum_probs=152.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc-----------------CCChHHHHHHHHHHH
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-----------------APSETAMTDVRREVL 176 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~ 176 (300)
....++|.+.+.||+|+||.||++++..+++.||||++.......... .......+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 345678999999999999999999999999999999997653211000 001123457889999
Q ss_pred HHHHCCCCceeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 177 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+|+.++||||+++++++.++....+++||||++++++.+... ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999998766678999999999999887654 4579999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++.++.+||+|||++..............||+.|+|||++.|
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCT
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhcc
Confidence 99999999999999999987655545556789999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.44 Aligned_cols=176 Identities=28% Similarity=0.447 Sum_probs=156.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 195 (300)
.++|.+++.||+|+||.||+++++.+++.||||++.+.... .......+.+|+.++..+ +|||||++++++.+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 81 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC------SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc------chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence 46899999999999999999999999999999999865321 345567788999999987 89999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||||+++++|..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 --~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 82 --ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 458999999999999998887777899999999999999999999999999999999999999999999999999986
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........+||+.|+|||++.|
T Consensus 160 ~~~~~~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 160 GLRPGDTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp SCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred ccCCCCcccccCCCccccCccccCC
Confidence 5444445566789999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=281.50 Aligned_cols=178 Identities=28% Similarity=0.487 Sum_probs=157.8
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.....++|.+++.||+|+||.||++++..+++.||||++.+..... ......+.+|+.+|+.++|||||+++++
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 83 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE------RNEVRNVFKELQIMQGLEHPFLVNLWYS 83 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc------HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3445678999999999999999999999999999999997654321 2245678899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
|.+ ...+|+||||+.+++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 84 FQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EEC--SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEe--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence 986 458999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|..+... ......+||+.|+|||++.
T Consensus 162 a~~~~~~-~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 162 AAMLPRE-TQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCGGGTC
T ss_pred eeeccCC-CceeccCCCccccCCeeec
Confidence 9976543 3445678999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=279.87 Aligned_cols=178 Identities=26% Similarity=0.425 Sum_probs=154.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
...++|.+.+.||+|+||.||+++++.+++.||||++++..... ......+..|..++..+ +||||+++++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------DDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh------hhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 34578999999999999999999999999999999997653211 12345677899998876 999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ...+|+||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 88 ~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 88 QT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 86 4589999999999999988877778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+............+||+.|+|||++.|
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred hhcccCCCcccCCCCCcccCChhhhcC
Confidence 865444444567789999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=269.02 Aligned_cols=174 Identities=25% Similarity=0.457 Sum_probs=153.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLHDVLHS-- 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--
Confidence 579999999999999999999999999999999875421 33455678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++.+.......+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 46899999999987666655666789999999999999999999999999999999999999999999999999999876
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTT
T ss_pred CccccccCCccccCCcChHHHcC
Confidence 55555566789999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.67 Aligned_cols=173 Identities=27% Similarity=0.542 Sum_probs=153.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+++.||+|+||.||+++++.+|+.||||++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~- 77 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD- 77 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-
Confidence 468999999999999999999999999999999997653321 1234678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||+++++|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+++..
T Consensus 78 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 78 -AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 4589999999999999998888888999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ..+.+||+.|+|||++.|
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 157 PDV---TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp SSC---BCCCCSCTTTCCHHHHTT
T ss_pred CCc---cccccCCccccCHhHhcC
Confidence 432 345689999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=279.45 Aligned_cols=178 Identities=26% Similarity=0.400 Sum_probs=154.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
...++|.+++.||+|+||.||+++++.+++.||||++.+..... ......+..|..+|..+ +||||+++++++
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc------chHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 34578999999999999999999999999999999998753321 22346778999999887 799999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ...+|+||||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 91 ~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 91 QT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred Ec--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 86 4589999999999999988877778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+............+||+.|+|||++.|
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccccCCcccccccCCccccChhhhcC
Confidence 875444445567789999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=284.19 Aligned_cols=177 Identities=25% Similarity=0.397 Sum_probs=153.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||+++++.+++.||||++.+..... ......+.+|+.++..++||||++++++|.
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK------RAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------TTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34578999999999999999999999999999999997643221 112234788999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ...+|+||||+++|+|..++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 145 ~--~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 145 D--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp C--SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred e--CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 6 4689999999999999988866 568999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+....... .....+||+.|+|||++.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHh
Confidence 87654332 334468999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.14 Aligned_cols=179 Identities=29% Similarity=0.466 Sum_probs=147.7
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHH-HHHCCCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~ 192 (300)
....++|.+++.||+|+||.||+++++.+++.||||++.+.... .......+..|..+ ++.++|||||+++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 34457899999999999999999999999999999999876432 12334456677776 577899999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+.+ .+.+|+||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 108 ~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~ 185 (373)
T 2r5t_A 108 FQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185 (373)
T ss_dssp EEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred EEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence 986 458999999999999998887777899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++..........+.+||+.|+|||++.|
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred ccccccCCCccccccCCccccCHHHhCC
Confidence 9865444445567789999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.42 Aligned_cols=176 Identities=30% Similarity=0.439 Sum_probs=151.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||+++++.+++.||||++.+...... .....+.+|+.+++.++|||||+++++|.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR------SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT------CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh------HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345789999999999999999999999999999999976433211 11234778999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~--~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 D--DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred E--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 6 4689999999999999887754 469999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc-ccccCCCccccccCcccC
Q 022241 275 VFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
....... ...+.+||+.|+|||++.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHH
T ss_pred eeccCCcccccCCcCCccccCHHHhh
Confidence 7654432 334678999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.54 Aligned_cols=180 Identities=28% Similarity=0.466 Sum_probs=156.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.+.+.|.+.+.||+|+||.||+++++.+|+.||||++.+..... .........+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA---SRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT---CSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc---ccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 34567999999999999999999999999999999998654321 111223567889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DF 270 (300)
+ ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 86 ~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred e--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 6 468999999999999999998888999999999999999999999999999999999999998877 7999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++...... ......+||+.|+|||++.|
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTT
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcC
Confidence 999986543 23456789999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=275.38 Aligned_cols=175 Identities=30% Similarity=0.520 Sum_probs=154.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||++++..+|+.||||++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------LKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34578999999999999999999999999999999997654321 123467889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+|+||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 112 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 112 D--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence 6 45899999999999999888777789999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ....+||+.|+|||++.|
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 190 RVKGR---TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp ECSSC---BCCCEECGGGCCHHHHTT
T ss_pred eccCC---cccccCCccccCHHHhcC
Confidence 76443 345679999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=282.11 Aligned_cols=177 Identities=28% Similarity=0.470 Sum_probs=154.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+.+|+.++|||||++++++.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-------SARDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 345689999999999999999999999999999999876432 2345567899999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc---cCCcEEEeccc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFS 271 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~---~~~~~kl~DFG 271 (300)
+ ....|+||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~--~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 81 E--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp C--SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred E--CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 6 468999999999999998888888899999999999999999999999999999999999998 45789999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|..............||+.|+|||++.|
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTT
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcC
Confidence 99887665555566789999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=269.12 Aligned_cols=175 Identities=29% Similarity=0.518 Sum_probs=151.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
+.++|++.+.||+|+||.||++++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--------cchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34689999999999999999999999999999999864321 2233568899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 77 --GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp --SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 468999999999999999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ecCCc--cccccCCCccccccCcccCC
Q 022241 276 FEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
+.... .......||+.|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred eccCCcccccCCCccCcCccCcHHhcc
Confidence 54322 23345679999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=267.99 Aligned_cols=172 Identities=28% Similarity=0.460 Sum_probs=152.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++++..+++.||||.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 88 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLV- 88 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---------cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-
Confidence 4679999999999999999999999999999999865421 124568899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+++||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 89 -GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 45899999999999998877543 6999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHC
T ss_pred CCcccccCCccCCcCccChhhhcC
Confidence 665555566789999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=280.99 Aligned_cols=177 Identities=27% Similarity=0.387 Sum_probs=153.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||+++++.+|+.||||++.+..... ......+.+|+.++..++||||++++++|.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~------~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK------RGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------HGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34578999999999999999999999999999999997643211 122345788999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ...+|+||||+++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 132 ~--~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 132 D--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred e--CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 6 45899999999999999888654 47999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+....... .....+||+.|+|||++.
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHh
Confidence 88654332 233568999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=265.57 Aligned_cols=173 Identities=25% Similarity=0.456 Sum_probs=150.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 78 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK- 78 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-
Confidence 46899999999999999999999999999999987432 45567789999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 79 -DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred -CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 4689999999999999988765 56799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcccc--------------ccCCCccccccCcccCC
Q 022241 276 FEDDNDVL--------------RRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~--------------~~~~gt~~y~aPE~l~G 300 (300)
........ ....||+.|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcC
Confidence 64332211 14579999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.94 Aligned_cols=180 Identities=29% Similarity=0.480 Sum_probs=151.7
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
+....++|++.+.||+|+||.||++++..+++.||||.+.... .........+.+|+.++..++||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 79 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP------REKEETLKRFEREVHNSSQLSHQNIVSMIDV 79 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS------SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc------cccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence 3456678999999999999999999999999999999986432 2245567789999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+.+ .+.+++||||+++++|.+++...+++++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 80 DEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred eee--CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence 985 468999999999999999887778899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCc-cccccCCCccccccCcccCC
Q 022241 273 SQVFEDDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... .......||+.|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp STTC-------------CCSSCCHHHHHT
T ss_pred ccccccccccccCccccCccccCHhHhcC
Confidence 98654332 22334579999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.93 Aligned_cols=178 Identities=29% Similarity=0.450 Sum_probs=142.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
..++|.+.+.||+|+||.||+++.. .+++.||||++.+..... .......+.+|+.+|+.++||||++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCEEEE
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 3468999999999999999999985 588999999997643211 22344567899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+.+ ...+|+||||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEC--SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEc--CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 986 457999999999999988887777899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++............+||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTT
T ss_pred ccccccCCccccccCCCcCccCHhhCcC
Confidence 9865444444556789999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=266.77 Aligned_cols=177 Identities=28% Similarity=0.502 Sum_probs=147.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++++.||+|+||.||++++. +++.||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 88 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-------DEGIPSTAIREISLLKELHHPNIVSLIDVI 88 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-------cchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 456688999999999999999999986 589999999865421 233456788999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ...+++||||++++.+.........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 89 HS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp CC--SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cc--CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCc
Confidence 75 4579999999997544444455567999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..............||+.|+|||++.|
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTT
T ss_pred eecCCCcccccCCcccCCcCCHHHhcC
Confidence 987655445556689999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=271.15 Aligned_cols=175 Identities=27% Similarity=0.469 Sum_probs=153.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.++.+++.||||++..... .......+.+|+.+++.++|||||++++++.+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQE 99 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 34679999999999999999999999999999999975432 34456789999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DFGl 272 (300)
....|+||||+++++|.+.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 100 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 100 --ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp --SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred --CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 458999999999999998888888899999999999999999999999999999999999998654 599999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...... .......||+.|+|||++.|
T Consensus 178 a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 178 AIEVNDS-EAWHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp CBCCTTC-CSCCCSCSCTTTCCHHHHTT
T ss_pred ceEecCC-cccccCCCCccccCHHHHcc
Confidence 9876543 23445789999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=280.08 Aligned_cols=180 Identities=34% Similarity=0.629 Sum_probs=159.1
Q ss_pred ccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 112 NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 112 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.+....++|.+.+.||+|+||.||++++..+|+.||||++.+..... ......+.+|+.+|+.++||||+++++
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 83 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS------LDVVGKIRREIQNLKLFRHPHIIKLYQ 83 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH------TTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34566789999999999999999999999999999999997653221 123467889999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
++.+ ...+++||||+++++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 84 VIST--PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEEC--SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 9986 35899999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... ....+.+||+.|+|||++.|
T Consensus 162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 162 LSNMMSDG-EFLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp SCEECCTT-CCBCCCCSCSTTCCHHHHTT
T ss_pred chhhcccc-ccccccCCCcCeEChhhccC
Confidence 99986543 33456789999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.62 Aligned_cols=176 Identities=34% Similarity=0.578 Sum_probs=152.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+++.||||++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK------SDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc------hhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45678999999999999999999999999999999997653221 112346889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+++||||+ ++.+.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~--~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 80 T--PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp C--SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred e--CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 6 35899999999 56777777667789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......+||+.|+|||++.|
T Consensus 157 ~~~~~-~~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 157 IMTDG-NFLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp TTTTS-BTTCCCTTSTTTSCGGGSCC
T ss_pred eccCC-cccccccCCcCcCCHHHHcC
Confidence 76443 33456789999999999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=283.23 Aligned_cols=178 Identities=28% Similarity=0.404 Sum_probs=155.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||+++++.+|+.||||++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK------RKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34578999999999999999999999999999999997654321 123467889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
+ ...+|+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 256 ~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 256 T--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp C--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred e--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeec
Confidence 6 4589999999999999876644 346999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+++.+..........+||+.|+|||++.|
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred ceeeeccCCCcccccccCCccccChhhhcC
Confidence 999987655444455689999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=266.38 Aligned_cols=177 Identities=23% Similarity=0.421 Sum_probs=147.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||+++++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--------RELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3467999999999999999999999999999999986432 33456789999999999999999999999865
Q ss_pred CCC-------------------------------------------------------CEEEEEEEeeCCCccccccCCC
Q 022241 196 PNS-------------------------------------------------------DHFYMVLEYVEGKWDNDGFGQP 220 (300)
Q Consensus 196 ~~~-------------------------------------------------------~~~~lv~E~~~~~~l~~~~~~~ 220 (300)
... ..+++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 321 2489999999999998887654
Q ss_pred C---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc------------ccccc
Q 022241 221 G---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN------------DVLRR 285 (300)
Q Consensus 221 ~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------~~~~~ 285 (300)
. ..++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... .....
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 4 35667789999999999999999999999999999999999999999999999865432 12234
Q ss_pred CCCccccccCcccCC
Q 022241 286 SPGTPVFTAPECCLG 300 (300)
Q Consensus 286 ~~gt~~y~aPE~l~G 300 (300)
..||+.|+|||++.|
T Consensus 236 ~~gt~~y~aPE~~~~ 250 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHG 250 (332)
T ss_dssp CC-CGGGSCHHHHHC
T ss_pred cCCCcCccChHHhcC
Confidence 579999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=270.46 Aligned_cols=178 Identities=30% Similarity=0.486 Sum_probs=151.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.|++.+.||+|+||.||++.++.+++.||||++........ .......+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS----PGLSTEDLKREASICHMLKHPHIVELLETYSS- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS----SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc----ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence 3579999999999999999999999999999999976432210 11234678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc---EEEec
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGD 269 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---~kl~D 269 (300)
...+|+||||+++++|.+.+. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|
T Consensus 98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 468999999999998876553 2346899999999999999999999999999999999999987654 99999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++.............+||+.|+|||++.|
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence 9999987665444556789999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=284.23 Aligned_cols=178 Identities=29% Similarity=0.463 Sum_probs=145.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++++.||+|+||.||++++..+|+.||||++.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------------CCCCCSCTTSCCEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh------hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 3457899999999999999999999999999999999765321 2334456788999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ .+.+++||||+++++|..++.....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+|
T Consensus 219 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 T--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp E--TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred e--CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 6 45899999999999998888777889999999999999999999998 99999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+............+||+.|+|||++.|
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHT
T ss_pred eeccCCCcccccccCCccccCHhhcCC
Confidence 865444445567789999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.03 Aligned_cols=171 Identities=25% Similarity=0.419 Sum_probs=150.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 72 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----------GTDQVLVKKEISILNIARHRNILHLHESFES- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----------cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-
Confidence 46899999999999999999999999999999988532 2345678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--CCcEEEecccCc
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVS 273 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DFGla 273 (300)
...+++||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 73 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 73 -MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp -TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred -CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 45899999999999998888664 47999999999999999999999999999999999999997 789999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..+.... ......||+.|+|||++.|
T Consensus 152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 152 RQLKPGD-NFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp EECCTTC-EEEEEESCGGGSCHHHHTT
T ss_pred eECCCCC-ccccccCChhhcCcHHhcC
Confidence 9865432 3345679999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.72 Aligned_cols=179 Identities=30% Similarity=0.483 Sum_probs=154.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.|.+.+.||+|+||.||++++..+|+.||||++.+..... .........+.+|+.+|+.++||||+++++++.+
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS---SRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTT---CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccc---ccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3457999999999999999999999999999999997653221 1112235678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEeccc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFS 271 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DFG 271 (300)
...+++||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 86 --KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 458999999999999999988888999999999999999999999999999999999999999887 89999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++....... ......||+.|+|||++.+
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTT
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecC
Confidence 998865432 3345679999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=279.90 Aligned_cols=176 Identities=27% Similarity=0.423 Sum_probs=138.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||+++++.+++.||||++.... ........+.+|+.+|+.++|||||++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 4578999999999999999999999999999999986431 134566789999999999999999999999854
Q ss_pred C---CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 196 P---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 196 ~---~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
. ....+|+||||++ +.+...+.....+++..++.++.||+.||+|||+.+|+||||||+||||+.++.+||+|||+
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp SCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 2 2257999999986 56777777777899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCc---------------------------cccccCCCccccccCcccC
Q 022241 273 SQVFEDDN---------------------------DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~ 299 (300)
|+...... ...+..+||+.|+|||+++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 98754221 1234457899999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=262.94 Aligned_cols=175 Identities=28% Similarity=0.487 Sum_probs=146.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||++++..+|+.||||++.... ........+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 73 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR- 73 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-------cchHHHHHHHHHHHHHHhCCCCCccchhheeec-
Confidence 468999999999999999999999999999999885432 234456678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||++++++..++.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 74 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 74 -KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 4589999999999998888877788999999999999999999999999999999999999999999999999999987
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp C------------GGGCCHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhc
Confidence 655555556789999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=275.06 Aligned_cols=177 Identities=27% Similarity=0.413 Sum_probs=149.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++..+++.||||++.... ........+.+|+.+|+.++||||+++++++.
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-------EDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 34578999999999999999999999999999999986431 13456678999999999999999999999987
Q ss_pred cCCC---CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 195 DPNS---DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 195 ~~~~---~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.... ..+|+||||+++ +|...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 5321 579999999985 777777777889999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCc----------------------cccccCCCccccccCcccC
Q 022241 272 VSQVFEDDN----------------------DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~----------------------~~~~~~~gt~~y~aPE~l~ 299 (300)
+|+...... ...+..+||+.|+|||+++
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 998764332 1235678999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=272.15 Aligned_cols=176 Identities=28% Similarity=0.475 Sum_probs=140.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
..++|++++.||+|+||.||++.+..+|+.||||++.+.. ........+.+|+.+|..+. ||||+++++++.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-------QNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 4568999999999999999999999999999999986431 13456677889999999997 999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
..+...+|+|||||++ ++...+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+
T Consensus 80 ~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 80 ADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CTTSSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 7666689999999985 55555543 479999999999999999999999999999999999999999999999999998
Q ss_pred eecCC---------------------ccccccCCCccccccCcccCC
Q 022241 275 VFEDD---------------------NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~---------------------~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+... .......+||+.|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 75321 122344679999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=282.60 Aligned_cols=177 Identities=25% Similarity=0.383 Sum_probs=153.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||+++++.+|+.||||++.+..... ......+.+|+.+|+.++|||||++++++.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 45578999999999999999999999999999999997654321 123456789999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ...+|+||||+++++|..++...+ .+++..++.++.||+.||+|||+++|+||||||+||||+.+|.+||+|||+
T Consensus 255 ~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 255 T--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred e--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence 6 458999999999999987775543 499999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+...... .....+||+.|+|||++.|
T Consensus 333 a~~~~~~~-~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 333 AVHVPEGQ-TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp CEECCTTC-CEECCCSCGGGCCHHHHTT
T ss_pred ceecccCc-cccccCCCccccCHHHHcC
Confidence 98865433 3345689999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=290.65 Aligned_cols=178 Identities=26% Similarity=0.400 Sum_probs=155.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
...++|.+++.||+|+||.||+++++.+++.||||++.+..... ......+..|..+|..+ +||+|+++++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~------~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH------TTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc------HHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 34678999999999999999999999999999999998653321 22345678899999887 799999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ .+.+||||||+++++|..++...+.+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 412 ~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 412 QT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp BC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred Ee--CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 86 4689999999999999998887788999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..........+.+||+.|+|||++.|
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHHTC
T ss_pred eccccCCcccccccCCCcccCHhhhcC
Confidence 975544455667889999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.73 Aligned_cols=175 Identities=25% Similarity=0.431 Sum_probs=143.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++++.||+|+||.||++++..+++.||||++.+... .......+.+|+.+|+.++|||||++++++.
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 456889999999999999999999999999999999875421 3455678899999999999999999999997
Q ss_pred cCC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
... ...+|+||||++++.+.. +. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~~l~~~-~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDANLCQV-IQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSEEHHHH-HT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCccccCCeEEEEEeCCCCCHHHH-Hh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEE
Confidence 532 257899999998764433 32 24899999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|+..... ......+||+.|+|||++.|
T Consensus 209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 209 GLARTAGTS-FMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp CCC-----C-CCC----CCCTTCCHHHHTT
T ss_pred EeeeecCCC-cccCCCcccccccCHHHHcC
Confidence 999876443 33456789999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=268.93 Aligned_cols=172 Identities=31% Similarity=0.495 Sum_probs=141.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||++++..+++.||||++..... ....+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----------IDENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----------ccHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 34689999999999999999999999999999999865321 12467899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc--EEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~--~kl~DFGla 273 (300)
...+++||||+++++|...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 88 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 88 --PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred --CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 4589999999999999988877778999999999999999999999999999999999999987765 999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..... .......||+.|+|||++.|
T Consensus 166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 166 KSSVLH-SQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp ----------------CTTSCHHHHHC
T ss_pred cccccc-CCCCCCcCCCCcCChhhhcC
Confidence 854322 23345679999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=261.66 Aligned_cols=175 Identities=31% Similarity=0.430 Sum_probs=140.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||+++. +++.||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-------HAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3456899999999999999999875 688999999865422 3455678999999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcEEEec
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~kl~D 269 (300)
+ ...+++||||+++++|.+++..... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 105 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 105 Q--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp S--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred E--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 6 3468999999999999988866553 999999999999999999999999 99999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++..............||+.|+|||++.|
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp CC-----------------CCTTSCHHHHTT
T ss_pred CCCCccccccccccccCCCCccccChhhhcC
Confidence 9999875544444455679999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=267.10 Aligned_cols=171 Identities=30% Similarity=0.423 Sum_probs=148.1
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
..+.++|.+.+.||+|+||.||++.++.+++.||||++.+... ...+|+.++..+ +||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~E~~~l~~~~~hp~iv~~~~~ 84 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------------DPTEEIEILLRYGQHPNIITLKDV 84 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------------CCHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------------ChHHHHHHHHHhcCCCCcCeEEEE
Confidence 3455789999999999999999999999999999999875421 123677788777 79999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC----CcEEEe
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIG 268 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~----~~~kl~ 268 (300)
+.+ ...+|+||||+++++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+... +.+||+
T Consensus 85 ~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 85 YDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp EEC--SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred EEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 986 46899999999999999888888889999999999999999999999999999999999998543 359999
Q ss_pred cccCceeecCCccccccCCCccccccCcccC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|||+++..........+.+||+.|+|||++.
T Consensus 163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp CCTTCEECBCTTCCBCCSSCCSSCCCHHHHH
T ss_pred ECCCcccCcCCCCceeccCCCccccCHHHhc
Confidence 9999998766555556778999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=260.76 Aligned_cols=174 Identities=25% Similarity=0.386 Sum_probs=150.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+++.||||++..... ......+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 3579999999999999999999999999999999875432 12345678999999999999999999999876
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE----ccCCcEEEec
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGD 269 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----~~~~~~kl~D 269 (300)
....+++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 6668999999999999988776543 39999999999999999999999999999999999999 7788899999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++....... ......||+.|+|||++.
T Consensus 160 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 160 FGAARELEDDE-QFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred CCCceecCCCC-ceeecccCCCccCHHHhh
Confidence 99999875543 334567999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=264.77 Aligned_cols=181 Identities=24% Similarity=0.396 Sum_probs=147.7
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..+.++|++.+.||+|+||.||++++..+++.||||++..... ........+.+|+.++..++||||+++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA------RDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT------TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc------CCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4556789999999999999999999999999999999865421 2445667899999999999999999999998
Q ss_pred EcCCC--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 194 DDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 194 ~~~~~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
..... ...|+||||+++++|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 75322 2459999999999999988777789999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc---ccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
++..+..... ......||+.|+|||++.|
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp CC------------------CCTTCCHHHHHT
T ss_pred CcccccccccccccccccCcCcccCCHHHhcC
Confidence 9987643321 2234569999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=266.74 Aligned_cols=170 Identities=14% Similarity=0.163 Sum_probs=144.1
Q ss_pred ecceeEeeeecCCCceEEEEE-----EEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceee
Q 022241 117 INEYVHVRKIGAGSYGKVVLY-----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVN 188 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 188 (300)
.++|.+.+.||+|+||.||++ .+..+++.||||++... ....+..|+.++..++ |+||++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------------NPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------------CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------------ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 467999999999999999999 46778999999998543 2346778888888887 999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-- 261 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-- 261 (300)
+++++.. .+..++||||+++++|.+++. ....+++..++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 132 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 132 FYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred hheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence 9999986 357899999999999998875 4567999999999999999999999999999999999999998
Q ss_pred ---------CCcEEEecccCceeec--CCccccccCCCccccccCcccCC
Q 022241 262 ---------SGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 ---------~~~~kl~DFGla~~~~--~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++.+||+|||+|+.+. .........+||+.|+|||++.|
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 8999999999998653 22334456789999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=261.10 Aligned_cols=172 Identities=29% Similarity=0.488 Sum_probs=140.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++++ .+++.||||++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-------DEGIPSTTIREISILKELKHSNIVKLYDVIHT-- 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-------ccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--
Confidence 5799999999999999999998 5789999999865422 11223567899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++ ++...+. ..+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 3579999999987 5554443 3467999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp CC---------CCCTTCCHHHHTT
T ss_pred CccccccccccccccccCchheeC
Confidence 544334445679999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=262.76 Aligned_cols=169 Identities=28% Similarity=0.423 Sum_probs=131.1
Q ss_pred cceeEe---eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEE
Q 022241 118 NEYVHV---RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~---~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 193 (300)
++|.+. +.||+|+||.||++.+..+++.||||++.+. ....+.+|+.+++.+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------------MEANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------------GHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------------hhhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 456665 7899999999999999999999999998643 2356778999999997 99999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDF 270 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DF 270 (300)
.+ ....|+||||+++++|.+.+.....+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+||
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 76 HD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EC--SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred Ec--CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 86 468999999999999999888888899999999999999999999999999999999999998766 8999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++.............+||+.|+|||++.+
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp TTCEECCC----------------------
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcC
Confidence 999987655555566789999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=265.97 Aligned_cols=175 Identities=19% Similarity=0.271 Sum_probs=151.7
Q ss_pred ecceeEeeeecCC--CceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 117 INEYVHVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~~~iG~G--~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.++|++++.||+| +||.||++++..+++.||||++..... .......+.+|+.+++.++|||||++++++.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 4679999999999 999999999999999999999976432 3456678899999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ...+++||||++++++.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 97 A--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp E--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred E--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 6 45899999999999998877543 6799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCc-------cccccCCCccccccCcccCC
Q 022241 273 SQVFEDDN-------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~-------~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... .......||+.|+|||++.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ceeeccccccccccccccccccccccccCHHHHhc
Confidence 87643221 12223479999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=259.50 Aligned_cols=170 Identities=28% Similarity=0.415 Sum_probs=149.7
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS 198 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 198 (300)
.|...+.||+|+||.||++++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 114 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---------QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV--G 114 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEE--C
Confidence 4778889999999999999999999999999986432 2234678899999999999999999999986 4
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 115 ~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 115 EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 589999999999999887754 4799999999999999999999999999999999999999999999999999988765
Q ss_pred CccccccCCCccccccCcccCC
Q 022241 279 DNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 279 ~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........||+.|+|||++.+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISR 215 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTT
T ss_pred CccccccccCCccccCHhhhcC
Confidence 4444456789999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.95 Aligned_cols=172 Identities=26% Similarity=0.486 Sum_probs=133.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 74 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--------EEGTPSTAIREISLMKELKHENIVRLYDVIHT-- 74 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--------TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--------ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--
Confidence 57999999999999999999999999999999986542 12233567899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.+.+++||||+++ ++.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 75 ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCS
T ss_pred CCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCc
Confidence 4589999999995 5554442 22469999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++..............||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred cceecCCCcccCCCCcccccccCchHhhC
Confidence 99987554444456679999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=264.64 Aligned_cols=173 Identities=27% Similarity=0.479 Sum_probs=150.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.|.+++.||+|+||.||++.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 119 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---------YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---------chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence 456899999999999999999999999999999998653 22344578899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--CCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DFGl 272 (300)
...+++||||+++++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 120 --~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 120 --KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp --SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 46899999999999998887655 47999999999999999999999999999999999999974 46899999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......||+.|+|||++.|
T Consensus 198 a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 198 ATKLNPDE-IVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp CEECCTTS-CEEEECSSGGGCCHHHHTT
T ss_pred ceecCCCc-ceeeeccCCCccCchhccC
Confidence 99865433 3344579999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=263.13 Aligned_cols=178 Identities=26% Similarity=0.448 Sum_probs=148.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++++.||+|+||.||++++..+|+.||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-------SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-------cccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 35789999999999999999999999999999998865422 12233467799999999999999999999876
Q ss_pred CC------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 196 PN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 196 ~~------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
.. ...+++||||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp C--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred cccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 32 357899999999755555555556799999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCC----ccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDD----NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~----~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|..+... ........||+.|+|||++.|
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred chhcccccccccccccccCCcccccCccCchhhcC
Confidence 9999876422 223345678999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.53 Aligned_cols=175 Identities=21% Similarity=0.264 Sum_probs=141.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---------CCcee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---------HPNIV 187 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~niv 187 (300)
.++|++.+.||+|+||.||++++ +|+.||||++........ ..........+.+|+.+|+.++ |||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLV-NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCB-TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCcccc-ccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 46799999999999999999987 689999999986532110 0112334567889999998886 77777
Q ss_pred eeeeEEE-----------------c-----------CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHH
Q 022241 188 NLIEVID-----------------D-----------PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239 (300)
Q Consensus 188 ~~~~~~~-----------------~-----------~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l 239 (300)
++.+++. + .....+|+||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 7666542 1 014689999999999976666644 5789999999999999999
Q ss_pred HHHH-hCCcEeCCCCCCCEEEccCC--------------------cEEEecccCceeecCCccccccCCCccccccCccc
Q 022241 240 MYLH-GHNVVHGDIKPDNLLVAPSG--------------------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 240 ~yLH-~~~iiHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+||| +++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||++
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence 9999 99999999999999999887 8999999999976543 34799999999998
Q ss_pred CC
Q 022241 299 LG 300 (300)
Q Consensus 299 ~G 300 (300)
.|
T Consensus 250 ~g 251 (336)
T 2vuw_A 250 TG 251 (336)
T ss_dssp CC
T ss_pred cC
Confidence 76
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=260.81 Aligned_cols=177 Identities=33% Similarity=0.577 Sum_probs=148.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++++.||+|+||.||++++..+++.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 34578999999999999999999999999999999986432 13445567889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ....++||||++++++..+......+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 95 ~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 95 K--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp E--TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred c--CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 6 46899999999999888877777789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............||+.|+|||++.|
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVG 198 (331)
T ss_dssp -----------CCCCCTTCCHHHHTT
T ss_pred eecCCccccCCCcCCccccCcccccC
Confidence 76555445556779999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.98 Aligned_cols=176 Identities=31% Similarity=0.416 Sum_probs=155.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED- 86 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc------cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-
Confidence 3579999999999999999999999999999999876432 134566788999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+..++||||++++++.+.+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 87 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 87 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 4589999999999999888877778999999999999999999999999999999999999999999999999999886
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 166 EYDGERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHTT
T ss_pred ccCccccccccCCCCcCCcchhcc
Confidence 544444455679999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=257.83 Aligned_cols=173 Identities=28% Similarity=0.417 Sum_probs=139.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~ 195 (300)
.++|++.++||+|+||.||++++..+++.||||++..... ..........|+..+. ..+||||+++++++.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-------GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-------SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-------ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 3679999999999999999999999999999998754321 2333344555555554 4599999999999986
Q ss_pred CCCCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++||||+++ ++...+ .....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 129 --~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 129 --GGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp --TTEEEEEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred --CCEEEEEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence 4689999999965 444443 334579999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... .......||+.|+|||++.|
T Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 206 ELGTA-GAGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp ECC-------CCCCCGGGCCGGGGGT
T ss_pred ecccC-CCCcccCCCccccCHhHhcC
Confidence 76443 23345679999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=263.86 Aligned_cols=175 Identities=21% Similarity=0.356 Sum_probs=147.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCcee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV 187 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 187 (300)
..++|.+.+.||+|+||.||++++.. ++..||||+++... .......+.+|+.+|+.+ +||||+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--------BHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--------CHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45789999999999999999998752 45679999986431 345567899999999999 899999
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCC
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrD 251 (300)
++++++.+ ...+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+|||
T Consensus 151 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 151 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999976 35799999999999998776432 3589999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 252 lkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
|||+|||++.++.+||+|||+++....... ......+|+.|+|||++.|
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 999999999999999999999987654322 2233467889999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=253.09 Aligned_cols=176 Identities=29% Similarity=0.464 Sum_probs=136.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+++.||||.+....... ......+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK------AGMVQRVQNEVKIHCQLKHPSILELYNYFED- 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh------hhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-
Confidence 467999999999999999999999999999999997543211 1234678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||++++++.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 83 -SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp -SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred -CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 46899999999999988877654 6799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
............||+.|+|||++.|
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 162 LKMPHEKHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp CC-----------------------
T ss_pred ccCCCCcceeccCCCCcCCcchhcC
Confidence 6544434445679999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.46 Aligned_cols=175 Identities=27% Similarity=0.437 Sum_probs=145.3
Q ss_pred eecceeEeeeecCCCceEEEEEE----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
..++|++++.||+|+||.||+++ +..+++.||||++... .......+.+|+.+++.++||||+++++
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34689999999999999999998 5668999999998643 3455678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.......+++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 986544456899999999999998875543 5999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc---ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......+|+.|+|||++.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 99987644322 223345788899999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=259.43 Aligned_cols=176 Identities=31% Similarity=0.416 Sum_probs=155.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 112 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED- 112 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 3579999999999999999999999999999999876532 134566788999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||++++++.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 4589999999999999888877778999999999999999999999999999999999999999999999999999987
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 192 EYDGERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHHT
T ss_pred ccCcccccccCCCccccCHHHhcc
Confidence 544444456679999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=247.57 Aligned_cols=174 Identities=29% Similarity=0.522 Sum_probs=153.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIKKEICINKMLNHENVVKFYGHRRE- 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--------CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--------chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-
Confidence 467999999999999999999999999999999986542 22345678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||+++++|.+.+.....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..+
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 77 -GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp -TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 4589999999999999999988888999999999999999999999999999999999999999999999999999875
Q ss_pred cCCc--cccccCCCccccccCcccCC
Q 022241 277 EDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
.... .......||+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred CCCcchhcccCCccccCccChHHHhc
Confidence 4322 22345679999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=259.22 Aligned_cols=175 Identities=29% Similarity=0.365 Sum_probs=146.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|.+.+.||+|+||.||++++..+++ .||||.+.... .......+.+|+.+++.++||||+++++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--------TERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 345789999999999999999999986655 49999986431 3455678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.+ ....++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+||
T Consensus 118 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 118 VVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence 9976 4578999999999999888754 467999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc---ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......+|+.|+|||++.
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhc
Confidence 99998654322 122334678899999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.99 Aligned_cols=177 Identities=28% Similarity=0.468 Sum_probs=140.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++++.||+|+||.||++++..+++.||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-------EEGVPGTAIREVSLLKELQHRNIIELKSVI 102 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-------ccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence 3445789999999999999999999999999999999865421 223345677999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc-----cCCcEEEe
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-----PSGTVKIG 268 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~-----~~~~~kl~ 268 (300)
.+ ...+++||||+++ ++.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 103 ~~--~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 103 HH--NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EE--TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred ec--CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 86 4589999999985 7777777777899999999999999999999999999999999999994 45569999
Q ss_pred cccCceeecCCccccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||++..............||+.|+|||++.|
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTT
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcC
Confidence 99999876544444555678999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=261.53 Aligned_cols=172 Identities=31% Similarity=0.480 Sum_probs=136.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...+.|.+.+.||+|+||.||++++..+++.||||++.... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----------DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----------hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 34567999999999999999999999999999999986431 2346778999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCcEEEeccc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFS 271 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~~kl~DFG 271 (300)
+ ...+++||||+++++|.+.+...+.+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 119 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 119 T--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred c--CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 6 4589999999999999998888888999999999999999999999999999999999999975 8899999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++...... .......||+.|+|||++.|
T Consensus 197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 197 LSKIVEHQ-VLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp -----------------CGGGSCHHHHTT
T ss_pred cccccCcc-cccccccCCCCccCHHHhcC
Confidence 99876443 23345679999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=251.32 Aligned_cols=175 Identities=27% Similarity=0.464 Sum_probs=153.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
+.++|.+.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence 44689999999999999999999999999999999876432 34556788999999999999999999999985
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc---EEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DFGl 272 (300)
....++||||++++++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 77 --ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred --CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 4588999999999998887777778999999999999999999999999999999999999987665 99999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......||+.|+|||++.|
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 155 AIEVNDSE-AWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp CEECCSSC-BCCCSCSCGGGCCHHHHTT
T ss_pred eEEcccCc-cccCCCCCcCCcCchhhcC
Confidence 98765433 3345679999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=259.97 Aligned_cols=173 Identities=21% Similarity=0.255 Sum_probs=146.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++.+.||+|+||.||+++.. ++.||||++... .........|+.++..++|||||++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----------DKQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----------chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34468999999999999999999765 889999998643 223345667999999999999999999998
Q ss_pred cCC--CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeCCCCCCCEEEccC
Q 022241 195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH----------NVVHGDIKPDNLLVAPS 262 (300)
Q Consensus 195 ~~~--~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------~iiHrDlkp~NIll~~~ 262 (300)
+.. ...+++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 633 3357999999999999988755 4599999999999999999999999 99999999999999999
Q ss_pred CcEEEecccCceeecCCcc--ccccCCCccccccCcccCC
Q 022241 263 GTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 263 ~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
+.+||+|||+|..+..... ......||+.|+|||++.|
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence 9999999999987654332 2334579999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=266.27 Aligned_cols=174 Identities=25% Similarity=0.386 Sum_probs=151.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 4579999999999999999999999999999999875422 12345678999999999999999999999876
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE----ccCCcEEEec
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGD 269 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----~~~~~~kl~D 269 (300)
.....++||||+++++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 6668899999999999988886543 39999999999999999999999999999999999999 7778899999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+++...... ......||+.|+|||++.
T Consensus 160 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 160 FGAARELEDDE-QFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp GGGCEECCCGG-GSSCSSSCCTTCCHHHHH
T ss_pred CCCceEccCCC-ccccccCCccccCHHHhh
Confidence 99998865433 334567999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=263.69 Aligned_cols=174 Identities=26% Similarity=0.468 Sum_probs=142.7
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||++.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 34578999999999999999999999999999999985432 13455678899999999999999999999997
Q ss_pred cCCC----CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~~----~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.... ..+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence 5321 3579999999 6677766654 57999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+++..... .....||+.|+|||++.|
T Consensus 173 g~a~~~~~~---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 173 GLARQADSE---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp TTCEECCSS---CCSSCSCGGGCCTHHHHT
T ss_pred ecccccccc---cCcCcCCCCcCCHHHHhC
Confidence 999875432 345679999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=265.43 Aligned_cols=176 Identities=18% Similarity=0.289 Sum_probs=146.8
Q ss_pred eeecceeEeeeecCCCceEEEEEE-----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVN 188 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 188 (300)
...++|.+.+.||+|+||.||+++ ...+++.||||++.... .......+.+|+.++..+ +|||||+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--------CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345789999999999999999998 45577899999986431 344567899999999999 7999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCCCCC----------------------------------------------
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---------------------------------------------- 222 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~---------------------------------------------- 222 (300)
+++++.+. ...+++||||+++++|.+++.....
T Consensus 91 ~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999864 3568999999999998877654322
Q ss_pred --------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc-
Q 022241 223 --------------------IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND- 281 (300)
Q Consensus 223 --------------------l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~- 281 (300)
+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 89999999999999999999999999999999999999999999999999986533222
Q ss_pred -ccccCCCccccccCcccC
Q 022241 282 -VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 -~~~~~~gt~~y~aPE~l~ 299 (300)
......||+.|+|||++.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp EEC--CEECGGGCCHHHHH
T ss_pred hhccccCCCceeEChhhhc
Confidence 233456899999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=255.93 Aligned_cols=175 Identities=26% Similarity=0.472 Sum_probs=147.1
Q ss_pred ecceeEeeeecCCCceEEEEEE----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
...|++.+.||+|+||.||+++ +..+++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------GGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--------cchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3569999999999999999998 56689999999986532 22345678899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.+.....+++||||+++++|.+++ .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 9876556799999999999999887 344579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc---ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
++........ ......||+.|+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeec
Confidence 9988754432 233456889999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=273.03 Aligned_cols=175 Identities=33% Similarity=0.589 Sum_probs=150.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||++++..+++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 92 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-------NKDTSTILREVELLKKLDHPNIMKLFEILED 92 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence 446899999999999999999999999999999999764321 1234678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc---cCCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~---~~~~~kl~DFGl 272 (300)
...+++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 93 --SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 468999999999999988887777899999999999999999999999999999999999995 456799999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|..+... .......||+.|+|||++.|
T Consensus 171 a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 171 STCFQQN-TKMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp TTTBCCC-----CCTTGGGGCCGGGGGS
T ss_pred CeECCCC-CccCCCcCCCCCCCHHHhCC
Confidence 9866443 23455679999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=256.40 Aligned_cols=180 Identities=27% Similarity=0.450 Sum_probs=155.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...+.|.+.+.||+|+||.||++++..+|+.||||++....... .........+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA---SRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS---CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc---cccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 34567999999999999999999999999999999997653221 111223567889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DF 270 (300)
+ ...+++||||+++++|.+++.....+++..++.++.|++.||+|||+.+|+||||||+|||++.++ .+||+||
T Consensus 86 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred c--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 6 468999999999999999888888899999999999999999999999999999999999999888 7999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++....... ......||+.|+|||++.|
T Consensus 164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp TTCEECCTTC-CCCCCCSCGGGCCHHHHTT
T ss_pred ccceecCccc-cccccCCCCCccCcccccC
Confidence 9998765432 3345679999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=263.33 Aligned_cols=181 Identities=23% Similarity=0.364 Sum_probs=152.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||++.......... ........+.+|+.+|+.++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW-IEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSE-EEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4568999999999999999999999999999999997653211000 001123356789999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCC-ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++||||+.++ ++..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 101 --~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 --QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp --SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred --CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 46899999999776 888888888889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......||+.|+|||++.|
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTT
T ss_pred ECCCCC-ceeccCCCccccChhhhcC
Confidence 865433 3345679999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=258.51 Aligned_cols=171 Identities=22% Similarity=0.296 Sum_probs=146.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|.+.+.||+|+||.||++++..+++.||||++..... ...+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----------APQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----------SCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----------hHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 34679999999999999999999999999999999864321 12577899999999 9999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc-----EEEe
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIG 268 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~-----~kl~ 268 (300)
. ....++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++. +||+
T Consensus 76 ~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 76 C--GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred c--CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 6 46899999999 7888877754 468999999999999999999999999999999999999998887 9999
Q ss_pred cccCceeecCCccc-------cccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDV-------LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~l~G 300 (300)
|||+++.+...... .....||+.|+|||++.|
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence 99999976543321 245679999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.51 Aligned_cols=172 Identities=28% Similarity=0.454 Sum_probs=136.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+++.||+|+||.||++++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 71 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--------GAPCTAIREVSLLKDLKHANIVTLHDIIHT-- 71 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--------ccchhHHHHHHHHHhcCCCCCCeeeeEEee--
Confidence 5799999999999999999999999999999998643211 111234579999999999999999999986
Q ss_pred CCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++ ++...+ .....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 72 EKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred CCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 3579999999986 444444 34456999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........||+.|+|||++.|
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 151 SIPTKTYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp ------------CGGGCCHHHHTT
T ss_pred cCCccccccccCcccccChhhhcC
Confidence 554444555679999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=250.77 Aligned_cols=173 Identities=30% Similarity=0.509 Sum_probs=152.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---------EDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---------chHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34679999999999999999999999999999999876422 234678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DFGl 272 (300)
....++||||++++++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 78 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 78 --NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred --CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 46899999999999998888777789999999999999999999999999999999999999 7788999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......||+.|+|||++.|
T Consensus 156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 156 AARFKPGK-MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp CEECCTTS-CBCCCCSCTTTCCHHHHTT
T ss_pred ceeccCcc-chhccCCCCCccChHHhcc
Confidence 98765433 3455679999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.10 Aligned_cols=174 Identities=34% Similarity=0.613 Sum_probs=147.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||+++++.++..||||++.+.... ......+.+|+.+|+.++|||||++++++.+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-------TSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-------chHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 446799999999999999999999999999999999765321 1224578899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC---CcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DFGl 272 (300)
...+++||||+++++|.+.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.. +.+||+|||+
T Consensus 108 --~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 108 --KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred --CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 45899999999999998888777789999999999999999999999999999999999999764 4599999999
Q ss_pred ceeecCCccccccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|..+.... .....+||+.|+|||++.
T Consensus 186 a~~~~~~~-~~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 186 SAVFENQK-KMKERLGTAYYIAPEVLR 211 (494)
T ss_dssp CEECBTTB-CBCCCCSCTTTCCHHHHT
T ss_pred CeECCCCc-cccccCCCcCeeCHHHHc
Confidence 98875443 345567999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=270.70 Aligned_cols=183 Identities=37% Similarity=0.595 Sum_probs=151.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc----CCChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV----APSETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
...++|.+++.||+|+||.||+++++.+++.||||++.+........ .........+.+|+.+|+.++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45578999999999999999999999999999999997654321100 00113456789999999999999999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEE
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKI 267 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl 267 (300)
+++.+ ...+++||||+++++|.+.+.....+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||
T Consensus 113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99986 468999999999999988887777899999999999999999999999999999999999999776 6999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|||+|....... ......||+.|+|||++.+
T Consensus 191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp CCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT
T ss_pred EECCCCEEcCCCC-ccccccCCcCCCCHHHhcc
Confidence 9999999875433 3455679999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.58 Aligned_cols=169 Identities=30% Similarity=0.503 Sum_probs=145.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|..++.||+|+||.||++++..+++.||||++..... ........+.+|+.+|+.++||||+++++++.+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 125 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-- 125 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc------cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--
Confidence 469999999999999999999999999999999865321 123455678999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....++||||+.++ +.+.+ .....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 126 ~~~~~lv~e~~~g~-l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 126 EHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp TTEEEEEEECCSEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred CCeEEEEEecCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 45899999999854 44433 34567999999999999999999999999999999999999999999999999999865
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... ....||+.|+|||++.
T Consensus 205 ~~~----~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 205 APA----NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp SSB----CCCCSCGGGCCHHHHH
T ss_pred CCC----CcccCCcceeCHhhhc
Confidence 432 3457999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=251.00 Aligned_cols=171 Identities=23% Similarity=0.329 Sum_probs=142.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH--CCCCceeeeeeE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEV 192 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~ 192 (300)
...++|++.+.||+|+||.||+++. +++.||||++... ....+..|..++.. ++||||++++++
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------------~~~~~~~e~~~~~~~~l~h~niv~~~~~ 70 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------------DEKSWFRETELYNTVMLRHENILGFIAS 70 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------------GHHHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------------cchhhHHHHHHHHHhhccCcCeeeEEEe
Confidence 3457899999999999999998876 6899999998543 23455667777776 799999999998
Q ss_pred EEcC--CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeCCCCCCCEEEccC
Q 022241 193 IDDP--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH--------GHNVVHGDIKPDNLLVAPS 262 (300)
Q Consensus 193 ~~~~--~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~iiHrDlkp~NIll~~~ 262 (300)
+.+. ....+++||||+++++|.+++.. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred eccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 6542 23568999999999999988854 57999999999999999999999 9999999999999999999
Q ss_pred CcEEEecccCceeecCCccc----cccCCCccccccCcccCC
Q 022241 263 GTVKIGDFSVSQVFEDDNDV----LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 263 ~~~kl~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~G 300 (300)
+.+||+|||+|......... .....||+.|+|||++.|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence 99999999999876544322 223479999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=262.16 Aligned_cols=177 Identities=26% Similarity=0.446 Sum_probs=142.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+|+.||||++....... ........+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE----AKDGINRTALREIKLLQELSHPNIIGLLDAFGH- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch----hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-
Confidence 467999999999999999999999999999999987542211 011123467899999999999999999999975
Q ss_pred CCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++ .+...+. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 4578999999997 4444443 345799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...........||+.|+|||++.|
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred ccCCcccCCcccccccccCchHhhC
Confidence 6555555566789999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=252.32 Aligned_cols=176 Identities=30% Similarity=0.463 Sum_probs=149.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------HTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch------hhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 34578999999999999999999999999999999987643221 123456889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ....++||||++++++.+.+.....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 80 ~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 80 D--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred c--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 6 45899999999999998888777789999999999999999999999999999999999999999999999999986
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......||+.|+|||++.|
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 158 HAPSS--RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp CC----------CCCCTTCCHHHHTT
T ss_pred cCCcc--cccccCCCCCccCHhHhcc
Confidence 54332 2345679999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=254.77 Aligned_cols=181 Identities=28% Similarity=0.462 Sum_probs=141.8
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLI 190 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~ 190 (300)
....++|++.+.||+|+||.||++++..+++.||||++........ .......+.+|+.+++.+ +||||++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG----GGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTT----SSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccc----ccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 3445789999999999999999999999999999999875432110 111123455677766665 599999999
Q ss_pred eEEEcCCCC---EEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcE
Q 022241 191 EVIDDPNSD---HFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 191 ~~~~~~~~~---~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~ 265 (300)
+++...... .+++||||+++ ++.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred eeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 999764322 58999999985 6666665443 39999999999999999999999999999999999999999999
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||++...... .......||+.|+|||++.+
T Consensus 160 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 160 KLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp EECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT
T ss_pred EEeeCccccccCCC-cccCCccccccccCchHHcC
Confidence 99999999865433 23345679999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=262.25 Aligned_cols=172 Identities=26% Similarity=0.441 Sum_probs=138.5
Q ss_pred ceeecceeEe-eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHH-HHCCCCceeeeee
Q 022241 114 TKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIE 191 (300)
Q Consensus 114 ~~~~~~y~~~-~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~ 191 (300)
....++|.+. +.||+|+||.||++++..+++.||||++... ..+.+|+.++ +..+||||+++++
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~ 122 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVD 122 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeE
Confidence 3455778877 7899999999999999999999999998532 2456788876 5568999999999
Q ss_pred EEEc--CCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCc
Q 022241 192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGT 264 (300)
Q Consensus 192 ~~~~--~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~ 264 (300)
++.. .....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.
T Consensus 123 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCC
T ss_pred EEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCcc
Confidence 8864 2245789999999999998888654 35999999999999999999999999999999999999997 789
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||+++..... ......+||+.|+|||++.+
T Consensus 203 ~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 203 LKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp EEECCCTTCEECC------------CTTCCGGGSCC
T ss_pred EEEEecccccccCCC-CccccCCCCCCccCHhhcCC
Confidence 999999999876433 23456789999999999854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=273.83 Aligned_cols=177 Identities=33% Similarity=0.576 Sum_probs=154.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++..+++.||||++.+.... .......+.+|+.+|+.++|||||++++++.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK------QKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc------cchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456899999999999999999999999999999998765321 2234567899999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEeccc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS 271 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DFG 271 (300)
+ ...+++||||+.+++|.+.+.....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 97 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 97 D--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred e--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 6 46899999999999999888888899999999999999999999999999999999999999 467899999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|..+.... ......||+.|+|||++.|
T Consensus 175 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 175 LSTHFEASK-KMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp HHHHBCCCC-SHHHHTTGGGTCCHHHHHT
T ss_pred eeEEccccc-ccccCCCCccccCceeecC
Confidence 998764433 3345679999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=256.52 Aligned_cols=174 Identities=26% Similarity=0.389 Sum_probs=149.2
Q ss_pred cccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-----CCc
Q 022241 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----HPN 185 (300)
Q Consensus 111 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 185 (300)
..+....++|.++++||+|+||.||++++..+++.||||++.. .......+..|+.+++.+. |||
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----------IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----------CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----------chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 3456667899999999999999999999999999999999853 2344567788999999997 999
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-- 261 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-- 261 (300)
||++++++.. .+.+++||||+ +++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 98 iv~~~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 98 IVKYHGKFMY--YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp BCCEEEEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred eecccceeeE--CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence 9999999986 35899999999 77777766443 35999999999999999999999999999999999999975
Q ss_pred -----------------------CCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 262 -----------------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++.+||+|||+|...... .....||+.|+|||++.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN 233 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC
Confidence 789999999999875432 345679999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=264.07 Aligned_cols=178 Identities=28% Similarity=0.442 Sum_probs=150.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
..++|.+.+.||+|+||.||+++.. .+++.||||++++..... .......+.+|+.+|..+ +||||+++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----EESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-----hhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 3478999999999999999999984 488999999987643211 111223456789999998 6999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
++.. ...+++||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 127 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 127 AFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred EEee--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 9986 35899999999999999888777789999999999999999999999999999999999999999999999999
Q ss_pred CceeecCC-ccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDD-NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~-~~~~~~~~gt~~y~aPE~l~G 300 (300)
+++.+... .......+||+.|+|||++.|
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcC
Confidence 99876432 223345679999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=258.04 Aligned_cols=177 Identities=32% Similarity=0.486 Sum_probs=145.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+..+++.||||++.+..... ........+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ----INPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc----cCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 467999999999999999999999999999999997653321 123456789999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCC----------------------------------------CCCCCHHHHHHHHHHHH
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ----------------------------------------PGAIGESMARKYLRDIV 236 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~----------------------------------------~~~l~~~~~~~i~~qi~ 236 (300)
....++||||+++++|.+.+.. ...+++..++.++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 4689999999999998776631 11246778899999999
Q ss_pred HHHHHHHhCCcEeCCCCCCCEEEccCC--cEEEecccCceeecCCcc----ccccCCCccccccCcccC
Q 022241 237 SGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 237 ~~l~yLH~~~iiHrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
.||+|||+.+|+||||||+|||++.++ .+||+|||++..+..... ......||+.|+|||++.
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 999999999999999999999998776 899999999987643221 234567999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=255.58 Aligned_cols=173 Identities=27% Similarity=0.416 Sum_probs=150.3
Q ss_pred cceeEeeeecCCCceEEEEEE----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|++.+.||+|+||.||+++ +..+++.||||++... .......+.+|+.+++.++||||+++++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---------GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---------CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 679999999999999999998 5668899999998643 344567799999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
..+....+++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 86666789999999999999888765 34699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc---ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
+........ ......||+.|+|||++.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhc
Confidence 987654332 223446889999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=258.06 Aligned_cols=174 Identities=25% Similarity=0.436 Sum_probs=132.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||++.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 44578999999999999999999999999999999986431 13455678889999999999999999999987
Q ss_pred cCC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
... ...+|+||||+ +++|...+.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 531 24689999999 5677776654 57999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+++..... .....||+.|+|||++.|
T Consensus 177 G~a~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 177 GLARHTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp -----------------CCCTTCCHHHHTT
T ss_pred ccccccccc---CCCcCcCcCccChHHHcC
Confidence 999875432 345679999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=250.76 Aligned_cols=174 Identities=30% Similarity=0.594 Sum_probs=145.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 90 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--------SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--------CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--------cchhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence 34578999999999999999999999999999999987643 1223567889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEE
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKI 267 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl 267 (300)
+ ....++||||+++++|.+.+.. ...+++..++.++.|++.||+|||+.+|+||||||+|||+ +.++.+||
T Consensus 91 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 91 D--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp C--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred c--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 6 4589999999999988876633 3679999999999999999999999999999999999999 45678999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++....... ......||+.|+|||++.
T Consensus 169 ~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 169 IDFGLAELFKSDE-HSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp CCCCCCCC-----------CTTGGGCCHHHHT
T ss_pred EeeecceecCCcc-cCcCcccccCcCChHHhc
Confidence 9999998764432 334567999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=251.93 Aligned_cols=179 Identities=23% Similarity=0.321 Sum_probs=146.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|+||.||++.+..+++.||||++...... .......+.+|+.+++.++||||+++++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS------DPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34467899999999999999999999999999999998654321 344567899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.. ...+++||||+++++|.+++.....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 104 EI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EE--TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred ee--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 86 4589999999999999988877778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCc-cccccCCCccccccCcccCC
Q 022241 274 QVFEDDN-DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~-~~~~~~~gt~~y~aPE~l~G 300 (300)
....... .......||+.|+|||++.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp ---------------CCGGGCCGGGTCC
T ss_pred ccccccccccccccCCCcCccCHHHHcC
Confidence 8764432 22334579999999998854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=258.56 Aligned_cols=168 Identities=25% Similarity=0.439 Sum_probs=139.7
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
...+.||+|+||.||++.+..+|+.||||++... .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 160 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---------GMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KND 160 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 3367899999999999999999999999998653 23455678999999999999999999999986 458
Q ss_pred EEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE--ccCCcEEEecccCceeec
Q 022241 201 FYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll--~~~~~~kl~DFGla~~~~ 277 (300)
+++||||+++++|.+.+.. ...+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999999998776643 3469999999999999999999999999999999999999 567799999999999865
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ......||+.|+|||++.+
T Consensus 241 ~~~-~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 241 PRE-KLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp TTC-BCCCCCSSCTTCCHHHHTT
T ss_pred Ccc-ccccccCCCcEeChhhccC
Confidence 433 3345679999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=248.27 Aligned_cols=179 Identities=35% Similarity=0.620 Sum_probs=146.6
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
+....++|.+.+.||+|+||.||++.+..+++.||||++...... .......+.+|+.+++.++||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR------SLDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc------chhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 455668899999999999999999999999999999998764321 12234578899999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+.+ ....++||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 80 IST--PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred Eec--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence 986 458999999999999998887777899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......||+.|+|||++.|
T Consensus 158 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 158 SNMMSDGE-FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp GGCCCC--------------CCTGGGTT
T ss_pred ccccCCCc-ceecccCCccccCHHHHcC
Confidence 98764432 2345579999999999764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=253.98 Aligned_cols=174 Identities=24% Similarity=0.353 Sum_probs=148.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---------SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---------CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 445678999999999999999999865 6899999987543 234567889999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG----AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
.+ ....++||||+++++|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 105 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 105 DE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CC--TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECC
T ss_pred cC--CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEee
Confidence 75 457899999999999998885543 589999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCc--cccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
||++....... .......||+.|+|||++.
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHH
T ss_pred cccccccccccccccccccCCCccccCHHHhc
Confidence 99998754322 2223456899999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=247.95 Aligned_cols=172 Identities=28% Similarity=0.472 Sum_probs=152.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|.+++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 91 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-- 91 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 56999999999999999999999999999999986542 22346788999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++||||++++++.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 4589999999999998887754 579999999999999999999999999999999999999999999999999998876
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTT
T ss_pred ccccccCccCCCcCccCHHHHhc
Confidence 55444456679999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=247.20 Aligned_cols=172 Identities=28% Similarity=0.434 Sum_probs=147.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|.+.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-------GSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-------TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 34679999999999999999999999999999999875421 234556788999999999 9999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC--------
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-------- 262 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-------- 262 (300)
+ .+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 82 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 82 E--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp E--TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred c--CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 6 45899999999999998887553 679999999999999999999999999999999999999844
Q ss_pred -----------CcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 263 -----------GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 263 -----------~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..+||+|||++...... ....||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQE 204 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTT
T ss_pred ccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcC
Confidence 47999999999876443 23459999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=248.84 Aligned_cols=176 Identities=31% Similarity=0.478 Sum_probs=152.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++..+++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------EGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch------HHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 34578999999999999999999999999999999987643221 122457889999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ....++||||+++++|.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 85 D--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred c--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 6 46899999999999998888777789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......||+.|+|||++.|
T Consensus 163 ~~~~~--~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 163 HAPSL--RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp ECSSS--CBCCCCSCGGGCCHHHHTT
T ss_pred cCccc--ccccccCCCCcCCHHHhcc
Confidence 75432 2345679999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=253.29 Aligned_cols=177 Identities=28% Similarity=0.470 Sum_probs=150.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++++..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 4689999999999999999999999999999999875422 345567899999999999999999999988654
Q ss_pred CCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeCCCCCCCEEEccCCcEEE
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHN-----VVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~-----iiHrDlkp~NIll~~~~~~kl 267 (300)
....+++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 55789999999999998887743 345999999999999999999999998 999999999999999999999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccCC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|||++..............||+.|+|||++.|
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred ecCchheeeccccccccccCCCccccChHHhcc
Confidence 999999876544333344569999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.25 Aligned_cols=169 Identities=22% Similarity=0.426 Sum_probs=148.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
..++|++.+.||+|+||.||++++..+++.||||++... ....+.+|+.+++.++ ||||+++++++.
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------------KKKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------------chHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 346899999999999999999999999999999998532 2356889999999997 999999999999
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla 273 (300)
++.....++||||++++++...+. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 866678999999999998887763 489999999999999999999999999999999999999777 8999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
....... ......||+.|+|||++.+
T Consensus 179 ~~~~~~~-~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 179 EFYHPGQ-EYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp EECCTTC-CCCSCCSCGGGCCHHHHTT
T ss_pred eEcCCCC-ccccccccccccChhhhcC
Confidence 8765433 3345679999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=246.71 Aligned_cols=177 Identities=29% Similarity=0.515 Sum_probs=149.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.+.+.||+|+||.||++++..+++.||||++........ ........+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS---RRGVSREEIEREVNILREIRHPNIITLHDIFEN-- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC---SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccc---ccchHHHHHHHHHHHHHhCCCCCeeehhheecC--
Confidence 579999999999999999999999999999999976543211 112245678999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DFGla 273 (300)
....++||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 458999999999999998887777899999999999999999999999999999999999998877 8999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
....... ......||+.|+|||++.+
T Consensus 160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~ 185 (283)
T 3bhy_A 160 HKIEAGN-EFKNIFGTPEFVAPEIVNY 185 (283)
T ss_dssp EECC---------CCCGGGCCHHHHTT
T ss_pred eeccCCC-cccccCCCcCccCcceecC
Confidence 8764432 2345579999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.19 Aligned_cols=179 Identities=27% Similarity=0.434 Sum_probs=141.0
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++.+.||+|+||.||++.+..+|+.||||++..... ........+.+|+.+++.++||||+++++++
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL------MDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3455789999999999999999999999999999999865321 1345667899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
.. ....++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 102 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 102 IE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EE--TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred Ec--CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEe
Confidence 86 458999999999999887764 356799999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++..............||+.|+|||++.+
T Consensus 180 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp C------------------CCSSCCHHHHTT
T ss_pred ccceeeecCCCccccccCCCeeEeChHHhCC
Confidence 9999876554444445679999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=252.83 Aligned_cols=173 Identities=27% Similarity=0.412 Sum_probs=143.1
Q ss_pred eecceeEe-eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 116 MINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 116 ~~~~y~~~-~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
+.+.|.+. +.||+|+||.||++++..+++.||||++.... ......+.+|+.++.++ .||||+++++++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---------GHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---------SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---------chhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44678885 78999999999999999999999999986531 22345788999999885 799999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc---EEEecc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDF 270 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DF 270 (300)
.+ .+.+++||||+++++|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 81 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 81 EE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EE--TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred ee--CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 86 4589999999999999988877778999999999999999999999999999999999999998775 999999
Q ss_pred cCceeecCCc-------cccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDN-------DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~-------~~~~~~~gt~~y~aPE~l~ 299 (300)
|++....... ......+||+.|+|||++.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHH
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhh
Confidence 9987653211 1223456999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.62 Aligned_cols=175 Identities=25% Similarity=0.324 Sum_probs=147.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 189 (300)
...++|.+.+.||+|+||.||++++. .+++.||||++.... .......+.+|+.+++.++||||+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 34578999999999999999999987 345899999986431 34556789999999999999999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP------------------------GAIGESMARKYLRDIVSGLMYLHGH 245 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~~l~yLH~~ 245 (300)
++++.+ ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++
T Consensus 116 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999976 45789999999999988776432 5799999999999999999999999
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
+|+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 249 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence 99999999999999999999999999998653322 1223456899999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=278.16 Aligned_cols=172 Identities=16% Similarity=0.148 Sum_probs=135.3
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeeccccccc-ccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL-RVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 201 (300)
...+.|++|.+..++....|+.||||.+.+...... .....+...+.+.+|+.+|+++ .|+||+++++++++ ...+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 346788888888788888999999999986543211 1111234556799999999999 69999999999986 4689
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
||||||++|++|.+.+...+++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999999988888865 5889999999999999999999999999999999999999999998766555
Q ss_pred ccccCCCccccccCcccCC
Q 022241 282 VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 282 ~~~~~~gt~~y~aPE~l~G 300 (300)
...+.+||+.|+|||++.|
T Consensus 395 ~~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp CSHHHHHHHHHHHHHHC--
T ss_pred cccCceechhhccHHHhCC
Confidence 5667789999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=257.80 Aligned_cols=170 Identities=26% Similarity=0.399 Sum_probs=140.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++++..+|+.||||++..... ...+|+.+|+.++|||||+++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 4689999999999999999999999999999999864321 123799999999999999999998542
Q ss_pred ------------------------------------CCCEEEEEEEeeCCC---ccccccCCCCCCCHHHHHHHHHHHHH
Q 022241 197 ------------------------------------NSDHFYMVLEYVEGK---WDNDGFGQPGAIGESMARKYLRDIVS 237 (300)
Q Consensus 197 ------------------------------------~~~~~~lv~E~~~~~---~l~~~~~~~~~l~~~~~~~i~~qi~~ 237 (300)
....+++||||++++ .+..+......+++..++.++.||+.
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 234588999999964 22233345678999999999999999
Q ss_pred HHHHHHhCCcEeCCCCCCCEEEc-cCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 238 GLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 238 ~l~yLH~~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||++||+||||||+|||++ .++.+||+|||+|+.+.... ......||+.|+|||++.|
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLG 215 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTT
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcC
Confidence 99999999999999999999998 68899999999999764433 3345678999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=251.88 Aligned_cols=175 Identities=21% Similarity=0.314 Sum_probs=147.6
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 189 (300)
...++|.+.+.||+|+||.||++.+. .+++.||||++... ........+.+|+.+++.++||||+++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--------ASPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--------CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--------CCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 34578999999999999999999874 35689999998643 134566789999999999999999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCC------------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG------------------------AIGESMARKYLRDIVSGLMYLHGH 245 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~------------------------~l~~~~~~~i~~qi~~~l~yLH~~ 245 (300)
++++.+ ....++||||+++++|.+++.... .+++..++.++.||+.||+|||++
T Consensus 92 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 92 YGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 999976 357899999999999887775432 389999999999999999999999
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+|+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 999999999999999999999999999987644332 223345788999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=255.66 Aligned_cols=175 Identities=25% Similarity=0.428 Sum_probs=138.8
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+++.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-------CChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 45688999999999999999999999999999999986532 13455677889999999999999999999997
Q ss_pred cCC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
... ...+++||||++++ +...+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSEE-HHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccccccceEEEEEcCCCC-HHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 532 23789999999864 444443 35899999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++...... .......||+.|+|||++.|
T Consensus 172 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 172 GLARTAGTS-FMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp CC-----------------CTTCCHHHHTT
T ss_pred ecccccccc-cccCCceecCCccCHHHhcC
Confidence 999875433 23345679999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=250.80 Aligned_cols=172 Identities=28% Similarity=0.551 Sum_probs=147.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---------AFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---------ccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 3467999999999999999999999999999999987532 1223568899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DFGl 272 (300)
...+++||||+++++|.+.+...+.+++..++.++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||+
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 78 --TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred --CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 45899999999999998888777789999999999999999999999999999999999999 7788999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...... ......||+.|+|||++.|
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 156 SKMEQNG--IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp TCCCCCB--TTHHHHSCCCBCCTTTBSS
T ss_pred ceecCCC--ccccccCCCCccChHHhcc
Confidence 9764332 2334569999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=259.03 Aligned_cols=170 Identities=24% Similarity=0.398 Sum_probs=143.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CCceeeeeeEEEc
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVIDD 195 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 195 (300)
..|.+.+.||+|+||.||++.+.. ++.||||++..... .......+.+|+.+|..++ |||||++++++..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 469999999999999999998874 89999999875421 3456678999999999997 5999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+||| +.+++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++ ++.+||+|||++..
T Consensus 128 --~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 128 --DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp --SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred --CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 457999999 56678888887777899999999999999999999999999999999999996 68999999999987
Q ss_pred ecCCcc--ccccCCCccccccCcccC
Q 022241 276 FEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+..... .....+||+.|+|||++.
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 229 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIK 229 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHH
T ss_pred ccCCCccccCCCCCcCCCccChHHhh
Confidence 643321 234567999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=260.75 Aligned_cols=176 Identities=24% Similarity=0.299 Sum_probs=143.8
Q ss_pred ceeecceeEeeeecCCCceEEEEEE-----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN 188 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 188 (300)
....++|.+.+.||+|+||.||+++ +..+++.||||.+... ........+.+|+.+++.++|||||+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------CSEQDELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--------cChhhHHHHHHHHHHHHhCCCCCCCe
Confidence 3445789999999999999999999 4457789999998532 13455567889999999999999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
+++++.+ ....++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 139 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 139 CIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 9999976 3467999999999998877643 246999999999999999999999999999999999999995
Q ss_pred CC---cEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 262 SG---TVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ~~---~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
++ .+||+|||+|+...... .......||+.|+|||++.
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 259 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence 55 59999999997643221 2223456899999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=250.44 Aligned_cols=179 Identities=31% Similarity=0.552 Sum_probs=146.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+++.||||++....... .......+.+|+.+++.++||||+++++++..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 4568999999999999999999999999999999997653321 12345678999999999999999999999875
Q ss_pred CCCCEEEEEEEeeCCCcccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
......++||||++++. .+.+ .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp C---CEEEEEECCSEEH-HHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCeEEEEehhccCCH-HHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence 55568999999999873 3322 23457999999999999999999999999999999999999999999999999999
Q ss_pred eeecCC--ccccccCCCccccccCcccCC
Q 022241 274 QVFEDD--NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~--~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ........||+.|+|||++.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred cccCccccccccccCCCCCCCcChhhccC
Confidence 876432 223345679999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=257.36 Aligned_cols=177 Identities=21% Similarity=0.360 Sum_probs=148.2
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCc
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPN 185 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 185 (300)
....++|.+.+.||+|+||.||++++.. .+..||||++... ........+.+|+.+++.+ +|||
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~~hpn 136 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--------ATEKDLSDLISEMEMMKMIGKHKN 136 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--------CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--------cCHHHHHHHHHHHHHHHHhcCCch
Confidence 3345789999999999999999999754 3357999998643 1445667899999999999 8999
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVH 249 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 249 (300)
||++++++.+ ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+|
T Consensus 137 Iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 137 IINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp BCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hhhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 9999999986 35689999999999988776433 35999999999999999999999999999
Q ss_pred CCCCCCCEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccCC
Q 022241 250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 250 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
|||||+|||++.++.+||+|||+|....... .......+|+.|+|||++.|
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 9999999999999999999999998764332 22334567899999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.28 Aligned_cols=173 Identities=25% Similarity=0.389 Sum_probs=150.5
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC--
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-- 196 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 196 (300)
.|.+.+.||+|+||.||++.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 48899999999999999999999999999999875432 345567899999999999999999999998642
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEc-cCCcEEEecccCc
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVA-PSGTVKIGDFSVS 273 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~-~~~~~kl~DFGla 273 (300)
....+++||||+++++|.+++.....+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 24568999999999999998877778999999999999999999999999 99999999999998 7889999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......||+.|+|||++.|
T Consensus 180 ~~~~~~--~~~~~~~t~~y~aPE~~~~ 204 (290)
T 1t4h_A 180 TLKRAS--FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp GGCCTT--SBEESCSSCCCCCGGGGGT
T ss_pred cccccc--ccccccCCcCcCCHHHHhc
Confidence 754332 3345679999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=254.90 Aligned_cols=171 Identities=25% Similarity=0.401 Sum_probs=142.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC--CceeeeeeEEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~ 194 (300)
.++|.+++.||+|+||.||++.+. +++.||||++.... ........+.+|+.+|..++| |||+++++++.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 356999999999999999999875 68899999986542 244566789999999999987 99999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+++||| +.+++|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||++.
T Consensus 80 ~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 80 T--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp C--SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred e--CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 6 458999999 45678888887778899999999999999999999999999999999999997 7899999999998
Q ss_pred eecCCcc--ccccCCCccccccCcccC
Q 022241 275 VFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
.+..... ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp CC------------CCCCSSCCHHHHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHh
Confidence 7643322 233567999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.41 Aligned_cols=174 Identities=26% Similarity=0.332 Sum_probs=147.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||+++...+++.||||.+.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 3468999999999999999999999999999999886431 23445678899999999999999999999975
Q ss_pred CCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 184 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 184 --KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred --CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 35789999999999998877654 369999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccc--cCCCccccccCcccC
Q 022241 275 VFEDDNDVLR--RSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~--~~~gt~~y~aPE~l~ 299 (300)
.......... ...+++.|+|||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 288 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALN 288 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHH
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhc
Confidence 7543321111 123577899999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=251.89 Aligned_cols=178 Identities=29% Similarity=0.511 Sum_probs=145.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+++.||||++........ ..........+.+|+.+|+.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG-SAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc-ccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34679999999999999999999999999999999875432110 01122234468899999999999999999999975
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc---EEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DFGl 272 (300)
. ..++||||+++++|.+.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 87 ~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 E---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred C---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 2 48999999999999988888889999999999999999999999999999999999999987664 99999999
Q ss_pred ceeecCCccccccCCCccccccCccc
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+....... ......||+.|+|||++
T Consensus 164 ~~~~~~~~-~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 164 SKILGETS-LMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp CEECCCCH-HHHHHHSCCTTCCHHHH
T ss_pred ceeccccc-ccccccCCcCccCchhh
Confidence 98764432 23345699999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=247.75 Aligned_cols=182 Identities=25% Similarity=0.380 Sum_probs=153.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 193 (300)
...++|.+.+.||+|+||.||++.+..+++.||||++...................+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999999999999999987543211000001234567889999999996 99999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+ ....++||||+++++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 94 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 85 4689999999999999988877778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......||+.|+|||++.
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred hhcCCCc-ccccccCCccccCHHHhc
Confidence 8765432 334567999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=251.92 Aligned_cols=176 Identities=27% Similarity=0.410 Sum_probs=144.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
....++|++.+.||+|+||.||++++..+++.||||++.... .....+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----------DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----------ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 345678999999999999999999999999999999986431 1235788999999998 79999999999
Q ss_pred EEcCC----CCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 193 IDDPN----SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 193 ~~~~~----~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
+.... ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 97632 46899999999999988877543 5799999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCccccccCCCccccccCcccC
Q 022241 267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 267 l~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++..............||+.|+|||++.
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhc
Confidence 999999987654433444567999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=249.38 Aligned_cols=182 Identities=27% Similarity=0.488 Sum_probs=153.9
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccccc--------CCChHHHHHHHHHHHHHHHCCCC
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV--------APSETAMTDVRREVLIMKMLQHP 184 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~ 184 (300)
.....++|.+.+.||+|+||.||++.+ +++.||||.+.......... .........+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 355678999999999999999999998 89999999997654321100 00112236889999999999999
Q ss_pred ceeeeeeEEEcCCCCEEEEEEEeeCCCccccc------cCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCC
Q 022241 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQ--PGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPD 255 (300)
Q Consensus 185 niv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~------~~~--~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~ 255 (300)
||+++++++.+ .+.+++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .||+||||||+
T Consensus 104 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 104 YCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp TBCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CcceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999986 4589999999999999987 655 5789999999999999999999999 99999999999
Q ss_pred CEEEccCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 256 NLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 256 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||++.++.+||+|||++...... ......||+.|+|||++.|
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 224 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSN 224 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSS
T ss_pred hEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcC
Confidence 999999999999999999876443 3445679999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.57 Aligned_cols=175 Identities=26% Similarity=0.470 Sum_probs=147.2
Q ss_pred eecce-eEeeeecCCCceEEEEEEE----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 116 MINEY-VHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 116 ~~~~y-~~~~~iG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
+.++| ++++.||+|+||.||++.. ..+++.||||++.... .......+.+|+.+|+.++||||++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--------GPQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--------ChHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 34455 9999999999999988753 3478899999986431 345567899999999999999999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
+++.+.....+++||||+++++|.+++... .+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 999876567899999999999999887654 4999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc---ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......||+.|+|||++.
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhc
Confidence 99998754332 223456889999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=248.68 Aligned_cols=174 Identities=26% Similarity=0.484 Sum_probs=143.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++++..+++.||||++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------EEKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 35799999999999999999999999999999998542 34557789999999999999999999988642
Q ss_pred -----------CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc
Q 022241 197 -----------NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 197 -----------~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~ 264 (300)
....+++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC
Confidence 13578999999999999888763 346889999999999999999999999999999999999999999
Q ss_pred EEEecccCceeecCC--------------ccccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDD--------------NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~--------------~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||++...... ........||+.|+|||++.|
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 999999999765321 122334569999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=245.98 Aligned_cols=170 Identities=25% Similarity=0.366 Sum_probs=144.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 76 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 76 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----------CHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----------CHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 367999999999999999999987 577899999865422 23568899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||++++++.+++.. ...+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 77 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred -CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence 3579999999999999888744 45699999999999999999999999999999999999999999999999999986
Q ss_pred ecCCc-cccccCCCccccccCcccC
Q 022241 276 FEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
..... .......+|+.|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFS 180 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred ccccccccccCcccccccCCHHHhc
Confidence 54322 1223445788899999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=257.92 Aligned_cols=175 Identities=25% Similarity=0.390 Sum_probs=151.9
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 100 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAF 100 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence 344578999999999999999999999999999999986531 345567899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+ ...+++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 101 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 101 YS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp EE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EE--CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence 86 458999999999999999887777899999999999999999999985 999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...... ......||+.|+|||++.|
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 179 SGQLIDS--MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp CHHHHHH--C----CCCCTTCCHHHHTT
T ss_pred Ccccccc--cccCCCCCCCeECHHHHcC
Confidence 9765332 2345679999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=248.40 Aligned_cols=172 Identities=26% Similarity=0.392 Sum_probs=145.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+|+.||||.+.... ....+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----------DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----------CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----------HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 4467999999999999999999999999999999986431 23568899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+|+|+||||+|||++.++.+||+|||++.
T Consensus 96 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 96 --NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp --TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 458999999999999988775 35679999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............||+.|+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSS
T ss_pred hhhhhccccCccCCCCCccChhhcCC
Confidence 87655444455679999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=253.87 Aligned_cols=172 Identities=30% Similarity=0.465 Sum_probs=146.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||++++..+++.||||++... ........+.+|+.+|..++||||+++++++..+.
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 5799999999999999999999999999999998642 13455678899999999999999999999997532
Q ss_pred ---CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 198 ---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ---~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
...+++||||+++ ++...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 2468999999985 55555533 469999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc---ccccCCCccccccCcccC
Q 022241 275 VFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......||+.|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhc
Confidence 7643322 234557999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=248.85 Aligned_cols=174 Identities=21% Similarity=0.313 Sum_probs=145.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC-
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP- 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 196 (300)
++|.+.+.||+|+||.||++++..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---------EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 5799999999999999999999999999999988643 345567889999999999999999999998632
Q ss_pred -CCCEEEEEEEeeCCCccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 197 -NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 197 -~~~~~~lv~E~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.....++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 23478999999999998876643 5679999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc---------ccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDND---------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~---------~~~~~~gt~~y~aPE~l~G 300 (300)
++........ ......||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSC
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhcc
Confidence 9876432111 1123357999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=250.36 Aligned_cols=175 Identities=21% Similarity=0.356 Sum_probs=146.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEc-------cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCce
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSS-------LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNI 186 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 186 (300)
...++|.+.+.||+|+||.||++++. .++..||||++.... .......+.+|+.+++.+ +||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--------cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 34478999999999999999999875 357789999986431 345667899999999999 89999
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeC
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHG 250 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~yLH~~~iiHr 250 (300)
+++++++.+ ...+++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+|+||
T Consensus 104 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 181 (334)
T 2pvf_A 104 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181 (334)
T ss_dssp CCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 999999976 357899999999999988775433 48999999999999999999999999999
Q ss_pred CCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 251 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||||+|||++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 9999999999999999999999987654322 223345788999999864
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=249.08 Aligned_cols=174 Identities=32% Similarity=0.557 Sum_probs=144.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|.+.+.||+|+||.||++++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 73 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHT- 73 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCcc-------chhhHHHHHHHHHHHHHcCCCCeeeEEEEEec-
Confidence 3679999999999999999999999999999999865421 12233567899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+..++||||+++ ++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 74 -~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 151 (299)
T 2r3i_A 74 -ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151 (299)
T ss_dssp -TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHH
T ss_pred -CCceEEEEEcccC-CHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhh
Confidence 3589999999984 666555332 568999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.............||+.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 152 AFGVPVRTYTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp HHCCCSBCTTSCBCCCTTCCHHHHTT
T ss_pred hccCCccccCcccccccccCcHHhhc
Confidence 76544444455679999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=259.68 Aligned_cols=173 Identities=28% Similarity=0.373 Sum_probs=136.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|.+.+.||+|+||.||+++.. .++..||||.++.. ........+.+|+.+|+.++||||+++++++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--------YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 457999999999999999999877 45778999998643 1345567899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+ ...+++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 116 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 116 TK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred ee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 75 35789999999999999888654 4799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcccc---ccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVL---RRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~---~~~~gt~~y~aPE~l~ 299 (300)
+.......... ....+|+.|+|||++.
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223 (373)
T ss_dssp --------------------CTTSCHHHHH
T ss_pred ccccccCCccceeccCCCcCCCccChhhhc
Confidence 98765432211 1223577899999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=246.94 Aligned_cols=172 Identities=20% Similarity=0.321 Sum_probs=143.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++++.||+|+||.||++... ++..||||++..... ....+.+|+.++..++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----------SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----------CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----------CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 44578999999999999999999876 677899999865422 2356889999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 90 K--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp S--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred c--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence 5 4579999999999999888765 567999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCc-cccccCCCccccccCcccC
Q 022241 274 QVFEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
....... .......+|+.|+|||++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHH
T ss_pred ccccccccccccCCccCcccCCHHHhc
Confidence 8654322 1223345788999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=244.10 Aligned_cols=170 Identities=22% Similarity=0.339 Sum_probs=144.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||++... ++..||||++..... ....+.+|+.++..++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----------SEDEFFQEAQTMMKLSHPKLVKFYGVCSK- 74 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----------cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 467999999999999999999776 567899999865422 23568899999999999999999999975
Q ss_pred CCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||++++++.+++... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 75 -EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred -CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 45799999999999988877554 3599999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc-ccccCCCccccccCcccC
Q 022241 276 FEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
...... ......+|+.|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFH 178 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHH
T ss_pred cchhhhhcccCCCcCcccCCHHHHh
Confidence 654332 222345778899999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=244.27 Aligned_cols=173 Identities=21% Similarity=0.301 Sum_probs=147.0
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
....++|.+.+.||+|+||.||++.+..+++.||||++.... ....+.+|+.++..+ +|+|+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~e~~~~~~l~~~~~i~~~~~~ 74 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----------DAPQLRDEYRTYKLLAGCTGIPNVYYF 74 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----------TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----------ccHHHHHHHHHHHHHhcCCCCCeEEee
Confidence 445578999999999999999999999999999999886432 113467899999999 79999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc-----EE
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VK 266 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~-----~k 266 (300)
+.+ ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +|
T Consensus 75 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 75 GQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp EEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred cCC--CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence 975 46899999999 88888877643 46999999999999999999999999999999999999987775 99
Q ss_pred EecccCceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 267 IGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
|+|||++........ ......||+.|+|||++.|
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcC
Confidence 999999998654322 2345579999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=254.14 Aligned_cols=180 Identities=26% Similarity=0.423 Sum_probs=152.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID 194 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 194 (300)
..++|.+.+.||+|+||.||++++..+|+.||||++....... ...........+.+|+.++..+ +||||+++++++.
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL-SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3467999999999999999999999899999999987542110 0000122355788999999998 7999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ....++||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 171 ~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 S--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp B--SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred e--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 6 46899999999999999888777789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.+.... ......||+.|+|||++.
T Consensus 249 ~~~~~~-~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 249 HLEPGE-KLRELCGTPGYLAPEILK 272 (365)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred ccCCCc-ccccCCCCCCccChhhcc
Confidence 765432 345578999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=249.48 Aligned_cols=169 Identities=16% Similarity=0.221 Sum_probs=145.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCC-------ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 189 (300)
.++|.+.+.||+|+||.||++++..++ ..||+|.+... .....+.+.+|+.+++.++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---------HRNYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---------GGGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---------cHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 367999999999999999999998877 46999998653 23345678999999999999999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc----
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---- 264 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---- 264 (300)
++++.+ ....++||||+++++|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 78 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 78 YGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp EEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred EEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence 999986 3468999999999999988866544 999999999999999999999999999999999999998887
Q ss_pred ----EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 ----VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ----~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||++...... ....||+.|+|||++.+
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK----DILQERIPWVPPECIEN 191 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC
T ss_pred ccceeeeccCcccccccCc----cccCCcCcccCHHHhCC
Confidence 999999998754322 23458899999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=247.19 Aligned_cols=174 Identities=28% Similarity=0.477 Sum_probs=144.9
Q ss_pred ecceeEe-eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEE
Q 022241 117 INEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~-~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 194 (300)
.+.|.+. +.||+|+||.||++++..+++.||||++..... .......+.+|+.++..+. ||||+++++++.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-------GQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-------TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3467777 899999999999999999999999999876432 2234567889999999985 699999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCcEEEec
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGD 269 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~~kl~D 269 (300)
+ ...+++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 100 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 100 N--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp C--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred e--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 6 4589999999999999888754 367999999999999999999999999999999999999997 78999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++....... ......||+.|+|||++.+
T Consensus 178 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 178 FGMSRKIGHAC-ELREIMGTPEYLAPEILNY 207 (327)
T ss_dssp GGGCEEC----------CCCGGGCCHHHHTT
T ss_pred CccccccCCcc-ccccccCCcCccCCeeecC
Confidence 99999765432 2345679999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=256.18 Aligned_cols=182 Identities=18% Similarity=0.194 Sum_probs=140.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccC-----CceEEEEEeecccccccccC--CChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVA--PSETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
++|.+.+.||+|+||.||++.+..+ ++.||||++........... -.......+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999988764 58899999865421100000 0000112345566777888999999999
Q ss_pred eEEEcCC--CCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc--cCCcE
Q 022241 191 EVIDDPN--SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTV 265 (300)
Q Consensus 191 ~~~~~~~--~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~--~~~~~ 265 (300)
+++.... ....+|||||+ +++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 9987532 24689999999 88888877554 6799999999999999999999999999999999999999 88999
Q ss_pred EEecccCceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||+|+.+..... ......||+.|+|||++.|
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence 9999999987643321 1133459999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=254.73 Aligned_cols=172 Identities=22% Similarity=0.368 Sum_probs=140.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCce----EEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.++|++.+.||+|+||.||++++..+++. ||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--------GRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--------SCSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--------cHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 35799999999999999999999888876 5666553221 11222356789999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.+ ...++||||+++++|.+++... +.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 84 CPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp ECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred EcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 863 4689999999999998877654 579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc--ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+++....... ......||+.|+|||++.
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIH 190 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHH
T ss_pred cccccCcccccccccCCCCcccccChHHhc
Confidence 9987643322 234456888999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=245.12 Aligned_cols=170 Identities=25% Similarity=0.475 Sum_probs=146.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
...+|.+.+.||+|+||.||++++..+++.||||.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 3467999999999999999999999999999999986431 245689999999999999999998853
Q ss_pred --------------CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE
Q 022241 196 --------------PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259 (300)
Q Consensus 196 --------------~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll 259 (300)
.....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 113458999999999999887743 3579999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 260 ~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+.++.+||+|||++....... ......||+.|+|||++.
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 194 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQIS 194 (284)
T ss_dssp EETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHH
T ss_pred cCCCCEEECcchhheeccccc-cccccCCcccccChhhhc
Confidence 999999999999998765433 334567999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=246.60 Aligned_cols=174 Identities=25% Similarity=0.320 Sum_probs=136.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|++.+.||+|+||.||++.+..+ +..||||.+... ........+.+|+.+++.++||||+++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--------CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 3456899999999999999999998653 457999987542 13455678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.+ +..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 9853 4689999999999998877544 47999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc-ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......+|+.|+|||++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp ------------------CCGGGCCHHHHH
T ss_pred ccccccCcccccccccCCCcccccChhhcc
Confidence 99987644322 223345788999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=253.73 Aligned_cols=172 Identities=21% Similarity=0.335 Sum_probs=137.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceE----EEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.++|.+.+.||+|+||.||++++..+++.+ |+|.+... ........+.+|+.+++.++||||++++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--------TSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--------cCHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 367999999999999999999988877755 66665432 123445678999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.+. ..++|+||+.++++.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 86 CLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp EESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred EecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence 9863 47899999999999887754 4579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc--ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+|+....... ......||+.|+|||++.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHH
T ss_pred ceeEccCCcccccccCCCccccccChHHhc
Confidence 9987644332 222345788999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=240.65 Aligned_cols=173 Identities=28% Similarity=0.370 Sum_probs=145.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHH---HHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA---MTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|.+.+.||+|+||.||++++..+++.||||++....... .... ...+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-----ETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-----CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-----chhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 34478999999999999999999999999999999986542211 1111 167889999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCc----
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGT---- 264 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~---- 264 (300)
++.+. .++||||++++++.+.+. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 91 LMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EETTT----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred eecCC----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 99653 269999999988876654 4457999999999999999999999999 999999999999988776
Q ss_pred -EEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 265 -VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 265 -~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+||+|||++..... ......||+.|+|||++.
T Consensus 167 ~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSS
T ss_pred eEEeCCCCccccccc---cccccCCCccccCchhhc
Confidence 99999999985433 234567999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=249.38 Aligned_cols=172 Identities=24% Similarity=0.392 Sum_probs=143.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..+.|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 346799999999999999999999999999999998643 22345678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
....++||||++++++..++.. ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 88 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 88 --DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp --C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred --CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 3579999999999998876644 4579999999999999999999999999999999999999999999999999986
Q ss_pred eecCCccccccCCCccccccCccc
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
.............||+.|+|||++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHH
T ss_pred cccccccccccccCChhhcCCeee
Confidence 533222233445799999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.83 Aligned_cols=174 Identities=22% Similarity=0.277 Sum_probs=143.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
..++|.+.+.||+|+||.||++.+. .++..||||++.... .......+.+|+.++..+ .||||+++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--------CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 4478999999999999999999973 356789999986432 223446789999999999 89999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-----------------------AIGESMARKYLRDIVSGLMYLHGHN 246 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~qi~~~l~yLH~~~ 246 (300)
++++.. .+.+++||||+++++|.+++.... .+++..++.++.||+.||+|||++|
T Consensus 115 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 115 LGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999986 357899999999999988775432 3799999999999999999999999
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 99999999999999999999999999987643322 222345788999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=252.22 Aligned_cols=183 Identities=26% Similarity=0.367 Sum_probs=140.3
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeeccccccc--ccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL--RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..++|.+.+.||+|+||.||++.+.. |+.||||++........ ...........+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34689999999999999999998864 99999999865432110 0112334457899999999999999999999998
Q ss_pred Ec---CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 194 DD---PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 194 ~~---~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.. .....+++||||++++.+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 64 234578999999996554444455567999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++....... ......||+.|+|||++.|
T Consensus 179 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 179 NLAREDTADA-NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TC----------------CGGGCCHHHHTT
T ss_pred Cccccccccc-ccceecccceecCcHHhcC
Confidence 9998644332 3345679999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=245.93 Aligned_cols=177 Identities=21% Similarity=0.273 Sum_probs=137.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
..++|.+.+.||+|+||.||++.... ++..||||.+.... ........+.+|+.+++.++||||++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-------SSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-------cchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34689999999999999999998765 45589999986542 134556789999999999999999999999
Q ss_pred EEcCCCC---EEEEEEEeeCCCcccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC
Q 022241 193 IDDPNSD---HFYMVLEYVEGKWDNDGF------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 193 ~~~~~~~---~~~lv~E~~~~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~ 263 (300)
+.+.... ..++||||+++++|.+++ .....+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 9864322 469999999999988766 3456799999999999999999999999999999999999999999
Q ss_pred cEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 264 TVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
.+||+|||++....... .......+++.|+|||++.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 222 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhc
Confidence 99999999998764332 1223345788999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=251.34 Aligned_cols=174 Identities=29% Similarity=0.471 Sum_probs=143.1
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
..+.++|.+.+.||+|+||.||++.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-------QSEIFAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-------cchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 345678999999999999999999999999999999986532 1345567889999999999999999999999
Q ss_pred EcCCCC----EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEec
Q 022241 194 DDPNSD----HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269 (300)
Q Consensus 194 ~~~~~~----~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~D 269 (300)
...... .+++||||+.+ .+...+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECS
T ss_pred eccCCcccceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEe
Confidence 764321 24999999985 5555443 3599999999999999999999999999999999999999999999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++...... .....||+.|+|||++.|
T Consensus 188 fg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 188 FGLARHADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp TTCC-----------CTTCCCTTSCHHHHSC
T ss_pred cCcccccccC---cCCcccCccccCHHHhcC
Confidence 9999865432 345679999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=265.21 Aligned_cols=172 Identities=23% Similarity=0.333 Sum_probs=148.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..++..||||.+.... .....+.+|+.+|+.++|||||++++++.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----------cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4567999999999999999999999889999999986432 234678999999999999999999999975
Q ss_pred CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
...+++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 288 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 288 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred --CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 3578999999999999888753 456999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+....... ......+|+.|+|||++.
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred eeccCCceeecCCCcCCcceeCHhHHh
Confidence 87644322 222345678899999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=248.84 Aligned_cols=174 Identities=27% Similarity=0.435 Sum_probs=146.9
Q ss_pred ecceeEeeeecCCCceEEEEEE----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.++|++++.||+|+||.||+++ +..+++.||||++... .......+.+|+.+++.++||||++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---------CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3579999999999999999998 4568999999998643 34556789999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.......+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 8765555789999999999998877554 469999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccc---cccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
++......... .....+|+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhc
Confidence 99986543321 22345788899999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=256.60 Aligned_cols=170 Identities=26% Similarity=0.367 Sum_probs=138.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..+|.+.+.||+|+||.||++++..+|+.||||++..... ...+|+.+|+.++|||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 3579999999999999999999999999999999864311 123699999999999999999988531
Q ss_pred ----CCCEEEEEEEeeCCCcccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEEe
Q 022241 197 ----NSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIG 268 (300)
Q Consensus 197 ----~~~~~~lv~E~~~~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl~ 268 (300)
....+++||||++++.+.. +......+++..++.++.||+.||+|||+++|+||||||+||||+.+ +.+||+
T Consensus 120 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp ETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEec
Confidence 1224679999998753321 12345679999999999999999999999999999999999999965 578999
Q ss_pred cccCceeecCCccccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+++.+.... ......||+.|+|||++.|
T Consensus 200 DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 200 DFGSAKQLVRGE-PNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp CCTTCEECCTTC-CCCSCCSCTTSCCHHHHTT
T ss_pred cchhhhhcccCC-CceeeeeCCCcCCHHHHcC
Confidence 999999764432 2345679999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=247.06 Aligned_cols=173 Identities=24% Similarity=0.334 Sum_probs=149.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..++..||||.+... ......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----------STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3457899999999999999999999999999999998542 234567899999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 80 R--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp S--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred c--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 6 4579999999999999887754 44699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+........ ......+|+.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred ceeccCCccccccCCccccCcCChhhhc
Confidence 987644332 222345788999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=248.47 Aligned_cols=174 Identities=23% Similarity=0.296 Sum_probs=146.5
Q ss_pred eecceeEeeeecCCCceEEEEEEE-----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
..++|.+.+.||+|+||.||++.. ..+++.||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--------hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 446899999999999999999985 4467899999986431 334567899999999999 99999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG------------------AIGESMARKYLRDIVSGLMYLHGHNVVHGD 251 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~qi~~~l~yLH~~~iiHrD 251 (300)
++++.+ .+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++|+|||
T Consensus 93 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 170 (313)
T 1t46_A 93 LGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (313)
T ss_dssp EEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 999976 357899999999999887764332 489999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 252 lkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|||+|||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence 999999999999999999999987654332 223345788999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=257.28 Aligned_cols=171 Identities=29% Similarity=0.497 Sum_probs=127.7
Q ss_pred cceeE-eeeecCCCceEEEEEEEc--cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVH-VRKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~-~~~iG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
+.|.+ .++||+|+||.||+++.+ .+++.||||++..... ...+.+|+.+|+.++|||||++++++.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------CHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------CHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 45766 458999999999999966 4788999999864321 135779999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE----cc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFG---------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----AP 261 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----~~ 261 (300)
......+++||||++++ +.+.+. ....+++..++.++.||+.||+|||+++|+||||||+|||| +.
T Consensus 89 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECCSEE-HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCCCCC-HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 65667899999999864 333321 22359999999999999999999999999999999999999 67
Q ss_pred CCcEEEecccCceeecCCc---cccccCCCccccccCcccCC
Q 022241 262 SGTVKIGDFSVSQVFEDDN---DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 ~~~~kl~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~G 300 (300)
++.+||+|||+|..+.... ......+||+.|+|||++.|
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 7899999999998764322 22345679999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=259.48 Aligned_cols=169 Identities=27% Similarity=0.423 Sum_probs=142.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|+||.||++... ++.||||+++... ..+.+.+|+.+|+.++|||||++++++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~ 255 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVI 255 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----------TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----------HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence 344578999999999999999988764 7899999986431 335788999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.+. ...+++||||+++++|.+++...+ .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 256 ~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 256 VEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp ECT-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EcC-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 763 347999999999999998886543 47999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+++..... .....+|+.|+|||++.
T Consensus 335 ~a~~~~~~---~~~~~~~~~y~aPE~~~ 359 (450)
T 1k9a_A 335 LTKEASST---QDTGKLPVKWTAPEALR 359 (450)
T ss_dssp TCEECC---------CCCTTTSCHHHHH
T ss_pred Cccccccc---ccCCCCCcceeCHHHhc
Confidence 99864332 22346789999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=247.86 Aligned_cols=173 Identities=29% Similarity=0.481 Sum_probs=143.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-------cchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 34578999999999999999999999999999999986532 13455678899999999999999999999997
Q ss_pred cCCC----CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~~----~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
.... ..+++||||+++ ++...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp SCSSGGGCCCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred cccccccceeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeec
Confidence 6432 245999999984 6666553 35999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++...... .....||+.|+|||++.|
T Consensus 171 g~~~~~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 171 GLARHADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TCTTC-----------CCSBCCSCHHHHSC
T ss_pred ccccCCCCC---ccccccCcCcCCHHHHhC
Confidence 999865332 334579999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=250.84 Aligned_cols=178 Identities=20% Similarity=0.259 Sum_probs=131.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|.+.+.||+|+||.||++++..++. .||||++..... .......+.+|+.+++.++||||+++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-------ASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-------CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 345689999999999999999999887665 899999865422 2345678999999999999999999999
Q ss_pred EEEcCCCC----EEEEEEEeeCCCccccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 192 VIDDPNSD----HFYMVLEYVEGKWDNDGFGQ------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 192 ~~~~~~~~----~~~lv~E~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
++...... ..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 99763321 23899999999998877632 226999999999999999999999999999999999999999
Q ss_pred CCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 262 SGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
++.+||+|||++........ ......+|+.|+|||++.
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA 212 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhc
Confidence 99999999999987643322 222345788999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.30 Aligned_cols=172 Identities=13% Similarity=0.134 Sum_probs=138.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHH---HHHHHCCCCceeeee---
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV---LIMKMLQHPNIVNLI--- 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~~--- 190 (300)
.++|.+.+.||+|+||.||++++..+|+.||||++..... ......+.+.+|+ .+|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc------cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 4679999999999999999999998999999999975422 1334567889999 555566899999998
Q ss_pred ----eEEEcCCC----------C-----EEEEEEEeeCCCccccccCCCCCCC-------HHHHHHHHHHHHHHHHHHHh
Q 022241 191 ----EVIDDPNS----------D-----HFYMVLEYVEGKWDNDGFGQPGAIG-------ESMARKYLRDIVSGLMYLHG 244 (300)
Q Consensus 191 ----~~~~~~~~----------~-----~~~lv~E~~~~~~l~~~~~~~~~l~-------~~~~~~i~~qi~~~l~yLH~ 244 (300)
+++.+++. . ..|+||||+ +|+|.+++...+.++ +..++.++.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 66654321 1 378999999 468887775444344 48888999999999999999
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
++|+||||||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~ 275 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEA 275 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhc
Confidence 9999999999999999999999999999986432 3345678 9999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=249.63 Aligned_cols=175 Identities=18% Similarity=0.299 Sum_probs=146.7
Q ss_pred eecceeEeeeecCCCceEEEEEEE-----ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL 189 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 189 (300)
..++|.+.+.||+|+||.||++++ ..+++.||||++.... .......+.+|+.++..+ +||||+++
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--------CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 346899999999999999999985 3467899999986431 344566889999999999 79999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccCCCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeCCCC
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA----------------IGESMARKYLRDIVSGLMYLHGHNVVHGDIK 253 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~----------------l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlk 253 (300)
++++... ...+++||||+++++|.+++..... +++..++.++.|++.||.|||+.+|+|||||
T Consensus 97 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 97 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 9998764 3568999999999999887765443 8999999999999999999999999999999
Q ss_pred CCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 254 PDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 254 p~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+|||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence 9999999999999999999987543322 222345889999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=254.59 Aligned_cols=174 Identities=23% Similarity=0.347 Sum_probs=145.9
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--------CCc
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--------HPN 185 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~n 185 (300)
....++|.+.+.||+|+||.||++++..+++.||||++.. .......+.+|+.+|+.++ |||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----------AEHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----------CCcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 4455789999999999999999999999999999999853 2345567889999999986 788
Q ss_pred eeeeeeEEEc--CCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEcc
Q 022241 186 IVNLIEVIDD--PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAP 261 (300)
Q Consensus 186 iv~~~~~~~~--~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~ 261 (300)
|+++++++.. .....+++||||+.++++....... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 9999999873 1345899999999766655544433 5799999999999999999999998 9999999999999997
Q ss_pred CC-------------------------------------------------cEEEecccCceeecCCccccccCCCcccc
Q 022241 262 SG-------------------------------------------------TVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292 (300)
Q Consensus 262 ~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~gt~~y 292 (300)
++ .+||+|||+|...... .....||+.|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y 259 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQY 259 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcc
Confidence 75 7999999999876432 3456799999
Q ss_pred ccCcccCC
Q 022241 293 TAPECCLG 300 (300)
Q Consensus 293 ~aPE~l~G 300 (300)
+|||++.|
T Consensus 260 ~aPE~~~~ 267 (397)
T 1wak_A 260 RSLEVLIG 267 (397)
T ss_dssp CCHHHHHT
T ss_pred cCChhhcC
Confidence 99998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=241.99 Aligned_cols=172 Identities=16% Similarity=0.263 Sum_probs=148.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++. ++.||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-------STRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-------CHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 34578999999999999999999875 88999999865421 3455678999999999999999999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.....++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 765578899999999999998886654 5899999999999999999999999 999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|++.... .....||+.|+|||++.|
T Consensus 158 ~~~~~~~-----~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 158 DVKFSFQ-----SPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp GSCCTTS-----CTTCBSCGGGSCHHHHHS
T ss_pred cceeeec-----ccCccCCccccChhhhcc
Confidence 8875422 233568999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=247.97 Aligned_cols=170 Identities=26% Similarity=0.390 Sum_probs=138.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH--CCCCceeeeeeEE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEVI 193 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~ 193 (300)
..++|++.+.||+|+||.||+++.. ++.||||++... ....+..|..++.. ++||||+++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------------EEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------------ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 4468999999999999999998765 899999998543 12334455555554 4899999999998
Q ss_pred EcCCC--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeCCCCCCCEEEccCC
Q 022241 194 DDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--------NVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 194 ~~~~~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~iiHrDlkp~NIll~~~~ 263 (300)
..... ..+++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 86432 589999999999999888754 3699999999999999999999998 999999999999999999
Q ss_pred cEEEecccCceeecCCccc----cccCCCccccccCcccCC
Q 022241 264 TVKIGDFSVSQVFEDDNDV----LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 264 ~~kl~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~G 300 (300)
.+||+|||++..+...... .....||+.|+|||++.|
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 9999999999876443222 124579999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=251.52 Aligned_cols=173 Identities=23% Similarity=0.359 Sum_probs=144.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||+++.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--------GGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--------hHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 3467999999999999999999754 6899999998654221 112258899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcEeCCCCCCCEEEccCCcEEEe
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~---~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
. ...++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 99 P--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred C--CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 3 4688999999999988777543 3599999999999999999999999 99999999999999999999999
Q ss_pred cccCceeecCCc-cccccCCCccccccCcccC
Q 022241 269 DFSVSQVFEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 269 DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
|||++....... .......||+.|+|||++.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred cCccccccCcccccccccccCCcCccCHHHhc
Confidence 999998765433 2334456999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.63 Aligned_cols=171 Identities=29% Similarity=0.381 Sum_probs=142.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|.....||+|+||.||++.+..+++.||||.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 90 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---------DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-- 90 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---------CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---------chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--
Confidence 3455556899999999999999999999999998653 22345678899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-CCcEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DFGla 273 (300)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 45899999999999988776433 35779999999999999999999999999999999999987 889999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..............||+.|+|||++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 171 KRLAGINPCTETFTGTLQYMAPEIID 196 (295)
T ss_dssp EESCC-----CCCCCCGGGCCHHHHH
T ss_pred cccCCCCCcccccCCCccccChhhhc
Confidence 87654443445567999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=247.82 Aligned_cols=175 Identities=22% Similarity=0.393 Sum_probs=144.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.+..+|+.||||.+... ........+.+|+.+++.++||||+++++++.
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--------DKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 3457899999999999999999999999999999998532 13445667889999999999999999999876
Q ss_pred cC---CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 195 DP---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 195 ~~---~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. .....++||||+++ ++...+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CSCSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 42 13578999999985 55555443 479999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc----------ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND----------VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~----------~~~~~~gt~~y~aPE~l~ 299 (300)
++........ ......||+.|+|||++.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeec
Confidence 9987643211 122357899999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=243.06 Aligned_cols=175 Identities=28% Similarity=0.470 Sum_probs=140.4
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+++.||+|+||.||++.+..+++.||||.+... .......+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 77 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---------DPQSVKHALREIKIIRRLDHDNIVKVFEIL 77 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---------ChHHHHHHHHHHHHHHhcCCCCeeEEEEec
Confidence 45567899999999999999999999999999999988643 345667889999999999999999999987
Q ss_pred EcC------------CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc-
Q 022241 194 DDP------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA- 260 (300)
Q Consensus 194 ~~~------------~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~- 260 (300)
... .....++||||+++ ++.+.+.. +.+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 78 GPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp CTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred cccccccccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 532 23688999999984 67766643 5799999999999999999999999999999999999997
Q ss_pred cCCcEEEecccCceeecCCc---cccccCCCccccccCcccC
Q 022241 261 PSGTVKIGDFSVSQVFEDDN---DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 261 ~~~~~kl~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~ 299 (300)
.++.+||+|||++....... .......+|+.|+|||++.
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence 56799999999998754321 1223445799999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=268.33 Aligned_cols=172 Identities=27% Similarity=0.400 Sum_probs=144.7
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEcc-CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
+....++|++.+.||+|+||.||++.+.. +++.||||++... ........+.+|+.++..++|||||++++
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 146 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--------GDAEAQAMAMAERQFLAEVVHPSIVQIFN 146 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--------CCHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--------CCHHHHHHHHHHHHHHHhcCCCCcCeEee
Confidence 34556889999999999999999999976 7899999987542 13455667899999999999999999999
Q ss_pred EEEcCCC--C-EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 192 VIDDPNS--D-HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 192 ~~~~~~~--~-~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
++..... . ..||||||+++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence 9986322 1 26999999999999887654 79999999999999999999999999999999999999964 99999
Q ss_pred cccCceeecCCccccccCCCccccccCcccC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|||+++..... ....||+.|+|||++.
T Consensus 224 DFG~a~~~~~~----~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 224 DLGAVSRINSF----GYLYGTPGFQAPEIVR 250 (681)
T ss_dssp CCTTCEETTCC----SCCCCCTTTSCTTHHH
T ss_pred ecccchhcccC----CccCCCccccCHHHHc
Confidence 99999876443 4467999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=249.65 Aligned_cols=176 Identities=20% Similarity=0.297 Sum_probs=137.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||++++..+++.||+|+..+... ..........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEEC----CCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeec----cccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 3679999999999999999999988888765444332211 111334556788999999999999999999999863
Q ss_pred CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..++|+||+.++++.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 90 ---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp ---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred ---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 48899999999998887754 45799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCcc--ccccCCCccccccCcccC
Q 022241 276 FEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
...... ......+|+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp -------------CCCGGGSCHHHHH
T ss_pred ccCccccccccCCCccccccCHHHHc
Confidence 643322 222345788999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=248.32 Aligned_cols=182 Identities=23% Similarity=0.259 Sum_probs=141.2
Q ss_pred cceeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccC--CChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVA--PSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
++|.+.+.||+|+||.||++++.. ++..||||.+........... ........+.+|+.++..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 788999999875421100000 000012346788899999999999999999
Q ss_pred EEc--CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC--cEEEe
Q 022241 193 IDD--PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIG 268 (300)
Q Consensus 193 ~~~--~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~--~~kl~ 268 (300)
+.. .....+++||||+ +++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 875 2246899999999 889999888777899999999999999999999999999999999999999887 99999
Q ss_pred cccCceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
|||+|+.+..... ......||+.|+|||++.|
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 9999987643221 1244579999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.09 Aligned_cols=172 Identities=24% Similarity=0.353 Sum_probs=132.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++++..+++.||||++..... .......+..+...++.++||||+++++++.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-------SQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-------cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 34689999999999999999999999999999999865321 22333445556666888999999999999986
Q ss_pred CCCCEEEEEEEeeCCCcccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
....++||||+++ ++.+.+ .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 78 --~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 78 --EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp --SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred --cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 3579999999986 443333 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cCceeecCCccccccCCCccccccCccc
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
|++....... ......||+.|+|||++
T Consensus 155 g~~~~~~~~~-~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 155 GISGYLVDDV-AKDIDAGCKPYMAPERI 181 (290)
T ss_dssp ----------------CCCCCCSCHHHH
T ss_pred CCcccccccc-cccccCCCccccChhhc
Confidence 9998764432 23345799999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=240.09 Aligned_cols=171 Identities=26% Similarity=0.409 Sum_probs=133.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+. ++.||||++...... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 77 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK- 77 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 468999999999999999999864 889999998654221 123345678899999999999999999999976
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeCCCCCCCEEEcc--------CCcE
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN---VVHGDIKPDNLLVAP--------SGTV 265 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~---iiHrDlkp~NIll~~--------~~~~ 265 (300)
....++||||++++++.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 78 -~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 78 -EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp -C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred -CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 357899999999999888775 457999999999999999999999999 999999999999986 6789
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|||++....... .....||+.|+|||++.
T Consensus 156 kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 156 KITDFGLAREWHRTT--KMSAAGAYAWMAPEVIR 187 (271)
T ss_dssp EECCCCC---------------CCGGGSCHHHHH
T ss_pred EEccCCccccccccc--ccCCCCccceeCHHHhc
Confidence 999999998764432 23457999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=246.70 Aligned_cols=171 Identities=24% Similarity=0.341 Sum_probs=136.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHH--HHHCCCCceeeeeeE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI--MKMLQHPNIVNLIEV 192 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~ 192 (300)
...++|++.+.||+|+||.||+++. +++.||||++.... ...+..|..+ +..++||||+++++.
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhheec
Confidence 3457899999999999999998865 68999999986432 2233344444 456899999999986
Q ss_pred EEc---CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeCCCCCCCEEEc
Q 022241 193 IDD---PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---------NVVHGDIKPDNLLVA 260 (300)
Q Consensus 193 ~~~---~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------~iiHrDlkp~NIll~ 260 (300)
+.. .....+++||||+++++|.+++... ..++..+..++.||+.||+|||+. +|+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 542 2334678999999999998887544 458999999999999999999999 999999999999999
Q ss_pred cCCcEEEecccCceeecCCc--------cccccCCCccccccCcccCC
Q 022241 261 PSGTVKIGDFSVSQVFEDDN--------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 261 ~~~~~kl~DFGla~~~~~~~--------~~~~~~~gt~~y~aPE~l~G 300 (300)
.++.+||+|||++..+.... .......||+.|+|||++.|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99999999999998764321 12234579999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.36 Aligned_cols=174 Identities=16% Similarity=0.180 Sum_probs=128.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC--CCCceeeee----
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML--QHPNIVNLI---- 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~---- 190 (300)
..+|.+.+.||+|+||.||++++..+++.||||++...... .......+.+|+.++..+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN------SRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT------HHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc------cccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 44599999999999999999999999999999999764321 234556778886555544 699988755
Q ss_pred ---eEEEcCCC---------------CEEEEEEEeeCCCccccccCCC-CCCCHHHH------HHHHHHHHHHHHHHHhC
Q 022241 191 ---EVIDDPNS---------------DHFYMVLEYVEGKWDNDGFGQP-GAIGESMA------RKYLRDIVSGLMYLHGH 245 (300)
Q Consensus 191 ---~~~~~~~~---------------~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~------~~i~~qi~~~l~yLH~~ 245 (300)
+++..+.. ..+++||||++ ++|.+++... ..+++..+ ..++.||+.||+|||++
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 44443221 35899999999 7888777542 23444444 67779999999999999
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|+||||||+|||++.++.+||+|||+|+...... ....+|+.|+|||++.|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNA 265 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccC
Confidence 99999999999999999999999999999754322 24457799999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=239.63 Aligned_cols=171 Identities=24% Similarity=0.375 Sum_probs=145.3
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++... ++..||||.+.... .....+.+|+.+++.++||||+++++++.
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----------MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----------ccHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 34468999999999999999999875 56789999986432 12457889999999999999999999986
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ +..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 79 Q---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp S---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred C---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 4 35899999999999998887643 699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+........ ......+|+.|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred cccccCcccccccCCCCccCccChhhhc
Confidence 988654332 223345788999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=242.41 Aligned_cols=173 Identities=22% Similarity=0.316 Sum_probs=144.4
Q ss_pred ecceeEee-eecCCCceEEEEEEE--ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVR-KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~-~iG~G~fg~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|.+.+ .||+|+||.||++.. ..+++.||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45799988 999999999999954 55678999999865421 334567899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.. ...++||||+++++|.+++.....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CC---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 53 468999999999999998887778999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccc---cccCCCccccccCcccC
Q 022241 274 QVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
......... .....+|+.|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred eeeccCCCcccccccCCCCceeeChHHhc
Confidence 876543321 12334778999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=252.22 Aligned_cols=173 Identities=27% Similarity=0.430 Sum_probs=140.7
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
+.....+|.+.+.||+|+||.||++++..+++ ||+|.+..... ...+|+.+|+.++||||++++++
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------------~~~~E~~il~~l~h~niv~l~~~ 100 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------------FKNRELQIMRIVKHPNVVDLKAF 100 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------------hHHHHHHHHHhCCCCCcceEEEE
Confidence 34556789999999999999999999886665 88888754321 11269999999999999999999
Q ss_pred EEcCC----CCEEEEEEEeeCCCccccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc-cCCc
Q 022241 193 IDDPN----SDHFYMVLEYVEGKWDNDG---FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGT 264 (300)
Q Consensus 193 ~~~~~----~~~~~lv~E~~~~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~-~~~~ 264 (300)
|.... ...+++||||++++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp EEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred EEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc
Confidence 86422 2347899999998654322 23356799999999999999999999999999999999999999 7999
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||+|+...... ......||+.|+|||++.|
T Consensus 181 ~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp EEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTT
T ss_pred EEEeeCCCcccccCCC-CCcccccCcCccCHHHHcC
Confidence 9999999999864433 3345679999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=242.90 Aligned_cols=173 Identities=21% Similarity=0.344 Sum_probs=135.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|++.++||+|+||.||+++.. ..||||++.... ........+.+|+.+++.++||||++++++.
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 344568999999999999999998754 359999986432 2455677899999999999999999999976
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ...++||||+++++|.+.+. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 90 TA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp CS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred cC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 43 46899999999999888774 445799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCC--ccccccCCCccccccCcccC
Q 022241 273 SQVFEDD--NDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~--~~~~~~~~gt~~y~aPE~l~ 299 (300)
+...... ........||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -----------------CCCTTCCHHHHC
T ss_pred ccccccccccccccccCCCccccCchhhc
Confidence 9865421 22334457999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=247.69 Aligned_cols=176 Identities=21% Similarity=0.257 Sum_probs=147.1
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN 188 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 188 (300)
....++|.+.+.||+|+||.||++.+. .+++.||||.+.... .......+.+|+.+++.++||||++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--------CHHHHHHHHHHHHHHHhcCCCCEee
Confidence 344578999999999999999999876 357889999986431 3345567899999999999999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEE
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL 258 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIl 258 (300)
+++++.+ ....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 93 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 93 LLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eEEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 9999975 3578999999999998887643 246799999999999999999999999999999999999
Q ss_pred EccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 259 VAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 259 l~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence 99999999999999986543321 222345789999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=249.68 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=133.7
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||++..... ......+++..+..++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----------FRNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----------CCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----------ccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 34689999999999999999999999999999998854321 12345677888899999999999999864
Q ss_pred CC-----CCEEEEEEEeeCCCccc---cccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeCCCCCCCEEEcc-CCc
Q 022241 196 PN-----SDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVAP-SGT 264 (300)
Q Consensus 196 ~~-----~~~~~lv~E~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~iiHrDlkp~NIll~~-~~~ 264 (300)
.. ...+++||||++++.+. ........+++..++.++.|++.||.||| +++|+||||||+|||++. ++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 22 22478999999986433 33456678999999999999999999999 999999999999999996 899
Q ss_pred EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||++....... ......||+.|+|||++.|
T Consensus 171 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFG 205 (360)
T ss_dssp EEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTT
T ss_pred EEEeeCCCceecCCCC-CcccccCCcceeCHHHHcC
Confidence 9999999998765433 3345679999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=248.89 Aligned_cols=173 Identities=24% Similarity=0.341 Sum_probs=145.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCc-----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGK-----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 190 (300)
.++|.+.+.||+|+||.||++.+..+++ .||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--------HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--------ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3679999999999999999999876654 79999886431 344567899999999999 899999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+++.+ ...+++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 117 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 194 (333)
T 2i1m_A 117 GACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194 (333)
T ss_dssp EEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence 99976 3578999999999998877642 3468999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 239 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence 9999999999999999987543322 223345788999999763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.45 Aligned_cols=173 Identities=23% Similarity=0.247 Sum_probs=145.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
.|...+.||+|+||.||++....+++ .||+|.+... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--------TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 47788999999999999998765554 7999988542 134566789999999999999999999999976
Q ss_pred CCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.. ...++||||+.++++.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 94 PE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SS-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CC-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 43 455899999999999888765 4578999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc----cccccCCCccccccCcccCC
Q 022241 275 VFEDDN----DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~----~~~~~~~gt~~y~aPE~l~G 300 (300)
...... .......+|+.|+|||.+.|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred cccCCcccccccCcCCCCCccccChhhhcc
Confidence 653322 22234568899999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=239.11 Aligned_cols=172 Identities=27% Similarity=0.356 Sum_probs=145.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||++..... ...+.+|+.+++.++|++++..+.++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----------CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----------hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence 45689999999999999999999999999999998764321 1257899999999999988877776654
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEeccc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS 271 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DFG 271 (300)
.....++||||+ +++|.+++. ....+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 76 -~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 76 -EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred -CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 346889999999 778887775 45679999999999999999999999999999999999999 478899999999
Q ss_pred CceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
++........ ......||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred CcccccccccccccccccccccccccccCChhhhcC
Confidence 9988654332 1245579999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=242.55 Aligned_cols=173 Identities=20% Similarity=0.207 Sum_probs=142.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
..|.+.+.||+|+||.||++....++ ..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 46999999999999999999876433 35899987542 24456678999999999999999999999976
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.. ....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 97 RS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred cC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence 53 3578899999999999888754 456899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc----ccccCCCccccccCcccC
Q 022241 274 QVFEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
........ ......||+.|+|||++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHH
T ss_pred ccccccchhccccccCCCCCccccChHHhc
Confidence 87643221 223345788999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=252.37 Aligned_cols=171 Identities=24% Similarity=0.376 Sum_probs=143.7
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC------CCCcee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML------QHPNIV 187 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv 187 (300)
.....+|++++.||+|+||.||++.+..+++.||||++... ......+.+|+.+++.+ .|+||+
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv 162 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----------KRFHRQAAEEIRILEHLRKQDKDNTMNVI 162 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----------cchHHHHHHHHHHHHHHhhccccCCcCEE
Confidence 34557899999999999999999999999999999998542 33445677888888877 577999
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc-
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT- 264 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~- 264 (300)
++++++.. ...+++||||+.+ ++.+.+... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.
T Consensus 163 ~~~~~~~~--~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 163 HMLENFTF--RNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp CEEEEEEE--TTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSC
T ss_pred EEEeeccc--CCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCc
Confidence 99999986 3689999999975 555555332 45999999999999999999999999999999999999999887
Q ss_pred -EEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 265 -VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 -~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||+|..... ......||+.|+|||++.|
T Consensus 240 ~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHT
T ss_pred ceEEeecccceecCC---cccccCCCCCccChHHHhC
Confidence 99999999986433 2345679999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=239.58 Aligned_cols=172 Identities=27% Similarity=0.359 Sum_probs=141.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||++.... ....+.+|+.+++.++|++++..+..+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----------KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------------CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----------cchHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 3468999999999999999999999999999999865432 11247789999999999988888777654
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEeccc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS 271 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DFG 271 (300)
.....++||||+ +++|.+++. ....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 76 -~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 76 -EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred -CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 346889999999 778877765 35579999999999999999999999999999999999999 788999999999
Q ss_pred CceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
++........ ......||+.|+|||++.|
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcC
Confidence 9988654322 2234579999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=241.72 Aligned_cols=172 Identities=26% Similarity=0.359 Sum_probs=143.7
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
|...+.||+|+||.||++.. +++.||||.+..... .........+.+|+.+++.++||||+++++++.+ ..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 103 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-----ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GD 103 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-----SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CC
Confidence 44558999999999998875 688999999864321 1134456789999999999999999999999976 35
Q ss_pred EEEEEEEeeCCCccccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 78999999999998877642 456999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc--ccccCCCccccccCcccCC
Q 022241 277 EDDND--VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~--~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......||+.|+|||++.|
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred ccccccccccccCCCcCcCChHHhcC
Confidence 44222 2334579999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-33 Score=246.49 Aligned_cols=173 Identities=25% Similarity=0.328 Sum_probs=142.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceE--EEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeE
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV 192 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 192 (300)
..++|.+.+.||+|+||.||++++..++..+ |||.+.... .......+.+|+.++..+ +||||++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--------chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 3468999999999999999999999888865 999886421 233445788999999999 89999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~N 256 (300)
+.+ ...+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 95 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 95 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 986 458999999999999988875543 79999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 257 LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 257 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++.++.+||+|||++...... .......+|+.|+|||++.
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLN 214 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHH
T ss_pred EEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhc
Confidence 99999999999999999753221 1223345788999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=237.15 Aligned_cols=172 Identities=25% Similarity=0.354 Sum_probs=144.7
Q ss_pred ecceeEee-eecCCCceEEEEEEEc--cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVR-KIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~-~iG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|.+.+ .||+|+||.||++... .++..||||++... ........+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------TEKADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 35677776 9999999999999854 46788999998653 1345667899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. +..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 53 458999999999999887754 45699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccc---cccCCCccccccCcccC
Q 022241 273 SQVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
+......... .....||+.|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhc
Confidence 9876433221 22345789999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=245.67 Aligned_cols=173 Identities=28% Similarity=0.355 Sum_probs=138.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCC----ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
..+|.+.+.||+|+||.||++....++ ..||||.+.... .......+.+|+.+++.++||||++++++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--------TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 457999999999999999999887653 359999986431 34456679999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.+ ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 115 ISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp ECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred Eec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 975 4579999999999999888754 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc---ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
++........ ......+|+.|+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp C-----------------CCCGGGSCHHHHH
T ss_pred cchhhccccccccccCCCCccccccCchhcc
Confidence 9987644321 112234688999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=247.60 Aligned_cols=174 Identities=29% Similarity=0.460 Sum_probs=128.4
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEEEEES
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 3468999999999999999999999899999999886432 12345578899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEE
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl 267 (300)
. +..++||||+++++|.+++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 85 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 85 K--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp S--SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred c--CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 3 47999999999999887764 3456999999999999999999999999999999999999999999999
Q ss_pred ecccCceeecCCc-----cccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDN-----DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~-----~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++....... .......||+.|+|||++.
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhc
Confidence 9999987653321 1223457999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=241.76 Aligned_cols=175 Identities=33% Similarity=0.594 Sum_probs=149.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-------KNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-------SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 34679999999999999999999999999999999876432 12345678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---cEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DFGl 272 (300)
...+++||||++++++.+.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 93 --SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred --CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 458999999999999888776667899999999999999999999999999999999999997644 699999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......||+.|+|||++.|
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 171 STCFQQNT-KMKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp GGTBCCCS-SCSCHHHHHTTCCHHHHTT
T ss_pred ceeecCCC-ccccccCcccccChHHhcC
Confidence 98654332 2233458999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=242.99 Aligned_cols=172 Identities=25% Similarity=0.436 Sum_probs=144.6
Q ss_pred cceeecceeEeeeecCCCceEEEEEEE-ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc------
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN------ 185 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------ 185 (300)
+....++|++.+.||+|+||.||++.+ ..+++.||||++.. .......+.+|+.+++.++|++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 78 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----------VDRYCEAARSEIQVLEHLNTTDPNSTFR 78 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------SHHHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----------CCchhHHHHHHHHHHHHhhhcCCCCcee
Confidence 455667899999999999999999998 55889999999853 2344567889999999887665
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-- 261 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-- 261 (300)
++++++++.+ .+.+++||||+ ++++.+.+.... .+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 79 i~~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 79 CVQMLEWFEH--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp BCCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred eEeeeccccc--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 9999999986 45899999999 666766664443 6899999999999999999999999999999999999987
Q ss_pred -----------------CCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 262 -----------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 262 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
++.+||+|||++...... .....||+.|+|||++.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC
Confidence 668999999999874332 345679999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=242.52 Aligned_cols=171 Identities=23% Similarity=0.358 Sum_probs=130.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc-
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD- 195 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~- 195 (300)
.+|++.+.||+|+||.||++++..+++.||||++... .......+.+|+.++..+. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---------chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 4799999999999999999999999999999988543 3445667899999999996 9999999999842
Q ss_pred -----CCCCEEEEEEEeeCCCccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEccCCcE
Q 022241 196 -----PNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTV 265 (300)
Q Consensus 196 -----~~~~~~~lv~E~~~~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~~~~~~ 265 (300)
.....+++||||+++ +|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 234568999999974 5555443 3567999999999999999999999999 9999999999999999999
Q ss_pred EEecccCceeecCCccc------------cccCCCccccccCccc
Q 022241 266 KIGDFSVSQVFEDDNDV------------LRRSPGTPVFTAPECC 298 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~------------~~~~~gt~~y~aPE~l 298 (300)
||+|||++......... .....||+.|+|||++
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp EBCCCTTCBCCSSCC------------------------------
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 99999999876432211 1134699999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-33 Score=257.57 Aligned_cols=172 Identities=23% Similarity=0.343 Sum_probs=145.6
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|+||.||++... ++..||||+++... ...+.+.+|+.+|+.++|||||++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----------MSVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----------BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----------ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 445678999999999999999999876 57789999986532 2356789999999999999999999998
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ..+++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 253 ~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 253 TK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp CS---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred eC---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 63 4689999999999999888654 368999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc-ccccCCCccccccCcccC
Q 022241 272 VSQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 272 la~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+++....... ......+|+.|+|||++.
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred CceEcCCCceeccCCCcccccccCHHHhc
Confidence 9987643221 122345778899999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=246.27 Aligned_cols=176 Identities=23% Similarity=0.269 Sum_probs=140.3
Q ss_pred ceeecceeEeeeecCCCceEEEEEE-----EccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN 188 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 188 (300)
....++|.+.+.||+|+||.||+++ +..+++.||||.+... ........+.+|+.+++.++||||++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------CSEQDELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--------cchhhHHHHHHHHHHHhhCCCCCCCe
Confidence 3455789999999999999999998 5567889999998532 13455668899999999999999999
Q ss_pred eeeEEEcCCCCEEEEEEEeeCCCccccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc
Q 022241 189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261 (300)
Q Consensus 189 ~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~ 261 (300)
+++++.+ ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.
T Consensus 98 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 98 CIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEec
Confidence 9999986 34689999999999988777443 45899999999999999999999999999999999999984
Q ss_pred ---CCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 262 ---SGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 262 ---~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
+..+||+|||++....... .......||+.|+|||++.
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 218 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence 4469999999997543322 1222346899999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=242.96 Aligned_cols=169 Identities=27% Similarity=0.345 Sum_probs=144.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHH--CCCCceeeeeeEEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 194 (300)
.++|.+.+.||+|+||.||+++. +++.||||++... ....+.+|+.++.. ++||||+++++++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------------hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 45799999999999999999887 5899999998542 23567789999888 78999999999998
Q ss_pred cCCC--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeCCCCCCCEEEccCCc
Q 022241 195 DPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH--------GHNVVHGDIKPDNLLVAPSGT 264 (300)
Q Consensus 195 ~~~~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~iiHrDlkp~NIll~~~~~ 264 (300)
.... ..+++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 6432 278999999999999888754 46999999999999999999999 899999999999999999999
Q ss_pred EEEecccCceeecCCcc----ccccCCCccccccCcccCC
Q 022241 265 VKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 265 ~kl~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~G 300 (300)
+||+|||++........ ......||+.|+|||++.|
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 99999999987654432 2244579999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=7.7e-33 Score=250.79 Aligned_cols=172 Identities=19% Similarity=0.204 Sum_probs=134.8
Q ss_pred ceeEeeeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
.|.+.+.||+|+||.||++....++ ..||||.+... ........+.+|+.+++.++||||+++++++..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 5888999999999999999876543 46899987532 134566789999999999999999999998764
Q ss_pred CCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
. ....++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 162 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred C-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence 3 34688999999999999888654 468999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc----ccccCCCccccccCcccC
Q 022241 275 VFEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......+|+.|+|||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 269 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQ 269 (373)
T ss_dssp -----------------CCGGGSCHHHHH
T ss_pred cccccccccccccCCCCCcccccChHHhc
Confidence 6543221 122345788999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=266.58 Aligned_cols=166 Identities=23% Similarity=0.354 Sum_probs=138.1
Q ss_pred eeecCCCceEEEEEEE--ccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
+.||+|+||.||++.. ..+++.||||+++.... .......+.+|+.+|+.++|||||++++++.. +.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCE
Confidence 4899999999999854 44678999999875422 33456789999999999999999999999974 358
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
++||||+++++|.+++.....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 89999999999999988788899999999999999999999999999999999999999999999999999987643321
Q ss_pred ---ccccCCCccccccCcccC
Q 022241 282 ---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ---~~~~~~gt~~y~aPE~l~ 299 (300)
......+|+.|+|||++.
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~ 545 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECIN 545 (635)
T ss_dssp ----------CGGGSCHHHHH
T ss_pred ccccccCCCCceeeeChhhhc
Confidence 222345788999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=240.17 Aligned_cols=174 Identities=26% Similarity=0.337 Sum_probs=142.9
Q ss_pred eeecceeEeeeecCCCceEEEEEEEcc---CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|.+.+.||+|+||.||+++... ++..||||.+.... .......+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--------TLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--------CHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--------CchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345689999999999999999998664 33469999986531 3445678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.+ ...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 81 IIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 9864 346899999999999887754 346999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc-ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......+|+.|+|||++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHH
T ss_pred CCCcccccccccccccCCCCcceeCchhhc
Confidence 99987644322 223445788999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=249.32 Aligned_cols=167 Identities=14% Similarity=0.211 Sum_probs=140.9
Q ss_pred cceeEeeeecCCCceEEEEEEEcc--------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceee-
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL--------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN- 188 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 188 (300)
++|.+.+.||+|+||.||++++.. .++.||||.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchhhh
Confidence 689999999999999999999987 4889999998643 25779999999999999987
Q ss_pred --------------eeeEEEcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC
Q 022241 189 --------------LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDI 252 (300)
Q Consensus 189 --------------~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl 252 (300)
+++++.. .....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+++|+||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred hhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 5666654 246899999999 88999888665 68999999999999999999999999999999
Q ss_pred CCCCEEEccCC--cEEEecccCceeecCCcc-------ccccCCCccccccCcccCC
Q 022241 253 KPDNLLVAPSG--TVKIGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 253 kp~NIll~~~~--~~kl~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||++.++ .+||+|||++..+..... ......||+.|+|||++.|
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 99999999988 999999999987643221 1233479999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=240.21 Aligned_cols=164 Identities=27% Similarity=0.416 Sum_probs=134.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||+++.. ++.||||.+.. ......+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----------ESERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 467999999999999999998764 78899998743 2345678999999999999999999998863
Q ss_pred CCCEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeCCCCCCCEEEccCCc-EEEec
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHG---HNVVHGDIKPDNLLVAPSGT-VKIGD 269 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~---~~iiHrDlkp~NIll~~~~~-~kl~D 269 (300)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|
T Consensus 73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 3789999999999988876554 47899999999999999999999 89999999999999998886 79999
Q ss_pred ccCceeecCCccccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||++...... .....||+.|+|||++.|
T Consensus 150 fg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 150 FGTACDIQTH---MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp CCC---------------CCTTSSCHHHHTC
T ss_pred cccccccccc---cccCCCCCceEChhhhCC
Confidence 9999865332 234569999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=237.84 Aligned_cols=170 Identities=25% Similarity=0.361 Sum_probs=144.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||++.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 74 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 74 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----------CHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----------CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 357999999999999999999887 678899999865421 23578899999999999999999999976
Q ss_pred CCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 -QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred -CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 35789999999999998877543 5689999999999999999999999999999999999999999999999999986
Q ss_pred ecCCc-cccccCCCccccccCcccC
Q 022241 276 FEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
..... .......+|+.|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFS 178 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred cccccccccccccccccccChhhhc
Confidence 53322 1223345788999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-33 Score=245.19 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=149.2
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CCceeeeee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIE 191 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~ 191 (300)
....++|++.+.||+|+||.||++++..+++.||||++.......... ......+.+|+.+++.+. ||||+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE---LPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE---CTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh---hhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 345578999999999999999999999999999999997654321100 011234567999999996 599999999
Q ss_pred EEEcCCCCEEEEEEEeeCC-CccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc-cCCcEEEec
Q 022241 192 VIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGD 269 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~-~~~~~kl~D 269 (300)
++.. ....++||||+.+ ++|.+++.....+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 116 WFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9986 4589999999976 78888877777899999999999999999999999999999999999999 788999999
Q ss_pred ccCceeecCCccccccCCCccccccCcccC
Q 022241 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 270 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||++...... ......||+.|+|||++.
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHH
T ss_pred Cccccccccc--cccCCCCCccCCChHHhc
Confidence 9999876543 234567999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=255.17 Aligned_cols=171 Identities=25% Similarity=0.335 Sum_probs=139.5
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++.... +..||||+++... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----------CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 445789999999999999999998874 4679999986532 12357899999999999999999999986
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ..+++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 250 ~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 250 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp S---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred C---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 4 4689999999999999888642 4699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
++....... ......+|+.|+|||++.
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 354 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAAL 354 (452)
T ss_dssp TC--------------CCGGGSCHHHHH
T ss_pred ceecCCCceecccCCcccccccCHhHHh
Confidence 987643321 122345788999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.56 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=124.8
Q ss_pred ceeecceeEee-eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 114 TKMINEYVHVR-KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 114 ~~~~~~y~~~~-~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
....++|.+.+ .||+|+||.||++++..+++.||||++... .. ........+..+.||||++++++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~---~~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----------PK---ARQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----------HH---HHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----------HH---HHHHHHHHHHhcCCCChHHHHHH
Confidence 44567899965 699999999999999999999999998542 11 12223344677899999999999
Q ss_pred EEc--CCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC---CcE
Q 022241 193 IDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTV 265 (300)
Q Consensus 193 ~~~--~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~---~~~ 265 (300)
+.. .....+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 864 2234589999999999998887654 369999999999999999999999999999999999999864 459
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|||++...... ......||+.|+|||++.
T Consensus 171 kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 171 KLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp EECCCTTCEEC-----------------------
T ss_pred EEeccccceecccc--ccccCCCCcCccChhhhC
Confidence 99999999875432 234567999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=240.87 Aligned_cols=176 Identities=29% Similarity=0.457 Sum_probs=140.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEc-cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSS-LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIE 191 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~ 191 (300)
..++|.+.+.||+|+||.||++++. .+++.||||++....... .....+.+|+.+++.+ .||||+++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~h~~i~~~~~ 81 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------GMPLSTIREVAVLRHLETFEHPNVVRLFD 81 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------SCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-------cCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence 3468999999999999999999995 678999999987543211 1112345666666555 8999999999
Q ss_pred EEEc---CCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEE
Q 022241 192 VIDD---PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266 (300)
Q Consensus 192 ~~~~---~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~k 266 (300)
++.. .....+++||||+++ ++.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 82 VCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence 9862 134578999999985 66665533 33599999999999999999999999999999999999999999999
Q ss_pred EecccCceeecCCccccccCCCccccccCcccCC
Q 022241 267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 267 l~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|||++...... .......||+.|+|||++.+
T Consensus 161 l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 161 LADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp ECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT
T ss_pred EecCcccccccCC-CCccccccccceeCHHHHhc
Confidence 9999999876433 23345679999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=237.83 Aligned_cols=174 Identities=29% Similarity=0.394 Sum_probs=135.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-CCc--eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|++.+.||+|+||.||++++.. +++ .||||++...... .......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC------CHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3579999999999999999998654 333 6899998654221 345667899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+. ..++||||++++++.+.+... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 91 LTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp CSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 753 388999999999988877543 5699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc---ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
+........ ......+|+.|+|||++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred cccccccccchhhhccCCCCceeeCchhhc
Confidence 987654332 222346888999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=240.21 Aligned_cols=173 Identities=20% Similarity=0.312 Sum_probs=143.5
Q ss_pred cceeecceeEeeeecCCCceEEEEEEEccCC-ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc------
Q 022241 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN------ 185 (300)
Q Consensus 113 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------ 185 (300)
+....++|.+.+.||+|+||.||++.+..++ +.||||++.. .......+.+|+.+++.++|++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 83 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----------VGKYREAARLEINVLKKIKEKDKENKFL 83 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------CHHHHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----------cccchhHHHHHHHHHHHHhhcCCCCcee
Confidence 3456678999999999999999999998776 6899999854 2344567889999999998766
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE-----
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----- 259 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll----- 259 (300)
++.+++++.. ...+++||||++++++....... ..+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 84 ~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 84 CVLMSDWFNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp BCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred EEEeeeeeee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 8999999886 45899999999665554433332 479999999999999999999999999999999999999
Q ss_pred --------------ccCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 260 --------------APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 260 --------------~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+.++.+||+|||++...... .....||+.|+|||++.|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE 213 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT
T ss_pred cccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec
Confidence 56789999999999874332 345679999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=251.31 Aligned_cols=173 Identities=23% Similarity=0.331 Sum_probs=141.6
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|.+.+.||+|+||.||++++..+++.||||++..... ...+..|+.+++.++|++.+..+.++.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----------SCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----------cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 345789999999999999999999999999999998764321 124778999999998855554444443
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE---ccCCcEEEecc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDF 270 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DF 270 (300)
. .....+|||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+||
T Consensus 73 ~-~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 73 V-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp E-ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred e-eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 3 346889999999 7788877753 5579999999999999999999999999999999999999 58899999999
Q ss_pred cCceeecCCccc-------cccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDV-------LRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~-------~~~~~gt~~y~aPE~l~G 300 (300)
|+++.+...... .....||+.|+|||++.|
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcC
Confidence 999987543321 125679999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=261.06 Aligned_cols=171 Identities=25% Similarity=0.365 Sum_probs=138.4
Q ss_pred cceeEee-eecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVR-KIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~-~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
+++.+.+ .||+|+||.||++..+. ++..||||+++... .......+.+|+.+|+.++|||||++++++.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 4455555 89999999999997764 55679999986531 2335578999999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ +.+++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++
T Consensus 407 ~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 407 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp S---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred c---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 5 358999999999999987754 456999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccc---cccCCCccccccCcccC
Q 022241 274 QVFEDDNDV---LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~---~~~~~gt~~y~aPE~l~ 299 (300)
+.+...... .....+|+.|+|||++.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp TTCC--------------CCTTSCHHHHH
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhc
Confidence 875432211 11234668999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=239.43 Aligned_cols=167 Identities=27% Similarity=0.434 Sum_probs=135.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.. +|+.||||++... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----------C--HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 457899999999999999999876 4889999988532 234678899999999999999999999765
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
. ...+++||||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 86 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred C-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 3 347899999999999988775543 3899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...... .....+|+.|+|||++.
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~ 187 (278)
T 1byg_A 165 KEASST---QDTGKLPVKWTAPEALR 187 (278)
T ss_dssp --------------CCTTTSCHHHHH
T ss_pred cccccc---ccCCCccccccCHHHhC
Confidence 865432 22346889999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-33 Score=243.87 Aligned_cols=179 Identities=25% Similarity=0.395 Sum_probs=141.9
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC----CCCceeee
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML----QHPNIVNL 189 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~~ 189 (300)
....++|.+.+.||+|+||.||++++..+++.||||++........ ........+.+|+.++..+ +||||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW---SPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc---ccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4456789999999999999999999999999999999865432110 0011223456789999888 89999999
Q ss_pred eeEEEcCCCCEEEEEEEe-eCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc-cCCcEEE
Q 022241 190 IEVIDDPNSDHFYMVLEY-VEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVKI 267 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~-~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~-~~~~~kl 267 (300)
++++.+ .+..++|||| +.+++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 104 ~~~~~~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 104 LDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEec--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 999875 3578999999 78889988887777899999999999999999999999999999999999999 7899999
Q ss_pred ecccCceeecCCccccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+|||++...... ......||+.|+|||++.
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHHHHH
T ss_pred EEcchhhhcccC--cccccCCcccccCceeee
Confidence 999999876543 234567999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=239.85 Aligned_cols=172 Identities=23% Similarity=0.351 Sum_probs=126.4
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHH-HHHHCCCCceeeeeeEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~ 193 (300)
...++|.+.+.||+|+||.||++.+..+|+.||||++.... .......+..|+. +++.++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 34578999999999999999999999999999999986531 2334445556665 77778999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG-----QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl 267 (300)
.+ .+..++||||+++ .+.+.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 91 ~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 91 FR--EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EC--SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred Ee--CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 86 3589999999996 4443332 256799999999999999999999998 9999999999999999999999
Q ss_pred ecccCceeecCCccccccCCCccccccCccc
Q 022241 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 268 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
+|||++....... ......||+.|+|||++
T Consensus 168 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 168 CDFGISGQLVDSI-AKTRDAGCRPYMAPERI 197 (327)
T ss_dssp CCCSSSCC-----------------------
T ss_pred ccCCCceeccccc-ccccCCCCccccCceee
Confidence 9999998764432 22344799999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=257.35 Aligned_cols=171 Identities=25% Similarity=0.335 Sum_probs=144.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
...++|++.+.||+|+||.||++.+.. +..||||+++... ...+.+.+|+.+|+.++|||||++++++.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----------CCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445789999999999999999998874 4679999986532 12357899999999999999999999986
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+ ..++|||||+.+++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 4 4689999999999999888642 4699999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
++....... ......+|+.|+|||++.
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 437 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAAL 437 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHH
T ss_pred ceecCCCceecccCCcCcccccCHHHhc
Confidence 986543221 122345788999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=242.02 Aligned_cols=173 Identities=25% Similarity=0.436 Sum_probs=144.3
Q ss_pred ccceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CC-----c
Q 022241 112 NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP-----N 185 (300)
Q Consensus 112 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----n 185 (300)
.+....++|.+.+.||+|+||.||++++..+++.||||++... ......+..|+.+++.+. |+ +
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~ 117 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----------KAFLNQAQIEVRLLELMNKHDTEMKYY 117 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----------HHHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----------HHHHHHHHHHHHHHHHHHhccccccee
Confidence 3456678999999999999999999999999999999998632 334567778899888885 55 4
Q ss_pred eeeeeeEEEcCCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeCCCCCCCEEEc-
Q 022241 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVA- 260 (300)
Q Consensus 186 iv~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH--~~~iiHrDlkp~NIll~- 260 (300)
|+++++++.. ...+++||||+++ +|.+.+... ..+++..++.++.|++.||.||| +.+|+||||||+|||++
T Consensus 118 iv~~~~~~~~--~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 118 IVHLKRHFMF--RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194 (382)
T ss_dssp BCCEEEEEEE--TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred EEEeeeeecc--CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence 9999999986 3589999999976 666655433 46999999999999999999999 57999999999999995
Q ss_pred -cCCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 261 -PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 261 -~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.++.+||+|||+|...... .....||+.|+|||++.|
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTT
T ss_pred CCCCcEEEEeccCceecccc---cccccCCccccChHHHcC
Confidence 4778999999999876432 345679999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=236.24 Aligned_cols=171 Identities=25% Similarity=0.398 Sum_probs=140.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CCceeeeeeEEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVID 194 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 194 (300)
.++|.+.+.||+|+||.||++.+. +++.||||++.... ........+.+|+.++..++ ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-------ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 457999999999999999999886 58899999986532 13456678999999999997 599999999998
Q ss_pred cCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+ ...+++||| +.+++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++ ++.+||+|||++.
T Consensus 99 ~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 T--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp C--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred c--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 6 458999999 56678888887777899999999999999999999999999999999999996 5899999999998
Q ss_pred eecCCcc--ccccCCCccccccCcccC
Q 022241 275 VFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......||+.|+|||++.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 201 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIK 201 (313)
T ss_dssp C--------------CCGGGCCHHHHT
T ss_pred cccCccccccccCCCCCCCcCCHHHHh
Confidence 7643322 223457999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=245.82 Aligned_cols=166 Identities=27% Similarity=0.372 Sum_probs=130.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 196 (300)
.+|...+.||+|+||.|+ ++...+++.||||.+...... .+.+|+.+|+.+ +|||||++++++.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l~~~~~~- 89 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRYFCTEKD- 89 (432)
T ss_dssp EEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCEEEEEEE-
T ss_pred EEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeEEEEEec-
Confidence 359999999999999986 566778999999998653221 245799999999 79999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-----CCcEEEecc
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-----SGTVKIGDF 270 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-----~~~~kl~DF 270 (300)
....|+||||+++ +|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++. ...+||+||
T Consensus 90 -~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 90 -RQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp -TTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred -CCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 4589999999985 66655543 335666677899999999999999999999999999999953 236889999
Q ss_pred cCceeecCCc---cccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDN---DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~---~~~~~~~gt~~y~aPE~l~ 299 (300)
|+|+...... ......+||+.|+|||++.
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTS
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhh
Confidence 9998764332 2334567999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=235.85 Aligned_cols=173 Identities=27% Similarity=0.396 Sum_probs=128.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+++.||+|+||.||++++..+|+.||||++..... .......+..+..+++.++||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-------KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 45789999999999999999999999999999999875421 12233445556667888999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
...+++||||++ +.+..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 --~~~~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 96 --NTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp --SSEEEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred --CCcEEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 458999999994 33333332 246799999999999999999999995 9999999999999999999999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
....... ......||+.|+|||++.
T Consensus 173 ~~~~~~~-~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 173 GRLVDDK-AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp ---------------CCTTCCHHHHC
T ss_pred hhccCCc-cccccCCCccccChhhcc
Confidence 8764432 234457999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=241.72 Aligned_cols=170 Identities=24% Similarity=0.408 Sum_probs=142.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-----------CCc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----------HPN 185 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 185 (300)
.++|.+.+.||+|+||.||++++..+++.||||++... ......+.+|+.+++.+. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----------ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 35799999999999999999999999999999998642 334567888999998886 899
Q ss_pred eeeeeeEEEcC--CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeCCCCCCCEEEc
Q 022241 186 IVNLIEVIDDP--NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVA 260 (300)
Q Consensus 186 iv~~~~~~~~~--~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiHrDlkp~NIll~ 260 (300)
|+++++++... ....+++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 99999998752 233789999999 6777766643 34699999999999999999999998 999999999999995
Q ss_pred c------CCcEEEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 261 P------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 261 ~------~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
. .+.+||+|||++...... .....||+.|+|||++.|
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT
T ss_pred ccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC
Confidence 3 448999999999876432 344579999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=258.17 Aligned_cols=174 Identities=25% Similarity=0.319 Sum_probs=143.0
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccC---CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
...++|.+.+.||+|+||.||++....+ +..||||.+... ........+.+|+.+|+.++||||+++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--------TCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3457899999999999999999988653 457999987532 13455678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.+ +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 459 ~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 459 VITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEec
Confidence 9853 4589999999999998887643 46999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCcc-ccccCCCccccccCcccC
Q 022241 271 SVSQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 271 Gla~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
|++........ ......+|+.|+|||++.
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHH
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhc
Confidence 99987644322 222345788999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=245.71 Aligned_cols=168 Identities=27% Similarity=0.368 Sum_probs=128.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 195 (300)
.+.|...+.||+|+||+||.+ ...+|+.||||.+... ....+.+|+.+|..+ +|||||++++++.+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------------FCDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------------HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 345677889999999999864 5668999999988543 224567899999875 89999999999985
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC------
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAI-------GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS------ 262 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l-------~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~------ 262 (300)
...+++||||++ ++|.+++...... ++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 81 --~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 81 --DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp --SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred --CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 468999999997 4777776554332 233457899999999999999999999999999999754
Q ss_pred -------CcEEEecccCceeecCCcc----ccccCCCccccccCcccCC
Q 022241 263 -------GTVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 263 -------~~~kl~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~G 300 (300)
+.+||+|||+++....... ......||+.|+|||++.|
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 4899999999998754322 1234579999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=257.67 Aligned_cols=176 Identities=29% Similarity=0.414 Sum_probs=147.0
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|.+.+.||+|+||.||++.+..+|+.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 447899999999999999999999999999999988542 144566789999999999999999999998754
Q ss_pred ----CCCCEEEEEEEeeCCCccccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCc---E
Q 022241 196 ----PNSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---V 265 (300)
Q Consensus 196 ----~~~~~~~lv~E~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~---~ 265 (300)
......++||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++. +
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeE
Confidence 12457899999999999988775533 6999999999999999999999999999999999999997764 9
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||++....... ......||+.|+|||++.|
T Consensus 164 KL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 164 KIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp EECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCC
T ss_pred EEccccccccccccc-ccccccCCcccCChHHhcc
Confidence 999999998764432 3345679999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=237.32 Aligned_cols=173 Identities=24% Similarity=0.343 Sum_probs=139.5
Q ss_pred ceeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 114 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
....++|.+.+.||+|+||.||++.... .||+|.+..... .......+.+|+.+++.++||||+++++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-------NEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-------CCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-------CHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4446789999999999999999998753 599999865422 112233566899999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+. ..+++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+|+||||||+|||++ ++.+||+|||+
T Consensus 99 ~~~--~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 99 MSP--PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp ECS--SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ecC--CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 863 47999999999999998887654 799999999999999999999999999999999999998 78999999999
Q ss_pred ceeecC-----CccccccCCCccccccCcccC
Q 022241 273 SQVFED-----DNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~-----~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..... .........||+.|+|||++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 207 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHS
T ss_pred ccccccccccccccccccCCCcccccChHHhh
Confidence 876432 112233456999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=217.70 Aligned_cols=149 Identities=11% Similarity=0.090 Sum_probs=130.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||++++..+++.||||++..... ........+.+|+.++..++||||+++++++.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV------LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc------cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 34679999999999999999999999999999999875421 234566789999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+..|+||||+++++|.+++... ..+..+..++.|++.||+|||++||+||||||+|||++.++.+||+++|...
T Consensus 103 --~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 103 --RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp --TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred --CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 35899999999999999888543 4566788899999999999999999999999999999999999999887643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=218.61 Aligned_cols=151 Identities=26% Similarity=0.460 Sum_probs=130.3
Q ss_pred ceeecceeEe-eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHH-HHCCCCceeeeee
Q 022241 114 TKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIE 191 (300)
Q Consensus 114 ~~~~~~y~~~-~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~ 191 (300)
....++|.+. +.||+|+||.||++.+..+++.||||++... ..+.+|+.++ +.++||||+++++
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~ 78 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVD 78 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHh
Confidence 3455778887 7899999999999999999999999998532 2456788887 6779999999999
Q ss_pred EEEc--CCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCc
Q 022241 192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGT 264 (300)
Q Consensus 192 ~~~~--~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~ 264 (300)
++.. .....+++||||+++++|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++. ++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCc
Confidence 9864 2345789999999999998877543 36999999999999999999999999999999999999998 789
Q ss_pred EEEecccCceeecC
Q 022241 265 VKIGDFSVSQVFED 278 (300)
Q Consensus 265 ~kl~DFGla~~~~~ 278 (300)
+||+|||++.....
T Consensus 159 ~kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 159 LKLTDFGFAKETTG 172 (299)
T ss_dssp EEECCCTTCEECTT
T ss_pred EEEecccccccccc
Confidence 99999999987643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=245.57 Aligned_cols=164 Identities=18% Similarity=0.159 Sum_probs=121.0
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCE
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 200 (300)
...+.||+|+||.||++ ...++.+|+|......... .........+.+.+|+.+|+.++||||+++..++... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~-~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRD-ERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DN 413 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSC-HHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccc-hhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--Cc
Confidence 34568999999999988 5568889999875432110 0000122345689999999999999999544444432 35
Q ss_pred EEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCc
Q 022241 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280 (300)
Q Consensus 201 ~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 280 (300)
.||||||+++++|.+++.. +..++.|++.||+|||+++|+||||||+|||++. .+||+|||+|+......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 6999999999999988766 5689999999999999999999999999999997 99999999999875432
Q ss_pred cc-------cccCCCccccccCcccC
Q 022241 281 DV-------LRRSPGTPVFTAPECCL 299 (300)
Q Consensus 281 ~~-------~~~~~gt~~y~aPE~l~ 299 (300)
.. ....+||+.|+|||++.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHH
Confidence 21 23567999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=229.90 Aligned_cols=171 Identities=15% Similarity=0.144 Sum_probs=127.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC-Ccee--------
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIV-------- 187 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv-------- 187 (300)
...|...+.||+|+||.||++.+..+|+.||||++..... ......+.+.+|+.+++.+.| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~------~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC------ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3468899999999999999999999999999998863321 122345678899999999987 2211
Q ss_pred -e------------eeeEEEcCC---CCEEEEEEEeeCCCccccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022241 188 -N------------LIEVIDDPN---SDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSGLMYLHG 244 (300)
Q Consensus 188 -~------------~~~~~~~~~---~~~~~lv~E~~~~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~ 244 (300)
. +..++.... ...++++|+++. ++|.+++. ....+++..+..++.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1 111111111 224567777664 55555541 23457888999999999999999999
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCceeecCCccccccCCCccccccCccc
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l 298 (300)
++|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETT 279 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhh
Confidence 99999999999999999999999999999875432 445678 999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=209.68 Aligned_cols=142 Identities=20% Similarity=0.182 Sum_probs=110.0
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCCh---------HHHHHHHHHHHHHHHCCCCceeeee
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE---------TAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
|.+.+.||+|+||.||++.+ .+|+.||||+++............. .....+.+|+.+|+.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 7899999999865422110000011 24567899999999999 4 6666
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus 168 ~~~~~---~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 168 KVYAW---EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CEEEE---ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred eEEec---cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 66543 24699999999999887 422 23457999999999999999999999999999999 999999999
Q ss_pred cCceee
Q 022241 271 SVSQVF 276 (300)
Q Consensus 271 Gla~~~ 276 (300)
|+|...
T Consensus 237 G~a~~~ 242 (282)
T 1zar_A 237 PQSVEV 242 (282)
T ss_dssp TTCEET
T ss_pred CCCeEC
Confidence 999753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=182.88 Aligned_cols=148 Identities=16% Similarity=0.162 Sum_probs=108.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCce--EEEEEeeccccccc----------cc-----CCChHHHHHHHHHHHHHHHCC
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKL----------RV-----APSETAMTDVRREVLIMKMLQ 182 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~--vavK~~~~~~~~~~----------~~-----~~~~~~~~~~~~E~~~l~~l~ 182 (300)
|.+.+.||+|+||.||++.+..+|+. ||||+++....... +. .........+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778999 99998754321100 00 000122346789999999998
Q ss_pred CCce--eeeeeEEEcCCCCEEEEEEEeeCC-C----ccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeCCCCC
Q 022241 183 HPNI--VNLIEVIDDPNSDHFYMVLEYVEG-K----WDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKP 254 (300)
Q Consensus 183 h~ni--v~~~~~~~~~~~~~~~lv~E~~~~-~----~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~iiHrDlkp 254 (300)
|+++ +.++++ ...+|||||+++ | .+.+... ..++..+..++.|++.||.||| +.||+||||||
T Consensus 129 ~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8864 334432 135899999952 3 2322221 1234567889999999999999 99999999999
Q ss_pred CCEEEccCCcEEEecccCceeecC
Q 022241 255 DNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 255 ~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
+|||++. .++|+|||+|.....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETTS
T ss_pred HHEEEcC--cEEEEECcccccCCC
Confidence 9999997 999999999987644
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-21 Score=173.57 Aligned_cols=148 Identities=18% Similarity=0.225 Sum_probs=101.7
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccC-----CChHHHHH--------HHHHHHHHHHCCCCce
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-----PSETAMTD--------VRREVLIMKMLQHPNI 186 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~~--------~~~E~~~l~~l~h~ni 186 (300)
|.+.+.||+|+||.||+|.+. +|+.||||+++.....-.... ........ ..+|...|..+.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999875 799999999865422100000 00001111 2345666666654443
Q ss_pred eeeeeEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC---
Q 022241 187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--- 263 (300)
Q Consensus 187 v~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~--- 263 (300)
....-+... ..+|||||++|..+...... ..+..++.|++.+|.|||+.|||||||||.|||++.++
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeecc----CceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 211111111 12699999998887654322 23457889999999999999999999999999998876
Q ss_pred -------cEEEecccCceeecC
Q 022241 264 -------TVKIGDFSVSQVFED 278 (300)
Q Consensus 264 -------~~kl~DFGla~~~~~ 278 (300)
.+.|+||+.+.....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccceEEEEeCCcccCCC
Confidence 489999998876443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1e-13 Score=118.69 Aligned_cols=141 Identities=16% Similarity=0.183 Sum_probs=108.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP 196 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 196 (300)
..|.+...++.|+.+.||.+.. .++.+++|....... .....+.+|+.+|+.+. +..+.++++++.+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---------~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~- 81 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---------GTTYDVEREKDMMLWLEGKLPVPKVLHFERH- 81 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---------CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-
Confidence 4688889999999999988764 367899998754211 01125778999999885 6778889988875
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------- 244 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-------------------------------- 244 (300)
.+..|+||||++|..+...+.. ......++.+++.+|..||+
T Consensus 82 -~~~~~lv~e~i~G~~l~~~~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 82 -DGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHCCT-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred -CCceEEEEEecCCeehhhccCC-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 3578999999999887654321 12234778899999999998
Q ss_pred ---------------------------CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 245 ---------------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 245 ---------------------------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 34899999999999986556679999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=111.59 Aligned_cols=135 Identities=16% Similarity=0.154 Sum_probs=97.2
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeeeEEEcC
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDP 196 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~ 196 (300)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++..+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~- 86 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------------ALNELQDEAARLSWLATTGVPCAAVLDVVTE- 86 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------------cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-
Confidence 455544444666799998854 46778999986432 1134678999998886544 4568887765
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN------------------------------ 246 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------ 246 (300)
.+..++||||++|..+. ... .. ...++.+++..|..||+..
T Consensus 87 -~~~~~~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 87 -AGRDWLLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp -SSCEEEEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred -CCCCEEEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 34689999999998774 211 22 2356778888888888643
Q ss_pred ----------------------------cEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 247 ----------------------------VVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 247 ----------------------------iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
++|+|++|.|||++.++.+.|+|||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987666779999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.36 E-value=7.1e-12 Score=112.22 Aligned_cols=143 Identities=20% Similarity=0.341 Sum_probs=105.6
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEee--cccccccccCCChHHHHHHHHHHHHHHHCC--CCceeeeeeEEEcCC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFH--KSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVIDDPN 197 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 197 (300)
.++.|+.|.++.||++... +..+++|... .... ......+.+|+.+++.+. +..+++++.++.+..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--------LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 4678999999999987653 5678899764 2210 112346778999999987 455788888876532
Q ss_pred C-CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 022241 198 S-DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------- 244 (300)
Q Consensus 198 ~-~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-------------------------------- 244 (300)
. +..|+||||++|..+.+.. ...+++.....++.+++..|..||.
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 1 3578999999988775422 2347788888999999999999996
Q ss_pred --------------------------CCcEeCCCCCCCEEEccCCc--EEEecccCceee
Q 022241 245 --------------------------HNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQVF 276 (300)
Q Consensus 245 --------------------------~~iiHrDlkp~NIll~~~~~--~kl~DFGla~~~ 276 (300)
..++|+|++|.|||++.++. +.|+||+.+...
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 699999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.2e-09 Score=90.83 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=96.5
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCc--eeeeeeEEEcCCC-
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPN--IVNLIEVIDDPNS- 198 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~- 198 (300)
++.++.|....||.+. ..+++|+... ......+.+|+.+|+.+. +.. +.+++........
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-----------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-----------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 3568999999998753 4688997432 234567889999998873 333 3344444322111
Q ss_pred CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 022241 199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG---------------------------------- 244 (300)
Q Consensus 199 ~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~---------------------------------- 244 (300)
...|+||++++|..+..... ..++......++.|++..|+.||+
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred CcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 13478999999987654221 346777778888888888888885
Q ss_pred ------------------------CCcEeCCCCCCCEEEcc--CCcEEEecccCceee
Q 022241 245 ------------------------HNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVF 276 (300)
Q Consensus 245 ------------------------~~iiHrDlkp~NIll~~--~~~~kl~DFGla~~~ 276 (300)
..++|+|++|.||+++. ...+.|+||+.+...
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999997 456899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=4.9e-08 Score=85.34 Aligned_cols=135 Identities=16% Similarity=0.267 Sum_probs=93.7
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC---ceeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP---NIVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~ 199 (300)
++.++.|....||.+ |..+++|+-. .......+.+|+.+|..+.+. .+.+++.+... ..+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g 86 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDG 86 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCC
Confidence 356788888899877 5678899742 223456789999999998753 35566666653 234
Q ss_pred EEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 022241 200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---------------------------------- 245 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------------------------- 245 (300)
..++||||++|..+.... ...++......++.++...|..||+.
T Consensus 87 ~~~~v~e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 87 NPFVGYRKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp CEEEEEECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred ceEEEEeccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 678999999987765421 11234555555666666666655532
Q ss_pred --------------------------CcEeCCCCCCCEEEcc---CCc-EEEecccCceee
Q 022241 246 --------------------------NVVHGDIKPDNLLVAP---SGT-VKIGDFSVSQVF 276 (300)
Q Consensus 246 --------------------------~iiHrDlkp~NIll~~---~~~-~kl~DFGla~~~ 276 (300)
.++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 355 589999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-07 Score=80.80 Aligned_cols=134 Identities=17% Similarity=0.207 Sum_probs=88.7
Q ss_pred eecCCCce-EEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEcCCCCEEE
Q 022241 125 KIGAGSYG-KVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHFY 202 (300)
Q Consensus 125 ~iG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 202 (300)
.+..|..| .||.......+..+.+|.-.. .....+.+|...|+.+. +--+.+++.++.++ +..+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~ 96 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAW 96 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEE
Confidence 34445555 688877777778899997532 23456788999998875 33466788887763 5789
Q ss_pred EEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 022241 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------------- 244 (300)
Q Consensus 203 lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-------------------------------------- 244 (300)
+|||+++|..+...... .......+..+++..|.-||.
T Consensus 97 lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999998654432211 011112233333344444442
Q ss_pred -------------C-------CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 245 -------------H-------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 245 -------------~-------~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
. .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 1699999999999997777779999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-06 Score=77.36 Aligned_cols=89 Identities=7% Similarity=0.132 Sum_probs=54.9
Q ss_pred eEeeee-cCCCceEEEEEEEcc------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC---Cceeeee
Q 022241 121 VHVRKI-GAGSYGKVVLYRSSL------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH---PNIVNLI 190 (300)
Q Consensus 121 ~~~~~i-G~G~fg~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~ 190 (300)
...+.| +.|....+|++.... +++.+++|.......... . ....+.+|+.+|+.+.. ..+.+++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~--~----~~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV--F----PTYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS--S----SCCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc--C----chhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 345778 888899999876431 256788997543210000 0 01245678888877742 3566778
Q ss_pred eEEEcCC-CCEEEEEEEeeCCCcccc
Q 022241 191 EVIDDPN-SDHFYMVLEYVEGKWDND 215 (300)
Q Consensus 191 ~~~~~~~-~~~~~lv~E~~~~~~l~~ 215 (300)
.+..+.. .+..++||||++|..+..
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEccCCCccCCceEEEEecCCCChhh
Confidence 7765421 134679999999876654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=3.6e-07 Score=82.59 Aligned_cols=83 Identities=14% Similarity=0.111 Sum_probs=48.2
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC--Cc-eeeeeeEEEcCCC
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PN-IVNLIEVIDDPNS 198 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~ 198 (300)
..+.||.|.++.||++....+++.|+||....... ............+..|+.+|+.+.. |. +.+++.+ ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r--~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~--- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK--VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT--- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET---
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhc--ccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC---
Confidence 35689999999999987665678899998653210 0000001122356678888887642 33 3455544 32
Q ss_pred CEEEEEEEeeCC
Q 022241 199 DHFYMVLEYVEG 210 (300)
Q Consensus 199 ~~~~lv~E~~~~ 210 (300)
+..++||||+++
T Consensus 108 ~~~~lvmE~l~g 119 (397)
T 2olc_A 108 EMAVTVMEDLSH 119 (397)
T ss_dssp TTTEEEECCCTT
T ss_pred CccEEEEEeCCC
Confidence 235799999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.4e-05 Score=65.89 Aligned_cols=31 Identities=19% Similarity=0.278 Sum_probs=28.3
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998865
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=7.5e-05 Score=65.18 Aligned_cols=77 Identities=17% Similarity=0.215 Sum_probs=57.5
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC---CCceeeeeeEEEcCC
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPN 197 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 197 (300)
...+.|+.|....+|++.. ++..+++|+.... ....+..|+..|+.|. ...+++++.+...
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-- 102 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-- 102 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--
Confidence 3457899999999988764 4678899976432 2456788998888874 3567788888765
Q ss_pred CCEEEEEEEeeCCCcc
Q 022241 198 SDHFYMVLEYVEGKWD 213 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l 213 (300)
.+..++||||+++...
T Consensus 103 ~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 103 QGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSEEEEEEECCCCCCC
T ss_pred CCceEEEEEeccCCCC
Confidence 3578999999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=5.8e-05 Score=68.63 Aligned_cols=33 Identities=18% Similarity=0.331 Sum_probs=28.8
Q ss_pred HhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 243 H~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+...++|+|++|.|||++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999999776 999999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.83 E-value=6.9e-05 Score=64.85 Aligned_cols=29 Identities=24% Similarity=0.216 Sum_probs=25.3
Q ss_pred cEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 247 iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
++|+|+.|.||+ ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 799999999999 55778899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00031 Score=61.12 Aligned_cols=142 Identities=17% Similarity=0.208 Sum_probs=76.8
Q ss_pred eEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc--eeeeeeEEEc---
Q 022241 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDD--- 195 (300)
Q Consensus 121 ~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~--- 195 (300)
..++.|+.|....+|++... +..+++|...... ....+..|+.++..|...+ +.+++.....
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~ 91 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 91 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC--------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEE
Confidence 34577888888999887643 3368899875420 1123456777766654222 2333321000
Q ss_pred -CCCCEEEEEEEeeCCCccccc---------------------cCCC--CCCC---HHHHHH------------HHHHHH
Q 022241 196 -PNSDHFYMVLEYVEGKWDNDG---------------------FGQP--GAIG---ESMARK------------YLRDIV 236 (300)
Q Consensus 196 -~~~~~~~lv~E~~~~~~l~~~---------------------~~~~--~~l~---~~~~~~------------i~~qi~ 236 (300)
...+..+++|+|++|..+... +... .... |..... +...+.
T Consensus 92 ~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~ 171 (322)
T 2ppq_A 92 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 171 (322)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHH
Confidence 012467899999998653210 0000 0011 111000 001133
Q ss_pred HHHHHHHh-------CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 237 SGLMYLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 237 ~~l~yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..++++.. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 172 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 44555552 3589999999999999766668999998865
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0002 Score=61.46 Aligned_cols=78 Identities=18% Similarity=0.148 Sum_probs=52.8
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC---CceeeeeeEEEc
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH---PNIVNLIEVIDD 195 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~ 195 (300)
+...++.+|.|..+.||++... +|+.|.+|+..... ......+..|+..|+.|.- .-+.+++++..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~---------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~- 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA---------PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD- 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC---------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET-
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC---------cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC-
Confidence 3556788999999999988754 78999999754321 1112357789999988842 23445555421
Q ss_pred CCCCEEEEEEEeeCCCc
Q 022241 196 PNSDHFYMVLEYVEGKW 212 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~ 212 (300)
-++||||++++.
T Consensus 85 -----~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 -----RTLAMEWVDERP 96 (288)
T ss_dssp -----TEEEEECCCCCC
T ss_pred -----ceEEEEeecccC
Confidence 268999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00041 Score=63.29 Aligned_cols=75 Identities=15% Similarity=0.268 Sum_probs=48.7
Q ss_pred EeeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce-eeeeeEE
Q 022241 122 HVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVI 193 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~ 193 (300)
.++.|+.|....||++.... .+..|++|+.... .. ...+..|..++..|...++ .++++.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--------~~---~~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--------ET---ESHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--------CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--------Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 45678888889999887542 2578999976321 01 1344578888887753334 5667665
Q ss_pred EcCCCCEEEEEEEeeCCCcc
Q 022241 194 DDPNSDHFYMVLEYVEGKWD 213 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l 213 (300)
. + .+|+||++|..+
T Consensus 146 ~--~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 146 S--G----GRLEEYIPSRPL 159 (429)
T ss_dssp T--T----EEEECCCCEEEC
T ss_pred C--C----CEEEEEeCCccc
Confidence 3 2 289999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00047 Score=61.77 Aligned_cols=138 Identities=14% Similarity=0.178 Sum_probs=80.3
Q ss_pred eeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc-eeeeeeEEE
Q 022241 123 VRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEVID 194 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~ 194 (300)
++.|..|-...+|++.... +++.|.+|+.... ......+.+|..+++.|.-.+ ..++++++.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----------LQGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 3567777778888877532 3578999975221 112345568888887774222 356676653
Q ss_pred cCCCCEEEEEEEeeCCCccccc-c-----------------CC----CCCC--CHHHHHHHHHHHH--------------
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDG-F-----------------GQ----PGAI--GESMARKYLRDIV-------------- 236 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~-~-----------------~~----~~~l--~~~~~~~i~~qi~-------------- 236 (300)
+ .+||||++|..+... + .. .... -+..+..++.++.
T Consensus 125 --~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 125 --E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp --T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred --C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 2 289999998554311 0 00 1112 2344555544432
Q ss_pred -----HHHHHHH----h----CCcEeCCCCCCCEEEccC----CcEEEecccCceee
Q 022241 237 -----SGLMYLH----G----HNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVF 276 (300)
Q Consensus 237 -----~~l~yLH----~----~~iiHrDlkp~NIll~~~----~~~kl~DFGla~~~ 276 (300)
..+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|...
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 1233333 2 248999999999999876 68999999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00042 Score=61.70 Aligned_cols=76 Identities=12% Similarity=0.089 Sum_probs=42.8
Q ss_pred EeeeecCCCceEEEEEEEcc--------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCc-eeeeeeE
Q 022241 122 HVRKIGAGSYGKVVLYRSSL--------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEV 192 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~ 192 (300)
..+.|+.|..-.+|++.... .+..+++|+...... .......|..+++.+...+ ..++++.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----------~~~~~~~E~~~l~~L~~~g~~P~~~~~ 106 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----------ELYNTISEFEVYKTMSKYKIAPQLLNT 106 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----------GTSCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----------ceecHHHHHHHHHHHHhcCCCCceEEe
Confidence 34678888888999887543 136788897643211 1112356777777765333 3466655
Q ss_pred EEcCCCCEEEEEEEeeCCCcc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWD 213 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l 213 (300)
+. + ++||||++|..+
T Consensus 107 ~~---~---~~v~e~i~G~~l 121 (369)
T 3c5i_A 107 FN---G---GRIEEWLYGDPL 121 (369)
T ss_dssp ET---T---EEEEECCCSEEC
T ss_pred cC---C---cEEEEEecCCcC
Confidence 41 1 589999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.001 Score=57.88 Aligned_cols=138 Identities=13% Similarity=0.171 Sum_probs=76.2
Q ss_pred eeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCC--ceeeeeeEEEcC----C
Q 022241 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP--NIVNLIEVIDDP----N 197 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~ 197 (300)
..|+ |....||++... +|+.+++|...... .....+..|..++..+... .+++++.. ... .
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~----------~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~ 98 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER----------WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNH 98 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT----------SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC----------CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEE
Confidence 4566 777889876532 56679999875321 1123556677777766422 23444433 110 1
Q ss_pred CCEEEEEEEeeCCCccccc------------------cC-----CCCCCCHHHH----HHHH---------------HHH
Q 022241 198 SDHFYMVLEYVEGKWDNDG------------------FG-----QPGAIGESMA----RKYL---------------RDI 235 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~------------------~~-----~~~~l~~~~~----~~i~---------------~qi 235 (300)
.+..+++|+|++|..+... .. ....++.... ..++ ..+
T Consensus 99 ~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 178 (328)
T 1zyl_A 99 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT 178 (328)
T ss_dssp TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHH
Confidence 3467889999998543210 00 0011222110 0011 011
Q ss_pred HHHHHHHH-------hCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 236 VSGLMYLH-------GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 236 ~~~l~yLH-------~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
-..++.+. ...++|+|++|.|||++ + .+.|+||+.+...
T Consensus 179 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 179 DELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 11223332 23489999999999999 4 8999999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0043 Score=56.99 Aligned_cols=76 Identities=17% Similarity=0.212 Sum_probs=47.5
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce-eeeeeEEEcCCCCE
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVIDDPNSDH 200 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~ 200 (300)
.++.|+.|-...+|++.....+..|++|+...... . .-...+|..++..|...++ .++++.+. +
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~---------~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--- 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E---------IINREREKKISCILYNKNIAKKIYVFFT--N--- 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S---------CSCHHHHHHHHHHHTTSSSBCCEEEEET--T---
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h---------hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C---
Confidence 45778888889999887654357889997643210 0 0012478888888875555 46777662 2
Q ss_pred EEEEEEeeCCCcc
Q 022241 201 FYMVLEYVEGKWD 213 (300)
Q Consensus 201 ~~lv~E~~~~~~l 213 (300)
.+||||++|..+
T Consensus 177 -G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 -GRIEEFMDGYAL 188 (458)
T ss_dssp -EEEEECCCSEEC
T ss_pred -eEEEEeeCCccC
Confidence 259999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00043 Score=60.60 Aligned_cols=33 Identities=30% Similarity=0.386 Sum_probs=28.5
Q ss_pred CCcEeCCCCCCCEEEccC----CcEEEecccCceeec
Q 022241 245 HNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFE 277 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~----~~~kl~DFGla~~~~ 277 (300)
..++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999874 689999999988643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0071 Score=53.12 Aligned_cols=32 Identities=25% Similarity=0.348 Sum_probs=28.5
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
..++|+|+.|.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35899999999999998888999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.026 Score=51.19 Aligned_cols=30 Identities=23% Similarity=0.474 Sum_probs=26.6
Q ss_pred CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 246 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.++|+|+.+.||+ +.++.+.|+||..|...
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 3899999999999 77889999999998763
|
| >1gxc_A CHK2, CDS1, serine/threonine-protein kinase CHK2; phosphoprotein-binding domain, checkpoint kinase, transferase; HET: TPO; 2.7A {Homo sapiens} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=95.95 E-value=0.00073 Score=52.19 Aligned_cols=64 Identities=25% Similarity=0.270 Sum_probs=45.1
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
...|++||+..|++++..+..+....+..+|..|++|......+....-...|.|.||+..|..
T Consensus 47 ~~~~~IGR~~~~di~l~d~~~~~~~~~~~VSr~Ha~I~~~~~~~~~~~~~i~D~StNGT~VNg~ 110 (149)
T 1gxc_A 47 NDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTE 110 (149)
T ss_dssp SSEEEEESSTTCSEECCCGGGGGSSGGGGSCTTCEEEEEEECTTSSEEEEEEECCSSCEEETTE
T ss_pred CCCEEecCCCCCCEEECCccccccccCCcCchhheEEEEECCCCceeEEEEEECCCCCeEECCE
Confidence 4679999999999999988544444456799999999765321111122345579999988764
|
| >4h87_A Kanadaptin; FHA domain of PF00498, mRNA processing, nucleus, structural joint center for structural genomics, JCSG, protein structu initiative; HET: SO4; 1.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.87 E-value=0.018 Score=43.17 Aligned_cols=54 Identities=19% Similarity=0.179 Sum_probs=36.0
Q ss_pred ccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCC------CCCCCCCC-CCCCCCCCCCC
Q 022241 4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGD------DIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 4 ~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~------~~~~~~~d-~s~~~~~~~~~ 66 (300)
+.|++||+..|++++..+ .+|..|..|.-...... ...-...| .|.||+..|..
T Consensus 41 ~~~~IGR~~~~di~l~~~---------~VSr~HA~I~~r~~~~~~~~~~~~~~~~l~Dl~StNGT~vNg~ 101 (130)
T 4h87_A 41 SYCLFGRLSGCDVCLEHP---------SVSRYHAVLQHRASGPDGECDSNGPGFYLYDLGSTHGTFLNKT 101 (130)
T ss_dssp SEEEEESSTTSSEECCCT---------TSCSSCEEEEEBCCCCCC------CCEEEEECSCSSCEEETTE
T ss_pred ceEEEcCCcCCCEEeCCC---------CcchhcEEEEEecccCccceeccCCcceEeeCCCCCceEECCE
Confidence 558999999999999877 78999998842111110 00112234 58899998774
|
| >1qu5_A Protein kinase SPK1; FHA, RAD53, transferase; NMR {Saccharomyces cerevisiae} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=93.84 E-value=0.014 Score=46.41 Aligned_cols=53 Identities=11% Similarity=-0.121 Sum_probs=37.7
Q ss_pred cchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCC----------CCCCCCCCCCCCCCCCCC
Q 022241 5 TCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDD----------IDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 5 ~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~----------~~~~~~d~s~~~~~~~~~ 66 (300)
.|++||+..|++++..+ .+|..|++|......... ..-...|.|.||+..|..
T Consensus 52 ~~~IGR~~~~di~l~d~---------~VSr~HA~I~~~~~~~g~~~~e~~~~~~~~~~l~DlStNGT~VNg~ 114 (182)
T 1qu5_A 52 PFFIGRSEDCNCKIEDN---------RLSRVHCFIFKKRHAVGKSMYESPAQGLDDIWYCHTGTNVSYLNNN 114 (182)
T ss_dssp SEEESSSTTSSSCCCCT---------TSCSSCEEEEEECCCCCSSCCSSCCCSCCEEEECCCSSSCCEETTE
T ss_pred eEEECCCCCCCEEECCC---------CcChHHeEEEEecCccccccccccccccceEEEEECCcCCeEECCE
Confidence 49999999999999877 789999999764211111 111335568899988864
|
| >3hx1_A SLR1951 protein; P74513_SYNY3, adenylate cyclase-like protein, NESG, structural genomics, PSI-2, protein structure initiative; 2.50A {Synechocystis SP} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.0081 Score=45.14 Aligned_cols=55 Identities=13% Similarity=-0.091 Sum_probs=36.4
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC------CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD------NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d------~s~~~~~~~~~ 66 (300)
.+.+++||+..|++++..+ .+|..|.+|......++...-...| .|.||+..|..
T Consensus 29 ~~~~~IGR~~~~di~l~d~---------~VSr~Ha~I~~~~~~~g~~~~~l~Dl~~~~~~S~NGT~vNg~ 89 (131)
T 3hx1_A 29 ETFYTIGRSPRADIRIKSQ---------FVSRIHAVLVRKSSDDVQAAYRIIDGDEDGQSSVNGLMINGK 89 (131)
T ss_dssp SSEEEEESSTTSSEECCCS---------SSCTTCEEEEEC------CCEEEEESCTTSCCCSSCEEETTE
T ss_pred CCCEEECCCCCCCEEECCC---------CcChhheEEEEEccCCCceEEEEEECCCCCCCCCCceEECCE
Confidence 4679999999999999876 7999999997653211110112233 48888887663
|
| >1dmz_A Protein (protein kinase SPK1); beta-sandwich, antiparallel beta-sheets, transferase; NMR {Saccharomyces cerevisiae} SCOP: b.26.1.2 PDB: 1fhq_A 1fhr_A* 1j4k_A* 1j4l_A* 1k2m_A* 1k2n_A* | Back alignment and structure |
|---|
Probab=92.85 E-value=0.015 Score=45.25 Aligned_cols=53 Identities=11% Similarity=-0.121 Sum_probs=37.3
Q ss_pred cchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCC----------CCCCCCCCCCCCCCCCCC
Q 022241 5 TCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDD----------IDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 5 ~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~----------~~~~~~d~s~~~~~~~~~ 66 (300)
.|++||+..|++++..+ .+|..|.+|..+...... ..-...|.|.||+..|..
T Consensus 28 ~~~IGR~~~~di~l~d~---------~VSr~Ha~I~~~~~~~g~~~~~~~~~~~~~~~l~DlStNGT~VNg~ 90 (158)
T 1dmz_A 28 PFFIGRSEDCNCKIEDN---------RLSRVHCFIFKKRHAVGKSMYESPAQGLDDIWYCHTGTNVSYLNNN 90 (158)
T ss_dssp CEEEESSTTSSEECCCT---------TSCSSSEEEEEEECCCCCCCSSCSCSSCEEEEEEECSTTCCEETTE
T ss_pred eEEECCCCCCCEEeCCC---------CcChHHeEEEEecCccccccccccccccccEEEEECCcCCeEECCE
Confidence 49999999999999877 789999999764211111 111334568888888764
|
| >1r21_A Antigen KI-67; beta sandwich, cell cycle; NMR {Homo sapiens} SCOP: b.26.1.2 PDB: 2aff_A* | Back alignment and structure |
|---|
Probab=91.26 E-value=0.06 Score=40.07 Aligned_cols=50 Identities=16% Similarity=0.191 Sum_probs=37.0
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|..|..+ +..-..+|. |.||+..|..
T Consensus 32 ~~~~~IGR~~~~di~l~d~---------~VSr~Ha~i~~~-----~~~~~l~Dl~S~nGt~vNg~ 82 (128)
T 1r21_A 32 LSTCLFGRGIECDIRIQLP---------VVSKQHCKIEIH-----EQEAILHNFSSTNPTQVNGS 82 (128)
T ss_dssp SSEEEEESSTTSSEECCCT---------TSCTTCEEEEEC-----SSCEEECCCCSSSCCEETTE
T ss_pred CCCEEECCCCCCCEEECCC---------CCChhHEEEEEE-----CCEEEEEECCCCCCEEECCE
Confidence 4679999999999999876 789999999653 111233444 7888887763
|
| >1g6g_A Protein kinase RAD53; beta-sandwich, phosphopeptide complex, cell cycle; HET: TPO; 1.60A {Saccharomyces cerevisiae} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=91.17 E-value=0.044 Score=40.76 Aligned_cols=52 Identities=21% Similarity=0.226 Sum_probs=37.0
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
+..+++||+..|++++..+ ..+|..|.+|..+ .+..-..+|.|.||+..|..
T Consensus 35 ~~~~~IGR~~~~di~l~~~--------~~vSr~Ha~i~~~----~~g~~~l~DlS~NGT~vNg~ 86 (127)
T 1g6g_A 35 KKVWTFGRNPACDYHLGNI--------SRLSNKHFQILLG----EDGNLLLNDISTNGTWLNGQ 86 (127)
T ss_dssp CEEEEEESSTTSSEECCSC--------TTSCSSCEEEEEC----TTSCEEEEECCSSCCEETTE
T ss_pred CCCEEECCCCCCCEEeCCC--------CCCChhHeEEEEC----CCCcEEEEECCcCCeEECCE
Confidence 3589999999999999864 1488999999653 11122345558899988763
|
| >3po8_A RV0020C protein, putative uncharacterized protein TB39.8; FHA domain, synthetic peptide, peptide binding protein; 1.50A {Mycobacterium tuberculosis} SCOP: b.26.1.0 PDB: 3poa_A* 2lc1_A | Back alignment and structure |
|---|
Probab=91.07 E-value=0.044 Score=38.86 Aligned_cols=50 Identities=20% Similarity=0.009 Sum_probs=36.3
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+ +..-..+|. |.||+..|..
T Consensus 22 ~~~~~IGR~~~~di~l~d~---------~vSr~Ha~i~~~-----~~~~~l~Dl~S~nGt~vng~ 72 (100)
T 3po8_A 22 EGSNIIGRGQDAQFRLPDT---------GVSRRHLEIRWD-----GQVALLADLNSTNGTTVNNA 72 (100)
T ss_dssp SEEEEEESSTTCSEECCCT---------TSCSSCEEEEEC-----SSCEEEEECSCSSCCEETTE
T ss_pred CCCEEEeCCCCCCEECCCC---------CcChhhCEEEEe-----CCEEEEEECCCCCCEEECCE
Confidence 4579999999999999866 789999999653 111233444 7788887753
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=90.78 E-value=0.05 Score=42.05 Aligned_cols=50 Identities=20% Similarity=0.009 Sum_probs=37.1
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+ +..-..+|. |.||+..|..
T Consensus 84 ~~~~~IGR~~~~dI~L~d~---------~VSr~HA~I~~~-----~~~~~l~DlgStNGT~VNG~ 134 (157)
T 3oun_A 84 EGSNIIGRGQDAQFRLPDT---------GVSRRHLEIRWD-----GQVALLADLNSTNGTTVNNA 134 (157)
T ss_dssp SEEEEEESSTTCSEECCCT---------TSCTTCEEEEEC-----SSCEEEEECSCSSCCEETTE
T ss_pred CCcEEEEeCCCCCEEeCCC---------CcChhHEEEEEE-----CCEEEEEECCCCCCeEECCE
Confidence 4579999999999999876 789999999653 111233444 7888888763
|
| >1g3g_A Protien kinase SPK1; FHA domain, RAD53, phosphopeptide, phosphoprotein, transferase; NMR {Saccharomyces cerevisiae} SCOP: b.26.1.2 PDB: 1j4o_A 1j4p_A* 1j4q_A* 1k3j_A 1k3n_A* 1k3q_A* 2a0t_A* 2jqi_A* | Back alignment and structure |
|---|
Probab=90.56 E-value=0.042 Score=42.86 Aligned_cols=52 Identities=21% Similarity=0.226 Sum_probs=36.8
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
++.+++||+..|++++..+ ..+|..|++|..+ .+..-..+|.|.||+..|..
T Consensus 63 ~~~~~IGR~~~~di~l~d~--------~~vSr~Ha~I~~~----~~g~~~l~DlS~NGT~vNg~ 114 (164)
T 1g3g_A 63 KKVWTFGRNPACDYHLGNI--------SRLSNKHFQILLG----EDGNLLLNDISTNGTWLNGQ 114 (164)
T ss_dssp CEEEEEESSSSSSEECCCC--------TTTTSSCEEEEEC----STTCEEEEECCSSCEEETTE
T ss_pred CCcEEECCCCCCCEEeCCc--------CCcChhHEEEEEC----CCCCEEEEECCCCCeEECCE
Confidence 3589999999999999864 1488899999653 11122344558899888763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.37 E-value=0.02 Score=52.59 Aligned_cols=63 Identities=13% Similarity=0.075 Sum_probs=17.3
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEE------EEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAI------KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
+.+.|| ||.||++.......+||| |..+.... +......+.+|..+++.++|||+++.+++-.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-------~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-------SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-------cccccccccccccccccccccccCCCcceEE
Confidence 345676 999988776654567888 65443211 2344456888999999999999999887654
|
| >1lgp_A Cell cycle checkpoint protein CHFR; FHA, tungstate, domain swapping; 2.00A {Homo sapiens} SCOP: b.26.1.2 PDB: 1lgq_A | Back alignment and structure |
|---|
Probab=90.27 E-value=0.068 Score=38.98 Aligned_cols=53 Identities=23% Similarity=0.245 Sum_probs=37.9
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
...+++||+..|++++... ..+|..|++|..+.. +..-...|.|.||+..|..
T Consensus 23 ~~~~~iGR~~~~di~l~~~--------~~vSr~Ha~i~~~~~---~~~~~l~D~S~NGt~vng~ 75 (116)
T 1lgp_A 23 KREWTIGRRRGCDLSFPSN--------KLVSGDHCRIVVDEK---SGQVTLEDTSTSGTVINKL 75 (116)
T ss_dssp SSEEEEESSTTSSEECTTC--------TTSCTTCEEEEECTT---TCCEEEEECSSSCCCCCCC
T ss_pred CCCEEECCCCCCCEEeCCC--------CCCChhHeEEEEECC---CCeEEEEECCcCCcEECCE
Confidence 4678999999999999642 168899999965411 1122334588999998875
|
| >2jqj_A DNA damage response protein kinase DUN1; protein/phosphopeptide, cell cycle; HET: DNA; NMR {Saccharomyces cerevisiae} PDB: 2jql_A* | Back alignment and structure |
|---|
Probab=90.08 E-value=0.025 Score=43.53 Aligned_cols=55 Identities=16% Similarity=0.039 Sum_probs=38.6
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCcccccccc-C--CCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLL-G--DDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~-~--~~~~~~~~d~s~~~~~~~~~ 66 (300)
+..+++||+..|++++..+ .+|..|++|...... + .+..-...|.|.||+..|..
T Consensus 37 ~~~~~IGR~~~~di~l~d~---------~VSr~Ha~I~~~~~~~~~~~~~~~~l~DlS~NGT~VNg~ 94 (151)
T 2jqj_A 37 RNVTTIGRSRSCDVILSEP---------DISTFHAEFHLLQMDVDNFQRNLINVIDKSRNGTFINGN 94 (151)
T ss_dssp CSCEEEESSTTSSEECCCT---------TCCTTSEEEEEEEEEETTEEEEEEEEEECCSSCEEETTE
T ss_pred CCeEEeCCCCCCCEEECCC---------CCccccCEEEEecccCCcCcCCEEEEEECCCCCeEECCE
Confidence 3689999999999999976 789999999763211 1 11112345568899988763
|
| >2jpe_A Nuclear inhibitor of protein phosphatase 1; FHA domain, NIPP1, mRNA splicing, transcription; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=89.45 E-value=0.12 Score=38.98 Aligned_cols=50 Identities=12% Similarity=-0.057 Sum_probs=37.1
Q ss_pred cchhhhccc-ccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 5 TCSWIRDMG-CCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 5 ~~~~~r~~~-c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
.+++||+.. |++++..+ .+|..|.+|..+.. +..-...| .|.||+..|..
T Consensus 56 ~~~IGR~~~~~di~l~d~---------~VSr~Ha~i~~~~~---~~~~~l~Dl~S~NGT~vNg~ 107 (140)
T 2jpe_A 56 YYLFGRNPDLCDFTIDHQ---------SCSRVHAALVYHKH---LKRVFLIDLNSTHGTFLGHI 107 (140)
T ss_dssp BCCBSSCTTTSSSCCCCS---------SSCTTSBEEEEBSS---SCCEEEECCSCSSCEESSSC
T ss_pred eEEecCCCccCCEEeCCC---------CcChhheEEEEECC---CCcEEEEECCCCCCeEECCE
Confidence 499999999 99999866 78999999965421 11233455 58899988764
|
| >2kfu_A RV1827 PThr 22; FHA domain, phosphorylation, intramolecular interaction, glutamate metabolism, phosphoprotein, protein binding; HET: TPO; NMR {Mycobacterium tuberculosis} PDB: 2kkl_A | Back alignment and structure |
|---|
Probab=89.30 E-value=0.061 Score=41.85 Aligned_cols=50 Identities=14% Similarity=0.012 Sum_probs=37.0
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+ +..-...|. |.||+..|..
T Consensus 74 ~~~~~IGR~~~~di~l~d~---------~VSr~HA~I~~~-----~~~~~l~DlgS~NGT~VNg~ 124 (162)
T 2kfu_A 74 QAITSAGRHPDSDIFLDDV---------TVSRRHAEFRLE-----NNEFNVVDVGSLNGTYVNRE 124 (162)
T ss_dssp SSEEEEESCSSSSEESTTT---------SSSSCSEEEEEE-----TTEEEEECCCCSSCEEETTB
T ss_pred CCCEEECCCCCCCEEECCC---------CcChhhEEEEEE-----CCEEEEEECCCCCCeEECCE
Confidence 4678999999999999865 789999999653 111233444 7888888764
|
| >2pie_A E3 ubiquitin-protein ligase RNF8; FHA domain, complex, ligase, signaling protein; HET: TPO; 1.35A {Homo sapiens} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=89.19 E-value=0.065 Score=40.47 Aligned_cols=55 Identities=18% Similarity=-0.017 Sum_probs=38.1
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
..++++||+..|++++..+.. ...+|..|.+|..+ .+..-...|. |.||+..|..
T Consensus 27 ~~~~~IGR~~~~di~l~~~~~-----~~~VSr~Ha~i~~~----~~g~~~l~Dl~S~NGT~vNg~ 82 (138)
T 2pie_A 27 GCEVTVGRGFGVTYQLVSKIC-----PLMISRNHCVLKQN----PEGQWTIMDNKSLNGVWLNRA 82 (138)
T ss_dssp TCCEEEESSSSSSEECCCSSC-----TTSSCSSCEEEEEC----TTSCEEEEECSCSSCEEETTE
T ss_pred CCeEEECCCCCCCEEeCCCCc-----CCCCChhHeEEEEc----CCCcEEEEECCCCCCeEECCE
Confidence 367999999999999998721 12489999999652 1112234454 8899888763
|
| >2kb3_A Oxoglutarate dehydrogenase inhibitor; forkhead-associated domain, kinase substrate, GARA, FHA, cytoplasm, phosphoprotein; HET: TPO; NMR {Corynebacterium glutamicum} PDB: 2kb4_A | Back alignment and structure |
|---|
Probab=88.94 E-value=0.06 Score=40.94 Aligned_cols=50 Identities=14% Similarity=0.028 Sum_probs=36.6
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+ +..-...| .|.||+..|..
T Consensus 65 ~~~~~IGR~~~~di~l~d~---------~VSr~Ha~I~~~-----~~~~~l~DlgS~NGT~VNg~ 115 (143)
T 2kb3_A 65 QPTTTAGRHPESDIFLDDV---------TVSRRHAEFRIN-----EGEFEVVDVGSLNGTYVNRE 115 (143)
T ss_dssp SSEEEESSCTTCSBCCCCS---------SCCSSSEEEEEE-----TTEEEEEESCCSSCCEETTE
T ss_pred CCCeeccCCCCCCEEeCCC---------CcChhhEEEEEE-----CCEEEEEECCCcCCeEECCE
Confidence 3578999999999999865 789999998653 11122344 47899887753
|
| >1uht_A Expressed protein; FHA domain, beta-sandwich, antiparallel beta-sheets, phosphopeptide binding motif, structural genomics; NMR {Arabidopsis thaliana} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=88.73 E-value=0.1 Score=38.13 Aligned_cols=49 Identities=24% Similarity=0.051 Sum_probs=36.2
Q ss_pred ccchhhhc-ccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 4 KTCSWIRD-MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 4 ~~~~~~r~-~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
+.+++||+ ..|++++..+ .+|..|.+|..+ +..-..+|. |.||+..|..
T Consensus 33 ~~~~iGR~~~~~di~l~d~---------~vSr~Ha~i~~~-----~~~~~l~Dl~S~nGT~vng~ 83 (118)
T 1uht_A 33 STIRVGRIVRGNEIAIKDA---------GISTKHLRIESD-----SGNWVIQDLGSSNGTLLNSN 83 (118)
T ss_dssp CCEEEESSSTTCSEECCSS---------SSCTTCEEEEEC-----SSSEEEECCCCSSCCEESSS
T ss_pred CEEEEcCCCCCCCEEeCCC---------CCchHHeEEEEE-----CCEEEEEECCCCCCeEECCE
Confidence 46899999 8999999865 789999999653 112233454 8899988764
|
| >3elv_A PRE-mRNA leakage protein 1; intrinsically unstructured domain, forkhead-associated domai domain, PRE-mRNA retention and splicing; 2.40A {Saccharomyces cerevisiae} PDB: 2jkd_A | Back alignment and structure |
|---|
Probab=88.25 E-value=0.05 Score=43.84 Aligned_cols=54 Identities=19% Similarity=0.055 Sum_probs=37.0
Q ss_pred cccchhhhccc---------------ccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMG---------------CCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~---------------c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
+..|+|||+++ |++++..+ .+|..|..|......+ ...-...| .|.||+..|..
T Consensus 102 ~s~y~IGR~~~~~~~~~~~~~~e~~~cDIvL~dp---------~VSR~HA~I~~~~~~~-~~~~~l~DLgStNGTfVNG~ 171 (205)
T 3elv_A 102 RSCYLVGRELGHSLDTDLDDRTEIVVADIGIPEE---------TSSKQHCVIQFRNVRG-ILKCYVMDLDSSNGTCLNNV 171 (205)
T ss_dssp CSEEEEEECCCC---------CCCCCCSEEECCT---------TSCTTCEEEEEEEETT-EEEEEEEECSCSSCCEETTE
T ss_pred CCceeecccccccccccccccccCccceEEeCCC---------CCCcccEEEEEecCCC-ceeEEEEeCCCCCCCeECCE
Confidence 46899999974 99999876 7899999985431110 00012334 58999998874
|
| >2xt9_B Putative signal transduction protein GARA; lyase-signaling protein complex, KDH, KGD; HET: TPP; 2.20A {Mycobacterium smegmatis} | Back alignment and structure |
|---|
Probab=88.01 E-value=0.054 Score=39.51 Aligned_cols=50 Identities=16% Similarity=-0.003 Sum_probs=36.2
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+ +..-...|. |.||+..|..
T Consensus 30 ~~~~~IGR~~~~di~l~d~---------~vSr~Ha~i~~~-----~~~~~l~Dl~S~nGt~vng~ 80 (115)
T 2xt9_B 30 QPTTSAGRHPDSDIFLDDV---------TVSRRHAEFRLE-----GGEFQVVDVGSLNGTYVNRE 80 (115)
T ss_dssp SSEEEEESSTTSSEECCST---------TSCSSCEEEEEE-----TTEEEEEECSCSSCEEETTE
T ss_pred CCCEEECCCCCCCEEeCCc---------ccChhheEEEEE-----CCEEEEEECCCCCCeEECCE
Confidence 3578999999999999865 789999999653 111223444 7888887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.88 E-value=0.29 Score=43.81 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=25.3
Q ss_pred cEeCCCCCCCEEE------ccCCcEEEecccCcee
Q 022241 247 VVHGDIKPDNLLV------APSGTVKIGDFSVSQV 275 (300)
Q Consensus 247 iiHrDlkp~NIll------~~~~~~kl~DFGla~~ 275 (300)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456899999999876
|
| >3els_A PRE-mRNA leakage protein 1; intrinsically unstructured domain, forkhead-associated domai domain, PRE-mRNA retention and splicing; 1.80A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=87.86 E-value=0.053 Score=42.02 Aligned_cols=54 Identities=19% Similarity=0.023 Sum_probs=37.2
Q ss_pred cccchhhhccc---------------ccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMG---------------CCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDN-SYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~---------------c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~-s~~~~~~~~~ 66 (300)
+..|+|||+.+ |++++..+ .+|..|..|......+. ..-...|. |.||+..|..
T Consensus 55 ~~~~~IGR~~~~~~~~~~~~~n~~~~~Di~l~~~---------~VSr~HA~I~~~~~~~~-~~~~l~Dl~StNGT~VNg~ 124 (158)
T 3els_A 55 RSCYLVGRELGHSLDTDLDDRTEIVVADIGIPEE---------TSSKQHCVIQFRNVRGI-LKCYVMDLDSSNGTCLNNV 124 (158)
T ss_dssp CSEEEEEECCCC---------CCCCCCSEEECCT---------TSCSSCEEEEEEEETTE-EEEEEEECSCSSCCEETTE
T ss_pred CCceEeccccccccccccccccccccCCEEcCCC---------CCCcccEEEEEEccCCe-eEEEEEeCCCCCccEECCE
Confidence 36799999964 99999877 88999999965422100 01223444 8999998874
|
| >3va4_A Mediator of DNA damage checkpoint protein 1; cell cycle, FHA domain, DNA-damage, CHK2 and MDC1 dimerizati; HET: TPO; 1.54A {Mus musculus} PDB: 3va1_A* 3umz_A 3unm_A 3unn_A* 3uot_A* 3un0_B | Back alignment and structure |
|---|
Probab=87.79 E-value=0.11 Score=38.95 Aligned_cols=52 Identities=17% Similarity=0.099 Sum_probs=36.9
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|.+|..+.. +..-..+| .|.||+..|..
T Consensus 44 ~~~~~IGR~~~~di~l~d~---------~VSr~HA~i~~~~~---~~~~~l~Dl~S~NGT~vNg~ 96 (132)
T 3va4_A 44 LGKNVVGRSPDCSVALPFP---------SISKQHAVIEISAW---NKAPILQDCGSLNGTQIVKP 96 (132)
T ss_dssp SEEEEEESSTTSSEECCCT---------TSCTTCEEEEECST---TSCCEEEECSCSSCEEETTT
T ss_pred CCCEEEccCCCCCEEeCCC---------CcChhHEEEEEEcC---CCEEEEEECCCCCCeEECCE
Confidence 3578999999999999876 78999999964311 11122334 58888888774
|
| >2csw_A Ubiquitin ligase protein RNF8; 11-stranded beta sandwich, ring finger protein 8, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.26.1.2 | Back alignment and structure |
|---|
Probab=87.59 E-value=0.12 Score=39.39 Aligned_cols=55 Identities=16% Similarity=-0.035 Sum_probs=38.1
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
...+++||+..|++++..+.. ...+|..|.+|..+ .+..-...| .|.||+..|..
T Consensus 35 ~~~~~IGR~~~~di~l~~~~~-----~~~VSr~Ha~i~~~----~~g~~~l~Dl~S~NGT~vNg~ 90 (145)
T 2csw_A 35 GCEVTVGRGFGVTYQLVSKIC-----PLMISRNHCVLKQN----PEGQWTIMDNKSLNGVWLNRA 90 (145)
T ss_dssp TCCEEEESSTTSSEECCCSSC-----GGGSCTTCEEEEEC----TTSCEEEEBSSCSSCEEESSC
T ss_pred CCcEEECCCCCCCEEECCCCc-----CCCCChhHeEEEEc----CCCeEEEEECCCCCCeEECCE
Confidence 357899999999999987721 11489999999653 111123445 68899988764
|
| >3gqs_A Adenylate cyclase-like protein; FHA domain, structural genomics, PSI-2, protein structure in midwest center for structural genomics, MCSG; 2.20A {Chlamydia trachomatis} | Back alignment and structure |
|---|
Probab=86.25 E-value=0.15 Score=36.47 Aligned_cols=50 Identities=20% Similarity=-0.023 Sum_probs=35.2
Q ss_pred ccchhhhcc-cccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 4 KTCSWIRDM-GCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 4 ~~~~~~r~~-~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
.+|++||+. .|++++..+ .+|..|.+|..+. +..-..+| .|.||+..|..
T Consensus 25 ~~~~iGR~~~~~di~l~d~---------~vSr~Ha~i~~~~----~~~~~l~Dl~S~nGt~vng~ 76 (106)
T 3gqs_A 25 KTYIVGSDPQVADIVLSDM---------SISRQHAKIIIGN----DNSVLIEDLGSKNGVIVEGR 76 (106)
T ss_dssp CEEEEESCTTTCSEECCCT---------TSCSSCEEEEECT----TSCEEEEECSCSSCCEETTE
T ss_pred CEEEEeECCCcCCEEeCCC---------CcchhhcEEEECC----CCcEEEEECcCCCCeEECCE
Confidence 468999999 799999875 7899999996431 11122334 47888887663
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=85.30 E-value=13 Score=32.18 Aligned_cols=139 Identities=14% Similarity=0.150 Sum_probs=73.6
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE-------
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV------- 192 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------- 192 (300)
+..++..-.|..|. |.+.. ++..|.||... ....+-+-.++...-.+.-|+.--+.-.
T Consensus 71 v~~I~~s~~Gstgv-ff~~t--d~~~~VVK~s~------------~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~ 135 (342)
T 1cja_A 71 FKGIERSEKGTEGL-FFVET--ESGVFIVKRST------------NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNM 135 (342)
T ss_dssp EEEEEECCSTTSCE-EEEEE--SSCEEEEECCT------------THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHH
T ss_pred eeEEEeccCCCCCe-EEEEe--CCCEEEEeCcH------------HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHH
Confidence 66777777777654 44444 57789999541 1122333344444444555553211100
Q ss_pred -------------EEcCCCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeCCC
Q 022241 193 -------------IDDPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHN-----VVHGDI 252 (300)
Q Consensus 193 -------------~~~~~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~-----iiHrDl 252 (300)
........++++|||.+|..+...-.. ...+.+.....+. -+-++.++..+. +.+.--
T Consensus 136 ~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~G 213 (342)
T 1cja_A 136 LECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEG 213 (342)
T ss_dssp HHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCC
T ss_pred HHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCC
Confidence 000012257799999997655543211 0113333322211 134566666443 222235
Q ss_pred CCCCEEEccCC-cEEEecccCcee
Q 022241 253 KPDNLLVAPSG-TVKIGDFSVSQV 275 (300)
Q Consensus 253 kp~NIll~~~~-~~kl~DFGla~~ 275 (300)
.|.|||++.++ .+.++|-+++..
T Consensus 214 N~~NIL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 214 NLDNIMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp CGGGEEEESBTTCEEECSCCCCCC
T ss_pred ChhheEEeCCCCeEEEEcCCcccc
Confidence 78999998755 599999999865
|
| >2ff4_A Probable regulatory protein EMBR; winged-helix, tetratricopeptide repeat, beta-sandwich, trans; HET: DNA TPO; 1.90A {Mycobacterium tuberculosis} SCOP: a.4.6.1 a.118.8.3 b.26.1.2 PDB: 2fez_A* | Back alignment and structure |
|---|
Probab=83.99 E-value=0.23 Score=44.28 Aligned_cols=50 Identities=12% Similarity=-0.041 Sum_probs=37.7
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
...+++||+..|++++..+ .+|..|..|..+ +..-...| .|.||+..|..
T Consensus 305 ~~~~~iGR~~~~di~l~~~---------~vSr~Ha~i~~~-----~~~~~l~Dl~S~nGt~vng~ 355 (388)
T 2ff4_A 305 AAATRIGRLHDNDIVLDSA---------NVSRHHAVIVDT-----GTNYVINDLRSSNGVHVQHE 355 (388)
T ss_dssp SSEEEEESSTTSSEECCCT---------TSCTTCEEEEEC-----SSCEEEEECSCSSCCEETTE
T ss_pred CCCEEEecCCCCeEEECCC---------ccChhHeEEEEE-----CCEEEEEECCCCCCeEECCE
Confidence 4678999999999999865 789999999653 11223445 58899988763
|
| >3uv0_A Mutator 2, isoform B; FHA, protein binding, dimerization; 1.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=81.74 E-value=0.38 Score=33.80 Aligned_cols=29 Identities=7% Similarity=-0.148 Sum_probs=25.7
Q ss_pred ccchhhhcccccccccccccccCCCCCCCCCCCCcccc
Q 022241 4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISR 41 (300)
Q Consensus 4 ~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~ 41 (300)
.-|.+||+++|++|++.+ ++|..|-.|.+
T Consensus 21 ~~~rIGR~~~~~l~Lddp---------sVs~~HAti~~ 49 (102)
T 3uv0_A 21 TIYRIGRQKGLEISIADE---------SMELAHATACI 49 (102)
T ss_dssp CCEEEESSTTSTEECCCT---------TSCTTCEEEEE
T ss_pred cEEEEcCCCCCcEEECCc---------ccccceEEEEe
Confidence 468999999999999988 88999988855
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 300 | ||||
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-39 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-46
Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
+ +R+IG GS+G V R + + AIK S S D+ +EV ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQ 70
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
L+HPN + + ++V+EY G + + E + GL
Sbjct: 71 KLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
YLH HN++H D+K N+L++ G VK+GDF + + N + GTP + APE L
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEVIL 184
Query: 300 G 300
Sbjct: 185 A 185
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-46
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 12/186 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ ++ V+ +G G+YG+V L + + + A+K ++++E+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--------ENIKKEIC 55
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
I KML H N+V + N Y+ LEY G D + E A+++ ++
Sbjct: 56 INKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 113
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTA 294
+G++YLHG + H DIKP+NLL+ +KI DF ++ VF +N +L + GT + A
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 295 PECCLG 300
PE
Sbjct: 174 PELLKR 179
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-44
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
+Y + IG GSYG+ R DGK K ++ E + EV ++
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVNLL 57
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
+ L+HPNIV + I D + Y+V+EY EG G + + E + +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 235 IVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
+ L H GH V+H D+KP N+ + VK+GDF ++++ D + GT
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177
Query: 290 PVFTAPECCLG 300
P + +PE
Sbjct: 178 PYYMSPEQMNR 188
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-44
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 15/194 (7%)
Query: 111 ENGTKMIN---EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
E+ T+ +N + + ++G G++GKV ++ A K SE
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---------SEEE 52
Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGES 226
+ D E+ I+ HPNIV L++ N + ++++E+ G D + ES
Sbjct: 53 LEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTES 110
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
+ + + L YLH + ++H D+K N+L G +K+ DF VS
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170
Query: 287 PGTPVFTAPECCLG 300
GTP + APE +
Sbjct: 171 IGTPYWMAPEVVMC 184
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-44
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 10/184 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ ++ R +G G +G V L R A+K K+ L K +RREV
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVE 58
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
I L+HPNI+ L D Y++LEY + E Y+ ++
Sbjct: 59 IQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+ L Y H V+H DIKP+NLL+ +G +KI DF S + GT + PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 174
Query: 297 CCLG 300
G
Sbjct: 175 MIEG 178
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 13/184 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+++ + ++GAG+ G V G A K H +R + RE+ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--------NQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ P IV + +E+++G + + G I E + K ++
Sbjct: 58 LHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL YL H ++H D+KP N+LV G +K+ DF VS D + GT + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLG 300
G
Sbjct: 174 RLQG 177
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
K ++ + +G GS+ VVL R + YAIK K H+ K E + V RE
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRE 58
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
+M L HP V L D + Y L Y + + G+ E+ R Y +
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS--PGTPVF 292
IVS L YLHG ++H D+KP+N+L+ ++I DF ++V ++ R + GT +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 293 TAPECCLG 300
+PE
Sbjct: 177 VSPELLTE 184
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 12/181 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y KIG G+ G V G+ AI+ + K + E+L+M+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMR 72
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
++PNIVN ++ D ++V+EY+ G + E R+ + L
Sbjct: 73 ENKNPNIVNYLDSYLVG--DELWVVMEYLAGG-SLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
+LH + V+H DIK DN+L+ G+VK+ DF + GTP + APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 300 G 300
Sbjct: 190 R 190
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (363), Expect = 3e-41
Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
++ Y ++G G++G V G ++A K H S VR+E+
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---------TVRKEIQ 75
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDI 235
M +L+HP +VNL + +D N M+ E++ G + + + E A +Y+R +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
GL ++H +N VH D+KP+N++ S +K+ DF ++ D ++ + GT F
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFA 192
Query: 294 APECCLG 300
APE G
Sbjct: 193 APEVAEG 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-40
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 6/177 (3%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+G G + V R + AIK H S+ + + RE+ +++ L H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK----DGINRTALREIKLLQELSH 59
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
PNI+ L++ + +V +++E + + S + Y+ + GL YLH
Sbjct: 60 PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
H ++H D+KP+NLL+ +G +K+ DF +++ F N T + APE G
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 138 bits (349), Expect = 2e-39
Identities = 48/184 (26%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ ++ +R +G GS+G+V L RS +G++YA+K K + +L+ + E L
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK------QVEHTNDERL 56
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
++ ++ HP I+ + D +M+++Y+EG + +A+ Y ++
Sbjct: 57 MLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 114
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L YLH ++++ D+KP+N+L+ +G +KI DF ++ D GTP + APE
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPE 171
Query: 297 CCLG 300
Sbjct: 172 VVST 175
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (350), Expect = 3e-39
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 7/184 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+N++ R IG G +G+V R + GK YA+K K + + ET + R +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLS 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
++ P IV + P D +L+ + G + Q G E+ R Y +I+
Sbjct: 60 LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 117
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL ++H VV+ D+KP N+L+ G V+I D ++ F S GT + APE
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPE 175
Query: 297 CCLG 300
Sbjct: 176 VLQK 179
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-39
Identities = 42/186 (22%), Positives = 79/186 (42%), Gaps = 16/186 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ ++IG+GS+G V Y+ G A+K + + AP+ + + EV +
Sbjct: 8 GQITVGQRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIV 236
++ +H NI+ + P +V ++ EG + R
Sbjct: 58 LRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTA 294
G+ YLH +++H D+K +N+ + TVKIGDF ++ V + + G+ ++ A
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 295 PECCLG 300
PE
Sbjct: 175 PEVIRM 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (344), Expect = 2e-38
Identities = 45/189 (23%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
+ + Y + ++G+G++G V G+ + K + + V+ E
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---------TVKNE 76
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLR 233
+ IM L HP ++NL + +D ++LE++ G D + + E+ Y+R
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 134
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
GL ++H H++VH DIKP+N++ + +VKI DF ++ + +++++ + T
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAE 193
Query: 292 FTAPECCLG 300
F APE
Sbjct: 194 FAAPEIVDR 202
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 14/182 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
+IG GS+ V + A L+K + + E ++K LQH
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-------SERQRFKEEAEMLKGLQH 67
Query: 184 PNIVNLIEVIDDP--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
PNIV + + +V E + + + + R + R I+ GL +
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 242 LH--GHNVVHGDIKPDN-LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
LH ++H D+K DN + P+G+VKIGD ++ + + GTP F APE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMY 185
Query: 299 LG 300
Sbjct: 186 EE 187
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (336), Expect = 6e-38
Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 4/182 (2%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y +G G V K YA+K + + +EV I++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ HPNI+ L + + F++V + ++ D + + E RK +R ++
Sbjct: 65 KVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
+ LH N+VH D+KP+N+L+ +K+ DF S D + LR GTP + APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 181
Query: 299 LG 300
Sbjct: 182 EC 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-38
Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 17/186 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
V ++GAG +G+V + + A+K+ + +S E +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----------DAFLAEANL 61
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM--ARKYLRDI 235
MK LQH +V L V+ + Y++ EY+E D P I ++ I
Sbjct: 62 MKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGTPVFTA 294
G+ ++ N +H D++ N+LV+ + + KI DF ++++ ED+ R + +TA
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 295 PECCLG 300
PE
Sbjct: 179 PEAINY 184
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-38
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 10/187 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y ++G+G + V R G YA K K R + D+ REV I
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR---RGVSREDIEREVSI 66
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K +QHPN++ L EV ++ ++LE V G D + ++ E A ++L+ I++
Sbjct: 67 LKEIQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
G+ YLH + H D+KP+N+++ P +KI DF ++ + N+ + GTP F
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFV 183
Query: 294 APECCLG 300
APE
Sbjct: 184 APEIVNY 190
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 1e-37
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y +G G++ +V+L K AIK K L + E+ +
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--------GSMENEIAV 60
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+ ++HPNIV L ++ + H Y++++ V G D + G E A + + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGG--HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ YLH +VH D+KP+NLL + I DF +S+ ED VL + GTP + A
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVA 177
Query: 295 PECCLG 300
PE
Sbjct: 178 PEVLAQ 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (332), Expect = 2e-37
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 11/188 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ Y +G G +V L R + A+K + RRE
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------DPSFYLRFRREAQN 60
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
L HP IV + + + P Y+V+EYV+G D G + A + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVF 292
L + H + ++H D+KP N++++ + VK+ DF +++ D + + ++ GT +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 293 TAPECCLG 300
+PE G
Sbjct: 181 LSPEQARG 188
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-36
Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 124 RKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
+++G+G++G V Y+ K A+K ++ E +M+ L
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQL 65
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
+P IV +I + + + + +V+E E N Q + + + + + G+ Y
Sbjct: 66 DNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP---GTPVFTAPECC 298
L N VH D+ N+L+ KI DF +S+ D + + + APEC
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 299 LG 300
Sbjct: 183 NY 184
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 2e-36
Identities = 45/186 (24%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ E ++ IG G +G V G A+K ++ E
Sbjct: 6 MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ-----------AFLAEAS 52
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRD 234
+M L+H N+V L+ VI + Y+V EY+ D G +G K+ D
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ + YL G+N VH D+ N+LV+ K+ DF +++ D +TA
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTA 168
Query: 295 PECCLG 300
PE
Sbjct: 169 PEALRE 174
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-36
Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
++Y +G+G +G V D AIK K +S P+ T V EV++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN---GTRVPMEVVL 60
Query: 178 MKMLQ--HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRD 234
+K + ++ L++ + P D F ++LE E D F + GA+ E +AR +
Sbjct: 61 LKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
++ + + H V+H DIK +N+L+ + G +K+ DF + +D GT V++
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYS 176
Query: 294 APECCLG 300
PE
Sbjct: 177 PPEWIRY 183
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-36
Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 8/184 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+N++ +++ +G G++GKV+L R G++YA+K K + ++ + E
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESR 57
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
+++ +HP + L D V+EY G + E AR Y +IV
Sbjct: 58 VLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
S L YLH +VV+ DIK +NL++ G +KI DF + + D ++ GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 297 CCLG 300
Sbjct: 176 VLED 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-35
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y ++ IG G+YG V +++ AIK K+ +T RE+ I
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK--------KISPFEHQTYCQRTLREIKI 59
Query: 178 MKMLQHPNIVNLIEVIDDPNSD---HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
+ +H NI+ + ++I P + Y+V + + + +L
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK--LLKTQHLSNDHICYFLYQ 117
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
I+ GL Y+H NV+H D+KP NLL+ + +KI DF +++V + D+D L T
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 292 FTAPEC 297
+ APE
Sbjct: 178 YRAPEI 183
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-35
Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 7/184 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
I +++ + +G GS+GKV L + +AIKA K + + + + +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRV 55
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
+ +HP + ++ ++ + V+EY+ G S A Y +I+
Sbjct: 56 LSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 113
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
GL +LH +V+ D+K DN+L+ G +KI DF + + + GTP + APE
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 297 CCLG 300
LG
Sbjct: 174 ILLG 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-35
Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 17/194 (8%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+++Y + KIG G++G+V R G+ A+K + E RE+
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALREIK 61
Query: 177 IMKMLQHPNIVNLIEVIDDPNS------DHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
I+++L+H N+VNLIE+ S Y+V ++ E S ++
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--- 287
++ +++GL Y+H + ++H D+K N+L+ G +K+ DF +++ F +
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 288 -GTPVFTAPECCLG 300
T + PE LG
Sbjct: 182 VVTLWYRPPELLLG 195
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 2e-35
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 13/190 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
I+ + IGAG +G+V L GK A + L+ +E D E
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA-----IKTLKSGYTEKQRRDFLSEAS 79
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDI 235
IM HPN+++L V+ ++ E++E D+ G LR I
Sbjct: 80 IMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-----PGTP 290
+G+ YL N VH D+ N+LV + K+ DF +S+ EDD +
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 291 VFTAPECCLG 300
+TAPE
Sbjct: 198 RWTAPEAIQY 207
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-35
Identities = 38/184 (20%), Positives = 70/184 (38%), Gaps = 8/184 (4%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
E+ ++ +G+G++G V +G+ I K +LR A S A ++ E +M
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK----ELREATSPKANKEILDEAYVM 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
+ +P++ L+ + + G + IG + I G
Sbjct: 66 ASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPE 296
+ YL +VH D+ N+LV VKI DF ++++ + + A E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 297 CCLG 300
L
Sbjct: 184 SILH 187
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-35
Identities = 52/194 (26%), Positives = 72/194 (37%), Gaps = 17/194 (8%)
Query: 114 TKMINE--YVHVRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
T +I E + K+G GS+G V S A+K LS AM
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAM 55
Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESM 227
D REV M L H N++ L V+ P MV E D G
Sbjct: 56 DDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRR 285
+Y + G+ YL +H D+ NLL+A VKIGDF + + ++D V++
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 286 SPGTPVFTAPECCL 299
P L
Sbjct: 173 HRKVPFAWCAPESL 186
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 47/183 (25%), Positives = 70/183 (38%), Gaps = 17/183 (9%)
Query: 124 RKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
++G G++G V +YR AIK L+ + ++ RE IM L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIK--------VLKQGTEKADTEEMMREAQIMHQL 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLM 240
+P IV LI V +V+E G G+ I S + L + G+
Sbjct: 67 DNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVFTAPEC 297
YL N VH D+ N+L+ KI DF +S+ D+ + APEC
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 298 CLG 300
Sbjct: 184 INF 186
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-34
Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 17/186 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
K+G G +G+V + + AIK +S +E +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP----------EAFLQEAQV 65
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDI 235
MK L+H +V L V+ + + Y+V EY+ D + I
Sbjct: 66 MKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTA 294
SG+ Y+ N VH D++ N+LV + K+ DF ++++ ED+ R+ +TA
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 295 PECCLG 300
PE L
Sbjct: 183 PEAALY 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-34
Identities = 38/185 (20%), Positives = 67/185 (36%), Gaps = 15/185 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ ++++G G +G V + AIK + +S+ + E +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----------DEFIEEAKV 52
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
M L H +V L V +++ EY+ G N + +D+
Sbjct: 53 MMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND-VLRRSPGTPVFTAP 295
+ YL +H D+ N LV G VK+ DF +S+ DD S ++ P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 296 ECCLG 300
E +
Sbjct: 171 EVLMY 175
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 7e-34
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y+ +G G +G V + K Y K ++ V ++E+ I+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----------KKEISILN 56
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSG 238
+ +H NI++L E + + M+ E++ G + + E Y+ +
Sbjct: 57 IARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 239 LMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
L +LH HN+ H DI+P+N++ S T+KI +F ++ D R P + APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPE 173
Query: 297 CCLG 300
Sbjct: 174 VHQH 177
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 7e-34
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 95 RQFPVKESNKLIR--SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFH 152
++F K ++ T ++++ ++ +G GS+G+V+L + G HYA+K
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
K + KL+ + E I++ + P +V L D + + YMV+EYV G
Sbjct: 76 KQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGE 127
Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
+ G E AR Y IV YLH ++++ D+KP+NLL+ G +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300
++ + L GTP APE L
Sbjct: 188 AKRVKGRTWTL---CGTPEALAPEIILS 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-34
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 28/197 (14%)
Query: 115 KMINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+I++Y V + +G G GKV+ + + +A+K RR
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARR 53
Query: 174 EVLIM-KMLQHPNIVNLIEVIDDP--NSDHFYMVLEYVEG----KWDNDGFGQPGAIGES 226
EV + + Q P+IV +++V ++ +V+E ++G D Q E
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTER 111
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVL 283
A + ++ I + YLH N+ H D+KP+NLL P+ +K+ DF ++ N +
Sbjct: 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 170
Query: 284 RRSPGTPVFTAPECCLG 300
TP + APE
Sbjct: 171 TTPCYTPYYVAPEVLGP 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-33
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 15/185 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+E V++IG+G +G V L L+ AIK + +S+ D E +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----------EDFIEEAEV 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
M L HP +V L V + +V E++E G + Q G D+
Sbjct: 54 MMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTAP 295
G+ YL V+H D+ N LV + +K+ DF +++ DD + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 296 ECCLG 300
E
Sbjct: 172 EVFSF 176
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-33
Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y ++ +G+G+YG V G AIK ++ S E RE+ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRL 70
Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
+K ++H N++ L++V + FY+V+ ++ + +GE + +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVY 128
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
++ GL Y+H ++H D+KP NL V +KI DF +++ + + + T +
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYR 185
Query: 294 APECCLG 300
APE L
Sbjct: 186 APEVILN 192
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 5e-33
Identities = 41/186 (22%), Positives = 70/186 (37%), Gaps = 15/186 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ K+G G YG+V A+K + + + +E +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAV 66
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGESMARKYLRDI 235
MK ++HPN+V L+ V FY++ E++ D + + I
Sbjct: 67 MKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGTPVFTA 294
S + YL N +H D+ N LV + VK+ DF +S++ D + +TA
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 295 PECCLG 300
PE
Sbjct: 185 PESLAY 190
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-33
Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 9/183 (4%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+Y + KIG G+YG V ++ + A+K E + RE+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICL 54
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L+H NIV L +V+ +V E+ + G + + + +L ++
Sbjct: 55 LKELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
GL + H NV+H D+KP NLL+ +G +K+ +F +++ F T + P+
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 298 CLG 300
G
Sbjct: 173 LFG 175
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 6e-33
Identities = 41/186 (22%), Positives = 83/186 (44%), Gaps = 18/186 (9%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
++Y VRK+G G Y +V + + + +K K ++RE+
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------------IKREIK 81
Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
I++ L+ PNI+ L +++ DP S +V E+V D + + R Y+ +I
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEI 138
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
+ L Y H ++H D+KP N+++ +++ D+ +++ + + R + F
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKG 197
Query: 295 PECCLG 300
PE +
Sbjct: 198 PELLVD 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 10/185 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ + V KIG G+YG V R+ L G+ A+K + E + RE+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-------EGVPSTAIREIS 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN-DGFGQPGAIGESMARKYLRDI 235
++K L HPNIV L++VI N Y+V E++ I + + YL +
Sbjct: 54 LLKELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
+ GL + H H V+H D+KP NLL+ G +K+ DF +++ F T + AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 296 ECCLG 300
E LG
Sbjct: 172 EILLG 176
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (299), Expect = 2e-32
Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 10/183 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+Y + KIG G+YG V +++ G+ +A+K E + RE+ I
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-------EGIPSTTIREISI 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
+K L+H NIV L +VI +V E+++ G + A+ +L +++
Sbjct: 54 LKELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
G+ Y H V+H D+KP NLL+ G +KI DF +++ F T + AP+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 298 CLG 300
+G
Sbjct: 172 LMG 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 46/189 (24%), Positives = 69/189 (36%), Gaps = 22/189 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
Y + IG GS+G V + G+ AIK + K RE+ IM+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQIMR 68
Query: 180 MLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYL 232
L H NIV L + +VL+YV + + Y+
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
+ L Y+H + H DIKP NLL+ P +K+ DF ++ +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 292 FTAPECCLG 300
+ APE G
Sbjct: 188 YRAPELIFG 196
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-32
Identities = 45/197 (22%), Positives = 70/197 (35%), Gaps = 27/197 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
V IG G +G+V +R G+ A+K F E+
Sbjct: 3 RTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFR----------EAEIYQ 50
Query: 178 MKMLQHPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
ML+H NI+ I + N ++V +Y E + + K
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG-SLFDYLNRYTVTVEGMIKLALST 109
Query: 236 VSGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
SGL +LH + H D+K N+LV +GT I D ++ + D + +P
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 288 ----GTPVFTAPECCLG 300
GT + APE
Sbjct: 170 NHRVGTKRYMAPEVLDD 186
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-32
Identities = 37/209 (17%), Positives = 70/209 (33%), Gaps = 31/209 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
+ +G+G++GKV+ + K + L+ + + E+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKM 93
Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----------------------KWD 213
M L H NIVNL+ Y++ EY +
Sbjct: 94 MTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
+ + + + G+ +L + VH D+ N+LV VKI DF ++
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 274 QVFEDDND--VLRRSPGTPVFTAPECCLG 300
+ D++ V + + APE
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE 240
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-32
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 9/183 (4%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
R IG G +G V A + + S++ +E L
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVA-----IKTCKNCTSDSVREKFLQEALT 61
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
M+ HP+IV LI VI + + ++++E G+ + + ++ + Y +
Sbjct: 62 MRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
+ L YL VH DI N+LV+ + VK+GDF +S+ ED P+
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 297 CCL 299
+
Sbjct: 179 ESI 181
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-31
Identities = 43/188 (22%), Positives = 86/188 (45%), Gaps = 15/188 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
+ Y +++ IG+G+ G V ++ ++ AIK + + +T RE++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELV 68
Query: 177 IMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
+MK + H NI++L+ V + Y+V+E ++ + L
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLL 125
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
++ G+ +LH ++H D+KP N++V T+KI DF +++ + ++ T +
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYY 184
Query: 293 TAPECCLG 300
APE LG
Sbjct: 185 RAPEVILG 192
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 9e-31
Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 22/193 (11%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
N Y RKIG+GS+G + L G+ AIK +T + E I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----------KTKHPQLHIESKI 55
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
KM+Q + I D+ MV+E + ++ ++S
Sbjct: 56 YKMMQGGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDND-------VLRRSP 287
+ Y+H N +H D+KPDN L+ V I DF +++ + D +
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 288 GTPVFTAPECCLG 300
GT + + LG
Sbjct: 175 GTARYASINTHLG 187
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 39/209 (18%), Positives = 73/209 (34%), Gaps = 36/209 (17%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
N + +GAG++GKVV + S A+K L+ + T +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--------MLKPSAHLTEREALM 74
Query: 173 REVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG------------------KWD 213
E+ ++ L H NIVNL+ ++ EY
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
A+ + + G+ +L N +H D+ N+L+ KI DF ++
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 274 QVFEDDNDVLRRSP--GTPVFTAPECCLG 300
+ ++D++ + + + APE
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN 221
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-30
Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y ++ +G+G+YG V + G A+K + S + RE+ +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-------RTYRELRL 70
Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
+K ++H N++ L++V S + Y+V + +N + + + + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIY 128
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
I+ GL Y+H +++H D+KP NL V +KI DF +++ +D+ T +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYR 185
Query: 294 APECCLG 300
APE L
Sbjct: 186 APEIMLN 192
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-30
Identities = 52/191 (27%), Positives = 73/191 (38%), Gaps = 18/191 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ + IGAG +G+V S AIK + K RV D
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--------DFLG 58
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESMARKYL 232
E IM H NI+ L VI ++ EY+E + + G L
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGT 289
R I +G+ YL N VH D+ N+LV + K+ DF +S+V EDD +
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 290 PVFTAPECCLG 300
+TAPE
Sbjct: 177 IRWTAPEAISY 187
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 7e-29
Identities = 42/214 (19%), Positives = 70/214 (32%), Gaps = 41/214 (19%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
N +VR IG G++G+V R+ A+K + + ++ D +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--------ADFQ 64
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK--------------------- 211
RE +M +PNIV L+ V ++ EY+
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 212 ---WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268
P + + R + +G+ YL VH D+ N LV + VKI
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 269 DFSVSQVFEDDND--VLRRSPGTPVFTAPECCLG 300
DF +S+ + + PE
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 16/194 (8%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
+ +Y V +IG G+YGKV R G+ A+K E R
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EGMPLSTIR 56
Query: 174 EVLIMKML---QHPNIVNLIEVIDDPNSD---HFYMVLEYVEGKWDNDGFGQP-GAIGES 226
EV +++ L +HPN+V L +V +D +V E+V+ P +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
+ + ++ GL +LH H VVH D+KP N+LV SG +K+ DF +++++ L
Sbjct: 117 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSV 175
Query: 287 PGTPVFTAPECCLG 300
T + APE L
Sbjct: 176 VVTLWYRAPEVLLQ 189
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (268), Expect = 6e-28
Identities = 33/195 (16%), Positives = 69/195 (35%), Gaps = 24/195 (12%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
Y R+IG GS+G + + L+ + AIK + + +R E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----------QLRDEYRT 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
K+L + + H +V++ + ++ + +++
Sbjct: 54 YKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA-----PSGTVKIGDFSVSQVFEDDNDVLRRSP----- 287
+ +H ++V+ DIKPDN L+ + + + DF + + + D
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 288 --GTPVFTAPECCLG 300
GT + + LG
Sbjct: 173 LSGTARYMSINTHLG 187
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 38/201 (18%), Positives = 70/201 (34%), Gaps = 26/201 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
N+ IG G++G+V+ R DG + +++ S+ D E+
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA------IKRMKEYASKDDHRDFAGELE 62
Query: 177 IMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWDNDGFGQ 219
++ L HPNI+NL+ + + Y+ +EY
Sbjct: 63 VLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
+ + D+ G+ YL +H D+ N+LV + KI DF +S+ ++
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV 179
Query: 280 NDVLRRSPGTPVFTAPECCLG 300
+ A E
Sbjct: 180 YVKKTMGRLPVRWMAIESLNY 200
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 37/200 (18%), Positives = 72/200 (36%), Gaps = 27/200 (13%)
Query: 118 NEYVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
+ R++G GS+G V AIK +++ + R+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--------EFL 71
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGA 222
E +MK ++V L+ V+ +++E + +
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
S + +I G+ YL+ + VH D+ N +VA TVKIGDF +++ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 283 LRRSP--GTPVFTAPECCLG 300
+ + +PE
Sbjct: 190 RKGGKGLLPVRWMSPESLKD 209
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
I + ++ +G G+YGKV L R GK YA+K K+ + + R
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRT 77
Query: 174 EVLIMKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
E +++ ++ P +V L +++L+Y+ G Q E + Y+
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED-DNDVLRRSPGTPV 291
+IV L +LH +++ DIK +N+L+ +G V + DF +S+ F + + GT
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 292 FTAPECCLG 300
+ AP+ G
Sbjct: 196 YMAPDIVRG 204
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-26
Identities = 40/209 (19%), Positives = 74/209 (35%), Gaps = 36/209 (17%)
Query: 118 NEYVHVRKIGAGSYGKVVLYR-------SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
+ V + +G G++G+VVL A+K L+ +E ++D
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--------MLKSDATEKDLSD 64
Query: 171 VRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWD 213
+ E+ +MKM+ +H NI+NL+ Y+++EY
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSY 122
Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
N + + G+ YL +H D+ N+LV +KI DF ++
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 274 QVFEDDNDVLR--RSPGTPVFTAPECCLG 300
+ + + + APE
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFD 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 5e-26
Identities = 35/185 (18%), Positives = 66/185 (35%), Gaps = 17/185 (9%)
Query: 124 RKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
IG G +G V L + H A+K+ ++ ++ E +IMK
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--------DIGEVSQFLTEGIIMKD 84
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGL 239
HPN+++L+ + +VL Y++ N + + + G+
Sbjct: 85 FSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAP 295
+L VH D+ N ++ TVK+ DF +++ D + + A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 296 ECCLG 300
E
Sbjct: 204 ESLQT 208
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-25
Identities = 32/206 (15%), Positives = 71/206 (34%), Gaps = 31/206 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
+ + +G G++G+V+ + + A+K + A +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-------LMS 65
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND----------------G 216
+++ + H N+VNL+ P +++E+ + +
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 217 FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
+ Y + G+ +L +H D+ N+L++ VKI DF +++
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 277 EDDNDVLRRSP--GTPVFTAPECCLG 300
D D +R+ + APE
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 3e-20
Identities = 35/192 (18%), Positives = 77/192 (40%), Gaps = 14/192 (7%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR-REVLIM 178
Y+ VRK+G G + V L + ++ H A+K + + V +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDI 235
+ +I+ L++ + + ++V+ + + + I ++ + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 236 VSGLMYL-HGHNVVHGDIKPDNLLVAPSGT------VKIGDFSVSQVFEDDNDVLRRSPG 288
+ GL Y+ ++H DIKP+N+L+ + +KI D + +++ S
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSIQ 191
Query: 289 TPVFTAPECCLG 300
T + +PE LG
Sbjct: 192 TREYRSPEVLLG 203
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 3e-19
Identities = 34/173 (19%), Positives = 60/173 (34%), Gaps = 26/173 (15%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP---------SETAMTDVRRE 174
+ +G G V S +K H S +V S A+ R E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
++ LQ + + + +++E ++ K + L
Sbjct: 65 FRALQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVR-------VENPDEVLDM 111
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRR 285
I+ + + +VHGD+ N+LV+ G + I DF SV E ++L R
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d1gxca_ | 116 | Chk2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d1lgpa_ | 113 | Cell cycle checkpoint protein Chfr {Human (Homo sa | 95.11 | |
| d1dmza_ | 158 | Phosphotyrosine binding domain of Rad53 {Baker's y | 95.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.95 | |
| d1g6ga_ | 127 | Phosphotyrosine binding domain of Rad53 {Baker's y | 94.41 | |
| d2ff4a3 | 99 | Probable regulatory protein EmbR, C-terminal domai | 92.75 | |
| d1uhta_ | 118 | FHA domain containing protein At4G14490 {Thale cre | 87.89 | |
| d2affa1 | 98 | Antigen ki-67 {Human (Homo sapiens) [TaxId: 9606]} | 85.99 | |
| d2piea1 | 127 | Ubiquitin ligase protein RNF8 {Human (Homo sapiens | 80.1 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=318.49 Aligned_cols=174 Identities=29% Similarity=0.518 Sum_probs=152.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~- 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRRE- 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--------chHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 4679999999999999999999999999999999875421 2233568899999999999999999999987
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+||||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 75 -~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 75 -GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp -TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 4589999999999999999988889999999999999999999999999999999999999999999999999999986
Q ss_pred cCCc--cccccCCCccccccCcccCC
Q 022241 277 EDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ......+||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred ccCCccccccceeeCcCccCHhHhcC
Confidence 4332 23456789999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=314.80 Aligned_cols=171 Identities=28% Similarity=0.464 Sum_probs=153.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 88 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---------hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--
Confidence 479999999999999999999999999999999876421 124578899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
.+.+|||||||++|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 4589999999999999876644 579999999999999999999999999999999999999999999999999999876
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.........+||+.|+|||++.|
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTR 190 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSS
T ss_pred cccccccccccCCCccChhhhcC
Confidence 65555667789999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=320.42 Aligned_cols=176 Identities=30% Similarity=0.472 Sum_probs=159.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++.+..... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 76 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA------KDEVAHTVTESRVLQNTRHPFLTALKYAFQT- 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC------HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-
Confidence 468999999999999999999999999999999998764321 2245678899999999999999999999996
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+|||||++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 77 -~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 77 -HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred -ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 4689999999999999999888889999999999999999999999999999999999999999999999999999987
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
........+.+||+.|+|||++.|
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSS
T ss_pred ccCCcccccceeCHHHhhhhhccC
Confidence 655556667889999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=311.15 Aligned_cols=174 Identities=30% Similarity=0.477 Sum_probs=155.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++.+.||+|+||.||+|+++.+++.||||++.+..... ......+.+|+.+|+.++|||||++++++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~- 77 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVEIQSHLRHPNILRLYGYFHD- 77 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-
Confidence 468999999999999999999999999999999997654321 2234678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+|||||++|+|.+.+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 78 -~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 78 -ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred -CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 4589999999999999998888788999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... .....+||+.|+|||++.|
T Consensus 157 ~~~--~~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 157 PSS--RRTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp CCC--CCEETTEEGGGCCHHHHTT
T ss_pred CCC--cccccCCCCcccCHHHHcC
Confidence 443 3455789999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=313.75 Aligned_cols=176 Identities=28% Similarity=0.474 Sum_probs=141.7
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||+++++.+|+.||||.+..... .+...+.+.+|+.+|++++|||||++++++.+..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 579999999999999999999999999999999876432 3455678999999999999999999999998655
Q ss_pred CCEEEEEEEeeCCCccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeCCCCCCCEEEccCCcEEEe
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHN-----VVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----iiHrDlkp~NIll~~~~~~kl~ 268 (300)
...+|+|||||++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 567999999999999988764 3467999999999999999999999865 9999999999999999999999
Q ss_pred cccCceeecCCccccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+|+.+..........+||+.|+|||++.|
T Consensus 157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp CHHHHHHC-----------CCCSCCCHHHHTT
T ss_pred eccceeecccCCCccccCCCCcccCCHHHHcC
Confidence 99999987665555667889999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=312.78 Aligned_cols=171 Identities=25% Similarity=0.416 Sum_probs=152.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
+.|++++.||+|+||.||+++++.+++.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-- 80 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---------SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-- 80 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--
Confidence 4699999999999999999999999999999998754 22344578899999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+++|||||++|+|..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 3589999999999999887644 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
........+.+||+.|+|||++.
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHT
T ss_pred CCCcccccccccccccCCHHHHh
Confidence 55444455678999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=311.90 Aligned_cols=176 Identities=30% Similarity=0.497 Sum_probs=152.7
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|+.++|||||+++++|.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 79 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD- 79 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc------CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-
Confidence 35799999999999999999999999999999999765432 12345678999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+||||+++|+|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 -~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 80 -DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp -SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence 4689999999999999988888889999999999999999999999999999999999999999999999999999987
Q ss_pred cCCc--cccccCCCccccccCcccCC
Q 022241 277 EDDN--DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~--~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ....+.+||+.|+|||++.|
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp C----------CCCCGGGCCHHHHHT
T ss_pred ccCCcccccccccCCccccCceeecc
Confidence 5332 23445689999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-44 Score=312.43 Aligned_cols=171 Identities=29% Similarity=0.466 Sum_probs=151.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
..|+.++.||+|+||.||+|+++.+++.||||++.+.... .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 86 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-- 86 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--
Confidence 3599999999999999999999999999999998764321 23456779999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+|+|||||.+|++.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|....
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 35899999999999887766677789999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
. ....+||+.|+|||++.|
T Consensus 167 ~----~~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 167 P----ANSFVGTPYWMAPEVILA 185 (309)
T ss_dssp S----BCCCCSCGGGCCHHHHTT
T ss_pred C----CCccccCccccCHHHHhc
Confidence 3 245679999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=318.28 Aligned_cols=172 Identities=26% Similarity=0.414 Sum_probs=151.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|+++++||+|+||.||+++++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS- 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 367999999999999999999999999999999986532 23445688999999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
...+|+|||||++|+|.+++...+.+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.
T Consensus 76 -~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 76 -DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp -SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred -CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 35899999999999999988888889999999999999999999997 5999999999999999999999999999987
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+.. ....+.+||+.|+|||++.|
T Consensus 155 ~~~--~~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 155 LID--SMANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHH--HTC---CCSSCCCCHHHHHC
T ss_pred cCC--CccccccCCccccCchHHcC
Confidence 643 23456789999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-43 Score=310.98 Aligned_cols=173 Identities=27% Similarity=0.542 Sum_probs=155.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++++..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD- 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC------HHHHHHHHHHHHHHHhccCcChhheeeeEee-
Confidence 467999999999999999999999999999999997654321 2245678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+|||||+|+++...+.....+++..++.++.||+.||+|||+++|+||||||+||||+.+|.+||+|||+|+..
T Consensus 76 -~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 76 -AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred -CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 4689999999999999998888889999999999999999999999999999999999999999999999999999986
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+. ..+.+||+.|+|||++.|
T Consensus 155 ~~~---~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 155 PDV---TYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp SSC---BCCCCSCTTTCCHHHHTT
T ss_pred ccc---cccccCcccccCHHHHcC
Confidence 543 345789999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=299.50 Aligned_cols=172 Identities=26% Similarity=0.399 Sum_probs=149.8
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC--C
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP--N 197 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 197 (300)
|++.++||+|+||.||+++++.+++.||||.+..... .....+.+.+|+.+|++++|||||+++++|.+. .
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 3677789999999999999999999999999876432 344567899999999999999999999998652 3
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeCCCCCCCEEEc-cCCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVA-PSGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiHrDlkp~NIll~-~~~~~kl~DFGla~ 274 (300)
...+|+||||+++++|.+++.....+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 4578999999999999998888888999999999999999999999998 99999999999996 57899999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... ......+||+.|+|||++.|
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT
T ss_pred eccC--CccCCcccCccccCHHHhCC
Confidence 6433 23456789999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-43 Score=307.88 Aligned_cols=173 Identities=28% Similarity=0.480 Sum_probs=136.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.+.|++.+.||+|+||.||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--------GKEGSMENEIAVLHKIKHPNIVALDDIYES- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 35699999999999999999999999999999999765321 223467899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc---cCCcEEEecccCc
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVS 273 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~---~~~~~kl~DFGla 273 (300)
.+.+|||||||++++|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||+. .++.+||+|||+|
T Consensus 79 -~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 79 -GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred -CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 468999999999999999998888999999999999999999999999999999999999995 4789999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+..... ....+.+||+.|+|||++.|
T Consensus 158 ~~~~~~-~~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 158 KMEDPG-SVLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp ----------------CTTSCHHHHTT
T ss_pred EEccCC-CeeeeeeeCccccCcHHHcC
Confidence 876443 34456789999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-42 Score=308.87 Aligned_cols=173 Identities=28% Similarity=0.534 Sum_probs=152.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++++.||+|+||.||+|+++.+|+.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 94 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED 94 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 457899999999999999999999999999999998653 23455678999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc--CCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DFGl 272 (300)
.+.+|||||||++|+|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 95 --~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 95 --DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp --TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 468999999999999988774 4567999999999999999999999999999999999999964 57899999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+.+.... ......||+.|+|||++.|
T Consensus 173 a~~~~~~~-~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 173 TAHLDPKQ-SVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp CEECCTTS-CEEEECSCTTTCCHHHHHT
T ss_pred heeccccc-ccceecCcccccCHHHHcC
Confidence 99875443 3456789999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-42 Score=309.90 Aligned_cols=173 Identities=30% Similarity=0.529 Sum_probs=155.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~- 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKD- 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC------HHHHHHHHHHHHHHHHcCCCcEeeccccccc-
Confidence 478999999999999999999999999999999997654321 2345678899999999999999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+.+|++...+...+.+++..++.++.||+.||.|||+++||||||||+||||+.+|.+||+|||+|+.+
T Consensus 113 -~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 113 -NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 4589999999999999988888889999999999999999999999999999999999999999999999999999986
Q ss_pred cCCccccccCCCccccccCcccCC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
... ..+.+||+.|+|||++.|
T Consensus 192 ~~~---~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 192 KGR---TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp SSC---BCCCEECGGGCCHHHHTT
T ss_pred ccc---cccccCccccCCHHHHcC
Confidence 543 345679999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=299.70 Aligned_cols=177 Identities=30% Similarity=0.492 Sum_probs=155.4
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||+|+++.+|+.||||++.+..... .......+.+.+|+.+|+.++|||||+++++|.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS---SRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT---CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcch---hhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 56999999999999999999999999999999998754321 1123346788999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC----cEEEecccCc
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSVS 273 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DFGla 273 (300)
...+|||||||++|+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 468999999999999999888888999999999999999999999999999999999999998776 5999999999
Q ss_pred eeecCCccccccCCCccccccCcccCC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
....... ...+..||+.|+|||++.|
T Consensus 165 ~~~~~~~-~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 165 HKIDFGN-EFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp EECTTSC-BCSCCCCCGGGCCHHHHTT
T ss_pred hhcCCCc-cccccCCCCcccCHHHHcC
Confidence 9875443 3456789999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-42 Score=305.25 Aligned_cols=173 Identities=27% Similarity=0.481 Sum_probs=151.9
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++++.||+|+||.||+|+++.+|+.||||++.+. .......+.+|+.+|+.++|||||+++++|.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---------YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---------chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 346799999999999999999999999999999998654 22344678899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEc--cCCcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~--~~~~~kl~DFGl 272 (300)
...+|||||||++|+|.+.+... .++++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+
T Consensus 98 --~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 98 --KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp --SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred --CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 46899999999999998766554 4799999999999999999999999999999999999998 568999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|..+... ....+..||+.|+|||++.|
T Consensus 176 a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 176 ATKLNPD-EIVKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp CEECCTT-SCEEEECSSGGGCCHHHHTT
T ss_pred ceecCCC-CceeeccCcccccCHHHHcC
Confidence 9987543 34456789999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-42 Score=298.23 Aligned_cols=180 Identities=25% Similarity=0.383 Sum_probs=156.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
.++|++.+.||+|+||+||+|++..+|+.||||++.+...............+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998764332111111234457889999999997 9999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+.+|||||||++++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 468999999999999999998888999999999999999999999999999999999999999999999999999998
Q ss_pred ecCCccccccCCCccccccCcccC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..... ..+..+||+.|+|||++.
T Consensus 160 ~~~~~-~~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 160 LDPGE-KLREVCGTPSYLAPEIIE 182 (277)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred ccCCC-ceeeeeccCCCCCHHHhh
Confidence 75433 345678999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-42 Score=301.25 Aligned_cols=172 Identities=24% Similarity=0.336 Sum_probs=149.2
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||+|+++.+++.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----------chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3468999999999999999999999999999999986532 234578999999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
.+.+++|||||++|++..++. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 85 --~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 85 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred --CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence 357899999999999888773 3467999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+....... ......||+.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~ 189 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLA 189 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred eecCCCCceeeccccccccccChHHHc
Confidence 87654432 223345899999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.7e-42 Score=305.67 Aligned_cols=176 Identities=28% Similarity=0.412 Sum_probs=151.2
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++.+...... ...........++.+++.++|||||+++++|.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~---~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH---TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh---hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-
Confidence 4689999999999999999999999999999999976543211 122223334455777778889999999999986
Q ss_pred CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.+.+|+|||||++++|..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 4589999999999999999888889999999999999999999999999999999999999999999999999999976
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
... .....+||+.|+|||++.
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQ 178 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHS
T ss_pred CCC--cccccccccccchhHHhh
Confidence 543 345668999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=299.20 Aligned_cols=176 Identities=27% Similarity=0.431 Sum_probs=154.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~ 195 (300)
+++|++++.||+|+||+||+|+++.+|+.||||++++..... ......+..|+.++. .++|||||++++++.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~------~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC------hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 367999999999999999999999999999999997653321 123455667777664 7899999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.+.+|||||||++|+|..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 75 --~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 75 --KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred --CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 468999999999999999998888999999999999999999999999999999999999999999999999999997
Q ss_pred ecCCccccccCCCccccccCcccCC
Q 022241 276 FEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...........+||+.|+|||++.|
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 153 NMLGDAKTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccccccccccCCCCCcCCHHHHcC
Confidence 6655555666789999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=296.96 Aligned_cols=171 Identities=22% Similarity=0.325 Sum_probs=142.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|.+.+.||+|+||.||+++.. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-------CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 467999999999999999998643 3599999865422 34567789999999999999999999999864
Q ss_pred CCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
..+++|||||++|+|.+++. ....+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.
T Consensus 76 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 --PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp --SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred --cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 35899999999999998874 456799999999999999999999999999999999999999999999999999987
Q ss_pred ecCC--ccccccCCCccccccCcccCC
Q 022241 276 FEDD--NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 276 ~~~~--~~~~~~~~gt~~y~aPE~l~G 300 (300)
.... .....+..||+.|+|||++.|
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp ------------CCCCGGGCCHHHHTT
T ss_pred ccccCCcccccccccCcccCCHHHHhc
Confidence 6432 233456689999999999853
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=298.42 Aligned_cols=172 Identities=26% Similarity=0.443 Sum_probs=146.3
Q ss_pred EeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 122 ~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
.+++||+|+||+||+|+++.+|+.||||+++...... ........+.+|+.+|+.++|||||++++++.+ .+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE----AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh----hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCce
Confidence 4689999999999999999999999999987653221 112223568899999999999999999999986 3579
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
||||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99999999998888777788899999999999999999999999999999999999999999999999999987766555
Q ss_pred ccccCCCccccccCcccC
Q 022241 282 VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ~~~~~~gt~~y~aPE~l~ 299 (300)
.....+||+.|+|||++.
T Consensus 156 ~~~~~~gt~~y~aPE~~~ 173 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLF 173 (299)
T ss_dssp CCCCSCCCCTTCCHHHHT
T ss_pred cccceecChhhccHHHHc
Confidence 556678999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-41 Score=291.98 Aligned_cols=180 Identities=24% Similarity=0.376 Sum_probs=149.1
Q ss_pred eeecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
.+.++|++.+.||+|+||.||+|++..+|+.||||++++... ........+.+|+.+|+.++|||||++++++.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT------TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc------cCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 445789999999999999999999999999999999976432 24556678999999999999999999999987
Q ss_pred cCC--CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 195 ~~~--~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
... ...+||||||+++++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhh
Confidence 532 245899999999999998888888999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCc---cccccCCCccccccCcccCC
Q 022241 273 SQVFEDDN---DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~---~~~~~~~gt~~y~aPE~l~G 300 (300)
+....... ......+||+.|+|||++.|
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp CEECC----------------TTCCHHHHTT
T ss_pred hhhhccccccccccccccCcccccCHHHHcC
Confidence 88653322 23445679999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=290.42 Aligned_cols=170 Identities=25% Similarity=0.353 Sum_probs=137.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||+++.. +++.||||+++... ...+.+.+|+.+++.++|||||++++++.+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~- 72 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ- 72 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----------CcHHHHHHHHHHHHhcCCCCcccccceeccC-
Confidence 57999999999999999999876 67789999986532 1235789999999999999999999999863
Q ss_pred CCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+.+++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 73 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 73 -APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred -CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 57899999999999988764 4467899999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCccccccCcccCC
Q 022241 277 EDDND-VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 277 ~~~~~-~~~~~~gt~~y~aPE~l~G 300 (300)
..... ......||+.|+|||++.|
T Consensus 152 ~~~~~~~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 152 LDDQYTSSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp -------------CTTSCCHHHHTT
T ss_pred cCCCceeecceecCcccCChHHhcC
Confidence 54332 2234579999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=291.32 Aligned_cols=170 Identities=24% Similarity=0.381 Sum_probs=146.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|++.+.||+|+||.||+++.+ +++.||||+++... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3468999999999999999999876 67889999986432 223578999999999999999999998864
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 80 ---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp ---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 35799999999999987665433 5999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc-ccccCCCccccccCcccC
Q 022241 274 QVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
+.+..... ......||+.|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~ 183 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAIN 183 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred EEccCCccccccccCCcccccChHHHh
Confidence 98754432 334567999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-41 Score=294.63 Aligned_cols=173 Identities=30% Similarity=0.394 Sum_probs=135.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCc---eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|++.+.||+|+||.||+++++.+++ .||||.+... ......+.+.+|+.+|++++|||||++++++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--------YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--------cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4679999999999999999999887665 5888877542 2445667899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+ .+.+++|||||++|+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 97 ~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 97 TK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp CS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred ee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCccc
Confidence 76 3579999999999999886655 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcccc-----ccCCCccccccCcccC
Q 022241 273 SQVFEDDNDVL-----RRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~~~-----~~~~gt~~y~aPE~l~ 299 (300)
|+.+....... ....||+.|+|||++.
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206 (299)
T ss_dssp ---------------------CGGGSCHHHHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHh
Confidence 98765432211 1235799999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=293.57 Aligned_cols=173 Identities=31% Similarity=0.539 Sum_probs=148.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||.||+|++..+|+.||||+++.... .+.....+.+|+.+|++++|||||+++++|.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-- 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHT-- 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------ChHHHHHHHHHHHHHHhCCCCcEEEecccccc--
Confidence 689999999999999999999999999999999965422 12234678899999999999999999999987
Q ss_pred CCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+|+||||+.++.+.... .....+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus 73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceec
Confidence 45899999999876555433 44567999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccCCCccccccCcccC
Q 022241 277 EDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
...........||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~ 175 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILL 175 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHT
T ss_pred cCCcccceeecccceeeehhhhc
Confidence 66555666678999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=292.21 Aligned_cols=172 Identities=24% Similarity=0.432 Sum_probs=150.5
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
+.++|++++.||+|+||.||+|.++.+++.||||++++.. .....+.+|+.+|+.++|||||+++++|.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 72 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----------TDQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4578999999999999999999999999999999986532 233568899999999999999999999986
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC--CcEEEecccC
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFSV 272 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~--~~~kl~DFGl 272 (300)
...+|||||||++++|.+.+...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 73 --~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 --MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp --TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred --CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence 458999999999999998887654 79999999999999999999999999999999999999854 4899999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+...... .......||+.|+|||.+.|
T Consensus 151 ~~~~~~~-~~~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 151 ARQLKPG-DNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp CEECCTT-CEEEEEESCGGGSCHHHHTT
T ss_pred hhccccC-CcccccccccccccchhccC
Confidence 9876443 33455679999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=293.47 Aligned_cols=171 Identities=27% Similarity=0.430 Sum_probs=145.9
Q ss_pred eeecceeEee-eecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHH-HCCCCceeeeeeE
Q 022241 115 KMINEYVHVR-KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEV 192 (300)
Q Consensus 115 ~~~~~y~~~~-~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~ 192 (300)
...++|.++. .||+|+||.||+|++..+++.||||++++. ..+.+|+.++. .++|||||+++++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~ 73 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDV 73 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 3467898875 599999999999999999999999998642 34668998865 5589999999999
Q ss_pred EEc--CCCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCcE
Q 022241 193 IDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTV 265 (300)
Q Consensus 193 ~~~--~~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~~ 265 (300)
|.+ .....+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+
T Consensus 74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence 875 2345789999999999999888553 47999999999999999999999999999999999999985 4579
Q ss_pred EEecccCceeecCCccccccCCCccccccCcccCC
Q 022241 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 266 kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|||+|+...... .....+||+.|+|||++.|
T Consensus 154 Kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 154 KLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp EECCCTTCEECCCCC-CCCCCSCCCSSCCCCCCCG
T ss_pred cccccceeeeccCCC-ccccccCCcccCCcHHHcC
Confidence 999999999865543 3456789999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=285.68 Aligned_cols=171 Identities=25% Similarity=0.373 Sum_probs=144.7
Q ss_pred cceeEee-eecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVR-KIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~-~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|.+.+ +||+|+||.||++..+. ++..||||.++.. ......+.+.+|+.+|++++|||||++++++.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--------cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 4677777 49999999999997764 4557999998643 13456678999999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ +.+|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 80 ~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 80 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp S---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred c---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence 5 358999999999999987644 567999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc---ccccCCCccccccCcccC
Q 022241 274 QVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
+.+..... ......||+.|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred hcccccccccccccccccCccccChHHHh
Confidence 98754322 223456899999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=287.93 Aligned_cols=166 Identities=23% Similarity=0.364 Sum_probs=139.6
Q ss_pred eeecCCCceEEEEEEEcc--CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCCEE
Q 022241 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 124 ~~iG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 201 (300)
++||+|+||.||++.... +++.||||+++.... .....+.+.+|+.+|++++|||||++++++.+ +..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~ 82 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 82 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-------CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCE
Confidence 579999999999997653 557899999864321 34456789999999999999999999999974 357
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecCCcc
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 281 (300)
+|||||+++|+|.+++.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 89999999999999888888999999999999999999999999999999999999999999999999999997644322
Q ss_pred ---ccccCCCccccccCcccC
Q 022241 282 ---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 282 ---~~~~~~gt~~y~aPE~l~ 299 (300)
......||+.|+|||++.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECIN 183 (277)
T ss_dssp EEEC----CCCGGGCCHHHHH
T ss_pred ccccccccCCCceecCchhhc
Confidence 222356999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=287.00 Aligned_cols=174 Identities=28% Similarity=0.345 Sum_probs=139.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCC----ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 192 (300)
.+.|.+.++||+|+||.||++..+.++ ..||||++.... .......+.+|+.+|++++|||||+++++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--------TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--------ChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 357999999999999999999887654 479999986432 34455679999999999999999999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
+.+ ...+++||||+.++++.+.+. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||
T Consensus 78 ~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 78 ISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp ECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred Eec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence 976 357899999999998877664 44679999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCcc---ccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDND---VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~---~~~~~~gt~~y~aPE~l~G 300 (300)
+|+.+..... ......||+.|+|||++.+
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHS
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHcc
Confidence 9987644322 2223468999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=293.81 Aligned_cols=173 Identities=22% Similarity=0.291 Sum_probs=143.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCc-----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGK-----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 190 (300)
.++|++.+.||+|+||.||+|+....++ .||||.+.... .......+.+|+.+|.++ +|||||+++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--------CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3679999999999999999999876543 69999886432 223445788999999988 899999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-----------------------GAIGESMARKYLRDIVSGLMYLHGHNV 247 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~i 247 (300)
+++.+. +.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|
T Consensus 108 ~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I 185 (325)
T d1rjba_ 108 GACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185 (325)
T ss_dssp EEECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEeeC--CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 999864 5789999999999998877443 358999999999999999999999999
Q ss_pred EeCCCCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 248 iHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+||||||+|||++.++.+||+|||+|+....... ...+..||+.|+|||++.
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc
Confidence 9999999999999999999999999987654332 223456899999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=287.35 Aligned_cols=175 Identities=27% Similarity=0.407 Sum_probs=147.3
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC--CCceeeeeeEEEc
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVIDD 195 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 195 (300)
++|++.+.||+|+||.||+|+++.+|+.||||++.+......... .....+.+|+.+|++++ |||||++++++.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh---hHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 579999999999999999999999999999999987644321110 11224568999999987 8999999999986
Q ss_pred CCCCEEEEEEEeeCC-CccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccC-CcEEEecccCc
Q 022241 196 PNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVS 273 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DFGla 273 (300)
.+.+++||||+.+ +++.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence 4589999999976 5666677677789999999999999999999999999999999999999854 79999999999
Q ss_pred eeecCCccccccCCCccccccCcccC
Q 022241 274 QVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
+..... ..++..||+.|+|||++.
T Consensus 159 ~~~~~~--~~~~~~GT~~y~aPE~~~ 182 (273)
T d1xwsa_ 159 ALLKDT--VYTDFDGTRVYSPPEWIR 182 (273)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHH
T ss_pred eecccc--cccccccCCCcCCHHHHc
Confidence 875433 345678999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-40 Score=280.44 Aligned_cols=169 Identities=21% Similarity=0.331 Sum_probs=146.1
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.++||+|+||.||+++.+ +++.||||.+++... ..+.+.+|+.+++.++|||||++++++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-- 70 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----------SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-- 70 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----------CHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----------CHHHHHHHHHHHHhcCCCceeeEEEEEee--
Confidence 57999999999999999999985 778999999876422 23578999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCcccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
...+++||||+++|++..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence 35799999999999988774 44567999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCccccccCcccC
Q 022241 277 EDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 277 ~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
..... ......||+.|+|||++.
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~ 174 (258)
T d1k2pa_ 151 LDDEYTSSVGSKFPVRWSPPEVLM 174 (258)
T ss_dssp SSSSCCCCCCSCCCGGGCCHHHHH
T ss_pred cCCCceeecccCCCCCcCCcHHhc
Confidence 44332 233467999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-39 Score=283.24 Aligned_cols=168 Identities=23% Similarity=0.433 Sum_probs=146.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
.++|+++++||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+.+. ||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------------KKKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------------HHHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 36899999999999999999999999999999998542 2356789999999985 9999999999987
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecccCce
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQ 274 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~ 274 (300)
.....+++||||+.++++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred cCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 6667899999999999887653 4699999999999999999999999999999999999998655 69999999998
Q ss_pred eecCCccccccCCCccccccCcccCC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
...... ......||+.|+|||.+.|
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 179 FYHPGQ-EYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTT
T ss_pred eccCCC-cccccccCccccCcccccC
Confidence 765432 3456679999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-40 Score=284.49 Aligned_cols=173 Identities=29% Similarity=0.482 Sum_probs=147.5
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|+++++||+|+||.||+|+++ +|+.||||++..... .+.....+.+|+.+|+.++|||||+++++|.+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 72 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-------DEGIPSTTIREISILKELKHSNIVKLYDVIHTK- 72 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-
Confidence 58999999999999999999986 789999999865432 122346788999999999999999999999863
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
...+++|||+.++.+.......+.+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|....
T Consensus 73 -~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 73 -KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp -SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred -CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 5799999999998888888888899999999999999999999999999999999999999999999999999998766
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
.+........||+.|+|||.+.+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMG 174 (286)
T ss_dssp C---------CCCTTCCHHHHTT
T ss_pred cCccccceecccchhhhHHHHhC
Confidence 55544555679999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=284.63 Aligned_cols=171 Identities=21% Similarity=0.337 Sum_probs=137.9
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCc----eEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
++|++++.||+|+||.||++++..+|+ +||||.+.... .....+.+.+|+.+|+.++|||||++++++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 469999999999999999999988776 47777764321 233456899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+. ..+++|||+.++.+.+.+. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 81 ~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 81 LTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp ESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred ecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccc
Confidence 863 4788899998888776554 456799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc--ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|+....... ......||+.|+|||++.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~ 186 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESIL 186 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHH
T ss_pred ceecccccccccccccccCccccChHHHh
Confidence 987644332 223346899999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=279.77 Aligned_cols=169 Identities=25% Similarity=0.351 Sum_probs=138.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||+++.+. ++.||||+++... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc----------CCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 4689999999999999999998874 4679999986432 123578999999999999999999999864
Q ss_pred CCCEEEEEEEeeCCCccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
+.+++||||+++|++...+.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 84 --~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 84 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp --SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred --CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence 357899999999988877654 3469999999999999999999999999999999999999999999999999998
Q ss_pred eecCCc-cccccCCCccccccCcccC
Q 022241 275 VFEDDN-DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~-~~~~~~~gt~~y~aPE~l~ 299 (300)
...... .......||+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 187 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAAL 187 (285)
T ss_dssp --------------CCGGGSCHHHHH
T ss_pred hccCCCceeeccccccccccChHHHh
Confidence 764333 2233467999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=280.67 Aligned_cols=177 Identities=26% Similarity=0.457 Sum_probs=147.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
+++|.+++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-------TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 5789999999999999999999999999999999865432 223445678999999999999999999998652
Q ss_pred C------CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 197 N------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 197 ~------~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
. ...+++||||+.++.+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeec
Confidence 1 2468999999998888777777788999999999999999999999999999999999999999999999999
Q ss_pred cCceeecCCc----cccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDN----DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~----~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|..+.... ......+||+.|+|||+++|
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcC
Confidence 9998764322 22334579999999998764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=284.49 Aligned_cols=173 Identities=25% Similarity=0.435 Sum_probs=142.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|+++++||+|+||.||+|.++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|..
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 45789999999999999999999999999999999865321 44566789999999999999999999999976
Q ss_pred CC----CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~~----~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
.. ...+|+||||++ .++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFMG-TDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CSSTTTCCCCEEEEECCS-EEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CccccccceEEEEEeccc-ccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 32 235799999994 3444433 34579999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+|+.... ..+...||+.|+|||+++|
T Consensus 167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 167 LARQADS---EMTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp TCEECCS---SCCSSCSCGGGCCTHHHHT
T ss_pred ceeccCC---ccccccccccccCHHHHcC
Confidence 9987643 2356789999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=281.03 Aligned_cols=173 Identities=18% Similarity=0.296 Sum_probs=136.0
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeee
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE 191 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 191 (300)
++|++.+.||+|+||.||+|+... +++.||||+++... .......+.+|..++.++ +|||||.+++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--------CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 679999999999999999998754 45689999986432 334556777888877766 6899999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCC
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPD 255 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~ 255 (300)
++..+ ...+++|||||++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+
T Consensus 85 ~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 85 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 98764 4578999999999999887642 235899999999999999999999999999999999
Q ss_pred CEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 256 NLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 256 NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
||||+.++.+||+|||+|+....... ......||+.|+|||++.
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 209 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 209 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh
Confidence 99999999999999999987644332 334567999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=274.02 Aligned_cols=174 Identities=25% Similarity=0.457 Sum_probs=155.8
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-- 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLHDVLHS-- 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-------ChHHHHHHHHHHHHHHhcCcCCEEeecccccc--
Confidence 579999999999999999999999999999999965421 34566789999999999999999999999986
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeec
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 277 (300)
....++|||++.++.+.......+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+...
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 45899999999999988888888899999999999999999999999999999999999999999999999999999876
Q ss_pred CCccccccCCCccccccCcccCC
Q 022241 278 DDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 278 ~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
..........+++.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTT
T ss_pred CCCccceeeccccchhhhhHhcc
Confidence 65555556678899999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=276.30 Aligned_cols=172 Identities=26% Similarity=0.333 Sum_probs=134.6
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 193 (300)
.++|++.+.||+|+||.||+|++..++ ..||||.++.. ........+.+|+.+|+.++|||||++++++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 357999999999999999999887543 46888887532 2445567899999999999999999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.+ +.+|+||||+++|++..++. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 78 TE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp CS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 64 46899999999999887653 455799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCcc-ccccCCCccccccCcccC
Q 022241 273 SQVFEDDND-VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 273 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 299 (300)
|+.+..... ......||+.|+|||++.
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp ----------------CCGGGCCHHHHH
T ss_pred heeccCCcceeccceecCcccchhhHhc
Confidence 987654322 334556899999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-38 Score=279.77 Aligned_cols=174 Identities=28% Similarity=0.408 Sum_probs=142.5
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
..+|++++.||+|+||+||+|++..+|+.||||++.+.. .......+.+|+.+|+.++|||||++++++..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--------HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 357999999999999999999999999999999986431 345567889999999999999999999998753
Q ss_pred CC--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.. ...+++++|+.+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 21 123344556678888887754 479999999999999999999999999999999999999999999999999998
Q ss_pred eecCCcc---ccccCCCccccccCcccC
Q 022241 275 VFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
....... .....+||+.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 185 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIML 185 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred eccCCCccceeeccccccceechHHHhh
Confidence 7643221 234567999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-38 Score=280.48 Aligned_cols=168 Identities=27% Similarity=0.378 Sum_probs=142.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC--
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-- 196 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 196 (300)
+|..+++||+|+||+||+|++..+|+.||||++.+... ...+|+.+|+.++|||||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 69999999999999999999999999999999865421 123799999999999999999998542
Q ss_pred --CCCEEEEEEEeeCCCcccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCC-cEEEecc
Q 022241 197 --NSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDF 270 (300)
Q Consensus 197 --~~~~~~lv~E~~~~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DF 270 (300)
+..+++||||||+++++.. .......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence 3346899999999775333 334566899999999999999999999999999999999999999775 8999999
Q ss_pred cCceeecCCccccccCCCccccccCcccCC
Q 022241 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 271 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+|....... ...+..||+.|+|||.++|
T Consensus 168 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 196 (350)
T d1q5ka_ 168 GSAKQLVRGE-PNVSYICSRYYRAPELIFG 196 (350)
T ss_dssp TTCEECCTTS-CCCSCCSCTTSCCHHHHTT
T ss_pred cchhhccCCc-ccccccccccccChHHhhc
Confidence 9998865433 3455689999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=278.56 Aligned_cols=173 Identities=25% Similarity=0.353 Sum_probs=144.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 191 (300)
.++|++.+.||+|+||.||+|+.+. +++.||||+++... .......+.+|+.+|+.++||||+++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--------ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 4679999999999999999998753 56789999986432 3445678999999999999999999999
Q ss_pred EEEcCCCCEEEEEEEeeCCCccccccCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022241 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ------------------------PGAIGESMARKYLRDIVSGLMYLHGHNV 247 (300)
Q Consensus 192 ~~~~~~~~~~~lv~E~~~~~~l~~~~~~------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~i 247 (300)
++.+ ....+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+++|
T Consensus 84 ~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i 161 (301)
T d1lufa_ 84 VCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161 (301)
T ss_dssp EECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence 9986 3578999999999998876632 2248899999999999999999999999
Q ss_pred EeCCCCCCCEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 248 iHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
|||||||+||||+.++.+||+|||+|+...... ....+..||+.|+|||++.
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc
Confidence 999999999999999999999999998654332 2233567999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=277.09 Aligned_cols=176 Identities=29% Similarity=0.456 Sum_probs=142.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEccC-CceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC---CCCceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~ 192 (300)
.++|++++.||+|+||.||+|++..+ ++.||||+++...... .....+.+|+.+|+.| +|||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------GMPLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------SCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-------hHHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 36899999999999999999999765 6779999997653221 1112344666666554 89999999999
Q ss_pred EEc---CCCCEEEEEEEeeCCCccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEe
Q 022241 193 IDD---PNSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268 (300)
Q Consensus 193 ~~~---~~~~~~~lv~E~~~~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~ 268 (300)
|.. .....++++|||+.++.+... ......+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeec
Confidence 863 223578999999998876533 3455679999999999999999999999999999999999999999999999
Q ss_pred cccCceeecCCccccccCCCccccccCcccCC
Q 022241 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 269 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|||+++..... .......||+.|+|||++.|
T Consensus 159 dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 159 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT
T ss_pred chhhhhhhccc-ccCCCcccChhhcCcchhcC
Confidence 99999875433 34456789999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=272.18 Aligned_cols=173 Identities=28% Similarity=0.378 Sum_probs=134.7
Q ss_pred cceeEeeeecCCCceEEEEEEEcc-CC--ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEE
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSL-DG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID 194 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 194 (300)
++|++++.||+|+||.||+++... ++ ..||||++.+.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~------~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 579999999999999999998654 33 36899998765322 3455678999999999999999999999997
Q ss_pred cCCCCEEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCc
Q 022241 195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla 273 (300)
+ ..+++||||++++++.+.+.. .+.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++
T Consensus 82 ~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 82 T---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp S---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred e---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 5 357899999999888766543 457999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCcc---ccccCCCccccccCcccC
Q 022241 274 QVFEDDND---VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~y~aPE~l~ 299 (300)
+.+..... ......||+.|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 187 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLK 187 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred hhcccCCCcceecCccccCcccCCHHHHh
Confidence 98644322 223346888999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-38 Score=273.06 Aligned_cols=169 Identities=26% Similarity=0.327 Sum_probs=137.6
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
.+|.+.+.||+|+||.||+++. +|+.||||++.... ........|+..+..++|||||++++++.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 4689999999999999999875 68999999985431 11122334555566789999999999997643
Q ss_pred C--CEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeCCCCCCCEEEccCCcEEE
Q 022241 198 S--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG--------HNVVHGDIKPDNLLVAPSGTVKI 267 (300)
Q Consensus 198 ~--~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~--------~~iiHrDlkp~NIll~~~~~~kl 267 (300)
. ..+++|||||++|+|..++... .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 2 3689999999999999888654 69999999999999999999996 58999999999999999999999
Q ss_pred ecccCceeecCCcc----ccccCCCccccccCcccC
Q 022241 268 GDFSVSQVFEDDND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 268 ~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
+|||+++....... ......||+.|+|||++.
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhcc
Confidence 99999998754332 223467999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=276.45 Aligned_cols=174 Identities=25% Similarity=0.424 Sum_probs=139.8
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 44789999999999999999999999999999999975422 34556788999999999999999999999965
Q ss_pred C----CCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEeccc
Q 022241 196 P----NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271 (300)
Q Consensus 196 ~----~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFG 271 (300)
. ....+|+||||+.++++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ccccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechh
Confidence 3 34689999999988766544 3468999999999999999999999999999999999999999999999999
Q ss_pred CceeecCCccccccCCCccccccCcccCC
Q 022241 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 272 la~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
+++..... ......+||+.|+|||++.|
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 165 LARTAGTS-FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp C----------------CCTTCCHHHHTT
T ss_pred hhhccccc-cccccccccccccChhhhcC
Confidence 98875443 33455679999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-38 Score=274.30 Aligned_cols=172 Identities=25% Similarity=0.336 Sum_probs=142.0
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCce--EEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeeeeEE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI 193 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 193 (300)
.++|++.+.||+|+||.||+++++.+|.. ||||.+.... .....+.+.+|+.+|..+ +|||||++++++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--------ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 46899999999999999999999888874 6777664321 223455789999999998 799999999999
Q ss_pred EcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCE
Q 022241 194 DDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL 257 (300)
Q Consensus 194 ~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NI 257 (300)
.+ .+.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 81 ~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158 (309)
T ss_dssp EE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence 86 45899999999999999887443 5799999999999999999999999999999999999
Q ss_pred EEccCCcEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 258 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
|++.++.+||+|||+|+...... ......||+.|+|||.+.
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~ 199 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN 199 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHH
T ss_pred EEcCCCceEEccccccccccccc-cccceecCCcccchHHhc
Confidence 99999999999999998653322 223456999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-37 Score=268.60 Aligned_cols=171 Identities=26% Similarity=0.317 Sum_probs=141.0
Q ss_pred cceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCC
Q 022241 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN 197 (300)
Q Consensus 118 ~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 197 (300)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+.+++.++|+|+|..+..+.. .
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~ 74 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGA-E 74 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----------SCCHHHHHHHHHHSTTSTTCCCEEEEEE-E
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----------CHHHHHHHHHHHHccCCCcccEEEEEEe-c
Confidence 579999999999999999999999999999998765321 1246789999999998876666555543 2
Q ss_pred CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc---CCcEEEecccCce
Q 022241 198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFSVSQ 274 (300)
Q Consensus 198 ~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~---~~~~kl~DFGla~ 274 (300)
....++||||++++.+.........+++..+..++.|++.||+|||+++|+||||||+|||++. +..+||+|||+|+
T Consensus 75 ~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 4689999999987766655566678999999999999999999999999999999999999864 4579999999999
Q ss_pred eecCCcc-------ccccCCCccccccCcccCC
Q 022241 275 VFEDDND-------VLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 275 ~~~~~~~-------~~~~~~gt~~y~aPE~l~G 300 (300)
.+..... ...+..||+.|+|||++.|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhC
Confidence 8754321 2345679999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=269.21 Aligned_cols=166 Identities=27% Similarity=0.429 Sum_probs=135.8
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcC
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP 196 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 196 (300)
.++|++.+.||+|+||.||+++. .|+.||||++++. ...+.+.+|+.++++++|||||++++++.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 46799999999999999999887 4889999998643 2335788999999999999999999998653
Q ss_pred CCCEEEEEEEeeCCCccccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCce
Q 022241 197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274 (300)
Q Consensus 197 ~~~~~~lv~E~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 274 (300)
.+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 73 -~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 73 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred -CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence 34689999999999999887543 358999999999999999999999999999999999999999999999999998
Q ss_pred eecCCccccccCCCccccccCcccC
Q 022241 275 VFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 275 ~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
..... .....+|+.|+|||++.
T Consensus 152 ~~~~~---~~~~~~~~~y~aPE~l~ 173 (262)
T d1byga_ 152 EASST---QDTGKLPVKWTAPEALR 173 (262)
T ss_dssp -------------CCTTTSCHHHHH
T ss_pred ecCCC---CccccccccCCChHHHh
Confidence 75432 23456899999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-36 Score=265.14 Aligned_cols=170 Identities=21% Similarity=0.283 Sum_probs=141.1
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC-CceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 195 (300)
-++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+..++.++| +|++.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----------cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3679999999999999999999999999999998754311 1246688999999976 899999999886
Q ss_pred CCCCEEEEEEEeeCCCccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEcc-----CCcEEEec
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-----SGTVKIGD 269 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~-----~~~~kl~D 269 (300)
....++||||++ +++.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 73 --~~~~~~vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 --GLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred --CCccEEEEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 468999999995 45555553 3457999999999999999999999999999999999999974 56899999
Q ss_pred ccCceeecCCc-------cccccCCCccccccCcccCC
Q 022241 270 FSVSQVFEDDN-------DVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 270 FGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~G 300 (300)
||+|+.+.... ......+||+.|+|||++.|
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcC
Confidence 99999865322 12334679999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=268.79 Aligned_cols=174 Identities=22% Similarity=0.361 Sum_probs=142.1
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCC-------ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCcee
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV 187 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 187 (300)
..++|++.+.||+|+||.||+|+...++ ..||||++++.. .......+.+|+..+.++ +|||||
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--------ChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 3478999999999999999999876544 479999986532 345567888999998887 799999
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCccccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeCC
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrD 251 (300)
+++++|.+ .+.+++||||+++|++.+++... ..+++..+..++.||+.||+|||+++|+|||
T Consensus 83 ~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 83 NLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp CEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 99999986 35799999999999998877433 3589999999999999999999999999999
Q ss_pred CCCCCEEEccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 252 lkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 210 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc
Confidence 999999999999999999999987654322 234457999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=270.76 Aligned_cols=175 Identities=21% Similarity=0.252 Sum_probs=147.2
Q ss_pred eeecceeEeeeecCCCceEEEEEEEcc-----CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeee
Q 022241 115 KMINEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189 (300)
Q Consensus 115 ~~~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 189 (300)
...++|.+.+.||+|+||.||+|.+.. +++.||||++++.. .......+.+|+.++++++|||||++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--------~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--------ChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 345789999999999999999998753 45789999986431 34556679999999999999999999
Q ss_pred eeEEEcCCCCEEEEEEEeeCCCccccccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEE
Q 022241 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFG----------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259 (300)
Q Consensus 190 ~~~~~~~~~~~~~lv~E~~~~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll 259 (300)
++++.. ...+++||||+++|++.+++. ....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 89 ~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 89 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 999975 357899999999999887653 22457899999999999999999999999999999999999
Q ss_pred ccCCcEEEecccCceeecCCcc--ccccCCCccccccCcccC
Q 022241 260 APSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 260 ~~~~~~kl~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~ 299 (300)
+.++.+||+|||+|+.+..... ......||+.|+|||.+.
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~ 208 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc
Confidence 9999999999999987644332 223446899999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=271.63 Aligned_cols=173 Identities=23% Similarity=0.274 Sum_probs=146.4
Q ss_pred ecceeEeeeecCCCceEEEEEEEc-----cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHC-CCCceeeee
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI 190 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 190 (300)
.++|++.++||+|+||.||+|+.. .+++.||||+++... .......+.+|+.+++.+ +|||||+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--------CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 468999999999999999999863 366789999986532 345566899999999998 699999999
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCC
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI 252 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDl 252 (300)
+++.+. ..+++|||||+++++.+++.. ...+++..+..++.||+.||+|||+++|+||||
T Consensus 94 g~~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL 171 (311)
T d1t46a_ 94 GACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (311)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEeeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 999863 568999999999998876632 236899999999999999999999999999999
Q ss_pred CCCCEEEccCCcEEEecccCceeecCCc--cccccCCCccccccCcccC
Q 022241 253 KPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 253 kp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~ 299 (300)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 220 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc
Confidence 9999999999999999999999765433 2233457999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-37 Score=273.09 Aligned_cols=174 Identities=24% Similarity=0.384 Sum_probs=144.6
Q ss_pred eecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEc
Q 022241 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD 195 (300)
Q Consensus 116 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 195 (300)
..++|+++++||+|+||+||+|+++.+|+.||||++.+... +......+.+|+.+|+.++|||||++++++..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 35789999999999999999999999999999999875421 34456678999999999999999999999864
Q ss_pred CC---CCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 196 PN---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 196 ~~---~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
.. ....+++|+|+.+++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 21 2344566778888888887754 4799999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccccccCCCccccccCcccCC
Q 022241 273 SQVFEDDNDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~~~~~~~~~gt~~y~aPE~l~G 300 (300)
|..... ...+..||+.|+|||++.+
T Consensus 168 a~~~~~---~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 168 ARHTDD---EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp --CCTG---GGSSSCHHHHTSCHHHHTT
T ss_pred hcccCc---ccccccccccccCchhhcC
Confidence 986433 3455679999999998654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=273.95 Aligned_cols=177 Identities=27% Similarity=0.450 Sum_probs=151.3
Q ss_pred ecceeEeeeecCCCceEEEEEEEc---cCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC-CceeeeeeE
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIEV 192 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~ 192 (300)
.++|++++.||+|+||.||+|++. .+|+.||||++++..... .....+.+.+|+.+|++++| |||++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----EESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-----chHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 478999999999999999999874 468999999997654321 11223457789999999976 899999999
Q ss_pred EEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccC
Q 022241 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272 (300)
Q Consensus 193 ~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGl 272 (300)
+.+. ..++++|||+.+++|...+...+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~--~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 98 FQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEET--TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eccC--CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence 9874 58999999999999999988888899999999999999999999999999999999999999999999999999
Q ss_pred ceeecCC-ccccccCCCccccccCcccCC
Q 022241 273 SQVFEDD-NDVLRRSPGTPVFTAPECCLG 300 (300)
Q Consensus 273 a~~~~~~-~~~~~~~~gt~~y~aPE~l~G 300 (300)
|+.+... ........||+.|+|||.+.|
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred hhhhcccccccccccccccccchhHHhhc
Confidence 9876433 233445679999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=264.85 Aligned_cols=168 Identities=20% Similarity=0.222 Sum_probs=140.5
Q ss_pred eeeecCCCceEEEEEEEccCC---ceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCceeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 199 (300)
.++||+|+||+||+++...++ ..||||.+++. ........+.+|+.+|++++|||||++++++.+. ..
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~ 102 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 102 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TT
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CC
Confidence 578999999999999886643 36899988532 2456678899999999999999999999998753 35
Q ss_pred EEEEEEEeeCCCccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecccCceeecC
Q 022241 200 HFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278 (300)
Q Consensus 200 ~~~lv~E~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 278 (300)
..++|||||+++++.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+++....
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 79999999999999887654 44688889999999999999999999999999999999999999999999999987643
Q ss_pred Ccc----ccccCCCccccccCcccC
Q 022241 279 DND----VLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 279 ~~~----~~~~~~gt~~y~aPE~l~ 299 (300)
... ......||+.|+|||.+.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~ 207 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQ 207 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred cccccceecccccccccccChHHHh
Confidence 322 222356899999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.6e-31 Score=238.87 Aligned_cols=168 Identities=21% Similarity=0.354 Sum_probs=137.1
Q ss_pred ceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-----------CCcee
Q 022241 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----------HPNIV 187 (300)
Q Consensus 119 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv 187 (300)
+|+++++||+|+||.||+|+++.+|+.||||++++. ....+.+.+|+.+++.++ |+|||
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 599999999999999999999999999999998753 233456778898888775 57899
Q ss_pred eeeeEEEcCCCCEEEEEEEeeCCCccc---cccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeCCCCCCCEEEccCC
Q 022241 188 NLIEVIDDPNSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSG 263 (300)
Q Consensus 188 ~~~~~~~~~~~~~~~lv~E~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiHrDlkp~NIll~~~~ 263 (300)
++++++........+++|+++...... ........+++..++.++.||+.||+|||+ .||+||||||+||||+.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 999988754445777888877554322 223455679999999999999999999997 8999999999999998765
Q ss_pred ------cEEEecccCceeecCCccccccCCCccccccCcccC
Q 022241 264 ------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299 (300)
Q Consensus 264 ------~~kl~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~ 299 (300)
.+|++|||.|..... .....+||+.|+|||++.
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~ 202 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLL 202 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHH
T ss_pred cccccceeeEeeccccccccc---ccccccccccccChhhcc
Confidence 499999999986543 234567999999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.4e-26 Score=188.45 Aligned_cols=145 Identities=20% Similarity=0.179 Sum_probs=109.4
Q ss_pred eeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccC-------C--ChHHHHHHHHHHHHHHHCCCCceeeee
Q 022241 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-------P--SETAMTDVRREVLIMKMLQHPNIVNLI 190 (300)
Q Consensus 120 y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-------~--~~~~~~~~~~E~~~l~~l~h~niv~~~ 190 (300)
+.+.++||+|+||.||+|.+. +|+.||||+++.......... . .........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999875 789999998764322110000 0 011233456788999999999999988
Q ss_pred eEEEcCCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeCCCCCCCEEEccCCcEEEecc
Q 022241 191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270 (300)
Q Consensus 191 ~~~~~~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiHrDlkp~NIll~~~~~~kl~DF 270 (300)
++.. .+++|||+++..... +++..+..++.|++.+|+|||++||+||||||+|||+++ +.++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCC
T ss_pred EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEEC
Confidence 7642 268999999865443 344556789999999999999999999999999999995 55899999
Q ss_pred cCceeecCC
Q 022241 271 SVSQVFEDD 279 (300)
Q Consensus 271 Gla~~~~~~ 279 (300)
|+|.....+
T Consensus 147 G~a~~~~~~ 155 (191)
T d1zara2 147 PQSVEVGEE 155 (191)
T ss_dssp TTCEETTST
T ss_pred CCcccCCCC
Confidence 999876433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=5.4e-07 Score=74.38 Aligned_cols=142 Identities=16% Similarity=0.177 Sum_probs=87.9
Q ss_pred ecceeEeeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-CCceeeeeeEEEc
Q 022241 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD 195 (300)
Q Consensus 117 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 195 (300)
...|+..+..+.++.+.||.+. .+++.+.+|........ ....+.+|+..+..+. +--+.+++.+..+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---------~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---------TTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---------STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---------chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 3457777766555667898664 45667888877543211 1224567888877664 4345677777664
Q ss_pred CCCCEEEEEEEeeCCCccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------
Q 022241 196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-------------------------------- 243 (300)
Q Consensus 196 ~~~~~~~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-------------------------------- 243 (300)
.+..++||++++|..+........ . ...++.+++..+..||
T Consensus 82 --~~~~~lv~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 82 --DGWSNLLMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp --TTEEEEEEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred --CCceEEEEEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 357899999999876543221111 1 1112222222223232
Q ss_pred ---------------------hC------CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 244 ---------------------GH------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 244 ---------------------~~------~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
+. .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 11 2799999999999997666679999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=9.6e-07 Score=77.69 Aligned_cols=84 Identities=13% Similarity=0.026 Sum_probs=48.1
Q ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCC-C--CceeeeeeEEEcCCCC
Q 022241 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H--PNIVNLIEVIDDPNSD 199 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~ 199 (300)
.+.||.|..-.||.+....+++.|+||....... .....-.....+...|+..|..+. + ..+++++.+.. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r--~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK--VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----E 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGG--C--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhc--ccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----C
Confidence 4578999999999998877788999997643211 000101112234456777776552 2 34555665432 2
Q ss_pred EEEEEEEeeCCCc
Q 022241 200 HFYMVLEYVEGKW 212 (300)
Q Consensus 200 ~~~lv~E~~~~~~ 212 (300)
..++|||++++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 3578999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=1.2e-05 Score=65.74 Aligned_cols=133 Identities=14% Similarity=0.101 Sum_probs=78.6
Q ss_pred eecCCCc-eEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCC--CceeeeeeEEEcCCCCEE
Q 022241 125 KIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDPNSDHF 201 (300)
Q Consensus 125 ~iG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 201 (300)
.+..|.. +.||++... .+..+.+|...... ...+..|+..|+.+.. ..+.+++.+..++ +..
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~ 81 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRD 81 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cce
Confidence 4455544 678876543 56678889754321 1245677777776643 3355677776653 468
Q ss_pred EEEEEeeCCCccccccCCCCCCCHHHHHHHH---H--------------------------------------------H
Q 022241 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYL---R--------------------------------------------D 234 (300)
Q Consensus 202 ~lv~E~~~~~~l~~~~~~~~~l~~~~~~~i~---~--------------------------------------------q 234 (300)
++||++++|..+...... ....+..+. . .
T Consensus 82 ~~v~~~i~G~~~~~~~~~----~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLSSHLA----PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp EEEEECCSSEETTTSCCC----HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EEEEEeeecccccccccc----HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 899999988654432110 000000000 0 0
Q ss_pred HHHHHHHHHhC-------CcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 235 IVSGLMYLHGH-------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 235 i~~~l~yLH~~-------~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
....+..+... .++|+|+.|.|||++.+..+-|+||+.+...
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 11223333321 2799999999999997666789999998763
|
| >d1gxca_ b.26.1.2 (A:) Chk2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Chk2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=3.8e-06 Score=60.51 Aligned_cols=65 Identities=25% Similarity=0.267 Sum_probs=50.4
Q ss_pred CcccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 2 FRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 2 ~~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
.+++|++||+..|++++..+..........+|..|++|.++....++.....+|.|.||+..|..
T Consensus 18 ~~~~~~iGR~~~cdi~l~~~~~~~~~~~~~ISr~H~~I~~~~~~~~~~~~~i~d~S~NGT~vN~~ 82 (116)
T d1gxca_ 18 VNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTE 82 (116)
T ss_dssp CSSEEEEESSTTCSEECCCGGGGGSSGGGGSCTTCEEEEEEECTTSSEEEEEEECCSSCEEETTE
T ss_pred CCCCEEeeeCCCCCeEecCCccccccccceEecceEEEEEecccCCCCEEEEECCCccCceECCE
Confidence 46789999999999999987655555566899999999886544444344567789999998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.0004 Score=58.75 Aligned_cols=130 Identities=14% Similarity=0.219 Sum_probs=72.1
Q ss_pred eEEEEEEEccCCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce--eeeee-----EEEcCCCCEEEEE
Q 022241 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI--VNLIE-----VIDDPNSDHFYMV 204 (300)
Q Consensus 132 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~-----~~~~~~~~~~~lv 204 (300)
-.||++... +|+.|++|+.+... .....+..|...+..|....+ +..+. .+. .....+.+
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~----------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l 102 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPER----------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAV 102 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTT----------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCC----------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEE
Confidence 478877654 78889999875421 123557778888777653222 11111 111 23578889
Q ss_pred EEeeCCCcccccc-----------------------CCCCCCCHHH-------------------HHHHHHHHHHHHHHH
Q 022241 205 LEYVEGKWDNDGF-----------------------GQPGAIGESM-------------------ARKYLRDIVSGLMYL 242 (300)
Q Consensus 205 ~E~~~~~~l~~~~-----------------------~~~~~l~~~~-------------------~~~i~~qi~~~l~yL 242 (300)
+++++|......- .....++... ...+...+...++.+
T Consensus 103 ~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 182 (325)
T d1zyla1 103 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 182 (325)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874432100 0111122111 111111222233333
Q ss_pred Hh-------CCcEeCCCCCCCEEEccCCcEEEecccCceee
Q 022241 243 HG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276 (300)
Q Consensus 243 H~-------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 276 (300)
.. .++||+|+.|.|||++. + ..++||+-+...
T Consensus 183 ~~~~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g 221 (325)
T d1zyla1 183 TAHWREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARNG 221 (325)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCEE
T ss_pred HHhccccCCceeecCCCCcccEEEeC-C-ceEEechhcccC
Confidence 21 35899999999999974 4 458999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.0014 Score=56.85 Aligned_cols=74 Identities=18% Similarity=0.290 Sum_probs=47.6
Q ss_pred eeeecCCCceEEEEEEEcc-------CCceEEEEEeecccccccccCCChHHHHHHHHHHHHHHHCCCCce-eeeeeEEE
Q 022241 123 VRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVID 194 (300)
Q Consensus 123 ~~~iG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~ 194 (300)
++.|+.|-.=.+|++.... ..+.|.+++.-. ... .....+|..+++.+.-.++ .++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----------~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----------PET-ESHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----------CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----------cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 4678888888899887653 245677776531 111 2245678888887753344 47777763
Q ss_pred cCCCCEEEEEEEeeCCCcc
Q 022241 195 DPNSDHFYMVLEYVEGKWD 213 (300)
Q Consensus 195 ~~~~~~~~lv~E~~~~~~l 213 (300)
+ .+||||++|..+
T Consensus 116 ~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G------GRLEEYIPSRPL 128 (395)
T ss_dssp T------EEEECCCCEEEC
T ss_pred C------ceEEEEeccccC
Confidence 2 579999987543
|
| >d1lgpa_ b.26.1.2 (A:) Cell cycle checkpoint protein Chfr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Cell cycle checkpoint protein Chfr species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.11 E-value=0.0036 Score=44.02 Aligned_cols=55 Identities=22% Similarity=0.219 Sum_probs=39.2
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADG 68 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~~~ 68 (300)
+++|++||+..|++++... ..+|..|+.|..+.. ...-..+|.|.||+..|..-.
T Consensus 23 ~~~~~iGR~~~~di~l~d~--------~~iSr~Ha~I~~~~~---~~~~~~~d~S~nGT~vNg~~i 77 (113)
T d1lgpa_ 23 KREWTIGRRRGCDLSFPSN--------KLVSGDHCRIVVDEK---SGQVTLEDTSTSGTVINKLKV 77 (113)
T ss_dssp SSEEEEESSTTSSEECTTC--------TTSCTTCEEEEECTT---TCCEEEEECSSSCCCCCCCCC
T ss_pred CCCEeeCCCCCCCeEecCC--------CCcChHHeEEEEccc---eeeEEecCCCceeeEECCEEc
Confidence 5689999999999998532 168999999975421 112234567999999887543
|
| >d1dmza_ b.26.1.2 (A:) Phosphotyrosine binding domain of Rad53 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Phosphotyrosine binding domain of Rad53 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.09 E-value=0.003 Score=47.26 Aligned_cols=55 Identities=11% Similarity=-0.113 Sum_probs=39.3
Q ss_pred ccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCC----------CCCCCCCCCCCCCCCCCCC
Q 022241 4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDD----------IDDDDDDNSYNGEATNTAD 67 (300)
Q Consensus 4 ~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~----------~~~~~~d~s~~~~~~~~~~ 67 (300)
..|++||+..|++++..+ .+|..|+.|.++...... ......|.|.||+..|...
T Consensus 27 ~~~~iGR~~~~d~~i~~~---------~vS~~H~~I~~~~~~~~~~~~~~~~~~~~~~~l~D~S~NGt~vN~~~ 91 (158)
T d1dmza_ 27 NPFFIGRSEDCNCKIEDN---------RLSRVHCFIFKKRHAVGKSMYESPAQGLDDIWYCHTGTNVSYLNNNR 91 (158)
T ss_dssp SCEEEESSTTSSEECCCT---------TSCSSSEEEEEEECCCCCCCSSCSCSSCEEEEEEECSTTCCEETTEE
T ss_pred CcEEecCCcCccEEECCC---------cccCcceEEEEeccccccccccccccCCCcEEEEecCCCCeEECCEE
Confidence 469999999999999876 899999999875321110 0112246788999988753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.95 E-value=0.004 Score=51.82 Aligned_cols=31 Identities=23% Similarity=0.294 Sum_probs=27.5
Q ss_pred CCcEeCCCCCCCEEEccCCcEEEecccCcee
Q 022241 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275 (300)
Q Consensus 245 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 275 (300)
.|+||+|+.+.||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4699999999999999877778999999865
|
| >d1g6ga_ b.26.1.2 (A:) Phosphotyrosine binding domain of Rad53 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Phosphotyrosine binding domain of Rad53 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.41 E-value=0.0036 Score=45.04 Aligned_cols=51 Identities=22% Similarity=0.202 Sum_probs=37.7
Q ss_pred cccchhhhcccccccccc-cccccCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGF-TRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~-~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d~s~~~~~~~~~ 66 (300)
++.|++||+..|++++.. + .+|..|++|+.+- +..-..++.|.||+..|..
T Consensus 35 ~~~~~iGR~~~~d~~l~d~~---------~VSr~Ha~i~~~~----~~~~~~d~~S~NGT~vNg~ 86 (127)
T d1g6ga_ 35 KKVWTFGRNPACDYHLGNIS---------RLSNKHFQILLGE----DGNLLLNDISTNGTWLNGQ 86 (127)
T ss_dssp CEEEEEESSTTSSEECCSCT---------TSCSSCEEEEECT----TSCEEEEECCSSCCEETTE
T ss_pred CccEEEccCcccCccCCCcc---------hhhHHHHHeeecc----cEEEEEECCCcceeEECCE
Confidence 478999999999999864 4 5899999996541 1112345678999998764
|
| >d2ff4a3 b.26.1.2 (A:284-382) Probable regulatory protein EmbR, C-terminal domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Probable regulatory protein EmbR, C-terminal domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=92.75 E-value=0.011 Score=40.31 Aligned_cols=49 Identities=12% Similarity=-0.041 Sum_probs=35.9
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNT 65 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~ 65 (300)
...+++||+..|++++..+ .+|..|..|..+ +..-..+| .|.||+..|.
T Consensus 22 ~~~~~IGR~~~~di~l~d~---------~VSr~Ha~i~~~-----~~~~~i~Dl~S~nGt~vNg 71 (99)
T d2ff4a3 22 AAATRIGRLHDNDIVLDSA---------NVSRHHAVIVDT-----GTNYVINDLRSSNGVHVQH 71 (99)
T ss_dssp SSEEEEESSTTSSEECCCT---------TSCTTCEEEEEC-----SSCEEEEECSCSSCCEETT
T ss_pred CCCEEEeeCcCCCEEECCc---------cccceeEEEEEe-----CCEEEEEECCCcCCCeECC
Confidence 4678999999999999876 789999999643 11123344 5778888765
|
| >d1uhta_ b.26.1.2 (A:) FHA domain containing protein At4G14490 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: FHA domain containing protein At4G14490 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=87.89 E-value=0.061 Score=37.66 Aligned_cols=49 Identities=24% Similarity=0.075 Sum_probs=35.4
Q ss_pred ccchhhhc-ccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 4 KTCSWIRD-MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 4 ~~~~~~r~-~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
+++++||+ ..|++++..+ .+|..|.+|..+ +..-..+| .|.||+..|..
T Consensus 33 ~~~~iGR~~~~~di~l~d~---------~VSr~Ha~i~~~-----~~~~~i~Dl~S~nGT~vng~ 83 (118)
T d1uhta_ 33 STIRVGRIVRGNEIAIKDA---------GISTKHLRIESD-----SGNWVIQDLGSSNGTLLNSN 83 (118)
T ss_dssp CCEEEESSSTTCSEECCSS---------SSCTTCEEEEEC-----SSSEEEECCCCSSCCEESSS
T ss_pred CEEEECCCCcCCeEEeCcc---------CcchheeEEEEE-----CCEEEEEECCCcceeEECCE
Confidence 46899997 5899999865 789999999654 11123344 58888888663
|
| >d2affa1 b.26.1.2 (A:3-100) Antigen ki-67 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Antigen ki-67 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.99 E-value=0.099 Score=35.11 Aligned_cols=32 Identities=16% Similarity=0.259 Sum_probs=26.8
Q ss_pred CcccchhhhcccccccccccccccCCCCCCCCCCCCccccc
Q 022241 2 FRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRD 42 (300)
Q Consensus 2 ~~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 42 (300)
....+++||+..|++++..+ .+|..|.+|..+
T Consensus 21 ~~~~~~IGr~~~~di~l~~~---------~is~~Ha~i~~~ 52 (98)
T d2affa1 21 SLSTCLFGRGIECDIRIQLP---------VVSKQHCKIEIH 52 (98)
T ss_dssp CSSEEEEESSTTSSEEECCT---------TSCSSBEEEEEC
T ss_pred CCCCEEEeeCCCCCEEeCCC---------CcCceeEEEEEe
Confidence 45789999999999999866 688899999654
|
| >d2piea1 b.26.1.2 (A:13-139) Ubiquitin ligase protein RNF8 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SMAD/FHA domain superfamily: SMAD/FHA domain family: FHA domain domain: Ubiquitin ligase protein RNF8 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.10 E-value=0.15 Score=36.12 Aligned_cols=55 Identities=16% Similarity=-0.044 Sum_probs=38.1
Q ss_pred cccchhhhcccccccccccccccCCCCCCCCCCCCccccccccCCCCCCCCCC-CCCCCCCCCCC
Q 022241 3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDD-NSYNGEATNTA 66 (300)
Q Consensus 3 ~~~~~~~r~~~c~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~d-~s~~~~~~~~~ 66 (300)
.+++++||...|.+.+..+... ..+|..|++|..+. +..-...| .|.||+..|..
T Consensus 23 ~~~~tiGR~~~~~~~l~~~~~~-----~~VSR~Ha~i~~~~----~g~~~l~D~~S~NGt~lNg~ 78 (127)
T d2piea1 23 GCEVTVGRGFGVTYQLVSKICP-----LMISRNHCVLKQNP----EGQWTIMDNKSLNGVWLNRA 78 (127)
T ss_dssp TCCEEEESSSSSSEECCCSSCT-----TSSCSSCEEEEECT----TSCEEEEECSCSSCEEETTE
T ss_pred CCEEEeccCCCccEEECCCCcc-----cccchhheEEEECC----CCeEEEEECCCcCCeEECCE
Confidence 3678999999999999876221 25899999996431 11123445 58899888764
|